data_2kd2_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kd2 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 68.3 p . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.836 0.35 . . . . 72.310000000000002 111.143 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -159.65 127.98 4.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.23 -0.441 . . . . 62.32 111.134 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.3 m -106.17 152.79 23.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 61.539999999999999 110.863 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 7.9 m -140.66 154.79 46.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.147 -0.479 . . . . 74.319999999999993 111.172 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 14.0 m-90 -151.12 131.54 13.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.231 -0.44 . . . . 73.109999999999999 110.915 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.2 t -113.03 114.61 47.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 64.430000000000007 111.115 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -139.36 145.95 39.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 74.430000000000007 110.888 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 17.2 ttt180 -74.0 93.39 2.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 63.219999999999999 110.827 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -126.27 152.95 45.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.187 -0.46 . . . . 73.019999999999996 110.911 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 3.1 t70 64.51 15.32 9.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 64.400000000000006 110.894 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.23 1.55 84.04 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.734 -0.746 . . . . 53.329999999999998 112.467 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -139.83 173.07 11.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.876 0.37 . . . . 75.219999999999999 110.899 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -69.63 87.97 0.5 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.146 -0.479 . . . . 64.109999999999999 110.876 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -70.39 126.7 30.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 75.230000000000004 110.913 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 12.3 ttt180 -108.14 116.72 32.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 75.239999999999995 110.865 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.6 139.96 30.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 73.349999999999994 111.128 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 47.3 t -135.66 139.36 46.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 72.519999999999996 111.109 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.9 tp -114.75 99.87 7.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 75.420000000000002 110.93 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.22 134.24 42.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.441 . . . . 75.439999999999998 110.88 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.7 mmmt -73.81 -17.63 61.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.13 -0.486 . . . . 75.120000000000005 110.907 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -51.27 -52.75 42.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 65.019999999999996 110.886 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 17.0 p -134.92 16.98 3.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 71.430000000000007 111.204 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 53.13 28.66 7.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 75.430000000000007 110.92 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.62 159.67 19.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 63.549999999999997 110.914 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 85.8 t -104.93 134.09 47.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 73.319999999999993 111.121 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 4.1 t90 -115.94 120.24 38.53 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.154 -0.475 . . . . 70.420000000000002 110.933 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 11.3 t -136.6 132.05 34.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.242 -0.436 . . . . 74.329999999999998 110.857 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 50.51 48.03 23.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.197 -0.456 . . . . 75.140000000000001 110.851 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 49.45 47.88 35.27 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.785 -0.722 . . . . 54.119999999999997 112.508 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.18 113.85 4.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.835 0.35 . . . . 74.319999999999993 110.88 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 2.5 ttpm? -53.71 101.72 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 75.230000000000004 110.897 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 25.1 mmm -60.97 169.92 1.76 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 75.219999999999999 110.897 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -119.17 106.96 12.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 74.239999999999995 110.906 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 24.4 p -95.6 -175.28 3.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 74.040000000000006 111.198 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -95.12 -39.47 10.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.259 -0.428 . . . . 75.140000000000001 111.124 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 69.53 40.03 78.69 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.727 -0.749 . . . . 72.439999999999998 112.466 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 . . . . . 0 C--N 1.329 -0.312 0 CA-C-O 120.858 0.361 . . . . 75.230000000000004 110.902 -179.876 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 N-CA-C 112.54 -0.224 . . . . 73.129999999999995 112.54 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.24 130.71 35.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.73 0.3 . . . . 75.329999999999998 111.186 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -106.35 96.36 6.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.259 -0.428 . . . . 75.420000000000002 110.867 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.06 110.26 15.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 74.420000000000002 111.153 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 77.1 m-70 -104.83 105.38 15.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.455 . . . . 74.409999999999997 110.87 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -126.13 132.92 51.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.471 . . . . 75.010000000000005 110.887 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 54.7 p -83.33 144.48 29.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 65.109999999999999 110.88 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.6 t -134.58 98.1 2.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 75.209999999999994 111.102 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 52.12 -119.29 8.71 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.674 -0.774 . . . . 75.420000000000002 112.537 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -100.4 28.25 5.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.851 0.358 . . . . 71.129999999999995 110.849 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 49.0 m-70 -130.87 165.67 22.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 73.129999999999995 110.868 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -124.35 88.9 2.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 74.409999999999997 110.866 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 9.8 m -98.49 172.76 7.31 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.207 -0.451 . . . . 63.229999999999997 110.903 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 55.5 p90 -175.22 145.6 0.79 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.196 -0.456 . . . . 75.25 110.937 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 23.2 mt -97.43 111.23 26.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.117 -0.492 . . . . 74.409999999999997 111.127 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -80.18 102.86 9.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 71.310000000000002 110.868 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -95.49 146.44 24.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 53.130000000000003 111.088 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.4 t -143.89 120.49 5.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.264 -0.425 . . . . 72.319999999999993 111.14 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.3 p -87.25 140.72 29.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 64.450000000000003 110.869 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 5.0 p -132.56 148.68 52.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.118 -0.492 . . . . 75.5 110.863 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 111.06 -162.93 12.32 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.792 -0.718 . . . . 63.229999999999997 112.479 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.47 -44.87 85.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.794 0.331 . . . . 75.430000000000007 110.906 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.23 -60.83 0.13 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 73.439999999999998 110.852 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 17.7 mtmt -137.18 37.72 2.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 74.329999999999998 110.86 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.25 -62.21 1.84 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.266 -0.424 . . . . 75.150000000000006 110.884 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -135.16 122.47 2.83 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.768 -0.73 . . . . 51.539999999999999 112.516 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 69.6 mt -110.77 144.85 17.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.846 0.355 . . . . 74.150000000000006 111.112 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 3.0 mt -129.84 127.97 64.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 74.209999999999994 111.173 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 13.0 m80 -105.01 136.51 44.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 74.319999999999993 110.857 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.61 106.1 8.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 64.519999999999996 111.092 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 30.4 tp -65.29 139.36 58.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.193 -0.458 . . . . 74.129999999999995 110.917 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 9.4 mt -137.43 129.97 42.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 74.430000000000007 111.118 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 99.5 t -125.49 115.43 43.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.47 . . . . 74.109999999999999 111.125 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 63.66 46.88 3.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.15 -0.477 . . . . 74.430000000000007 110.918 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 58.69 42.8 19.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.143 -0.481 . . . . 74.409999999999997 110.918 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.19 124.9 19.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 71.200000000000003 110.85 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -62.56 146.2 52.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 74.439999999999998 110.903 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -120.73 131.12 24.56 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.606 0.717 . . . . 63.43 111.135 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 134.4 27.9 Favored 'Trans proline' 0 N--CA 1.465 -0.161 0 C-N-CA 122.714 2.276 . . . . 73.400000000000006 112.348 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.234 -0.439 . . . . 61.439999999999998 110.913 -179.998 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 40.4 p . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.871 0.367 . . . . 73.450000000000003 111.161 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -159.52 128.33 5.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.193 -0.458 . . . . 71.010000000000005 111.091 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.9 m -105.8 152.79 22.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 74.319999999999993 110.844 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 56.1 m -147.52 137.42 22.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 74.140000000000001 111.15 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 16.7 m-90 -130.27 156.86 43.94 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.202 -0.453 . . . . 73.239999999999995 110.883 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 19.7 t -128.95 114.84 34.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.234 -0.439 . . . . 73.409999999999997 111.163 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.33 147.52 38.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.27 -0.423 . . . . 73.230000000000004 110.899 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.54 92.78 2.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 74.409999999999997 110.853 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.1 152.66 39.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 72.25 110.852 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 64.93 14.78 9.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.17 -0.468 . . . . 61.509999999999998 110.887 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.08 0.43 80.77 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.747 -0.739 . . . . 72.310000000000002 112.514 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -139.92 172.78 12.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.847 0.356 . . . . 73.319999999999993 110.873 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -68.29 89.44 0.33 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.158 -0.473 . . . . 61.32 110.836 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.36 127.27 32.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.221 -0.445 . . . . 74.340000000000003 110.937 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 12.2 ttp180 -106.08 116.01 31.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.135 -0.484 . . . . 73.310000000000002 110.897 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -101.83 141.98 17.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.248 -0.433 . . . . 75.450000000000003 111.081 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 96.9 t -135.93 126.47 42.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 64.120000000000005 111.168 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.5 tp -110.48 111.9 23.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.468 . . . . 75.349999999999994 110.871 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.26 135.25 33.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 71.420000000000002 110.888 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.16 -16.25 61.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.476 . . . . 73.129999999999995 110.885 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -51.74 -55.87 17.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 75.409999999999997 110.879 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.1 p -136.22 17.09 3.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.436 . . . . 74.400000000000006 111.122 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 69.0 mtp 58.16 29.33 17.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 72.120000000000005 110.947 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.64 146.05 34.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 74.120000000000005 110.909 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 98.4 t -105.0 123.51 59.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.235 -0.439 . . . . 75.030000000000001 111.154 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 2.3 t90 -105.27 131.59 52.54 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.178 -0.465 . . . . 73.340000000000003 110.943 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 1.2 m -128.3 103.3 7.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.258 -0.428 . . . . 75.209999999999994 110.883 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 24.2 m-20 45.56 70.54 0.35 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 71.340000000000003 110.886 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 48.6 40.16 24.3 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.748 -0.739 . . . . 70.219999999999999 112.438 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.04 107.23 4.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.903 0.383 . . . . 71.239999999999995 110.91 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 4.3 mttt -53.41 152.62 4.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 63.409999999999997 110.945 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 27.2 mmm -123.89 164.83 18.47 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.295 -0.411 . . . . 73.109999999999999 110.867 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -118.97 110.14 16.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 75.299999999999997 110.941 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 19.3 p -95.63 174.34 7.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 73.329999999999998 111.162 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -174.77 -169.59 0.43 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 72.219999999999999 111.116 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 118.63 -111.54 2.15 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.736 -0.745 . . . . 65.140000000000001 112.523 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 . . . . . 0 C--N 1.33 -0.277 0 CA-C-O 120.832 0.348 . . . . 75.129999999999995 110.931 -179.902 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.282 0 N-CA-C 112.472 -0.251 . . . . 72.010000000000005 112.472 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -134.8 130.76 36.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.727 0.299 . . . . 73.519999999999996 111.134 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -87.32 96.5 10.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 75.299999999999997 110.963 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.92 110.17 15.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 74.209999999999994 111.133 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -108.31 111.96 24.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 74.109999999999999 110.861 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -125.46 134.02 52.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 74.150000000000006 110.854 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 60.6 p -78.6 139.2 38.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.169 -0.469 . . . . 71.109999999999999 110.896 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.4 t -130.87 98.06 3.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 74.129999999999995 111.123 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 51.85 -124.24 23.15 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.669 -0.777 . . . . 54.140000000000001 112.502 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -95.89 25.23 4.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.813 0.34 . . . . 71.340000000000003 110.856 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 45.9 m-70 -121.64 -169.99 1.96 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 74.519999999999996 110.838 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -149.83 81.48 1.39 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 73.230000000000004 110.847 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 8.3 m -96.29 166.07 11.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.242 -0.435 . . . . 62.100000000000001 110.843 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -167.27 144.48 4.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 74.209999999999994 110.961 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 44.9 mt -99.5 111.21 28.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 72.420000000000002 111.139 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 5.0 tttp -80.56 103.11 10.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.153 -0.476 . . . . 74.140000000000001 110.851 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -95.23 143.07 26.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.462 . . . . 64.349999999999994 111.074 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.2 t -136.58 120.61 24.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 73.420000000000002 111.077 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.2 p -90.75 132.84 35.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 74.040000000000006 110.794 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 9.5 p -124.38 138.64 54.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.091 -0.504 . . . . 74.019999999999996 110.907 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 132.85 -104.05 0.53 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.71 -0.757 . . . . 71.530000000000001 112.471 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 12.3 ttmt -142.73 -46.14 0.32 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.785 0.326 . . . . 71.25 110.906 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 5.9 ttt180 -137.21 -45.83 0.56 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.216 -0.447 . . . . 75.340000000000003 110.869 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 11.6 tttt -167.83 55.64 0.07 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 75.540000000000006 110.955 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -82.43 -64.53 1.16 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 74.209999999999994 110.849 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -135.34 114.2 1.2 Allowed Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.685 -0.769 . . . . 70.120000000000005 112.441 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 76.2 mt -105.97 139.56 26.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.848 0.356 . . . . 74.519999999999996 111.121 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 72.0 mt -126.43 122.83 62.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.46 . . . . 75.150000000000006 111.131 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 18.1 m80 -96.66 137.8 35.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 73.200000000000003 110.881 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.79 104.26 7.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.21 -0.45 . . . . 74.329999999999998 111.138 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 15.9 tp -63.81 138.97 58.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.289 -0.414 . . . . 73.340000000000003 110.925 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 10.0 mt -137.76 120.75 20.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 73.140000000000001 111.089 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 89.5 t -121.32 130.83 74.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.095 -0.502 . . . . 73.349999999999994 111.089 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 58.79 36.91 24.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.12 -0.491 . . . . 75.439999999999998 110.832 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 2.6 t30 63.34 43.07 6.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 72.349999999999994 110.877 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.14 128.77 21.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 74.140000000000001 110.875 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -62.62 146.5 51.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 74.230000000000004 110.856 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -123.81 131.37 24.25 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.569 0.699 . . . . 73.140000000000001 111.097 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 135.18 29.81 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.7 2.266 . . . . 63.200000000000003 112.334 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 74.5 110.91 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.187 0 CA-C-O 120.866 0.365 . . . . 73.230000000000004 111.099 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -159.56 127.89 5.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 75.310000000000002 111.197 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.7 m -106.22 155.04 19.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.241 -0.436 . . . . 72.319999999999993 110.894 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 72.3 p -144.88 155.08 43.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 73.319999999999993 111.177 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 15.3 m-90 -151.35 133.54 15.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.242 -0.435 . . . . 74.25 110.928 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.3 t -112.95 114.84 48.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.283 -0.417 . . . . 71.109999999999999 111.055 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -139.73 145.87 38.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 73.400000000000006 110.914 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -74.62 92.99 2.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 73.329999999999998 110.851 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -124.9 153.73 42.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.471 . . . . 75.519999999999996 110.987 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.7 t70 64.5 15.42 9.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.271 -0.422 . . . . 73.400000000000006 110.805 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.69 1.31 83.12 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.768 -0.729 . . . . 74.239999999999995 112.502 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -139.92 173.03 11.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.779 0.323 . . . . 75.099999999999994 110.884 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -69.74 87.85 0.52 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.161 -0.472 . . . . 73.519999999999996 110.884 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.52 127.43 32.7 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.258 -0.428 . . . . 74.329999999999998 110.93 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 8.8 ttm180 -107.87 115.29 29.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.185 -0.461 . . . . 75.450000000000003 110.83 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -106.67 137.64 36.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.12 -0.491 . . . . 75.319999999999993 111.081 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 90.1 t -135.76 128.56 47.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.187 -0.461 . . . . 74.340000000000003 111.182 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.5 tp -110.2 103.46 12.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.476 . . . . 75.120000000000005 110.96 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.24 134.95 37.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.232 -0.44 . . . . 75.450000000000003 110.863 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 9.2 mmmt -73.13 -17.2 61.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.126 -0.488 . . . . 73.109999999999999 110.889 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -51.6 -55.18 20.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 71.129999999999995 110.838 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.45 16.97 4.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 74.129999999999995 111.105 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 4.0 ttm 53.54 32.36 14.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.232 -0.44 . . . . 73.409999999999997 110.848 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.99 155.03 20.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.289 -0.414 . . . . 61.140000000000001 110.863 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 99.6 t -104.83 130.18 56.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 70.140000000000001 111.172 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 7.7 t-105 -112.7 122.88 48.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.089 -0.505 . . . . 75.030000000000001 110.872 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 24.6 t -128.48 131.78 48.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.134 -0.485 . . . . 75.129999999999995 110.805 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 27.3 m-20 50.08 54.63 10.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 73.230000000000004 110.862 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 49.82 37.42 28.25 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.754 -0.736 . . . . 64.540000000000006 112.483 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -143.38 165.77 26.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.868 0.366 . . . . 70.030000000000001 110.916 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -85.93 157.92 20.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 74.200000000000003 110.88 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 35.2 mmm -124.76 166.98 15.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 73.430000000000007 110.88 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -119.23 106.59 12.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 71.140000000000001 110.853 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 19.2 p -95.91 -175.26 3.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 73.129999999999995 111.113 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -104.61 -29.54 10.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 72.109999999999999 111.107 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 61.98 39.92 98.2 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.733 -0.746 . . . . 55.130000000000003 112.452 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 49.5 tt0 . . . . . 0 C--N 1.329 -0.287 0 CA-C-O 120.865 0.364 . . . . 73.400000000000006 110.898 -179.868 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 N-CA-C 112.549 -0.22 . . . . 74.140000000000001 112.549 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.25 130.8 35.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.762 0.315 . . . . 72.319999999999993 111.145 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -108.18 103.62 12.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.481 . . . . 73.430000000000007 110.982 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.13 110.35 17.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.211 -0.45 . . . . 75.340000000000003 111.14 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 68.4 m-70 -105.37 105.26 15.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 73.25 110.784 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 18.2 p90 -123.85 134.56 53.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 74.109999999999999 110.913 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 3.3 p -77.8 139.51 39.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 61.530000000000001 110.867 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.6 t -133.48 106.3 9.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 62.439999999999998 111.092 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 53.31 -116.35 5.65 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.741 -0.742 . . . . 73.030000000000001 112.435 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -110.25 26.22 10.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.795 0.331 . . . . 74.040000000000006 110.872 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 24.6 m-70 -124.1 -169.81 2.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 71.200000000000003 110.86 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -140.85 81.69 1.81 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 71.209999999999994 110.902 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 11.1 m -91.62 157.43 16.98 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.24 -0.436 . . . . 74.25 110.917 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 39.3 p90 -159.83 143.33 14.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 74.510000000000005 110.882 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 35.5 mt -97.54 111.67 27.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.126 -0.488 . . . . 72.209999999999994 111.064 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 33.2 ttmt -80.04 102.87 9.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.475 . . . . 75.400000000000006 110.968 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -95.02 142.21 27.77 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.176 -0.465 . . . . 73.25 111.137 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.3 t -138.8 124.58 23.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.254 -0.43 . . . . 75.439999999999998 111.138 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.4 p -95.81 133.14 40.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 53.240000000000002 110.932 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -133.68 133.21 41.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.151 -0.477 . . . . 65.319999999999993 110.891 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 112.01 -176.33 17.95 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.754 -0.736 . . . . 72.129999999999995 112.428 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.84 130.55 35.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.849 0.357 . . . . 74.430000000000007 110.916 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 20.5 mmt180 54.31 43.06 31.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 74.450000000000003 110.874 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 3.0 mttt 55.51 48.06 19.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.136 -0.484 . . . . 75.409999999999997 110.911 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -52.17 -68.42 0.17 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 64.219999999999999 110.889 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -110.86 125.43 7.39 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.768 -0.73 . . . . 63.520000000000003 112.526 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 64.7 mt -114.81 143.98 23.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.824 0.345 . . . . 73.510000000000005 111.085 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 64.4 mt -132.18 127.35 57.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 74.510000000000005 111.102 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 12.7 m80 -102.81 140.07 37.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.161 -0.472 . . . . 73.329999999999998 110.893 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.37 106.44 8.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.163 -0.471 . . . . 74.319999999999993 111.166 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 30.7 tp -66.8 136.61 55.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 72.0 110.964 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 10.2 mt -137.78 129.78 40.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.446 . . . . 74.349999999999994 111.12 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 57.6 t -126.46 117.78 49.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 65.439999999999998 111.164 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.9 t0 63.69 41.81 6.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.178 -0.464 . . . . 40.200000000000003 110.834 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 62.5 42.92 8.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 74.340000000000003 110.861 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -138.32 124.5 20.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.179 -0.464 . . . . 72.439999999999998 110.892 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -62.59 145.92 53.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.2 -0.455 . . . . 54.310000000000002 110.86 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -121.02 131.16 24.56 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.623 0.725 . . . . 74.030000000000001 111.123 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 134.44 28.0 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.689 2.259 . . . . 73.219999999999999 112.356 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.24 -0.436 . . . . 75.310000000000002 110.874 -179.993 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 13.5 p . . . . . 0 C--O 1.233 0.195 0 CA-C-O 120.883 0.373 . . . . 74.319999999999993 111.179 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.1 p -159.36 128.07 5.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 71.430000000000007 111.159 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -105.97 149.63 26.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.26 -0.427 . . . . 73.510000000000005 110.912 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 92.3 m -137.88 138.47 39.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 73.310000000000002 111.133 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 12.0 m-90 -133.36 123.27 25.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.204 -0.453 . . . . 73.549999999999997 110.969 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 18.7 t -103.63 115.01 44.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 73.409999999999997 111.122 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.25 146.0 36.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 74.219999999999999 110.888 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 56.4 mtm-85 -76.34 93.75 3.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 74.019999999999996 110.862 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -125.73 155.43 40.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 74.430000000000007 110.844 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.3 t0 64.7 15.06 9.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 75.129999999999995 110.891 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 88.17 0.91 82.43 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.756 -0.735 . . . . 75.239999999999995 112.561 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -139.93 172.98 11.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.862 0.363 . . . . 74.329999999999998 110.887 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -70.33 88.16 0.63 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.142 -0.481 . . . . 71.409999999999997 110.875 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.36 123.6 22.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.202 -0.454 . . . . 75.530000000000001 110.875 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 4.9 ttp180 -101.94 109.38 21.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.107 -0.497 . . . . 74.010000000000005 110.804 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.2 t -95.6 134.55 32.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.452 . . . . 74.230000000000004 111.126 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 76.4 t -137.25 125.31 32.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 62.210000000000001 111.083 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.0 tp -110.35 106.8 16.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 72.120000000000005 110.883 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.83 136.46 34.63 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.142 -0.481 . . . . 73.510000000000005 110.887 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.9 mmmt -73.77 -16.51 61.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 73.319999999999993 110.853 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -51.41 -54.21 28.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.466 . . . . 74.099999999999994 110.89 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.86 17.03 3.05 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.191 -0.459 . . . . 73.230000000000004 111.179 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 81.6 mtp 56.77 26.26 11.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 65.329999999999998 110.895 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.55 151.71 32.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.273 -0.421 . . . . 73.140000000000001 110.862 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 70.6 t -105.04 133.5 49.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.171 -0.468 . . . . 70.109999999999999 111.074 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 6.6 t-105 -117.64 123.77 46.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.2 -0.454 . . . . 75.129999999999995 110.891 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 17.9 m -131.18 132.19 44.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.216 -0.447 . . . . 65.129999999999995 110.934 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 40.9 m-20 50.99 53.83 12.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.125 -0.489 . . . . 75.209999999999994 110.93 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 49.09 39.64 27.09 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.765 -0.731 . . . . 74.109999999999999 112.436 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.02 154.81 41.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.848 0.356 . . . . 74.200000000000003 110.907 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 15.8 ttpt -75.67 159.5 31.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 75.120000000000005 110.855 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 38.8 mmm -125.51 166.12 17.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.239 -0.437 . . . . 53.549999999999997 110.879 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -119.25 106.53 12.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.269 -0.423 . . . . 75.209999999999994 110.877 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 17.6 p -95.53 -175.29 3.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 73.400000000000006 111.175 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -107.49 -28.77 9.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.476 . . . . 73.439999999999998 111.102 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 55.64 53.59 40.48 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.78 -0.724 . . . . 71.420000000000002 112.514 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.325 0 CA-C-O 120.887 0.375 . . . . 75.420000000000002 110.897 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 112.512 -0.235 . . . . 62.130000000000003 112.512 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.37 130.83 35.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.706 0.289 . . . . 64.430000000000007 111.176 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -108.6 96.6 6.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 74.019999999999996 110.889 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.67 110.47 16.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.173 -0.467 . . . . 71.409999999999997 111.151 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 -105.22 106.61 17.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 73.25 110.805 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 17.8 p90 -124.02 129.54 51.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 74.010000000000005 110.906 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 90.9 p -79.58 156.98 27.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 65.030000000000001 110.88 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 86.6 t -149.62 98.49 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 70.420000000000002 111.118 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 57.01 -106.63 0.75 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.767 -0.73 . . . . 62.329999999999998 112.486 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 21.5 t30 -116.9 24.56 11.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.896 0.379 . . . . 75.219999999999999 110.911 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 66.0 m-70 -117.25 -175.3 2.77 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.13 -0.486 . . . . 74.430000000000007 110.815 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -143.73 78.56 1.6 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 75.340000000000003 110.878 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 12.0 m -93.49 158.89 15.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.146 -0.479 . . . . 75.319999999999993 110.916 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -161.75 144.15 11.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.445 . . . . 75.310000000000002 110.935 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 22.7 mt -97.46 111.2 26.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.169 -0.469 . . . . 73.099999999999994 111.149 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 61.6 tttt -80.1 102.79 9.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.455 . . . . 75.219999999999999 110.897 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -93.65 143.51 26.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.283 -0.417 . . . . 54.100000000000001 111.08 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.3 t -139.89 119.64 13.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 64.230000000000004 111.093 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.2 p -89.04 148.42 23.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.121 -0.49 . . . . 72.319999999999993 110.883 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.55 140.11 24.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.47 . . . . 73.340000000000003 110.906 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 132.47 -152.23 20.17 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.79 -0.719 . . . . 55.210000000000001 112.493 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 9.3 mttp -79.04 -29.84 43.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.77 0.319 . . . . 74.400000000000006 110.921 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 21.0 ptt-85 -169.16 -41.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 72.209999999999994 110.849 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 3.0 ttmm -157.06 30.41 0.3 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 75.230000000000004 110.893 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -56.81 -61.98 2.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 75.209999999999994 110.892 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -136.11 157.91 23.67 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.716 -0.754 . . . . 74.519999999999996 112.48 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 57.5 mt -141.19 146.42 23.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.725 0.298 . . . . 75.430000000000007 111.188 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 2.9 mt -133.01 124.36 49.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.188 -0.46 . . . . 74.239999999999995 111.169 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 12.1 m80 -103.44 138.34 40.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 73.219999999999999 110.845 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.63 109.28 10.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.162 -0.472 . . . . 75.340000000000003 111.132 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 21.0 tp -67.45 137.6 56.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.224 -0.444 . . . . 73.040000000000006 110.884 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 9.6 mt -138.32 129.64 37.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 73.319999999999993 111.147 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 58.4 t -125.68 122.77 63.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 75.409999999999997 111.12 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 58.84 41.29 21.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 74.109999999999999 110.859 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 63.22 43.09 6.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.248 -0.433 . . . . 71.439999999999998 110.888 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 15.4 mtp180 -138.52 125.3 21.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.166 -0.47 . . . . 73.450000000000003 110.865 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -62.36 146.54 50.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 62.229999999999997 110.901 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -123.06 131.01 24.38 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.576 0.703 . . . . 74.219999999999999 111.156 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.72 137.57 35.91 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.611 2.207 . . . . 72.129999999999995 112.404 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.44 . . . . 53.229999999999997 110.834 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 50.6 p . . . . . 0 N--CA 1.457 -0.12 0 CA-C-O 120.897 0.379 . . . . 73.239999999999995 111.169 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -159.51 127.99 5.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 74.319999999999993 111.136 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.3 m -106.05 149.64 26.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 72.109999999999999 110.894 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 90.1 m -136.98 137.15 39.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.139 -0.482 . . . . 75.519999999999996 111.095 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 9.9 m-90 -132.98 122.81 24.79 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.126 -0.488 . . . . 75.439999999999998 110.891 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 20.0 t -102.7 114.89 43.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.247 -0.433 . . . . 73.430000000000007 111.181 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -142.56 147.3 35.7 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.257 -0.429 . . . . 73.420000000000002 110.927 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 5.6 mtt180 -74.63 92.23 2.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 72.219999999999999 110.864 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.95 153.94 37.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 73.450000000000003 110.908 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 65.17 14.37 9.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 72.209999999999994 110.91 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.99 -0.39 78.99 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.735 -0.745 . . . . 70.329999999999998 112.48 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -139.92 172.89 12.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.797 0.332 . . . . 60.119999999999997 110.919 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -68.36 88.42 0.32 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.155 -0.475 . . . . 72.519999999999996 110.841 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.65 125.94 29.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.236 -0.438 . . . . 65.049999999999997 110.937 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 29.5 ttt180 -102.36 110.9 22.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.191 -0.459 . . . . 75.140000000000001 110.85 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.5 t -95.12 136.43 26.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 72.329999999999998 111.168 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 96.8 t -136.99 127.04 39.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.258 -0.428 . . . . 65.340000000000003 111.137 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.1 tp -110.32 104.44 13.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 72.200000000000003 110.847 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.14 136.42 35.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.113 -0.494 . . . . 75.299999999999997 110.949 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 3.6 mmmt -73.73 -16.74 61.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 74.030000000000001 110.936 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -51.38 -53.0 40.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.232 -0.44 . . . . 72.150000000000006 110.854 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.38 17.04 2.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 74.109999999999999 111.151 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 2.4 ttp 55.55 26.29 8.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.234 -0.439 . . . . 74.140000000000001 110.889 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -80.65 154.54 27.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 61.420000000000002 110.871 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 53.5 t -105.16 134.8 45.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.469 . . . . 72.209999999999994 111.156 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 6.0 t-105 -119.41 126.54 51.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.156 -0.475 . . . . 73.120000000000005 110.826 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 64.4 m -132.93 131.9 41.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 75.409999999999997 110.838 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 43.5 m-20 49.85 54.39 11.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 64.109999999999999 110.837 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 48.55 40.53 24.48 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.797 -0.716 . . . . 64.409999999999997 112.481 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.94 147.7 28.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.873 0.368 . . . . 75.430000000000007 110.893 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 13.1 tttp -68.04 159.91 29.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.258 -0.428 . . . . 75.030000000000001 110.918 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 41.0 mmm -124.55 164.31 20.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.212 -0.449 . . . . 75.409999999999997 110.897 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -119.3 106.29 12.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 63.020000000000003 110.86 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 21.3 p -95.96 -175.05 3.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.112 -0.494 . . . . 65.019999999999996 111.111 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -100.22 -32.2 11.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 74.420000000000002 111.125 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 59.99 96.4 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.709 -0.757 . . . . 73.140000000000001 112.519 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 . . . . . 0 C--N 1.329 -0.296 0 CA-C-O 120.909 0.385 . . . . 70.319999999999993 110.91 -179.855 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 N-CA-C 112.481 -0.248 . . . . 63.340000000000003 112.481 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -136.1 130.79 33.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.733 0.301 . . . . 72.129999999999995 111.146 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -104.13 96.29 6.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.234 -0.439 . . . . 71.310000000000002 110.923 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.98 109.73 19.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.173 -0.467 . . . . 62.520000000000003 111.177 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 70.3 m-70 -102.68 106.84 17.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.24 -0.436 . . . . 75.349999999999994 110.836 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -121.9 123.02 40.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.148 -0.478 . . . . 73.310000000000002 110.903 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.03 153.78 22.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 62.32 110.85 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 47.0 t -147.19 106.7 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 74.129999999999995 111.096 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 56.59 -110.14 1.94 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.733 -0.746 . . . . 74.400000000000006 112.529 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 29.4 m120 -117.38 25.68 10.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.871 0.367 . . . . 75.230000000000004 110.88 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 24.4 m-70 -123.26 163.57 20.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 73.109999999999999 110.891 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -122.23 122.07 38.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 74.450000000000003 110.914 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 1.2 p -141.48 146.95 37.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.448 . . . . 72.530000000000001 110.887 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 26.0 p90 -149.79 147.61 28.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.471 . . . . 73.239999999999995 110.937 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 12.0 mt -97.97 111.74 28.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.136 -0.484 . . . . 72.219999999999999 111.129 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 62.1 tttt -82.52 102.71 11.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 74.049999999999997 110.907 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -95.89 146.05 24.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 64.25 111.127 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.5 t -145.32 116.86 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.273 -0.421 . . . . 75.219999999999999 111.09 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 14.7 p -89.53 147.41 23.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 51.219999999999999 110.853 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 30.6 p -145.88 152.59 39.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.076 -0.511 . . . . 70.140000000000001 110.88 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 112.98 179.29 19.47 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.785 -0.721 . . . . 71.099999999999994 112.501 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.58 -64.0 1.11 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.725 0.298 . . . . 70.329999999999998 110.891 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 11.3 ttm-85 -133.39 83.78 2.08 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.265 -0.425 . . . . 74.230000000000004 110.897 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 13.6 mtmt 52.59 44.52 29.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 74.25 110.83 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -66.63 -49.18 67.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 73.099999999999994 110.871 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -144.96 132.02 4.53 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.774 -0.727 . . . . 51.340000000000003 112.524 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 50.8 mt -119.37 146.88 23.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.826 0.346 . . . . 74.140000000000001 111.129 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 58.9 mt -132.45 126.89 56.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 74.549999999999997 111.159 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 8.5 m80 -109.63 135.34 50.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.258 -0.428 . . . . 74.510000000000005 110.893 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.26 116.91 22.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 73.0 111.191 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 17.7 tp -72.85 133.52 44.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 75.209999999999994 110.944 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 10.9 mt -136.3 118.16 20.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 73.219999999999999 111.07 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 14.6 t -120.54 127.06 75.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.435 . . . . 74.439999999999998 111.133 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 63.6 36.64 10.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.213 -0.449 . . . . 72.209999999999994 110.853 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 62.84 43.04 7.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 74.530000000000001 110.927 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 20.4 mtt180 -142.14 128.12 19.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.112 -0.494 . . . . 75.409999999999997 110.862 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -62.48 146.47 51.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.199 -0.455 . . . . 73.319999999999993 110.916 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -121.85 131.29 24.46 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.685 0.755 . . . . 75.420000000000002 111.126 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 137.93 36.53 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.638 2.225 . . . . 73.340000000000003 112.351 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.465 . . . . 73.209999999999994 110.904 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 82.3 p . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.876 0.37 . . . . 74.420000000000002 111.094 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.1 p -159.47 128.1 5.12 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.214 -0.448 . . . . 74.340000000000003 111.093 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.03 152.2 23.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.196 -0.456 . . . . 71.040000000000006 110.897 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -139.17 156.76 46.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.126 -0.488 . . . . 75.140000000000001 111.125 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 12.6 m-90 -151.62 127.28 10.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.23 -0.441 . . . . 73.329999999999998 111.004 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 18.8 t -105.63 115.21 46.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.236 -0.438 . . . . 72.319999999999993 111.156 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.67 147.36 37.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.199 -0.455 . . . . 75.319999999999993 110.958 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 61.4 mtt180 -72.93 91.7 1.56 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 75.120000000000005 110.955 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -121.64 152.01 39.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 74.310000000000002 110.898 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 15.2 t0 65.09 14.51 9.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.144 -0.48 . . . . 63.119999999999997 110.854 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.7 0.12 79.17 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.773 -0.727 . . . . 65.420000000000002 112.498 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -139.94 172.73 12.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.843 0.354 . . . . 70.25 110.889 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -68.54 89.49 0.36 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.137 -0.483 . . . . 62.119999999999997 110.884 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.21 130.63 38.49 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.126 -0.488 . . . . 73.329999999999998 110.951 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 6.1 ttp180 -106.4 113.84 27.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 73.019999999999996 110.882 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 1.7 t -95.52 139.43 18.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 73.25 111.093 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 92.0 t -136.46 124.95 36.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.473 . . . . 72.340000000000003 111.125 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.4 tp -111.16 105.45 14.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 73.200000000000003 110.943 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.19 134.85 36.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 75.439999999999998 110.884 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 3.9 mmmt -73.87 -16.72 61.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.074 -0.512 . . . . 75.329999999999998 110.849 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -51.45 -55.97 15.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.228 -0.442 . . . . 63.109999999999999 110.857 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.34 17.1 3.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 74.109999999999999 111.133 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER 61.95 18.11 9.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.44 . . . . 73.120000000000005 110.921 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.77 139.23 58.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.186 -0.461 . . . . 72.129999999999995 110.843 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 96.0 t -105.0 118.12 51.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.111 -0.495 . . . . 75.310000000000002 111.153 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -100.6 129.05 46.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 75.030000000000001 110.898 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -123.76 103.37 8.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 72.040000000000006 110.87 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 45.44 69.97 0.4 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 74.239999999999995 110.905 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 49.09 38.73 25.53 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.698 -0.763 . . . . 71.030000000000001 112.505 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -146.38 114.04 6.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.812 0.339 . . . . 74.010000000000005 110.877 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -53.39 160.38 1.19 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.249 -0.432 . . . . 70.209999999999994 110.856 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 30.2 mmm -126.82 163.62 23.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 74.409999999999997 110.875 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -118.79 106.44 12.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.239 -0.437 . . . . 74.129999999999995 110.848 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 17.1 p -95.55 -177.76 4.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.478 . . . . 73.040000000000006 111.155 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -92.5 -31.3 15.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.22 -0.445 . . . . 54.399999999999999 111.068 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 55.09 69.25 1.32 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.78 -0.724 . . . . 73.030000000000001 112.492 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 . . . . . 0 C--N 1.329 -0.286 0 CA-C-O 120.888 0.375 . . . . 74.129999999999995 110.899 -179.838 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.276 0 N-CA-C 112.459 -0.257 . . . . 73.409999999999997 112.459 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -134.73 131.03 37.13 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.73 0.3 . . . . 73.219999999999999 111.175 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -115.34 96.33 5.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 72.25 110.895 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.1 110.02 11.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.117 -0.492 . . . . 61.43 111.139 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 81.4 m-70 -106.93 104.26 13.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.259 -0.428 . . . . 74.019999999999996 110.862 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -124.72 -175.96 3.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 75.25 110.856 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 58.4 p -148.71 160.78 42.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.12 -0.491 . . . . 75.310000000000002 110.84 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 90.8 t -135.2 97.92 2.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.12 -0.491 . . . . 62.200000000000003 111.137 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 54.49 -113.12 3.15 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.752 -0.737 . . . . 63.240000000000002 112.521 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -103.01 25.46 9.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.814 0.34 . . . . 55.420000000000002 110.899 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 28.9 m-70 -111.18 -170.33 1.62 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 71.120000000000005 110.852 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -154.39 107.52 2.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.439 . . . . 75.049999999999997 110.821 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -142.69 161.81 37.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 64.209999999999994 110.91 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -159.4 149.33 18.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.242 -0.435 . . . . 74.540000000000006 110.88 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 8.2 mt -99.12 113.82 35.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.121 -0.49 . . . . 74.340000000000003 111.162 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.54 102.67 10.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.102 -0.499 . . . . 74.450000000000003 110.921 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -100.57 145.46 28.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.24 -0.436 . . . . 71.329999999999998 111.113 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.3 t -144.84 133.74 17.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.202 -0.454 . . . . 74.510000000000005 111.144 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.1 p -104.94 130.34 53.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 64.450000000000003 110.891 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 79.7 p -143.7 150.83 39.26 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.151 -0.477 . . . . 75.310000000000002 110.824 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 129.26 171.27 12.92 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.698 -0.763 . . . . 55.340000000000003 112.452 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 38.1 mttp -63.78 94.55 0.1 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.795 0.331 . . . . 72.150000000000006 110.947 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 15.6 mtt-85 62.86 60.69 1.23 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.227 -0.442 . . . . 73.109999999999999 110.84 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 58.11 82.33 0.13 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.45 . . . . 75.519999999999996 110.885 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -103.73 -53.2 2.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.244 -0.435 . . . . 74.510000000000005 110.938 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -133.66 147.56 19.08 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.795 -0.717 . . . . 75.439999999999998 112.517 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 58.5 mt -127.45 140.99 47.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.768 0.318 . . . . 74.540000000000006 111.137 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 66.1 mt -124.99 141.1 46.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.469 . . . . 75.450000000000003 111.105 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 10.0 m80 -115.92 142.91 46.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.103 -0.498 . . . . 73.319999999999993 110.847 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.6 107.69 8.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.193 -0.458 . . . . 74.219999999999999 111.155 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 16.8 tp -68.61 133.01 47.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.243 -0.435 . . . . 74.030000000000001 110.939 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 12.7 mt -135.01 113.89 16.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.45 . . . . 75.310000000000002 111.099 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 21.3 t -118.38 129.37 74.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 73.430000000000007 111.164 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 63.52 34.64 12.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.155 -0.475 . . . . 72.420000000000002 110.878 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 63.36 42.96 6.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 72.5 110.923 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -142.22 128.54 19.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.1 -0.5 . . . . 65.019999999999996 110.892 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -62.74 146.32 52.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.264 -0.425 . . . . 72.329999999999998 110.959 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -123.04 131.23 24.36 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.629 0.728 . . . . 72.319999999999993 111.101 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.68 137.01 34.68 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.628 2.219 . . . . 74.420000000000002 112.365 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.236 -0.438 . . . . 75.140000000000001 110.866 -179.958 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 30.2 p . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.864 0.364 . . . . 63.340000000000003 111.166 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -159.55 128.4 5.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 74.450000000000003 111.095 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.3 m -105.95 151.88 24.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.171 -0.468 . . . . 71.349999999999994 110.843 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.24 158.86 43.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.155 -0.475 . . . . 74.010000000000005 111.112 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 18.9 m-90 -151.75 157.32 41.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.218 -0.447 . . . . 74.530000000000001 110.93 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.3 t -135.9 114.98 16.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.448 . . . . 75.109999999999999 111.129 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -142.61 148.47 37.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.1 -0.5 . . . . 74.209999999999994 110.956 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 2.4 mmm180 -72.48 89.66 1.28 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 74.349999999999994 110.886 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -117.16 148.95 41.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.205 -0.452 . . . . 73.230000000000004 110.857 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.3 t0 64.88 14.77 9.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.458 . . . . 73.049999999999997 110.878 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.67 1.25 77.67 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.675 -0.774 . . . . 63.420000000000002 112.487 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -139.82 168.83 18.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.858 0.361 . . . . 75.099999999999994 110.899 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.97 89.01 0.16 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 75.530000000000001 110.85 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -79.8 130.61 35.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 74.209999999999994 110.846 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 10.9 ttp85 -105.73 121.92 45.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 75.530000000000001 110.917 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -106.59 144.99 14.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.145 -0.48 . . . . 74.319999999999993 111.139 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 85.5 t -135.83 144.45 33.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.456 . . . . 74.230000000000004 111.169 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.2 tp -128.8 102.84 6.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.253 -0.431 . . . . 74.129999999999995 110.989 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.26 132.56 42.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 64.400000000000006 110.853 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 9.9 mmmt -73.8 -16.88 61.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.446 . . . . 74.409999999999997 110.884 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -51.44 -55.81 16.72 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.225 -0.443 . . . . 74.409999999999997 110.865 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.45 17.06 3.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.188 -0.46 . . . . 75.319999999999993 111.094 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 8.8 ttm 60.11 29.71 19.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 72.409999999999997 110.869 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -77.07 145.39 37.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.211 -0.449 . . . . 73.150000000000006 110.783 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 36.1 t -104.75 139.24 26.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 72.219999999999999 111.108 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 2.7 t-105 -125.19 124.22 41.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.16 -0.473 . . . . 75.230000000000004 110.891 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -114.06 109.95 19.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.238 -0.437 . . . . 62.100000000000001 110.862 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 12.6 m-20 47.89 67.43 0.83 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 65.239999999999995 110.826 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 49.52 30.64 13.21 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.701 -0.762 . . . . 70.319999999999993 112.497 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.66 120.95 20.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.863 0.363 . . . . 75.439999999999998 110.901 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 18.5 tttt -53.86 151.25 6.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.224 -0.444 . . . . 74.540000000000006 110.84 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 44.2 mmm -117.89 165.61 13.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 74.120000000000005 110.88 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -118.97 106.49 12.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 75.409999999999997 110.829 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 21.7 p -95.95 168.93 10.33 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.126 -0.488 . . . . 55.039999999999999 111.137 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -95.82 -24.26 16.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.204 -0.453 . . . . 72.230000000000004 111.118 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 62.36 76.07 0.28 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.763 -0.732 . . . . 61.43 112.536 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 . . . . . 0 C--N 1.329 -0.286 0 CA-C-O 120.881 0.372 . . . . 74.519999999999996 110.894 -179.871 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 N-CA-C 112.494 -0.242 . . . . 73.299999999999997 112.494 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.39 133.41 25.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.827 0.346 . . . . 73.409999999999997 111.111 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -108.2 132.96 53.1 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.253 -0.431 . . . . 75.329999999999998 110.884 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.67 110.28 17.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.155 -0.475 . . . . 73.049999999999997 111.067 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 22.6 m-70 -100.88 110.5 22.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.157 -0.474 . . . . 75.109999999999999 110.868 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -135.38 134.7 40.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 73.140000000000001 110.908 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 2.9 p -84.39 151.85 24.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.153 -0.476 . . . . 62.119999999999997 110.865 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 94.0 t -136.74 97.98 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.117 -0.492 . . . . 73.219999999999999 111.096 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 54.2 -106.34 0.47 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.731 -0.747 . . . . 64.319999999999993 112.492 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 22.8 t30 -116.28 26.32 10.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.868 0.366 . . . . 73.239999999999995 110.851 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 50.3 m-70 -125.19 -169.93 2.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 73.120000000000005 110.823 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -143.18 105.61 4.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.261 -0.427 . . . . 74.230000000000004 110.894 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 13.3 m -120.5 158.41 27.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.444 . . . . 75.310000000000002 110.865 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -158.72 143.61 16.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 73.140000000000001 110.886 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.1 mt -99.27 111.06 27.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.139 -0.482 . . . . 74.519999999999996 111.178 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 7.8 tttm -80.87 102.96 10.38 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.194 -0.457 . . . . 74.040000000000006 110.877 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -92.5 132.45 36.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.246 -0.433 . . . . 60.43 111.092 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.5 t -127.0 125.6 66.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.243 -0.435 . . . . 64.109999999999999 111.105 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.3 p -93.56 136.97 33.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 74.219999999999999 110.798 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 1.4 p -138.94 146.12 40.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.08 -0.509 . . . . 71.430000000000007 110.793 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 132.44 162.48 10.34 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.679 -0.772 . . . . 65.109999999999999 112.501 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -54.72 -41.37 70.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.816 0.341 . . . . 63.329999999999998 110.898 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 12.9 mmt180 -136.35 46.08 2.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.237 -0.438 . . . . 64.219999999999999 110.843 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.54 74.23 0.36 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.191 -0.459 . . . . 75.430000000000007 110.908 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -113.04 -36.58 5.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.222 -0.444 . . . . 75.450000000000003 110.888 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -112.15 111.24 2.79 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.71 -0.757 . . . . 73.439999999999998 112.5 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 46.2 mt -109.91 147.98 13.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.803 0.335 . . . . 75.540000000000006 111.084 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 66.4 mt -137.88 122.17 22.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.136 -0.484 . . . . 74.420000000000002 111.191 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 12.0 m80 -94.95 135.82 36.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 72.329999999999998 110.864 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.09 106.75 10.16 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.147 -0.479 . . . . 75.019999999999996 111.095 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 43.9 tp -66.74 136.47 55.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.215 -0.448 . . . . 74.420000000000002 110.895 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 10.2 mt -137.09 125.73 34.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.196 -0.456 . . . . 73.340000000000003 111.171 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 67.4 t -122.6 119.89 59.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 72.540000000000006 111.146 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 64.0 39.34 8.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 72.5 110.847 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 63.23 43.06 6.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 75.420000000000002 110.886 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -138.94 127.14 22.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.227 -0.442 . . . . 75.25 110.882 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -62.44 146.38 51.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.18 -0.464 . . . . 70.5 110.888 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -119.99 130.88 24.62 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.645 0.736 . . . . 74.109999999999999 111.136 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 127.64 14.87 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.642 2.228 . . . . 72.340000000000003 112.302 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 64.439999999999998 110.888 -179.988 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 16.6 p . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.923 0.392 . . . . 73.5 111.132 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -159.48 128.04 5.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 63.200000000000003 111.176 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.2 m -106.19 153.33 22.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.185 -0.462 . . . . 73.5 110.813 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 78.9 p -138.54 155.05 48.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.095 -0.502 . . . . 71.409999999999997 111.141 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 10.8 m-90 -151.52 123.64 8.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 75.150000000000006 110.903 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 19.5 t -105.14 114.9 45.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.246 -0.434 . . . . 64.140000000000001 111.168 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -142.74 146.96 34.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.166 -0.47 . . . . 75.530000000000001 110.936 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -73.85 93.0 2.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 75.219999999999999 110.914 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -123.54 152.87 41.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 74.510000000000005 110.922 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.1 t70 64.8 15.03 9.59 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.201 -0.454 . . . . 74.400000000000006 110.882 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 88.55 0.65 81.81 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.79 -0.719 . . . . 62.340000000000003 112.548 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -139.85 172.92 12.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.796 0.331 . . . . 73.219999999999999 110.909 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.69 89.0 0.37 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.134 -0.485 . . . . 73.129999999999995 110.877 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.12 125.41 28.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.147 -0.479 . . . . 65.25 110.911 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 3.6 ttm180 -104.54 109.63 21.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 74.120000000000005 110.888 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -95.78 136.19 27.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 75.439999999999998 111.111 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 94.0 t -136.25 127.03 42.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.097 -0.501 . . . . 72.430000000000007 111.127 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.9 tp -110.11 107.31 17.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.48 . . . . 74.400000000000006 110.885 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.17 136.08 34.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 74.140000000000001 110.918 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 6.6 mmmt -73.54 -16.34 61.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.171 -0.468 . . . . 72.319999999999993 110.888 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -51.51 -55.49 18.68 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.237 -0.438 . . . . 73.129999999999995 110.904 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -136.43 17.0 3.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 75.099999999999994 111.187 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 70.9 mtp 58.49 23.25 10.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 64.439999999999998 110.849 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.99 147.61 42.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 75.530000000000001 110.778 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 85.8 t -105.13 122.54 58.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.138 -0.483 . . . . 75.109999999999999 111.176 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 2.8 t90 -103.63 131.78 50.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.203 -0.453 . . . . 63.520000000000003 110.926 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 1.2 m -126.86 108.21 10.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.286 -0.415 . . . . 54.210000000000001 110.847 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 4.8 p30 39.42 70.1 0.25 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 73.230000000000004 110.83 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 49.75 42.42 36.92 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.775 -0.726 . . . . 64.25 112.466 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -148.12 110.09 4.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.885 0.374 . . . . 72.219999999999999 110.917 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.3 154.95 2.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 65.310000000000002 110.912 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 29.9 mmm -124.61 160.53 28.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 75.120000000000005 110.848 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -115.47 106.96 14.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 72.519999999999996 110.845 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 18.8 p -95.36 179.03 5.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.171 -0.468 . . . . 74.519999999999996 111.098 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -90.58 -40.41 11.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 72.109999999999999 111.098 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 58.6 60.23 9.31 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.769 -0.729 . . . . 72.209999999999994 112.449 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 . . . . . 0 C--N 1.329 -0.303 0 CA-C-O 120.834 0.349 . . . . 62.240000000000002 110.973 -179.918 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.282 0 N-CA-C 112.493 -0.243 . . . . 73.439999999999998 112.493 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.25 130.82 35.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.683 0.278 . . . . 73.349999999999994 111.155 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -113.73 96.87 6.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 73.239999999999995 110.867 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.42 110.43 16.83 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.127 -0.488 . . . . 74.209999999999994 111.175 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 82.4 m-70 -103.89 106.01 16.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.446 . . . . 61.100000000000001 110.827 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -124.48 131.99 53.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 72.340000000000003 110.871 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 22.9 p -82.02 146.9 29.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.459 . . . . 63.240000000000002 110.852 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.9 t -137.68 98.35 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.097 -0.501 . . . . 75.120000000000005 111.137 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 52.34 -121.28 13.72 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.71 -0.757 . . . . 61.299999999999997 112.501 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -98.75 26.74 5.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.901 0.382 . . . . 71.109999999999999 110.886 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 31.1 m-70 -126.7 174.21 8.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.177 -0.465 . . . . 71.409999999999997 110.834 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -132.79 88.35 2.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 73.409999999999997 110.821 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 10.4 m -100.67 164.78 11.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.166 -0.47 . . . . 75.230000000000004 110.938 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -167.85 144.85 4.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.213 -0.449 . . . . 75.099999999999994 110.97 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 22.7 mt -97.6 111.4 27.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.117 -0.492 . . . . 55.219999999999999 111.066 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 1.8 ttmt -80.12 102.82 9.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 73.25 110.927 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -93.38 146.47 23.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.271 -0.422 . . . . 74.430000000000007 111.067 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.2 t -144.28 121.42 5.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 72.209999999999994 111.157 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -94.26 137.21 33.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 72.319999999999993 110.889 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 2.2 t -132.45 133.21 43.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.112 -0.494 . . . . 65.209999999999994 110.833 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 143.87 -174.94 24.04 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.795 -0.717 . . . . 73.109999999999999 112.488 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.96 -26.51 67.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.728 0.299 . . . . 73.530000000000001 110.881 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.65 -41.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.267 -0.424 . . . . 71.340000000000003 110.861 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 25.4 tttp -162.56 55.75 0.22 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 74.129999999999995 110.842 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -76.74 -62.66 1.56 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.267 -0.424 . . . . 75.120000000000005 110.86 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -141.35 160.38 26.84 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.813 -0.708 . . . . 55.32 112.457 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 64.1 mt -136.4 139.61 45.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.82 0.343 . . . . 75.209999999999994 111.162 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 64.4 mt -126.7 131.05 71.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.138 -0.483 . . . . 73.450000000000003 111.13 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 14.5 m80 -105.83 139.63 40.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.445 . . . . 62.310000000000002 110.883 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.64 103.98 6.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.435 . . . . 73.310000000000002 111.155 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 28.2 tp -65.5 137.8 57.66 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.243 -0.435 . . . . 73.230000000000004 110.878 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 9.8 mt -137.6 130.04 41.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 74.310000000000002 111.168 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 74.2 t -126.51 116.36 44.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.451 . . . . 74.25 111.166 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.4 t0 63.64 46.12 4.29 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.196 -0.456 . . . . 62.240000000000002 110.82 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 1.6 m120 59.08 42.93 18.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.262 -0.426 . . . . 60.420000000000002 110.879 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 10.4 mtm180 -139.69 124.99 18.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 75.140000000000001 110.955 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -62.55 146.48 51.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 64.319999999999993 110.84 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -120.32 130.97 24.59 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.597 0.713 . . . . 73.219999999999999 111.195 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.74 134.15 27.33 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.64 2.227 . . . . 75.329999999999998 112.402 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.269 -0.423 . . . . 73.530000000000001 110.907 -179.977 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.853 0.359 . . . . 73.109999999999999 111.083 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -159.74 127.77 4.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 72.219999999999999 111.114 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 62.5 m -106.52 116.83 32.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 71.439999999999998 110.841 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 71.6 p -112.34 163.88 13.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.15 -0.477 . . . . 73.219999999999999 111.134 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 21.8 m-90 -149.56 152.17 35.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.196 -0.456 . . . . 74.200000000000003 110.86 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 20.3 t -124.84 115.11 43.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.217 -0.447 . . . . 73.420000000000002 111.079 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.17 147.22 38.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.132 -0.485 . . . . 75.049999999999997 110.934 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 8.7 mtm-85 -72.17 90.99 1.25 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 75.400000000000006 110.913 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.62 151.62 40.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.105 -0.498 . . . . 72.510000000000005 110.922 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.7 t70 65.11 14.59 9.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 73.310000000000002 110.853 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.63 0.14 79.38 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.738 -0.744 . . . . 63.119999999999997 112.479 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -139.88 172.77 12.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.839 0.352 . . . . 75.510000000000005 110.898 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -69.02 89.22 0.42 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.206 -0.452 . . . . 63.420000000000002 110.906 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.56 130.95 39.65 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.164 -0.471 . . . . 73.230000000000004 110.897 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 8.2 ttt180 -107.02 113.12 26.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 74.340000000000003 110.88 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -95.52 141.2 15.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 75.430000000000007 111.19 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 47.5 t -135.85 126.41 42.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 73.349999999999994 111.149 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.2 tp -113.17 99.82 8.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.463 . . . . 74.019999999999996 110.897 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.59 123.54 26.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 71.329999999999998 110.924 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.47 -16.07 59.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 73.519999999999996 110.867 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -51.4 -56.02 15.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 74.340000000000003 110.906 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 76.3 p -132.49 16.94 4.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 74.140000000000001 111.128 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 48.2 mtp 55.7 28.43 12.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 75.200000000000003 110.868 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -81.37 147.14 29.97 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.212 -0.449 . . . . 64.430000000000007 110.867 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 79.5 t -104.81 129.41 57.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.445 . . . . 71.310000000000002 111.163 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 6.1 t-105 -119.95 109.57 15.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.173 -0.467 . . . . 74.439999999999998 110.962 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 7.7 m -97.0 117.81 32.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.441 . . . . 75.540000000000006 110.939 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 64.8 -82.75 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.468 . . . . 72.299999999999997 110.874 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -156.88 46.17 0.49 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.774 -0.727 . . . . 75.319999999999993 112.449 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -159.01 134.29 8.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.908 0.385 . . . . 75.150000000000006 110.899 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 24.9 ttpt -53.74 162.11 0.96 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.161 -0.472 . . . . 72.230000000000004 110.897 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 31.4 mmm -127.76 167.11 16.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 72.129999999999995 110.888 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -119.19 106.62 12.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.285 -0.416 . . . . 74.310000000000002 110.92 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 19.6 p -95.61 -175.3 3.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.118 -0.492 . . . . 73.120000000000005 111.127 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -104.95 -25.16 12.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 62.109999999999999 111.087 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 53.23 47.63 61.04 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.752 -0.737 . . . . 73.120000000000005 112.453 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 . . . . . 0 C--N 1.33 -0.278 0 CA-C-O 120.816 0.341 . . . . 75.430000000000007 110.945 -179.944 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 N-CA-C 112.462 -0.255 . . . . 74.310000000000002 112.462 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -134.83 130.8 36.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.74 0.305 . . . . 75.409999999999997 111.214 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -106.43 96.37 6.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.256 -0.429 . . . . 73.230000000000004 110.886 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.86 110.09 16.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 71.430000000000007 111.173 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 76.7 m-70 -106.86 106.42 16.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 73.400000000000006 110.814 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -121.74 128.82 52.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 72.450000000000003 110.855 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 56.1 p -89.35 159.3 17.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.112 -0.495 . . . . 65.120000000000005 110.85 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 87.0 t -147.86 109.22 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 73.120000000000005 111.101 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 52.0 -118.92 7.92 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.68 -0.771 . . . . 74.329999999999998 112.563 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -107.16 23.49 14.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.881 0.372 . . . . 70.420000000000002 110.916 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -112.57 -169.6 1.51 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 72.129999999999995 110.893 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -151.64 118.9 5.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 73.530000000000001 110.866 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 1.4 p -142.53 163.67 32.21 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.274 -0.421 . . . . 72.310000000000002 110.898 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -167.16 145.53 4.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.173 -0.467 . . . . 75.409999999999997 110.878 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 22.5 mt -97.58 111.55 27.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.086 -0.506 . . . . 72.120000000000005 111.172 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -80.9 106.96 13.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 73.219999999999999 110.879 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -101.83 146.6 27.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.256 -0.429 . . . . 73.099999999999994 111.126 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.3 t -142.05 132.94 25.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.246 -0.434 . . . . 72.129999999999995 111.108 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.1 p -101.17 140.35 35.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.09 -0.505 . . . . 71.519999999999996 110.881 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -133.32 136.74 45.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.138 -0.483 . . . . 73.209999999999994 110.841 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 135.73 -169.16 23.64 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.763 -0.732 . . . . 73.019999999999996 112.477 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 14.2 mttt -64.2 -28.6 69.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.734 0.302 . . . . 74.219999999999999 110.891 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.73 -46.9 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.25 -0.432 . . . . 75.200000000000003 110.904 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 51.6 pttt -162.79 56.21 0.2 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 73.430000000000007 110.901 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -75.2 -56.1 5.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.233 -0.439 . . . . 72.140000000000001 110.915 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -138.85 141.56 12.05 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.714 -0.755 . . . . 75.120000000000005 112.458 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 73.7 mt -125.4 137.19 58.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.739 0.304 . . . . 70.340000000000003 111.188 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 2.8 mt -123.94 131.53 72.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 74.439999999999998 111.08 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 16.4 m80 -105.09 144.94 31.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 74.5 110.813 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.99 105.09 5.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.142 -0.481 . . . . 72.140000000000001 111.07 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 11.7 tp -64.06 135.21 56.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 74.239999999999995 110.923 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 11.0 mt -136.22 104.78 4.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 72.549999999999997 111.118 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 42.2 t -112.66 135.42 52.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 75.329999999999998 111.096 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 63.62 31.69 14.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.137 -0.483 . . . . 73.0 110.86 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 2.2 t30 63.33 42.93 6.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.46 . . . . 73.340000000000003 110.851 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 9.9 mtt85 -143.94 130.18 19.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 74.430000000000007 110.968 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -62.61 146.42 52.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.257 -0.429 . . . . 74.129999999999995 110.879 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -125.03 131.34 24.08 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.686 0.755 . . . . 73.019999999999996 111.078 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.86 133.22 24.87 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.658 2.238 . . . . 75.329999999999998 112.356 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 74.120000000000005 110.876 -179.948 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 15.2 t . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.852 0.358 . . . . 63.229999999999997 111.117 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -159.62 128.22 5.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.231 -0.44 . . . . 75.019999999999996 111.157 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.4 m -105.8 147.47 28.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 72.430000000000007 110.872 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -136.35 138.25 41.45 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.118 -0.492 . . . . 74.530000000000001 111.176 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 11.1 m-90 -133.42 123.0 24.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.198 -0.456 . . . . 75.319999999999993 110.995 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 19.9 t -102.48 114.92 43.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.339 -0.391 . . . . 74.319999999999993 111.114 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -142.61 147.27 35.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.153 -0.476 . . . . 75.209999999999994 110.925 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 83.4 mtt180 -74.34 92.08 2.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 73.439999999999998 110.946 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.48 153.57 37.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.193 -0.458 . . . . 74.219999999999999 110.947 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 65.03 14.65 9.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.175 -0.466 . . . . 73.25 110.873 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.61 -0.06 79.7 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.705 -0.759 . . . . 63.509999999999998 112.492 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -139.82 172.67 12.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.824 0.345 . . . . 72.310000000000002 110.897 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.3 88.64 0.32 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.141 -0.481 . . . . 72.209999999999994 110.875 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.45 125.82 29.76 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.251 -0.431 . . . . 72.310000000000002 110.911 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 10.1 ttt180 -102.4 111.06 23.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 75.519999999999996 110.881 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.4 t -94.8 135.89 27.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.14 -0.482 . . . . 74.400000000000006 111.153 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 99.4 t -136.55 126.43 39.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 54.200000000000003 111.137 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.7 tp -111.6 103.84 12.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 74.400000000000006 110.871 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -80.26 129.69 34.68 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.183 -0.462 . . . . 75.510000000000005 110.891 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 58.4 mttt -68.71 -15.41 63.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 73.340000000000003 110.895 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -51.27 -52.72 42.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.273 -0.421 . . . . 61.539999999999999 110.831 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -138.2 16.93 2.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.213 -0.449 . . . . 73.219999999999999 111.136 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 1.9 ttp 57.48 26.54 12.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 75.430000000000007 110.874 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -80.38 150.68 29.75 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.29 -0.414 . . . . 71.439999999999998 110.846 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 62.0 t -104.86 134.37 46.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.15 -0.477 . . . . 71.040000000000006 111.13 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 1.1 t90 -123.5 116.2 22.8 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.184 -0.462 . . . . 74.140000000000001 110.909 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 17.9 p -120.95 132.94 55.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.302 -0.408 . . . . 74.140000000000001 110.819 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 58.9 m-20 44.57 51.54 7.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.125 -0.489 . . . . 73.409999999999997 110.865 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 50.82 40.83 42.67 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.748 -0.739 . . . . 63.520000000000003 112.456 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.46 122.61 12.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.854 0.359 . . . . 65.099999999999994 110.965 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.49 147.98 9.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.44 . . . . 72.25 110.894 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 32.5 mmm -114.14 169.05 9.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 74.120000000000005 110.847 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.56 106.37 12.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 74.0 110.903 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 17.4 p -99.35 -175.11 2.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 70.409999999999997 111.178 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -94.77 -44.8 7.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 75.109999999999999 111.06 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 65.11 52.87 37.3 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.707 -0.759 . . . . 75.430000000000007 112.483 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 . . . . . 0 C--N 1.329 -0.306 0 CA-C-O 120.889 0.376 . . . . 74.239999999999995 110.903 -179.894 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 N-CA-C 112.508 -0.237 . . . . 61.539999999999999 112.508 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -134.86 130.91 36.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.735 0.302 . . . . 71.439999999999998 111.203 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -111.91 96.3 5.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 74.439999999999998 110.882 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.81 110.23 13.8 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.22 -0.446 . . . . 71.519999999999996 111.157 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 82.7 m-70 -104.52 106.38 16.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 75.030000000000001 110.87 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -128.09 175.52 8.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 73.200000000000003 110.845 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 83.3 p -142.42 155.75 45.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.088 -0.506 . . . . 73.230000000000004 110.911 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 84.7 t -136.87 105.29 4.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.469 . . . . 73.420000000000002 111.073 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 62.34 -103.48 0.61 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.726 -0.749 . . . . 71.439999999999998 112.496 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -114.23 -27.43 7.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.81 0.338 . . . . 73.140000000000001 110.893 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 52.0 m-70 -61.37 -170.43 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.191 -0.459 . . . . 74.349999999999994 110.855 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -152.6 116.39 4.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 74.019999999999996 110.921 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -142.66 161.98 36.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.242 -0.435 . . . . 72.319999999999993 110.852 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 18.3 p90 -156.71 152.72 27.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 73.129999999999995 110.905 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 13.4 mt -99.55 111.53 29.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 74.430000000000007 111.14 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 1.1 ttpp -81.89 102.62 10.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 72.140000000000001 110.893 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -98.6 147.99 24.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.281 -0.418 . . . . 62.439999999999998 111.119 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.5 t -145.18 122.44 4.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 73.400000000000006 111.122 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.2 p -89.67 139.97 30.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.472 . . . . 74.099999999999994 110.852 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 14.7 t -141.67 142.17 33.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.084 -0.507 . . . . 60.340000000000003 110.859 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 128.65 175.64 14.14 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.792 -0.718 . . . . 62.509999999999998 112.519 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 9.6 mttt -58.48 -38.11 76.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.749 0.309 . . . . 74.040000000000006 110.938 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -158.74 76.98 0.75 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 70.310000000000002 110.868 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 2.3 mtmt 55.85 28.89 13.11 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.208 -0.451 . . . . 74.299999999999997 110.88 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -54.39 -44.74 72.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 71.319999999999993 110.892 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -143.87 132.3 4.83 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.705 -0.759 . . . . 43.219999999999999 112.434 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 50.5 mt -121.13 147.15 25.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.812 0.339 . . . . 72.0 111.126 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 59.9 mt -129.45 131.01 67.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 74.140000000000001 111.118 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 10.8 m80 -108.69 137.27 46.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.446 . . . . 74.239999999999995 110.869 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.99 112.0 13.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.253 -0.43 . . . . 73.109999999999999 111.177 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 18.1 tp -70.22 134.85 48.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 73.319999999999993 110.938 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 10.7 mt -136.74 121.45 25.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.474 . . . . 75.299999999999997 111.098 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 16.4 t -121.86 124.08 70.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 72.510000000000005 111.178 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 63.63 37.96 9.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.235 -0.439 . . . . 73.030000000000001 110.868 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 62.83 42.9 7.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.142 -0.481 . . . . 71.349999999999994 110.887 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -140.67 127.98 21.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.169 -0.469 . . . . 74.230000000000004 110.879 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -62.67 146.5 52.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.45 . . . . 75.430000000000007 110.856 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -122.18 131.31 24.43 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.675 0.75 . . . . 74.409999999999997 111.043 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 137.79 36.23 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.731 2.288 . . . . 73.319999999999993 112.292 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.462 . . . . 73.120000000000005 110.914 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 30.7 p . . . . . 0 C--O 1.233 0.188 0 CA-C-O 120.856 0.36 . . . . 75.310000000000002 111.09 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -159.61 128.14 5.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.265 -0.425 . . . . 62.530000000000001 111.175 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -106.04 155.01 19.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 74.319999999999993 110.903 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 68.4 p -146.81 154.73 41.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.113 -0.494 . . . . 73.439999999999998 111.154 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 14.2 m-90 -151.26 133.98 15.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.19 -0.459 . . . . 74.319999999999993 110.919 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.3 t -113.14 114.77 47.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 72.349999999999994 111.172 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -138.91 146.01 40.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 71.209999999999994 110.918 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -74.22 94.1 2.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 74.140000000000001 110.833 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -127.44 153.39 46.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 75.340000000000003 110.927 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 64.43 15.65 9.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.204 -0.453 . . . . 72.340000000000003 110.824 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 86.3 2.05 85.73 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.665 -0.779 . . . . 74.540000000000006 112.503 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -139.94 173.06 11.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.89 0.376 . . . . 73.430000000000007 110.859 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.1 87.88 0.4 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.458 . . . . 75.109999999999999 110.872 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.4 tp -69.04 124.87 24.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.471 . . . . 73.230000000000004 110.906 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 10.8 ttm180 -107.05 113.91 27.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 73.549999999999997 110.87 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -106.37 139.37 27.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.456 . . . . 74.450000000000003 111.131 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 85.8 t -135.8 135.36 50.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.125 -0.488 . . . . 72.430000000000007 111.207 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.2 tp -117.58 100.35 7.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 73.430000000000007 110.954 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.57 134.85 40.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 73.239999999999995 110.878 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.3 mttt -73.78 -17.46 61.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.474 . . . . 64.510000000000005 110.924 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -51.33 -54.12 29.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 70.049999999999997 110.853 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -134.29 17.01 3.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.219 -0.446 . . . . 72.439999999999998 111.138 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 3.9 ttm 54.41 27.09 7.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.252 -0.431 . . . . 61.299999999999997 110.914 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -80.97 149.39 29.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 73.430000000000007 110.851 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 31.3 t -104.84 128.92 58.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.107 -0.497 . . . . 70.129999999999995 111.163 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 3.7 t90 -113.1 127.55 56.24 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.093 -0.503 . . . . 75.340000000000003 110.951 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 9.2 t -141.6 129.52 21.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 74.239999999999995 110.93 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 48.25 50.79 15.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 73.409999999999997 110.945 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 49.29 47.46 34.58 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.774 -0.727 . . . . 75.439999999999998 112.44 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.44 114.71 4.79 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.81 0.338 . . . . 74.120000000000005 110.966 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 7.5 ttmt -55.56 100.36 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 75.329999999999998 110.857 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 65.5 mtp -59.63 159.7 8.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 73.409999999999997 110.916 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -104.97 106.38 16.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.212 -0.449 . . . . 71.129999999999995 110.892 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 13.9 p -99.2 -175.21 2.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.161 -0.472 . . . . 61.020000000000003 111.16 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -114.01 -47.86 2.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 61.109999999999999 111.136 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 74.83 50.43 8.99 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.716 -0.754 . . . . 70.129999999999995 112.484 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 . . . . . 0 C--N 1.328 -0.326 0 CA-C-O 120.878 0.37 . . . . 74.319999999999993 110.835 -179.827 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 N-CA-C 112.501 -0.24 . . . . 75.239999999999995 112.501 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.63 130.81 34.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.706 0.288 . . . . 73.129999999999995 111.132 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -103.18 97.98 7.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.273 -0.422 . . . . 72.400000000000006 110.895 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.72 110.26 16.05 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.157 -0.474 . . . . 75.140000000000001 111.135 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 73.9 m-70 -102.0 109.3 21.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 72.120000000000005 110.809 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -138.75 153.33 48.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.252 -0.431 . . . . 74.310000000000002 110.905 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 89.6 p -114.52 167.44 10.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 73.120000000000005 110.812 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 83.8 t -149.39 98.12 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.119 -0.492 . . . . 65.200000000000003 111.09 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 60.18 -101.93 0.31 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.777 -0.725 . . . . 74.400000000000006 112.461 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -123.59 29.24 6.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.945 0.403 . . . . 75.030000000000001 110.943 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 75.3 m-70 -121.31 -175.02 2.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.475 . . . . 75.030000000000001 110.951 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -145.09 117.48 8.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.287 -0.415 . . . . 73.310000000000002 110.84 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 1.3 p -142.45 156.41 45.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.216 -0.447 . . . . 71.049999999999997 110.893 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -151.66 146.32 25.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 75.239999999999995 110.875 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.8 mt -97.37 111.69 27.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.082 -0.508 . . . . 74.349999999999994 111.113 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 8.1 tttt -79.83 102.5 9.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.253 -0.431 . . . . 74.430000000000007 110.88 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -95.12 139.68 31.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.242 -0.436 . . . . 74.430000000000007 111.156 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.3 t -135.68 123.01 35.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.252 -0.431 . . . . 75.400000000000006 111.135 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.3 p -91.12 150.4 21.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 74.209999999999994 110.87 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 63.4 p -144.8 128.45 17.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.104 -0.498 . . . . 65.430000000000007 110.885 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 136.03 -144.03 15.68 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.712 -0.756 . . . . 64.519999999999996 112.526 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 19.7 mtmt -95.04 -63.42 1.17 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.721 0.296 . . . . 75.25 110.866 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.99 -36.38 3.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.308 -0.405 . . . . 74.430000000000007 110.926 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -173.17 52.3 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 73.510000000000005 110.916 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -69.23 -61.98 1.57 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 65.140000000000001 110.922 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -143.33 138.77 8.41 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.734 -0.746 . . . . 70.209999999999994 112.55 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 61.2 mt -124.54 146.11 30.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.796 0.331 . . . . 75.409999999999997 111.159 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 59.4 mt -133.92 123.18 44.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.242 -0.436 . . . . 73.310000000000002 111.171 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 9.7 m80 -99.41 141.49 32.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.464 . . . . 71.519999999999996 110.875 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.33 106.93 8.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 75.420000000000002 111.073 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 14.5 tp -65.14 134.02 52.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 72.519999999999996 110.936 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 10.7 mt -137.01 111.27 9.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 74.549999999999997 111.113 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 35.6 t -113.56 124.71 70.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.458 . . . . 73.120000000000005 111.143 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 4.5 t0 63.37 43.22 6.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.451 . . . . 63.340000000000003 110.883 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 58.3 m-20 56.8 41.54 27.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.111 -0.495 . . . . 70.140000000000001 110.841 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 26.4 mtt180 -137.94 125.76 22.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 75.200000000000003 110.849 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -62.7 144.96 55.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.174 -0.466 . . . . 73.140000000000001 110.889 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -122.99 131.16 24.38 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.581 0.705 . . . . 75.230000000000004 111.143 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 138.21 37.31 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.725 2.283 . . . . 74.450000000000003 112.299 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 72.430000000000007 110.855 -179.956 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 39.2 p . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.831 0.348 . . . . 74.219999999999999 111.107 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -159.46 127.78 5.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.286 -0.416 . . . . 70.340000000000003 111.096 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.4 m -106.48 152.18 23.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.443 . . . . 71.549999999999997 110.833 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 6.9 m -135.86 155.19 50.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.126 -0.488 . . . . 72.549999999999997 111.124 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 16.6 m-90 -148.97 133.02 17.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.208 -0.451 . . . . 74.239999999999995 110.88 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.0 t -113.03 114.92 48.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 71.439999999999998 111.124 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.03 147.27 40.13 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.179 -0.464 . . . . 72.430000000000007 110.892 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -73.29 93.44 1.89 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.133 -0.485 . . . . 73.150000000000006 110.874 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -124.8 151.74 44.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 72.329999999999998 110.868 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.8 t0 64.54 15.21 9.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 75.310000000000002 110.847 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.37 1.8 83.43 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.758 -0.734 . . . . 60.100000000000001 112.527 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -139.92 172.88 12.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.841 0.353 . . . . 74.010000000000005 110.902 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.67 89.28 0.37 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 73.140000000000001 110.855 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -74.38 131.49 41.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 64.530000000000001 110.955 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 11.7 ttp180 -110.8 118.48 36.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 75.120000000000005 110.862 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -108.63 143.74 18.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 75.230000000000004 111.112 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 15.6 t -135.85 153.04 31.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.13 -0.486 . . . . 73.5 111.111 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.3 tp -129.71 105.92 8.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.165 -0.471 . . . . 74.409999999999997 110.927 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.43 135.51 35.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.231 -0.44 . . . . 74.430000000000007 110.823 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.0 mtmt -73.52 -16.54 61.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.098 -0.501 . . . . 65.030000000000001 110.859 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -51.34 -55.85 16.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.254 -0.43 . . . . 71.409999999999997 110.884 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.86 16.81 3.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 73.109999999999999 111.207 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 1.9 mtp 59.99 20.21 9.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.464 . . . . 63.210000000000001 110.891 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -70.91 151.03 45.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 73.099999999999994 110.886 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.408 ' HB ' ' HB2' ' A' ' 127' ' ' MET . 80.4 t -105.07 117.81 51.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 74.400000000000006 111.095 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 55.2 t-105 -95.61 113.63 25.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.211 -0.45 . . . . 71.329999999999998 110.946 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 9.0 t -140.26 133.03 29.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.246 -0.434 . . . . 75.040000000000006 110.897 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 57.98 34.06 23.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 71.140000000000001 110.915 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 57.76 49.85 70.62 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.743 -0.741 . . . . 71.340000000000003 112.476 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.93 121.6 2.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.836 0.35 . . . . 73.439999999999998 110.934 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -54.08 100.39 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 73.340000000000003 110.942 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' MET . . . . . 0.408 ' HB2' ' HB ' ' A' ' 120' ' ' VAL . 17.2 mmm -56.47 174.23 0.15 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.283 -0.417 . . . . 72.340000000000003 110.868 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -119.27 106.29 12.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.212 -0.449 . . . . 75.430000000000007 110.847 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 19.8 p -98.64 -175.23 3.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.135 -0.484 . . . . 75.099999999999994 111.16 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -99.87 -38.38 8.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.269 -0.423 . . . . 71.040000000000006 111.092 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 69.77 43.56 66.47 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.711 -0.756 . . . . 72.239999999999995 112.55 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 . . . . . 0 C--N 1.329 -0.291 0 CA-C-O 120.922 0.392 . . . . 74.510000000000005 110.921 -179.898 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 N-CA-C 112.508 -0.237 . . . . 75.549999999999997 112.508 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.03 130.78 36.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.763 0.316 . . . . 74.519999999999996 111.109 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -108.57 96.78 6.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.444 . . . . 74.129999999999995 110.893 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.64 109.99 17.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.168 -0.469 . . . . 71.310000000000002 111.075 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 71.8 m-70 -101.83 104.53 15.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 70.5 110.86 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 23.2 p90 -126.43 135.63 51.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 72.140000000000001 110.896 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 36.6 p -102.72 157.38 16.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.441 . . . . 74.209999999999994 110.849 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 90.5 t -138.7 105.59 2.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.101 -0.499 . . . . 72.530000000000001 111.093 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 55.06 -105.58 0.41 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.701 -0.761 . . . . 72.030000000000001 112.512 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -117.32 24.81 10.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.793 0.33 . . . . 74.230000000000004 110.869 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -117.1 172.18 7.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 60.119999999999997 110.877 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -130.24 120.74 24.92 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.241 -0.436 . . . . 74.200000000000003 110.867 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -142.68 170.73 15.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.179 -0.464 . . . . 74.430000000000007 110.913 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -175.2 147.71 0.93 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.21 -0.45 . . . . 75.340000000000003 110.914 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 12.9 mt -97.5 111.16 26.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.086 -0.506 . . . . 74.140000000000001 111.097 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 20.2 tttt -82.03 102.65 11.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.25 -0.432 . . . . 74.310000000000002 110.827 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -95.07 147.15 23.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 73.5 111.113 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.5 t -145.08 119.22 2.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 70.099999999999994 111.173 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.3 p -84.26 137.95 33.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.471 . . . . 74.510000000000005 110.871 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 1.5 t -133.54 152.47 51.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 72.209999999999994 110.794 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 112.25 -126.57 7.65 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.763 -0.732 . . . . 74.349999999999994 112.476 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -121.75 -65.05 1.16 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.756 0.313 . . . . 74.019999999999996 110.928 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -136.8 91.9 2.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.172 -0.467 . . . . 75.120000000000005 110.927 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 60.1 26.5 15.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 74.349999999999994 110.888 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.91 -69.96 0.19 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.198 -0.456 . . . . 75.219999999999999 110.931 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -137.39 120.49 2.09 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.719 -0.753 . . . . 54.340000000000003 112.479 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 72.2 mt -110.1 144.97 17.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.746 0.308 . . . . 74.420000000000002 111.158 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 3.0 mt -128.16 130.53 69.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.262 -0.426 . . . . 71.319999999999993 111.112 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 13.1 m80 -108.2 137.29 46.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 73.230000000000004 110.862 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.38 107.19 9.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.243 -0.435 . . . . 73.319999999999993 111.149 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 13.6 tp -67.37 137.21 55.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.249 -0.432 . . . . 75.109999999999999 110.982 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 9.7 mt -138.76 114.21 9.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.184 -0.462 . . . . 65.219999999999999 111.161 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 43.8 t -115.88 126.5 73.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 75.400000000000006 111.104 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.3 t0 63.53 39.26 9.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 74.439999999999998 110.935 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 60.06 42.3 15.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.47 . . . . 73.040000000000006 110.872 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -138.45 124.99 20.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 72.120000000000005 110.883 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -62.65 140.49 58.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.272 -0.422 . . . . 74.129999999999995 110.891 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -118.64 131.26 24.36 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.616 0.722 . . . . 70.409999999999997 111.126 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.66 135.85 31.74 Favored 'Trans proline' 0 N--CA 1.465 -0.179 0 C-N-CA 122.744 2.296 . . . . 73.129999999999995 112.386 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.259 -0.428 . . . . 72.140000000000001 110.854 -179.936 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 54.4 p . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.829 0.347 . . . . 75.5 111.108 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -159.58 127.94 5.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.265 -0.425 . . . . 64.430000000000007 111.207 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.1 m -106.27 151.9 24.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.271 -0.422 . . . . 73.310000000000002 110.85 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.3 m -137.85 148.46 45.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.125 -0.488 . . . . 71.239999999999995 111.095 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 10.1 m-90 -146.4 124.67 12.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.206 -0.452 . . . . 73.5 110.936 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 19.1 t -108.37 114.81 47.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.284 -0.416 . . . . 64.299999999999997 111.164 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -139.94 147.62 40.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.205 -0.452 . . . . 74.420000000000002 110.894 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -73.32 92.83 1.84 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 74.319999999999993 110.856 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.82 151.0 43.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 73.25 110.89 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 64.43 15.45 9.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 74.109999999999999 110.832 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.83 1.42 82.65 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.717 -0.754 . . . . 73.239999999999995 112.516 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -139.81 172.81 12.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.894 0.378 . . . . 64.230000000000004 110.808 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -69.53 89.64 0.52 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.081 -0.509 . . . . 71.340000000000003 110.878 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.5 129.33 36.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 73.439999999999998 110.937 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 2.5 ttm180 -107.76 118.3 36.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 73.140000000000001 110.893 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.73 115.68 50.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 72.319999999999993 111.201 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 28.3 t -114.51 140.29 36.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.242 -0.435 . . . . 75.040000000000006 111.127 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.1 tp -114.0 108.66 17.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.17 -0.468 . . . . 64.109999999999999 110.962 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -81.8 134.79 35.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 63.130000000000003 110.874 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.7 mmmt -73.79 -16.31 61.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 73.200000000000003 110.883 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -51.49 -53.82 33.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 74.299999999999997 110.871 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.54 17.0 2.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.117 -0.492 . . . . 75.109999999999999 111.158 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 64.6 mtp 56.49 33.12 22.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.216 -0.447 . . . . 72.400000000000006 110.89 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.73 154.22 20.74 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.229 -0.441 . . . . 74.030000000000001 110.88 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 45.3 t -104.81 131.0 54.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.227 -0.442 . . . . 73.150000000000006 111.09 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 2.2 t90 -111.85 124.69 52.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 73.540000000000006 110.973 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 16.5 t -121.45 103.35 8.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.293 -0.412 . . . . 73.140000000000001 110.926 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 46.56 70.99 0.34 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.236 -0.438 . . . . 74.219999999999999 110.9 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 47.69 40.31 17.69 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.71 -0.757 . . . . 74.099999999999994 112.503 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -141.78 102.27 4.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.92 0.391 . . . . 74.439999999999998 110.847 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 4.6 tttt -53.44 102.11 0.05 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 65.340000000000003 110.862 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 21.7 mmm -64.79 167.29 7.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.481 . . . . 74.140000000000001 110.867 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -119.33 106.09 11.95 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.204 -0.453 . . . . 74.329999999999998 110.882 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 18.8 p -95.83 177.9 5.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 72.310000000000002 111.144 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -125.08 83.59 2.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 73.420000000000002 111.128 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -51.58 113.68 2.54 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.751 -0.738 . . . . 72.340000000000003 112.498 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.297 0 CA-C-O 120.813 0.34 . . . . 73.420000000000002 110.894 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.252 0 N-CA-C 112.455 -0.258 . . . . 64.230000000000004 112.455 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -134.87 130.87 36.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.761 0.315 . . . . 74.120000000000005 111.138 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -104.38 98.19 8.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 71.209999999999994 110.914 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.24 109.85 11.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.458 . . . . 75.200000000000003 111.134 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 86.6 m-70 -101.15 108.04 19.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.158 -0.474 . . . . 71.400000000000006 110.861 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -123.97 124.26 42.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.142 -0.481 . . . . 75.200000000000003 110.799 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 66.5 p -85.86 157.97 20.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.119 -0.491 . . . . 74.120000000000005 110.838 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 97.5 t -150.16 104.32 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.085 -0.507 . . . . 65.25 111.14 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 52.75 -113.58 2.88 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.697 -0.763 . . . . 70.120000000000005 112.516 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -110.46 25.81 11.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.844 0.354 . . . . 74.349999999999994 110.867 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 20.9 m-70 -124.84 159.66 30.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.242 -0.435 . . . . 74.239999999999995 110.897 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -121.02 123.68 42.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.255 -0.43 . . . . 74.230000000000004 110.841 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 1.2 p -142.49 154.6 44.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.141 -0.481 . . . . 71.239999999999995 110.946 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -157.62 149.03 21.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.218 -0.446 . . . . 74.430000000000007 110.943 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 9.4 mt -97.84 113.93 33.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 73.209999999999994 111.067 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 2.4 tttt -80.13 102.65 9.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.207 -0.451 . . . . 74.25 110.866 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -98.8 143.92 28.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 75.409999999999997 111.115 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 39.4 t -146.68 124.93 4.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.212 -0.449 . . . . 63.399999999999999 111.164 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.2 p -94.22 139.54 30.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.221 -0.445 . . . . 65.430000000000007 110.823 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.23 145.72 35.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 74.200000000000003 110.844 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 129.81 -179.12 17.02 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.701 -0.762 . . . . 53.329999999999998 112.491 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 6.4 mtmt -52.81 -58.02 8.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.801 0.334 . . . . 73.109999999999999 110.915 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 3.9 ptm180 -150.17 79.45 1.35 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.255 -0.429 . . . . 74.540000000000006 110.912 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 15.6 ttmt 61.73 56.49 2.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 75.230000000000004 110.915 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -90.89 -68.81 0.77 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.176 -0.465 . . . . 71.439999999999998 110.894 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -111.63 128.44 8.63 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.792 -0.718 . . . . 75.230000000000004 112.512 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 56.9 mt -120.29 145.0 27.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.767 0.318 . . . . 74.450000000000003 111.11 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 57.2 mt -128.58 140.12 50.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.177 -0.465 . . . . 75.319999999999993 111.12 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 9.4 m80 -117.91 135.48 54.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.137 -0.483 . . . . 60.299999999999997 110.816 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.82 109.88 12.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.133 -0.485 . . . . 73.5 111.126 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 15.1 tp -68.43 135.63 52.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 73.439999999999998 110.981 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 10.5 mt -138.63 117.27 13.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.455 . . . . 75.439999999999998 111.119 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 21.7 t -117.93 125.82 74.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.172 -0.467 . . . . 73.409999999999997 111.103 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 63.56 37.98 10.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 72.439999999999998 110.934 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 61.4 43.0 10.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 74.340000000000003 110.864 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 16.5 mtt180 -140.23 129.1 23.29 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.177 -0.465 . . . . 72.140000000000001 110.852 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -62.69 146.43 52.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.136 -0.484 . . . . 74.340000000000003 110.899 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -122.85 130.89 24.45 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.699 0.762 . . . . 71.030000000000001 111.14 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 135.57 30.82 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.66 2.24 . . . . 61.299999999999997 112.332 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 116.229 -0.441 . . . . 71.219999999999999 110.889 179.999 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.873 0.368 . . . . 73.310000000000002 111.157 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -159.54 127.8 4.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.234 -0.439 . . . . 74.040000000000006 111.181 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.3 m -106.37 153.95 21.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 75.219999999999999 110.879 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -142.21 156.57 45.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.104 -0.498 . . . . 74.129999999999995 111.11 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 17.2 m-90 -151.45 130.6 12.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.237 -0.438 . . . . 74.239999999999995 110.97 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.3 t -110.25 114.79 48.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.249 -0.432 . . . . 75.329999999999998 111.107 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.69 148.42 39.06 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.197 -0.456 . . . . 74.140000000000001 110.95 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.3 mtm180 -74.73 92.79 2.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.178 -0.464 . . . . 75.140000000000001 110.857 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -121.79 152.07 39.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 72.450000000000003 110.979 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 64.72 15.03 9.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.213 -0.449 . . . . 74.129999999999995 110.889 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.0 0.48 80.95 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.719 -0.753 . . . . 60.340000000000003 112.444 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -139.84 172.76 12.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.854 0.359 . . . . 75.010000000000005 110.914 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -68.58 89.68 0.37 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 73.219999999999999 110.858 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.91 128.58 33.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 71.150000000000006 110.878 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.74 119.7 40.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.131 -0.486 . . . . 62.32 110.875 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -107.13 142.61 19.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.124 -0.489 . . . . 74.430000000000007 111.131 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 48.1 t -135.82 146.72 29.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 72.5 111.153 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.1 tp -128.4 101.24 6.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 74.120000000000005 110.878 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.11 122.77 26.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.189 -0.459 . . . . 73.439999999999998 110.878 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.39 -15.94 59.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 73.519999999999996 110.946 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -51.44 -56.0 15.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.455 . . . . 74.120000000000005 110.868 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 9.5 p -133.87 16.98 3.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.458 . . . . 72.420000000000002 111.129 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 9.6 mtp 58.43 24.55 11.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.302 -0.408 . . . . 71.120000000000005 110.856 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -76.18 144.55 40.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.267 -0.424 . . . . 71.439999999999998 110.842 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 71.4 t -105.1 118.26 52.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 70.0 111.156 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 2.2 t90 -98.34 134.86 40.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.173 -0.467 . . . . 73.329999999999998 110.909 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -131.18 103.14 6.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 75.25 110.914 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 22.7 m-20 45.43 69.66 0.43 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 73.519999999999996 110.992 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 48.65 41.02 25.99 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.773 -0.727 . . . . 70.400000000000006 112.428 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -149.81 115.3 5.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.801 0.334 . . . . 64.109999999999999 110.927 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -53.56 162.21 0.87 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.247 -0.433 . . . . 75.400000000000006 110.85 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 35.1 mmm -126.54 166.49 17.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.445 . . . . 73.420000000000002 110.945 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -119.26 106.41 12.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.268 -0.424 . . . . 74.140000000000001 110.861 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 21.7 p -95.8 -175.17 3.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.161 -0.472 . . . . 74.420000000000002 111.126 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -93.33 -35.76 12.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.449 . . . . 73.010000000000005 111.138 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 73.88 40.57 43.97 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.769 -0.729 . . . . 51.43 112.496 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 . . . . . 0 C--N 1.33 -0.28 0 CA-C-O 120.907 0.384 . . . . 72.310000000000002 110.832 -179.846 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 N-CA-C 112.483 -0.247 . . . . 73.219999999999999 112.483 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.04 130.82 36.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.807 0.336 . . . . 63.119999999999997 111.164 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -104.86 96.63 6.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.222 -0.445 . . . . 73.439999999999998 110.858 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.39 110.21 18.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 72.329999999999998 111.098 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 41.9 m170 -109.53 106.24 15.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 75.030000000000001 110.821 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 9.1 p90 -124.54 144.66 50.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 72.319999999999993 110.899 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 77.0 p -91.28 141.61 28.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 74.040000000000006 110.892 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 17.4 t -138.87 103.47 2.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.175 -0.466 . . . . 72.230000000000004 111.096 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 53.76 31.43 46.01 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.704 -0.76 . . . . 71.120000000000005 112.476 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 63.36 25.35 14.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.874 0.369 . . . . 72.540000000000006 110.883 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 77.6 m-70 -93.5 -11.93 30.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.14 -0.482 . . . . 75.319999999999993 110.825 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 63.87 104.88 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.244 -0.434 . . . . 73.239999999999995 110.801 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 10.9 m -137.91 167.86 20.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.165 -0.47 . . . . 65.400000000000006 110.846 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 18.4 p90 -174.39 142.79 0.8 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.474 . . . . 75.109999999999999 110.919 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 32.0 mt -98.59 111.3 27.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.076 -0.511 . . . . 72.420000000000002 111.141 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 16.9 tttt -80.11 104.03 10.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.485 . . . . 71.310000000000002 110.858 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -99.04 146.67 25.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 73.140000000000001 111.084 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.2 t -144.9 124.3 6.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.251 -0.431 . . . . 75.239999999999995 111.174 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -93.32 129.62 39.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.21 -0.45 . . . . 60.439999999999998 110.839 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -130.17 153.45 48.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 74.019999999999996 110.858 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 83.3 90.24 0.71 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.659 -0.782 . . . . 64.109999999999999 112.516 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.01 -170.13 0.16 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.845 0.355 . . . . 74.140000000000001 110.913 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 11.1 mtt180 -52.89 -32.34 44.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.239 -0.437 . . . . 74.219999999999999 110.854 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 11.7 pttt -173.41 124.1 0.39 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 72.219999999999999 110.916 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -158.58 -54.0 0.07 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.227 -0.442 . . . . 75.049999999999997 110.91 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -128.06 105.98 0.76 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.712 -0.756 . . . . 70.120000000000005 112.482 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 63.3 mt -103.91 134.76 44.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.751 0.31 . . . . 75.510000000000005 111.121 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 53.5 mt -121.04 133.34 68.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.227 -0.442 . . . . 73.099999999999994 111.135 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 14.2 m80 -108.96 137.94 46.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 72.310000000000002 110.848 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.65 103.64 6.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 75.120000000000005 111.128 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 15.9 tp -66.35 138.35 57.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.237 -0.438 . . . . 74.030000000000001 110.907 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 11.0 mt -135.95 119.53 23.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.216 -0.447 . . . . 73.420000000000002 111.105 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 88.2 t -118.5 135.46 58.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 65.319999999999993 111.082 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 54.01 37.01 25.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 63.420000000000002 110.898 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 10.3 t30 63.37 42.93 6.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.166 -0.47 . . . . 54.409999999999997 110.956 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 4.2 mtm180 -141.44 130.46 23.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 70.120000000000005 110.88 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -62.83 146.45 52.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.208 -0.451 . . . . 75.120000000000005 110.853 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -122.98 131.14 24.38 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.65 0.738 . . . . 63.229999999999997 111.11 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.74 135.89 31.66 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.624 2.216 . . . . 75.349999999999994 112.398 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 74.439999999999998 110.89 -179.962 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.881 0.372 . . . . 75.120000000000005 111.157 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -159.47 128.09 5.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 74.140000000000001 111.084 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.8 m -105.98 154.04 21.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.237 -0.438 . . . . 74.540000000000006 110.855 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 27.3 m -141.56 148.58 39.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.139 -0.482 . . . . 74.040000000000006 111.153 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 9.3 m-90 -145.37 122.91 11.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.198 -0.455 . . . . 73.409999999999997 110.89 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 19.5 t -103.32 114.79 43.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 71.239999999999995 111.075 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.97 146.6 35.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.119 -0.491 . . . . 75.049999999999997 110.898 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 4.8 mtt85 -74.44 92.18 2.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 74.439999999999998 110.88 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -122.99 153.74 39.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.207 -0.452 . . . . 74.420000000000002 110.926 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.5 t70 65.14 14.44 9.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.181 -0.463 . . . . 53.399999999999999 110.877 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.55 0.0 79.81 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.791 -0.719 . . . . 51.130000000000003 112.503 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -139.86 172.91 12.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.868 0.366 . . . . 74.340000000000003 110.836 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -68.78 88.13 0.36 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.112 -0.495 . . . . 74.209999999999994 110.879 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.26 124.85 26.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.259 -0.428 . . . . 74.340000000000003 110.907 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -102.03 109.79 21.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 73.120000000000005 110.893 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.5 t -95.25 136.7 25.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 71.519999999999996 111.09 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 86.6 t -136.51 128.58 44.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.163 -0.471 . . . . 75.0 111.126 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.9 tp -110.07 102.31 11.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.138 -0.483 . . . . 74.319999999999993 110.875 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.7 136.15 37.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.211 -0.449 . . . . 64.239999999999995 110.914 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 21.0 mmmt -73.77 -17.15 61.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.135 -0.484 . . . . 73.420000000000002 110.861 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -51.49 -53.88 32.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 63.109999999999999 110.869 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.82 17.0 3.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.201 -0.454 . . . . 72.140000000000001 111.112 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 2.6 ttp 53.67 28.22 7.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 65.510000000000005 110.876 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -85.23 158.62 20.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 73.150000000000006 110.87 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 21.6 t -104.87 138.4 29.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.207 -0.451 . . . . 74.349999999999994 111.15 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 1.2 t90 -123.28 121.12 35.07 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.252 -0.431 . . . . 75.200000000000003 110.872 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 60.8 m -132.21 131.77 42.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.236 -0.438 . . . . 63.109999999999999 110.877 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 41.0 m-20 49.3 50.24 18.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.189 -0.459 . . . . 63.43 110.92 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 49.04 45.08 33.12 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.795 -0.717 . . . . 71.329999999999998 112.447 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -147.96 116.96 6.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.828 0.347 . . . . 74.400000000000006 110.921 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 13.2 mttt -53.17 102.3 0.05 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.295 -0.411 . . . . 72.450000000000003 110.922 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 23.4 mmm -64.52 166.5 8.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 75.25 110.882 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.17 106.0 11.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.994 0.426 . . . . 73.140000000000001 110.836 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 16.0 p -97.72 175.29 6.23 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.099 -0.501 . . . . 75.329999999999998 111.117 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -122.48 90.13 3.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.227 -0.442 . . . . 73.209999999999994 111.074 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -50.85 117.19 5.09 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.726 -0.749 . . . . 73.019999999999996 112.482 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 . . . . . 0 C--N 1.33 -0.252 0 CA-C-O 120.952 0.406 . . . . 74.430000000000007 110.823 -179.864 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 N-CA-C 112.446 -0.262 . . . . 73.099999999999994 112.446 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -134.19 130.78 37.73 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.734 0.302 . . . . 72.140000000000001 111.184 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -98.08 96.13 7.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.296 -0.411 . . . . 63.530000000000001 110.914 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.14 109.4 13.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 75.349999999999994 111.202 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 38.0 m170 -100.66 112.69 25.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.306 -0.406 . . . . 71.400000000000006 110.832 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -125.84 114.43 18.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 74.420000000000002 110.852 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 98.4 p -78.28 151.57 32.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.081 -0.508 . . . . 53.520000000000003 110.842 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 46.9 t -146.81 108.67 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.086 -0.506 . . . . 54.229999999999997 111.147 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 52.92 -109.98 1.14 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.759 -0.734 . . . . 74.219999999999999 112.488 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -116.6 26.4 9.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.881 0.372 . . . . 71.439999999999998 110.916 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 23.9 m-70 -123.49 164.2 19.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 64.430000000000007 110.853 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -126.06 123.17 37.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 72.109999999999999 110.809 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -142.67 150.66 40.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.226 -0.443 . . . . 74.430000000000007 110.878 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 17.6 p90 -150.87 149.61 29.89 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.181 -0.463 . . . . 74.200000000000003 110.979 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 7.6 mt -99.65 114.27 37.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.176 -0.465 . . . . 72.530000000000001 111.126 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.24 103.09 9.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.225 -0.443 . . . . 73.239999999999995 110.871 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -100.13 146.65 26.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.195 -0.457 . . . . 71.519999999999996 111.1 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 66.2 t -149.21 122.94 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.199 -0.455 . . . . 73.25 111.134 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.2 p -92.26 144.56 25.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.186 -0.461 . . . . 71.099999999999994 110.859 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.25 141.82 30.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.487 . . . . 63.140000000000001 110.851 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 129.71 -168.84 21.02 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.696 -0.764 . . . . 63.520000000000003 112.507 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 8.4 mtmt -56.39 -26.75 54.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.794 0.331 . . . . 73.310000000000002 110.93 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -176.97 -40.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 70.239999999999995 110.818 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 34.9 mttt -155.87 31.8 0.35 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 75.340000000000003 110.905 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -55.93 -60.57 3.28 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.179 -0.464 . . . . 74.140000000000001 110.92 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -143.6 142.24 11.09 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.773 -0.727 . . . . 74.420000000000002 112.5 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 47.8 mt -126.16 147.15 31.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.756 0.312 . . . . 75.400000000000006 111.087 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 38.3 mt -128.29 137.14 58.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.205 -0.452 . . . . 73.310000000000002 111.14 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 5.8 m80 -120.72 134.39 55.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 72.329999999999998 110.876 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.48 117.17 23.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.449 . . . . 70.409999999999997 111.183 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 14.0 tp -71.3 132.56 45.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 71.209999999999994 110.953 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 11.0 mt -135.92 116.53 18.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.263 -0.426 . . . . 74.019999999999996 111.126 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 17.0 t -119.08 127.99 75.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 71.099999999999994 111.171 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 2.2 t0 63.89 35.56 10.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 74.299999999999997 110.842 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 1.8 m120 63.33 43.09 6.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 64.439999999999998 110.887 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 58.3 mtt180 -142.97 128.72 19.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.112 -0.495 . . . . 72.430000000000007 110.867 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -62.44 146.5 51.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.457 . . . . 72.200000000000003 110.906 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -121.28 130.65 24.72 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.578 0.704 . . . . 63.130000000000003 111.121 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.67 143.92 52.84 Favored 'Trans proline' 0 N--CA 1.465 -0.157 0 C-N-CA 122.737 2.292 . . . . 74.329999999999998 112.364 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.268 -0.424 . . . . 74.099999999999994 110.835 -179.971 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.1 t . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.841 0.353 . . . . 74.420000000000002 111.158 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -159.62 133.08 7.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 73.530000000000001 111.119 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.3 m -105.66 150.43 25.46 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.197 -0.456 . . . . 75.120000000000005 110.776 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 2.2 m -141.79 154.7 45.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.053 -0.521 . . . . 73.0 111.12 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 12.1 m-90 -151.52 128.61 11.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.437 . . . . 70.140000000000001 110.957 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 19.5 t -108.1 114.9 47.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.237 -0.438 . . . . 74.439999999999998 111.21 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.19 146.06 38.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 75.239999999999995 110.887 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.9 mtm180 -73.37 92.54 1.84 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.137 -0.483 . . . . 75.319999999999993 110.872 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -124.89 153.14 43.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.096 -0.502 . . . . 73.219999999999999 110.867 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 64.62 15.14 9.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.475 . . . . 75.239999999999995 110.891 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 88.1 1.01 82.49 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.722 -0.752 . . . . 72.310000000000002 112.502 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -139.79 172.95 12.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.844 0.354 . . . . 74.140000000000001 110.866 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.42 87.01 0.44 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.165 -0.47 . . . . 54.009999999999998 110.886 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.05 125.29 26.21 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.225 -0.443 . . . . 74.299999999999997 110.855 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 17.3 ttm180 -103.99 109.79 21.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 74.540000000000006 110.841 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 1.4 t -95.54 136.37 26.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.216 -0.447 . . . . 73.030000000000001 111.155 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 93.2 t -136.03 122.65 32.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.204 -0.453 . . . . 74.099999999999994 111.142 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.4 tp -110.31 108.6 18.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.117 -0.492 . . . . 75.340000000000003 110.966 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -85.08 136.73 33.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 74.299999999999997 110.913 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.85 -16.42 61.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.138 -0.483 . . . . 73.530000000000001 110.892 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -51.46 -54.57 25.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.277 -0.419 . . . . 63.25 110.798 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.55 17.06 2.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 63.020000000000003 111.174 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 24.7 mtp 59.18 21.76 9.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 75.430000000000007 110.862 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.57 142.5 51.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.283 -0.417 . . . . 74.209999999999994 110.89 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 65.3 t -105.02 118.45 52.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 75.540000000000006 111.112 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 2.8 t90 -101.16 131.84 46.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.459 . . . . 70.200000000000003 110.908 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -123.97 103.76 8.51 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.22 -0.445 . . . . 74.010000000000005 110.922 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 4.9 p30 39.51 71.59 0.17 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.462 . . . . 72.219999999999999 110.915 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 51.0 41.05 44.61 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.773 -0.727 . . . . 73.310000000000002 112.523 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -150.45 112.66 4.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.878 0.371 . . . . 73.329999999999998 110.866 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 6.4 mtmm -53.63 162.05 0.93 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.217 -0.447 . . . . 75.230000000000004 110.888 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 27.7 mmm -127.89 162.99 25.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 75.049999999999997 110.91 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -119.28 106.35 12.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.295 -0.411 . . . . 75.230000000000004 110.901 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 18.0 p -95.46 -176.71 3.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.142 -0.481 . . . . 74.400000000000006 111.156 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -89.04 -34.57 16.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.44 . . . . 64.409999999999997 111.095 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 60.89 72.99 0.55 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.741 -0.742 . . . . 74.310000000000002 112.53 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 . . . . . 0 C--N 1.329 -0.3 0 CA-C-O 120.913 0.387 . . . . 64.340000000000003 110.895 -179.883 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.378 0 N-CA-C 112.449 -0.261 . . . . 63.5 112.449 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.37 130.81 35.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.748 0.308 . . . . 74.319999999999993 111.188 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -116.14 96.35 5.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 74.030000000000001 110.885 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.77 110.23 18.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 70.140000000000001 111.11 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 67.6 m-70 -109.25 107.1 17.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 75.329999999999998 110.891 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -119.64 -176.15 3.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.23 -0.441 . . . . 74.540000000000006 110.925 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 25.3 p -140.33 165.25 27.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 64.219999999999999 110.835 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 58.3 t -148.85 98.18 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.092 -0.504 . . . . 75.310000000000002 111.08 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 61.19 -108.25 1.83 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.77 -0.728 . . . . 75.299999999999997 112.529 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -106.14 -26.9 11.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.896 0.379 . . . . 71.140000000000001 110.914 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 52.3 m-70 -64.37 -170.19 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.124 -0.489 . . . . 74.209999999999994 110.859 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -153.68 116.38 4.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 74.439999999999998 110.861 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -142.66 163.5 32.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.261 -0.427 . . . . 73.140000000000001 110.886 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 28.5 p90 -161.17 152.87 19.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.191 -0.459 . . . . 73.120000000000005 110.877 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 21.0 mt -99.36 121.44 49.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.133 -0.485 . . . . 73.010000000000005 111.168 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 2.1 tttm -89.95 102.56 15.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 72.450000000000003 110.909 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -99.65 147.24 25.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.439 . . . . 72.209999999999994 111.064 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.8 t -145.46 131.29 13.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.184 -0.462 . . . . 72.329999999999998 111.045 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.1 p -102.2 145.48 29.35 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.162 -0.472 . . . . 71.140000000000001 110.83 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 2.0 p -150.54 165.62 32.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.08 -0.509 . . . . 71.439999999999998 110.897 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 112.56 -49.87 0.81 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.713 -0.756 . . . . 71.25 112.493 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -178.54 -64.81 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.806 0.336 . . . . 74.239999999999995 110.892 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.31 -42.93 0.29 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 75.420000000000002 110.887 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.77 26.82 0.64 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 72.530000000000001 110.833 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -62.52 -71.91 0.15 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.282 -0.417 . . . . 71.530000000000001 110.875 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -127.46 145.08 15.62 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.794 -0.717 . . . . 71.120000000000005 112.568 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 62.9 mt -138.59 139.97 40.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.823 0.344 . . . . 74.239999999999995 111.088 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 68.0 mt -127.37 140.36 49.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.122 -0.49 . . . . 75.25 111.147 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 11.1 m80 -113.21 142.21 46.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 71.140000000000001 110.831 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.87 106.57 7.36 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.197 -0.456 . . . . 75.150000000000006 111.123 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 17.1 tp -67.35 136.39 54.73 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.251 -0.431 . . . . 73.519999999999996 110.951 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 9.3 mt -138.31 121.16 19.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 75.349999999999994 111.158 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 18.0 t -121.93 124.98 72.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 70.439999999999998 111.12 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.5 t0 64.03 36.5 9.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 74.420000000000002 110.822 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 63.4 43.05 6.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.436 . . . . 71.420000000000002 110.873 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 3.9 mtm180 -140.51 128.98 22.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 74.310000000000002 110.92 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.69 146.52 52.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.434 . . . . 74.230000000000004 110.843 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -122.95 130.92 24.42 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.63 0.729 . . . . 75.549999999999997 111.189 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 140.4 42.68 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.738 2.292 . . . . 70.120000000000005 112.351 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 70.530000000000001 110.866 -179.967 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 2.1 p . . . . . 0 N--CA 1.457 -0.115 0 CA-C-O 120.886 0.374 . . . . 60.520000000000003 111.155 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.1 p -159.51 128.29 5.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.224 -0.444 . . . . 72.409999999999997 111.17 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -105.75 150.94 25.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.03 0.443 . . . . 71.409999999999997 110.838 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 12.0 m -143.05 153.07 42.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.095 -0.502 . . . . 62.520000000000003 111.214 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 11.0 m-90 -151.47 127.4 10.34 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.296 -0.411 . . . . 71.510000000000005 110.907 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.5 t -106.99 114.99 47.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.455 . . . . 62.140000000000001 111.148 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.17 147.36 38.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.117 -0.492 . . . . 74.299999999999997 110.962 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 2.7 mtt180 -72.82 91.81 1.53 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 74.230000000000004 110.798 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.1 151.99 40.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 72.239999999999995 110.892 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 64.84 14.75 9.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 75.430000000000007 110.946 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.15 0.39 80.57 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.775 -0.726 . . . . 71.230000000000004 112.506 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -139.72 172.86 12.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.797 0.332 . . . . 73.430000000000007 110.954 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -68.85 89.25 0.4 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.241 -0.436 . . . . 71.430000000000007 110.901 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.43 127.92 34.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 70.219999999999999 110.9 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 58.6 ttt180 -105.5 110.21 22.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.225 -0.443 . . . . 74.109999999999999 110.788 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -95.5 139.75 18.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.103 -0.499 . . . . 63.219999999999999 111.056 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 93.3 t -136.23 130.02 47.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.133 -0.485 . . . . 74.329999999999998 111.134 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.3 tp -118.07 104.46 10.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.102 -0.499 . . . . 74.319999999999993 110.846 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.6 124.67 29.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 63.030000000000001 110.854 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.59 -16.02 59.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 75.540000000000006 110.927 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -51.63 -55.98 16.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.203 -0.453 . . . . 72.150000000000006 110.884 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.3 m -132.76 17.02 4.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.264 -0.425 . . . . 74.310000000000002 111.147 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 82.5 mtp 54.68 31.53 15.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 73.420000000000002 110.85 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -86.46 147.18 26.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.444 . . . . 74.319999999999993 110.893 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 25.2 t -104.84 137.6 33.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.247 -0.433 . . . . 73.519999999999996 111.14 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 1.2 t90 -125.51 129.7 50.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.133 -0.485 . . . . 75.420000000000002 110.881 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 16.8 p -138.48 133.87 33.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.221 -0.445 . . . . 74.329999999999998 110.912 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 46.05 49.14 12.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 63.119999999999997 110.859 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 50.79 44.1 48.27 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.657 -0.782 . . . . 73.319999999999993 112.533 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -147.89 119.0 7.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.849 0.357 . . . . 73.120000000000005 110.952 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 1.5 mtpt -53.1 136.39 35.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 73.340000000000003 110.877 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 67.7 mtp -102.78 165.19 11.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 73.420000000000002 110.87 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -113.31 107.1 15.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.215 -0.448 . . . . 74.430000000000007 110.878 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 16.6 p -99.98 -175.15 2.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.49 . . . . 75.310000000000002 111.099 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -115.06 -29.49 6.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 64.299999999999997 111.109 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 52.41 32.4 37.69 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.724 -0.75 . . . . 71.040000000000006 112.482 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 . . . . . 0 C--N 1.329 -0.312 0 CA-C-O 120.831 0.348 . . . . 75.200000000000003 110.853 -179.854 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 N-CA-C 112.483 -0.247 . . . . 74.219999999999999 112.483 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -134.85 130.84 36.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.71 0.291 . . . . 72.549999999999997 111.144 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -109.49 96.35 6.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 74.5 110.818 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.29 110.24 14.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.449 . . . . 72.409999999999997 111.116 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -105.68 113.03 26.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.272 -0.422 . . . . 73.109999999999999 110.907 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -133.92 178.99 6.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.177 -0.465 . . . . 74.209999999999994 110.883 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 90.7 p -140.39 162.62 34.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 73.099999999999994 110.874 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 39.7 t -146.55 99.48 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 73.230000000000004 111.146 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 68.41 -108.05 2.31 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.704 -0.76 . . . . 73.310000000000002 112.482 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -111.66 -26.35 9.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.781 0.324 . . . . 75.340000000000003 110.913 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 24.7 m-70 -65.9 -169.97 0.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.484 . . . . 75.129999999999995 110.794 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -149.79 119.51 7.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.135 -0.484 . . . . 64.230000000000004 110.885 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -142.41 161.53 37.8 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.252 -0.431 . . . . 71.349999999999994 110.9 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 22.2 p90 -156.89 150.36 24.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.251 -0.431 . . . . 64.430000000000007 110.904 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 10.3 mt -97.61 112.83 30.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.089 -0.505 . . . . 73.310000000000002 111.156 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.92 102.68 10.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.126 -0.488 . . . . 74.319999999999993 110.872 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -98.05 148.13 23.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.259 -0.428 . . . . 64.219999999999999 111.154 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.0 t -144.5 127.31 11.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.262 -0.427 . . . . 65.439999999999998 111.21 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.1 p -97.13 133.71 41.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 64.349999999999994 110.845 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -127.9 137.66 52.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.083 -0.508 . . . . 62.200000000000003 110.8 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 134.55 -174.17 21.13 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.738 -0.744 . . . . 60.119999999999997 112.489 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 5.7 mttm -86.66 -48.88 7.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.79 0.329 . . . . 73.329999999999998 110.914 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 44.4 mtm180 -134.77 69.18 1.45 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 71.310000000000002 110.84 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 26.1 mttp 58.32 60.36 2.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.226 -0.443 . . . . 73.519999999999996 110.889 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -77.81 -65.22 1.0 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 73.540000000000006 110.859 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -136.8 145.23 17.05 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.758 -0.734 . . . . 73.040000000000006 112.511 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 69.4 mt -126.5 143.45 39.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.807 0.337 . . . . 71.109999999999999 111.145 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 60.1 mt -128.44 132.93 67.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.143 -0.48 . . . . 75.219999999999999 111.131 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 13.5 m80 -106.91 141.11 38.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 55.109999999999999 110.873 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.6 106.36 7.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.225 -0.443 . . . . 74.409999999999997 111.124 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 17.1 tp -64.91 135.87 56.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 72.329999999999998 110.891 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 10.0 mt -138.1 117.38 14.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.061 -0.518 . . . . 74.230000000000004 111.193 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 20.2 t -119.45 127.02 75.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 72.519999999999996 111.149 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 2.9 t0 63.8 35.29 11.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.144 -0.48 . . . . 73.120000000000005 110.897 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 63.43 43.11 6.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.235 -0.439 . . . . 64.150000000000006 110.872 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 42.4 mtt180 -140.85 129.7 23.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.484 . . . . 73.200000000000003 110.831 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -62.77 146.47 52.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 73.299999999999997 110.848 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -123.04 130.86 24.43 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.581 0.705 . . . . 74.230000000000004 111.132 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.76 139.03 39.21 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.643 2.229 . . . . 75.319999999999993 112.369 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.199 -0.455 . . . . 73.430000000000007 110.899 -179.97 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 13.4 t . . . . . 0 C--O 1.233 0.204 0 CA-C-O 120.811 0.338 . . . . 74.519999999999996 111.13 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.1 p -159.35 128.1 5.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.27 -0.423 . . . . 72.340000000000003 111.181 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.4 m -105.92 149.61 26.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.455 . . . . 64.400000000000006 110.847 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 24.7 m -140.19 138.81 35.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.15 -0.477 . . . . 54.439999999999998 111.153 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 18.7 m-90 -131.68 133.51 44.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.242 -0.436 . . . . 71.040000000000006 110.951 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.2 t -112.88 114.78 47.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.451 . . . . 75.129999999999995 111.157 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.2 146.48 36.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 74.439999999999998 110.9 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.9 91.89 2.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 74.109999999999999 110.874 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -123.09 152.97 40.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 73.129999999999995 110.915 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 64.87 14.86 9.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.165 -0.47 . . . . 75.329999999999998 110.829 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 88.94 0.4 81.2 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.745 -0.74 . . . . 72.120000000000005 112.498 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -139.83 173.0 11.98 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.788 0.327 . . . . 75.239999999999995 110.89 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -68.98 87.45 0.37 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.138 -0.483 . . . . 71.140000000000001 110.886 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.3 127.51 32.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 74.129999999999995 110.909 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -107.6 117.35 33.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 75.439999999999998 110.916 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -107.25 146.02 13.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 70.409999999999997 111.106 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 22.0 t -135.92 152.69 31.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 74.530000000000001 111.182 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.1 tp -131.38 99.83 4.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 70.120000000000005 110.882 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.83 134.37 43.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 74.450000000000003 110.896 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 3.0 mmmt -73.78 -17.92 61.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 74.010000000000005 110.861 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -51.35 -55.1 20.28 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.216 -0.447 . . . . 75.150000000000006 110.83 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.86 16.72 4.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 75.5 111.156 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 3.8 ttm 54.05 27.24 7.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.208 -0.451 . . . . 72.120000000000005 110.886 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.83 160.51 22.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.184 -0.462 . . . . 73.129999999999995 110.835 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 55.5 t -104.64 143.58 15.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 74.400000000000006 111.125 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 2.3 t90 -123.75 120.89 34.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.185 -0.461 . . . . 74.519999999999996 110.924 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 19.6 t -136.55 132.55 35.35 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.276 -0.42 . . . . 72.239999999999995 110.905 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 51.92 48.33 22.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.157 -0.474 . . . . 54.439999999999998 110.884 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 48.62 47.21 30.1 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.733 -0.746 . . . . 71.310000000000002 112.474 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.6 118.76 5.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.838 0.351 . . . . 75.329999999999998 110.932 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.24 101.95 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.212 -0.449 . . . . 72.299999999999997 110.88 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 38.5 mmm -55.68 176.65 0.06 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 73.340000000000003 110.843 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -119.16 106.51 12.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 72.340000000000003 110.914 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 59.4 p -99.14 -175.3 2.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 73.109999999999999 111.151 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -106.55 -44.64 4.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 72.450000000000003 111.126 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 77.04 53.07 5.42 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.825 -0.702 . . . . 73.310000000000002 112.456 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 . . . . . 0 C--N 1.329 -0.286 0 CA-C-O 120.86 0.362 . . . . 75.030000000000001 110.846 -179.875 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.255 0 N-CA-C 112.499 -0.24 . . . . 63.229999999999997 112.499 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.04 130.79 36.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.688 0.28 . . . . 74.340000000000003 111.218 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -98.89 100.23 11.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.271 -0.422 . . . . 73.430000000000007 110.955 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.98 110.24 17.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.46 . . . . 74.010000000000005 111.193 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 63.7 m-70 -100.77 105.78 17.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.257 -0.429 . . . . 75.310000000000002 110.814 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -139.29 156.54 46.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.245 -0.434 . . . . 75.099999999999994 110.849 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -111.64 123.73 50.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.086 -0.506 . . . . 75.340000000000003 110.917 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 27.2 t -106.15 125.89 61.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.114 -0.494 . . . . 65.120000000000005 111.082 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 52.36 41.3 54.84 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.727 -0.749 . . . . 70.219999999999999 112.478 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 64.33 26.02 13.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.799 0.333 . . . . 74.510000000000005 110.837 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 25.7 m-70 -113.12 -169.27 1.45 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 73.549999999999997 110.832 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -116.48 110.63 18.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 62.329999999999998 110.898 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 12.1 m -138.38 173.47 11.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 74.010000000000005 110.923 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 32.0 p90 -174.97 143.44 0.71 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.199 -0.455 . . . . 75.209999999999994 110.953 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 20.6 mt -97.73 113.63 32.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.076 -0.511 . . . . 73.120000000000005 111.094 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 27.9 tttt -79.84 102.74 9.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 72.340000000000003 110.914 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -97.19 136.02 38.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 74.420000000000002 111.075 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.3 t -133.91 121.14 38.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.23 -0.441 . . . . 74.049999999999997 111.185 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.3 p -94.53 143.1 26.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.145 -0.48 . . . . 74.25 110.833 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 2.3 t -136.52 134.14 37.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.091 -0.504 . . . . 73.549999999999997 110.89 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 136.12 171.92 12.46 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.728 -0.749 . . . . 71.129999999999995 112.493 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 6.5 mmtt -59.06 -28.64 66.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.764 0.316 . . . . 65.530000000000001 110.884 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 2.1 mtt180 -148.82 -63.43 0.24 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 72.409999999999997 110.872 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -152.75 44.39 0.67 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 75.510000000000005 110.84 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -57.68 -58.55 7.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.313 -0.403 . . . . 74.239999999999995 110.866 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -145.1 162.27 28.14 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.725 -0.75 . . . . 64.129999999999995 112.5 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 55.4 mt -144.85 145.45 21.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.786 0.327 . . . . 74.329999999999998 111.144 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 75.6 mt -133.82 123.68 45.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.466 . . . . 75.049999999999997 111.186 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 5.6 m80 -104.38 137.19 42.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 72.120000000000005 110.932 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.91 108.8 11.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 75.299999999999997 111.2 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 14.8 tp -66.33 136.36 55.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.277 -0.419 . . . . 73.420000000000002 110.904 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 12.4 mt -133.62 129.41 55.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.146 -0.479 . . . . 74.230000000000004 111.17 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 95.6 t -127.17 118.17 49.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.446 . . . . 74.340000000000003 111.149 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 63.61 41.0 7.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.134 -0.485 . . . . 72.329999999999998 110.853 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 63.34 43.01 6.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 73.430000000000007 110.812 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 17.7 mtm180 -138.98 121.97 16.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.216 -0.447 . . . . 74.439999999999998 110.922 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -62.75 146.48 52.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 70.140000000000001 110.913 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -123.99 131.55 24.24 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.619 0.723 . . . . 63.240000000000002 111.117 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 133.44 25.49 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.625 2.217 . . . . 74.430000000000007 112.34 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.246 -0.433 . . . . 73.239999999999995 110.924 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 71.8 p . . . . . 0 N--CA 1.458 -0.069 0 CA-C-O 120.864 0.364 . . . . 74.140000000000001 111.209 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -159.53 127.77 4.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.187 -0.46 . . . . 74.120000000000005 111.151 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 14.5 m -106.42 113.16 26.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.263 -0.426 . . . . 72.109999999999999 110.842 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 17.2 p -110.18 159.59 17.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.121 -0.491 . . . . 74.140000000000001 111.064 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 14.6 m-90 -149.57 155.97 41.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.223 -0.444 . . . . 72.450000000000003 110.911 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 18.9 t -131.52 114.95 26.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 74.340000000000003 111.158 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.22 147.63 38.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 75.150000000000006 110.884 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.65 94.29 3.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.155 -0.475 . . . . 71.140000000000001 110.834 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.68 154.05 39.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 71.299999999999997 110.908 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.1 t70 64.91 14.87 9.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.19 -0.459 . . . . 74.519999999999996 110.833 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 88.79 0.48 81.43 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.714 -0.755 . . . . 62.109999999999999 112.489 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -139.79 172.88 12.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.88 0.372 . . . . 75.019999999999996 110.855 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -68.43 89.4 0.35 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 71.310000000000002 110.907 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.72 123.99 26.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.437 . . . . 74.299999999999997 110.96 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -104.09 115.04 29.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 74.109999999999999 110.87 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -102.98 138.89 25.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.183 -0.462 . . . . 73.219999999999999 111.184 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 96.3 t -135.77 126.99 44.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.434 . . . . 74.409999999999997 111.169 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.3 tp -110.36 100.4 9.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.444 . . . . 72.230000000000004 110.959 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.4 136.15 38.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.447 . . . . 65.439999999999998 110.921 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 3.6 mtmt -73.21 -17.48 61.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 75.219999999999999 110.834 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -51.39 -54.91 21.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.222 -0.445 . . . . 74.140000000000001 110.871 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 14.9 p -132.55 16.82 4.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.176 -0.465 . . . . 72.129999999999995 111.12 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 81.2 mtp 51.59 31.1 7.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 74.209999999999994 110.895 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -86.57 153.27 21.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 71.299999999999997 110.875 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 95.6 t -104.92 123.09 58.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.233 -0.439 . . . . 72.109999999999999 111.18 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -104.94 131.97 51.77 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.232 -0.44 . . . . 70.010000000000005 110.91 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 24.4 t -126.99 103.19 7.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 73.340000000000003 110.931 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 12.0 m-20 45.35 70.28 0.37 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 71.549999999999997 110.885 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 48.72 39.01 23.34 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.78 -0.724 . . . . 61.240000000000002 112.504 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.25 107.42 4.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.893 0.377 . . . . 72.040000000000006 110.88 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.28 143.27 18.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 73.519999999999996 110.89 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 22.7 mmm -111.24 163.99 13.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 60.299999999999997 110.866 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -117.79 107.8 14.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 75.140000000000001 110.876 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 19.2 p -95.26 -179.36 4.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.144 -0.48 . . . . 71.099999999999994 111.177 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -92.41 -31.26 15.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 71.25 111.114 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 58.82 54.69 35.88 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.791 -0.718 . . . . 72.0 112.458 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.309 0 CA-C-O 120.915 0.388 . . . . 75.140000000000001 110.957 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 N-CA-C 112.498 -0.241 . . . . 61.32 112.498 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.21 130.8 35.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.686 0.279 . . . . 71.120000000000005 111.21 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -109.82 97.44 6.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.302 -0.408 . . . . 73.230000000000004 110.865 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.51 110.44 19.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 72.219999999999999 111.142 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 67.5 m-70 -106.15 105.6 15.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 73.519999999999996 110.837 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -122.97 131.07 53.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 70.510000000000005 110.808 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 27.8 p -83.07 149.79 26.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 74.0 110.857 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.8 t -140.65 99.65 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.051 -0.522 . . . . 74.030000000000001 111.066 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 54.58 -115.88 5.88 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.726 -0.749 . . . . 61.5 112.479 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -106.04 25.41 10.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.81 0.338 . . . . 72.219999999999999 110.884 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 67.4 m-70 -119.2 -175.48 2.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 72.439999999999998 110.824 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -145.33 84.42 1.7 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 61.0 110.872 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 6.8 m -99.53 165.08 11.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.231 -0.441 . . . . 74.150000000000006 110.897 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 19.9 p90 -167.48 145.04 4.56 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.175 -0.466 . . . . 75.019999999999996 110.89 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 32.9 mt -98.63 111.26 27.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.134 -0.485 . . . . 75.019999999999996 111.155 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.33 103.14 12.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.122 -0.49 . . . . 63.539999999999999 110.902 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -94.27 146.08 24.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 74.109999999999999 111.157 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.5 t -138.41 124.79 25.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.289 -0.414 . . . . 74.299999999999997 111.126 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -99.86 146.87 26.14 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.184 -0.462 . . . . 73.530000000000001 110.878 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 1.4 p -149.29 150.6 32.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 73.340000000000003 110.826 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 109.1 64.56 0.55 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.778 -0.725 . . . . 72.420000000000002 112.507 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.19 -75.44 0.07 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.794 0.33 . . . . 73.209999999999994 110.876 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -138.72 -58.97 0.62 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 73.310000000000002 110.962 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 2.9 tttt -135.39 103.07 5.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.116 -0.493 . . . . 72.540000000000006 110.98 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -144.87 -62.8 0.36 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 72.420000000000002 110.852 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -135.16 127.38 4.35 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.765 -0.731 . . . . 64.140000000000001 112.459 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 69.1 mt -122.99 138.57 52.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.763 0.316 . . . . 64.209999999999994 111.185 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 54.9 mt -127.53 128.92 70.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.178 -0.464 . . . . 75.510000000000005 111.088 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 15.3 m80 -100.22 137.98 37.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 73.439999999999998 110.914 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.88 109.3 11.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 74.349999999999994 111.107 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 19.1 tp -67.3 138.46 56.85 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.152 -0.477 . . . . 75.439999999999998 110.893 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 8.6 mt -139.01 128.59 30.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 75.5 111.114 179.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 64.1 t -127.81 122.73 59.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.109 -0.496 . . . . 74.409999999999997 111.15 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 2.4 t0 63.77 38.24 9.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.204 -0.453 . . . . 72.209999999999994 110.867 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 2.0 t30 63.32 43.11 6.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 70.340000000000003 110.842 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.14 131.61 23.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 74.209999999999994 110.879 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -62.34 146.4 51.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.218 -0.446 . . . . 75.239999999999995 110.954 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -123.72 130.52 24.43 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.646 0.736 . . . . 73.129999999999995 111.137 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 147.83 63.53 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.713 2.275 . . . . 73.430000000000007 112.324 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 116.245 -0.434 . . . . 75.420000000000002 110.91 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 2.4 m . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.837 0.351 . . . . 75.340000000000003 111.115 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -159.8 128.15 4.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 73.109999999999999 111.138 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.9 m -106.04 151.99 23.95 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.209 -0.451 . . . . 73.239999999999995 110.826 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 95.7 m -146.34 141.81 27.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.111 -0.495 . . . . 63.32 111.145 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 21.7 m-90 -132.35 158.8 41.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 75.25 110.968 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.0 t -133.26 114.82 21.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.342 -0.39 . . . . 73.25 111.144 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.64 147.58 37.79 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.226 -0.443 . . . . 75.109999999999999 110.919 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 42.3 mtp180 -72.72 92.09 1.53 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 75.430000000000007 110.858 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -121.61 151.52 40.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 72.120000000000005 110.904 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 64.85 14.69 9.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.232 -0.44 . . . . 75.120000000000005 110.884 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.2 0.69 80.03 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.752 -0.737 . . . . 74.450000000000003 112.489 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -139.87 172.73 12.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.867 0.365 . . . . 74.420000000000002 110.942 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -68.24 89.88 0.33 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.162 -0.472 . . . . 63.340000000000003 110.865 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.96 134.14 38.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 74.409999999999997 110.912 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 25.9 ttm180 -111.11 119.51 39.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 70.019999999999996 110.877 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -105.41 145.13 13.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.2 -0.455 . . . . 74.540000000000006 111.167 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 91.4 t -134.37 144.24 35.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.249 -0.432 . . . . 70.040000000000006 111.135 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.4 tp -131.52 101.53 5.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 75.209999999999994 110.929 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.63 132.11 42.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.27 -0.423 . . . . 72.450000000000003 110.881 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.35 -16.58 61.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 72.510000000000005 110.93 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -52.59 -55.96 18.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 74.299999999999997 110.829 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.56 16.99 3.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 74.200000000000003 111.116 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 68.1 mtp 57.91 30.23 18.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.445 . . . . 62.350000000000001 110.884 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -77.83 143.07 38.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.455 . . . . 72.150000000000006 110.902 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 17.2 t -104.62 128.06 58.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 74.510000000000005 111.209 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 3.2 t90 -119.97 114.39 21.96 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.23 -0.441 . . . . 74.120000000000005 110.894 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 3.0 t -100.97 103.09 14.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.25 -0.432 . . . . 73.349999999999994 110.892 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 67.91 -76.16 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 73.150000000000006 110.926 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -159.08 45.77 0.44 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.739 -0.744 . . . . 74.340000000000003 112.462 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.86 114.2 4.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.893 0.378 . . . . 74.219999999999999 110.868 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.3 101.94 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.459 . . . . 73.109999999999999 110.879 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 64.1 mtp -60.85 157.32 15.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 73.420000000000002 110.9 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -102.9 106.65 17.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 72.409999999999997 110.868 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 15.5 p -98.66 -176.28 3.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 73.329999999999998 111.111 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -112.89 -75.36 0.6 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.275 -0.42 . . . . 65.439999999999998 111.094 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 104.68 86.15 1.9 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.727 -0.749 . . . . 73.319999999999993 112.511 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 . . . . . 0 C--N 1.329 -0.297 0 CA-C-O 120.869 0.366 . . . . 73.340000000000003 110.914 -179.889 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 N-CA-C 112.539 -0.224 . . . . 63.149999999999999 112.539 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.32 130.87 33.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.76 0.314 . . . . 75.030000000000001 111.145 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.73 97.68 11.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 73.530000000000001 110.881 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -77.46 110.55 12.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.114 -0.494 . . . . 74.140000000000001 111.112 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -98.91 111.63 23.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.267 -0.424 . . . . 63.020000000000003 110.869 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -144.8 159.55 42.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.454 . . . . 64.209999999999994 110.903 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.8 166.5 14.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 63.420000000000002 110.895 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 24.2 t -145.54 97.97 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.159 -0.473 . . . . 75.129999999999995 111.084 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 67.22 -88.98 0.16 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.738 -0.744 . . . . 61.020000000000003 112.478 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -139.5 25.9 2.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.828 0.347 . . . . 61.340000000000003 110.86 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 67.1 m-70 -115.77 -175.77 2.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 73.0 110.899 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -140.89 116.56 10.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.26 -0.427 . . . . 72.540000000000006 110.893 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 1.9 p -142.56 158.19 43.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 70.25 110.959 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 19.9 p90 -150.84 145.34 25.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.227 -0.442 . . . . 75.439999999999998 110.926 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.2 mt -97.74 112.46 29.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.095 -0.502 . . . . 74.219999999999999 111.174 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.69 102.88 9.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 74.400000000000006 110.93 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -99.02 143.85 28.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.229 -0.441 . . . . 71.439999999999998 111.098 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 20.9 t -142.33 124.43 13.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 73.25 111.149 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.3 p -94.38 140.43 29.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.455 . . . . 73.310000000000002 110.821 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 10.4 t -134.47 135.7 42.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.068 -0.515 . . . . 62.020000000000003 110.886 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 135.78 -145.65 17.65 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.709 -0.757 . . . . 74.450000000000003 112.447 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -88.79 -36.4 16.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.819 0.342 . . . . 73.430000000000007 110.858 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 1.7 mtm-85 -152.35 -47.5 0.1 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.284 -0.416 . . . . 72.439999999999998 110.831 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 7.7 pttp -159.55 37.82 0.2 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.165 -0.471 . . . . 72.430000000000007 110.931 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -59.08 -70.6 0.15 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.236 -0.438 . . . . 74.129999999999995 110.896 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -129.58 128.23 5.66 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.76 -0.733 . . . . 74.430000000000007 112.485 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 48.6 mt -120.44 147.46 24.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.816 0.341 . . . . 72.439999999999998 111.122 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 3.0 mt -131.96 130.23 61.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 73.340000000000003 111.074 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 8.7 m80 -108.71 134.96 50.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 74.25 110.917 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.28 110.14 13.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.188 -0.46 . . . . 71.010000000000005 111.156 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 11.8 tp -66.96 135.38 53.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.212 -0.449 . . . . 73.209999999999994 110.951 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 10.8 mt -136.81 106.19 4.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 74.109999999999999 111.206 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 47.7 t -109.39 128.94 64.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 74.310000000000002 111.142 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 63.31 41.28 7.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.194 -0.457 . . . . 74.120000000000005 110.816 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 56.6 42.68 26.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.237 -0.438 . . . . 72.319999999999993 110.87 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 10.5 mtp180 -140.44 126.44 19.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 75.310000000000002 110.836 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.58 145.29 54.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 74.409999999999997 110.885 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -123.61 131.29 24.28 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.663 0.744 . . . . 75.409999999999997 111.125 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 132.25 22.99 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.755 2.303 . . . . 73.5 112.336 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.245 -0.434 . . . . 73.099999999999994 110.85 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 CA-C-O 121.444 0.469 . . . . 52.399999999999999 112.478 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 138.8 38.84 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.724 2.283 . . . . 72.140000000000001 112.318 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -81.0 58.29 3.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.441 . . . . 74.120000000000005 110.918 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -177.39 178.95 48.31 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.735 -0.745 . . . . 55.420000000000002 112.493 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 9.3 t 59.25 -179.0 0.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.831 0.348 . . . . 72.239999999999995 110.879 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -165.94 -51.2 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 72.140000000000001 110.89 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -158.23 58.66 0.46 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 75.340000000000003 110.835 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.75 98.57 3.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.464 . . . . 72.439999999999998 110.868 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 36.5 m -120.6 35.81 4.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.454 . . . . 75.129999999999995 110.835 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.83 -31.59 68.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 73.430000000000007 110.89 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 68.3 p -110.19 29.87 7.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 72.310000000000002 111.143 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -159.65 127.98 4.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.23 -0.441 . . . . 62.32 111.134 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.3 m -106.17 152.79 23.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 61.539999999999999 110.863 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 7.9 m -140.66 154.79 46.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.147 -0.479 . . . . 74.319999999999993 111.172 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 14.0 m-90 -151.12 131.54 13.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.231 -0.44 . . . . 73.109999999999999 110.915 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.2 t -113.03 114.61 47.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 64.430000000000007 111.115 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -139.36 145.95 39.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 74.430000000000007 110.888 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 17.2 ttt180 -74.0 93.39 2.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 63.219999999999999 110.827 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -126.27 152.95 45.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.187 -0.46 . . . . 73.019999999999996 110.911 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 3.1 t70 64.51 15.32 9.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 64.400000000000006 110.894 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.23 1.55 84.04 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.734 -0.746 . . . . 53.329999999999998 112.467 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -139.83 173.07 11.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.876 0.37 . . . . 75.219999999999999 110.899 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -69.63 87.97 0.5 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.146 -0.479 . . . . 64.109999999999999 110.876 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -70.39 126.7 30.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 75.230000000000004 110.913 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 12.3 ttt180 -108.14 116.72 32.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 75.239999999999995 110.865 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.6 139.96 30.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 73.349999999999994 111.128 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 47.3 t -135.66 139.36 46.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 72.519999999999996 111.109 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.9 tp -114.75 99.87 7.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 75.420000000000002 110.93 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.22 134.24 42.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.441 . . . . 75.439999999999998 110.88 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.7 mmmt -73.81 -17.63 61.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.13 -0.486 . . . . 75.120000000000005 110.907 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -51.27 -52.75 42.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 65.019999999999996 110.886 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 17.0 p -134.92 16.98 3.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 71.430000000000007 111.204 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 53.13 28.66 7.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 75.430000000000007 110.92 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.62 159.67 19.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 63.549999999999997 110.914 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 85.8 t -104.93 134.09 47.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 73.319999999999993 111.121 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 4.1 t90 -115.94 120.24 38.53 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.154 -0.475 . . . . 70.420000000000002 110.933 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 11.3 t -136.6 132.05 34.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.242 -0.436 . . . . 74.329999999999998 110.857 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 50.51 48.03 23.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.197 -0.456 . . . . 75.140000000000001 110.851 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 49.45 47.88 35.27 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.785 -0.722 . . . . 54.119999999999997 112.508 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.18 113.85 4.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.835 0.35 . . . . 74.319999999999993 110.88 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 2.5 ttpm? -53.71 101.72 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 75.230000000000004 110.897 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 25.1 mmm -60.97 169.92 1.76 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 75.219999999999999 110.897 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -119.17 106.96 12.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 74.239999999999995 110.906 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 24.4 p -95.6 -175.28 3.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 74.040000000000006 111.198 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -95.12 -39.47 10.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.259 -0.428 . . . . 75.140000000000001 111.124 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 69.53 40.03 78.69 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.727 -0.749 . . . . 72.439999999999998 112.466 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -87.2 117.78 26.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.858 0.361 . . . . 75.230000000000004 110.902 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -95.46 114.36 26.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 74.430000000000007 110.848 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 23.5 m -93.34 -178.47 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.137 -0.483 . . . . 63.229999999999997 111.112 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -55.49 -34.07 64.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 74.430000000000007 110.875 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -151.93 102.05 2.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.202 -0.453 . . . . 75.200000000000003 110.835 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 111.98 178.36 20.01 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.749 -0.739 . . . . 73.129999999999995 112.54 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.24 130.71 35.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.73 0.3 . . . . 75.329999999999998 111.186 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -106.35 96.36 6.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.259 -0.428 . . . . 75.420000000000002 110.867 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.06 110.26 15.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 74.420000000000002 111.153 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 77.1 m-70 -104.83 105.38 15.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.455 . . . . 74.409999999999997 110.87 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -126.13 132.92 51.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.471 . . . . 75.010000000000005 110.887 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 54.7 p -83.33 144.48 29.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 65.109999999999999 110.88 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.6 t -134.58 98.1 2.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 75.209999999999994 111.102 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 52.12 -119.29 8.71 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.674 -0.774 . . . . 75.420000000000002 112.537 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -100.4 28.25 5.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.851 0.358 . . . . 71.129999999999995 110.849 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 49.0 m-70 -130.87 165.67 22.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 73.129999999999995 110.868 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -124.35 88.9 2.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 74.409999999999997 110.866 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 9.8 m -98.49 172.76 7.31 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.207 -0.451 . . . . 63.229999999999997 110.903 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 55.5 p90 -175.22 145.6 0.79 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.196 -0.456 . . . . 75.25 110.937 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 23.2 mt -97.43 111.23 26.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.117 -0.492 . . . . 74.409999999999997 111.127 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -80.18 102.86 9.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 71.310000000000002 110.868 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -95.49 146.44 24.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 53.130000000000003 111.088 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.4 t -143.89 120.49 5.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.264 -0.425 . . . . 72.319999999999993 111.14 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.3 p -87.25 140.72 29.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 64.450000000000003 110.869 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 5.0 p -132.56 148.68 52.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.118 -0.492 . . . . 75.5 110.863 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 111.06 -162.93 12.32 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.792 -0.718 . . . . 63.229999999999997 112.479 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.47 -44.87 85.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.794 0.331 . . . . 75.430000000000007 110.906 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.23 -60.83 0.13 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 73.439999999999998 110.852 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 17.7 mtmt -137.18 37.72 2.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 74.329999999999998 110.86 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.25 -62.21 1.84 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.266 -0.424 . . . . 75.150000000000006 110.884 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -135.16 122.47 2.83 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.768 -0.73 . . . . 51.539999999999999 112.516 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 69.6 mt -110.77 144.85 17.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.846 0.355 . . . . 74.150000000000006 111.112 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 3.0 mt -129.84 127.97 64.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 74.209999999999994 111.173 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 13.0 m80 -105.01 136.51 44.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 74.319999999999993 110.857 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.61 106.1 8.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 64.519999999999996 111.092 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 30.4 tp -65.29 139.36 58.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.193 -0.458 . . . . 74.129999999999995 110.917 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 9.4 mt -137.43 129.97 42.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 74.430000000000007 111.118 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 99.5 t -125.49 115.43 43.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.47 . . . . 74.109999999999999 111.125 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 63.66 46.88 3.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.15 -0.477 . . . . 74.430000000000007 110.918 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 58.69 42.8 19.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.143 -0.481 . . . . 74.409999999999997 110.918 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.19 124.9 19.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 71.200000000000003 110.85 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -62.56 146.2 52.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 74.439999999999998 110.903 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -120.73 131.12 24.56 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.606 0.717 . . . . 63.43 111.135 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 134.4 27.9 Favored 'Trans proline' 0 N--CA 1.465 -0.161 0 C-N-CA 122.714 2.276 . . . . 73.400000000000006 112.348 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -91.37 152.01 20.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.234 -0.439 . . . . 61.439999999999998 110.913 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -52.13 -36.96 52.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 73.200000000000003 110.938 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 63.4 p -51.72 118.97 3.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 65.209999999999994 111.133 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 75.340000000000003 110.965 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 CA-C-O 121.485 0.492 . . . . 63.439999999999998 112.488 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.77 140.58 42.99 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.737 2.292 . . . . 63.299999999999997 112.324 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.33 -45.67 2.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.191 -0.459 . . . . 72.099999999999994 110.903 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 109.52 -47.83 1.0 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.665 -0.778 . . . . 74.140000000000001 112.497 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 56.03 28.12 12.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.866 0.365 . . . . 75.540000000000006 110.88 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -103.52 67.88 0.92 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 64.439999999999998 110.91 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -113.02 -66.62 1.07 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.484 . . . . 74.319999999999993 110.867 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.06 130.2 56.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.148 -0.478 . . . . 72.430000000000007 110.857 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 20.2 m -67.19 161.14 25.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.192 -0.458 . . . . 71.310000000000002 110.903 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.11 124.13 32.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.173 -0.467 . . . . 73.409999999999997 110.927 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 40.4 p -96.65 -31.04 12.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.24 -0.436 . . . . 73.450000000000003 111.161 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -159.52 128.33 5.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.193 -0.458 . . . . 71.010000000000005 111.091 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.9 m -105.8 152.79 22.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 74.319999999999993 110.844 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 56.1 m -147.52 137.42 22.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 74.140000000000001 111.15 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 16.7 m-90 -130.27 156.86 43.94 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.202 -0.453 . . . . 73.239999999999995 110.883 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 19.7 t -128.95 114.84 34.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.234 -0.439 . . . . 73.409999999999997 111.163 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.33 147.52 38.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.27 -0.423 . . . . 73.230000000000004 110.899 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.54 92.78 2.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 74.409999999999997 110.853 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.1 152.66 39.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 72.25 110.852 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 64.93 14.78 9.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.17 -0.468 . . . . 61.509999999999998 110.887 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.08 0.43 80.77 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.747 -0.739 . . . . 72.310000000000002 112.514 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -139.92 172.78 12.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.847 0.356 . . . . 73.319999999999993 110.873 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -68.29 89.44 0.33 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.158 -0.473 . . . . 61.32 110.836 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.36 127.27 32.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.221 -0.445 . . . . 74.340000000000003 110.937 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 12.2 ttp180 -106.08 116.01 31.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.135 -0.484 . . . . 73.310000000000002 110.897 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -101.83 141.98 17.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.248 -0.433 . . . . 75.450000000000003 111.081 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 96.9 t -135.93 126.47 42.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 64.120000000000005 111.168 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.5 tp -110.48 111.9 23.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.468 . . . . 75.349999999999994 110.871 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.26 135.25 33.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 71.420000000000002 110.888 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.16 -16.25 61.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.476 . . . . 73.129999999999995 110.885 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -51.74 -55.87 17.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 75.409999999999997 110.879 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.1 p -136.22 17.09 3.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.436 . . . . 74.400000000000006 111.122 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 69.0 mtp 58.16 29.33 17.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 72.120000000000005 110.947 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.64 146.05 34.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 74.120000000000005 110.909 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 98.4 t -105.0 123.51 59.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.235 -0.439 . . . . 75.030000000000001 111.154 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 2.3 t90 -105.27 131.59 52.54 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.178 -0.465 . . . . 73.340000000000003 110.943 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 1.2 m -128.3 103.3 7.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.258 -0.428 . . . . 75.209999999999994 110.883 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 24.2 m-20 45.56 70.54 0.35 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 71.340000000000003 110.886 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 48.6 40.16 24.3 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.748 -0.739 . . . . 70.219999999999999 112.438 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.04 107.23 4.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.903 0.383 . . . . 71.239999999999995 110.91 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 4.3 mttt -53.41 152.62 4.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 63.409999999999997 110.945 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 27.2 mmm -123.89 164.83 18.47 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.295 -0.411 . . . . 73.109999999999999 110.867 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -118.97 110.14 16.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 75.299999999999997 110.941 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 19.3 p -95.63 174.34 7.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 73.329999999999998 111.162 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -174.77 -169.59 0.43 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 72.219999999999999 111.116 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 118.63 -111.54 2.15 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.736 -0.745 . . . . 65.140000000000001 112.523 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -177.55 175.52 1.4 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.832 0.348 . . . . 75.129999999999995 110.931 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -110.85 145.07 38.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 72.049999999999997 110.929 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 7.6 m -108.34 -179.77 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.15 -0.477 . . . . 75.409999999999997 111.147 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -52.68 -29.34 26.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 44.340000000000003 110.872 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -151.66 97.32 2.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.25 -0.432 . . . . 74.25 110.851 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 111.44 169.24 18.71 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.726 -0.75 . . . . 72.010000000000005 112.472 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -134.8 130.76 36.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.727 0.299 . . . . 73.519999999999996 111.134 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -87.32 96.5 10.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 75.299999999999997 110.963 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.92 110.17 15.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 74.209999999999994 111.133 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -108.31 111.96 24.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 74.109999999999999 110.861 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -125.46 134.02 52.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 74.150000000000006 110.854 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 60.6 p -78.6 139.2 38.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.169 -0.469 . . . . 71.109999999999999 110.896 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.4 t -130.87 98.06 3.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 74.129999999999995 111.123 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 51.85 -124.24 23.15 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.669 -0.777 . . . . 54.140000000000001 112.502 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -95.89 25.23 4.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.813 0.34 . . . . 71.340000000000003 110.856 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 45.9 m-70 -121.64 -169.99 1.96 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 74.519999999999996 110.838 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -149.83 81.48 1.39 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 73.230000000000004 110.847 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 8.3 m -96.29 166.07 11.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.242 -0.435 . . . . 62.100000000000001 110.843 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -167.27 144.48 4.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 74.209999999999994 110.961 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 44.9 mt -99.5 111.21 28.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 72.420000000000002 111.139 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 5.0 tttp -80.56 103.11 10.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.153 -0.476 . . . . 74.140000000000001 110.851 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -95.23 143.07 26.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.462 . . . . 64.349999999999994 111.074 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.2 t -136.58 120.61 24.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 73.420000000000002 111.077 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.2 p -90.75 132.84 35.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 74.040000000000006 110.794 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 9.5 p -124.38 138.64 54.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.091 -0.504 . . . . 74.019999999999996 110.907 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 132.85 -104.05 0.53 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.71 -0.757 . . . . 71.530000000000001 112.471 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 12.3 ttmt -142.73 -46.14 0.32 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.785 0.326 . . . . 71.25 110.906 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 5.9 ttt180 -137.21 -45.83 0.56 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.216 -0.447 . . . . 75.340000000000003 110.869 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 11.6 tttt -167.83 55.64 0.07 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 75.540000000000006 110.955 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -82.43 -64.53 1.16 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 74.209999999999994 110.849 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -135.34 114.2 1.2 Allowed Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.685 -0.769 . . . . 70.120000000000005 112.441 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 76.2 mt -105.97 139.56 26.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.848 0.356 . . . . 74.519999999999996 111.121 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 72.0 mt -126.43 122.83 62.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.46 . . . . 75.150000000000006 111.131 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 18.1 m80 -96.66 137.8 35.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 73.200000000000003 110.881 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.79 104.26 7.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.21 -0.45 . . . . 74.329999999999998 111.138 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 15.9 tp -63.81 138.97 58.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.289 -0.414 . . . . 73.340000000000003 110.925 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 10.0 mt -137.76 120.75 20.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 73.140000000000001 111.089 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 89.5 t -121.32 130.83 74.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.095 -0.502 . . . . 73.349999999999994 111.089 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 58.79 36.91 24.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.12 -0.491 . . . . 75.439999999999998 110.832 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 2.6 t30 63.34 43.07 6.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 72.349999999999994 110.877 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.14 128.77 21.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 74.140000000000001 110.875 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -62.62 146.5 51.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 74.230000000000004 110.856 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -123.81 131.37 24.25 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.569 0.699 . . . . 73.140000000000001 111.097 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 135.18 29.81 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.7 2.266 . . . . 63.200000000000003 112.334 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -91.06 151.14 21.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 74.5 110.91 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.3 tp -68.28 102.48 1.39 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.149 -0.478 . . . . 74.430000000000007 110.969 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 80.5 p -111.25 -42.1 4.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 74.310000000000002 111.166 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.248 -0.433 . . . . 73.310000000000002 110.886 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.245 0 CA-C-O 121.419 0.455 . . . . 71.519999999999996 112.54 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.66 156.78 62.7 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.661 2.241 . . . . 74.010000000000005 112.347 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 9.7 mt -112.86 -26.73 8.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 73.430000000000007 110.95 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 111.38 -40.8 2.42 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.759 -0.734 . . . . 71.340000000000003 112.506 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.9 m 56.56 -173.68 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.857 0.36 . . . . 74.340000000000003 110.85 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -116.65 164.71 14.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.471 . . . . 74.109999999999999 110.935 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -85.34 170.45 12.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.137 -0.483 . . . . 74.519999999999996 110.85 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 9.5 ttt180 56.32 54.24 7.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 74.340000000000003 110.925 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 83.4 p -141.3 38.9 1.73 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.114 -0.494 . . . . 72.209999999999994 110.841 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.16 44.3 1.15 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.118 -0.492 . . . . 74.319999999999993 110.892 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -158.99 -42.75 0.06 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 73.230000000000004 111.099 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -159.56 127.89 5.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 75.310000000000002 111.197 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.7 m -106.22 155.04 19.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.241 -0.436 . . . . 72.319999999999993 110.894 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 72.3 p -144.88 155.08 43.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 73.319999999999993 111.177 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 15.3 m-90 -151.35 133.54 15.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.242 -0.435 . . . . 74.25 110.928 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.3 t -112.95 114.84 48.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.283 -0.417 . . . . 71.109999999999999 111.055 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -139.73 145.87 38.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 73.400000000000006 110.914 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -74.62 92.99 2.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 73.329999999999998 110.851 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -124.9 153.73 42.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.471 . . . . 75.519999999999996 110.987 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.7 t70 64.5 15.42 9.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.271 -0.422 . . . . 73.400000000000006 110.805 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.69 1.31 83.12 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.768 -0.729 . . . . 74.239999999999995 112.502 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -139.92 173.03 11.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.779 0.323 . . . . 75.099999999999994 110.884 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -69.74 87.85 0.52 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.161 -0.472 . . . . 73.519999999999996 110.884 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.52 127.43 32.7 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.258 -0.428 . . . . 74.329999999999998 110.93 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 8.8 ttm180 -107.87 115.29 29.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.185 -0.461 . . . . 75.450000000000003 110.83 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -106.67 137.64 36.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.12 -0.491 . . . . 75.319999999999993 111.081 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 90.1 t -135.76 128.56 47.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.187 -0.461 . . . . 74.340000000000003 111.182 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.5 tp -110.2 103.46 12.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.476 . . . . 75.120000000000005 110.96 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.24 134.95 37.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.232 -0.44 . . . . 75.450000000000003 110.863 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 9.2 mmmt -73.13 -17.2 61.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.126 -0.488 . . . . 73.109999999999999 110.889 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -51.6 -55.18 20.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 71.129999999999995 110.838 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.45 16.97 4.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 74.129999999999995 111.105 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 4.0 ttm 53.54 32.36 14.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.232 -0.44 . . . . 73.409999999999997 110.848 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.99 155.03 20.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.289 -0.414 . . . . 61.140000000000001 110.863 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 99.6 t -104.83 130.18 56.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 70.140000000000001 111.172 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 7.7 t-105 -112.7 122.88 48.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.089 -0.505 . . . . 75.030000000000001 110.872 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 24.6 t -128.48 131.78 48.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.134 -0.485 . . . . 75.129999999999995 110.805 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 27.3 m-20 50.08 54.63 10.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 73.230000000000004 110.862 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 49.82 37.42 28.25 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.754 -0.736 . . . . 64.540000000000006 112.483 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -143.38 165.77 26.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.868 0.366 . . . . 70.030000000000001 110.916 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -85.93 157.92 20.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 74.200000000000003 110.88 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 35.2 mmm -124.76 166.98 15.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 73.430000000000007 110.88 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -119.23 106.59 12.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 71.140000000000001 110.853 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 19.2 p -95.91 -175.26 3.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 73.129999999999995 111.113 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -104.61 -29.54 10.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 72.109999999999999 111.107 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 61.98 39.92 98.2 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.733 -0.746 . . . . 55.130000000000003 112.452 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 49.5 tt0 -71.43 138.72 49.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.865 0.364 . . . . 73.400000000000006 110.898 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -109.95 125.66 53.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.161 -0.472 . . . . 74.209999999999994 110.908 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 31.1 m -105.56 -178.36 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.471 . . . . 72.140000000000001 111.197 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -53.47 -30.37 40.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 63.329999999999998 110.878 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -160.65 88.45 0.78 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.174 -0.466 . . . . 72.129999999999995 110.866 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 134.44 -178.32 18.52 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.765 -0.731 . . . . 74.140000000000001 112.549 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.25 130.8 35.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.762 0.315 . . . . 72.319999999999993 111.145 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -108.18 103.62 12.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.481 . . . . 73.430000000000007 110.982 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.13 110.35 17.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.211 -0.45 . . . . 75.340000000000003 111.14 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 68.4 m-70 -105.37 105.26 15.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 73.25 110.784 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 18.2 p90 -123.85 134.56 53.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 74.109999999999999 110.913 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 3.3 p -77.8 139.51 39.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 61.530000000000001 110.867 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.6 t -133.48 106.3 9.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 62.439999999999998 111.092 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 53.31 -116.35 5.65 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.741 -0.742 . . . . 73.030000000000001 112.435 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -110.25 26.22 10.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.795 0.331 . . . . 74.040000000000006 110.872 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 24.6 m-70 -124.1 -169.81 2.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 71.200000000000003 110.86 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -140.85 81.69 1.81 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 71.209999999999994 110.902 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 11.1 m -91.62 157.43 16.98 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.24 -0.436 . . . . 74.25 110.917 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 39.3 p90 -159.83 143.33 14.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 74.510000000000005 110.882 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 35.5 mt -97.54 111.67 27.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.126 -0.488 . . . . 72.209999999999994 111.064 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 33.2 ttmt -80.04 102.87 9.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.475 . . . . 75.400000000000006 110.968 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -95.02 142.21 27.77 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.176 -0.465 . . . . 73.25 111.137 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.3 t -138.8 124.58 23.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.254 -0.43 . . . . 75.439999999999998 111.138 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.4 p -95.81 133.14 40.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 53.240000000000002 110.932 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -133.68 133.21 41.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.151 -0.477 . . . . 65.319999999999993 110.891 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 112.01 -176.33 17.95 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.754 -0.736 . . . . 72.129999999999995 112.428 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.84 130.55 35.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.849 0.357 . . . . 74.430000000000007 110.916 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 20.5 mmt180 54.31 43.06 31.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 74.450000000000003 110.874 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 3.0 mttt 55.51 48.06 19.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.136 -0.484 . . . . 75.409999999999997 110.911 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -52.17 -68.42 0.17 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 64.219999999999999 110.889 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -110.86 125.43 7.39 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.768 -0.73 . . . . 63.520000000000003 112.526 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 64.7 mt -114.81 143.98 23.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.824 0.345 . . . . 73.510000000000005 111.085 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 64.4 mt -132.18 127.35 57.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 74.510000000000005 111.102 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 12.7 m80 -102.81 140.07 37.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.161 -0.472 . . . . 73.329999999999998 110.893 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.37 106.44 8.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.163 -0.471 . . . . 74.319999999999993 111.166 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 30.7 tp -66.8 136.61 55.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 72.0 110.964 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 10.2 mt -137.78 129.78 40.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.446 . . . . 74.349999999999994 111.12 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 57.6 t -126.46 117.78 49.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 65.439999999999998 111.164 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.9 t0 63.69 41.81 6.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.178 -0.464 . . . . 40.200000000000003 110.834 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 62.5 42.92 8.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 74.340000000000003 110.861 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -138.32 124.5 20.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.179 -0.464 . . . . 72.439999999999998 110.892 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -62.59 145.92 53.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.2 -0.455 . . . . 54.310000000000002 110.86 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -121.02 131.16 24.56 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.623 0.725 . . . . 74.030000000000001 111.123 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 134.44 28.0 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.689 2.259 . . . . 73.219999999999999 112.356 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -92.57 112.82 24.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.24 -0.436 . . . . 75.310000000000002 110.874 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 9.6 tp -59.03 120.39 9.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 73.209999999999994 110.941 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 4.0 t -173.98 129.39 0.39 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.153 -0.476 . . . . 74.010000000000005 111.074 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.109 -0.496 . . . . 73.239999999999995 110.887 180.0 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 CA-C-O 121.396 0.442 . . . . 73.319999999999993 112.506 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 95.55 0.56 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.687 2.258 . . . . 64.5 112.297 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -70.22 -43.73 70.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.186 -0.461 . . . . 75.109999999999999 110.906 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 84.94 26.86 36.03 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.744 -0.741 . . . . 64.450000000000003 112.469 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 36.2 p -74.44 128.73 36.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.748 0.309 . . . . 74.219999999999999 110.882 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 60.31 98.27 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.217 -0.447 . . . . 74.230000000000004 110.874 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -116.93 46.96 1.56 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 74.230000000000004 110.871 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 45.9 mtm180 -140.51 44.12 1.86 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 72.150000000000006 110.842 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.6 m -141.18 -179.01 5.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 75.040000000000006 110.863 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.81 -28.95 14.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 74.530000000000001 110.92 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 13.5 p 49.89 41.03 22.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.261 -0.427 . . . . 74.319999999999993 111.179 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.1 p -159.36 128.07 5.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 71.430000000000007 111.159 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -105.97 149.63 26.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.26 -0.427 . . . . 73.510000000000005 110.912 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 92.3 m -137.88 138.47 39.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 73.310000000000002 111.133 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 12.0 m-90 -133.36 123.27 25.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.204 -0.453 . . . . 73.549999999999997 110.969 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 18.7 t -103.63 115.01 44.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 73.409999999999997 111.122 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.25 146.0 36.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 74.219999999999999 110.888 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 56.4 mtm-85 -76.34 93.75 3.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 74.019999999999996 110.862 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -125.73 155.43 40.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 74.430000000000007 110.844 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.3 t0 64.7 15.06 9.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 75.129999999999995 110.891 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 88.17 0.91 82.43 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.756 -0.735 . . . . 75.239999999999995 112.561 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -139.93 172.98 11.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.862 0.363 . . . . 74.329999999999998 110.887 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -70.33 88.16 0.63 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.142 -0.481 . . . . 71.409999999999997 110.875 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.36 123.6 22.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.202 -0.454 . . . . 75.530000000000001 110.875 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 4.9 ttp180 -101.94 109.38 21.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.107 -0.497 . . . . 74.010000000000005 110.804 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.2 t -95.6 134.55 32.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.452 . . . . 74.230000000000004 111.126 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 76.4 t -137.25 125.31 32.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 62.210000000000001 111.083 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.0 tp -110.35 106.8 16.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 72.120000000000005 110.883 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.83 136.46 34.63 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.142 -0.481 . . . . 73.510000000000005 110.887 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.9 mmmt -73.77 -16.51 61.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 73.319999999999993 110.853 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -51.41 -54.21 28.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.466 . . . . 74.099999999999994 110.89 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.86 17.03 3.05 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.191 -0.459 . . . . 73.230000000000004 111.179 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 81.6 mtp 56.77 26.26 11.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 65.329999999999998 110.895 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.55 151.71 32.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.273 -0.421 . . . . 73.140000000000001 110.862 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 70.6 t -105.04 133.5 49.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.171 -0.468 . . . . 70.109999999999999 111.074 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 6.6 t-105 -117.64 123.77 46.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.2 -0.454 . . . . 75.129999999999995 110.891 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 17.9 m -131.18 132.19 44.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.216 -0.447 . . . . 65.129999999999995 110.934 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 40.9 m-20 50.99 53.83 12.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.125 -0.489 . . . . 75.209999999999994 110.93 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 49.09 39.64 27.09 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.765 -0.731 . . . . 74.109999999999999 112.436 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.02 154.81 41.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.848 0.356 . . . . 74.200000000000003 110.907 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 15.8 ttpt -75.67 159.5 31.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 75.120000000000005 110.855 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 38.8 mmm -125.51 166.12 17.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.239 -0.437 . . . . 53.549999999999997 110.879 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -119.25 106.53 12.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.269 -0.423 . . . . 75.209999999999994 110.877 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 17.6 p -95.53 -175.29 3.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 73.400000000000006 111.175 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -107.49 -28.77 9.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.476 . . . . 73.439999999999998 111.102 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 55.64 53.59 40.48 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.78 -0.724 . . . . 71.420000000000002 112.514 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -85.45 102.77 13.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.887 0.375 . . . . 75.420000000000002 110.897 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -77.7 114.07 16.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.108 -0.496 . . . . 72.510000000000005 110.85 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 35.6 m -95.75 -177.29 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.17 -0.468 . . . . 73.010000000000005 111.136 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.99 -26.29 64.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.144 -0.48 . . . . 74.340000000000003 110.861 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -157.99 102.32 1.81 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 71.530000000000001 110.839 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 111.41 -177.23 18.9 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.766 -0.73 . . . . 62.130000000000003 112.512 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.37 130.83 35.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.706 0.289 . . . . 64.430000000000007 111.176 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -108.6 96.6 6.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 74.019999999999996 110.889 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.67 110.47 16.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.173 -0.467 . . . . 71.409999999999997 111.151 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 -105.22 106.61 17.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 73.25 110.805 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 17.8 p90 -124.02 129.54 51.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 74.010000000000005 110.906 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 90.9 p -79.58 156.98 27.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 65.030000000000001 110.88 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 86.6 t -149.62 98.49 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 70.420000000000002 111.118 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 57.01 -106.63 0.75 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.767 -0.73 . . . . 62.329999999999998 112.486 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 21.5 t30 -116.9 24.56 11.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.896 0.379 . . . . 75.219999999999999 110.911 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 66.0 m-70 -117.25 -175.3 2.77 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.13 -0.486 . . . . 74.430000000000007 110.815 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -143.73 78.56 1.6 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 75.340000000000003 110.878 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 12.0 m -93.49 158.89 15.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.146 -0.479 . . . . 75.319999999999993 110.916 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -161.75 144.15 11.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.445 . . . . 75.310000000000002 110.935 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 22.7 mt -97.46 111.2 26.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.169 -0.469 . . . . 73.099999999999994 111.149 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 61.6 tttt -80.1 102.79 9.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.455 . . . . 75.219999999999999 110.897 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -93.65 143.51 26.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.283 -0.417 . . . . 54.100000000000001 111.08 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.3 t -139.89 119.64 13.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 64.230000000000004 111.093 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.2 p -89.04 148.42 23.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.121 -0.49 . . . . 72.319999999999993 110.883 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.55 140.11 24.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.47 . . . . 73.340000000000003 110.906 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 132.47 -152.23 20.17 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.79 -0.719 . . . . 55.210000000000001 112.493 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 9.3 mttp -79.04 -29.84 43.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.77 0.319 . . . . 74.400000000000006 110.921 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 21.0 ptt-85 -169.16 -41.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 72.209999999999994 110.849 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 3.0 ttmm -157.06 30.41 0.3 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 75.230000000000004 110.893 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -56.81 -61.98 2.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 75.209999999999994 110.892 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -136.11 157.91 23.67 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.716 -0.754 . . . . 74.519999999999996 112.48 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 57.5 mt -141.19 146.42 23.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.725 0.298 . . . . 75.430000000000007 111.188 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 2.9 mt -133.01 124.36 49.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.188 -0.46 . . . . 74.239999999999995 111.169 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 12.1 m80 -103.44 138.34 40.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 73.219999999999999 110.845 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.63 109.28 10.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.162 -0.472 . . . . 75.340000000000003 111.132 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 21.0 tp -67.45 137.6 56.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.224 -0.444 . . . . 73.040000000000006 110.884 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 9.6 mt -138.32 129.64 37.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 73.319999999999993 111.147 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 58.4 t -125.68 122.77 63.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 75.409999999999997 111.12 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 58.84 41.29 21.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 74.109999999999999 110.859 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 63.22 43.09 6.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.248 -0.433 . . . . 71.439999999999998 110.888 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 15.4 mtp180 -138.52 125.3 21.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.166 -0.47 . . . . 73.450000000000003 110.865 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -62.36 146.54 50.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 62.229999999999997 110.901 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -123.06 131.01 24.38 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.576 0.703 . . . . 74.219999999999999 111.156 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.72 137.57 35.91 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.611 2.207 . . . . 72.129999999999995 112.404 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.59 167.56 12.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.44 . . . . 53.229999999999997 110.834 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 11.4 tp -116.86 114.76 24.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.12 -0.491 . . . . 74.310000000000002 110.919 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 4.9 t -176.24 -36.3 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 73.230000000000004 111.081 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 116.297 -0.41 . . . . 71.400000000000006 110.941 179.994 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 CA-C-O 121.465 0.48 . . . . 60.340000000000003 112.513 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 125.78 12.56 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.738 2.292 . . . . 64.230000000000004 112.303 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -107.55 151.39 25.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.248 -0.433 . . . . 75.519999999999996 110.915 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -94.61 -148.17 23.64 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.713 -0.756 . . . . 51.299999999999997 112.495 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.7 p -148.87 98.81 2.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.833 0.349 . . . . 62.340000000000003 110.852 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -111.86 109.74 19.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 74.239999999999995 110.886 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -162.91 123.61 2.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.123 -0.489 . . . . 63.030000000000001 110.894 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.5 mtm180 -141.42 97.49 3.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 71.299999999999997 110.908 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 15.4 m 55.09 31.86 17.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 72.409999999999997 110.794 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.37 129.67 49.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.174 -0.466 . . . . 73.450000000000003 110.883 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 50.6 p -136.44 37.15 2.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.17 -0.468 . . . . 73.239999999999995 111.169 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -159.51 127.99 5.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 74.319999999999993 111.136 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.3 m -106.05 149.64 26.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 72.109999999999999 110.894 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 90.1 m -136.98 137.15 39.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.139 -0.482 . . . . 75.519999999999996 111.095 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 9.9 m-90 -132.98 122.81 24.79 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.126 -0.488 . . . . 75.439999999999998 110.891 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 20.0 t -102.7 114.89 43.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.247 -0.433 . . . . 73.430000000000007 111.181 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -142.56 147.3 35.7 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.257 -0.429 . . . . 73.420000000000002 110.927 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 5.6 mtt180 -74.63 92.23 2.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 72.219999999999999 110.864 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.95 153.94 37.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 73.450000000000003 110.908 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 65.17 14.37 9.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 72.209999999999994 110.91 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.99 -0.39 78.99 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.735 -0.745 . . . . 70.329999999999998 112.48 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -139.92 172.89 12.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.797 0.332 . . . . 60.119999999999997 110.919 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -68.36 88.42 0.32 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.155 -0.475 . . . . 72.519999999999996 110.841 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.65 125.94 29.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.236 -0.438 . . . . 65.049999999999997 110.937 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 29.5 ttt180 -102.36 110.9 22.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.191 -0.459 . . . . 75.140000000000001 110.85 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.5 t -95.12 136.43 26.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 72.329999999999998 111.168 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 96.8 t -136.99 127.04 39.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.258 -0.428 . . . . 65.340000000000003 111.137 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.1 tp -110.32 104.44 13.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 72.200000000000003 110.847 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.14 136.42 35.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.113 -0.494 . . . . 75.299999999999997 110.949 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 3.6 mmmt -73.73 -16.74 61.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 74.030000000000001 110.936 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -51.38 -53.0 40.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.232 -0.44 . . . . 72.150000000000006 110.854 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.38 17.04 2.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 74.109999999999999 111.151 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 2.4 ttp 55.55 26.29 8.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.234 -0.439 . . . . 74.140000000000001 110.889 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -80.65 154.54 27.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 61.420000000000002 110.871 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 53.5 t -105.16 134.8 45.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.469 . . . . 72.209999999999994 111.156 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 6.0 t-105 -119.41 126.54 51.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.156 -0.475 . . . . 73.120000000000005 110.826 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 64.4 m -132.93 131.9 41.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 75.409999999999997 110.838 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 43.5 m-20 49.85 54.39 11.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 64.109999999999999 110.837 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 48.55 40.53 24.48 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.797 -0.716 . . . . 64.409999999999997 112.481 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.94 147.7 28.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.873 0.368 . . . . 75.430000000000007 110.893 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 13.1 tttp -68.04 159.91 29.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.258 -0.428 . . . . 75.030000000000001 110.918 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 41.0 mmm -124.55 164.31 20.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.212 -0.449 . . . . 75.409999999999997 110.897 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -119.3 106.29 12.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 63.020000000000003 110.86 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 21.3 p -95.96 -175.05 3.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.112 -0.494 . . . . 65.019999999999996 111.111 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -100.22 -32.2 11.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 74.420000000000002 111.125 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 59.99 96.4 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.709 -0.757 . . . . 73.140000000000001 112.519 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -150.49 102.85 3.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.909 0.385 . . . . 70.319999999999993 110.91 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -83.2 148.79 27.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 64.329999999999998 110.883 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 19.3 m -140.45 -177.09 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.162 -0.472 . . . . 70.439999999999998 111.121 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -57.24 -22.11 38.76 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.166 -0.47 . . . . 71.230000000000004 110.877 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -92.29 -73.69 0.54 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 73.420000000000002 110.827 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -150.17 -123.22 1.16 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.77 -0.728 . . . . 63.340000000000003 112.481 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -136.1 130.79 33.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.733 0.301 . . . . 72.129999999999995 111.146 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -104.13 96.29 6.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.234 -0.439 . . . . 71.310000000000002 110.923 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.98 109.73 19.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.173 -0.467 . . . . 62.520000000000003 111.177 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 70.3 m-70 -102.68 106.84 17.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.24 -0.436 . . . . 75.349999999999994 110.836 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -121.9 123.02 40.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.148 -0.478 . . . . 73.310000000000002 110.903 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.03 153.78 22.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 62.32 110.85 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 47.0 t -147.19 106.7 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 74.129999999999995 111.096 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 56.59 -110.14 1.94 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.733 -0.746 . . . . 74.400000000000006 112.529 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 29.4 m120 -117.38 25.68 10.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.871 0.367 . . . . 75.230000000000004 110.88 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 24.4 m-70 -123.26 163.57 20.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 73.109999999999999 110.891 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -122.23 122.07 38.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 74.450000000000003 110.914 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 1.2 p -141.48 146.95 37.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.448 . . . . 72.530000000000001 110.887 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 26.0 p90 -149.79 147.61 28.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.471 . . . . 73.239999999999995 110.937 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 12.0 mt -97.97 111.74 28.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.136 -0.484 . . . . 72.219999999999999 111.129 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 62.1 tttt -82.52 102.71 11.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 74.049999999999997 110.907 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -95.89 146.05 24.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 64.25 111.127 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.5 t -145.32 116.86 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.273 -0.421 . . . . 75.219999999999999 111.09 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 14.7 p -89.53 147.41 23.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 51.219999999999999 110.853 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 30.6 p -145.88 152.59 39.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.076 -0.511 . . . . 70.140000000000001 110.88 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 112.98 179.29 19.47 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.785 -0.721 . . . . 71.099999999999994 112.501 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.58 -64.0 1.11 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.725 0.298 . . . . 70.329999999999998 110.891 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 11.3 ttm-85 -133.39 83.78 2.08 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.265 -0.425 . . . . 74.230000000000004 110.897 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 13.6 mtmt 52.59 44.52 29.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 74.25 110.83 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -66.63 -49.18 67.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 73.099999999999994 110.871 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -144.96 132.02 4.53 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.774 -0.727 . . . . 51.340000000000003 112.524 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 50.8 mt -119.37 146.88 23.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.826 0.346 . . . . 74.140000000000001 111.129 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 58.9 mt -132.45 126.89 56.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 74.549999999999997 111.159 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 8.5 m80 -109.63 135.34 50.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.258 -0.428 . . . . 74.510000000000005 110.893 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.26 116.91 22.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 73.0 111.191 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 17.7 tp -72.85 133.52 44.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 75.209999999999994 110.944 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 10.9 mt -136.3 118.16 20.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 73.219999999999999 111.07 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 14.6 t -120.54 127.06 75.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.435 . . . . 74.439999999999998 111.133 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 63.6 36.64 10.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.213 -0.449 . . . . 72.209999999999994 110.853 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 62.84 43.04 7.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 74.530000000000001 110.927 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 20.4 mtt180 -142.14 128.12 19.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.112 -0.494 . . . . 75.409999999999997 110.862 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -62.48 146.47 51.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.199 -0.455 . . . . 73.319999999999993 110.916 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -121.85 131.29 24.46 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.685 0.755 . . . . 75.420000000000002 111.126 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 137.93 36.53 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.638 2.225 . . . . 73.340000000000003 112.351 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.12 105.1 17.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.465 . . . . 73.209999999999994 110.904 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 4.6 tp -52.11 130.55 30.41 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.138 -0.483 . . . . 75.540000000000006 110.916 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 53.7 p -121.06 -44.84 2.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 73.420000000000002 111.186 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 73.420000000000002 110.853 -179.933 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 CA-C-O 121.505 0.503 . . . . 74.150000000000006 112.552 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 161.17 46.97 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.76 2.307 . . . . 74.329999999999998 112.344 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -163.8 128.05 2.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 70.120000000000005 110.931 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 155.54 -161.33 30.49 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.747 -0.739 . . . . 72.450000000000003 112.478 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.4 m -163.97 57.1 0.16 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.866 0.365 . . . . 74.439999999999998 110.875 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -140.31 71.9 1.38 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.151 -0.477 . . . . 73.340000000000003 110.907 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -163.56 169.4 18.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.106 -0.497 . . . . 70.349999999999994 110.865 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.22 -68.24 0.2 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.144 -0.48 . . . . 74.209999999999994 110.887 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 25.3 m -129.7 38.81 3.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.257 -0.428 . . . . 73.25 110.845 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 6.1 mtpt -117.71 -30.79 5.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.094 -0.503 . . . . 75.129999999999995 110.908 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 82.3 p -94.17 40.61 1.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.292 -0.413 . . . . 74.420000000000002 111.094 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.1 p -159.47 128.1 5.12 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.214 -0.448 . . . . 74.340000000000003 111.093 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.03 152.2 23.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.196 -0.456 . . . . 71.040000000000006 110.897 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -139.17 156.76 46.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.126 -0.488 . . . . 75.140000000000001 111.125 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 12.6 m-90 -151.62 127.28 10.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.23 -0.441 . . . . 73.329999999999998 111.004 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 18.8 t -105.63 115.21 46.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.236 -0.438 . . . . 72.319999999999993 111.156 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.67 147.36 37.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.199 -0.455 . . . . 75.319999999999993 110.958 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 61.4 mtt180 -72.93 91.7 1.56 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 75.120000000000005 110.955 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -121.64 152.01 39.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 74.310000000000002 110.898 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 15.2 t0 65.09 14.51 9.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.144 -0.48 . . . . 63.119999999999997 110.854 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.7 0.12 79.17 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.773 -0.727 . . . . 65.420000000000002 112.498 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -139.94 172.73 12.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.843 0.354 . . . . 70.25 110.889 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -68.54 89.49 0.36 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.137 -0.483 . . . . 62.119999999999997 110.884 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.21 130.63 38.49 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.126 -0.488 . . . . 73.329999999999998 110.951 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 6.1 ttp180 -106.4 113.84 27.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 73.019999999999996 110.882 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 1.7 t -95.52 139.43 18.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 73.25 111.093 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 92.0 t -136.46 124.95 36.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.473 . . . . 72.340000000000003 111.125 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.4 tp -111.16 105.45 14.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 73.200000000000003 110.943 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.19 134.85 36.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 75.439999999999998 110.884 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 3.9 mmmt -73.87 -16.72 61.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.074 -0.512 . . . . 75.329999999999998 110.849 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -51.45 -55.97 15.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.228 -0.442 . . . . 63.109999999999999 110.857 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.34 17.1 3.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 74.109999999999999 111.133 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER 61.95 18.11 9.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.44 . . . . 73.120000000000005 110.921 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.77 139.23 58.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.186 -0.461 . . . . 72.129999999999995 110.843 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 96.0 t -105.0 118.12 51.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.111 -0.495 . . . . 75.310000000000002 111.153 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -100.6 129.05 46.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 75.030000000000001 110.898 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -123.76 103.37 8.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 72.040000000000006 110.87 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 45.44 69.97 0.4 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 74.239999999999995 110.905 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 49.09 38.73 25.53 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.698 -0.763 . . . . 71.030000000000001 112.505 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -146.38 114.04 6.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.812 0.339 . . . . 74.010000000000005 110.877 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -53.39 160.38 1.19 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.249 -0.432 . . . . 70.209999999999994 110.856 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 30.2 mmm -126.82 163.62 23.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 74.409999999999997 110.875 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -118.79 106.44 12.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.239 -0.437 . . . . 74.129999999999995 110.848 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 17.1 p -95.55 -177.76 4.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.478 . . . . 73.040000000000006 111.155 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -92.5 -31.3 15.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.22 -0.445 . . . . 54.399999999999999 111.068 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 55.09 69.25 1.32 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.78 -0.724 . . . . 73.030000000000001 112.492 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -127.1 113.93 17.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.888 0.375 . . . . 74.129999999999995 110.899 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -85.16 115.72 23.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.457 . . . . 75.150000000000006 110.874 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 22.1 m -84.82 -177.54 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.477 . . . . 63.030000000000001 111.143 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -53.02 -29.95 32.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.264 -0.425 . . . . 75.349999999999994 110.813 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -163.49 93.0 0.74 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 72.299999999999997 110.824 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 128.96 178.31 15.31 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.808 -0.71 . . . . 73.409999999999997 112.459 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -134.73 131.03 37.13 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.73 0.3 . . . . 73.219999999999999 111.175 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -115.34 96.33 5.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 72.25 110.895 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.1 110.02 11.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.117 -0.492 . . . . 61.43 111.139 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 81.4 m-70 -106.93 104.26 13.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.259 -0.428 . . . . 74.019999999999996 110.862 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -124.72 -175.96 3.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 75.25 110.856 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 58.4 p -148.71 160.78 42.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.12 -0.491 . . . . 75.310000000000002 110.84 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 90.8 t -135.2 97.92 2.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.12 -0.491 . . . . 62.200000000000003 111.137 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 54.49 -113.12 3.15 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.752 -0.737 . . . . 63.240000000000002 112.521 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -103.01 25.46 9.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.814 0.34 . . . . 55.420000000000002 110.899 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 28.9 m-70 -111.18 -170.33 1.62 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 71.120000000000005 110.852 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -154.39 107.52 2.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.439 . . . . 75.049999999999997 110.821 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -142.69 161.81 37.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 64.209999999999994 110.91 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -159.4 149.33 18.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.242 -0.435 . . . . 74.540000000000006 110.88 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 8.2 mt -99.12 113.82 35.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.121 -0.49 . . . . 74.340000000000003 111.162 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.54 102.67 10.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.102 -0.499 . . . . 74.450000000000003 110.921 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -100.57 145.46 28.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.24 -0.436 . . . . 71.329999999999998 111.113 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.3 t -144.84 133.74 17.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.202 -0.454 . . . . 74.510000000000005 111.144 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.1 p -104.94 130.34 53.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 64.450000000000003 110.891 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 79.7 p -143.7 150.83 39.26 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.151 -0.477 . . . . 75.310000000000002 110.824 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 129.26 171.27 12.92 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.698 -0.763 . . . . 55.340000000000003 112.452 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 38.1 mttp -63.78 94.55 0.1 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.795 0.331 . . . . 72.150000000000006 110.947 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 15.6 mtt-85 62.86 60.69 1.23 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.227 -0.442 . . . . 73.109999999999999 110.84 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 58.11 82.33 0.13 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.45 . . . . 75.519999999999996 110.885 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -103.73 -53.2 2.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.244 -0.435 . . . . 74.510000000000005 110.938 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -133.66 147.56 19.08 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.795 -0.717 . . . . 75.439999999999998 112.517 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 58.5 mt -127.45 140.99 47.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.768 0.318 . . . . 74.540000000000006 111.137 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 66.1 mt -124.99 141.1 46.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.469 . . . . 75.450000000000003 111.105 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 10.0 m80 -115.92 142.91 46.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.103 -0.498 . . . . 73.319999999999993 110.847 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.6 107.69 8.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.193 -0.458 . . . . 74.219999999999999 111.155 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 16.8 tp -68.61 133.01 47.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.243 -0.435 . . . . 74.030000000000001 110.939 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 12.7 mt -135.01 113.89 16.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.45 . . . . 75.310000000000002 111.099 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 21.3 t -118.38 129.37 74.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 73.430000000000007 111.164 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 63.52 34.64 12.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.155 -0.475 . . . . 72.420000000000002 110.878 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 63.36 42.96 6.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 72.5 110.923 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -142.22 128.54 19.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.1 -0.5 . . . . 65.019999999999996 110.892 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -62.74 146.32 52.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.264 -0.425 . . . . 72.329999999999998 110.959 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -123.04 131.23 24.36 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.629 0.728 . . . . 72.319999999999993 111.101 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.68 137.01 34.68 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.628 2.219 . . . . 74.420000000000002 112.365 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -89.98 132.66 35.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.236 -0.438 . . . . 75.140000000000001 110.866 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 28.1 tp -55.53 114.23 1.76 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 74.439999999999998 110.943 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 79.1 p -124.19 28.76 6.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 72.439999999999998 111.164 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.436 . . . . 72.430000000000007 110.843 179.958 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.237 0 CA-C-O 121.462 0.479 . . . . 73.340000000000003 112.468 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -38.86 7.22 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.733 2.288 . . . . 73.209999999999994 112.332 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.32 135.26 56.02 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.212 -0.449 . . . . 74.510000000000005 110.866 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 96.98 -140.23 14.93 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.739 -0.743 . . . . 62.409999999999997 112.514 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -156.28 173.13 17.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.842 0.353 . . . . 64.040000000000006 110.841 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -110.79 105.43 14.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.132 -0.486 . . . . 72.230000000000004 110.876 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 22.2 m-20 -78.13 -179.04 5.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 71.450000000000003 110.921 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -110.32 175.91 5.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 71.049999999999997 110.933 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -172.87 177.73 2.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.269 -0.423 . . . . 74.340000000000003 110.899 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -128.79 47.32 2.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 71.349999999999994 110.937 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 30.2 p -142.17 40.99 1.64 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.459 . . . . 63.340000000000003 111.166 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -159.55 128.4 5.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 74.450000000000003 111.095 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.3 m -105.95 151.88 24.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.171 -0.468 . . . . 71.349999999999994 110.843 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.24 158.86 43.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.155 -0.475 . . . . 74.010000000000005 111.112 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 18.9 m-90 -151.75 157.32 41.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.218 -0.447 . . . . 74.530000000000001 110.93 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.3 t -135.9 114.98 16.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.448 . . . . 75.109999999999999 111.129 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -142.61 148.47 37.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.1 -0.5 . . . . 74.209999999999994 110.956 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 2.4 mmm180 -72.48 89.66 1.28 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 74.349999999999994 110.886 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -117.16 148.95 41.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.205 -0.452 . . . . 73.230000000000004 110.857 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.3 t0 64.88 14.77 9.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.458 . . . . 73.049999999999997 110.878 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.67 1.25 77.67 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.675 -0.774 . . . . 63.420000000000002 112.487 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -139.82 168.83 18.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.858 0.361 . . . . 75.099999999999994 110.899 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.97 89.01 0.16 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 75.530000000000001 110.85 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -79.8 130.61 35.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 74.209999999999994 110.846 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 10.9 ttp85 -105.73 121.92 45.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 75.530000000000001 110.917 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -106.59 144.99 14.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.145 -0.48 . . . . 74.319999999999993 111.139 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 85.5 t -135.83 144.45 33.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.456 . . . . 74.230000000000004 111.169 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.2 tp -128.8 102.84 6.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.253 -0.431 . . . . 74.129999999999995 110.989 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.26 132.56 42.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 64.400000000000006 110.853 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 9.9 mmmt -73.8 -16.88 61.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.446 . . . . 74.409999999999997 110.884 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -51.44 -55.81 16.72 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.225 -0.443 . . . . 74.409999999999997 110.865 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.45 17.06 3.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.188 -0.46 . . . . 75.319999999999993 111.094 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 8.8 ttm 60.11 29.71 19.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 72.409999999999997 110.869 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -77.07 145.39 37.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.211 -0.449 . . . . 73.150000000000006 110.783 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 36.1 t -104.75 139.24 26.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 72.219999999999999 111.108 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 2.7 t-105 -125.19 124.22 41.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.16 -0.473 . . . . 75.230000000000004 110.891 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -114.06 109.95 19.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.238 -0.437 . . . . 62.100000000000001 110.862 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 12.6 m-20 47.89 67.43 0.83 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 65.239999999999995 110.826 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 49.52 30.64 13.21 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.701 -0.762 . . . . 70.319999999999993 112.497 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.66 120.95 20.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.863 0.363 . . . . 75.439999999999998 110.901 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 18.5 tttt -53.86 151.25 6.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.224 -0.444 . . . . 74.540000000000006 110.84 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 44.2 mmm -117.89 165.61 13.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 74.120000000000005 110.88 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -118.97 106.49 12.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 75.409999999999997 110.829 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 21.7 p -95.95 168.93 10.33 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.126 -0.488 . . . . 55.039999999999999 111.137 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -95.82 -24.26 16.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.204 -0.453 . . . . 72.230000000000004 111.118 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 62.36 76.07 0.28 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.763 -0.732 . . . . 61.43 112.536 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -128.94 101.89 6.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.881 0.372 . . . . 74.519999999999996 110.894 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -88.25 129.9 35.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.149 -0.478 . . . . 73.439999999999998 110.853 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 27.3 m -81.51 -175.59 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.157 -0.474 . . . . 74.109999999999999 111.14 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -52.1 -28.84 19.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.466 . . . . 64.150000000000006 110.927 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -133.58 -76.13 0.48 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 74.540000000000006 110.93 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -62.62 -162.8 0.31 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.718 -0.753 . . . . 73.299999999999997 112.494 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.39 133.41 25.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.827 0.346 . . . . 73.409999999999997 111.111 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -108.2 132.96 53.1 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.253 -0.431 . . . . 75.329999999999998 110.884 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.67 110.28 17.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.155 -0.475 . . . . 73.049999999999997 111.067 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 22.6 m-70 -100.88 110.5 22.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.157 -0.474 . . . . 75.109999999999999 110.868 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -135.38 134.7 40.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 73.140000000000001 110.908 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 2.9 p -84.39 151.85 24.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.153 -0.476 . . . . 62.119999999999997 110.865 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 94.0 t -136.74 97.98 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.117 -0.492 . . . . 73.219999999999999 111.096 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 54.2 -106.34 0.47 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.731 -0.747 . . . . 64.319999999999993 112.492 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 22.8 t30 -116.28 26.32 10.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.868 0.366 . . . . 73.239999999999995 110.851 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 50.3 m-70 -125.19 -169.93 2.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 73.120000000000005 110.823 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -143.18 105.61 4.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.261 -0.427 . . . . 74.230000000000004 110.894 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 13.3 m -120.5 158.41 27.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.444 . . . . 75.310000000000002 110.865 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -158.72 143.61 16.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 73.140000000000001 110.886 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.1 mt -99.27 111.06 27.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.139 -0.482 . . . . 74.519999999999996 111.178 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 7.8 tttm -80.87 102.96 10.38 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.194 -0.457 . . . . 74.040000000000006 110.877 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -92.5 132.45 36.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.246 -0.433 . . . . 60.43 111.092 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.5 t -127.0 125.6 66.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.243 -0.435 . . . . 64.109999999999999 111.105 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.3 p -93.56 136.97 33.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 74.219999999999999 110.798 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 1.4 p -138.94 146.12 40.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.08 -0.509 . . . . 71.430000000000007 110.793 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 132.44 162.48 10.34 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.679 -0.772 . . . . 65.109999999999999 112.501 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -54.72 -41.37 70.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.816 0.341 . . . . 63.329999999999998 110.898 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 12.9 mmt180 -136.35 46.08 2.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.237 -0.438 . . . . 64.219999999999999 110.843 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.54 74.23 0.36 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.191 -0.459 . . . . 75.430000000000007 110.908 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -113.04 -36.58 5.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.222 -0.444 . . . . 75.450000000000003 110.888 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -112.15 111.24 2.79 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.71 -0.757 . . . . 73.439999999999998 112.5 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 46.2 mt -109.91 147.98 13.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.803 0.335 . . . . 75.540000000000006 111.084 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 66.4 mt -137.88 122.17 22.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.136 -0.484 . . . . 74.420000000000002 111.191 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 12.0 m80 -94.95 135.82 36.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 72.329999999999998 110.864 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.09 106.75 10.16 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.147 -0.479 . . . . 75.019999999999996 111.095 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 43.9 tp -66.74 136.47 55.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.215 -0.448 . . . . 74.420000000000002 110.895 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 10.2 mt -137.09 125.73 34.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.196 -0.456 . . . . 73.340000000000003 111.171 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 67.4 t -122.6 119.89 59.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 72.540000000000006 111.146 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 64.0 39.34 8.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 72.5 110.847 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 63.23 43.06 6.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 75.420000000000002 110.886 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -138.94 127.14 22.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.227 -0.442 . . . . 75.25 110.882 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -62.44 146.38 51.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.18 -0.464 . . . . 70.5 110.888 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -119.99 130.88 24.62 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.645 0.736 . . . . 74.109999999999999 111.136 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 127.64 14.87 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.642 2.228 . . . . 72.340000000000003 112.302 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -93.29 126.63 38.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 64.439999999999998 110.888 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.16 99.33 5.38 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.222 -0.445 . . . . 60.140000000000001 110.927 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 3.1 t -153.03 151.47 30.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 75.519999999999996 111.104 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.127 -0.488 . . . . 74.349999999999994 110.88 -179.964 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 CA-C-O 121.451 0.473 . . . . 72.349999999999994 112.502 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.74 -177.29 1.8 Allowed 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.67 2.247 . . . . 73.430000000000007 112.328 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.8 mt -100.89 70.89 1.41 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.179 -0.464 . . . . 74.319999999999993 110.87 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -111.37 -67.22 0.54 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.804 -0.712 . . . . 72.219999999999999 112.481 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -175.25 -69.38 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.94 0.4 . . . . 75.310000000000002 110.898 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -165.89 156.85 13.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.056 -0.52 . . . . 72.230000000000004 110.877 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 9.0 m-20 -121.44 155.94 33.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.087 -0.506 . . . . 74.409999999999997 110.864 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 3.8 mtt180 -55.75 133.47 50.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.127 -0.488 . . . . 75.150000000000006 110.866 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.8 p -103.92 54.16 0.74 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.141 -0.481 . . . . 73.530000000000001 110.835 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -90.28 -28.79 18.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.106 -0.497 . . . . 74.129999999999995 110.91 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 16.6 p -124.36 26.48 7.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.45 . . . . 73.5 111.132 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -159.48 128.04 5.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 63.200000000000003 111.176 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.2 m -106.19 153.33 22.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.185 -0.462 . . . . 73.5 110.813 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 78.9 p -138.54 155.05 48.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.095 -0.502 . . . . 71.409999999999997 111.141 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 10.8 m-90 -151.52 123.64 8.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 75.150000000000006 110.903 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 19.5 t -105.14 114.9 45.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.246 -0.434 . . . . 64.140000000000001 111.168 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -142.74 146.96 34.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.166 -0.47 . . . . 75.530000000000001 110.936 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -73.85 93.0 2.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 75.219999999999999 110.914 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -123.54 152.87 41.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 74.510000000000005 110.922 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.1 t70 64.8 15.03 9.59 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.201 -0.454 . . . . 74.400000000000006 110.882 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 88.55 0.65 81.81 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.79 -0.719 . . . . 62.340000000000003 112.548 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -139.85 172.92 12.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.796 0.331 . . . . 73.219999999999999 110.909 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.69 89.0 0.37 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.134 -0.485 . . . . 73.129999999999995 110.877 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.12 125.41 28.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.147 -0.479 . . . . 65.25 110.911 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 3.6 ttm180 -104.54 109.63 21.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 74.120000000000005 110.888 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -95.78 136.19 27.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 75.439999999999998 111.111 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 94.0 t -136.25 127.03 42.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.097 -0.501 . . . . 72.430000000000007 111.127 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.9 tp -110.11 107.31 17.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.48 . . . . 74.400000000000006 110.885 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.17 136.08 34.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 74.140000000000001 110.918 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 6.6 mmmt -73.54 -16.34 61.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.171 -0.468 . . . . 72.319999999999993 110.888 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -51.51 -55.49 18.68 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.237 -0.438 . . . . 73.129999999999995 110.904 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -136.43 17.0 3.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 75.099999999999994 111.187 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 70.9 mtp 58.49 23.25 10.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 64.439999999999998 110.849 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.99 147.61 42.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 75.530000000000001 110.778 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 85.8 t -105.13 122.54 58.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.138 -0.483 . . . . 75.109999999999999 111.176 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 2.8 t90 -103.63 131.78 50.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.203 -0.453 . . . . 63.520000000000003 110.926 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 1.2 m -126.86 108.21 10.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.286 -0.415 . . . . 54.210000000000001 110.847 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 4.8 p30 39.42 70.1 0.25 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 73.230000000000004 110.83 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 49.75 42.42 36.92 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.775 -0.726 . . . . 64.25 112.466 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -148.12 110.09 4.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.885 0.374 . . . . 72.219999999999999 110.917 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.3 154.95 2.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 65.310000000000002 110.912 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 29.9 mmm -124.61 160.53 28.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 75.120000000000005 110.848 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -115.47 106.96 14.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 72.519999999999996 110.845 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 18.8 p -95.36 179.03 5.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.171 -0.468 . . . . 74.519999999999996 111.098 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -90.58 -40.41 11.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 72.109999999999999 111.098 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 58.6 60.23 9.31 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.769 -0.729 . . . . 72.209999999999994 112.449 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -115.43 109.23 17.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.834 0.349 . . . . 62.240000000000002 110.973 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -70.92 130.08 40.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.128 -0.487 . . . . 73.299999999999997 110.908 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 27.8 m -102.94 -177.0 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.159 -0.473 . . . . 71.25 111.134 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -53.21 -29.58 32.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 74.140000000000001 110.894 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -164.22 92.47 0.65 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.121 -0.491 . . . . 74.299999999999997 110.788 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 127.4 -176.56 17.83 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.782 -0.723 . . . . 73.439999999999998 112.493 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.25 130.82 35.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.683 0.278 . . . . 73.349999999999994 111.155 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -113.73 96.87 6.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 73.239999999999995 110.867 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.42 110.43 16.83 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.127 -0.488 . . . . 74.209999999999994 111.175 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 82.4 m-70 -103.89 106.01 16.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.446 . . . . 61.100000000000001 110.827 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -124.48 131.99 53.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 72.340000000000003 110.871 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 22.9 p -82.02 146.9 29.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.459 . . . . 63.240000000000002 110.852 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.9 t -137.68 98.35 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.097 -0.501 . . . . 75.120000000000005 111.137 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 52.34 -121.28 13.72 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.71 -0.757 . . . . 61.299999999999997 112.501 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -98.75 26.74 5.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.901 0.382 . . . . 71.109999999999999 110.886 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 31.1 m-70 -126.7 174.21 8.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.177 -0.465 . . . . 71.409999999999997 110.834 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -132.79 88.35 2.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 73.409999999999997 110.821 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 10.4 m -100.67 164.78 11.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.166 -0.47 . . . . 75.230000000000004 110.938 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -167.85 144.85 4.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.213 -0.449 . . . . 75.099999999999994 110.97 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 22.7 mt -97.6 111.4 27.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.117 -0.492 . . . . 55.219999999999999 111.066 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 1.8 ttmt -80.12 102.82 9.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 73.25 110.927 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -93.38 146.47 23.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.271 -0.422 . . . . 74.430000000000007 111.067 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.2 t -144.28 121.42 5.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 72.209999999999994 111.157 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -94.26 137.21 33.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 72.319999999999993 110.889 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 2.2 t -132.45 133.21 43.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.112 -0.494 . . . . 65.209999999999994 110.833 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 143.87 -174.94 24.04 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.795 -0.717 . . . . 73.109999999999999 112.488 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.96 -26.51 67.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.728 0.299 . . . . 73.530000000000001 110.881 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.65 -41.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.267 -0.424 . . . . 71.340000000000003 110.861 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 25.4 tttp -162.56 55.75 0.22 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 74.129999999999995 110.842 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -76.74 -62.66 1.56 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.267 -0.424 . . . . 75.120000000000005 110.86 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -141.35 160.38 26.84 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.813 -0.708 . . . . 55.32 112.457 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 64.1 mt -136.4 139.61 45.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.82 0.343 . . . . 75.209999999999994 111.162 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 64.4 mt -126.7 131.05 71.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.138 -0.483 . . . . 73.450000000000003 111.13 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 14.5 m80 -105.83 139.63 40.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.445 . . . . 62.310000000000002 110.883 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.64 103.98 6.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.435 . . . . 73.310000000000002 111.155 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 28.2 tp -65.5 137.8 57.66 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.243 -0.435 . . . . 73.230000000000004 110.878 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 9.8 mt -137.6 130.04 41.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 74.310000000000002 111.168 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 74.2 t -126.51 116.36 44.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.451 . . . . 74.25 111.166 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.4 t0 63.64 46.12 4.29 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.196 -0.456 . . . . 62.240000000000002 110.82 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 1.6 m120 59.08 42.93 18.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.262 -0.426 . . . . 60.420000000000002 110.879 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 10.4 mtm180 -139.69 124.99 18.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 75.140000000000001 110.955 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -62.55 146.48 51.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 64.319999999999993 110.84 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -120.32 130.97 24.59 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.597 0.713 . . . . 73.219999999999999 111.195 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.74 134.15 27.33 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.64 2.227 . . . . 75.329999999999998 112.402 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -92.4 131.7 37.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.269 -0.423 . . . . 73.530000000000001 110.907 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.68 136.5 47.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 74.430000000000007 110.889 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 69.4 p -145.99 160.84 41.29 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.149 -0.478 . . . . 72.140000000000001 111.154 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.216 -0.447 . . . . 73.439999999999998 110.936 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.349 0 CA-C-O 121.453 0.474 . . . . 75.25 112.533 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 154.0 68.43 Favored 'Trans proline' 0 C--O 1.233 0.231 0 C-N-CA 122.704 2.269 . . . . 74.319999999999993 112.386 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -135.21 147.67 49.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.236 -0.438 . . . . 74.200000000000003 110.95 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 130.8 -28.8 3.66 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.748 -0.739 . . . . 65.25 112.426 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 62.51 168.42 0.12 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.852 0.358 . . . . 75.329999999999998 110.869 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 60.13 44.07 13.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.127 -0.488 . . . . 75.310000000000002 110.905 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -77.96 119.94 22.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 74.219999999999999 110.88 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 8.0 mtt85 -149.29 -57.86 0.2 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.146 -0.479 . . . . 74.010000000000005 110.867 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -52.27 130.55 31.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 73.019999999999996 110.837 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.12 126.45 0.15 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.071 -0.513 . . . . 74.510000000000005 110.949 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.07 148.04 23.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.251 -0.432 . . . . 73.109999999999999 111.083 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -159.74 127.77 4.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 72.219999999999999 111.114 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 62.5 m -106.52 116.83 32.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 71.439999999999998 110.841 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 71.6 p -112.34 163.88 13.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.15 -0.477 . . . . 73.219999999999999 111.134 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 21.8 m-90 -149.56 152.17 35.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.196 -0.456 . . . . 74.200000000000003 110.86 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 20.3 t -124.84 115.11 43.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.217 -0.447 . . . . 73.420000000000002 111.079 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.17 147.22 38.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.132 -0.485 . . . . 75.049999999999997 110.934 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 8.7 mtm-85 -72.17 90.99 1.25 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 75.400000000000006 110.913 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.62 151.62 40.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.105 -0.498 . . . . 72.510000000000005 110.922 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.7 t70 65.11 14.59 9.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 73.310000000000002 110.853 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.63 0.14 79.38 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.738 -0.744 . . . . 63.119999999999997 112.479 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -139.88 172.77 12.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.839 0.352 . . . . 75.510000000000005 110.898 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -69.02 89.22 0.42 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.206 -0.452 . . . . 63.420000000000002 110.906 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.56 130.95 39.65 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.164 -0.471 . . . . 73.230000000000004 110.897 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 8.2 ttt180 -107.02 113.12 26.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 74.340000000000003 110.88 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -95.52 141.2 15.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 75.430000000000007 111.19 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 47.5 t -135.85 126.41 42.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 73.349999999999994 111.149 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.2 tp -113.17 99.82 8.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.463 . . . . 74.019999999999996 110.897 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.59 123.54 26.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 71.329999999999998 110.924 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.47 -16.07 59.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 73.519999999999996 110.867 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -51.4 -56.02 15.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 74.340000000000003 110.906 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 76.3 p -132.49 16.94 4.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 74.140000000000001 111.128 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 48.2 mtp 55.7 28.43 12.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 75.200000000000003 110.868 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -81.37 147.14 29.97 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.212 -0.449 . . . . 64.430000000000007 110.867 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 79.5 t -104.81 129.41 57.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.445 . . . . 71.310000000000002 111.163 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 6.1 t-105 -119.95 109.57 15.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.173 -0.467 . . . . 74.439999999999998 110.962 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 7.7 m -97.0 117.81 32.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.441 . . . . 75.540000000000006 110.939 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 64.8 -82.75 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.468 . . . . 72.299999999999997 110.874 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -156.88 46.17 0.49 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.774 -0.727 . . . . 75.319999999999993 112.449 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -159.01 134.29 8.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.908 0.385 . . . . 75.150000000000006 110.899 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 24.9 ttpt -53.74 162.11 0.96 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.161 -0.472 . . . . 72.230000000000004 110.897 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 31.4 mmm -127.76 167.11 16.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 72.129999999999995 110.888 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -119.19 106.62 12.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.285 -0.416 . . . . 74.310000000000002 110.92 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 19.6 p -95.61 -175.3 3.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.118 -0.492 . . . . 73.120000000000005 111.127 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -104.95 -25.16 12.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 62.109999999999999 111.087 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 53.23 47.63 61.04 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.752 -0.737 . . . . 73.120000000000005 112.453 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -81.92 101.97 10.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.816 0.341 . . . . 75.430000000000007 110.945 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -77.4 130.91 37.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.247 -0.433 . . . . 73.430000000000007 110.836 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 17.4 m -112.54 -178.16 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 74.409999999999997 111.128 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -55.58 -26.27 42.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.138 -0.483 . . . . 73.019999999999996 110.895 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -159.88 101.56 1.46 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.143 -0.48 . . . . 74.219999999999999 110.932 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 113.73 -179.26 18.78 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.669 -0.777 . . . . 74.310000000000002 112.462 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -134.83 130.8 36.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.74 0.305 . . . . 75.409999999999997 111.214 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -106.43 96.37 6.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.256 -0.429 . . . . 73.230000000000004 110.886 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.86 110.09 16.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 71.430000000000007 111.173 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 76.7 m-70 -106.86 106.42 16.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 73.400000000000006 110.814 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -121.74 128.82 52.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 72.450000000000003 110.855 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 56.1 p -89.35 159.3 17.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.112 -0.495 . . . . 65.120000000000005 110.85 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 87.0 t -147.86 109.22 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 73.120000000000005 111.101 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 52.0 -118.92 7.92 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.68 -0.771 . . . . 74.329999999999998 112.563 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -107.16 23.49 14.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.881 0.372 . . . . 70.420000000000002 110.916 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -112.57 -169.6 1.51 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 72.129999999999995 110.893 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -151.64 118.9 5.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 73.530000000000001 110.866 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 1.4 p -142.53 163.67 32.21 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.274 -0.421 . . . . 72.310000000000002 110.898 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -167.16 145.53 4.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.173 -0.467 . . . . 75.409999999999997 110.878 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 22.5 mt -97.58 111.55 27.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.086 -0.506 . . . . 72.120000000000005 111.172 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -80.9 106.96 13.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 73.219999999999999 110.879 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -101.83 146.6 27.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.256 -0.429 . . . . 73.099999999999994 111.126 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.3 t -142.05 132.94 25.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.246 -0.434 . . . . 72.129999999999995 111.108 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.1 p -101.17 140.35 35.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.09 -0.505 . . . . 71.519999999999996 110.881 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -133.32 136.74 45.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.138 -0.483 . . . . 73.209999999999994 110.841 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 135.73 -169.16 23.64 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.763 -0.732 . . . . 73.019999999999996 112.477 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 14.2 mttt -64.2 -28.6 69.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.734 0.302 . . . . 74.219999999999999 110.891 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.73 -46.9 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.25 -0.432 . . . . 75.200000000000003 110.904 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 51.6 pttt -162.79 56.21 0.2 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 73.430000000000007 110.901 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -75.2 -56.1 5.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.233 -0.439 . . . . 72.140000000000001 110.915 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -138.85 141.56 12.05 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.714 -0.755 . . . . 75.120000000000005 112.458 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 73.7 mt -125.4 137.19 58.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.739 0.304 . . . . 70.340000000000003 111.188 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 2.8 mt -123.94 131.53 72.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 74.439999999999998 111.08 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 16.4 m80 -105.09 144.94 31.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 74.5 110.813 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.99 105.09 5.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.142 -0.481 . . . . 72.140000000000001 111.07 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 11.7 tp -64.06 135.21 56.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 74.239999999999995 110.923 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 11.0 mt -136.22 104.78 4.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 72.549999999999997 111.118 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 42.2 t -112.66 135.42 52.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 75.329999999999998 111.096 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 63.62 31.69 14.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.137 -0.483 . . . . 73.0 110.86 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 2.2 t30 63.33 42.93 6.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.46 . . . . 73.340000000000003 110.851 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 9.9 mtt85 -143.94 130.18 19.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 74.430000000000007 110.968 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -62.61 146.42 52.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.257 -0.429 . . . . 74.129999999999995 110.879 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -125.03 131.34 24.08 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.686 0.755 . . . . 73.019999999999996 111.078 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.86 133.22 24.87 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.658 2.238 . . . . 75.329999999999998 112.356 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -89.87 133.67 34.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 74.120000000000005 110.876 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.53 106.82 17.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.192 -0.458 . . . . 72.200000000000003 110.871 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 8.3 t -161.39 154.94 21.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.185 -0.461 . . . . 73.120000000000005 111.113 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 65.5 mm-40 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 74.409999999999997 110.93 179.994 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 CA-C-O 121.447 0.471 . . . . 75.540000000000006 112.499 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -69.83 -178.07 2.2 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.719 2.279 . . . . 64.319999999999993 112.275 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -160.51 94.46 1.06 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 72.409999999999997 110.901 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -97.17 -147.4 22.55 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.795 -0.717 . . . . 75.209999999999994 112.536 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.2 p -173.03 120.49 0.36 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.854 0.359 . . . . 62.25 110.911 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -88.58 -66.15 0.95 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.152 -0.476 . . . . 73.530000000000001 110.977 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -173.91 127.15 0.38 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.105 -0.498 . . . . 75.109999999999999 110.876 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 2.2 tpt85 -142.51 156.13 45.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.117 -0.492 . . . . 74.409999999999997 110.845 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -111.25 89.75 3.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.127 -0.488 . . . . 54.340000000000003 110.859 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -132.33 174.84 9.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.1 -0.5 . . . . 73.420000000000002 110.892 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 15.2 t -140.54 21.11 2.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 63.229999999999997 111.117 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -159.62 128.22 5.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.231 -0.44 . . . . 75.019999999999996 111.157 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.4 m -105.8 147.47 28.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 72.430000000000007 110.872 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -136.35 138.25 41.45 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.118 -0.492 . . . . 74.530000000000001 111.176 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 11.1 m-90 -133.42 123.0 24.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.198 -0.456 . . . . 75.319999999999993 110.995 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 19.9 t -102.48 114.92 43.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.339 -0.391 . . . . 74.319999999999993 111.114 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -142.61 147.27 35.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.153 -0.476 . . . . 75.209999999999994 110.925 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 83.4 mtt180 -74.34 92.08 2.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 73.439999999999998 110.946 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.48 153.57 37.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.193 -0.458 . . . . 74.219999999999999 110.947 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 65.03 14.65 9.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.175 -0.466 . . . . 73.25 110.873 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.61 -0.06 79.7 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.705 -0.759 . . . . 63.509999999999998 112.492 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -139.82 172.67 12.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.824 0.345 . . . . 72.310000000000002 110.897 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.3 88.64 0.32 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.141 -0.481 . . . . 72.209999999999994 110.875 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.45 125.82 29.76 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.251 -0.431 . . . . 72.310000000000002 110.911 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 10.1 ttt180 -102.4 111.06 23.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 75.519999999999996 110.881 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.4 t -94.8 135.89 27.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.14 -0.482 . . . . 74.400000000000006 111.153 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 99.4 t -136.55 126.43 39.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 54.200000000000003 111.137 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.7 tp -111.6 103.84 12.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 74.400000000000006 110.871 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -80.26 129.69 34.68 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.183 -0.462 . . . . 75.510000000000005 110.891 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 58.4 mttt -68.71 -15.41 63.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 73.340000000000003 110.895 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -51.27 -52.72 42.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.273 -0.421 . . . . 61.539999999999999 110.831 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -138.2 16.93 2.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.213 -0.449 . . . . 73.219999999999999 111.136 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 1.9 ttp 57.48 26.54 12.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 75.430000000000007 110.874 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -80.38 150.68 29.75 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.29 -0.414 . . . . 71.439999999999998 110.846 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 62.0 t -104.86 134.37 46.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.15 -0.477 . . . . 71.040000000000006 111.13 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 1.1 t90 -123.5 116.2 22.8 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.184 -0.462 . . . . 74.140000000000001 110.909 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 17.9 p -120.95 132.94 55.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.302 -0.408 . . . . 74.140000000000001 110.819 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 58.9 m-20 44.57 51.54 7.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.125 -0.489 . . . . 73.409999999999997 110.865 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 50.82 40.83 42.67 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.748 -0.739 . . . . 63.520000000000003 112.456 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.46 122.61 12.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.854 0.359 . . . . 65.099999999999994 110.965 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.49 147.98 9.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.44 . . . . 72.25 110.894 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 32.5 mmm -114.14 169.05 9.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 74.120000000000005 110.847 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.56 106.37 12.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 74.0 110.903 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 17.4 p -99.35 -175.11 2.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 70.409999999999997 111.178 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -94.77 -44.8 7.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 75.109999999999999 111.06 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 65.11 52.87 37.3 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.707 -0.759 . . . . 75.430000000000007 112.483 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -103.89 102.18 11.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.889 0.376 . . . . 74.239999999999995 110.903 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -73.01 114.36 11.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 74.439999999999998 110.833 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 35.2 m -92.4 -179.98 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.101 -0.499 . . . . 73.420000000000002 111.093 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -52.62 -30.14 29.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.189 -0.46 . . . . 74.439999999999998 110.885 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -161.54 101.63 1.19 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.472 . . . . 74.109999999999999 110.817 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 116.4 176.48 18.0 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.767 -0.73 . . . . 61.539999999999999 112.508 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -134.86 130.91 36.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.735 0.302 . . . . 71.439999999999998 111.203 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -111.91 96.3 5.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 74.439999999999998 110.882 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.81 110.23 13.8 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.22 -0.446 . . . . 71.519999999999996 111.157 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 82.7 m-70 -104.52 106.38 16.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 75.030000000000001 110.87 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -128.09 175.52 8.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 73.200000000000003 110.845 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 83.3 p -142.42 155.75 45.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.088 -0.506 . . . . 73.230000000000004 110.911 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 84.7 t -136.87 105.29 4.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.469 . . . . 73.420000000000002 111.073 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 62.34 -103.48 0.61 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.726 -0.749 . . . . 71.439999999999998 112.496 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -114.23 -27.43 7.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.81 0.338 . . . . 73.140000000000001 110.893 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 52.0 m-70 -61.37 -170.43 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.191 -0.459 . . . . 74.349999999999994 110.855 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -152.6 116.39 4.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 74.019999999999996 110.921 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -142.66 161.98 36.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.242 -0.435 . . . . 72.319999999999993 110.852 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 18.3 p90 -156.71 152.72 27.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 73.129999999999995 110.905 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 13.4 mt -99.55 111.53 29.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 74.430000000000007 111.14 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 1.1 ttpp -81.89 102.62 10.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 72.140000000000001 110.893 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -98.6 147.99 24.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.281 -0.418 . . . . 62.439999999999998 111.119 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.5 t -145.18 122.44 4.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 73.400000000000006 111.122 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.2 p -89.67 139.97 30.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.472 . . . . 74.099999999999994 110.852 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 14.7 t -141.67 142.17 33.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.084 -0.507 . . . . 60.340000000000003 110.859 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 128.65 175.64 14.14 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.792 -0.718 . . . . 62.509999999999998 112.519 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 9.6 mttt -58.48 -38.11 76.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.749 0.309 . . . . 74.040000000000006 110.938 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -158.74 76.98 0.75 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 70.310000000000002 110.868 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 2.3 mtmt 55.85 28.89 13.11 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.208 -0.451 . . . . 74.299999999999997 110.88 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -54.39 -44.74 72.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 71.319999999999993 110.892 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -143.87 132.3 4.83 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.705 -0.759 . . . . 43.219999999999999 112.434 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 50.5 mt -121.13 147.15 25.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.812 0.339 . . . . 72.0 111.126 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 59.9 mt -129.45 131.01 67.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 74.140000000000001 111.118 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 10.8 m80 -108.69 137.27 46.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.446 . . . . 74.239999999999995 110.869 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.99 112.0 13.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.253 -0.43 . . . . 73.109999999999999 111.177 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 18.1 tp -70.22 134.85 48.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 73.319999999999993 110.938 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 10.7 mt -136.74 121.45 25.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.474 . . . . 75.299999999999997 111.098 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 16.4 t -121.86 124.08 70.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 72.510000000000005 111.178 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 63.63 37.96 9.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.235 -0.439 . . . . 73.030000000000001 110.868 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 62.83 42.9 7.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.142 -0.481 . . . . 71.349999999999994 110.887 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -140.67 127.98 21.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.169 -0.469 . . . . 74.230000000000004 110.879 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -62.67 146.5 52.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.45 . . . . 75.430000000000007 110.856 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -122.18 131.31 24.43 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.675 0.75 . . . . 74.409999999999997 111.043 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 137.79 36.23 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.731 2.288 . . . . 73.319999999999993 112.292 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.03 -172.66 3.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.462 . . . . 73.120000000000005 110.914 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 21.2 tp -79.84 -66.27 0.9 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.169 -0.469 . . . . 71.519999999999996 110.928 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 6.2 t -66.62 137.18 56.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.157 -0.474 . . . . 72.450000000000003 111.189 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.252 -0.431 . . . . 75.129999999999995 110.973 179.927 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.382 0 CA-C-O 121.452 0.473 . . . . 33.340000000000003 112.489 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.68 130.54 19.62 Favored 'Trans proline' 0 C--O 1.233 0.225 0 C-N-CA 122.674 2.249 . . . . 75.099999999999994 112.365 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.7 mt -131.01 -51.09 1.03 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.3 -0.409 . . . . 71.150000000000006 110.977 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -177.49 -114.61 0.4 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.643 -0.789 . . . . 75.430000000000007 112.416 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -135.84 155.83 49.72 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.785 0.326 . . . . 75.519999999999996 110.871 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -103.16 26.17 8.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.133 -0.485 . . . . 75.329999999999998 110.88 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 4.2 t30 54.06 49.58 18.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 73.549999999999997 110.834 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.6 mtt180 61.13 -170.25 0.16 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 72.400000000000006 110.893 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -51.99 -44.47 64.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.214 -0.448 . . . . 75.239999999999995 110.878 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 61.27 -174.33 0.13 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 72.430000000000007 110.917 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 30.7 p -84.5 54.37 2.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 75.310000000000002 111.09 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -159.61 128.14 5.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.265 -0.425 . . . . 62.530000000000001 111.175 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -106.04 155.01 19.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 74.319999999999993 110.903 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 68.4 p -146.81 154.73 41.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.113 -0.494 . . . . 73.439999999999998 111.154 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 14.2 m-90 -151.26 133.98 15.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.19 -0.459 . . . . 74.319999999999993 110.919 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.3 t -113.14 114.77 47.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 72.349999999999994 111.172 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -138.91 146.01 40.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 71.209999999999994 110.918 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -74.22 94.1 2.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 74.140000000000001 110.833 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -127.44 153.39 46.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 75.340000000000003 110.927 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 64.43 15.65 9.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.204 -0.453 . . . . 72.340000000000003 110.824 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 86.3 2.05 85.73 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.665 -0.779 . . . . 74.540000000000006 112.503 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -139.94 173.06 11.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.89 0.376 . . . . 73.430000000000007 110.859 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.1 87.88 0.4 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.458 . . . . 75.109999999999999 110.872 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.4 tp -69.04 124.87 24.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.471 . . . . 73.230000000000004 110.906 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 10.8 ttm180 -107.05 113.91 27.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 73.549999999999997 110.87 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -106.37 139.37 27.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.456 . . . . 74.450000000000003 111.131 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 85.8 t -135.8 135.36 50.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.125 -0.488 . . . . 72.430000000000007 111.207 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.2 tp -117.58 100.35 7.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 73.430000000000007 110.954 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.57 134.85 40.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 73.239999999999995 110.878 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.3 mttt -73.78 -17.46 61.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.474 . . . . 64.510000000000005 110.924 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -51.33 -54.12 29.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 70.049999999999997 110.853 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -134.29 17.01 3.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.219 -0.446 . . . . 72.439999999999998 111.138 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 3.9 ttm 54.41 27.09 7.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.252 -0.431 . . . . 61.299999999999997 110.914 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -80.97 149.39 29.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 73.430000000000007 110.851 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 31.3 t -104.84 128.92 58.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.107 -0.497 . . . . 70.129999999999995 111.163 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 3.7 t90 -113.1 127.55 56.24 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.093 -0.503 . . . . 75.340000000000003 110.951 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 9.2 t -141.6 129.52 21.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 74.239999999999995 110.93 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 48.25 50.79 15.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 73.409999999999997 110.945 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 49.29 47.46 34.58 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.774 -0.727 . . . . 75.439999999999998 112.44 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.44 114.71 4.79 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.81 0.338 . . . . 74.120000000000005 110.966 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 7.5 ttmt -55.56 100.36 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 75.329999999999998 110.857 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 65.5 mtp -59.63 159.7 8.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 73.409999999999997 110.916 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -104.97 106.38 16.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.212 -0.449 . . . . 71.129999999999995 110.892 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 13.9 p -99.2 -175.21 2.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.161 -0.472 . . . . 61.020000000000003 111.16 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -114.01 -47.86 2.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 61.109999999999999 111.136 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 74.83 50.43 8.99 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.716 -0.754 . . . . 70.129999999999995 112.484 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -80.82 110.81 16.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.878 0.37 . . . . 74.319999999999993 110.835 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -82.21 119.17 23.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 75.420000000000002 110.882 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 22.1 m -105.18 -177.71 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 73.439999999999998 111.12 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -55.39 -32.94 63.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.16 -0.473 . . . . 74.519999999999996 110.861 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -156.91 90.09 1.12 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 53.109999999999999 110.89 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 128.02 -179.39 16.54 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.777 -0.725 . . . . 75.239999999999995 112.501 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.63 130.81 34.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.706 0.288 . . . . 73.129999999999995 111.132 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -103.18 97.98 7.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.273 -0.422 . . . . 72.400000000000006 110.895 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.72 110.26 16.05 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.157 -0.474 . . . . 75.140000000000001 111.135 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 73.9 m-70 -102.0 109.3 21.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 72.120000000000005 110.809 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -138.75 153.33 48.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.252 -0.431 . . . . 74.310000000000002 110.905 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 89.6 p -114.52 167.44 10.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 73.120000000000005 110.812 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 83.8 t -149.39 98.12 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.119 -0.492 . . . . 65.200000000000003 111.09 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 60.18 -101.93 0.31 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.777 -0.725 . . . . 74.400000000000006 112.461 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -123.59 29.24 6.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.945 0.403 . . . . 75.030000000000001 110.943 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 75.3 m-70 -121.31 -175.02 2.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.475 . . . . 75.030000000000001 110.951 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -145.09 117.48 8.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.287 -0.415 . . . . 73.310000000000002 110.84 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 1.3 p -142.45 156.41 45.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.216 -0.447 . . . . 71.049999999999997 110.893 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -151.66 146.32 25.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 75.239999999999995 110.875 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.8 mt -97.37 111.69 27.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.082 -0.508 . . . . 74.349999999999994 111.113 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 8.1 tttt -79.83 102.5 9.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.253 -0.431 . . . . 74.430000000000007 110.88 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -95.12 139.68 31.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.242 -0.436 . . . . 74.430000000000007 111.156 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.3 t -135.68 123.01 35.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.252 -0.431 . . . . 75.400000000000006 111.135 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.3 p -91.12 150.4 21.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 74.209999999999994 110.87 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 63.4 p -144.8 128.45 17.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.104 -0.498 . . . . 65.430000000000007 110.885 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 136.03 -144.03 15.68 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.712 -0.756 . . . . 64.519999999999996 112.526 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 19.7 mtmt -95.04 -63.42 1.17 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.721 0.296 . . . . 75.25 110.866 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.99 -36.38 3.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.308 -0.405 . . . . 74.430000000000007 110.926 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -173.17 52.3 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 73.510000000000005 110.916 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -69.23 -61.98 1.57 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 65.140000000000001 110.922 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -143.33 138.77 8.41 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.734 -0.746 . . . . 70.209999999999994 112.55 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 61.2 mt -124.54 146.11 30.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.796 0.331 . . . . 75.409999999999997 111.159 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 59.4 mt -133.92 123.18 44.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.242 -0.436 . . . . 73.310000000000002 111.171 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 9.7 m80 -99.41 141.49 32.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.464 . . . . 71.519999999999996 110.875 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.33 106.93 8.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 75.420000000000002 111.073 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 14.5 tp -65.14 134.02 52.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 72.519999999999996 110.936 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 10.7 mt -137.01 111.27 9.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 74.549999999999997 111.113 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 35.6 t -113.56 124.71 70.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.458 . . . . 73.120000000000005 111.143 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 4.5 t0 63.37 43.22 6.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.451 . . . . 63.340000000000003 110.883 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 58.3 m-20 56.8 41.54 27.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.111 -0.495 . . . . 70.140000000000001 110.841 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 26.4 mtt180 -137.94 125.76 22.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 75.200000000000003 110.849 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -62.7 144.96 55.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.174 -0.466 . . . . 73.140000000000001 110.889 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -122.99 131.16 24.38 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.581 0.705 . . . . 75.230000000000004 111.143 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 138.21 37.31 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.725 2.283 . . . . 74.450000000000003 112.299 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -88.18 127.46 35.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 72.430000000000007 110.855 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.93 106.28 4.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 73.219999999999999 110.973 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 15.3 t -174.19 158.76 3.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.166 -0.47 . . . . 73.239999999999995 111.103 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.155 -0.475 . . . . 75.310000000000002 110.893 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 CA-C-O 121.471 0.484 . . . . 72.230000000000004 112.524 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.83 -42.61 3.18 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.63 2.22 . . . . 60.219999999999999 112.358 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.2 mp 56.66 88.83 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 72.310000000000002 110.985 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -102.8 115.51 5.21 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.682 -0.77 . . . . 72.519999999999996 112.492 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -133.21 95.64 3.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.861 0.363 . . . . 73.040000000000006 110.845 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 59.77 68.3 0.8 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.087 -0.506 . . . . 64.5 110.87 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -167.23 118.11 0.88 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 73.209999999999994 110.814 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 20.0 ptt180 -114.68 139.61 49.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 73.030000000000001 110.888 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.7 t -90.74 -70.35 0.68 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.22 -0.446 . . . . 71.019999999999996 110.834 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.06 -174.65 4.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.108 -0.497 . . . . 73.329999999999998 110.931 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 39.2 p -105.2 32.34 4.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.248 -0.433 . . . . 74.219999999999999 111.107 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -159.46 127.78 5.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.286 -0.416 . . . . 70.340000000000003 111.096 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.4 m -106.48 152.18 23.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.443 . . . . 71.549999999999997 110.833 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 6.9 m -135.86 155.19 50.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.126 -0.488 . . . . 72.549999999999997 111.124 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 16.6 m-90 -148.97 133.02 17.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.208 -0.451 . . . . 74.239999999999995 110.88 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.0 t -113.03 114.92 48.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 71.439999999999998 111.124 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.03 147.27 40.13 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.179 -0.464 . . . . 72.430000000000007 110.892 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -73.29 93.44 1.89 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.133 -0.485 . . . . 73.150000000000006 110.874 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -124.8 151.74 44.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 72.329999999999998 110.868 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.8 t0 64.54 15.21 9.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 75.310000000000002 110.847 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.37 1.8 83.43 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.758 -0.734 . . . . 60.100000000000001 112.527 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -139.92 172.88 12.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.841 0.353 . . . . 74.010000000000005 110.902 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.67 89.28 0.37 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 73.140000000000001 110.855 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -74.38 131.49 41.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 64.530000000000001 110.955 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 11.7 ttp180 -110.8 118.48 36.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 75.120000000000005 110.862 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -108.63 143.74 18.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 75.230000000000004 111.112 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 15.6 t -135.85 153.04 31.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.13 -0.486 . . . . 73.5 111.111 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.3 tp -129.71 105.92 8.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.165 -0.471 . . . . 74.409999999999997 110.927 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.43 135.51 35.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.231 -0.44 . . . . 74.430000000000007 110.823 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.0 mtmt -73.52 -16.54 61.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.098 -0.501 . . . . 65.030000000000001 110.859 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -51.34 -55.85 16.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.254 -0.43 . . . . 71.409999999999997 110.884 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.86 16.81 3.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 73.109999999999999 111.207 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 1.9 mtp 59.99 20.21 9.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.464 . . . . 63.210000000000001 110.891 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -70.91 151.03 45.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 73.099999999999994 110.886 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.408 ' HB ' ' HB2' ' A' ' 127' ' ' MET . 80.4 t -105.07 117.81 51.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 74.400000000000006 111.095 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 55.2 t-105 -95.61 113.63 25.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.211 -0.45 . . . . 71.329999999999998 110.946 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 9.0 t -140.26 133.03 29.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.246 -0.434 . . . . 75.040000000000006 110.897 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 57.98 34.06 23.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 71.140000000000001 110.915 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 57.76 49.85 70.62 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.743 -0.741 . . . . 71.340000000000003 112.476 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.93 121.6 2.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.836 0.35 . . . . 73.439999999999998 110.934 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -54.08 100.39 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 73.340000000000003 110.942 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' MET . . . . . 0.408 ' HB2' ' HB ' ' A' ' 120' ' ' VAL . 17.2 mmm -56.47 174.23 0.15 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.283 -0.417 . . . . 72.340000000000003 110.868 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -119.27 106.29 12.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.212 -0.449 . . . . 75.430000000000007 110.847 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 19.8 p -98.64 -175.23 3.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.135 -0.484 . . . . 75.099999999999994 111.16 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -99.87 -38.38 8.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.269 -0.423 . . . . 71.040000000000006 111.092 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 69.77 43.56 66.47 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.711 -0.756 . . . . 72.239999999999995 112.55 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -83.32 115.92 22.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.922 0.392 . . . . 74.510000000000005 110.921 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -91.35 121.01 32.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 72.140000000000001 110.895 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 27.3 m -101.83 177.56 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 73.040000000000006 111.074 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -52.92 -30.67 35.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.459 . . . . 73.129999999999995 110.925 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -158.03 91.88 1.14 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 51.329999999999998 110.841 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 128.21 179.31 15.8 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.716 -0.754 . . . . 75.549999999999997 112.508 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.03 130.78 36.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.763 0.316 . . . . 74.519999999999996 111.109 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -108.57 96.78 6.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.444 . . . . 74.129999999999995 110.893 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.64 109.99 17.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.168 -0.469 . . . . 71.310000000000002 111.075 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 71.8 m-70 -101.83 104.53 15.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 70.5 110.86 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 23.2 p90 -126.43 135.63 51.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 72.140000000000001 110.896 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 36.6 p -102.72 157.38 16.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.441 . . . . 74.209999999999994 110.849 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 90.5 t -138.7 105.59 2.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.101 -0.499 . . . . 72.530000000000001 111.093 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 55.06 -105.58 0.41 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.701 -0.761 . . . . 72.030000000000001 112.512 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -117.32 24.81 10.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.793 0.33 . . . . 74.230000000000004 110.869 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -117.1 172.18 7.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 60.119999999999997 110.877 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -130.24 120.74 24.92 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.241 -0.436 . . . . 74.200000000000003 110.867 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -142.68 170.73 15.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.179 -0.464 . . . . 74.430000000000007 110.913 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -175.2 147.71 0.93 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.21 -0.45 . . . . 75.340000000000003 110.914 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 12.9 mt -97.5 111.16 26.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.086 -0.506 . . . . 74.140000000000001 111.097 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 20.2 tttt -82.03 102.65 11.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.25 -0.432 . . . . 74.310000000000002 110.827 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -95.07 147.15 23.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 73.5 111.113 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.5 t -145.08 119.22 2.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 70.099999999999994 111.173 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.3 p -84.26 137.95 33.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.471 . . . . 74.510000000000005 110.871 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 1.5 t -133.54 152.47 51.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 72.209999999999994 110.794 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 112.25 -126.57 7.65 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.763 -0.732 . . . . 74.349999999999994 112.476 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -121.75 -65.05 1.16 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.756 0.313 . . . . 74.019999999999996 110.928 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -136.8 91.9 2.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.172 -0.467 . . . . 75.120000000000005 110.927 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 60.1 26.5 15.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 74.349999999999994 110.888 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.91 -69.96 0.19 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.198 -0.456 . . . . 75.219999999999999 110.931 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -137.39 120.49 2.09 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.719 -0.753 . . . . 54.340000000000003 112.479 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 72.2 mt -110.1 144.97 17.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.746 0.308 . . . . 74.420000000000002 111.158 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 3.0 mt -128.16 130.53 69.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.262 -0.426 . . . . 71.319999999999993 111.112 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 13.1 m80 -108.2 137.29 46.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 73.230000000000004 110.862 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.38 107.19 9.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.243 -0.435 . . . . 73.319999999999993 111.149 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 13.6 tp -67.37 137.21 55.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.249 -0.432 . . . . 75.109999999999999 110.982 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 9.7 mt -138.76 114.21 9.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.184 -0.462 . . . . 65.219999999999999 111.161 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 43.8 t -115.88 126.5 73.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 75.400000000000006 111.104 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.3 t0 63.53 39.26 9.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 74.439999999999998 110.935 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 60.06 42.3 15.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.47 . . . . 73.040000000000006 110.872 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -138.45 124.99 20.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 72.120000000000005 110.883 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -62.65 140.49 58.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.272 -0.422 . . . . 74.129999999999995 110.891 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -118.64 131.26 24.36 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.616 0.722 . . . . 70.409999999999997 111.126 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.66 135.85 31.74 Favored 'Trans proline' 0 N--CA 1.465 -0.179 0 C-N-CA 122.744 2.296 . . . . 73.129999999999995 112.386 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -89.51 131.51 35.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.259 -0.428 . . . . 72.140000000000001 110.854 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.35 126.7 31.55 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.143 -0.481 . . . . 74.5 110.85 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 30.0 p -135.53 174.42 10.63 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.188 -0.46 . . . . 74.219999999999999 111.092 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.181 -0.463 . . . . 75.200000000000003 110.842 -179.959 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 CA-C-O 121.416 0.453 . . . . 24.109999999999999 112.496 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -33.97 15.47 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.659 2.24 . . . . 73.219999999999999 112.303 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 61.03 170.08 0.1 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.267 -0.424 . . . . 72.219999999999999 110.963 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -106.82 -113.4 3.78 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.763 -0.732 . . . . 75.329999999999998 112.53 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 20.8 t -142.63 97.37 3.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.909 0.385 . . . . 74.120000000000005 110.838 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 61.13 170.36 0.1 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.082 -0.508 . . . . 72.319999999999993 110.896 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 10.8 p-10 -146.4 131.78 18.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 71.120000000000005 110.859 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 4.2 ttm180 61.27 171.74 0.11 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.133 -0.485 . . . . 63.210000000000001 110.878 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.1 t 52.53 55.55 8.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 75.340000000000003 110.823 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 6.5 ttpt -162.19 91.64 0.79 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.111 -0.495 . . . . 73.319999999999993 110.839 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 54.4 p -117.74 33.96 5.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.228 -0.442 . . . . 75.5 111.108 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -159.58 127.94 5.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.265 -0.425 . . . . 64.430000000000007 111.207 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.1 m -106.27 151.9 24.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.271 -0.422 . . . . 73.310000000000002 110.85 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.3 m -137.85 148.46 45.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.125 -0.488 . . . . 71.239999999999995 111.095 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 10.1 m-90 -146.4 124.67 12.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.206 -0.452 . . . . 73.5 110.936 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 19.1 t -108.37 114.81 47.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.284 -0.416 . . . . 64.299999999999997 111.164 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -139.94 147.62 40.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.205 -0.452 . . . . 74.420000000000002 110.894 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -73.32 92.83 1.84 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 74.319999999999993 110.856 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.82 151.0 43.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 73.25 110.89 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 64.43 15.45 9.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 74.109999999999999 110.832 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.83 1.42 82.65 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.717 -0.754 . . . . 73.239999999999995 112.516 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -139.81 172.81 12.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.894 0.378 . . . . 64.230000000000004 110.808 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -69.53 89.64 0.52 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.081 -0.509 . . . . 71.340000000000003 110.878 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.5 129.33 36.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 73.439999999999998 110.937 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 2.5 ttm180 -107.76 118.3 36.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 73.140000000000001 110.893 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.73 115.68 50.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 72.319999999999993 111.201 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 28.3 t -114.51 140.29 36.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.242 -0.435 . . . . 75.040000000000006 111.127 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.1 tp -114.0 108.66 17.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.17 -0.468 . . . . 64.109999999999999 110.962 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -81.8 134.79 35.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 63.130000000000003 110.874 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.7 mmmt -73.79 -16.31 61.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 73.200000000000003 110.883 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -51.49 -53.82 33.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 74.299999999999997 110.871 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.54 17.0 2.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.117 -0.492 . . . . 75.109999999999999 111.158 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 64.6 mtp 56.49 33.12 22.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.216 -0.447 . . . . 72.400000000000006 110.89 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.73 154.22 20.74 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.229 -0.441 . . . . 74.030000000000001 110.88 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 45.3 t -104.81 131.0 54.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.227 -0.442 . . . . 73.150000000000006 111.09 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 2.2 t90 -111.85 124.69 52.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 73.540000000000006 110.973 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 16.5 t -121.45 103.35 8.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.293 -0.412 . . . . 73.140000000000001 110.926 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 46.56 70.99 0.34 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.236 -0.438 . . . . 74.219999999999999 110.9 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 47.69 40.31 17.69 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.71 -0.757 . . . . 74.099999999999994 112.503 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -141.78 102.27 4.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.92 0.391 . . . . 74.439999999999998 110.847 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 4.6 tttt -53.44 102.11 0.05 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 65.340000000000003 110.862 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 21.7 mmm -64.79 167.29 7.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.481 . . . . 74.140000000000001 110.867 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -119.33 106.09 11.95 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.204 -0.453 . . . . 74.329999999999998 110.882 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 18.8 p -95.83 177.9 5.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 72.310000000000002 111.144 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -125.08 83.59 2.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 73.420000000000002 111.128 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -51.58 113.68 2.54 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.751 -0.738 . . . . 72.340000000000003 112.498 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -134.23 109.94 9.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.813 0.34 . . . . 73.420000000000002 110.894 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -69.46 113.77 7.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.2 -0.454 . . . . 73.450000000000003 110.887 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 34.1 m -102.34 -176.78 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 74.549999999999997 111.192 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -52.9 -43.8 66.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.44 . . . . 64.510000000000005 110.886 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -151.09 104.54 3.14 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.17 -0.468 . . . . 70.209999999999994 110.945 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 109.0 -171.13 15.1 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.739 -0.744 . . . . 64.230000000000004 112.455 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -134.87 130.87 36.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.761 0.315 . . . . 74.120000000000005 111.138 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -104.38 98.19 8.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 71.209999999999994 110.914 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.24 109.85 11.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.458 . . . . 75.200000000000003 111.134 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 86.6 m-70 -101.15 108.04 19.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.158 -0.474 . . . . 71.400000000000006 110.861 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -123.97 124.26 42.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.142 -0.481 . . . . 75.200000000000003 110.799 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 66.5 p -85.86 157.97 20.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.119 -0.491 . . . . 74.120000000000005 110.838 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 97.5 t -150.16 104.32 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.085 -0.507 . . . . 65.25 111.14 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 52.75 -113.58 2.88 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.697 -0.763 . . . . 70.120000000000005 112.516 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -110.46 25.81 11.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.844 0.354 . . . . 74.349999999999994 110.867 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 20.9 m-70 -124.84 159.66 30.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.242 -0.435 . . . . 74.239999999999995 110.897 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -121.02 123.68 42.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.255 -0.43 . . . . 74.230000000000004 110.841 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 1.2 p -142.49 154.6 44.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.141 -0.481 . . . . 71.239999999999995 110.946 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -157.62 149.03 21.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.218 -0.446 . . . . 74.430000000000007 110.943 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 9.4 mt -97.84 113.93 33.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 73.209999999999994 111.067 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 2.4 tttt -80.13 102.65 9.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.207 -0.451 . . . . 74.25 110.866 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -98.8 143.92 28.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 75.409999999999997 111.115 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 39.4 t -146.68 124.93 4.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.212 -0.449 . . . . 63.399999999999999 111.164 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.2 p -94.22 139.54 30.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.221 -0.445 . . . . 65.430000000000007 110.823 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.23 145.72 35.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 74.200000000000003 110.844 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 129.81 -179.12 17.02 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.701 -0.762 . . . . 53.329999999999998 112.491 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 6.4 mtmt -52.81 -58.02 8.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.801 0.334 . . . . 73.109999999999999 110.915 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 3.9 ptm180 -150.17 79.45 1.35 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.255 -0.429 . . . . 74.540000000000006 110.912 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 15.6 ttmt 61.73 56.49 2.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 75.230000000000004 110.915 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -90.89 -68.81 0.77 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.176 -0.465 . . . . 71.439999999999998 110.894 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -111.63 128.44 8.63 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.792 -0.718 . . . . 75.230000000000004 112.512 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 56.9 mt -120.29 145.0 27.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.767 0.318 . . . . 74.450000000000003 111.11 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 57.2 mt -128.58 140.12 50.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.177 -0.465 . . . . 75.319999999999993 111.12 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 9.4 m80 -117.91 135.48 54.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.137 -0.483 . . . . 60.299999999999997 110.816 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.82 109.88 12.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.133 -0.485 . . . . 73.5 111.126 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 15.1 tp -68.43 135.63 52.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 73.439999999999998 110.981 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 10.5 mt -138.63 117.27 13.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.455 . . . . 75.439999999999998 111.119 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 21.7 t -117.93 125.82 74.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.172 -0.467 . . . . 73.409999999999997 111.103 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 63.56 37.98 10.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 72.439999999999998 110.934 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 61.4 43.0 10.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 74.340000000000003 110.864 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 16.5 mtt180 -140.23 129.1 23.29 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.177 -0.465 . . . . 72.140000000000001 110.852 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -62.69 146.43 52.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.136 -0.484 . . . . 74.340000000000003 110.899 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -122.85 130.89 24.45 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.699 0.762 . . . . 71.030000000000001 111.14 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 135.57 30.82 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.66 2.24 . . . . 61.299999999999997 112.332 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -91.7 124.3 35.74 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.229 -0.441 . . . . 71.219999999999999 110.889 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 6.6 tp -52.23 123.15 10.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 75.420000000000002 110.869 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 69.5 p -131.91 128.66 39.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.228 -0.442 . . . . 65.129999999999995 111.135 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.268 -0.423 . . . . 72.239999999999995 110.941 179.892 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 CA-C-O 121.43 0.461 . . . . 73.219999999999999 112.473 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.84 128.83 16.52 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.664 2.243 . . . . 74.120000000000005 112.345 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.8 mt -110.94 -53.69 2.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.213 -0.449 . . . . 75.109999999999999 110.967 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 132.31 122.24 2.33 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.736 -0.745 . . . . 74.349999999999994 112.52 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.18 141.14 47.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.838 0.352 . . . . 71.230000000000004 110.868 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.95 173.12 6.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.476 . . . . 75.519999999999996 110.86 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -107.1 157.59 17.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.467 . . . . 73.510000000000005 110.857 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.03 81.59 2.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.159 -0.473 . . . . 73.140000000000001 110.88 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.0 145.24 21.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.026 0.441 . . . . 74.129999999999995 110.86 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 17.2 mttt -121.85 83.26 2.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.052 -0.522 . . . . 73.510000000000005 110.896 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -68.64 141.69 55.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.202 -0.454 . . . . 73.310000000000002 111.157 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -159.54 127.8 4.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.234 -0.439 . . . . 74.040000000000006 111.181 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.3 m -106.37 153.95 21.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 75.219999999999999 110.879 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -142.21 156.57 45.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.104 -0.498 . . . . 74.129999999999995 111.11 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 17.2 m-90 -151.45 130.6 12.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.237 -0.438 . . . . 74.239999999999995 110.97 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.3 t -110.25 114.79 48.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.249 -0.432 . . . . 75.329999999999998 111.107 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.69 148.42 39.06 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.197 -0.456 . . . . 74.140000000000001 110.95 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.3 mtm180 -74.73 92.79 2.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.178 -0.464 . . . . 75.140000000000001 110.857 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -121.79 152.07 39.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 72.450000000000003 110.979 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 64.72 15.03 9.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.213 -0.449 . . . . 74.129999999999995 110.889 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.0 0.48 80.95 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.719 -0.753 . . . . 60.340000000000003 112.444 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -139.84 172.76 12.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.854 0.359 . . . . 75.010000000000005 110.914 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -68.58 89.68 0.37 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 73.219999999999999 110.858 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.91 128.58 33.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 71.150000000000006 110.878 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.74 119.7 40.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.131 -0.486 . . . . 62.32 110.875 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -107.13 142.61 19.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.124 -0.489 . . . . 74.430000000000007 111.131 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 48.1 t -135.82 146.72 29.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 72.5 111.153 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.1 tp -128.4 101.24 6.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 74.120000000000005 110.878 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.11 122.77 26.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.189 -0.459 . . . . 73.439999999999998 110.878 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.39 -15.94 59.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 73.519999999999996 110.946 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -51.44 -56.0 15.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.455 . . . . 74.120000000000005 110.868 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 9.5 p -133.87 16.98 3.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.458 . . . . 72.420000000000002 111.129 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 9.6 mtp 58.43 24.55 11.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.302 -0.408 . . . . 71.120000000000005 110.856 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -76.18 144.55 40.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.267 -0.424 . . . . 71.439999999999998 110.842 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 71.4 t -105.1 118.26 52.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 70.0 111.156 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 2.2 t90 -98.34 134.86 40.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.173 -0.467 . . . . 73.329999999999998 110.909 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -131.18 103.14 6.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 75.25 110.914 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 22.7 m-20 45.43 69.66 0.43 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 73.519999999999996 110.992 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 48.65 41.02 25.99 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.773 -0.727 . . . . 70.400000000000006 112.428 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -149.81 115.3 5.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.801 0.334 . . . . 64.109999999999999 110.927 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -53.56 162.21 0.87 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.247 -0.433 . . . . 75.400000000000006 110.85 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 35.1 mmm -126.54 166.49 17.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.445 . . . . 73.420000000000002 110.945 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -119.26 106.41 12.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.268 -0.424 . . . . 74.140000000000001 110.861 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 21.7 p -95.8 -175.17 3.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.161 -0.472 . . . . 74.420000000000002 111.126 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -93.33 -35.76 12.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.449 . . . . 73.010000000000005 111.138 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 73.88 40.57 43.97 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.769 -0.729 . . . . 51.43 112.496 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -86.04 125.61 33.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.907 0.384 . . . . 72.310000000000002 110.832 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -113.16 127.05 56.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.474 . . . . 75.319999999999993 110.92 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 11.5 m -108.1 179.89 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 74.439999999999998 111.155 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -53.18 -29.75 33.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 75.329999999999998 110.845 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -158.12 92.66 1.18 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 65.439999999999998 110.897 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 128.93 172.7 13.23 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.74 -0.743 . . . . 73.219999999999999 112.483 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.04 130.82 36.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.807 0.336 . . . . 63.119999999999997 111.164 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -104.86 96.63 6.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.222 -0.445 . . . . 73.439999999999998 110.858 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.39 110.21 18.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 72.329999999999998 111.098 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 41.9 m170 -109.53 106.24 15.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 75.030000000000001 110.821 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 9.1 p90 -124.54 144.66 50.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 72.319999999999993 110.899 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 77.0 p -91.28 141.61 28.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 74.040000000000006 110.892 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 17.4 t -138.87 103.47 2.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.175 -0.466 . . . . 72.230000000000004 111.096 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 53.76 31.43 46.01 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.704 -0.76 . . . . 71.120000000000005 112.476 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 63.36 25.35 14.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.874 0.369 . . . . 72.540000000000006 110.883 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 77.6 m-70 -93.5 -11.93 30.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.14 -0.482 . . . . 75.319999999999993 110.825 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 63.87 104.88 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.244 -0.434 . . . . 73.239999999999995 110.801 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 10.9 m -137.91 167.86 20.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.165 -0.47 . . . . 65.400000000000006 110.846 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 18.4 p90 -174.39 142.79 0.8 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.474 . . . . 75.109999999999999 110.919 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 32.0 mt -98.59 111.3 27.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.076 -0.511 . . . . 72.420000000000002 111.141 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 16.9 tttt -80.11 104.03 10.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.485 . . . . 71.310000000000002 110.858 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -99.04 146.67 25.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 73.140000000000001 111.084 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.2 t -144.9 124.3 6.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.251 -0.431 . . . . 75.239999999999995 111.174 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -93.32 129.62 39.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.21 -0.45 . . . . 60.439999999999998 110.839 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -130.17 153.45 48.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 74.019999999999996 110.858 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 83.3 90.24 0.71 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.659 -0.782 . . . . 64.109999999999999 112.516 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.01 -170.13 0.16 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.845 0.355 . . . . 74.140000000000001 110.913 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 11.1 mtt180 -52.89 -32.34 44.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.239 -0.437 . . . . 74.219999999999999 110.854 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 11.7 pttt -173.41 124.1 0.39 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 72.219999999999999 110.916 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -158.58 -54.0 0.07 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.227 -0.442 . . . . 75.049999999999997 110.91 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -128.06 105.98 0.76 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.712 -0.756 . . . . 70.120000000000005 112.482 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 63.3 mt -103.91 134.76 44.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.751 0.31 . . . . 75.510000000000005 111.121 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 53.5 mt -121.04 133.34 68.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.227 -0.442 . . . . 73.099999999999994 111.135 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 14.2 m80 -108.96 137.94 46.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 72.310000000000002 110.848 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.65 103.64 6.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 75.120000000000005 111.128 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 15.9 tp -66.35 138.35 57.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.237 -0.438 . . . . 74.030000000000001 110.907 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 11.0 mt -135.95 119.53 23.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.216 -0.447 . . . . 73.420000000000002 111.105 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 88.2 t -118.5 135.46 58.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 65.319999999999993 111.082 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 54.01 37.01 25.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 63.420000000000002 110.898 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 10.3 t30 63.37 42.93 6.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.166 -0.47 . . . . 54.409999999999997 110.956 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 4.2 mtm180 -141.44 130.46 23.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 70.120000000000005 110.88 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -62.83 146.45 52.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.208 -0.451 . . . . 75.120000000000005 110.853 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -122.98 131.14 24.38 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.65 0.738 . . . . 63.229999999999997 111.11 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.74 135.89 31.66 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.624 2.216 . . . . 75.349999999999994 112.398 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -89.84 153.97 20.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 74.439999999999998 110.89 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -51.78 -36.91 49.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.162 -0.472 . . . . 75.0 110.89 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 72.8 p -51.77 149.9 4.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 74.129999999999995 111.087 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 73.129999999999995 110.891 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 CA-C-O 121.416 0.453 . . . . 72.340000000000003 112.483 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.83 153.58 68.44 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.699 2.266 . . . . 61.109999999999999 112.296 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -144.6 120.52 10.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 74.5 110.971 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.8 79.6 0.24 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.742 -0.742 . . . . 70.409999999999997 112.452 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -160.98 126.06 3.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.882 0.372 . . . . 75.019999999999996 110.873 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -125.08 151.83 45.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.109 -0.496 . . . . 74.019999999999996 110.923 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 69.19 -75.7 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 73.319999999999993 110.884 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 23.3 mtm180 56.66 35.37 26.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.166 -0.47 . . . . 73.25 110.865 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 7.2 t -178.78 133.29 0.13 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 74.409999999999997 110.866 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.31 -72.44 0.19 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.066 -0.515 . . . . 73.450000000000003 110.911 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.24 23.74 0.73 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 75.120000000000005 111.157 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -159.47 128.09 5.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 74.140000000000001 111.084 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.8 m -105.98 154.04 21.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.237 -0.438 . . . . 74.540000000000006 110.855 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 27.3 m -141.56 148.58 39.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.139 -0.482 . . . . 74.040000000000006 111.153 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 9.3 m-90 -145.37 122.91 11.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.198 -0.455 . . . . 73.409999999999997 110.89 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 19.5 t -103.32 114.79 43.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 71.239999999999995 111.075 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.97 146.6 35.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.119 -0.491 . . . . 75.049999999999997 110.898 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 4.8 mtt85 -74.44 92.18 2.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 74.439999999999998 110.88 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -122.99 153.74 39.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.207 -0.452 . . . . 74.420000000000002 110.926 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.5 t70 65.14 14.44 9.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.181 -0.463 . . . . 53.399999999999999 110.877 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.55 0.0 79.81 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.791 -0.719 . . . . 51.130000000000003 112.503 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -139.86 172.91 12.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.868 0.366 . . . . 74.340000000000003 110.836 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -68.78 88.13 0.36 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.112 -0.495 . . . . 74.209999999999994 110.879 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.26 124.85 26.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.259 -0.428 . . . . 74.340000000000003 110.907 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -102.03 109.79 21.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 73.120000000000005 110.893 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.5 t -95.25 136.7 25.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 71.519999999999996 111.09 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 86.6 t -136.51 128.58 44.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.163 -0.471 . . . . 75.0 111.126 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.9 tp -110.07 102.31 11.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.138 -0.483 . . . . 74.319999999999993 110.875 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.7 136.15 37.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.211 -0.449 . . . . 64.239999999999995 110.914 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 21.0 mmmt -73.77 -17.15 61.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.135 -0.484 . . . . 73.420000000000002 110.861 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -51.49 -53.88 32.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 63.109999999999999 110.869 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.82 17.0 3.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.201 -0.454 . . . . 72.140000000000001 111.112 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 2.6 ttp 53.67 28.22 7.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 65.510000000000005 110.876 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -85.23 158.62 20.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 73.150000000000006 110.87 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 21.6 t -104.87 138.4 29.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.207 -0.451 . . . . 74.349999999999994 111.15 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 1.2 t90 -123.28 121.12 35.07 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.252 -0.431 . . . . 75.200000000000003 110.872 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 60.8 m -132.21 131.77 42.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.236 -0.438 . . . . 63.109999999999999 110.877 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 41.0 m-20 49.3 50.24 18.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.189 -0.459 . . . . 63.43 110.92 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 49.04 45.08 33.12 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.795 -0.717 . . . . 71.329999999999998 112.447 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -147.96 116.96 6.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.828 0.347 . . . . 74.400000000000006 110.921 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 13.2 mttt -53.17 102.3 0.05 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.295 -0.411 . . . . 72.450000000000003 110.922 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 23.4 mmm -64.52 166.5 8.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 75.25 110.882 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.17 106.0 11.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.994 0.426 . . . . 73.140000000000001 110.836 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 16.0 p -97.72 175.29 6.23 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.099 -0.501 . . . . 75.329999999999998 111.117 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -122.48 90.13 3.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.227 -0.442 . . . . 73.209999999999994 111.074 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -50.85 117.19 5.09 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.726 -0.749 . . . . 73.019999999999996 112.482 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -146.05 101.97 3.58 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.952 0.406 . . . . 74.430000000000007 110.823 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -69.52 150.3 47.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.113 -0.494 . . . . 75.439999999999998 110.897 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 8.3 m -140.39 -177.79 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.168 -0.469 . . . . 64.519999999999996 111.087 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.55 -17.85 56.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.186 -0.461 . . . . 71.099999999999994 110.861 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -106.21 -75.32 0.63 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.159 -0.473 . . . . 55.219999999999999 110.854 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -137.72 -120.97 1.94 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.717 -0.754 . . . . 73.099999999999994 112.446 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -134.19 130.78 37.73 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.734 0.302 . . . . 72.140000000000001 111.184 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -98.08 96.13 7.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.296 -0.411 . . . . 63.530000000000001 110.914 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.14 109.4 13.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 75.349999999999994 111.202 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 38.0 m170 -100.66 112.69 25.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.306 -0.406 . . . . 71.400000000000006 110.832 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -125.84 114.43 18.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 74.420000000000002 110.852 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 98.4 p -78.28 151.57 32.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.081 -0.508 . . . . 53.520000000000003 110.842 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 46.9 t -146.81 108.67 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.086 -0.506 . . . . 54.229999999999997 111.147 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 52.92 -109.98 1.14 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.759 -0.734 . . . . 74.219999999999999 112.488 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -116.6 26.4 9.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.881 0.372 . . . . 71.439999999999998 110.916 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 23.9 m-70 -123.49 164.2 19.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 64.430000000000007 110.853 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -126.06 123.17 37.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 72.109999999999999 110.809 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -142.67 150.66 40.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.226 -0.443 . . . . 74.430000000000007 110.878 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 17.6 p90 -150.87 149.61 29.89 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.181 -0.463 . . . . 74.200000000000003 110.979 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 7.6 mt -99.65 114.27 37.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.176 -0.465 . . . . 72.530000000000001 111.126 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.24 103.09 9.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.225 -0.443 . . . . 73.239999999999995 110.871 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -100.13 146.65 26.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.195 -0.457 . . . . 71.519999999999996 111.1 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 66.2 t -149.21 122.94 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.199 -0.455 . . . . 73.25 111.134 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.2 p -92.26 144.56 25.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.186 -0.461 . . . . 71.099999999999994 110.859 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.25 141.82 30.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.487 . . . . 63.140000000000001 110.851 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 129.71 -168.84 21.02 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.696 -0.764 . . . . 63.520000000000003 112.507 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 8.4 mtmt -56.39 -26.75 54.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.794 0.331 . . . . 73.310000000000002 110.93 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -176.97 -40.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 70.239999999999995 110.818 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 34.9 mttt -155.87 31.8 0.35 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 75.340000000000003 110.905 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -55.93 -60.57 3.28 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.179 -0.464 . . . . 74.140000000000001 110.92 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -143.6 142.24 11.09 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.773 -0.727 . . . . 74.420000000000002 112.5 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 47.8 mt -126.16 147.15 31.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.756 0.312 . . . . 75.400000000000006 111.087 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 38.3 mt -128.29 137.14 58.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.205 -0.452 . . . . 73.310000000000002 111.14 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 5.8 m80 -120.72 134.39 55.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 72.329999999999998 110.876 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.48 117.17 23.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.449 . . . . 70.409999999999997 111.183 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 14.0 tp -71.3 132.56 45.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 71.209999999999994 110.953 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 11.0 mt -135.92 116.53 18.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.263 -0.426 . . . . 74.019999999999996 111.126 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 17.0 t -119.08 127.99 75.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 71.099999999999994 111.171 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 2.2 t0 63.89 35.56 10.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 74.299999999999997 110.842 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 1.8 m120 63.33 43.09 6.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 64.439999999999998 110.887 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 58.3 mtt180 -142.97 128.72 19.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.112 -0.495 . . . . 72.430000000000007 110.867 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -62.44 146.5 51.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.457 . . . . 72.200000000000003 110.906 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -121.28 130.65 24.72 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.578 0.704 . . . . 63.130000000000003 111.121 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.67 143.92 52.84 Favored 'Trans proline' 0 N--CA 1.465 -0.157 0 C-N-CA 122.737 2.292 . . . . 74.329999999999998 112.364 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -89.49 144.23 26.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.268 -0.424 . . . . 74.099999999999994 110.835 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -52.29 -38.86 59.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 74.109999999999999 110.917 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 30.0 p -51.99 141.18 18.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 74.239999999999995 111.124 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 82.1 mm-40 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.465 . . . . 75.019999999999996 110.869 179.966 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.35 0 CA-C-O 121.514 0.508 . . . . 64.010000000000005 112.464 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 159.34 53.75 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.688 2.259 . . . . 70.219999999999999 112.335 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -139.69 133.59 30.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.242 -0.435 . . . . 73.329999999999998 110.955 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -155.27 78.35 0.2 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.776 -0.726 . . . . 63.32 112.523 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 24.0 p -171.11 98.05 0.21 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.815 0.341 . . . . 74.310000000000002 110.86 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -165.36 138.35 4.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.074 -0.512 . . . . 71.549999999999997 110.937 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 30.8 m120 -76.43 161.72 28.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.17 -0.468 . . . . 74.25 110.827 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -133.47 33.93 3.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.084 -0.507 . . . . 73.129999999999995 110.822 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -126.76 48.4 2.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.241 -0.436 . . . . 75.010000000000005 110.877 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.81 91.41 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.107 -0.497 . . . . 75.310000000000002 110.882 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.1 t -142.15 118.44 10.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 74.420000000000002 111.158 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -159.62 133.08 7.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 73.530000000000001 111.119 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.3 m -105.66 150.43 25.46 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.197 -0.456 . . . . 75.120000000000005 110.776 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 2.2 m -141.79 154.7 45.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.053 -0.521 . . . . 73.0 111.12 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 12.1 m-90 -151.52 128.61 11.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.437 . . . . 70.140000000000001 110.957 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 19.5 t -108.1 114.9 47.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.237 -0.438 . . . . 74.439999999999998 111.21 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.19 146.06 38.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 75.239999999999995 110.887 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.9 mtm180 -73.37 92.54 1.84 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.137 -0.483 . . . . 75.319999999999993 110.872 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -124.89 153.14 43.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.096 -0.502 . . . . 73.219999999999999 110.867 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 64.62 15.14 9.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.475 . . . . 75.239999999999995 110.891 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 88.1 1.01 82.49 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.722 -0.752 . . . . 72.310000000000002 112.502 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -139.79 172.95 12.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.844 0.354 . . . . 74.140000000000001 110.866 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.42 87.01 0.44 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.165 -0.47 . . . . 54.009999999999998 110.886 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.05 125.29 26.21 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.225 -0.443 . . . . 74.299999999999997 110.855 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 17.3 ttm180 -103.99 109.79 21.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 74.540000000000006 110.841 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 1.4 t -95.54 136.37 26.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.216 -0.447 . . . . 73.030000000000001 111.155 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 93.2 t -136.03 122.65 32.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.204 -0.453 . . . . 74.099999999999994 111.142 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.4 tp -110.31 108.6 18.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.117 -0.492 . . . . 75.340000000000003 110.966 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -85.08 136.73 33.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 74.299999999999997 110.913 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.85 -16.42 61.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.138 -0.483 . . . . 73.530000000000001 110.892 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -51.46 -54.57 25.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.277 -0.419 . . . . 63.25 110.798 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.55 17.06 2.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 63.020000000000003 111.174 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 24.7 mtp 59.18 21.76 9.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 75.430000000000007 110.862 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.57 142.5 51.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.283 -0.417 . . . . 74.209999999999994 110.89 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 65.3 t -105.02 118.45 52.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 75.540000000000006 111.112 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 2.8 t90 -101.16 131.84 46.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.459 . . . . 70.200000000000003 110.908 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -123.97 103.76 8.51 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.22 -0.445 . . . . 74.010000000000005 110.922 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 4.9 p30 39.51 71.59 0.17 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.462 . . . . 72.219999999999999 110.915 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 51.0 41.05 44.61 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.773 -0.727 . . . . 73.310000000000002 112.523 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -150.45 112.66 4.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.878 0.371 . . . . 73.329999999999998 110.866 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 6.4 mtmm -53.63 162.05 0.93 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.217 -0.447 . . . . 75.230000000000004 110.888 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 27.7 mmm -127.89 162.99 25.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 75.049999999999997 110.91 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -119.28 106.35 12.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.295 -0.411 . . . . 75.230000000000004 110.901 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 18.0 p -95.46 -176.71 3.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.142 -0.481 . . . . 74.400000000000006 111.156 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -89.04 -34.57 16.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.44 . . . . 64.409999999999997 111.095 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 60.89 72.99 0.55 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.741 -0.742 . . . . 74.310000000000002 112.53 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -131.94 124.34 29.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.913 0.387 . . . . 64.340000000000003 110.895 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -95.7 115.77 27.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.126 -0.488 . . . . 71.530000000000001 110.88 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 30.2 m -83.14 -179.33 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.134 -0.484 . . . . 75.209999999999994 111.147 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -53.16 -28.95 28.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.244 -0.435 . . . . 74.310000000000002 110.891 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -164.02 85.01 0.46 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.166 -0.47 . . . . 74.219999999999999 110.919 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 140.29 -179.06 19.42 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.749 -0.739 . . . . 63.5 112.449 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.37 130.81 35.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.748 0.308 . . . . 74.319999999999993 111.188 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -116.14 96.35 5.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 74.030000000000001 110.885 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.77 110.23 18.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 70.140000000000001 111.11 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 67.6 m-70 -109.25 107.1 17.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 75.329999999999998 110.891 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -119.64 -176.15 3.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.23 -0.441 . . . . 74.540000000000006 110.925 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 25.3 p -140.33 165.25 27.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 64.219999999999999 110.835 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 58.3 t -148.85 98.18 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.092 -0.504 . . . . 75.310000000000002 111.08 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 61.19 -108.25 1.83 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.77 -0.728 . . . . 75.299999999999997 112.529 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -106.14 -26.9 11.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.896 0.379 . . . . 71.140000000000001 110.914 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 52.3 m-70 -64.37 -170.19 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.124 -0.489 . . . . 74.209999999999994 110.859 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -153.68 116.38 4.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 74.439999999999998 110.861 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -142.66 163.5 32.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.261 -0.427 . . . . 73.140000000000001 110.886 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 28.5 p90 -161.17 152.87 19.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.191 -0.459 . . . . 73.120000000000005 110.877 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 21.0 mt -99.36 121.44 49.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.133 -0.485 . . . . 73.010000000000005 111.168 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 2.1 tttm -89.95 102.56 15.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 72.450000000000003 110.909 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -99.65 147.24 25.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.439 . . . . 72.209999999999994 111.064 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.8 t -145.46 131.29 13.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.184 -0.462 . . . . 72.329999999999998 111.045 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.1 p -102.2 145.48 29.35 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.162 -0.472 . . . . 71.140000000000001 110.83 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 2.0 p -150.54 165.62 32.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.08 -0.509 . . . . 71.439999999999998 110.897 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 112.56 -49.87 0.81 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.713 -0.756 . . . . 71.25 112.493 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -178.54 -64.81 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.806 0.336 . . . . 74.239999999999995 110.892 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.31 -42.93 0.29 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 75.420000000000002 110.887 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.77 26.82 0.64 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 72.530000000000001 110.833 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -62.52 -71.91 0.15 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.282 -0.417 . . . . 71.530000000000001 110.875 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -127.46 145.08 15.62 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.794 -0.717 . . . . 71.120000000000005 112.568 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 62.9 mt -138.59 139.97 40.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.823 0.344 . . . . 74.239999999999995 111.088 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 68.0 mt -127.37 140.36 49.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.122 -0.49 . . . . 75.25 111.147 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 11.1 m80 -113.21 142.21 46.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 71.140000000000001 110.831 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.87 106.57 7.36 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.197 -0.456 . . . . 75.150000000000006 111.123 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 17.1 tp -67.35 136.39 54.73 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.251 -0.431 . . . . 73.519999999999996 110.951 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 9.3 mt -138.31 121.16 19.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 75.349999999999994 111.158 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 18.0 t -121.93 124.98 72.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 70.439999999999998 111.12 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.5 t0 64.03 36.5 9.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 74.420000000000002 110.822 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 63.4 43.05 6.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.436 . . . . 71.420000000000002 110.873 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 3.9 mtm180 -140.51 128.98 22.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 74.310000000000002 110.92 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.69 146.52 52.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.434 . . . . 74.230000000000004 110.843 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -122.95 130.92 24.42 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.63 0.729 . . . . 75.549999999999997 111.189 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 140.4 42.68 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.738 2.292 . . . . 70.120000000000005 112.351 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -85.63 55.54 3.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 70.530000000000001 110.866 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 72.53 -67.54 0.26 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.237 -0.438 . . . . 73.540000000000006 110.909 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 11.2 t -58.22 -32.01 67.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.248 -0.433 . . . . 73.510000000000005 111.097 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.235 -0.439 . . . . 75.140000000000001 110.945 179.984 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 CA-C-O 121.493 0.496 . . . . 72.109999999999999 112.491 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.73 -35.36 12.89 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.654 2.236 . . . . 75.540000000000006 112.328 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 53.2 59.97 4.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.255 -0.429 . . . . 74.319999999999993 110.982 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 101.7 78.28 1.31 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.728 -0.749 . . . . 70.549999999999997 112.507 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 21.4 p -106.46 -174.01 2.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.87 0.367 . . . . 75.25 110.806 -179.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -140.72 -72.28 0.36 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.127 -0.488 . . . . 75.150000000000006 110.849 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -103.24 -63.64 1.16 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.128 -0.487 . . . . 75.409999999999997 110.904 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 12.6 mmt180 54.17 28.23 8.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.147 -0.479 . . . . 74.450000000000003 110.927 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -85.88 112.77 21.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.149 -0.478 . . . . 62.329999999999998 110.896 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 15.1 mttt -83.24 -74.38 0.37 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.117 -0.492 . . . . 74.099999999999994 110.912 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 2.1 p -155.23 22.22 0.42 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.246 -0.434 . . . . 60.520000000000003 111.155 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.1 p -159.51 128.29 5.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.224 -0.444 . . . . 72.409999999999997 111.17 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -105.75 150.94 25.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.03 0.443 . . . . 71.409999999999997 110.838 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 12.0 m -143.05 153.07 42.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.095 -0.502 . . . . 62.520000000000003 111.214 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 11.0 m-90 -151.47 127.4 10.34 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.296 -0.411 . . . . 71.510000000000005 110.907 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.5 t -106.99 114.99 47.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.455 . . . . 62.140000000000001 111.148 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.17 147.36 38.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.117 -0.492 . . . . 74.299999999999997 110.962 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 2.7 mtt180 -72.82 91.81 1.53 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 74.230000000000004 110.798 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.1 151.99 40.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 72.239999999999995 110.892 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 64.84 14.75 9.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 75.430000000000007 110.946 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.15 0.39 80.57 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.775 -0.726 . . . . 71.230000000000004 112.506 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -139.72 172.86 12.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.797 0.332 . . . . 73.430000000000007 110.954 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -68.85 89.25 0.4 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.241 -0.436 . . . . 71.430000000000007 110.901 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.43 127.92 34.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 70.219999999999999 110.9 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 58.6 ttt180 -105.5 110.21 22.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.225 -0.443 . . . . 74.109999999999999 110.788 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -95.5 139.75 18.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.103 -0.499 . . . . 63.219999999999999 111.056 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 93.3 t -136.23 130.02 47.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.133 -0.485 . . . . 74.329999999999998 111.134 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.3 tp -118.07 104.46 10.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.102 -0.499 . . . . 74.319999999999993 110.846 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.6 124.67 29.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 63.030000000000001 110.854 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.59 -16.02 59.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 75.540000000000006 110.927 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -51.63 -55.98 16.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.203 -0.453 . . . . 72.150000000000006 110.884 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.3 m -132.76 17.02 4.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.264 -0.425 . . . . 74.310000000000002 111.147 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 82.5 mtp 54.68 31.53 15.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 73.420000000000002 110.85 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -86.46 147.18 26.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.444 . . . . 74.319999999999993 110.893 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 25.2 t -104.84 137.6 33.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.247 -0.433 . . . . 73.519999999999996 111.14 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 1.2 t90 -125.51 129.7 50.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.133 -0.485 . . . . 75.420000000000002 110.881 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 16.8 p -138.48 133.87 33.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.221 -0.445 . . . . 74.329999999999998 110.912 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 46.05 49.14 12.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 63.119999999999997 110.859 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 50.79 44.1 48.27 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.657 -0.782 . . . . 73.319999999999993 112.533 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -147.89 119.0 7.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.849 0.357 . . . . 73.120000000000005 110.952 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 1.5 mtpt -53.1 136.39 35.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 73.340000000000003 110.877 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 67.7 mtp -102.78 165.19 11.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 73.420000000000002 110.87 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -113.31 107.1 15.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.215 -0.448 . . . . 74.430000000000007 110.878 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 16.6 p -99.98 -175.15 2.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.49 . . . . 75.310000000000002 111.099 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -115.06 -29.49 6.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 64.299999999999997 111.109 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 52.41 32.4 37.69 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.724 -0.75 . . . . 71.040000000000006 112.482 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -55.14 108.96 0.46 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.831 0.348 . . . . 75.200000000000003 110.853 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -82.91 116.18 22.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.147 -0.478 . . . . 75.340000000000003 110.902 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 19.7 m -100.46 -178.35 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.21 -0.45 . . . . 63.240000000000002 111.183 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -53.13 -30.53 37.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 75.430000000000007 110.896 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -159.19 91.75 1.04 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.199 -0.455 . . . . 70.019999999999996 110.9 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 128.86 178.96 15.63 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.634 -0.793 . . . . 74.219999999999999 112.483 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -134.85 130.84 36.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.71 0.291 . . . . 72.549999999999997 111.144 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -109.49 96.35 6.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 74.5 110.818 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.29 110.24 14.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.449 . . . . 72.409999999999997 111.116 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -105.68 113.03 26.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.272 -0.422 . . . . 73.109999999999999 110.907 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -133.92 178.99 6.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.177 -0.465 . . . . 74.209999999999994 110.883 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 90.7 p -140.39 162.62 34.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 73.099999999999994 110.874 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 39.7 t -146.55 99.48 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 73.230000000000004 111.146 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 68.41 -108.05 2.31 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.704 -0.76 . . . . 73.310000000000002 112.482 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -111.66 -26.35 9.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.781 0.324 . . . . 75.340000000000003 110.913 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 24.7 m-70 -65.9 -169.97 0.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.484 . . . . 75.129999999999995 110.794 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -149.79 119.51 7.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.135 -0.484 . . . . 64.230000000000004 110.885 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -142.41 161.53 37.8 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.252 -0.431 . . . . 71.349999999999994 110.9 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 22.2 p90 -156.89 150.36 24.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.251 -0.431 . . . . 64.430000000000007 110.904 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 10.3 mt -97.61 112.83 30.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.089 -0.505 . . . . 73.310000000000002 111.156 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.92 102.68 10.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.126 -0.488 . . . . 74.319999999999993 110.872 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -98.05 148.13 23.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.259 -0.428 . . . . 64.219999999999999 111.154 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.0 t -144.5 127.31 11.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.262 -0.427 . . . . 65.439999999999998 111.21 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.1 p -97.13 133.71 41.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 64.349999999999994 110.845 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -127.9 137.66 52.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.083 -0.508 . . . . 62.200000000000003 110.8 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 134.55 -174.17 21.13 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.738 -0.744 . . . . 60.119999999999997 112.489 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 5.7 mttm -86.66 -48.88 7.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.79 0.329 . . . . 73.329999999999998 110.914 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 44.4 mtm180 -134.77 69.18 1.45 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 71.310000000000002 110.84 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 26.1 mttp 58.32 60.36 2.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.226 -0.443 . . . . 73.519999999999996 110.889 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -77.81 -65.22 1.0 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 73.540000000000006 110.859 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -136.8 145.23 17.05 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.758 -0.734 . . . . 73.040000000000006 112.511 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 69.4 mt -126.5 143.45 39.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.807 0.337 . . . . 71.109999999999999 111.145 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 60.1 mt -128.44 132.93 67.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.143 -0.48 . . . . 75.219999999999999 111.131 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 13.5 m80 -106.91 141.11 38.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 55.109999999999999 110.873 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.6 106.36 7.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.225 -0.443 . . . . 74.409999999999997 111.124 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 17.1 tp -64.91 135.87 56.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 72.329999999999998 110.891 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 10.0 mt -138.1 117.38 14.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.061 -0.518 . . . . 74.230000000000004 111.193 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 20.2 t -119.45 127.02 75.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 72.519999999999996 111.149 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 2.9 t0 63.8 35.29 11.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.144 -0.48 . . . . 73.120000000000005 110.897 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 63.43 43.11 6.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.235 -0.439 . . . . 64.150000000000006 110.872 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 42.4 mtt180 -140.85 129.7 23.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.484 . . . . 73.200000000000003 110.831 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -62.77 146.47 52.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 73.299999999999997 110.848 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -123.04 130.86 24.43 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.581 0.705 . . . . 74.230000000000004 111.132 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.76 139.03 39.21 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.643 2.229 . . . . 75.319999999999993 112.369 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -88.57 153.41 21.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.199 -0.455 . . . . 73.430000000000007 110.899 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 26.4 tp -52.05 -73.45 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 75.319999999999993 110.932 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 21.5 p 48.92 49.88 18.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 63.149999999999999 111.099 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.453 . . . . 73.25 110.914 179.994 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 CA-C-O 121.42 0.455 . . . . 61.43 112.508 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 168.29 21.96 Favored 'Trans proline' 0 C--O 1.232 0.213 0 C-N-CA 122.728 2.285 . . . . 73.239999999999995 112.356 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -124.12 167.64 13.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.26 -0.427 . . . . 74.239999999999995 110.924 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -107.83 144.54 16.11 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.752 -0.737 . . . . 53.240000000000002 112.446 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 80.7 p -88.68 -178.38 5.78 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.912 0.387 . . . . 73.150000000000006 110.836 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -123.92 32.32 5.6 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.066 -0.515 . . . . 63.140000000000001 110.852 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -85.4 132.88 34.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 61.520000000000003 110.899 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 5.2 mtt180 -138.11 -60.95 0.62 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 74.299999999999997 110.843 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.2 t -150.18 -42.73 0.13 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.187 -0.46 . . . . 72.310000000000002 110.822 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.29 -174.91 0.14 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.177 -0.465 . . . . 72.120000000000005 110.902 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 13.4 t -139.04 16.33 2.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.253 -0.43 . . . . 74.519999999999996 111.13 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.1 p -159.35 128.1 5.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.27 -0.423 . . . . 72.340000000000003 111.181 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.4 m -105.92 149.61 26.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.455 . . . . 64.400000000000006 110.847 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 24.7 m -140.19 138.81 35.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.15 -0.477 . . . . 54.439999999999998 111.153 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 18.7 m-90 -131.68 133.51 44.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.242 -0.436 . . . . 71.040000000000006 110.951 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.2 t -112.88 114.78 47.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.451 . . . . 75.129999999999995 111.157 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.2 146.48 36.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 74.439999999999998 110.9 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.9 91.89 2.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 74.109999999999999 110.874 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -123.09 152.97 40.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 73.129999999999995 110.915 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 64.87 14.86 9.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.165 -0.47 . . . . 75.329999999999998 110.829 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 88.94 0.4 81.2 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.745 -0.74 . . . . 72.120000000000005 112.498 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -139.83 173.0 11.98 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.788 0.327 . . . . 75.239999999999995 110.89 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -68.98 87.45 0.37 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.138 -0.483 . . . . 71.140000000000001 110.886 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.3 127.51 32.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 74.129999999999995 110.909 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -107.6 117.35 33.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 75.439999999999998 110.916 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -107.25 146.02 13.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 70.409999999999997 111.106 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 22.0 t -135.92 152.69 31.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 74.530000000000001 111.182 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.1 tp -131.38 99.83 4.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 70.120000000000005 110.882 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.83 134.37 43.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 74.450000000000003 110.896 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 3.0 mmmt -73.78 -17.92 61.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 74.010000000000005 110.861 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -51.35 -55.1 20.28 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.216 -0.447 . . . . 75.150000000000006 110.83 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.86 16.72 4.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 75.5 111.156 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 3.8 ttm 54.05 27.24 7.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.208 -0.451 . . . . 72.120000000000005 110.886 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.83 160.51 22.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.184 -0.462 . . . . 73.129999999999995 110.835 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 55.5 t -104.64 143.58 15.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 74.400000000000006 111.125 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 2.3 t90 -123.75 120.89 34.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.185 -0.461 . . . . 74.519999999999996 110.924 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 19.6 t -136.55 132.55 35.35 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.276 -0.42 . . . . 72.239999999999995 110.905 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 51.92 48.33 22.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.157 -0.474 . . . . 54.439999999999998 110.884 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 48.62 47.21 30.1 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.733 -0.746 . . . . 71.310000000000002 112.474 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.6 118.76 5.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.838 0.351 . . . . 75.329999999999998 110.932 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.24 101.95 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.212 -0.449 . . . . 72.299999999999997 110.88 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 38.5 mmm -55.68 176.65 0.06 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 73.340000000000003 110.843 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -119.16 106.51 12.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 72.340000000000003 110.914 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 59.4 p -99.14 -175.3 2.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 73.109999999999999 111.151 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -106.55 -44.64 4.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 72.450000000000003 111.126 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 77.04 53.07 5.42 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.825 -0.702 . . . . 73.310000000000002 112.456 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -97.08 115.02 26.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.86 0.362 . . . . 75.030000000000001 110.846 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -90.95 126.62 36.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 75.530000000000001 110.995 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 29.2 m -111.53 -178.29 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.178 -0.464 . . . . 71.109999999999999 111.123 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -52.71 -36.35 57.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 61.219999999999999 110.872 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -152.78 102.46 2.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 75.340000000000003 110.871 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 111.53 178.47 20.2 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.693 -0.765 . . . . 63.229999999999997 112.499 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.04 130.79 36.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.688 0.28 . . . . 74.340000000000003 111.218 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -98.89 100.23 11.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.271 -0.422 . . . . 73.430000000000007 110.955 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.98 110.24 17.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.46 . . . . 74.010000000000005 111.193 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 63.7 m-70 -100.77 105.78 17.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.257 -0.429 . . . . 75.310000000000002 110.814 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -139.29 156.54 46.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.245 -0.434 . . . . 75.099999999999994 110.849 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -111.64 123.73 50.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.086 -0.506 . . . . 75.340000000000003 110.917 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 27.2 t -106.15 125.89 61.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.114 -0.494 . . . . 65.120000000000005 111.082 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 52.36 41.3 54.84 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.727 -0.749 . . . . 70.219999999999999 112.478 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 64.33 26.02 13.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.799 0.333 . . . . 74.510000000000005 110.837 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 25.7 m-70 -113.12 -169.27 1.45 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 73.549999999999997 110.832 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -116.48 110.63 18.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 62.329999999999998 110.898 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 12.1 m -138.38 173.47 11.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 74.010000000000005 110.923 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 32.0 p90 -174.97 143.44 0.71 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.199 -0.455 . . . . 75.209999999999994 110.953 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 20.6 mt -97.73 113.63 32.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.076 -0.511 . . . . 73.120000000000005 111.094 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 27.9 tttt -79.84 102.74 9.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 72.340000000000003 110.914 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -97.19 136.02 38.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 74.420000000000002 111.075 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.3 t -133.91 121.14 38.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.23 -0.441 . . . . 74.049999999999997 111.185 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.3 p -94.53 143.1 26.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.145 -0.48 . . . . 74.25 110.833 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 2.3 t -136.52 134.14 37.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.091 -0.504 . . . . 73.549999999999997 110.89 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 136.12 171.92 12.46 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.728 -0.749 . . . . 71.129999999999995 112.493 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 6.5 mmtt -59.06 -28.64 66.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.764 0.316 . . . . 65.530000000000001 110.884 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 2.1 mtt180 -148.82 -63.43 0.24 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 72.409999999999997 110.872 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -152.75 44.39 0.67 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 75.510000000000005 110.84 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -57.68 -58.55 7.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.313 -0.403 . . . . 74.239999999999995 110.866 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -145.1 162.27 28.14 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.725 -0.75 . . . . 64.129999999999995 112.5 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 55.4 mt -144.85 145.45 21.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.786 0.327 . . . . 74.329999999999998 111.144 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 75.6 mt -133.82 123.68 45.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.466 . . . . 75.049999999999997 111.186 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 5.6 m80 -104.38 137.19 42.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 72.120000000000005 110.932 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.91 108.8 11.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 75.299999999999997 111.2 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 14.8 tp -66.33 136.36 55.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.277 -0.419 . . . . 73.420000000000002 110.904 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 12.4 mt -133.62 129.41 55.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.146 -0.479 . . . . 74.230000000000004 111.17 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 95.6 t -127.17 118.17 49.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.446 . . . . 74.340000000000003 111.149 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 63.61 41.0 7.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.134 -0.485 . . . . 72.329999999999998 110.853 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 63.34 43.01 6.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 73.430000000000007 110.812 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 17.7 mtm180 -138.98 121.97 16.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.216 -0.447 . . . . 74.439999999999998 110.922 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -62.75 146.48 52.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 70.140000000000001 110.913 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -123.99 131.55 24.24 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.619 0.723 . . . . 63.240000000000002 111.117 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 133.44 25.49 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.625 2.217 . . . . 74.430000000000007 112.34 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.22 163.52 14.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.246 -0.433 . . . . 73.239999999999995 110.924 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 22.0 tp -52.35 -73.93 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 74.439999999999998 110.952 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 1.3 p 46.61 78.14 0.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 73.230000000000004 111.155 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.273 -0.421 . . . . 74.340000000000003 110.882 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.286 0 CA-C-O 121.411 0.451 . . . . 75.099999999999994 112.557 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.69 -171.97 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.689 2.259 . . . . 74.319999999999993 112.326 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -126.32 132.55 51.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.122 -0.49 . . . . 75.040000000000006 110.876 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -129.26 97.46 0.41 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.706 -0.759 . . . . 62.299999999999997 112.418 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 77.3 p -141.14 76.61 1.56 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.805 0.336 . . . . 52.509999999999998 110.802 -179.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -130.58 131.29 44.91 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.137 -0.483 . . . . 61.009999999999998 110.88 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -132.83 151.72 51.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.121 -0.49 . . . . 73.230000000000004 110.919 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.61 160.53 22.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 72.310000000000002 110.924 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 58.0 m -73.22 112.49 9.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.239 -0.437 . . . . 72.319999999999993 110.882 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -146.26 111.03 5.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.069 -0.514 . . . . 73.540000000000006 110.872 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 71.8 p -94.56 47.1 1.16 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.456 . . . . 74.140000000000001 111.209 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -159.53 127.77 4.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.187 -0.46 . . . . 74.120000000000005 111.151 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 14.5 m -106.42 113.16 26.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.263 -0.426 . . . . 72.109999999999999 110.842 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 17.2 p -110.18 159.59 17.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.121 -0.491 . . . . 74.140000000000001 111.064 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 14.6 m-90 -149.57 155.97 41.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.223 -0.444 . . . . 72.450000000000003 110.911 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 18.9 t -131.52 114.95 26.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 74.340000000000003 111.158 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.22 147.63 38.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 75.150000000000006 110.884 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.65 94.29 3.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.155 -0.475 . . . . 71.140000000000001 110.834 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.68 154.05 39.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 71.299999999999997 110.908 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.1 t70 64.91 14.87 9.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.19 -0.459 . . . . 74.519999999999996 110.833 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 88.79 0.48 81.43 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.714 -0.755 . . . . 62.109999999999999 112.489 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -139.79 172.88 12.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.88 0.372 . . . . 75.019999999999996 110.855 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -68.43 89.4 0.35 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 71.310000000000002 110.907 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.72 123.99 26.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.437 . . . . 74.299999999999997 110.96 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -104.09 115.04 29.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 74.109999999999999 110.87 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -102.98 138.89 25.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.183 -0.462 . . . . 73.219999999999999 111.184 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 96.3 t -135.77 126.99 44.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.434 . . . . 74.409999999999997 111.169 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.3 tp -110.36 100.4 9.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.444 . . . . 72.230000000000004 110.959 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.4 136.15 38.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.447 . . . . 65.439999999999998 110.921 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 3.6 mtmt -73.21 -17.48 61.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 75.219999999999999 110.834 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -51.39 -54.91 21.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.222 -0.445 . . . . 74.140000000000001 110.871 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 14.9 p -132.55 16.82 4.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.176 -0.465 . . . . 72.129999999999995 111.12 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 81.2 mtp 51.59 31.1 7.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 74.209999999999994 110.895 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -86.57 153.27 21.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 71.299999999999997 110.875 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 95.6 t -104.92 123.09 58.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.233 -0.439 . . . . 72.109999999999999 111.18 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -104.94 131.97 51.77 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.232 -0.44 . . . . 70.010000000000005 110.91 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 24.4 t -126.99 103.19 7.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 73.340000000000003 110.931 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 12.0 m-20 45.35 70.28 0.37 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 71.549999999999997 110.885 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 48.72 39.01 23.34 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.78 -0.724 . . . . 61.240000000000002 112.504 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.25 107.42 4.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.893 0.377 . . . . 72.040000000000006 110.88 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.28 143.27 18.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 73.519999999999996 110.89 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 22.7 mmm -111.24 163.99 13.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 60.299999999999997 110.866 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -117.79 107.8 14.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 75.140000000000001 110.876 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 19.2 p -95.26 -179.36 4.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.144 -0.48 . . . . 71.099999999999994 111.177 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -92.41 -31.26 15.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 71.25 111.114 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 58.82 54.69 35.88 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.791 -0.718 . . . . 72.0 112.458 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -97.14 103.28 15.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.915 0.388 . . . . 75.140000000000001 110.957 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -84.61 116.21 23.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.176 -0.465 . . . . 73.409999999999997 110.904 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 20.4 m -97.94 -178.0 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.111 -0.495 . . . . 74.129999999999995 111.153 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.58 -27.73 67.93 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.138 -0.483 . . . . 71.540000000000006 110.84 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -155.53 102.46 2.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.251 -0.432 . . . . 74.430000000000007 110.834 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 110.92 174.98 20.28 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.743 -0.742 . . . . 61.32 112.498 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.21 130.8 35.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.686 0.279 . . . . 71.120000000000005 111.21 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -109.82 97.44 6.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.302 -0.408 . . . . 73.230000000000004 110.865 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.51 110.44 19.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 72.219999999999999 111.142 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 67.5 m-70 -106.15 105.6 15.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 73.519999999999996 110.837 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -122.97 131.07 53.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 70.510000000000005 110.808 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 27.8 p -83.07 149.79 26.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 74.0 110.857 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.8 t -140.65 99.65 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.051 -0.522 . . . . 74.030000000000001 111.066 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 54.58 -115.88 5.88 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.726 -0.749 . . . . 61.5 112.479 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -106.04 25.41 10.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.81 0.338 . . . . 72.219999999999999 110.884 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 67.4 m-70 -119.2 -175.48 2.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 72.439999999999998 110.824 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -145.33 84.42 1.7 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 61.0 110.872 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 6.8 m -99.53 165.08 11.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.231 -0.441 . . . . 74.150000000000006 110.897 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 19.9 p90 -167.48 145.04 4.56 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.175 -0.466 . . . . 75.019999999999996 110.89 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 32.9 mt -98.63 111.26 27.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.134 -0.485 . . . . 75.019999999999996 111.155 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.33 103.14 12.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.122 -0.49 . . . . 63.539999999999999 110.902 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -94.27 146.08 24.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 74.109999999999999 111.157 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.5 t -138.41 124.79 25.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.289 -0.414 . . . . 74.299999999999997 111.126 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -99.86 146.87 26.14 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.184 -0.462 . . . . 73.530000000000001 110.878 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 1.4 p -149.29 150.6 32.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 73.340000000000003 110.826 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 109.1 64.56 0.55 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.778 -0.725 . . . . 72.420000000000002 112.507 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.19 -75.44 0.07 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.794 0.33 . . . . 73.209999999999994 110.876 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -138.72 -58.97 0.62 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 73.310000000000002 110.962 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 2.9 tttt -135.39 103.07 5.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.116 -0.493 . . . . 72.540000000000006 110.98 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -144.87 -62.8 0.36 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 72.420000000000002 110.852 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -135.16 127.38 4.35 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.765 -0.731 . . . . 64.140000000000001 112.459 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 69.1 mt -122.99 138.57 52.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.763 0.316 . . . . 64.209999999999994 111.185 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 54.9 mt -127.53 128.92 70.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.178 -0.464 . . . . 75.510000000000005 111.088 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 15.3 m80 -100.22 137.98 37.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 73.439999999999998 110.914 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.88 109.3 11.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 74.349999999999994 111.107 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 19.1 tp -67.3 138.46 56.85 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.152 -0.477 . . . . 75.439999999999998 110.893 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 8.6 mt -139.01 128.59 30.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 75.5 111.114 179.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 64.1 t -127.81 122.73 59.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.109 -0.496 . . . . 74.409999999999997 111.15 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 2.4 t0 63.77 38.24 9.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.204 -0.453 . . . . 72.209999999999994 110.867 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 2.0 t30 63.32 43.11 6.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 70.340000000000003 110.842 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.14 131.61 23.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 74.209999999999994 110.879 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -62.34 146.4 51.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.218 -0.446 . . . . 75.239999999999995 110.954 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -123.72 130.52 24.43 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.646 0.736 . . . . 73.129999999999995 111.137 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 147.83 63.53 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.713 2.275 . . . . 73.430000000000007 112.324 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -89.83 -175.66 4.69 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.245 -0.434 . . . . 75.420000000000002 110.91 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 17.4 tp -76.82 109.09 10.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 72.329999999999998 110.915 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 53.3 p -135.3 -45.12 0.7 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 74.409999999999997 111.134 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 71.209999999999994 110.953 179.964 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.362 0 CA-C-O 121.425 0.458 . . . . 65.239999999999995 112.486 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 154.75 67.36 Favored 'Trans proline' 0 C--O 1.233 0.238 0 C-N-CA 122.666 2.244 . . . . 71.209999999999994 112.318 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.2 mt -144.9 148.05 33.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 74.420000000000002 110.922 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 99.2 -137.7 13.41 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.781 -0.723 . . . . 71.340000000000003 112.483 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.5 m -85.47 163.39 18.48 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.827 0.346 . . . . 73.340000000000003 110.856 -179.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -118.76 41.57 2.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 73.230000000000004 110.918 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 57.0 -172.06 0.08 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.117 -0.492 . . . . 64.150000000000006 110.864 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.78 -37.44 24.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 74.129999999999995 110.9 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 61.88 94.6 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.157 -0.474 . . . . 72.5 110.906 -179.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 14.0 pttp -174.03 -171.29 0.62 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 73.409999999999997 110.935 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 2.4 m 72.57 -68.62 0.22 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 75.340000000000003 111.115 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -159.8 128.15 4.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 73.109999999999999 111.138 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.9 m -106.04 151.99 23.95 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.209 -0.451 . . . . 73.239999999999995 110.826 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 95.7 m -146.34 141.81 27.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.111 -0.495 . . . . 63.32 111.145 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 21.7 m-90 -132.35 158.8 41.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 75.25 110.968 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.0 t -133.26 114.82 21.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.342 -0.39 . . . . 73.25 111.144 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.64 147.58 37.79 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.226 -0.443 . . . . 75.109999999999999 110.919 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 42.3 mtp180 -72.72 92.09 1.53 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 75.430000000000007 110.858 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -121.61 151.52 40.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 72.120000000000005 110.904 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 64.85 14.69 9.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.232 -0.44 . . . . 75.120000000000005 110.884 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.2 0.69 80.03 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.752 -0.737 . . . . 74.450000000000003 112.489 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -139.87 172.73 12.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.867 0.365 . . . . 74.420000000000002 110.942 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -68.24 89.88 0.33 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.162 -0.472 . . . . 63.340000000000003 110.865 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.96 134.14 38.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 74.409999999999997 110.912 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 25.9 ttm180 -111.11 119.51 39.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 70.019999999999996 110.877 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -105.41 145.13 13.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.2 -0.455 . . . . 74.540000000000006 111.167 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 91.4 t -134.37 144.24 35.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.249 -0.432 . . . . 70.040000000000006 111.135 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.4 tp -131.52 101.53 5.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 75.209999999999994 110.929 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.63 132.11 42.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.27 -0.423 . . . . 72.450000000000003 110.881 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.35 -16.58 61.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 72.510000000000005 110.93 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -52.59 -55.96 18.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 74.299999999999997 110.829 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.56 16.99 3.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 74.200000000000003 111.116 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 68.1 mtp 57.91 30.23 18.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.445 . . . . 62.350000000000001 110.884 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -77.83 143.07 38.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.455 . . . . 72.150000000000006 110.902 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 17.2 t -104.62 128.06 58.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 74.510000000000005 111.209 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 3.2 t90 -119.97 114.39 21.96 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.23 -0.441 . . . . 74.120000000000005 110.894 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 3.0 t -100.97 103.09 14.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.25 -0.432 . . . . 73.349999999999994 110.892 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 67.91 -76.16 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 73.150000000000006 110.926 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -159.08 45.77 0.44 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.739 -0.744 . . . . 74.340000000000003 112.462 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.86 114.2 4.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.893 0.378 . . . . 74.219999999999999 110.868 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.3 101.94 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.459 . . . . 73.109999999999999 110.879 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 64.1 mtp -60.85 157.32 15.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 73.420000000000002 110.9 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -102.9 106.65 17.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 72.409999999999997 110.868 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 15.5 p -98.66 -176.28 3.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 73.329999999999998 111.111 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -112.89 -75.36 0.6 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.275 -0.42 . . . . 65.439999999999998 111.094 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 104.68 86.15 1.9 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.727 -0.749 . . . . 73.319999999999993 112.511 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -148.17 132.54 17.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.869 0.366 . . . . 73.340000000000003 110.914 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -69.84 151.7 45.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 73.140000000000001 110.92 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 16.4 m -136.98 -176.42 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 72.299999999999997 111.182 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -55.88 -24.05 34.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 75.129999999999995 110.891 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.95 -77.2 0.6 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 53.450000000000003 110.865 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -129.99 -102.68 1.0 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.8 -0.714 . . . . 63.149999999999999 112.539 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.32 130.87 33.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.76 0.314 . . . . 75.030000000000001 111.145 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.73 97.68 11.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 73.530000000000001 110.881 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -77.46 110.55 12.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.114 -0.494 . . . . 74.140000000000001 111.112 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -98.91 111.63 23.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.267 -0.424 . . . . 63.020000000000003 110.869 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -144.8 159.55 42.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.454 . . . . 64.209999999999994 110.903 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.8 166.5 14.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 63.420000000000002 110.895 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 24.2 t -145.54 97.97 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.159 -0.473 . . . . 75.129999999999995 111.084 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 67.22 -88.98 0.16 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.738 -0.744 . . . . 61.020000000000003 112.478 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -139.5 25.9 2.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.828 0.347 . . . . 61.340000000000003 110.86 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 67.1 m-70 -115.77 -175.77 2.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 73.0 110.899 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -140.89 116.56 10.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.26 -0.427 . . . . 72.540000000000006 110.893 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 1.9 p -142.56 158.19 43.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 70.25 110.959 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 19.9 p90 -150.84 145.34 25.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.227 -0.442 . . . . 75.439999999999998 110.926 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.2 mt -97.74 112.46 29.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.095 -0.502 . . . . 74.219999999999999 111.174 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.69 102.88 9.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 74.400000000000006 110.93 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -99.02 143.85 28.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.229 -0.441 . . . . 71.439999999999998 111.098 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 20.9 t -142.33 124.43 13.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 73.25 111.149 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.3 p -94.38 140.43 29.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.455 . . . . 73.310000000000002 110.821 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 10.4 t -134.47 135.7 42.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.068 -0.515 . . . . 62.020000000000003 110.886 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 135.78 -145.65 17.65 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.709 -0.757 . . . . 74.450000000000003 112.447 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -88.79 -36.4 16.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.819 0.342 . . . . 73.430000000000007 110.858 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 1.7 mtm-85 -152.35 -47.5 0.1 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.284 -0.416 . . . . 72.439999999999998 110.831 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 7.7 pttp -159.55 37.82 0.2 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.165 -0.471 . . . . 72.430000000000007 110.931 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -59.08 -70.6 0.15 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.236 -0.438 . . . . 74.129999999999995 110.896 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -129.58 128.23 5.66 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.76 -0.733 . . . . 74.430000000000007 112.485 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 48.6 mt -120.44 147.46 24.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.816 0.341 . . . . 72.439999999999998 111.122 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 3.0 mt -131.96 130.23 61.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 73.340000000000003 111.074 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 8.7 m80 -108.71 134.96 50.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 74.25 110.917 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.28 110.14 13.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.188 -0.46 . . . . 71.010000000000005 111.156 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 11.8 tp -66.96 135.38 53.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.212 -0.449 . . . . 73.209999999999994 110.951 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 10.8 mt -136.81 106.19 4.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 74.109999999999999 111.206 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 47.7 t -109.39 128.94 64.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 74.310000000000002 111.142 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 63.31 41.28 7.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.194 -0.457 . . . . 74.120000000000005 110.816 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 56.6 42.68 26.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.237 -0.438 . . . . 72.319999999999993 110.87 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 10.5 mtp180 -140.44 126.44 19.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 75.310000000000002 110.836 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.58 145.29 54.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 74.409999999999997 110.885 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -123.61 131.29 24.28 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.663 0.744 . . . . 75.409999999999997 111.125 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 132.25 22.99 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.755 2.303 . . . . 73.5 112.336 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -92.52 164.01 13.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.245 -0.434 . . . . 73.099999999999994 110.85 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -81.33 99.58 8.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 74.310000000000002 110.927 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 22.9 p -117.59 34.11 5.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 74.439999999999998 111.144 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 74.439999999999998 110.912 179.984 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.503 ' O ' HG23 ' A' ' 97' ' ' THR . 68.3 p . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.836 0.35 . . . . 72.3 111.143 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.503 HG23 ' O ' ' A' ' 96' ' ' THR . 1.0 OUTLIER -159.65 127.98 4.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.23 -0.441 . . . . 53.41 111.134 -179.92 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.3 m -106.17 152.79 23.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 61.14 110.863 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.534 HG23 HG22 ' A' ' 112' ' ' VAL . 7.9 m -140.66 154.79 46.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.147 -0.479 . . . . 74.32 111.172 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 14.0 m-90 -151.12 131.54 13.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.231 -0.44 . . . . 72.33 110.915 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.2 t -113.03 114.61 47.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 64.21 111.115 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.688 HD11 HD12 ' A' ' 104' ' ' LEU . 0.5 OUTLIER -139.36 145.95 39.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 74.43 110.888 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 17.2 ttt180 -74.0 93.39 2.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 63.22 110.827 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.688 HD12 HD11 ' A' ' 102' ' ' LEU . 0.4 OUTLIER -126.27 152.95 45.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.187 -0.46 . . . . 62.12 110.911 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 3.1 t70 64.51 15.32 9.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 64.4 110.894 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.23 1.55 84.04 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.734 -0.746 . . . . 52.24 112.467 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -139.83 173.07 11.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.876 0.37 . . . . 75.22 110.899 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -69.63 87.97 0.5 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.146 -0.479 . . . . 64.11 110.876 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.638 HD13 ' HB3' ' A' ' 104' ' ' LEU . 0.8 OUTLIER -70.39 126.7 30.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 75.23 110.913 -179.948 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 12.3 ttt180 -108.14 116.72 32.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 75.24 110.865 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.412 HG21 ' CD2' ' A' ' 167' ' ' LEU . 0.0 OUTLIER -109.6 139.96 30.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 63.55 111.128 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.534 HG22 HG23 ' A' ' 99' ' ' THR . 47.3 t -135.66 139.36 46.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 72.52 111.109 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.529 HD22 HD13 ' A' ' 151' ' ' ILE . 2.9 tp -114.75 99.87 7.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 53.15 110.93 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.22 134.24 42.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.441 . . . . 75.44 110.88 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.7 mmmt -73.81 -17.63 61.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.13 -0.486 . . . . 75.02 110.907 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -51.27 -52.75 42.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 65.02 110.886 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 17.0 p -134.92 16.98 3.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 71.43 111.204 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' MET . . . . . 0.468 ' HA ' HD11 ' A' ' 113' ' ' LEU . 0.0 OUTLIER 53.13 28.66 7.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 71.04 110.92 179.934 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.62 159.67 19.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 63.55 110.914 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.731 HG22 HD12 ' A' ' 151' ' ' ILE . 85.8 t -104.93 134.09 47.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 73.1 111.121 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 4.1 t90 -115.94 120.24 38.53 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.154 -0.475 . . . . 70.42 110.933 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' CYS . . . . . 0.42 ' SG ' HD11 ' A' ' 109' ' ' LEU . 11.3 t -136.6 132.05 34.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.242 -0.436 . . . . 74.33 110.857 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 2.9 m120 50.51 48.03 23.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.197 -0.456 . . . . 62.13 110.851 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 49.45 47.88 35.27 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.785 -0.722 . . . . 54.12 112.508 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.18 113.85 4.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.835 0.35 . . . . 74.32 110.88 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 2.5 ttpm? -53.71 101.72 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 75.23 110.897 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' MET . . . . . 0.544 ' CE ' HG22 ' A' ' 144' ' ' VAL . 25.1 mmm -60.97 169.92 1.76 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 64.13 110.897 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -119.17 106.96 12.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 74.24 110.906 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.677 ' HB ' HG22 ' A' ' 140' ' ' THR . 24.4 p -95.6 -175.28 3.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 74.04 111.198 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.561 ' HB2' ' HB2' ' A' ' 141' ' ' HIS . . . -95.12 -39.47 10.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.259 -0.428 . . . . 75.14 111.124 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 69.53 40.03 78.69 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.727 -0.749 . . . . 72.44 112.466 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 . . . . . 0 C--N 1.329 -0.312 0 CA-C-O 120.858 0.361 . . . . 74.3 110.902 -179.876 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 N-CA-C 112.54 -0.224 . . . . 73.13 112.54 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.52 ' O ' ' HB3' ' A' ' 153' ' ' ALA . 0.1 OUTLIER -135.24 130.71 35.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.73 0.3 . . . . 75.33 111.186 -179.874 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -106.35 96.36 6.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.259 -0.428 . . . . 75.42 110.867 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.677 HG22 ' HB ' ' A' ' 129' ' ' THR . 0.0 OUTLIER -80.06 110.26 15.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 74.42 111.153 -179.963 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 141' ' ' HIS . . . . . 0.561 ' HB2' ' HB2' ' A' ' 130' ' ' ALA . 77.1 m-70 -104.83 105.38 15.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.455 . . . . 73.12 110.87 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.514 ' CE2' HG21 ' A' ' 120' ' ' VAL . 19.0 p90 -126.13 132.92 51.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.471 . . . . 75.01 110.887 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 54.7 p -83.33 144.48 29.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 62.24 110.88 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.544 HG22 ' CE ' ' A' ' 127' ' ' MET . 21.6 t -134.58 98.1 2.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 62.24 111.102 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 52.12 -119.29 8.71 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.674 -0.774 . . . . 75.42 112.537 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -100.4 28.25 5.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.851 0.358 . . . . 64.14 110.849 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 49.0 m-70 -130.87 165.67 22.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 72.15 110.868 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -124.35 88.9 2.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 74.41 110.866 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' CYS . . . . . 0.514 ' SG ' HG13 ' A' ' 169' ' ' VAL . 9.8 m -98.49 172.76 7.31 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.207 -0.451 . . . . 60.4 110.903 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 55.5 p90 -175.22 145.6 0.79 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.196 -0.456 . . . . 72.01 110.937 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.731 HD12 HG22 ' A' ' 120' ' ' VAL . 23.2 mt -97.43 111.23 26.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.117 -0.492 . . . . 74.41 111.127 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -80.18 102.86 9.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 54.33 110.868 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' ALA . . . . . 0.52 ' HB3' ' O ' ' A' ' 138' ' ' THR . . . -95.49 146.44 24.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 30.41 111.088 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.4 t -143.89 120.49 5.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.264 -0.425 . . . . 72.32 111.14 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.3 p -87.25 140.72 29.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 64.45 110.869 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 5.0 p -132.56 148.68 52.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.118 -0.492 . . . . 75.14 110.863 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 111.06 -162.93 12.32 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.792 -0.718 . . . . 63.23 112.479 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.47 -44.87 85.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.794 0.331 . . . . 72.44 110.906 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.23 -60.83 0.13 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 71.13 110.852 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 17.7 mtmt -137.18 37.72 2.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 35.33 110.86 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.25 -62.21 1.84 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.266 -0.424 . . . . 71.21 110.884 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -135.16 122.47 2.83 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.768 -0.73 . . . . 33.25 112.516 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 69.6 mt -110.77 144.85 17.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.846 0.355 . . . . 74.15 111.112 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 3.0 mt -129.84 127.97 64.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 74.21 111.173 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' HIS . . . . . 0.438 ' CG ' HD23 ' A' ' 113' ' ' LEU . 13.0 m80 -105.01 136.51 44.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 74.32 110.857 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.61 106.1 8.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 63.3 111.092 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.454 HD12 ' H ' ' A' ' 168' ' ' ILE . 30.4 tp -65.29 139.36 58.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.193 -0.458 . . . . 64.41 110.917 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.454 ' H ' HD12 ' A' ' 167' ' ' LEU . 9.4 mt -137.43 129.97 42.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 61.13 111.118 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.514 HG13 ' SG ' ' A' ' 149' ' ' CYS . 99.5 t -125.49 115.43 43.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.47 . . . . 74.11 111.125 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 63.66 46.88 3.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.15 -0.477 . . . . 74.43 110.918 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 58.69 42.8 19.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.143 -0.481 . . . . 74.41 110.918 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.19 124.9 19.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 70.25 110.85 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -62.56 146.2 52.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 74.44 110.903 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.573 HD12 HD22 ' A' ' 102' ' ' LEU . 0.9 OUTLIER -120.73 131.12 24.56 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.606 0.717 . . . . 63.43 111.135 179.986 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 134.4 27.9 Favored 'Trans proline' 0 N--CA 1.465 -0.161 0 C-N-CA 122.714 2.276 . . . . 73.4 112.348 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.234 -0.439 . . . . 52.2 110.913 -179.998 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.5 ' O ' HG23 ' A' ' 97' ' ' THR . 40.4 p . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.871 0.367 . . . . 73.45 111.161 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.5 HG23 ' O ' ' A' ' 96' ' ' THR . 1.0 OUTLIER -159.52 128.33 5.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.193 -0.458 . . . . 71.01 111.091 -179.974 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.9 m -105.8 152.79 22.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 74.32 110.844 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 56.1 m -147.52 137.42 22.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 63.13 111.15 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' TRP . . . . . 0.404 ' CB ' HD23 ' A' ' 167' ' ' LEU . 16.7 m-90 -130.27 156.86 43.94 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.202 -0.453 . . . . 64.53 110.883 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 19.7 t -128.95 114.84 34.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.234 -0.439 . . . . 63.25 111.163 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.914 HD11 HD12 ' A' ' 104' ' ' LEU . 0.5 OUTLIER -141.33 147.52 38.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.27 -0.423 . . . . 45.45 110.899 179.986 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.54 92.78 2.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 74.41 110.853 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.914 HD12 HD11 ' A' ' 102' ' ' LEU . 0.3 OUTLIER -122.1 152.66 39.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 70.13 110.852 -179.954 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 64.93 14.78 9.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.17 -0.468 . . . . 61.51 110.887 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.08 0.43 80.77 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.747 -0.739 . . . . 61.32 112.514 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -139.92 172.78 12.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.847 0.356 . . . . 73.32 110.873 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -68.29 89.44 0.33 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.158 -0.473 . . . . 60.23 110.836 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.591 HD13 ' HB3' ' A' ' 104' ' ' LEU . 0.4 OUTLIER -77.36 127.27 32.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.221 -0.445 . . . . 74.34 110.937 179.999 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 12.2 ttp180 -106.08 116.01 31.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.135 -0.484 . . . . 73.31 110.897 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.444 HG21 ' CD2' ' A' ' 167' ' ' LEU . 0.2 OUTLIER -101.83 141.98 17.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.248 -0.433 . . . . 75.45 111.081 -179.974 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 96.9 t -135.93 126.47 42.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 64.12 111.168 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.616 HD11 ' HA ' ' A' ' 118' ' ' MET . 2.5 tp -110.48 111.9 23.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.468 . . . . 74.1 110.871 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.486 ' N ' HD12 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -86.26 135.25 33.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 71.42 110.888 179.881 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.16 -16.25 61.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.476 . . . . 73.13 110.885 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -51.74 -55.87 17.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 75.41 110.879 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.1 p -136.22 17.09 3.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.436 . . . . 65.11 111.122 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' MET . . . . . 0.616 ' HA ' HD11 ' A' ' 113' ' ' LEU . 69.0 mtp 58.16 29.33 17.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 70.4 110.947 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.64 146.05 34.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 74.12 110.909 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.631 HG21 ' CE2' ' A' ' 142' ' ' PHE . 98.4 t -105.0 123.51 59.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.235 -0.439 . . . . 61.15 111.154 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 2.3 t90 -105.27 131.59 52.54 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.178 -0.465 . . . . 73.34 110.943 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' CYS . . . . . 0.436 ' SG ' HG13 ' A' ' 111' ' ' VAL . 1.2 m -128.3 103.3 7.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.258 -0.428 . . . . 75.21 110.883 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 24.2 m-20 45.56 70.54 0.35 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 71.34 110.886 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 48.6 40.16 24.3 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.748 -0.739 . . . . 70.22 112.438 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.04 107.23 4.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.903 0.383 . . . . 71.24 110.91 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 4.3 mttt -53.41 152.62 4.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 62.34 110.945 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' MET . . . . . 0.649 ' CE ' HG22 ' A' ' 144' ' ' VAL . 27.2 mmm -123.89 164.83 18.47 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.295 -0.411 . . . . 73.11 110.867 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -118.97 110.14 16.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 74.23 110.941 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.736 ' HB ' HG22 ' A' ' 140' ' ' THR . 19.3 p -95.63 174.34 7.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 73.33 111.162 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -174.77 -169.59 0.43 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 72.22 111.116 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 118.63 -111.54 2.15 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.736 -0.745 . . . . 63.13 112.523 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 . . . . . 0 C--N 1.33 -0.277 0 CA-C-O 120.832 0.348 . . . . 75.13 110.931 -179.902 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.282 0 N-CA-C 112.472 -0.251 . . . . 72.01 112.472 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.485 ' O ' ' HB3' ' A' ' 153' ' ' ALA . 0.1 OUTLIER -134.8 130.76 36.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.727 0.299 . . . . 72.33 111.134 -179.851 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -87.32 96.5 10.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 75.3 110.963 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.736 HG22 ' HB ' ' A' ' 129' ' ' THR . 0.0 OUTLIER -79.92 110.17 15.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 74.21 111.133 -179.907 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -108.31 111.96 24.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 74.11 110.861 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.631 ' CE2' HG21 ' A' ' 120' ' ' VAL . 15.1 p90 -125.46 134.02 52.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 73.41 110.854 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 60.6 p -78.6 139.2 38.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.169 -0.469 . . . . 71.11 110.896 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.649 HG22 ' CE ' ' A' ' 127' ' ' MET . 21.4 t -130.87 98.06 3.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 72.03 111.123 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 51.85 -124.24 23.15 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.669 -0.777 . . . . 54.14 112.502 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -95.89 25.23 4.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.813 0.34 . . . . 71.34 110.856 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 45.9 m-70 -121.64 -169.99 1.96 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 74.52 110.838 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -149.83 81.48 1.39 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 71.3 110.847 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' CYS . . . . . 0.52 ' SG ' HG13 ' A' ' 169' ' ' VAL . 8.3 m -96.29 166.07 11.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.242 -0.435 . . . . 60.21 110.843 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -167.27 144.48 4.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 74.21 110.961 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.6 HD12 HG22 ' A' ' 120' ' ' VAL . 44.9 mt -99.5 111.21 28.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 72.42 111.139 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 5.0 tttp -80.56 103.11 10.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.153 -0.476 . . . . 74.14 110.851 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' ALA . . . . . 0.485 ' HB3' ' O ' ' A' ' 138' ' ' THR . . . -95.23 143.07 26.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.462 . . . . 44.23 111.074 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.2 t -136.58 120.61 24.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 45.14 111.077 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.2 p -90.75 132.84 35.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 74.04 110.794 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 9.5 p -124.38 138.64 54.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.091 -0.504 . . . . 41.13 110.907 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 132.85 -104.05 0.53 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.71 -0.757 . . . . 63.51 112.471 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 12.3 ttmt -142.73 -46.14 0.32 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.785 0.326 . . . . 71.25 110.906 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 5.9 ttt180 -137.21 -45.83 0.56 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.216 -0.447 . . . . 71.51 110.869 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 11.6 tttt -167.83 55.64 0.07 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 75.23 110.955 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -82.43 -64.53 1.16 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 63.51 110.849 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -135.34 114.2 1.2 Allowed Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.685 -0.769 . . . . 70.12 112.441 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 76.2 mt -105.97 139.56 26.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.848 0.356 . . . . 73.13 111.121 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 72.0 mt -126.43 122.83 62.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.46 . . . . 73.53 111.131 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 18.1 m80 -96.66 137.8 35.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 54.25 110.881 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.79 104.26 7.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.21 -0.45 . . . . 71.42 111.138 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.607 HD12 ' H ' ' A' ' 168' ' ' ILE . 15.9 tp -63.81 138.97 58.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.289 -0.414 . . . . 64.33 110.925 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.607 ' H ' HD12 ' A' ' 167' ' ' LEU . 10.0 mt -137.76 120.75 20.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 62.41 111.089 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.663 HG21 HD13 ' A' ' 102' ' ' LEU . 89.5 t -121.32 130.83 74.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.095 -0.502 . . . . 64.34 111.089 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 58.79 36.91 24.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.12 -0.491 . . . . 53.21 110.832 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 2.6 t30 63.34 43.07 6.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 72.35 110.877 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.14 128.77 21.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 73.45 110.875 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -62.62 146.5 51.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 74.23 110.856 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -123.81 131.37 24.25 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.569 0.699 . . . . 64.03 111.097 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 135.18 29.81 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.7 2.266 . . . . 54.4 112.334 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 74.5 110.91 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.505 ' O ' HG23 ' A' ' 97' ' ' THR . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.187 0 CA-C-O 120.866 0.365 . . . . 73.23 111.099 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.505 HG23 ' O ' ' A' ' 96' ' ' THR . 1.0 OUTLIER -159.56 127.89 5.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 72.41 111.197 -179.956 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.7 m -106.22 155.04 19.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.241 -0.436 . . . . 71.23 110.894 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.808 HG22 HG22 ' A' ' 112' ' ' VAL . 72.3 p -144.88 155.08 43.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 53.52 111.177 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 15.3 m-90 -151.35 133.54 15.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.242 -0.435 . . . . 74.25 110.928 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.3 t -112.95 114.84 48.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.283 -0.417 . . . . 61.32 111.055 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.721 HD11 HD12 ' A' ' 104' ' ' LEU . 0.5 OUTLIER -139.73 145.87 38.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 73.11 110.914 179.916 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -74.62 92.99 2.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 55.34 110.851 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.721 HD12 HD11 ' A' ' 102' ' ' LEU . 0.4 OUTLIER -124.9 153.73 42.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.471 . . . . 64.52 110.987 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.7 t70 64.5 15.42 9.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.271 -0.422 . . . . 73.4 110.805 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.69 1.31 83.12 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.768 -0.729 . . . . 74.24 112.502 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -139.92 173.03 11.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.779 0.323 . . . . 65.32 110.884 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -69.74 87.85 0.52 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.161 -0.472 . . . . 62.51 110.884 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.643 HD13 ' HB3' ' A' ' 104' ' ' LEU . 0.7 OUTLIER -70.52 127.43 32.7 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.258 -0.428 . . . . 63.12 110.93 -179.96 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 8.8 ttm180 -107.87 115.29 29.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.185 -0.461 . . . . 71.53 110.83 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.434 HG21 ' CD2' ' A' ' 167' ' ' LEU . 0.1 OUTLIER -106.67 137.64 36.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.12 -0.491 . . . . 73.45 111.081 -179.99 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.808 HG22 HG22 ' A' ' 99' ' ' THR . 90.1 t -135.76 128.56 47.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.187 -0.461 . . . . 74.34 111.182 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.52 HD11 ' HA ' ' A' ' 118' ' ' MET . 2.5 tp -110.2 103.46 12.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.476 . . . . 72.22 110.96 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.437 ' HG3' HG22 ' A' ' 97' ' ' THR . 0.9 OUTLIER -78.24 134.95 37.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.232 -0.44 . . . . 75.45 110.863 179.977 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 9.2 mmmt -73.13 -17.2 61.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.126 -0.488 . . . . 53.53 110.889 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -51.6 -55.18 20.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 71.13 110.838 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.45 16.97 4.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 74.13 111.105 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' MET . . . . . 0.52 ' HA ' HD11 ' A' ' 113' ' ' LEU . 4.0 ttm 53.54 32.36 14.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.232 -0.44 . . . . 73.41 110.848 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.99 155.03 20.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.289 -0.414 . . . . 52.52 110.863 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.682 HG22 HD12 ' A' ' 151' ' ' ILE . 99.6 t -104.83 130.18 56.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 63.24 111.172 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 7.7 t-105 -112.7 122.88 48.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.089 -0.505 . . . . 75.03 110.872 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 24.6 t -128.48 131.78 48.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.134 -0.485 . . . . 75.13 110.805 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 27.3 m-20 50.08 54.63 10.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 71.12 110.862 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 49.82 37.42 28.25 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.754 -0.736 . . . . 64.54 112.483 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -143.38 165.77 26.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.868 0.366 . . . . 70.03 110.916 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -85.93 157.92 20.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 70.51 110.88 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 35.2 mmm -124.76 166.98 15.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 63.41 110.88 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -119.23 106.59 12.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 71.14 110.853 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.676 ' HB ' HG22 ' A' ' 140' ' ' THR . 19.2 p -95.91 -175.26 3.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 72.12 111.113 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -104.61 -29.54 10.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 72.11 111.107 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 61.98 39.92 98.2 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.733 -0.746 . . . . 54.25 112.452 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 49.5 tt0 . . . . . 0 C--N 1.329 -0.287 0 CA-C-O 120.865 0.364 . . . . 73.4 110.898 -179.868 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 N-CA-C 112.549 -0.22 . . . . 74.14 112.549 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.462 ' O ' ' HB3' ' A' ' 153' ' ' ALA . 0.1 OUTLIER -135.25 130.8 35.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.762 0.315 . . . . 71.44 111.145 -179.87 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -108.18 103.62 12.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.481 . . . . 73.43 110.982 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.676 HG22 ' HB ' ' A' ' 129' ' ' THR . 0.0 OUTLIER -83.13 110.35 17.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.211 -0.45 . . . . 63.55 111.14 -179.892 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 68.4 m-70 -105.37 105.26 15.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 73.25 110.784 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.491 ' CE2' HG21 ' A' ' 120' ' ' VAL . 18.2 p90 -123.85 134.56 53.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 74.11 110.913 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 3.3 p -77.8 139.51 39.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 42.31 110.867 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.6 t -133.48 106.3 9.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 62.44 111.092 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 53.31 -116.35 5.65 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.741 -0.742 . . . . 73.03 112.435 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -110.25 26.22 10.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.795 0.331 . . . . 74.04 110.872 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 16.0 m170 -124.1 -169.81 2.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 64.11 110.86 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -140.85 81.69 1.81 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 71.21 110.902 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' CYS . . . . . 0.417 ' SG ' HG13 ' A' ' 169' ' ' VAL . 11.1 m -91.62 157.43 16.98 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.24 -0.436 . . . . 74.25 110.917 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 39.3 p90 -159.83 143.33 14.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 74.51 110.882 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.682 HD12 HG22 ' A' ' 120' ' ' VAL . 35.5 mt -97.54 111.67 27.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.126 -0.488 . . . . 72.21 111.064 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 33.2 ttmt -80.04 102.87 9.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.475 . . . . 71.21 110.968 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' ALA . . . . . 0.462 ' HB3' ' O ' ' A' ' 138' ' ' THR . . . -95.02 142.21 27.77 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.176 -0.465 . . . . 55.13 111.137 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.3 t -138.8 124.58 23.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.254 -0.43 . . . . 75.44 111.138 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.4 p -95.81 133.14 40.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 53.24 110.932 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -133.68 133.21 41.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.151 -0.477 . . . . 63.24 110.891 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 112.01 -176.33 17.95 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.754 -0.736 . . . . 20.35 112.428 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.84 130.55 35.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.849 0.357 . . . . 74.43 110.916 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 20.5 mmt180 54.31 43.06 31.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 61.14 110.874 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 3.0 mttt 55.51 48.06 19.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.136 -0.484 . . . . 75.13 110.911 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -52.17 -68.42 0.17 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 64.22 110.889 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -110.86 125.43 7.39 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.768 -0.73 . . . . 21.21 112.526 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 64.7 mt -114.81 143.98 23.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.824 0.345 . . . . 73.51 111.085 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 64.4 mt -132.18 127.35 57.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 60.34 111.102 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' HIS . . . . . 0.42 ' CG ' HD23 ' A' ' 113' ' ' LEU . 12.7 m80 -102.81 140.07 37.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.161 -0.472 . . . . 73.25 110.893 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.37 106.44 8.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.163 -0.471 . . . . 62.43 111.166 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.434 ' CD2' HG21 ' A' ' 111' ' ' VAL . 30.7 tp -66.8 136.61 55.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 71.14 110.964 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.405 ' H ' HD12 ' A' ' 167' ' ' LEU . 10.2 mt -137.78 129.78 40.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.446 . . . . 72.54 111.12 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.417 HG21 HD13 ' A' ' 102' ' ' LEU . 57.6 t -126.46 117.78 49.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 65.44 111.164 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.9 t0 63.69 41.81 6.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.178 -0.464 . . . . 40.2 110.834 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 62.5 42.92 8.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 74.34 110.861 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -138.32 124.5 20.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.179 -0.464 . . . . 72.44 110.892 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -62.59 145.92 53.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.2 -0.455 . . . . 54.31 110.86 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.499 HD12 HD22 ' A' ' 102' ' ' LEU . 0.9 OUTLIER -121.02 131.16 24.56 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.623 0.725 . . . . 73.01 111.123 179.942 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 134.44 28.0 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.689 2.259 . . . . 73.22 112.356 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.24 -0.436 . . . . 75.31 110.874 -179.993 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.491 ' O ' HG23 ' A' ' 97' ' ' THR . 13.5 p . . . . . 0 C--O 1.233 0.195 0 CA-C-O 120.883 0.373 . . . . 62.15 111.179 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.638 HG22 ' HA ' ' A' ' 114' ' ' GLU . 1.1 p -159.36 128.07 5.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 71.43 111.159 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -105.97 149.63 26.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.26 -0.427 . . . . 73.11 110.912 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 92.3 m -137.88 138.47 39.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 73.31 111.133 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' TRP . . . . . 0.462 ' CB ' HD23 ' A' ' 167' ' ' LEU . 12.0 m-90 -133.36 123.27 25.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.204 -0.453 . . . . 63.31 110.969 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 18.7 t -103.63 115.01 44.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 40.5 111.122 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.661 HD11 HD12 ' A' ' 104' ' ' LEU . 0.5 OUTLIER -141.25 146.0 36.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 74.22 110.888 -179.979 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 56.4 mtm-85 -76.34 93.75 3.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 73.42 110.862 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.672 ' HB3' HD13 ' A' ' 109' ' ' LEU . 0.4 OUTLIER -125.73 155.43 40.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 72.34 110.844 -179.977 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.3 t0 64.7 15.06 9.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 75.13 110.891 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 88.17 0.91 82.43 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.756 -0.735 . . . . 75.24 112.561 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -139.93 172.98 11.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.862 0.363 . . . . 74.33 110.887 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -70.33 88.16 0.63 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.142 -0.481 . . . . 62.32 110.875 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.672 HD13 ' HB3' ' A' ' 104' ' ' LEU . 0.5 OUTLIER -70.36 123.6 22.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.202 -0.454 . . . . 74.02 110.875 -179.941 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 4.9 ttp180 -101.94 109.38 21.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.107 -0.497 . . . . 74.01 110.804 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.442 HG21 ' CD2' ' A' ' 167' ' ' LEU . 2.2 t -95.6 134.55 32.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.452 . . . . 74.23 111.126 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 76.4 t -137.25 125.31 32.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 53.25 111.083 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.568 HD11 ' HA ' ' A' ' 118' ' ' MET . 3.0 tp -110.35 106.8 16.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 42.31 110.883 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.638 ' HA ' HG22 ' A' ' 97' ' ' THR . 0.0 OUTLIER -82.83 136.46 34.63 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.142 -0.481 . . . . 73.51 110.887 179.945 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.9 mmmt -73.77 -16.51 61.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 73.32 110.853 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -51.41 -54.21 28.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.466 . . . . 74.1 110.89 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.86 17.03 3.05 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.191 -0.459 . . . . 62.25 111.179 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' MET . . . . . 0.568 ' HA ' HD11 ' A' ' 113' ' ' LEU . 81.6 mtp 56.77 26.26 11.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 65.33 110.895 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.55 151.71 32.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.273 -0.421 . . . . 73.14 110.862 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.561 HG22 HD12 ' A' ' 151' ' ' ILE . 70.6 t -105.04 133.5 49.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.171 -0.468 . . . . 62.32 111.074 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 6.6 t-105 -117.64 123.77 46.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.2 -0.454 . . . . 75.13 110.891 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 17.9 m -131.18 132.19 44.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.216 -0.447 . . . . 65.13 110.934 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 4.4 m120 50.99 53.83 12.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.125 -0.489 . . . . 70.25 110.93 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 49.09 39.64 27.09 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.765 -0.731 . . . . 74.11 112.436 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.02 154.81 41.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.848 0.356 . . . . 74.2 110.907 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 15.8 ttpt -75.67 159.5 31.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 75.12 110.855 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 38.8 mmm -125.51 166.12 17.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.239 -0.437 . . . . 53.55 110.879 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -119.25 106.53 12.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.269 -0.423 . . . . 73.43 110.877 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.566 ' HB ' HG22 ' A' ' 140' ' ' THR . 17.6 p -95.53 -175.29 3.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 63.11 111.175 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -107.49 -28.77 9.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.476 . . . . 44.11 111.102 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 55.64 53.59 40.48 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.78 -0.724 . . . . 71.42 112.514 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.325 0 CA-C-O 120.887 0.375 . . . . 75.42 110.897 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 112.512 -0.235 . . . . 43.14 112.512 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.454 ' O ' ' HB3' ' A' ' 153' ' ' ALA . 0.1 OUTLIER -135.37 130.83 35.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.706 0.289 . . . . 64.43 111.176 -179.919 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -108.6 96.6 6.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 72.2 110.889 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.566 HG22 ' HB ' ' A' ' 129' ' ' THR . 0.0 OUTLIER -80.67 110.47 16.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.173 -0.467 . . . . 71.41 111.151 -179.879 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 -105.22 106.61 17.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 73.25 110.805 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 17.8 p90 -124.02 129.54 51.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 71.11 110.906 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 90.9 p -79.58 156.98 27.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 65.03 110.88 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 86.6 t -149.62 98.49 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 60.13 111.118 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 57.01 -106.63 0.75 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.767 -0.73 . . . . 62.33 112.486 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 21.5 t30 -116.9 24.56 11.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.896 0.379 . . . . 74.51 110.911 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 35.4 m170 -117.25 -175.3 2.77 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.13 -0.486 . . . . 74.43 110.815 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -143.73 78.56 1.6 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 75.34 110.878 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' CYS . . . . . 0.431 ' SG ' HG13 ' A' ' 169' ' ' VAL . 12.0 m -93.49 158.89 15.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.146 -0.479 . . . . 75.32 110.916 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -161.75 144.15 11.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.445 . . . . 71.51 110.935 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.562 HD13 HD22 ' A' ' 113' ' ' LEU . 22.7 mt -97.46 111.2 26.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.169 -0.469 . . . . 73.1 111.149 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 61.6 tttt -80.1 102.79 9.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.455 . . . . 70.54 110.897 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' ALA . . . . . 0.454 ' HB3' ' O ' ' A' ' 138' ' ' THR . . . -93.65 143.51 26.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.283 -0.417 . . . . 42.13 111.08 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.3 t -139.89 119.64 13.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 33.32 111.093 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.2 p -89.04 148.42 23.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.121 -0.49 . . . . 72.32 110.883 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.55 140.11 24.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.47 . . . . 71.21 110.906 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 132.47 -152.23 20.17 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.79 -0.719 . . . . 55.21 112.493 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 9.3 mttp -79.04 -29.84 43.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.77 0.319 . . . . 74.4 110.921 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 21.0 ptt-85 -169.16 -41.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 52.02 110.849 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 3.0 ttmm -157.06 30.41 0.3 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 75.23 110.893 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -56.81 -61.98 2.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 75.21 110.892 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -136.11 157.91 23.67 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.716 -0.754 . . . . 74.52 112.48 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 57.5 mt -141.19 146.42 23.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.725 0.298 . . . . 71.24 111.188 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 2.9 mt -133.01 124.36 49.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.188 -0.46 . . . . 65.45 111.169 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 17.3 m-70 -103.44 138.34 40.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 61.22 110.845 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.63 109.28 10.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.162 -0.472 . . . . 73.13 111.132 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.511 HD12 ' H ' ' A' ' 168' ' ' ILE . 21.0 tp -67.45 137.6 56.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.224 -0.444 . . . . 45.14 110.884 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.511 ' H ' HD12 ' A' ' 167' ' ' LEU . 9.6 mt -138.32 129.64 37.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 62.04 111.147 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.431 HG13 ' SG ' ' A' ' 149' ' ' CYS . 58.4 t -125.68 122.77 63.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 74.34 111.12 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 58.84 41.29 21.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 74.11 110.859 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 63.22 43.09 6.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.248 -0.433 . . . . 55.12 110.888 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 15.4 mtp180 -138.52 125.3 21.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.166 -0.47 . . . . 73.45 110.865 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -62.36 146.54 50.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 62.23 110.901 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.407 HD12 HD22 ' A' ' 102' ' ' LEU . 0.9 OUTLIER -123.06 131.01 24.38 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.576 0.703 . . . . 72.43 111.156 179.938 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.72 137.57 35.91 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.611 2.207 . . . . 72.13 112.404 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.44 . . . . 53.23 110.834 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.496 ' O ' HG23 ' A' ' 97' ' ' THR . 50.6 p . . . . . 0 N--CA 1.457 -0.12 0 CA-C-O 120.897 0.379 . . . . 50.42 111.169 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.602 HG22 ' HA ' ' A' ' 114' ' ' GLU . 1.0 OUTLIER -159.51 127.99 5.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 65.42 111.136 -179.985 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.3 m -106.05 149.64 26.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 50.03 110.894 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 90.1 m -136.98 137.15 39.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.139 -0.482 . . . . 75.34 111.095 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' TRP . . . . . 0.498 ' CB ' HD23 ' A' ' 167' ' ' LEU . 9.9 m-90 -132.98 122.81 24.79 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.126 -0.488 . . . . 75.44 110.891 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 20.0 t -102.7 114.89 43.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.247 -0.433 . . . . 33.53 111.181 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.883 HD11 HD12 ' A' ' 104' ' ' LEU . 0.5 OUTLIER -142.56 147.3 35.7 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.257 -0.429 . . . . 54.52 110.927 179.935 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 5.6 mtt180 -74.63 92.23 2.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 71.31 110.864 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.883 HD12 HD11 ' A' ' 102' ' ' LEU . 0.4 OUTLIER -121.95 153.94 37.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 54.33 110.908 -179.975 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 65.17 14.37 9.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 62.2 110.91 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.99 -0.39 78.99 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.735 -0.745 . . . . 65.13 112.48 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -139.92 172.89 12.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.797 0.332 . . . . 52.15 110.919 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -68.36 88.42 0.32 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.155 -0.475 . . . . 72.52 110.841 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.607 HD13 ' HB3' ' A' ' 104' ' ' LEU . 0.4 OUTLIER -74.65 125.94 29.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.236 -0.438 . . . . 65.05 110.937 -179.961 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 29.5 ttt180 -102.36 110.9 22.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.191 -0.459 . . . . 74.42 110.85 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.5 t -95.12 136.43 26.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 72.33 111.168 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 96.8 t -136.99 127.04 39.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.258 -0.428 . . . . 65.34 111.137 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.638 HD22 HD13 ' A' ' 151' ' ' ILE . 4.1 tp -110.32 104.44 13.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 55.34 110.847 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.602 ' HA ' HG22 ' A' ' 97' ' ' THR . 0.0 OUTLIER -81.14 136.42 35.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.113 -0.494 . . . . 75.3 110.949 179.917 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 3.6 mmmt -73.73 -16.74 61.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 74.03 110.936 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -51.38 -53.0 40.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.232 -0.44 . . . . 72.15 110.854 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.38 17.04 2.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 61.52 111.151 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' MET . . . . . 0.495 ' HA ' HD11 ' A' ' 113' ' ' LEU . 2.4 ttp 55.55 26.29 8.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.234 -0.439 . . . . 74.14 110.889 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -80.65 154.54 27.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 51.24 110.871 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.6 HG22 HD12 ' A' ' 151' ' ' ILE . 53.5 t -105.16 134.8 45.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.469 . . . . 72.21 111.156 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 6.0 t-105 -119.41 126.54 51.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.156 -0.475 . . . . 73.12 110.826 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 64.4 m -132.93 131.9 41.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 75.41 110.838 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 2.9 m120 49.85 54.39 11.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 64.11 110.837 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 48.55 40.53 24.48 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.797 -0.716 . . . . 64.41 112.481 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.94 147.7 28.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.873 0.368 . . . . 64.42 110.893 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 13.1 tttp -68.04 159.91 29.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.258 -0.428 . . . . 74.34 110.918 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 41.0 mmm -124.55 164.31 20.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.212 -0.449 . . . . 71.34 110.897 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -119.3 106.29 12.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 63.02 110.86 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.69 ' CB ' HG22 ' A' ' 140' ' ' THR . 21.3 p -95.96 -175.05 3.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.112 -0.494 . . . . 64.51 111.111 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.432 ' HB2' ' HB2' ' A' ' 141' ' ' HIS . . . -100.22 -32.2 11.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 74.13 111.125 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 59.99 96.4 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.709 -0.757 . . . . 44.32 112.519 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 . . . . . 0 C--N 1.329 -0.296 0 CA-C-O 120.909 0.385 . . . . 70.32 110.91 -179.855 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 N-CA-C 112.481 -0.248 . . . . 63.34 112.481 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -136.1 130.79 33.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.733 0.301 . . . . 72.13 111.146 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -104.13 96.29 6.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.234 -0.439 . . . . 63.22 110.923 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.69 HG22 ' CB ' ' A' ' 129' ' ' THR . 0.0 OUTLIER -86.98 109.73 19.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.173 -0.467 . . . . 60.12 111.177 -179.887 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 141' ' ' HIS . . . . . 0.432 ' HB2' ' HB2' ' A' ' 130' ' ' ALA . 34.3 m80 -102.68 106.84 17.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.24 -0.436 . . . . 72.42 110.836 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -121.9 123.02 40.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.148 -0.478 . . . . 73.31 110.903 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.03 153.78 22.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 62.32 110.85 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.448 HG11 HD22 ' A' ' 104' ' ' LEU . 47.0 t -147.19 106.7 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 74.13 111.096 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 56.59 -110.14 1.94 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.733 -0.746 . . . . 64.44 112.529 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 29.4 m120 -117.38 25.68 10.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.871 0.367 . . . . 75.23 110.88 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 24.4 m-70 -123.26 163.57 20.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 73.11 110.891 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -122.23 122.07 38.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 74.45 110.914 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' CYS . . . . . 0.575 ' HB3' HG22 ' A' ' 169' ' ' VAL . 1.2 p -141.48 146.95 37.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.448 . . . . 72.53 110.887 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 26.0 p90 -149.79 147.61 28.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.471 . . . . 72.05 110.937 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.638 HD13 HD22 ' A' ' 113' ' ' LEU . 12.0 mt -97.97 111.74 28.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.136 -0.484 . . . . 71.22 111.129 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 62.1 tttt -82.52 102.71 11.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 71.43 110.907 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -95.89 146.05 24.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 64.24 111.127 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.5 t -145.32 116.86 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.273 -0.421 . . . . 64.15 111.09 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 14.7 p -89.53 147.41 23.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 43.21 110.853 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 30.6 p -145.88 152.59 39.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.076 -0.511 . . . . 70.14 110.88 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 112.98 179.29 19.47 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.785 -0.721 . . . . 71.1 112.501 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.58 -64.0 1.11 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.725 0.298 . . . . 65.45 110.891 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 11.3 ttm-85 -133.39 83.78 2.08 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.265 -0.425 . . . . 62.31 110.897 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 13.6 mtmt 52.59 44.52 29.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 63.12 110.83 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -66.63 -49.18 67.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 73.1 110.871 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -144.96 132.02 4.53 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.774 -0.727 . . . . 44.11 112.524 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 50.8 mt -119.37 146.88 23.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.826 0.346 . . . . 74.14 111.129 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 58.9 mt -132.45 126.89 56.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 70.42 111.159 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 11.9 m-70 -109.63 135.34 50.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.258 -0.428 . . . . 74.51 110.893 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.26 116.91 22.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 73.0 111.191 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.498 HD23 ' CB ' ' A' ' 100' ' ' TRP . 17.7 tp -72.85 133.52 44.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 75.21 110.944 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.472 ' N ' HD12 ' A' ' 167' ' ' LEU . 10.9 mt -136.3 118.16 20.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 72.4 111.07 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.575 HG22 ' HB3' ' A' ' 149' ' ' CYS . 14.6 t -120.54 127.06 75.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.435 . . . . 74.44 111.133 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 63.6 36.64 10.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.213 -0.449 . . . . 72.21 110.853 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 62.84 43.04 7.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 72.34 110.927 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 20.4 mtt180 -142.14 128.12 19.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.112 -0.494 . . . . 62.12 110.862 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -62.48 146.47 51.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.199 -0.455 . . . . 73.32 110.916 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -121.85 131.29 24.46 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.685 0.755 . . . . 75.42 111.126 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 137.93 36.53 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.638 2.225 . . . . 73.21 112.351 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.465 . . . . 73.21 110.904 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.498 ' O ' HG23 ' A' ' 97' ' ' THR . 82.3 p . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.876 0.37 . . . . 74.42 111.094 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.498 HG23 ' O ' ' A' ' 96' ' ' THR . 1.1 p -159.47 128.1 5.12 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.214 -0.448 . . . . 74.34 111.093 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.03 152.2 23.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.196 -0.456 . . . . 51.32 110.897 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.78 HG22 HG22 ' A' ' 112' ' ' VAL . 0.5 OUTLIER -139.17 156.76 46.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.126 -0.488 . . . . 75.14 111.125 -179.869 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 100' ' ' TRP . . . . . 0.502 ' CB ' HD23 ' A' ' 167' ' ' LEU . 12.6 m-90 -151.62 127.28 10.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.23 -0.441 . . . . 73.33 111.004 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 18.8 t -105.63 115.21 46.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.236 -0.438 . . . . 55.45 111.156 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.918 HD11 HD12 ' A' ' 104' ' ' LEU . 0.5 OUTLIER -141.67 147.36 37.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.199 -0.455 . . . . 75.32 110.958 179.953 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 61.4 mtt180 -72.93 91.7 1.56 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 64.04 110.955 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.918 HD12 HD11 ' A' ' 102' ' ' LEU . 0.3 OUTLIER -121.64 152.01 39.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 74.31 110.898 -179.925 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 15.2 t0 65.09 14.51 9.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.144 -0.48 . . . . 63.12 110.854 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.7 0.12 79.17 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.773 -0.727 . . . . 65.42 112.498 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -139.94 172.73 12.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.843 0.354 . . . . 61.35 110.889 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -68.54 89.49 0.36 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.137 -0.483 . . . . 62.12 110.884 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.592 HD13 ' HB3' ' A' ' 104' ' ' LEU . 0.4 OUTLIER -76.21 130.63 38.49 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.126 -0.488 . . . . 73.33 110.951 -179.946 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 6.1 ttp180 -106.4 113.84 27.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 72.15 110.882 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.496 HG21 ' CD2' ' A' ' 167' ' ' LEU . 1.7 t -95.52 139.43 18.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 73.25 111.093 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.78 HG22 HG22 ' A' ' 99' ' ' THR . 92.0 t -136.46 124.95 36.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.473 . . . . 72.34 111.125 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.538 HD22 HD13 ' A' ' 151' ' ' ILE . 3.4 tp -111.16 105.45 14.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 71.32 110.943 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.484 ' HA ' HG22 ' A' ' 97' ' ' THR . 0.0 OUTLIER -80.19 134.85 36.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 73.01 110.884 179.918 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 3.9 mmmt -73.87 -16.72 61.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.074 -0.512 . . . . 75.33 110.849 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -51.45 -55.97 15.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.228 -0.442 . . . . 63.11 110.857 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.34 17.1 3.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 72.24 111.133 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' MET . . . . . 0.51 ' HA ' HD11 ' A' ' 113' ' ' LEU . 0.2 OUTLIER 61.95 18.11 9.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.44 . . . . 73.12 110.921 179.911 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.77 139.23 58.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.186 -0.461 . . . . 72.13 110.843 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 96.0 t -105.0 118.12 51.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.111 -0.495 . . . . 75.22 111.153 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -100.6 129.05 46.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 75.03 110.898 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -123.76 103.37 8.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 72.04 110.87 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 45.44 69.97 0.4 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 73.45 110.905 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 49.09 38.73 25.53 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.698 -0.763 . . . . 71.03 112.505 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -146.38 114.04 6.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.812 0.339 . . . . 70.01 110.877 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -53.39 160.38 1.19 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.249 -0.432 . . . . 70.21 110.856 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 30.2 mmm -126.82 163.62 23.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 74.41 110.875 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -118.79 106.44 12.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.239 -0.437 . . . . 74.13 110.848 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.548 HG22 ' HD2' ' A' ' 142' ' ' PHE . 17.1 p -95.55 -177.76 4.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.478 . . . . 64.04 111.155 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.431 ' HB2' ' HB2' ' A' ' 141' ' ' HIS . . . -92.5 -31.3 15.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.22 -0.445 . . . . 51.43 111.068 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 55.09 69.25 1.32 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.78 -0.724 . . . . 73.03 112.492 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 . . . . . 0 C--N 1.329 -0.286 0 CA-C-O 120.888 0.375 . . . . 50.13 110.899 -179.838 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.276 0 N-CA-C 112.459 -0.257 . . . . 73.41 112.459 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.636 ' O ' ' HB3' ' A' ' 153' ' ' ALA . 0.1 OUTLIER -134.73 131.03 37.13 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.73 0.3 . . . . 70.11 111.175 -179.963 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -115.34 96.33 5.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 72.01 110.895 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.504 HG22 ' HB ' ' A' ' 129' ' ' THR . 0.0 OUTLIER -77.1 110.02 11.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.117 -0.492 . . . . 33.33 111.139 -179.918 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 141' ' ' HIS . . . . . 0.431 ' HB2' ' HB2' ' A' ' 130' ' ' ALA . 81.4 m-70 -106.93 104.26 13.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.259 -0.428 . . . . 74.02 110.862 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.548 ' HD2' HG22 ' A' ' 129' ' ' THR . 2.9 p90 -124.72 -175.96 3.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 75.25 110.856 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 58.4 p -148.71 160.78 42.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.12 -0.491 . . . . 75.31 110.84 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 90.8 t -135.2 97.92 2.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.12 -0.491 . . . . 43.02 111.137 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 54.49 -113.12 3.15 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.752 -0.737 . . . . 63.24 112.521 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -103.01 25.46 9.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.814 0.34 . . . . 53.01 110.899 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 22.9 m170 -111.18 -170.33 1.62 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 71.12 110.852 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -154.39 107.52 2.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.439 . . . . 62.14 110.821 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' CYS . . . . . 0.59 ' HB3' HG22 ' A' ' 169' ' ' VAL . 0.8 OUTLIER -142.69 161.81 37.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 64.21 110.91 -179.969 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -159.4 149.33 18.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.242 -0.435 . . . . 70.54 110.88 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.538 HD13 HD22 ' A' ' 113' ' ' LEU . 8.2 mt -99.12 113.82 35.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.121 -0.49 . . . . 74.34 111.162 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.54 102.67 10.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.102 -0.499 . . . . 74.23 110.921 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' ALA . . . . . 0.636 ' HB3' ' O ' ' A' ' 138' ' ' THR . . . -100.57 145.46 28.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.24 -0.436 . . . . 71.33 111.113 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.3 t -144.84 133.74 17.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.202 -0.454 . . . . 74.51 111.144 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.1 p -104.94 130.34 53.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 64.45 110.891 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 79.7 p -143.7 150.83 39.26 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.151 -0.477 . . . . 64.12 110.824 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 129.26 171.27 12.92 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.698 -0.763 . . . . 55.34 112.452 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 38.1 mttp -63.78 94.55 0.1 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.795 0.331 . . . . 64.31 110.947 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 15.6 mtt-85 62.86 60.69 1.23 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.227 -0.442 . . . . 73.11 110.84 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 58.11 82.33 0.13 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.45 . . . . 74.53 110.885 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -103.73 -53.2 2.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.244 -0.435 . . . . 72.55 110.938 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -133.66 147.56 19.08 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.795 -0.717 . . . . 41.22 112.517 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 58.5 mt -127.45 140.99 47.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.768 0.318 . . . . 44.21 111.137 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 66.1 mt -124.99 141.1 46.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.469 . . . . 71.1 111.105 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -115.92 142.91 46.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.103 -0.498 . . . . 73.32 110.847 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.6 107.69 8.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.193 -0.458 . . . . 74.22 111.155 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.502 HD23 ' CB ' ' A' ' 100' ' ' TRP . 16.8 tp -68.61 133.01 47.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.243 -0.435 . . . . 71.01 110.939 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.492 ' N ' HD12 ' A' ' 167' ' ' LEU . 12.7 mt -135.01 113.89 16.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.45 . . . . 75.31 111.099 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.59 HG22 ' HB3' ' A' ' 149' ' ' CYS . 21.3 t -118.38 129.37 74.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 71.02 111.164 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 63.52 34.64 12.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.155 -0.475 . . . . 72.42 110.878 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 63.36 42.96 6.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 71.01 110.923 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -142.22 128.54 19.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.1 -0.5 . . . . 65.02 110.892 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -62.74 146.32 52.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.264 -0.425 . . . . 72.02 110.959 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -123.04 131.23 24.36 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.629 0.728 . . . . 70.33 111.101 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.68 137.01 34.68 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.628 2.219 . . . . 71.02 112.365 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.236 -0.438 . . . . 75.14 110.866 -179.958 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.506 ' O ' HG23 ' A' ' 97' ' ' THR . 30.2 p . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.864 0.364 . . . . 54.2 111.166 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.506 HG23 ' O ' ' A' ' 96' ' ' THR . 1.0 OUTLIER -159.55 128.4 5.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 72.04 111.095 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.3 m -105.95 151.88 24.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.171 -0.468 . . . . 51.43 110.843 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.958 HG23 HG22 ' A' ' 112' ' ' VAL . 0.1 OUTLIER -141.24 158.86 43.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.155 -0.475 . . . . 74.01 111.112 -179.921 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 18.9 m-90 -151.75 157.32 41.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.218 -0.447 . . . . 74.04 110.93 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.3 t -135.9 114.98 16.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.448 . . . . 55.21 111.129 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 1.029 HD11 HD12 ' A' ' 104' ' ' LEU . 0.5 OUTLIER -142.61 148.47 37.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.1 -0.5 . . . . 71.12 110.956 179.973 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 2.4 mmm180 -72.48 89.66 1.28 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 64.22 110.886 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 1.029 HD12 HD11 ' A' ' 102' ' ' LEU . 0.3 OUTLIER -117.16 148.95 41.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.205 -0.452 . . . . 71.23 110.857 -179.906 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.3 t0 64.88 14.77 9.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.458 . . . . 61.43 110.878 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.67 1.25 77.67 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.675 -0.774 . . . . 63.42 112.487 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -139.82 168.83 18.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.858 0.361 . . . . 63.21 110.899 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.97 89.01 0.16 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 74.12 110.85 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.469 HD21 ' SG ' ' A' ' 122' ' ' CYS . 0.5 OUTLIER -79.8 130.61 35.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 74.21 110.846 -179.905 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 10.9 ttp85 -105.73 121.92 45.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 65.13 110.917 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.518 HG21 HD21 ' A' ' 167' ' ' LEU . 0.1 OUTLIER -106.59 144.99 14.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.145 -0.48 . . . . 62.43 111.139 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.958 HG22 HG23 ' A' ' 99' ' ' THR . 85.5 t -135.83 144.45 33.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.456 . . . . 73.22 111.169 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.527 HD11 ' HA ' ' A' ' 118' ' ' MET . 3.2 tp -128.8 102.84 6.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.253 -0.431 . . . . 74.13 110.989 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.26 132.56 42.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 44.33 110.853 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 9.9 mmmt -73.8 -16.88 61.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.446 . . . . 73.02 110.884 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -51.44 -55.81 16.72 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.225 -0.443 . . . . 74.41 110.865 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.45 17.06 3.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.188 -0.46 . . . . 75.32 111.094 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' MET . . . . . 0.527 ' HA ' HD11 ' A' ' 113' ' ' LEU . 8.8 ttm 60.11 29.71 19.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 72.41 110.869 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -77.07 145.39 37.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.211 -0.449 . . . . 73.15 110.783 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 36.1 t -104.75 139.24 26.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 70.54 111.108 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 2.7 t-105 -125.19 124.22 41.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.16 -0.473 . . . . 74.15 110.891 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' CYS . . . . . 0.469 ' SG ' HD21 ' A' ' 109' ' ' LEU . 0.8 OUTLIER -114.06 109.95 19.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.238 -0.437 . . . . 62.1 110.862 -179.954 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 12.6 m-20 47.89 67.43 0.83 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 55.22 110.826 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 49.52 30.64 13.21 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.701 -0.762 . . . . 62.21 112.497 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.66 120.95 20.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.863 0.363 . . . . 75.44 110.901 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 18.5 tttt -53.86 151.25 6.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.224 -0.444 . . . . 74.54 110.84 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' MET . . . . . 0.43 ' CE ' HG22 ' A' ' 144' ' ' VAL . 44.2 mmm -117.89 165.61 13.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 63.1 110.88 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -118.97 106.49 12.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 73.13 110.829 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.65 ' HB ' HG22 ' A' ' 140' ' ' THR . 21.7 p -95.95 168.93 10.33 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.126 -0.488 . . . . 53.43 111.137 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -95.82 -24.26 16.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.204 -0.453 . . . . 72.23 111.118 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 62.36 76.07 0.28 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.763 -0.732 . . . . 53.31 112.536 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 . . . . . 0 C--N 1.329 -0.286 0 CA-C-O 120.881 0.372 . . . . 74.52 110.894 -179.871 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 N-CA-C 112.494 -0.242 . . . . 71.24 112.494 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.559 ' O ' ' HB3' ' A' ' 153' ' ' ALA . 0.2 OUTLIER -142.39 133.41 25.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.827 0.346 . . . . 73.41 111.111 -179.851 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -108.2 132.96 53.1 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.253 -0.431 . . . . 72.53 110.884 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.65 HG22 ' HB ' ' A' ' 129' ' ' THR . 0.0 OUTLIER -118.67 110.28 17.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.155 -0.475 . . . . 43.33 111.067 -179.821 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 22.6 m-70 -100.88 110.5 22.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.157 -0.474 . . . . 74.42 110.868 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.757 ' CE2' HD12 ' A' ' 151' ' ' ILE . 5.9 p90 -135.38 134.7 40.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 73.14 110.908 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 2.9 p -84.39 151.85 24.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.153 -0.476 . . . . 32.51 110.865 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.43 HG22 ' CE ' ' A' ' 127' ' ' MET . 94.0 t -136.74 97.98 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.117 -0.492 . . . . 60.31 111.096 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 54.2 -106.34 0.47 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.731 -0.747 . . . . 64.32 112.492 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 22.8 t30 -116.28 26.32 10.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.868 0.366 . . . . 73.24 110.851 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 50.3 m-70 -125.19 -169.93 2.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 61.21 110.823 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -143.18 105.61 4.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.261 -0.427 . . . . 74.23 110.894 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' CYS . . . . . 0.432 ' SG ' HG13 ' A' ' 169' ' ' VAL . 13.3 m -120.5 158.41 27.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.444 . . . . 75.31 110.865 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -158.72 143.61 16.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 73.14 110.886 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.757 HD12 ' CE2' ' A' ' 142' ' ' PHE . 3.1 mt -99.27 111.06 27.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.139 -0.482 . . . . 71.41 111.178 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 7.8 tttm -80.87 102.96 10.38 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.194 -0.457 . . . . 72.43 110.877 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' ALA . . . . . 0.559 ' HB3' ' O ' ' A' ' 138' ' ' THR . . . -92.5 132.45 36.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.246 -0.433 . . . . 54.22 111.092 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.5 t -127.0 125.6 66.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.243 -0.435 . . . . 62.45 111.105 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.3 p -93.56 136.97 33.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 71.23 110.798 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 1.4 p -138.94 146.12 40.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.08 -0.509 . . . . 71.43 110.793 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 132.44 162.48 10.34 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.679 -0.772 . . . . 65.11 112.501 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -54.72 -41.37 70.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.816 0.341 . . . . 61.0 110.898 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 12.9 mmt180 -136.35 46.08 2.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.237 -0.438 . . . . 63.35 110.843 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.54 74.23 0.36 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.191 -0.459 . . . . 75.43 110.908 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -113.04 -36.58 5.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.222 -0.444 . . . . 72.31 110.888 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -112.15 111.24 2.79 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.71 -0.757 . . . . 73.44 112.5 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 46.2 mt -109.91 147.98 13.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.803 0.335 . . . . 63.33 111.084 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 66.4 mt -137.88 122.17 22.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.136 -0.484 . . . . 74.42 111.191 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 17.1 m-70 -94.95 135.82 36.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 62.32 110.864 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.09 106.75 10.16 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.147 -0.479 . . . . 75.02 111.095 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.518 HD21 HG21 ' A' ' 111' ' ' VAL . 43.9 tp -66.74 136.47 55.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.215 -0.448 . . . . 74.05 110.895 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 10.2 mt -137.09 125.73 34.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.196 -0.456 . . . . 71.5 111.171 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.432 HG13 ' SG ' ' A' ' 149' ' ' CYS . 67.4 t -122.6 119.89 59.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 71.3 111.146 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 64.0 39.34 8.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 72.43 110.847 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 63.23 43.06 6.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 75.42 110.886 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -138.94 127.14 22.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.227 -0.442 . . . . 65.12 110.882 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -62.44 146.38 51.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.18 -0.464 . . . . 70.5 110.888 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.712 HD12 HD22 ' A' ' 102' ' ' LEU . 0.9 OUTLIER -119.99 130.88 24.62 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.645 0.736 . . . . 74.11 111.136 179.921 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 127.64 14.87 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.642 2.228 . . . . 72.34 112.302 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 64.44 110.888 -179.988 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.497 ' O ' HG23 ' A' ' 97' ' ' THR . 16.6 p . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.923 0.392 . . . . 73.5 111.132 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.567 HG22 ' HA ' ' A' ' 114' ' ' GLU . 1.0 OUTLIER -159.48 128.04 5.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 63.2 111.176 179.972 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.2 m -106.19 153.33 22.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.185 -0.462 . . . . 73.5 110.813 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.56 HG22 HG22 ' A' ' 112' ' ' VAL . 78.9 p -138.54 155.05 48.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.095 -0.502 . . . . 71.41 111.141 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' TRP . . . . . 0.414 ' CB ' HD23 ' A' ' 167' ' ' LEU . 10.8 m-90 -151.52 123.64 8.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 75.15 110.903 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 19.5 t -105.14 114.9 45.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.246 -0.434 . . . . 62.33 111.168 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.868 HD11 HD12 ' A' ' 104' ' ' LEU . 0.5 OUTLIER -142.74 146.96 34.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.166 -0.47 . . . . 75.23 110.936 179.952 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -73.85 93.0 2.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 75.22 110.914 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.868 HD12 HD11 ' A' ' 102' ' ' LEU . 0.4 OUTLIER -123.54 152.87 41.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 53.42 110.922 -179.938 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.1 t70 64.8 15.03 9.59 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.201 -0.454 . . . . 74.4 110.882 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 88.55 0.65 81.81 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.79 -0.719 . . . . 61.34 112.548 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -139.85 172.92 12.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.796 0.331 . . . . 65.0 110.909 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.69 89.0 0.37 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.134 -0.485 . . . . 72.21 110.877 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.571 HD13 ' HB3' ' A' ' 104' ' ' LEU . 0.5 OUTLIER -74.12 125.41 28.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.147 -0.479 . . . . 65.25 110.911 -179.951 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 3.6 ttm180 -104.54 109.63 21.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 74.12 110.888 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.483 HG21 HD21 ' A' ' 167' ' ' LEU . 0.9 OUTLIER -95.78 136.19 27.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 54.12 111.111 179.995 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.56 HG22 HG22 ' A' ' 99' ' ' THR . 94.0 t -136.25 127.03 42.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.097 -0.501 . . . . 72.43 111.127 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.7 HD22 HD13 ' A' ' 151' ' ' ILE . 3.9 tp -110.11 107.31 17.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.48 . . . . 74.4 110.885 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.567 ' HA ' HG22 ' A' ' 97' ' ' THR . 0.0 OUTLIER -83.17 136.08 34.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 52.43 110.918 179.952 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 6.6 mmmt -73.54 -16.34 61.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.171 -0.468 . . . . 71.04 110.888 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -51.51 -55.49 18.68 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.237 -0.438 . . . . 73.13 110.904 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -136.43 17.0 3.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 75.1 111.187 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' MET . . . . . 0.528 ' HA ' HD11 ' A' ' 113' ' ' LEU . 70.9 mtp 58.49 23.25 10.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 64.21 110.849 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.99 147.61 42.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 75.53 110.778 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.547 HG22 HD12 ' A' ' 151' ' ' ILE . 85.8 t -105.13 122.54 58.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.138 -0.483 . . . . 75.11 111.176 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 2.8 t90 -103.63 131.78 50.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.203 -0.453 . . . . 61.12 110.926 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 1.2 m -126.86 108.21 10.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.286 -0.415 . . . . 54.21 110.847 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 39.42 70.1 0.25 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 73.23 110.83 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 49.75 42.42 36.92 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.775 -0.726 . . . . 64.25 112.466 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -148.12 110.09 4.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.885 0.374 . . . . 72.22 110.917 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.3 154.95 2.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 64.21 110.912 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' MET . . . . . 0.516 ' CE ' HG22 ' A' ' 144' ' ' VAL . 29.9 mmm -124.61 160.53 28.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 74.41 110.848 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -115.47 106.96 14.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 63.44 110.845 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.728 ' HB ' HG22 ' A' ' 140' ' ' THR . 18.8 p -95.36 179.03 5.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.171 -0.468 . . . . 74.52 111.098 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.502 ' HB2' ' HB2' ' A' ' 141' ' ' HIS . . . -90.58 -40.41 11.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 63.25 111.098 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 58.6 60.23 9.31 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.769 -0.729 . . . . 72.21 112.449 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 . . . . . 0 C--N 1.329 -0.303 0 CA-C-O 120.834 0.349 . . . . 62.24 110.973 -179.918 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.282 0 N-CA-C 112.493 -0.243 . . . . 31.13 112.493 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.575 ' O ' ' HB3' ' A' ' 153' ' ' ALA . 0.1 OUTLIER -135.25 130.82 35.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.683 0.278 . . . . 70.43 111.155 -179.858 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -113.73 96.87 6.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 73.24 110.867 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.728 HG22 ' HB ' ' A' ' 129' ' ' THR . 0.0 OUTLIER -81.42 110.43 16.83 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.127 -0.488 . . . . 74.21 111.175 -179.965 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 141' ' ' HIS . . . . . 0.502 ' HB2' ' HB2' ' A' ' 130' ' ' ALA . 82.4 m-70 -103.89 106.01 16.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.446 . . . . 61.1 110.827 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.435 ' HB3' HG22 ' A' ' 129' ' ' THR . 20.0 p90 -124.48 131.99 53.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 62.11 110.871 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 22.9 p -82.02 146.9 29.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.459 . . . . 63.24 110.852 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.516 HG22 ' CE ' ' A' ' 127' ' ' MET . 21.9 t -137.68 98.35 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.097 -0.501 . . . . 75.12 111.137 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 52.34 -121.28 13.72 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.71 -0.757 . . . . 42.31 112.501 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -98.75 26.74 5.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.901 0.382 . . . . 71.11 110.886 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 31.1 m-70 -126.7 174.21 8.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.177 -0.465 . . . . 71.41 110.834 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -132.79 88.35 2.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 73.41 110.821 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' CYS . . . . . 0.482 ' SG ' HG13 ' A' ' 169' ' ' VAL . 10.4 m -100.67 164.78 11.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.166 -0.47 . . . . 75.23 110.938 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -167.85 144.85 4.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.213 -0.449 . . . . 74.42 110.97 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.7 HD13 HD22 ' A' ' 113' ' ' LEU . 22.7 mt -97.6 111.4 27.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.117 -0.492 . . . . 53.31 111.066 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 1.8 ttmt -80.12 102.82 9.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 73.22 110.927 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' ALA . . . . . 0.575 ' HB3' ' O ' ' A' ' 138' ' ' THR . . . -93.38 146.47 23.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.271 -0.422 . . . . 74.43 111.067 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.2 t -144.28 121.42 5.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 54.32 111.157 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -94.26 137.21 33.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 72.32 110.889 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 2.2 t -132.45 133.21 43.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.112 -0.494 . . . . 61.45 110.833 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 143.87 -174.94 24.04 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.795 -0.717 . . . . 64.52 112.488 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.96 -26.51 67.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.728 0.299 . . . . 73.53 110.881 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.65 -41.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.267 -0.424 . . . . 65.31 110.861 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 25.4 tttp -162.56 55.75 0.22 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 74.13 110.842 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -76.74 -62.66 1.56 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.267 -0.424 . . . . 61.24 110.86 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -141.35 160.38 26.84 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.813 -0.708 . . . . 55.32 112.457 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 64.1 mt -136.4 139.61 45.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.82 0.343 . . . . 74.3 111.162 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 64.4 mt -126.7 131.05 71.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.138 -0.483 . . . . 73.45 111.13 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' HIS . . . . . 0.415 ' CG ' HD23 ' A' ' 113' ' ' LEU . 14.5 m80 -105.83 139.63 40.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.445 . . . . 62.31 110.883 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.64 103.98 6.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.435 . . . . 73.31 111.155 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.483 HD21 HG21 ' A' ' 111' ' ' VAL . 28.2 tp -65.5 137.8 57.66 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.243 -0.435 . . . . 63.23 110.878 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.462 ' H ' HD12 ' A' ' 167' ' ' LEU . 9.8 mt -137.6 130.04 41.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 33.01 111.168 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.482 HG13 ' SG ' ' A' ' 149' ' ' CYS . 74.2 t -126.51 116.36 44.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.451 . . . . 74.25 111.166 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.4 t0 63.64 46.12 4.29 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.196 -0.456 . . . . 62.24 110.82 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 1.6 m120 59.08 42.93 18.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.262 -0.426 . . . . 51.33 110.879 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 10.4 mtm180 -139.69 124.99 18.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 74.11 110.955 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -62.55 146.48 51.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 64.32 110.84 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.537 HD12 HD22 ' A' ' 102' ' ' LEU . 0.9 OUTLIER -120.32 130.97 24.59 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.597 0.713 . . . . 73.22 111.195 179.885 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.74 134.15 27.33 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.64 2.227 . . . . 75.33 112.402 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.269 -0.423 . . . . 73.53 110.907 -179.977 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.497 ' O ' HG23 ' A' ' 97' ' ' THR . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.853 0.359 . . . . 73.11 111.083 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.66 HG22 ' HA ' ' A' ' 114' ' ' GLU . 1.0 OUTLIER -159.74 127.77 4.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 72.22 111.114 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 62.5 m -106.52 116.83 32.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 71.44 110.841 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.536 HG22 HG22 ' A' ' 112' ' ' VAL . 71.6 p -112.34 163.88 13.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.15 -0.477 . . . . 73.22 111.134 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' TRP . . . . . 0.46 ' CB ' HD23 ' A' ' 167' ' ' LEU . 21.8 m-90 -149.56 152.17 35.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.196 -0.456 . . . . 74.2 110.86 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 20.3 t -124.84 115.11 43.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.217 -0.447 . . . . 61.0 111.079 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.901 HD11 HD12 ' A' ' 104' ' ' LEU . 0.5 OUTLIER -141.17 147.22 38.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.132 -0.485 . . . . 75.05 110.934 179.926 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 8.7 mtm-85 -72.17 90.99 1.25 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 72.32 110.913 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.901 HD12 HD11 ' A' ' 102' ' ' LEU . 0.4 OUTLIER -121.62 151.62 40.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.105 -0.498 . . . . 72.22 110.922 -179.969 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.7 t70 65.11 14.59 9.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 73.31 110.853 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.63 0.14 79.38 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.738 -0.744 . . . . 63.12 112.479 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -139.88 172.77 12.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.839 0.352 . . . . 75.51 110.898 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -69.02 89.22 0.42 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.206 -0.452 . . . . 63.42 110.906 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.601 HD13 ' HB3' ' A' ' 104' ' ' LEU . 0.4 OUTLIER -75.56 130.95 39.65 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.164 -0.471 . . . . 73.23 110.897 -179.92 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 8.2 ttt180 -107.02 113.12 26.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 74.34 110.88 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.555 HG21 ' CD2' ' A' ' 167' ' ' LEU . 0.8 OUTLIER -95.52 141.2 15.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 75.43 111.19 179.937 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.536 HG22 HG22 ' A' ' 99' ' ' THR . 47.5 t -135.85 126.41 42.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 73.35 111.149 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.565 HD11 ' HA ' ' A' ' 118' ' ' MET . 4.2 tp -113.17 99.82 8.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.463 . . . . 64.54 110.897 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.66 ' HA ' HG22 ' A' ' 97' ' ' THR . 0.0 OUTLIER -76.59 123.54 26.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 71.33 110.924 179.916 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.47 -16.07 59.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 62.14 110.867 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -51.4 -56.02 15.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 74.34 110.906 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 76.3 p -132.49 16.94 4.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 72.25 111.128 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' MET . . . . . 0.565 ' HA ' HD11 ' A' ' 113' ' ' LEU . 48.2 mtp 55.7 28.43 12.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 63.5 110.868 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -81.37 147.14 29.97 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.212 -0.449 . . . . 61.0 110.867 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.51 HG22 HD12 ' A' ' 151' ' ' ILE . 79.5 t -104.81 129.41 57.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.445 . . . . 71.23 111.163 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 6.1 t-105 -119.95 109.57 15.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.173 -0.467 . . . . 74.44 110.962 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' CYS . . . . . 0.538 ' HB3' HD21 ' A' ' 109' ' ' LEU . 7.7 m -97.0 117.81 32.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.441 . . . . 75.54 110.939 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 64.8 -82.75 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.468 . . . . 72.3 110.874 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -156.88 46.17 0.49 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.774 -0.727 . . . . 52.15 112.449 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -159.01 134.29 8.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.908 0.385 . . . . 62.35 110.899 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 24.9 ttpt -53.74 162.11 0.96 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.161 -0.472 . . . . 72.22 110.897 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 31.4 mmm -127.76 167.11 16.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 64.04 110.888 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -119.19 106.62 12.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.285 -0.416 . . . . 64.05 110.92 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.723 ' CB ' HG22 ' A' ' 140' ' ' THR . 19.6 p -95.61 -175.3 3.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.118 -0.492 . . . . 60.12 111.127 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -104.95 -25.16 12.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 53.42 111.087 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 53.23 47.63 61.04 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.752 -0.737 . . . . 73.12 112.453 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 . . . . . 0 C--N 1.33 -0.278 0 CA-C-O 120.816 0.341 . . . . 73.43 110.945 -179.944 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 N-CA-C 112.462 -0.255 . . . . 73.02 112.462 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.632 ' O ' ' HB3' ' A' ' 153' ' ' ALA . 0.1 OUTLIER -134.83 130.8 36.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.74 0.305 . . . . 64.34 111.214 -179.933 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -106.43 96.37 6.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.256 -0.429 . . . . 73.23 110.886 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.723 HG22 ' CB ' ' A' ' 129' ' ' THR . 0.0 OUTLIER -81.86 110.09 16.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 71.43 111.173 -179.9 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 76.7 m-70 -106.86 106.42 16.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 73.4 110.814 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -121.74 128.82 52.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 72.45 110.855 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 56.1 p -89.35 159.3 17.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.112 -0.495 . . . . 65.12 110.85 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 87.0 t -147.86 109.22 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 73.12 111.101 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 52.0 -118.92 7.92 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.68 -0.771 . . . . 74.33 112.563 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -107.16 23.49 14.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.881 0.372 . . . . 65.12 110.916 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -112.57 -169.6 1.51 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 72.13 110.893 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -151.64 118.9 5.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 73.53 110.866 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' CYS . . . . . 0.611 ' CB ' HG22 ' A' ' 169' ' ' VAL . 1.4 p -142.53 163.67 32.21 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.274 -0.421 . . . . 72.31 110.898 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -167.16 145.53 4.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.173 -0.467 . . . . 75.41 110.878 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.51 HD12 HG22 ' A' ' 120' ' ' VAL . 22.5 mt -97.58 111.55 27.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.086 -0.506 . . . . 72.12 111.172 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -80.9 106.96 13.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 73.22 110.879 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' ALA . . . . . 0.632 ' HB3' ' O ' ' A' ' 138' ' ' THR . . . -101.83 146.6 27.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.256 -0.429 . . . . 73.1 111.126 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.3 t -142.05 132.94 25.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.246 -0.434 . . . . 62.32 111.108 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.1 p -101.17 140.35 35.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.09 -0.505 . . . . 71.52 110.881 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -133.32 136.74 45.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.138 -0.483 . . . . 71.1 110.841 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 135.73 -169.16 23.64 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.763 -0.732 . . . . 73.02 112.477 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 14.2 mttt -64.2 -28.6 69.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.734 0.302 . . . . 73.52 110.891 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.73 -46.9 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.25 -0.432 . . . . 75.2 110.904 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 51.6 pttt -162.79 56.21 0.2 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 54.23 110.901 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -75.2 -56.1 5.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.233 -0.439 . . . . 62.22 110.915 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -138.85 141.56 12.05 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.714 -0.755 . . . . 75.12 112.458 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 73.7 mt -125.4 137.19 58.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.739 0.304 . . . . 53.24 111.188 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 2.8 mt -123.94 131.53 72.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 74.4 111.08 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 16.4 m80 -105.09 144.94 31.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 74.44 110.813 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.99 105.09 5.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.142 -0.481 . . . . 72.14 111.07 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.611 HD12 ' N ' ' A' ' 168' ' ' ILE . 11.7 tp -64.06 135.21 56.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 71.22 110.923 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.611 ' N ' HD12 ' A' ' 167' ' ' LEU . 11.0 mt -136.22 104.78 4.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 72.55 111.118 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.611 HG22 ' CB ' ' A' ' 149' ' ' CYS . 42.2 t -112.66 135.42 52.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 72.23 111.096 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 63.62 31.69 14.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.137 -0.483 . . . . 73.0 110.86 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 2.2 t30 63.33 42.93 6.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.46 . . . . 73.34 110.851 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 9.9 mtt85 -143.94 130.18 19.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 74.43 110.968 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -62.61 146.42 52.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.257 -0.429 . . . . 74.13 110.879 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -125.03 131.34 24.08 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.686 0.755 . . . . 62.21 111.078 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.86 133.22 24.87 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.658 2.238 . . . . 71.14 112.356 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 73.13 110.876 -179.948 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.492 ' O ' HG23 ' A' ' 97' ' ' THR . 15.2 t . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.852 0.358 . . . . 63.23 111.117 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.587 HG22 ' HA ' ' A' ' 114' ' ' GLU . 1.0 OUTLIER -159.62 128.22 5.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.231 -0.44 . . . . 75.02 111.157 -179.964 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.4 m -105.8 147.47 28.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 72.12 110.872 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' THR . . . . . 1.075 HG22 HG22 ' A' ' 112' ' ' VAL . 0.7 OUTLIER -136.35 138.25 41.45 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.118 -0.492 . . . . 44.22 111.176 -179.972 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 100' ' ' TRP . . . . . 0.491 ' CB ' HD23 ' A' ' 167' ' ' LEU . 11.1 m-90 -133.42 123.0 24.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.198 -0.456 . . . . 64.34 110.995 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 19.9 t -102.48 114.92 43.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.339 -0.391 . . . . 74.32 111.114 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.915 HD11 HD12 ' A' ' 104' ' ' LEU . 0.5 OUTLIER -142.61 147.27 35.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.153 -0.476 . . . . 75.21 110.925 -179.977 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 83.4 mtt180 -74.34 92.08 2.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 73.02 110.946 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.915 HD12 HD11 ' A' ' 102' ' ' LEU . 0.4 OUTLIER -121.48 153.57 37.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.193 -0.458 . . . . 63.5 110.947 -179.935 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 65.03 14.65 9.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.175 -0.466 . . . . 72.1 110.873 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.61 -0.06 79.7 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.705 -0.759 . . . . 63.51 112.492 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -139.82 172.67 12.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.824 0.345 . . . . 72.31 110.897 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.3 88.64 0.32 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.141 -0.481 . . . . 72.21 110.875 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.628 HD12 ' ND2' ' A' ' 123' ' ' ASN . 0.5 OUTLIER -75.45 125.82 29.76 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.251 -0.431 . . . . 62.2 110.911 -179.954 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 10.1 ttt180 -102.4 111.06 23.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 74.23 110.881 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.4 t -94.8 135.89 27.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.14 -0.482 . . . . 73.12 111.153 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 1.075 HG22 HG22 ' A' ' 99' ' ' THR . 99.4 t -136.55 126.43 39.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 52.25 111.137 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.597 HD11 ' HA ' ' A' ' 118' ' ' MET . 2.7 tp -111.6 103.84 12.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 62.32 110.871 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.587 ' HA ' HG22 ' A' ' 97' ' ' THR . 0.1 OUTLIER -80.26 129.69 34.68 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.183 -0.462 . . . . 75.51 110.891 179.947 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 58.4 mttt -68.71 -15.41 63.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 73.34 110.895 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -51.27 -52.72 42.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.273 -0.421 . . . . 61.54 110.831 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -138.2 16.93 2.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.213 -0.449 . . . . 71.22 111.136 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' MET . . . . . 0.597 ' HA ' HD11 ' A' ' 113' ' ' LEU . 1.9 ttp 57.48 26.54 12.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 74.14 110.874 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -80.38 150.68 29.75 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.29 -0.414 . . . . 71.44 110.846 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.534 HG22 HD12 ' A' ' 151' ' ' ILE . 62.0 t -104.86 134.37 46.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.15 -0.477 . . . . 71.04 111.13 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 1.1 t90 -123.5 116.2 22.8 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.184 -0.462 . . . . 73.12 110.909 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' CYS . . . . . 0.552 ' HB2' HD21 ' A' ' 109' ' ' LEU . 17.9 p -120.95 132.94 55.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.302 -0.408 . . . . 72.43 110.819 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ASN . . . . . 0.628 ' ND2' HD12 ' A' ' 109' ' ' LEU . 58.9 m-20 44.57 51.54 7.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.125 -0.489 . . . . 61.4 110.865 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 50.82 40.83 42.67 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.748 -0.739 . . . . 63.52 112.456 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.46 122.61 12.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.854 0.359 . . . . 65.1 110.965 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.49 147.98 9.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.44 . . . . 71.21 110.894 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' MET . . . . . 0.463 ' SD ' HG22 ' A' ' 144' ' ' VAL . 32.5 mmm -114.14 169.05 9.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 63.42 110.847 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.56 106.37 12.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 74.0 110.903 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.671 ' HB ' HG22 ' A' ' 140' ' ' THR . 17.4 p -99.35 -175.11 2.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 63.22 111.178 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.623 ' HB2' ' HB2' ' A' ' 141' ' ' HIS . . . -94.77 -44.8 7.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 75.11 111.06 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 65.11 52.87 37.3 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.707 -0.759 . . . . 64.04 112.483 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 . . . . . 0 C--N 1.329 -0.306 0 CA-C-O 120.889 0.376 . . . . 65.43 110.903 -179.894 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 N-CA-C 112.508 -0.237 . . . . 61.54 112.508 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.654 ' O ' ' HB3' ' A' ' 153' ' ' ALA . 0.1 OUTLIER -134.86 130.91 36.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.735 0.302 . . . . 71.44 111.203 -179.896 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -111.91 96.3 5.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 64.51 110.882 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.671 HG22 ' HB ' ' A' ' 129' ' ' THR . 0.0 OUTLIER -78.81 110.23 13.8 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.22 -0.446 . . . . 71.34 111.157 -179.939 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 141' ' ' HIS . . . . . 0.623 ' HB2' ' HB2' ' A' ' 130' ' ' ALA . 82.7 m-70 -104.52 106.38 16.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 75.03 110.87 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.527 ' HD2' HG22 ' A' ' 129' ' ' THR . 3.4 p90 -128.09 175.52 8.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 71.5 110.845 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 83.3 p -142.42 155.75 45.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.088 -0.506 . . . . 73.23 110.911 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.554 HG11 HD22 ' A' ' 104' ' ' LEU . 84.7 t -136.87 105.29 4.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.469 . . . . 71.54 111.073 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 62.34 -103.48 0.61 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.726 -0.749 . . . . 62.43 112.496 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -114.23 -27.43 7.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.81 0.338 . . . . 73.14 110.893 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 52.0 m-70 -61.37 -170.43 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.191 -0.459 . . . . 73.34 110.855 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -152.6 116.39 4.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 73.03 110.921 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' CYS . . . . . 0.597 ' HB3' HG22 ' A' ' 169' ' ' VAL . 0.7 OUTLIER -142.66 161.98 36.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.242 -0.435 . . . . 72.32 110.852 -179.844 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 18.3 p90 -156.71 152.72 27.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 73.13 110.905 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.563 HD13 HD22 ' A' ' 113' ' ' LEU . 13.4 mt -99.55 111.53 29.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 71.31 111.14 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.587 ' HD3' HD12 ' A' ' 168' ' ' ILE . 1.1 ttpp -81.89 102.62 10.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 65.35 110.893 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' ALA . . . . . 0.654 ' HB3' ' O ' ' A' ' 138' ' ' THR . . . -98.6 147.99 24.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.281 -0.418 . . . . 52.32 111.119 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.5 t -145.18 122.44 4.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 54.3 111.122 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.2 p -89.67 139.97 30.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.472 . . . . 70.53 110.852 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 14.7 t -141.67 142.17 33.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.084 -0.507 . . . . 52.23 110.859 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 128.65 175.64 14.14 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.792 -0.718 . . . . 52.01 112.519 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 9.6 mttt -58.48 -38.11 76.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.749 0.309 . . . . 74.04 110.938 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -158.74 76.98 0.75 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 70.31 110.868 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 2.3 mtmt 55.85 28.89 13.11 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.208 -0.451 . . . . 73.21 110.88 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -54.39 -44.74 72.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 71.32 110.892 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -143.87 132.3 4.83 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.705 -0.759 . . . . 43.22 112.434 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 50.5 mt -121.13 147.15 25.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.812 0.339 . . . . 64.52 111.126 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 59.9 mt -129.45 131.01 67.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 62.24 111.118 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 15.5 m-70 -108.69 137.27 46.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.446 . . . . 61.25 110.869 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.99 112.0 13.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.253 -0.43 . . . . 64.21 111.177 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.491 HD23 ' CB ' ' A' ' 100' ' ' TRP . 18.1 tp -70.22 134.85 48.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 55.11 110.938 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.587 HD12 ' HD3' ' A' ' 152' ' ' LYS . 10.7 mt -136.74 121.45 25.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.474 . . . . 75.3 111.098 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.597 HG22 ' HB3' ' A' ' 149' ' ' CYS . 16.4 t -121.86 124.08 70.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 72.25 111.178 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 63.63 37.96 9.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.235 -0.439 . . . . 73.03 110.868 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 62.83 42.9 7.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.142 -0.481 . . . . 51.35 110.887 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -140.67 127.98 21.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.169 -0.469 . . . . 71.41 110.879 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -62.67 146.5 52.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.45 . . . . 75.43 110.856 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -122.18 131.31 24.43 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.675 0.75 . . . . 74.41 111.043 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 137.79 36.23 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.731 2.288 . . . . 73.32 112.292 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.462 . . . . 63.12 110.914 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.505 ' O ' HG23 ' A' ' 97' ' ' THR . 30.7 p . . . . . 0 C--O 1.233 0.188 0 CA-C-O 120.856 0.36 . . . . 50.14 111.09 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.505 HG23 ' O ' ' A' ' 96' ' ' THR . 1.0 OUTLIER -159.61 128.14 5.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.265 -0.425 . . . . 54.43 111.175 179.961 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -106.04 155.01 19.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 74.32 110.903 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.746 HG22 HG22 ' A' ' 112' ' ' VAL . 68.4 p -146.81 154.73 41.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.113 -0.494 . . . . 71.13 111.154 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' TRP . . . . . 0.47 ' CB ' HD23 ' A' ' 167' ' ' LEU . 14.2 m-90 -151.26 133.98 15.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.19 -0.459 . . . . 61.51 110.919 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.3 t -113.14 114.77 47.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 64.45 111.172 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.644 HD11 HD12 ' A' ' 104' ' ' LEU . 0.5 OUTLIER -138.91 146.01 40.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 71.21 110.918 -179.997 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -74.22 94.1 2.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 74.14 110.833 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.644 HD12 HD11 ' A' ' 102' ' ' LEU . 0.4 OUTLIER -127.44 153.39 46.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 75.34 110.927 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 64.43 15.65 9.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.204 -0.453 . . . . 70.2 110.824 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 86.3 2.05 85.73 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.665 -0.779 . . . . 74.54 112.503 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -139.94 173.06 11.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.89 0.376 . . . . 73.43 110.859 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.1 87.88 0.4 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.458 . . . . 74.31 110.872 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.6 HD13 ' HB3' ' A' ' 104' ' ' LEU . 1.4 tp -69.04 124.87 24.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.471 . . . . 73.04 110.906 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 10.8 ttm180 -107.05 113.91 27.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 72.15 110.87 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -106.37 139.37 27.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.456 . . . . 74.45 111.131 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.746 HG22 HG22 ' A' ' 99' ' ' THR . 85.8 t -135.8 135.36 50.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.125 -0.488 . . . . 72.43 111.207 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.437 HD11 ' HA ' ' A' ' 118' ' ' MET . 3.2 tp -117.58 100.35 7.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 62.14 110.954 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.449 ' HG3' HG22 ' A' ' 97' ' ' THR . 0.0 OUTLIER -75.57 134.85 40.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 71.15 110.878 179.977 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.3 mttt -73.78 -17.46 61.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.474 . . . . 64.51 110.924 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -51.33 -54.12 29.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 64.14 110.853 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -134.29 17.01 3.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.219 -0.446 . . . . 65.13 111.138 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' MET . . . . . 0.437 ' HA ' HD11 ' A' ' 113' ' ' LEU . 3.9 ttm 54.41 27.09 7.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.252 -0.431 . . . . 61.3 110.914 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -80.97 149.39 29.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 73.43 110.851 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.503 HG23 HG21 ' A' ' 129' ' ' THR . 31.3 t -104.84 128.92 58.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.107 -0.497 . . . . 64.11 111.163 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 3.7 t90 -113.1 127.55 56.24 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.093 -0.503 . . . . 71.23 110.951 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 9.2 t -141.6 129.52 21.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 74.24 110.93 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 2.8 m120 48.25 50.79 15.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 73.41 110.945 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 49.29 47.46 34.58 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.774 -0.727 . . . . 75.44 112.44 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.44 114.71 4.79 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.81 0.338 . . . . 64.42 110.966 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 7.5 ttmt -55.56 100.36 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 75.33 110.857 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 65.5 mtp -59.63 159.7 8.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 73.41 110.916 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -104.97 106.38 16.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.212 -0.449 . . . . 62.13 110.892 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.819 ' HB ' HG22 ' A' ' 140' ' ' THR . 13.9 p -99.2 -175.21 2.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.161 -0.472 . . . . 44.35 111.16 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.42 ' HB2' ' HB2' ' A' ' 141' ' ' HIS . . . -114.01 -47.86 2.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 41.14 111.136 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 74.83 50.43 8.99 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.716 -0.754 . . . . 70.13 112.484 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 . . . . . 0 C--N 1.328 -0.326 0 CA-C-O 120.878 0.37 . . . . 74.32 110.835 -179.827 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 N-CA-C 112.501 -0.24 . . . . 64.13 112.501 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.63 130.81 34.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.706 0.288 . . . . 60.44 111.132 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -103.18 97.98 7.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.273 -0.422 . . . . 72.4 110.895 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.819 HG22 ' HB ' ' A' ' 129' ' ' THR . 0.0 OUTLIER -80.72 110.26 16.05 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.157 -0.474 . . . . 75.14 111.135 -179.897 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 141' ' ' HIS . . . . . 0.42 ' HB2' ' HB2' ' A' ' 130' ' ' ALA . 46.4 m80 -102.0 109.3 21.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 70.55 110.809 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.718 ' CE2' HD12 ' A' ' 151' ' ' ILE . 3.0 p90 -138.75 153.33 48.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.252 -0.431 . . . . 74.31 110.905 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 89.6 p -114.52 167.44 10.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 73.12 110.812 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 83.8 t -149.39 98.12 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.119 -0.492 . . . . 65.2 111.09 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 60.18 -101.93 0.31 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.777 -0.725 . . . . 74.4 112.461 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -123.59 29.24 6.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.945 0.403 . . . . 75.03 110.943 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 36.5 m80 -121.31 -175.02 2.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.475 . . . . 71.24 110.951 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -145.09 117.48 8.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.287 -0.415 . . . . 62.42 110.84 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' CYS . . . . . 0.611 ' HB3' HG22 ' A' ' 169' ' ' VAL . 1.3 p -142.45 156.41 45.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.216 -0.447 . . . . 54.45 110.893 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -151.66 146.32 25.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 70.1 110.875 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.718 HD12 ' CE2' ' A' ' 142' ' ' PHE . 3.8 mt -97.37 111.69 27.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.082 -0.508 . . . . 73.41 111.113 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.646 ' HD2' HD12 ' A' ' 168' ' ' ILE . 8.1 tttt -79.83 102.5 9.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.253 -0.431 . . . . 74.43 110.88 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -95.12 139.68 31.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.242 -0.436 . . . . 74.43 111.156 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.3 t -135.68 123.01 35.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.252 -0.431 . . . . 75.4 111.135 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.3 p -91.12 150.4 21.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 74.21 110.87 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 63.4 p -144.8 128.45 17.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.104 -0.498 . . . . 63.44 110.885 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 136.03 -144.03 15.68 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.712 -0.756 . . . . 64.52 112.526 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 19.7 mtmt -95.04 -63.42 1.17 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.721 0.296 . . . . 75.25 110.866 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.99 -36.38 3.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.308 -0.405 . . . . 74.43 110.926 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -173.17 52.3 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 35.23 110.916 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -69.23 -61.98 1.57 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 65.14 110.922 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -143.33 138.77 8.41 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.734 -0.746 . . . . 62.04 112.55 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 61.2 mt -124.54 146.11 30.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.796 0.331 . . . . 72.5 111.159 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 59.4 mt -133.92 123.18 44.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.242 -0.436 . . . . 72.3 111.171 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 9.7 m80 -99.41 141.49 32.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.464 . . . . 71.52 110.875 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.33 106.93 8.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 75.42 111.073 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.546 HD12 ' N ' ' A' ' 168' ' ' ILE . 14.5 tp -65.14 134.02 52.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 72.52 110.936 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.646 HD12 ' HD2' ' A' ' 152' ' ' LYS . 10.7 mt -137.01 111.27 9.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 53.12 111.113 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.611 HG22 ' HB3' ' A' ' 149' ' ' CYS . 35.6 t -113.56 124.71 70.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.458 . . . . 54.13 111.143 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 4.5 t0 63.37 43.22 6.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.451 . . . . 63.34 110.883 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 58.3 m-20 56.8 41.54 27.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.111 -0.495 . . . . 70.14 110.841 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 26.4 mtt180 -137.94 125.76 22.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 75.2 110.849 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -62.7 144.96 55.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.174 -0.466 . . . . 65.13 110.889 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -122.99 131.16 24.38 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.581 0.705 . . . . 73.22 111.143 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 138.21 37.31 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.725 2.283 . . . . 71.31 112.299 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 72.43 110.855 -179.956 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.495 ' O ' HG23 ' A' ' 97' ' ' THR . 39.2 p . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.831 0.348 . . . . 74.22 111.107 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.495 HG23 ' O ' ' A' ' 96' ' ' THR . 1.0 OUTLIER -159.46 127.78 5.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.286 -0.416 . . . . 64.43 111.096 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.4 m -106.48 152.18 23.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.443 . . . . 71.41 110.833 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.433 HG23 HG22 ' A' ' 112' ' ' VAL . 6.9 m -135.86 155.19 50.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.126 -0.488 . . . . 72.55 111.124 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' TRP . . . . . 0.426 ' CB ' HD23 ' A' ' 167' ' ' LEU . 16.6 m-90 -148.97 133.02 17.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.208 -0.451 . . . . 74.24 110.88 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.0 t -113.03 114.92 48.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 71.44 111.124 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.847 HD11 HD12 ' A' ' 104' ' ' LEU . 0.5 OUTLIER -140.03 147.27 40.13 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.179 -0.464 . . . . 72.43 110.892 179.973 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -73.29 93.44 1.89 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.133 -0.485 . . . . 42.43 110.874 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.847 HD12 HD11 ' A' ' 102' ' ' LEU . 0.3 OUTLIER -124.8 151.74 44.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 72.33 110.868 -179.901 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.8 t0 64.54 15.21 9.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 75.31 110.847 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.37 1.8 83.43 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.758 -0.734 . . . . 60.1 112.527 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -139.92 172.88 12.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.841 0.353 . . . . 74.01 110.902 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.67 89.28 0.37 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 73.14 110.855 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.616 HD13 ' HB3' ' A' ' 104' ' ' LEU . 0.6 OUTLIER -74.38 131.49 41.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 64.53 110.955 179.986 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 11.7 ttp180 -110.8 118.48 36.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 75.12 110.862 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.583 HG13 ' HB2' ' A' ' 122' ' ' CYS . 0.1 OUTLIER -108.63 143.74 18.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 52.42 111.112 179.955 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.433 HG22 HG23 ' A' ' 99' ' ' THR . 15.6 t -135.85 153.04 31.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.13 -0.486 . . . . 31.11 111.111 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.605 HD22 HD13 ' A' ' 151' ' ' ILE . 4.3 tp -129.71 105.92 8.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.165 -0.471 . . . . 74.41 110.927 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.488 ' HA ' HG22 ' A' ' 97' ' ' THR . 0.0 OUTLIER -81.43 135.51 35.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.231 -0.44 . . . . 74.43 110.823 179.955 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.0 mtmt -73.52 -16.54 61.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.098 -0.501 . . . . 64.44 110.859 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -51.34 -55.85 16.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.254 -0.43 . . . . 71.41 110.884 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.86 16.81 3.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 63.43 111.207 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' MET . . . . . 0.534 ' HA ' HD11 ' A' ' 113' ' ' LEU . 1.9 mtp 59.99 20.21 9.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.464 . . . . 53.22 110.891 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -70.91 151.03 45.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 73.1 110.886 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.7 HG22 HD12 ' A' ' 151' ' ' ILE . 80.4 t -105.07 117.81 51.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 74.4 111.095 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 55.2 t-105 -95.61 113.63 25.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.211 -0.45 . . . . 71.33 110.946 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' CYS . . . . . 0.583 ' HB2' HG13 ' A' ' 111' ' ' VAL . 9.0 t -140.26 133.03 29.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.246 -0.434 . . . . 74.32 110.897 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 57.98 34.06 23.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 62.01 110.915 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 57.76 49.85 70.62 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.743 -0.741 . . . . 55.4 112.476 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.93 121.6 2.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.836 0.35 . . . . 73.44 110.934 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -54.08 100.39 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 73.34 110.942 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' MET . . . . . 0.426 ' HB2' ' HB ' ' A' ' 120' ' ' VAL . 17.2 mmm -56.47 174.23 0.15 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.283 -0.417 . . . . 72.34 110.868 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -119.27 106.29 12.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.212 -0.449 . . . . 75.43 110.847 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.713 ' HB ' HG22 ' A' ' 140' ' ' THR . 19.8 p -98.64 -175.23 3.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.135 -0.484 . . . . 70.21 111.16 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.501 ' HB2' ' HB2' ' A' ' 141' ' ' HIS . . . -99.87 -38.38 8.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.269 -0.423 . . . . 71.04 111.092 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 69.77 43.56 66.47 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.711 -0.756 . . . . 44.03 112.55 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 . . . . . 0 C--N 1.329 -0.291 0 CA-C-O 120.922 0.392 . . . . 74.51 110.921 -179.898 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 N-CA-C 112.508 -0.237 . . . . 75.22 112.508 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.573 ' O ' ' HB3' ' A' ' 153' ' ' ALA . 0.1 OUTLIER -135.03 130.78 36.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.763 0.316 . . . . 74.52 111.109 -179.842 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -108.57 96.78 6.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.444 . . . . 74.13 110.893 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.713 HG22 ' HB ' ' A' ' 129' ' ' THR . 0.0 OUTLIER -83.64 109.99 17.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.168 -0.469 . . . . 64.13 111.075 -179.881 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 141' ' ' HIS . . . . . 0.501 ' HB2' ' HB2' ' A' ' 130' ' ' ALA . 44.4 m80 -101.83 104.53 15.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 64.53 110.86 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 23.2 p90 -126.43 135.63 51.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 71.35 110.896 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 36.6 p -102.72 157.38 16.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.441 . . . . 74.21 110.849 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 90.5 t -138.7 105.59 2.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.101 -0.499 . . . . 50.13 111.093 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 55.06 -105.58 0.41 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.701 -0.761 . . . . 72.03 112.512 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -117.32 24.81 10.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.793 0.33 . . . . 71.32 110.869 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -117.1 172.18 7.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 60.12 110.877 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -130.24 120.74 24.92 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.241 -0.436 . . . . 72.34 110.867 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' CYS . . . . . 0.592 ' HB3' HG22 ' A' ' 169' ' ' VAL . 1.0 OUTLIER -142.68 170.73 15.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.179 -0.464 . . . . 74.43 110.913 -179.932 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -175.2 147.71 0.93 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.21 -0.45 . . . . 75.34 110.914 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.7 HD12 HG22 ' A' ' 120' ' ' VAL . 12.9 mt -97.5 111.16 26.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.086 -0.506 . . . . 74.14 111.097 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 20.2 tttt -82.03 102.65 11.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.25 -0.432 . . . . 70.53 110.827 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' ALA . . . . . 0.573 ' HB3' ' O ' ' A' ' 138' ' ' THR . . . -95.07 147.15 23.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 53.4 111.113 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.5 t -145.08 119.22 2.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 65.33 111.173 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.3 p -84.26 137.95 33.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.471 . . . . 71.23 110.871 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 1.5 t -133.54 152.47 51.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 63.53 110.794 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 112.25 -126.57 7.65 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.763 -0.732 . . . . 74.35 112.476 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -121.75 -65.05 1.16 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.756 0.313 . . . . 74.02 110.928 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -136.8 91.9 2.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.172 -0.467 . . . . 71.32 110.927 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 60.1 26.5 15.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 63.04 110.888 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.91 -69.96 0.19 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.198 -0.456 . . . . 55.11 110.931 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -137.39 120.49 2.09 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.719 -0.753 . . . . 54.34 112.479 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 72.2 mt -110.1 144.97 17.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.746 0.308 . . . . 74.42 111.158 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 3.0 mt -128.16 130.53 69.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.262 -0.426 . . . . 62.34 111.112 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' HIS . . . . . 0.469 ' CG ' HD23 ' A' ' 113' ' ' LEU . 22.0 m-70 -108.2 137.29 46.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 73.23 110.862 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.38 107.19 9.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.243 -0.435 . . . . 73.32 111.149 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.597 HD12 ' N ' ' A' ' 168' ' ' ILE . 13.6 tp -67.37 137.21 55.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.249 -0.432 . . . . 75.11 110.982 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.597 ' N ' HD12 ' A' ' 167' ' ' LEU . 9.7 mt -138.76 114.21 9.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.184 -0.462 . . . . 65.22 111.161 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.592 HG22 ' HB3' ' A' ' 149' ' ' CYS . 43.8 t -115.88 126.5 73.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 75.4 111.104 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.3 t0 63.53 39.26 9.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 74.44 110.935 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 60.06 42.3 15.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.47 . . . . 72.24 110.872 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -138.45 124.99 20.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 64.41 110.883 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -62.65 140.49 58.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.272 -0.422 . . . . 74.13 110.891 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.475 HD12 HD22 ' A' ' 102' ' ' LEU . 0.9 OUTLIER -118.64 131.26 24.36 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.616 0.722 . . . . 70.41 111.126 179.992 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.66 135.85 31.74 Favored 'Trans proline' 0 N--CA 1.465 -0.179 0 C-N-CA 122.744 2.296 . . . . 73.13 112.386 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.259 -0.428 . . . . 72.14 110.854 -179.936 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.504 ' O ' HG23 ' A' ' 97' ' ' THR . 54.4 p . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.829 0.347 . . . . 75.41 111.108 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.504 HG23 ' O ' ' A' ' 96' ' ' THR . 1.0 OUTLIER -159.58 127.94 5.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.265 -0.425 . . . . 64.43 111.207 -179.986 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.413 ' O ' HG13 ' A' ' 112' ' ' VAL . 1.1 m -106.27 151.9 24.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.271 -0.422 . . . . 73.31 110.85 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.949 HG23 HG22 ' A' ' 112' ' ' VAL . 1.3 m -137.85 148.46 45.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.125 -0.488 . . . . 71.24 111.095 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' TRP . . . . . 0.445 ' CB ' HD23 ' A' ' 167' ' ' LEU . 10.1 m-90 -146.4 124.67 12.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.206 -0.452 . . . . 63.33 110.936 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 19.1 t -108.37 114.81 47.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.284 -0.416 . . . . 64.3 111.164 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.909 HD11 HD12 ' A' ' 104' ' ' LEU . 0.5 OUTLIER -139.94 147.62 40.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.205 -0.452 . . . . 64.33 110.894 -179.989 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -73.32 92.83 1.84 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 74.32 110.856 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.909 HD12 HD11 ' A' ' 102' ' ' LEU . 0.3 OUTLIER -123.82 151.0 43.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 54.1 110.89 179.967 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 64.43 15.45 9.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 74.11 110.832 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.83 1.42 82.65 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.717 -0.754 . . . . 54.21 112.516 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -139.81 172.81 12.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.894 0.378 . . . . 61.32 110.808 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -69.53 89.64 0.52 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.081 -0.509 . . . . 64.53 110.878 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.58 HD13 ' HB3' ' A' ' 104' ' ' LEU . 0.5 OUTLIER -76.5 129.33 36.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 73.44 110.937 -179.953 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 2.5 ttm180 -107.76 118.3 36.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 73.14 110.893 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.6 HG12 ' CG1' ' A' ' 120' ' ' VAL . 0.0 OUTLIER -111.73 115.68 50.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 72.32 111.201 179.933 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.949 HG22 HG23 ' A' ' 99' ' ' THR . 28.3 t -114.51 140.29 36.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.242 -0.435 . . . . 73.25 111.127 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.677 HD22 HD13 ' A' ' 151' ' ' ILE . 3.1 tp -114.0 108.66 17.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.17 -0.468 . . . . 52.2 110.962 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.424 ' N ' HD12 ' A' ' 113' ' ' LEU . 0.6 OUTLIER -81.8 134.79 35.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 63.13 110.874 179.984 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.7 mmmt -73.79 -16.31 61.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 73.13 110.883 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -51.49 -53.82 33.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 53.23 110.871 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.54 17.0 2.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.117 -0.492 . . . . 75.11 111.158 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' MET . . . . . 0.586 ' HA ' HD11 ' A' ' 113' ' ' LEU . 64.6 mtp 56.49 33.12 22.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.216 -0.447 . . . . 64.32 110.89 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.73 154.22 20.74 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.229 -0.441 . . . . 74.03 110.88 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.644 HG22 HD12 ' A' ' 151' ' ' ILE . 45.3 t -104.81 131.0 54.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.227 -0.442 . . . . 43.4 111.09 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 2.2 t90 -111.85 124.69 52.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 73.54 110.973 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 16.5 t -121.45 103.35 8.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.293 -0.412 . . . . 61.32 110.926 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 46.56 70.99 0.34 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.236 -0.438 . . . . 74.22 110.9 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 47.69 40.31 17.69 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.71 -0.757 . . . . 74.1 112.503 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -141.78 102.27 4.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.92 0.391 . . . . 74.44 110.847 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 4.6 tttt -53.44 102.11 0.05 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 65.34 110.862 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 21.7 mmm -64.79 167.29 7.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.481 . . . . 62.14 110.867 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -119.33 106.09 11.95 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.204 -0.453 . . . . 53.32 110.882 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.683 ' CB ' HG22 ' A' ' 140' ' ' THR . 18.8 p -95.83 177.9 5.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 50.31 111.144 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.674 ' HB3' ' HB2' ' A' ' 141' ' ' HIS . . . -125.08 83.59 2.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 73.42 111.128 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -51.58 113.68 2.54 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.751 -0.738 . . . . 55.13 112.498 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.297 0 CA-C-O 120.813 0.34 . . . . 73.42 110.894 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.252 0 N-CA-C 112.455 -0.258 . . . . 64.23 112.455 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.597 ' O ' ' HB3' ' A' ' 153' ' ' ALA . 0.1 OUTLIER -134.87 130.87 36.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.761 0.315 . . . . 74.12 111.138 -179.863 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -104.38 98.19 8.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 71.21 110.914 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.683 HG22 ' CB ' ' A' ' 129' ' ' THR . 0.0 OUTLIER -77.24 109.85 11.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.458 . . . . 75.2 111.134 -179.907 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 141' ' ' HIS . . . . . 0.674 ' HB2' ' HB3' ' A' ' 130' ' ' ALA . 86.6 m-70 -101.15 108.04 19.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.158 -0.474 . . . . 64.32 110.861 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -123.97 124.26 42.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.142 -0.481 . . . . 73.52 110.799 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 66.5 p -85.86 157.97 20.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.119 -0.491 . . . . 65.22 110.838 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 97.5 t -150.16 104.32 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.085 -0.507 . . . . 62.31 111.14 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 52.75 -113.58 2.88 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.697 -0.763 . . . . 52.14 112.516 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -110.46 25.81 11.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.844 0.354 . . . . 74.35 110.867 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 20.9 m-70 -124.84 159.66 30.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.242 -0.435 . . . . 63.1 110.897 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -121.02 123.68 42.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.255 -0.43 . . . . 74.23 110.841 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' CYS . . . . . 0.614 ' HB3' HG22 ' A' ' 169' ' ' VAL . 1.2 p -142.49 154.6 44.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.141 -0.481 . . . . 71.24 110.946 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -157.62 149.03 21.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.218 -0.446 . . . . 72.12 110.943 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.677 HD13 HD22 ' A' ' 113' ' ' LEU . 9.4 mt -97.84 113.93 33.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 61.22 111.067 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 2.4 tttt -80.13 102.65 9.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.207 -0.451 . . . . 74.25 110.866 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' ALA . . . . . 0.597 ' HB3' ' O ' ' A' ' 138' ' ' THR . . . -98.8 143.92 28.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 75.41 111.115 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 39.4 t -146.68 124.93 4.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.212 -0.449 . . . . 63.4 111.164 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.2 p -94.22 139.54 30.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.221 -0.445 . . . . 65.43 110.823 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.23 145.72 35.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 74.2 110.844 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 129.81 -179.12 17.02 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.701 -0.762 . . . . 53.33 112.491 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 6.4 mtmt -52.81 -58.02 8.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.801 0.334 . . . . 73.11 110.915 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 3.9 ptm180 -150.17 79.45 1.35 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.255 -0.429 . . . . 74.54 110.912 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 15.6 ttmt 61.73 56.49 2.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 73.52 110.915 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -90.89 -68.81 0.77 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.176 -0.465 . . . . 71.44 110.894 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -111.63 128.44 8.63 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.792 -0.718 . . . . 65.45 112.512 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 56.9 mt -120.29 145.0 27.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.767 0.318 . . . . 54.32 111.11 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 57.2 mt -128.58 140.12 50.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.177 -0.465 . . . . 75.32 111.12 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' HIS . . . . . 0.42 ' CG ' HD23 ' A' ' 113' ' ' LEU . 9.4 m80 -117.91 135.48 54.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.137 -0.483 . . . . 53.41 110.816 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.82 109.88 12.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.133 -0.485 . . . . 73.5 111.126 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.555 HD12 ' N ' ' A' ' 168' ' ' ILE . 15.1 tp -68.43 135.63 52.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 73.44 110.981 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.555 ' N ' HD12 ' A' ' 167' ' ' LEU . 10.5 mt -138.63 117.27 13.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.455 . . . . 75.44 111.119 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.614 HG22 ' HB3' ' A' ' 149' ' ' CYS . 21.7 t -117.93 125.82 74.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.172 -0.467 . . . . 63.31 111.103 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 63.56 37.98 10.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 72.44 110.934 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 61.4 43.0 10.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 72.24 110.864 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 16.5 mtt180 -140.23 129.1 23.29 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.177 -0.465 . . . . 72.14 110.852 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -62.69 146.43 52.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.136 -0.484 . . . . 74.34 110.899 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.435 HD12 HD22 ' A' ' 102' ' ' LEU . 0.8 OUTLIER -122.85 130.89 24.45 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.699 0.762 . . . . 71.03 111.14 179.961 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 135.57 30.82 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.66 2.24 . . . . 61.3 112.332 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 116.229 -0.441 . . . . 55.43 110.889 179.999 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.501 ' O ' HG23 ' A' ' 97' ' ' THR . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.873 0.368 . . . . 73.31 111.157 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.501 HG23 ' O ' ' A' ' 96' ' ' THR . 1.0 OUTLIER -159.54 127.8 4.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.234 -0.439 . . . . 74.04 111.181 179.993 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.3 m -106.37 153.95 21.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 70.02 110.879 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.968 HG22 HG22 ' A' ' 112' ' ' VAL . 0.6 OUTLIER -142.21 156.57 45.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.104 -0.498 . . . . 72.15 111.11 -179.904 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 17.2 m-90 -151.45 130.6 12.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.237 -0.438 . . . . 74.1 110.97 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.3 t -110.25 114.79 48.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.249 -0.432 . . . . 75.33 111.107 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.947 HD11 HD12 ' A' ' 104' ' ' LEU . 0.5 OUTLIER -141.69 148.42 39.06 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.197 -0.456 . . . . 74.14 110.95 179.932 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.3 mtm180 -74.73 92.79 2.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.178 -0.464 . . . . 70.5 110.857 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.947 HD12 HD11 ' A' ' 102' ' ' LEU . 0.3 OUTLIER -121.79 152.07 39.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 72.45 110.979 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 64.72 15.03 9.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.213 -0.449 . . . . 74.13 110.889 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.0 0.48 80.95 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.719 -0.753 . . . . 60.34 112.444 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -139.84 172.76 12.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.854 0.359 . . . . 75.01 110.914 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -68.58 89.68 0.37 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 73.22 110.858 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.551 HD13 ' HB3' ' A' ' 104' ' ' LEU . 0.5 OUTLIER -78.91 128.58 33.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 71.15 110.878 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.74 119.7 40.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.131 -0.486 . . . . 54.45 110.875 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.589 HG13 ' SG ' ' A' ' 122' ' ' CYS . 0.1 OUTLIER -107.13 142.61 19.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.124 -0.489 . . . . 50.41 111.131 179.956 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.968 HG22 HG22 ' A' ' 99' ' ' THR . 48.1 t -135.82 146.72 29.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 63.53 111.153 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.58 HD11 ' HA ' ' A' ' 118' ' ' MET . 3.1 tp -128.4 101.24 6.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 73.2 110.878 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.402 ' HG3' HG22 ' A' ' 97' ' ' THR . 0.2 OUTLIER -78.11 122.77 26.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.189 -0.459 . . . . 73.34 110.878 179.924 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.39 -15.94 59.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 65.51 110.946 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -51.44 -56.0 15.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.455 . . . . 74.12 110.868 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 9.5 p -133.87 16.98 3.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.458 . . . . 65.45 111.129 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' MET . . . . . 0.58 ' HA ' HD11 ' A' ' 113' ' ' LEU . 9.6 mtp 58.43 24.55 11.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.302 -0.408 . . . . 71.12 110.856 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -76.18 144.55 40.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.267 -0.424 . . . . 71.44 110.842 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.504 HG21 ' CE2' ' A' ' 142' ' ' PHE . 71.4 t -105.1 118.26 52.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 70.0 111.156 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 2.2 t90 -98.34 134.86 40.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.173 -0.467 . . . . 72.01 110.909 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' CYS . . . . . 0.589 ' SG ' HG13 ' A' ' 111' ' ' VAL . 0.6 OUTLIER -131.18 103.14 6.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 75.25 110.914 179.982 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 22.7 m-20 45.43 69.66 0.43 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 73.52 110.992 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 48.65 41.02 25.99 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.773 -0.727 . . . . 70.4 112.428 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -149.81 115.3 5.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.801 0.334 . . . . 64.11 110.927 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -53.56 162.21 0.87 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.247 -0.433 . . . . 75.4 110.85 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' MET . . . . . 0.526 ' CE ' HG22 ' A' ' 144' ' ' VAL . 35.1 mmm -126.54 166.49 17.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.445 . . . . 73.42 110.945 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -119.26 106.41 12.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.268 -0.424 . . . . 74.14 110.861 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.593 ' CB ' HG22 ' A' ' 140' ' ' THR . 21.7 p -95.8 -175.17 3.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.161 -0.472 . . . . 61.15 111.126 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.468 ' HB2' ' HB2' ' A' ' 141' ' ' HIS . . . -93.33 -35.76 12.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.449 . . . . 64.2 111.138 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 73.88 40.57 43.97 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.769 -0.729 . . . . 51.43 112.496 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 . . . . . 0 C--N 1.33 -0.28 0 CA-C-O 120.907 0.384 . . . . 65.4 110.832 -179.846 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 N-CA-C 112.483 -0.247 . . . . 64.11 112.483 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.42 ' O ' ' HB3' ' A' ' 153' ' ' ALA . 0.1 OUTLIER -135.04 130.82 36.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.807 0.336 . . . . 63.12 111.164 -179.862 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -104.86 96.63 6.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.222 -0.445 . . . . 73.44 110.858 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.593 HG22 ' CB ' ' A' ' 129' ' ' THR . 0.0 OUTLIER -85.39 110.21 18.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 43.23 111.098 -179.912 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 141' ' ' HIS . . . . . 0.468 ' HB2' ' HB2' ' A' ' 130' ' ' ALA . 41.9 m170 -109.53 106.24 15.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 75.03 110.821 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.547 ' HD2' HG22 ' A' ' 129' ' ' THR . 9.1 p90 -124.54 144.66 50.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 72.3 110.899 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 77.0 p -91.28 141.61 28.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 74.03 110.892 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.526 HG22 ' CE ' ' A' ' 127' ' ' MET . 17.4 t -138.87 103.47 2.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.175 -0.466 . . . . 54.21 111.096 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 53.76 31.43 46.01 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.704 -0.76 . . . . 70.44 112.476 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 63.36 25.35 14.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.874 0.369 . . . . 65.25 110.883 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -93.5 -11.93 30.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.14 -0.482 . . . . 75.32 110.825 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 63.87 104.88 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.244 -0.434 . . . . 73.24 110.801 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' CYS . . . . . 0.543 ' SG ' HG13 ' A' ' 169' ' ' VAL . 10.9 m -137.91 167.86 20.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.165 -0.47 . . . . 65.4 110.846 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 18.4 p90 -174.39 142.79 0.8 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.474 . . . . 75.11 110.919 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.504 HD13 HD22 ' A' ' 113' ' ' LEU . 32.0 mt -98.59 111.3 27.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.076 -0.511 . . . . 71.31 111.141 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 16.9 tttt -80.11 104.03 10.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.485 . . . . 71.31 110.858 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' ALA . . . . . 0.42 ' HB3' ' O ' ' A' ' 138' ' ' THR . . . -99.04 146.67 25.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 73.03 111.084 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.2 t -144.9 124.3 6.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.251 -0.431 . . . . 75.24 111.174 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -93.32 129.62 39.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.21 -0.45 . . . . 60.44 110.839 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -130.17 153.45 48.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 74.02 110.858 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 83.3 90.24 0.71 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.659 -0.782 . . . . 64.11 112.516 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.01 -170.13 0.16 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.845 0.355 . . . . 74.14 110.913 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 11.1 mtt180 -52.89 -32.34 44.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.239 -0.437 . . . . 74.22 110.854 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 11.7 pttt -173.41 124.1 0.39 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 70.2 110.916 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -158.58 -54.0 0.07 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.227 -0.442 . . . . 75.05 110.91 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -128.06 105.98 0.76 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.712 -0.756 . . . . 70.12 112.482 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 63.3 mt -103.91 134.76 44.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.751 0.31 . . . . 75.51 111.121 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 53.5 mt -121.04 133.34 68.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.227 -0.442 . . . . 73.1 111.135 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' HIS . . . . . 0.409 ' CG ' HD23 ' A' ' 113' ' ' LEU . 14.2 m80 -108.96 137.94 46.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 54.13 110.848 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.65 103.64 6.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 75.12 111.128 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.559 HD12 ' H ' ' A' ' 168' ' ' ILE . 15.9 tp -66.35 138.35 57.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.237 -0.438 . . . . 74.03 110.907 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.559 ' H ' HD12 ' A' ' 167' ' ' LEU . 11.0 mt -135.95 119.53 23.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.216 -0.447 . . . . 72.52 111.105 179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.543 HG13 ' SG ' ' A' ' 149' ' ' CYS . 88.2 t -118.5 135.46 58.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 64.52 111.082 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 54.01 37.01 25.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 63.42 110.898 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 10.3 t30 63.37 42.93 6.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.166 -0.47 . . . . 54.41 110.956 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 4.2 mtm180 -141.44 130.46 23.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 65.45 110.88 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -62.83 146.45 52.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.208 -0.451 . . . . 75.12 110.853 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.477 HD12 HD22 ' A' ' 102' ' ' LEU . 0.9 OUTLIER -122.98 131.14 24.38 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.65 0.738 . . . . 63.23 111.11 179.965 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.74 135.89 31.66 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.624 2.216 . . . . 75.35 112.398 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 73.1 110.89 -179.962 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.499 ' O ' HG23 ' A' ' 97' ' ' THR . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.881 0.372 . . . . 70.11 111.157 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.499 HG23 ' O ' ' A' ' 96' ' ' THR . 1.0 OUTLIER -159.47 128.09 5.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 41.44 111.084 -179.987 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.8 m -105.98 154.04 21.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.237 -0.438 . . . . 74.54 110.855 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 27.3 m -141.56 148.58 39.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.139 -0.482 . . . . 74.04 111.153 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' TRP . . . . . 0.54 ' CB ' HD23 ' A' ' 167' ' ' LEU . 9.3 m-90 -145.37 122.91 11.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.198 -0.455 . . . . 73.41 110.89 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 19.5 t -103.32 114.79 43.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 71.24 111.075 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.788 HD11 HD12 ' A' ' 104' ' ' LEU . 0.5 OUTLIER -141.97 146.6 35.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.119 -0.491 . . . . 75.05 110.898 179.925 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 4.8 mtt85 -74.44 92.18 2.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 73.54 110.88 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.788 HD12 HD11 ' A' ' 102' ' ' LEU . 0.4 OUTLIER -122.99 153.74 39.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.207 -0.452 . . . . 73.04 110.926 -179.974 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.5 t70 65.14 14.44 9.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.181 -0.463 . . . . 43.23 110.877 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.55 0.0 79.81 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.791 -0.719 . . . . 51.13 112.503 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -139.86 172.91 12.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.868 0.366 . . . . 74.34 110.836 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -68.78 88.13 0.36 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.112 -0.495 . . . . 74.21 110.879 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.608 HD13 ' HB3' ' A' ' 104' ' ' LEU . 0.5 OUTLIER -73.26 124.85 26.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.259 -0.428 . . . . 74.34 110.907 -179.907 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -102.03 109.79 21.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 73.12 110.893 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.568 HG13 ' SG ' ' A' ' 122' ' ' CYS . 2.5 t -95.25 136.7 25.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 65.33 111.09 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 86.6 t -136.51 128.58 44.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.163 -0.471 . . . . 75.0 111.126 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.609 HD22 HD13 ' A' ' 151' ' ' ILE . 4.9 tp -110.07 102.31 11.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.138 -0.483 . . . . 71.54 110.875 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.455 ' HA ' HG22 ' A' ' 97' ' ' THR . 0.1 OUTLIER -78.7 136.15 37.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.211 -0.449 . . . . 64.24 110.914 179.875 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.431 ' HG3' HG22 ' A' ' 96' ' ' THR . 21.0 mmmt -73.77 -17.15 61.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.135 -0.484 . . . . 73.42 110.861 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -51.49 -53.88 32.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 63.11 110.869 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.82 17.0 3.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.201 -0.454 . . . . 64.22 111.112 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' MET . . . . . 0.426 ' HA ' HD11 ' A' ' 113' ' ' LEU . 2.6 ttp 53.67 28.22 7.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 60.34 110.876 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -85.23 158.62 20.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 73.15 110.87 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.545 HG23 HG21 ' A' ' 129' ' ' THR . 21.6 t -104.87 138.4 29.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.207 -0.451 . . . . 72.2 111.15 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 1.2 t90 -123.28 121.12 35.07 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.252 -0.431 . . . . 75.2 110.872 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' CYS . . . . . 0.568 ' SG ' HG13 ' A' ' 111' ' ' VAL . 60.8 m -132.21 131.77 42.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.236 -0.438 . . . . 63.11 110.877 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 2.7 m120 49.3 50.24 18.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.189 -0.459 . . . . 63.43 110.92 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 49.04 45.08 33.12 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.795 -0.717 . . . . 71.33 112.447 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -147.96 116.96 6.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.828 0.347 . . . . 74.4 110.921 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 13.2 mttt -53.17 102.3 0.05 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.295 -0.411 . . . . 71.33 110.922 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 23.4 mmm -64.52 166.5 8.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 75.25 110.882 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.17 106.0 11.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.994 0.426 . . . . 72.34 110.836 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.603 ' CB ' HG22 ' A' ' 140' ' ' THR . 16.0 p -97.72 175.29 6.23 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.099 -0.501 . . . . 73.22 111.117 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.618 ' HB3' ' HB2' ' A' ' 141' ' ' HIS . . . -122.48 90.13 3.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.227 -0.442 . . . . 73.21 111.074 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -50.85 117.19 5.09 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.726 -0.749 . . . . 72.51 112.482 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 . . . . . 0 C--N 1.33 -0.252 0 CA-C-O 120.952 0.406 . . . . 74.43 110.823 -179.864 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 N-CA-C 112.446 -0.262 . . . . 35.01 112.446 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -134.19 130.78 37.73 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.734 0.302 . . . . 72.14 111.184 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -98.08 96.13 7.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.296 -0.411 . . . . 63.53 110.914 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.603 HG22 ' CB ' ' A' ' 129' ' ' THR . 0.0 OUTLIER -79.14 109.4 13.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 71.22 111.202 -179.973 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 141' ' ' HIS . . . . . 0.618 ' HB2' ' HB3' ' A' ' 130' ' ' ALA . 38.0 m170 -100.66 112.69 25.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.306 -0.406 . . . . 63.41 110.832 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.436 ' CD2' HG22 ' A' ' 129' ' ' THR . 6.5 p90 -125.84 114.43 18.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 74.42 110.852 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 98.4 p -78.28 151.57 32.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.081 -0.508 . . . . 53.52 110.842 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 46.9 t -146.81 108.67 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.086 -0.506 . . . . 54.23 111.147 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 52.92 -109.98 1.14 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.759 -0.734 . . . . 74.22 112.488 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -116.6 26.4 9.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.881 0.372 . . . . 71.44 110.916 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 23.9 m-70 -123.49 164.2 19.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 64.43 110.853 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -126.06 123.17 37.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 52.3 110.809 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' CYS . . . . . 0.594 ' HB3' HG22 ' A' ' 169' ' ' VAL . 0.9 OUTLIER -142.67 150.66 40.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.226 -0.443 . . . . 52.14 110.878 -179.93 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 17.6 p90 -150.87 149.61 29.89 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.181 -0.463 . . . . 73.23 110.979 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.609 HD13 HD22 ' A' ' 113' ' ' LEU . 7.6 mt -99.65 114.27 37.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.176 -0.465 . . . . 72.45 111.126 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.633 ' HD3' HD12 ' A' ' 168' ' ' ILE . 0.1 OUTLIER -80.24 103.09 9.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.225 -0.443 . . . . 73.24 110.871 179.834 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -100.13 146.65 26.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.195 -0.457 . . . . 61.11 111.1 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 66.2 t -149.21 122.94 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.199 -0.455 . . . . 61.3 111.134 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.2 p -92.26 144.56 25.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.186 -0.461 . . . . 71.1 110.859 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.25 141.82 30.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.487 . . . . 63.13 110.851 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 129.71 -168.84 21.02 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.696 -0.764 . . . . 63.52 112.507 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 8.4 mtmt -56.39 -26.75 54.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.794 0.331 . . . . 71.54 110.93 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -176.97 -40.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 70.24 110.818 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 34.9 mttt -155.87 31.8 0.35 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 73.2 110.905 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -55.93 -60.57 3.28 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.179 -0.464 . . . . 74.13 110.92 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -143.6 142.24 11.09 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.773 -0.727 . . . . 74.42 112.5 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 47.8 mt -126.16 147.15 31.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.756 0.312 . . . . 63.03 111.087 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 38.3 mt -128.29 137.14 58.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.205 -0.452 . . . . 65.23 111.14 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -120.72 134.39 55.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 63.23 110.876 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.48 117.17 23.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.449 . . . . 52.53 111.183 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.54 HD23 ' CB ' ' A' ' 100' ' ' TRP . 14.0 tp -71.3 132.56 45.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 70.42 110.953 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.633 HD12 ' HD3' ' A' ' 152' ' ' LYS . 11.0 mt -135.92 116.53 18.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.263 -0.426 . . . . 63.2 111.126 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.594 HG22 ' HB3' ' A' ' 149' ' ' CYS . 17.0 t -119.08 127.99 75.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 63.41 111.171 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 2.2 t0 63.89 35.56 10.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 74.3 110.842 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 1.8 m120 63.33 43.09 6.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 55.34 110.887 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 58.3 mtt180 -142.97 128.72 19.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.112 -0.495 . . . . 64.34 110.867 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -62.44 146.5 51.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.457 . . . . 71.44 110.906 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -121.28 130.65 24.72 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.578 0.704 . . . . 62.32 111.121 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.67 143.92 52.84 Favored 'Trans proline' 0 N--CA 1.465 -0.157 0 C-N-CA 122.737 2.292 . . . . 74.33 112.364 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.268 -0.424 . . . . 73.35 110.835 -179.971 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.499 ' O ' HG23 ' A' ' 97' ' ' THR . 1.1 t . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.841 0.353 . . . . 74.42 111.158 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.499 HG23 ' O ' ' A' ' 96' ' ' THR . 1.0 OUTLIER -159.62 133.08 7.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 72.53 111.119 -179.981 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.3 m -105.66 150.43 25.46 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.197 -0.456 . . . . 52.01 110.776 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.618 HG23 HG22 ' A' ' 112' ' ' VAL . 2.2 m -141.79 154.7 45.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.053 -0.521 . . . . 71.34 111.12 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' TRP . . . . . 0.494 ' CB ' HD23 ' A' ' 167' ' ' LEU . 12.1 m-90 -151.52 128.61 11.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.437 . . . . 65.13 110.957 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 19.5 t -108.1 114.9 47.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.237 -0.438 . . . . 74.44 111.21 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.735 HD11 HD12 ' A' ' 104' ' ' LEU . 0.5 OUTLIER -140.19 146.06 38.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 75.24 110.887 179.992 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.9 mtm180 -73.37 92.54 1.84 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.137 -0.483 . . . . 74.34 110.872 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.735 HD12 HD11 ' A' ' 102' ' ' LEU . 0.4 OUTLIER -124.89 153.14 43.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.096 -0.502 . . . . 73.22 110.867 -179.996 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 64.62 15.14 9.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.475 . . . . 75.2 110.891 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 88.1 1.01 82.49 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.722 -0.752 . . . . 71.21 112.502 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -139.79 172.95 12.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.844 0.354 . . . . 74.14 110.866 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.42 87.01 0.44 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.165 -0.47 . . . . 54.01 110.886 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.56 HD13 ' HB3' ' A' ' 104' ' ' LEU . 0.7 OUTLIER -69.05 125.29 26.21 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.225 -0.443 . . . . 74.3 110.855 -179.87 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 17.3 ttm180 -103.99 109.79 21.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 74.54 110.841 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.478 HG21 ' CD2' ' A' ' 167' ' ' LEU . 1.4 t -95.54 136.37 26.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.216 -0.447 . . . . 73.03 111.155 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.618 HG22 HG23 ' A' ' 99' ' ' THR . 93.2 t -136.03 122.65 32.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.204 -0.453 . . . . 63.24 111.142 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.579 HD11 ' HA ' ' A' ' 118' ' ' MET . 2.4 tp -110.31 108.6 18.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.117 -0.492 . . . . 63.14 110.966 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.437 ' N ' HD12 ' A' ' 113' ' ' LEU . 0.1 OUTLIER -85.08 136.73 33.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 74.3 110.913 179.91 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.449 ' HB2' HG23 ' A' ' 96' ' ' THR . 0.0 OUTLIER -73.85 -16.42 61.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.138 -0.483 . . . . 72.44 110.892 179.936 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -51.46 -54.57 25.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.277 -0.419 . . . . 63.25 110.798 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.55 17.06 2.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 53.1 111.174 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' MET . . . . . 0.579 ' HA ' HD11 ' A' ' 113' ' ' LEU . 24.7 mtp 59.18 21.76 9.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 75.43 110.862 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.57 142.5 51.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.283 -0.417 . . . . 63.23 110.89 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 65.3 t -105.02 118.45 52.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 74.23 111.112 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 2.8 t90 -101.16 131.84 46.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.459 . . . . 65.52 110.908 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -123.97 103.76 8.51 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.22 -0.445 . . . . 71.25 110.922 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 39.51 71.59 0.17 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.462 . . . . 63.34 110.915 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 51.0 41.05 44.61 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.773 -0.727 . . . . 73.31 112.523 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -150.45 112.66 4.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.878 0.371 . . . . 73.33 110.866 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 6.4 mtmm -53.63 162.05 0.93 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.217 -0.447 . . . . 61.04 110.888 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 27.7 mmm -127.89 162.99 25.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 75.05 110.91 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -119.28 106.35 12.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.295 -0.411 . . . . 75.23 110.901 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.613 ' CB ' HG22 ' A' ' 140' ' ' THR . 18.0 p -95.46 -176.71 3.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.142 -0.481 . . . . 73.35 111.156 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -89.04 -34.57 16.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.44 . . . . 42.22 111.095 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 60.89 72.99 0.55 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.741 -0.742 . . . . 74.31 112.53 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 . . . . . 0 C--N 1.329 -0.3 0 CA-C-O 120.913 0.387 . . . . 63.53 110.895 -179.883 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.378 0 N-CA-C 112.449 -0.261 . . . . 31.44 112.449 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.628 ' O ' ' HB3' ' A' ' 153' ' ' ALA . 0.1 OUTLIER -135.37 130.81 35.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.748 0.308 . . . . 64.33 111.188 -179.862 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -116.14 96.35 5.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 61.32 110.885 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.613 HG22 ' CB ' ' A' ' 129' ' ' THR . 0.0 OUTLIER -83.77 110.23 18.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 70.14 111.11 -179.903 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 67.6 m-70 -109.25 107.1 17.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 64.32 110.891 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.529 ' HD2' HG22 ' A' ' 129' ' ' THR . 1.8 p90 -119.64 -176.15 3.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.23 -0.441 . . . . 64.2 110.925 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 25.3 p -140.33 165.25 27.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 61.42 110.835 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.575 HG11 HD22 ' A' ' 104' ' ' LEU . 58.3 t -148.85 98.18 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.092 -0.504 . . . . 53.15 111.08 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 61.19 -108.25 1.83 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.77 -0.728 . . . . 75.3 112.529 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -106.14 -26.9 11.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.896 0.379 . . . . 42.42 110.914 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 52.3 m-70 -64.37 -170.19 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.124 -0.489 . . . . 74.21 110.859 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -153.68 116.38 4.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 72.2 110.861 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' CYS . . . . . 0.591 ' HB3' HG22 ' A' ' 169' ' ' VAL . 0.8 OUTLIER -142.66 163.5 32.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.261 -0.427 . . . . 51.33 110.886 -179.867 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 28.5 p90 -161.17 152.87 19.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.191 -0.459 . . . . 73.12 110.877 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.52 HD13 HD22 ' A' ' 113' ' ' LEU . 21.0 mt -99.36 121.44 49.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.133 -0.485 . . . . 73.01 111.168 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.435 ' HD2' HD12 ' A' ' 168' ' ' ILE . 2.1 tttm -89.95 102.56 15.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 72.45 110.909 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' ALA . . . . . 0.628 ' HB3' ' O ' ' A' ' 138' ' ' THR . . . -99.65 147.24 25.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.439 . . . . 72.21 111.064 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.8 t -145.46 131.29 13.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.184 -0.462 . . . . 71.43 111.045 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.1 p -102.2 145.48 29.35 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.162 -0.472 . . . . 52.05 110.83 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 2.0 p -150.54 165.62 32.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.08 -0.509 . . . . 71.04 110.897 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 112.56 -49.87 0.81 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.713 -0.756 . . . . 71.25 112.493 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -178.54 -64.81 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.806 0.336 . . . . 63.41 110.892 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.31 -42.93 0.29 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 75.42 110.887 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.77 26.82 0.64 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 63.41 110.833 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -62.52 -71.91 0.15 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.282 -0.417 . . . . 71.53 110.875 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -127.46 145.08 15.62 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.794 -0.717 . . . . 64.41 112.568 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 62.9 mt -138.59 139.97 40.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.823 0.344 . . . . 65.44 111.088 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 68.0 mt -127.37 140.36 49.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.122 -0.49 . . . . 73.35 111.147 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 16.0 m-70 -113.21 142.21 46.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 61.43 110.831 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.87 106.57 7.36 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.197 -0.456 . . . . 75.15 111.123 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.554 HD21 HD22 ' A' ' 102' ' ' LEU . 17.1 tp -67.35 136.39 54.73 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.251 -0.431 . . . . 73.52 110.951 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.534 ' H ' HD12 ' A' ' 167' ' ' LEU . 9.3 mt -138.31 121.16 19.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 75.35 111.158 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.66 HG21 HD13 ' A' ' 102' ' ' LEU . 18.0 t -121.93 124.98 72.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 64.34 111.12 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.5 t0 64.03 36.5 9.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 74.35 110.822 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 63.4 43.05 6.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.436 . . . . 51.54 110.873 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 3.9 mtm180 -140.51 128.98 22.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 74.31 110.92 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.69 146.52 52.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.434 . . . . 65.24 110.843 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -122.95 130.92 24.42 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.63 0.729 . . . . 75.55 111.189 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 140.4 42.68 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.738 2.292 . . . . 64.22 112.351 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 70.53 110.866 -179.967 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.509 ' O ' HG23 ' A' ' 97' ' ' THR . 2.1 p . . . . . 0 N--CA 1.457 -0.115 0 CA-C-O 120.886 0.374 . . . . 60.14 111.155 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.509 HG23 ' O ' ' A' ' 96' ' ' THR . 1.1 p -159.51 128.29 5.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.224 -0.444 . . . . 72.41 111.17 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -105.75 150.94 25.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.03 0.443 . . . . 54.25 110.838 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 12.0 m -143.05 153.07 42.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.095 -0.502 . . . . 62.52 111.214 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' TRP . . . . . 0.498 ' CB ' HD23 ' A' ' 167' ' ' LEU . 11.0 m-90 -151.47 127.4 10.34 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.296 -0.411 . . . . 64.24 110.907 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.5 t -106.99 114.99 47.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.455 . . . . 62.14 111.148 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.944 HD11 HD12 ' A' ' 104' ' ' LEU . 0.5 OUTLIER -141.17 147.36 38.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.117 -0.492 . . . . 74.3 110.962 179.973 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 2.7 mtt180 -72.82 91.81 1.53 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 74.23 110.798 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.944 HD12 HD11 ' A' ' 102' ' ' LEU . 0.3 OUTLIER -122.1 151.99 40.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 65.03 110.892 179.988 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 64.84 14.75 9.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 75.43 110.946 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.15 0.39 80.57 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.775 -0.726 . . . . 63.51 112.506 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -139.72 172.86 12.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.797 0.332 . . . . 73.43 110.954 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -68.85 89.25 0.4 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.241 -0.436 . . . . 71.43 110.901 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.587 HD13 ' HB3' ' A' ' 104' ' ' LEU . 0.4 OUTLIER -75.43 127.92 34.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 64.43 110.9 -179.893 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 58.6 ttt180 -105.5 110.21 22.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.225 -0.443 . . . . 74.11 110.788 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.41 HG21 ' CD2' ' A' ' 167' ' ' LEU . 0.9 OUTLIER -95.5 139.75 18.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.103 -0.499 . . . . 52.24 111.056 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 93.3 t -136.23 130.02 47.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.133 -0.485 . . . . 74.33 111.134 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.594 HD11 ' HA ' ' A' ' 118' ' ' MET . 2.3 tp -118.07 104.46 10.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.102 -0.499 . . . . 74.32 110.846 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.477 ' HG3' HG22 ' A' ' 97' ' ' THR . 0.1 OUTLIER -81.6 124.67 29.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 63.03 110.854 179.932 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.59 -16.02 59.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 71.44 110.927 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -51.63 -55.98 16.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.203 -0.453 . . . . 72.15 110.884 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.3 m -132.76 17.02 4.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.264 -0.425 . . . . 74.31 111.147 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' MET . . . . . 0.594 ' HA ' HD11 ' A' ' 113' ' ' LEU . 82.5 mtp 54.68 31.53 15.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 63.32 110.85 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -86.46 147.18 26.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.444 . . . . 74.32 110.893 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.537 HG23 HG21 ' A' ' 129' ' ' THR . 25.2 t -104.84 137.6 33.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.247 -0.433 . . . . 63.41 111.14 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 1.2 t90 -125.51 129.7 50.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.133 -0.485 . . . . 55.44 110.881 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 16.8 p -138.48 133.87 33.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.221 -0.445 . . . . 62.41 110.912 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 2.8 m120 46.05 49.14 12.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 52.22 110.859 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 50.79 44.1 48.27 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.657 -0.782 . . . . 73.32 112.533 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -147.89 119.0 7.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.849 0.357 . . . . 72.11 110.952 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 1.5 mtpt -53.1 136.39 35.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 73.24 110.877 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' MET . . . . . 0.412 ' HB2' ' HB ' ' A' ' 120' ' ' VAL . 67.7 mtp -102.78 165.19 11.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 64.21 110.87 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -113.31 107.1 15.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.215 -0.448 . . . . 74.43 110.878 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.709 ' HB ' HG22 ' A' ' 140' ' ' THR . 16.6 p -99.98 -175.15 2.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.49 . . . . 64.14 111.099 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -115.06 -29.49 6.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 64.3 111.109 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 52.41 32.4 37.69 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.724 -0.75 . . . . 51.35 112.482 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 . . . . . 0 C--N 1.329 -0.312 0 CA-C-O 120.831 0.348 . . . . 75.2 110.853 -179.854 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 N-CA-C 112.483 -0.247 . . . . 74.22 112.483 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.67 ' O ' ' HB3' ' A' ' 153' ' ' ALA . 0.1 OUTLIER -134.85 130.84 36.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.71 0.291 . . . . 62.4 111.144 -179.826 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -109.49 96.35 6.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 73.43 110.818 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.709 HG22 ' HB ' ' A' ' 129' ' ' THR . 0.0 OUTLIER -79.29 110.24 14.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.449 . . . . 72.41 111.116 -179.915 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -105.68 113.03 26.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.272 -0.422 . . . . 73.11 110.907 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.544 ' HD2' HG22 ' A' ' 129' ' ' THR . 3.2 p90 -133.92 178.99 6.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.177 -0.465 . . . . 74.21 110.883 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 90.7 p -140.39 162.62 34.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 72.41 110.874 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.598 HG11 HD22 ' A' ' 104' ' ' LEU . 39.7 t -146.55 99.48 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 72.02 111.146 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 68.41 -108.05 2.31 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.704 -0.76 . . . . 73.31 112.482 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -111.66 -26.35 9.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.781 0.324 . . . . 75.34 110.913 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 24.7 m-70 -65.9 -169.97 0.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.484 . . . . 75.13 110.794 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -149.79 119.51 7.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.135 -0.484 . . . . 61.34 110.885 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' CYS . . . . . 0.599 ' HB3' HG22 ' A' ' 169' ' ' VAL . 0.8 OUTLIER -142.41 161.53 37.8 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.252 -0.431 . . . . 71.35 110.9 -179.878 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 22.2 p90 -156.89 150.36 24.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.251 -0.431 . . . . 64.43 110.904 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.577 HD13 HD22 ' A' ' 113' ' ' LEU . 10.3 mt -97.61 112.83 30.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.089 -0.505 . . . . 73.31 111.156 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.611 ' HD2' HD12 ' A' ' 168' ' ' ILE . 0.2 OUTLIER -80.92 102.68 10.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.126 -0.488 . . . . 74.32 110.872 179.921 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 153' ' ' ALA . . . . . 0.67 ' HB3' ' O ' ' A' ' 138' ' ' THR . . . -98.05 148.13 23.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.259 -0.428 . . . . 64.22 111.154 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.0 t -144.5 127.31 11.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.262 -0.427 . . . . 63.43 111.21 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.1 p -97.13 133.71 41.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 64.35 110.845 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -127.9 137.66 52.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.083 -0.508 . . . . 51.23 110.8 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 134.55 -174.17 21.13 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.738 -0.744 . . . . 60.12 112.489 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 5.7 mttm -86.66 -48.88 7.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.79 0.329 . . . . 73.25 110.914 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 44.4 mtm180 -134.77 69.18 1.45 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 71.31 110.84 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 26.1 mttp 58.32 60.36 2.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.226 -0.443 . . . . 73.52 110.889 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -77.81 -65.22 1.0 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 72.11 110.859 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -136.8 145.23 17.05 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.758 -0.734 . . . . 72.21 112.511 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 69.4 mt -126.5 143.45 39.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.807 0.337 . . . . 61.04 111.145 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 60.1 mt -128.44 132.93 67.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.143 -0.48 . . . . 75.22 111.131 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 20.0 m-70 -106.91 141.11 38.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 52.22 110.873 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.6 106.36 7.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.225 -0.443 . . . . 74.41 111.124 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.537 HD21 HD22 ' A' ' 102' ' ' LEU . 17.1 tp -64.91 135.87 56.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 72.33 110.891 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.611 HD12 ' HD2' ' A' ' 152' ' ' LYS . 10.0 mt -138.1 117.38 14.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.061 -0.518 . . . . 64.33 111.193 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.599 HG22 ' HB3' ' A' ' 149' ' ' CYS . 20.2 t -119.45 127.02 75.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 72.52 111.149 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 2.9 t0 63.8 35.29 11.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.144 -0.48 . . . . 73.12 110.897 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 63.43 43.11 6.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.235 -0.439 . . . . 52.52 110.872 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 42.4 mtt180 -140.85 129.7 23.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.484 . . . . 73.2 110.831 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -62.77 146.47 52.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 73.3 110.848 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -123.04 130.86 24.43 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.581 0.705 . . . . 52.41 111.132 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.76 139.03 39.21 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.643 2.229 . . . . 71.03 112.369 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.199 -0.455 . . . . 73.43 110.899 -179.97 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.502 ' O ' HG23 ' A' ' 97' ' ' THR . 13.4 t . . . . . 0 C--O 1.233 0.204 0 CA-C-O 120.811 0.338 . . . . 74.52 111.13 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.502 HG23 ' O ' ' A' ' 96' ' ' THR . 1.1 p -159.35 128.1 5.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.27 -0.423 . . . . 72.34 111.181 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.4 m -105.92 149.61 26.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.455 . . . . 53.54 110.847 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 24.7 m -140.19 138.81 35.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.15 -0.477 . . . . 54.44 111.153 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 18.7 m-90 -131.68 133.51 44.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.242 -0.436 . . . . 71.04 110.951 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.2 t -112.88 114.78 47.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.451 . . . . 72.24 111.157 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.78 HD11 HD12 ' A' ' 104' ' ' LEU . 0.5 OUTLIER -141.2 146.48 36.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 73.24 110.9 -179.998 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.9 91.89 2.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 74.11 110.874 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.78 HD12 HD11 ' A' ' 102' ' ' LEU . 0.4 OUTLIER -123.09 152.97 40.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 70.42 110.915 -179.959 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 64.87 14.86 9.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.165 -0.47 . . . . 53.11 110.829 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 88.94 0.4 81.2 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.745 -0.74 . . . . 53.35 112.498 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -139.83 173.0 11.98 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.788 0.327 . . . . 75.24 110.89 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -68.98 87.45 0.37 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.138 -0.483 . . . . 64.13 110.886 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.624 HD13 ' HB3' ' A' ' 104' ' ' LEU . 0.5 OUTLIER -72.3 127.51 32.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 74.01 110.909 -179.896 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -107.6 117.35 33.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 75.44 110.916 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.429 HG21 ' CD2' ' A' ' 167' ' ' LEU . 0.1 OUTLIER -107.25 146.02 13.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 70.41 111.106 -179.982 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 22.0 t -135.92 152.69 31.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 62.14 111.182 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.504 HD22 HD13 ' A' ' 151' ' ' ILE . 5.1 tp -131.38 99.83 4.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 65.52 110.882 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.83 134.37 43.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 52.12 110.896 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 3.0 mmmt -73.78 -17.92 61.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 70.44 110.861 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -51.35 -55.1 20.28 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.216 -0.447 . . . . 75.15 110.83 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.86 16.72 4.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 74.45 111.156 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' MET . . . . . 0.431 ' HA ' HD11 ' A' ' 113' ' ' LEU . 3.8 ttm 54.05 27.24 7.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.208 -0.451 . . . . 54.14 110.886 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.83 160.51 22.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.184 -0.462 . . . . 73.13 110.835 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.714 HG22 HD12 ' A' ' 151' ' ' ILE . 55.5 t -104.64 143.58 15.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 74.4 111.125 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 2.3 t90 -123.75 120.89 34.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.185 -0.461 . . . . 74.52 110.924 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' CYS . . . . . 0.482 ' SG ' HD21 ' A' ' 109' ' ' LEU . 19.6 t -136.55 132.55 35.35 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.276 -0.42 . . . . 72.24 110.905 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 2.9 m120 51.92 48.33 22.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.157 -0.474 . . . . 41.34 110.884 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 48.62 47.21 30.1 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.733 -0.746 . . . . 71.31 112.474 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.6 118.76 5.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.838 0.351 . . . . 75.33 110.932 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.24 101.95 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.212 -0.449 . . . . 55.24 110.88 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' MET . . . . . 0.59 ' HE1' HG22 ' A' ' 144' ' ' VAL . 38.5 mmm -55.68 176.65 0.06 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 73.34 110.843 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -119.16 106.51 12.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 72.34 110.914 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.576 ' HB ' HG22 ' A' ' 140' ' ' THR . 59.4 p -99.14 -175.3 2.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 52.15 111.151 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.512 ' HB2' ' HB2' ' A' ' 141' ' ' HIS . . . -106.55 -44.64 4.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 72.22 111.126 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 77.04 53.07 5.42 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.825 -0.702 . . . . 73.31 112.456 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 . . . . . 0 C--N 1.329 -0.286 0 CA-C-O 120.86 0.362 . . . . 65.1 110.846 -179.875 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.255 0 N-CA-C 112.499 -0.24 . . . . 62.44 112.499 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.04 130.79 36.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.688 0.28 . . . . 72.23 111.218 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -98.89 100.23 11.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.271 -0.422 . . . . 73.35 110.955 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.576 HG22 ' HB ' ' A' ' 129' ' ' THR . 0.0 OUTLIER -82.98 110.24 17.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.46 . . . . 74.01 111.193 -179.93 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 141' ' ' HIS . . . . . 0.512 ' HB2' ' HB2' ' A' ' 130' ' ' ALA . 47.0 m80 -100.77 105.78 17.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.257 -0.429 . . . . 75.31 110.814 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.608 ' CE2' HG21 ' A' ' 120' ' ' VAL . 21.9 p90 -139.29 156.54 46.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.245 -0.434 . . . . 75.1 110.849 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -111.64 123.73 50.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.086 -0.506 . . . . 74.42 110.917 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.59 HG22 ' HE1' ' A' ' 127' ' ' MET . 27.2 t -106.15 125.89 61.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.114 -0.494 . . . . 52.41 111.082 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 52.36 41.3 54.84 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.727 -0.749 . . . . 65.32 112.478 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 64.33 26.02 13.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.799 0.333 . . . . 74.51 110.837 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 18.4 m170 -113.12 -169.27 1.45 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 73.55 110.832 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -116.48 110.63 18.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 62.33 110.898 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' CYS . . . . . 0.516 ' SG ' HG13 ' A' ' 169' ' ' VAL . 12.1 m -138.38 173.47 11.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 74.01 110.923 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 32.0 p90 -174.97 143.44 0.71 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.199 -0.455 . . . . 75.21 110.953 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.714 HD12 HG22 ' A' ' 120' ' ' VAL . 20.6 mt -97.73 113.63 32.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.076 -0.511 . . . . 61.11 111.094 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 27.9 tttt -79.84 102.74 9.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 72.34 110.914 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -97.19 136.02 38.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 64.41 111.075 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.3 t -133.91 121.14 38.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.23 -0.441 . . . . 74.05 111.185 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.3 p -94.53 143.1 26.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.145 -0.48 . . . . 74.25 110.833 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 2.3 t -136.52 134.14 37.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.091 -0.504 . . . . 73.55 110.89 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 136.12 171.92 12.46 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.728 -0.749 . . . . 71.13 112.493 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 6.5 mmtt -59.06 -28.64 66.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.764 0.316 . . . . 65.53 110.884 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 2.1 mtt180 -148.82 -63.43 0.24 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 72.41 110.872 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -152.75 44.39 0.67 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 75.51 110.84 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -57.68 -58.55 7.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.313 -0.403 . . . . 65.44 110.866 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -145.1 162.27 28.14 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.725 -0.75 . . . . 64.13 112.5 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 55.4 mt -144.85 145.45 21.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.786 0.327 . . . . 73.52 111.144 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 75.6 mt -133.82 123.68 45.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.466 . . . . 75.05 111.186 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 5.6 m80 -104.38 137.19 42.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 71.25 110.932 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.91 108.8 11.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 53.23 111.2 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.492 HD12 ' N ' ' A' ' 168' ' ' ILE . 14.8 tp -66.33 136.36 55.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.277 -0.419 . . . . 62.12 110.904 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.492 ' N ' HD12 ' A' ' 167' ' ' LEU . 12.4 mt -133.62 129.41 55.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.146 -0.479 . . . . 72.22 111.17 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.516 HG13 ' SG ' ' A' ' 149' ' ' CYS . 95.6 t -127.17 118.17 49.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.446 . . . . 74.34 111.149 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 63.61 41.0 7.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.134 -0.485 . . . . 72.33 110.853 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 63.34 43.01 6.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 73.43 110.812 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 17.7 mtm180 -138.98 121.97 16.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.216 -0.447 . . . . 74.44 110.922 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -62.75 146.48 52.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 52.4 110.913 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.582 HD12 HD22 ' A' ' 102' ' ' LEU . 0.9 OUTLIER -123.99 131.55 24.24 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.619 0.723 . . . . 63.24 111.117 179.996 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 133.44 25.49 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.625 2.217 . . . . 74.43 112.34 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.246 -0.433 . . . . 72.5 110.924 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.494 ' O ' HG23 ' A' ' 97' ' ' THR . 71.8 p . . . . . 0 N--CA 1.458 -0.069 0 CA-C-O 120.864 0.364 . . . . 64.51 111.209 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.661 HG22 ' HA ' ' A' ' 114' ' ' GLU . 1.0 OUTLIER -159.53 127.77 4.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.187 -0.46 . . . . 71.12 111.151 -179.968 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 14.5 m -106.42 113.16 26.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.263 -0.426 . . . . 72.11 110.842 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.982 HG22 HG22 ' A' ' 112' ' ' VAL . 17.2 p -110.18 159.59 17.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.121 -0.491 . . . . 73.23 111.064 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 14.6 m-90 -149.57 155.97 41.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.223 -0.444 . . . . 72.45 110.911 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 18.9 t -131.52 114.95 26.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 73.33 111.158 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.887 HD11 HD12 ' A' ' 104' ' ' LEU . 0.5 OUTLIER -141.22 147.63 38.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 73.32 110.884 179.985 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.65 94.29 3.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.155 -0.475 . . . . 71.14 110.834 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.887 HD12 HD11 ' A' ' 102' ' ' LEU . 0.3 OUTLIER -123.68 154.05 39.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 71.3 110.908 179.985 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.1 t70 64.91 14.87 9.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.19 -0.459 . . . . 74.52 110.833 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 88.79 0.48 81.43 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.714 -0.755 . . . . 62.11 112.489 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -139.79 172.88 12.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.88 0.372 . . . . 60.31 110.855 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -68.43 89.4 0.35 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 71.31 110.907 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.621 HD13 ' HB3' ' A' ' 104' ' ' LEU . 0.5 OUTLIER -75.72 123.99 26.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.437 . . . . 74.24 110.96 -179.999 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -104.09 115.04 29.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 71.52 110.87 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.465 HG21 HD21 ' A' ' 167' ' ' LEU . 0.2 OUTLIER -102.98 138.89 25.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.183 -0.462 . . . . 73.22 111.184 179.906 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.982 HG22 HG22 ' A' ' 99' ' ' THR . 96.3 t -135.77 126.99 44.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.434 . . . . 72.41 111.169 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.629 HD22 HD13 ' A' ' 151' ' ' ILE . 6.3 tp -110.36 100.4 9.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.444 . . . . 72.23 110.959 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.661 ' HA ' HG22 ' A' ' 97' ' ' THR . 0.0 OUTLIER -77.4 136.15 38.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.447 . . . . 62.55 110.921 179.962 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 3.6 mtmt -73.21 -17.48 61.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 62.4 110.834 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -51.39 -54.91 21.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.222 -0.445 . . . . 74.14 110.871 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 14.9 p -132.55 16.82 4.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.176 -0.465 . . . . 62.11 111.12 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 81.2 mtp 51.59 31.1 7.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 74.21 110.895 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -86.57 153.27 21.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 71.3 110.875 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.6 HG22 HD12 ' A' ' 151' ' ' ILE . 95.6 t -104.92 123.09 58.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.233 -0.439 . . . . 64.11 111.18 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -104.94 131.97 51.77 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.232 -0.44 . . . . 64.43 110.91 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' CYS . . . . . 0.4 ' SG ' HD21 ' A' ' 109' ' ' LEU . 24.4 t -126.99 103.19 7.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 73.34 110.931 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 12.0 m-20 45.35 70.28 0.37 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 53.33 110.885 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 48.72 39.01 23.34 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.78 -0.724 . . . . 61.24 112.504 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.25 107.42 4.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.893 0.377 . . . . 72.04 110.88 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.28 143.27 18.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 73.52 110.89 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' MET . . . . . 0.457 ' CE ' HG22 ' A' ' 144' ' ' VAL . 22.7 mmm -111.24 163.99 13.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 52.4 110.866 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -117.79 107.8 14.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 75.14 110.876 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.694 ' HB ' HG22 ' A' ' 140' ' ' THR . 19.2 p -95.26 -179.36 4.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.144 -0.48 . . . . 71.1 111.177 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.459 ' HB2' ' HB2' ' A' ' 141' ' ' HIS . . . -92.41 -31.26 15.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 71.25 111.114 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 58.82 54.69 35.88 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.791 -0.718 . . . . 72.0 112.458 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.309 0 CA-C-O 120.915 0.388 . . . . 74.25 110.957 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 N-CA-C 112.498 -0.241 . . . . 33.01 112.498 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.21 130.8 35.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.686 0.279 . . . . 71.12 111.21 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -109.82 97.44 6.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.302 -0.408 . . . . 63.12 110.865 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.694 HG22 ' HB ' ' A' ' 129' ' ' THR . 0.0 OUTLIER -85.51 110.44 19.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 72.22 111.142 -179.943 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 141' ' ' HIS . . . . . 0.459 ' HB2' ' HB2' ' A' ' 130' ' ' ALA . 67.5 m-70 -106.15 105.6 15.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 73.52 110.837 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.408 ' HB3' HG22 ' A' ' 129' ' ' THR . 18.8 p90 -122.97 131.07 53.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 70.51 110.808 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 27.8 p -83.07 149.79 26.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 74.0 110.857 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.457 HG22 ' CE ' ' A' ' 127' ' ' MET . 21.8 t -140.65 99.65 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.051 -0.522 . . . . 52.52 111.066 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 54.58 -115.88 5.88 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.726 -0.749 . . . . 61.5 112.479 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -106.04 25.41 10.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.81 0.338 . . . . 72.22 110.884 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 36.1 m170 -119.2 -175.48 2.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 72.44 110.824 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -145.33 84.42 1.7 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 61.0 110.872 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' CYS . . . . . 0.448 ' SG ' HG13 ' A' ' 169' ' ' VAL . 6.8 m -99.53 165.08 11.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.231 -0.441 . . . . 74.15 110.897 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 19.9 p90 -167.48 145.04 4.56 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.175 -0.466 . . . . 75.02 110.89 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.629 HD13 HD22 ' A' ' 113' ' ' LEU . 32.9 mt -98.63 111.26 27.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.134 -0.485 . . . . 72.12 111.155 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.33 103.14 12.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.122 -0.49 . . . . 63.54 110.902 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -94.27 146.08 24.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 71.32 111.157 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.5 t -138.41 124.79 25.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.289 -0.414 . . . . 74.3 111.126 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -99.86 146.87 26.14 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.184 -0.462 . . . . 73.53 110.878 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 1.4 p -149.29 150.6 32.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 64.01 110.826 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 109.1 64.56 0.55 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.778 -0.725 . . . . 72.42 112.507 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.19 -75.44 0.07 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.794 0.33 . . . . 73.21 110.876 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -138.72 -58.97 0.62 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 65.44 110.962 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 2.9 tttt -135.39 103.07 5.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.116 -0.493 . . . . 72.54 110.98 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -144.87 -62.8 0.36 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 61.11 110.852 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -135.16 127.38 4.35 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.765 -0.731 . . . . 64.14 112.459 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 69.1 mt -122.99 138.57 52.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.763 0.316 . . . . 62.41 111.185 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 54.9 mt -127.53 128.92 70.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.178 -0.464 . . . . 72.25 111.088 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 15.3 m80 -100.22 137.98 37.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 73.44 110.914 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.88 109.3 11.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 74.35 111.107 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.574 HD12 ' H ' ' A' ' 168' ' ' ILE . 19.1 tp -67.3 138.46 56.85 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.152 -0.477 . . . . 75.44 110.893 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.574 ' H ' HD12 ' A' ' 167' ' ' LEU . 8.6 mt -139.01 128.59 30.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 74.05 111.114 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.633 HG21 HD13 ' A' ' 102' ' ' LEU . 64.1 t -127.81 122.73 59.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.109 -0.496 . . . . 74.41 111.15 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 2.4 t0 63.77 38.24 9.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.204 -0.453 . . . . 72.21 110.867 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 2.0 t30 63.32 43.11 6.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 61.42 110.842 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.14 131.61 23.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 74.21 110.879 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -62.34 146.4 51.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.218 -0.446 . . . . 75.24 110.954 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.473 HD12 HD22 ' A' ' 102' ' ' LEU . 0.8 OUTLIER -123.72 130.52 24.43 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.646 0.736 . . . . 73.13 111.137 179.998 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 147.83 63.53 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.713 2.275 . . . . 73.43 112.324 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 116.245 -0.434 . . . . 75.42 110.91 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.511 ' O ' HG23 ' A' ' 97' ' ' THR . 2.4 m . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.837 0.351 . . . . 55.03 111.115 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.511 HG23 ' O ' ' A' ' 96' ' ' THR . 1.0 OUTLIER -159.8 128.15 4.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 53.54 111.138 -179.998 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.9 m -106.04 151.99 23.95 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.209 -0.451 . . . . 45.21 110.826 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 95.7 m -146.34 141.81 27.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.111 -0.495 . . . . 52.12 111.145 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 21.7 m-90 -132.35 158.8 41.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 75.25 110.968 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.0 t -133.26 114.82 21.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.342 -0.39 . . . . 63.51 111.144 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.952 HD11 HD12 ' A' ' 104' ' ' LEU . 0.5 OUTLIER -141.64 147.58 37.79 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.226 -0.443 . . . . 64.14 110.919 179.975 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 42.3 mtp180 -72.72 92.09 1.53 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 75.43 110.858 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.952 HD12 HD11 ' A' ' 102' ' ' LEU . 0.3 OUTLIER -121.61 151.52 40.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 72.12 110.904 -179.944 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 64.85 14.69 9.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.232 -0.44 . . . . 62.23 110.884 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.2 0.69 80.03 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.752 -0.737 . . . . 62.53 112.489 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -139.87 172.73 12.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.867 0.365 . . . . 74.42 110.942 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -68.24 89.88 0.33 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.162 -0.472 . . . . 63.34 110.865 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.596 HD13 ' HB3' ' A' ' 104' ' ' LEU . 0.6 OUTLIER -76.96 134.14 38.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 71.25 110.912 -179.981 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 25.9 ttm180 -111.11 119.51 39.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 64.45 110.877 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.447 HG21 ' CD2' ' A' ' 167' ' ' LEU . 0.1 OUTLIER -105.41 145.13 13.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.2 -0.455 . . . . 73.5 111.167 179.956 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 91.4 t -134.37 144.24 35.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.249 -0.432 . . . . 61.42 111.135 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.496 HD11 ' HA ' ' A' ' 118' ' ' MET . 3.4 tp -131.52 101.53 5.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 75.21 110.929 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.478 ' HG3' HG22 ' A' ' 97' ' ' THR . 0.0 OUTLIER -73.63 132.11 42.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.27 -0.423 . . . . 72.45 110.881 179.942 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.35 -16.58 61.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 70.52 110.93 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -52.59 -55.96 18.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 74.3 110.829 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.56 16.99 3.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 74.2 111.116 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' MET . . . . . 0.496 ' HA ' HD11 ' A' ' 113' ' ' LEU . 68.1 mtp 57.91 30.23 18.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.445 . . . . 62.35 110.884 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -77.83 143.07 38.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.455 . . . . 72.15 110.902 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.432 HG23 HG21 ' A' ' 129' ' ' THR . 17.2 t -104.62 128.06 58.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 74.51 111.209 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 3.2 t90 -119.97 114.39 21.96 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.23 -0.441 . . . . 73.11 110.894 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' CYS . . . . . 0.538 ' SG ' HD11 ' A' ' 109' ' ' LEU . 3.0 t -100.97 103.09 14.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.25 -0.432 . . . . 73.35 110.892 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 67.91 -76.16 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 60.31 110.926 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -159.08 45.77 0.44 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.739 -0.744 . . . . 60.43 112.462 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.86 114.2 4.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.893 0.378 . . . . 74.22 110.868 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.3 101.94 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.459 . . . . 72.0 110.879 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' MET . . . . . 0.443 ' HE2' ' CG ' ' A' ' 142' ' ' PHE . 64.1 mtp -60.85 157.32 15.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 61.42 110.9 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -102.9 106.65 17.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 72.41 110.868 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.803 ' HB ' HG22 ' A' ' 140' ' ' THR . 15.5 p -98.66 -176.28 3.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 45.2 111.111 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -112.89 -75.36 0.6 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.275 -0.42 . . . . 55.03 111.094 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 104.68 86.15 1.9 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.727 -0.749 . . . . 73.04 112.511 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 . . . . . 0 C--N 1.329 -0.297 0 CA-C-O 120.869 0.366 . . . . 73.34 110.914 -179.889 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 N-CA-C 112.539 -0.224 . . . . 54.01 112.539 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.32 130.87 33.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.76 0.314 . . . . 71.2 111.145 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.73 97.68 11.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 73.53 110.881 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.803 HG22 ' HB ' ' A' ' 129' ' ' THR . 0.1 OUTLIER -77.46 110.55 12.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.114 -0.494 . . . . 74.14 111.112 -179.878 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -98.91 111.63 23.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.267 -0.424 . . . . 63.02 110.869 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.764 ' CE2' HD12 ' A' ' 151' ' ' ILE . 1.4 p90 -144.8 159.55 42.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.454 . . . . 63.24 110.903 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.8 166.5 14.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 54.51 110.895 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 24.2 t -145.54 97.97 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.159 -0.473 . . . . 73.55 111.084 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 67.22 -88.98 0.16 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.738 -0.744 . . . . 61.02 112.478 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -139.5 25.9 2.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.828 0.347 . . . . 61.34 110.86 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 67.1 m-70 -115.77 -175.77 2.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 73.0 110.899 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -140.89 116.56 10.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.26 -0.427 . . . . 71.24 110.893 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' CYS . . . . . 0.708 ' CB ' HG22 ' A' ' 169' ' ' VAL . 1.9 p -142.56 158.19 43.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 70.25 110.959 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 19.9 p90 -150.84 145.34 25.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.227 -0.442 . . . . 72.43 110.926 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.764 HD12 ' CE2' ' A' ' 142' ' ' PHE . 3.2 mt -97.74 112.46 29.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.095 -0.502 . . . . 73.2 111.174 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.69 102.88 9.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 74.4 110.93 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -99.02 143.85 28.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.229 -0.441 . . . . 53.13 111.098 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 20.9 t -142.33 124.43 13.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 71.14 111.149 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.3 p -94.38 140.43 29.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.455 . . . . 73.31 110.821 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 10.4 t -134.47 135.7 42.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.068 -0.515 . . . . 62.02 110.886 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 135.78 -145.65 17.65 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.709 -0.757 . . . . 74.45 112.447 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -88.79 -36.4 16.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.819 0.342 . . . . 45.43 110.858 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 1.7 mtm-85 -152.35 -47.5 0.1 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.284 -0.416 . . . . 55.41 110.831 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 7.7 pttp -159.55 37.82 0.2 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.165 -0.471 . . . . 70.4 110.931 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -59.08 -70.6 0.15 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.236 -0.438 . . . . 74.13 110.896 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -129.58 128.23 5.66 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.76 -0.733 . . . . 74.43 112.485 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 48.6 mt -120.44 147.46 24.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.816 0.341 . . . . 64.34 111.122 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 3.0 mt -131.96 130.23 61.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 64.23 111.074 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 8.7 m80 -108.71 134.96 50.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 74.25 110.917 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.28 110.14 13.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.188 -0.46 . . . . 52.24 111.156 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.587 HD12 ' N ' ' A' ' 168' ' ' ILE . 11.8 tp -66.96 135.38 53.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.212 -0.449 . . . . 70.04 110.951 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.587 ' N ' HD12 ' A' ' 167' ' ' LEU . 10.8 mt -136.81 106.19 4.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 74.11 111.206 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.708 HG22 ' CB ' ' A' ' 149' ' ' CYS . 47.7 t -109.39 128.94 64.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 74.31 111.142 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 63.31 41.28 7.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.194 -0.457 . . . . 74.12 110.816 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 56.6 42.68 26.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.237 -0.438 . . . . 72.32 110.87 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 10.5 mtp180 -140.44 126.44 19.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 75.31 110.836 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.58 145.29 54.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 74.41 110.885 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.446 HD12 HD22 ' A' ' 102' ' ' LEU . 0.9 OUTLIER -123.61 131.29 24.28 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.663 0.744 . . . . 65.34 111.125 179.964 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 132.25 22.99 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.755 2.303 . . . . 73.5 112.336 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.245 -0.434 . . . . 73.1 110.85 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 CA-C-O 121.444 0.469 . . . . 45.41 112.478 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 138.8 38.84 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.724 2.283 . . . . 72.14 112.318 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -81.0 58.29 3.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.441 . . . . 74.12 110.918 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -177.39 178.95 48.31 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.735 -0.745 . . . . 51.12 112.493 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 9.3 t 59.25 -179.0 0.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.831 0.348 . . . . 61.11 110.879 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -165.94 -51.2 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 71.42 110.89 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -158.23 58.66 0.46 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 74.04 110.835 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.75 98.57 3.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.464 . . . . 72.34 110.868 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 36.5 m -120.6 35.81 4.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.454 . . . . 54.54 110.835 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.83 -31.59 68.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 72.11 110.89 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.503 ' O ' HG23 ' A' ' 97' ' ' THR . 68.3 p -110.19 29.87 7.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 72.3 111.143 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.503 HG23 ' O ' ' A' ' 96' ' ' THR . 1.0 OUTLIER -159.65 127.98 4.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.23 -0.441 . . . . 53.41 111.134 -179.92 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.3 m -106.17 152.79 23.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 61.14 110.863 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.534 HG23 HG22 ' A' ' 112' ' ' VAL . 7.9 m -140.66 154.79 46.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.147 -0.479 . . . . 74.32 111.172 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 14.0 m-90 -151.12 131.54 13.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.231 -0.44 . . . . 72.33 110.915 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.2 t -113.03 114.61 47.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 64.21 111.115 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.688 HD11 HD12 ' A' ' 104' ' ' LEU . 0.5 OUTLIER -139.36 145.95 39.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 74.43 110.888 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 17.2 ttt180 -74.0 93.39 2.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 63.22 110.827 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.688 HD12 HD11 ' A' ' 102' ' ' LEU . 0.4 OUTLIER -126.27 152.95 45.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.187 -0.46 . . . . 62.12 110.911 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 3.1 t70 64.51 15.32 9.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 64.4 110.894 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.23 1.55 84.04 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.734 -0.746 . . . . 52.24 112.467 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -139.83 173.07 11.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.876 0.37 . . . . 75.22 110.899 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -69.63 87.97 0.5 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.146 -0.479 . . . . 64.11 110.876 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.638 HD13 ' HB3' ' A' ' 104' ' ' LEU . 0.8 OUTLIER -70.39 126.7 30.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 75.23 110.913 -179.948 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 12.3 ttt180 -108.14 116.72 32.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 75.24 110.865 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.412 HG21 ' CD2' ' A' ' 167' ' ' LEU . 0.0 OUTLIER -109.6 139.96 30.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 63.55 111.128 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.534 HG22 HG23 ' A' ' 99' ' ' THR . 47.3 t -135.66 139.36 46.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 72.52 111.109 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.529 HD22 HD13 ' A' ' 151' ' ' ILE . 2.9 tp -114.75 99.87 7.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 53.15 110.93 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.22 134.24 42.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.441 . . . . 75.44 110.88 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.7 mmmt -73.81 -17.63 61.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.13 -0.486 . . . . 75.02 110.907 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -51.27 -52.75 42.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 65.02 110.886 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 17.0 p -134.92 16.98 3.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 71.43 111.204 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' MET . . . . . 0.468 ' HA ' HD11 ' A' ' 113' ' ' LEU . 0.0 OUTLIER 53.13 28.66 7.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 71.04 110.92 179.934 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.62 159.67 19.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 63.55 110.914 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.731 HG22 HD12 ' A' ' 151' ' ' ILE . 85.8 t -104.93 134.09 47.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 73.1 111.121 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 4.1 t90 -115.94 120.24 38.53 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.154 -0.475 . . . . 70.42 110.933 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' CYS . . . . . 0.42 ' SG ' HD11 ' A' ' 109' ' ' LEU . 11.3 t -136.6 132.05 34.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.242 -0.436 . . . . 74.33 110.857 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 2.9 m120 50.51 48.03 23.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.197 -0.456 . . . . 62.13 110.851 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 49.45 47.88 35.27 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.785 -0.722 . . . . 54.12 112.508 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.18 113.85 4.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.835 0.35 . . . . 74.32 110.88 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 2.5 ttpm? -53.71 101.72 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 75.23 110.897 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' MET . . . . . 0.544 ' CE ' HG22 ' A' ' 144' ' ' VAL . 25.1 mmm -60.97 169.92 1.76 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 64.13 110.897 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -119.17 106.96 12.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 74.24 110.906 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.677 ' HB ' HG22 ' A' ' 140' ' ' THR . 24.4 p -95.6 -175.28 3.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 74.04 111.198 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.561 ' HB2' ' HB2' ' A' ' 141' ' ' HIS . . . -95.12 -39.47 10.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.259 -0.428 . . . . 75.14 111.124 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 69.53 40.03 78.69 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.727 -0.749 . . . . 72.44 112.466 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -87.2 117.78 26.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.858 0.361 . . . . 74.3 110.902 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -95.46 114.36 26.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 72.13 110.848 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.405 HG22 ' O ' ' A' ' 137' ' ' GLY . 23.5 m -93.34 -178.47 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.137 -0.483 . . . . 63.23 111.112 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -55.49 -34.07 64.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 74.23 110.875 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -151.93 102.05 2.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.202 -0.453 . . . . 75.2 110.835 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.405 ' O ' HG22 ' A' ' 134' ' ' VAL . . . 111.98 178.36 20.01 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.749 -0.739 . . . . 73.13 112.54 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.52 ' O ' ' HB3' ' A' ' 153' ' ' ALA . 0.1 OUTLIER -135.24 130.71 35.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.73 0.3 . . . . 75.33 111.186 -179.874 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -106.35 96.36 6.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.259 -0.428 . . . . 75.42 110.867 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.677 HG22 ' HB ' ' A' ' 129' ' ' THR . 0.0 OUTLIER -80.06 110.26 15.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 74.42 111.153 -179.963 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 141' ' ' HIS . . . . . 0.561 ' HB2' ' HB2' ' A' ' 130' ' ' ALA . 77.1 m-70 -104.83 105.38 15.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.455 . . . . 73.12 110.87 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.514 ' CE2' HG21 ' A' ' 120' ' ' VAL . 19.0 p90 -126.13 132.92 51.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.471 . . . . 75.01 110.887 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 54.7 p -83.33 144.48 29.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 62.24 110.88 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.544 HG22 ' CE ' ' A' ' 127' ' ' MET . 21.6 t -134.58 98.1 2.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 62.24 111.102 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 52.12 -119.29 8.71 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.674 -0.774 . . . . 75.42 112.537 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -100.4 28.25 5.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.851 0.358 . . . . 64.14 110.849 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 49.0 m-70 -130.87 165.67 22.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 72.15 110.868 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -124.35 88.9 2.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 74.41 110.866 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' CYS . . . . . 0.514 ' SG ' HG13 ' A' ' 169' ' ' VAL . 9.8 m -98.49 172.76 7.31 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.207 -0.451 . . . . 60.4 110.903 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 55.5 p90 -175.22 145.6 0.79 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.196 -0.456 . . . . 72.01 110.937 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.731 HD12 HG22 ' A' ' 120' ' ' VAL . 23.2 mt -97.43 111.23 26.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.117 -0.492 . . . . 74.41 111.127 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -80.18 102.86 9.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 54.33 110.868 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.52 ' HB3' ' O ' ' A' ' 138' ' ' THR . . . -95.49 146.44 24.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 30.41 111.088 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.4 t -143.89 120.49 5.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.264 -0.425 . . . . 72.32 111.14 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.3 p -87.25 140.72 29.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 64.45 110.869 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 5.0 p -132.56 148.68 52.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.118 -0.492 . . . . 75.14 110.863 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 111.06 -162.93 12.32 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.792 -0.718 . . . . 63.23 112.479 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.47 -44.87 85.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.794 0.331 . . . . 72.44 110.906 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.23 -60.83 0.13 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 71.13 110.852 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 17.7 mtmt -137.18 37.72 2.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 35.33 110.86 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.25 -62.21 1.84 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.266 -0.424 . . . . 71.21 110.884 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -135.16 122.47 2.83 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.768 -0.73 . . . . 33.25 112.516 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 69.6 mt -110.77 144.85 17.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.846 0.355 . . . . 74.15 111.112 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 3.0 mt -129.84 127.97 64.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 74.21 111.173 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' HIS . . . . . 0.438 ' CG ' HD23 ' A' ' 113' ' ' LEU . 13.0 m80 -105.01 136.51 44.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 74.32 110.857 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.61 106.1 8.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 63.3 111.092 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.454 HD12 ' H ' ' A' ' 168' ' ' ILE . 30.4 tp -65.29 139.36 58.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.193 -0.458 . . . . 64.41 110.917 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.454 ' H ' HD12 ' A' ' 167' ' ' LEU . 9.4 mt -137.43 129.97 42.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 61.13 111.118 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.514 HG13 ' SG ' ' A' ' 149' ' ' CYS . 99.5 t -125.49 115.43 43.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.47 . . . . 74.11 111.125 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 63.66 46.88 3.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.15 -0.477 . . . . 74.43 110.918 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 58.69 42.8 19.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.143 -0.481 . . . . 74.41 110.918 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.19 124.9 19.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 70.25 110.85 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -62.56 146.2 52.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 74.44 110.903 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.573 HD12 HD22 ' A' ' 102' ' ' LEU . 0.9 OUTLIER -120.73 131.12 24.56 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.606 0.717 . . . . 63.43 111.135 179.986 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 134.4 27.9 Favored 'Trans proline' 0 N--CA 1.465 -0.161 0 C-N-CA 122.714 2.276 . . . . 73.4 112.348 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -91.37 152.01 20.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.234 -0.439 . . . . 52.2 110.913 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.567 ' O ' HD13 ' A' ' 177' ' ' LEU . 0.4 OUTLIER -52.13 -36.96 52.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 73.2 110.938 -179.985 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 63.4 p -51.72 118.97 3.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 65.21 111.133 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 74.55 110.965 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 CA-C-O 121.485 0.492 . . . . 63.44 112.488 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.77 140.58 42.99 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.737 2.292 . . . . 63.3 112.324 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.33 -45.67 2.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.191 -0.459 . . . . 65.44 110.903 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 109.52 -47.83 1.0 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.665 -0.778 . . . . 54.5 112.497 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 56.03 28.12 12.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.866 0.365 . . . . 75.54 110.88 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -103.52 67.88 0.92 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 64.44 110.91 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -113.02 -66.62 1.07 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.484 . . . . 74.32 110.867 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.06 130.2 56.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.148 -0.478 . . . . 71.4 110.857 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 20.2 m -67.19 161.14 25.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.192 -0.458 . . . . 70.35 110.903 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.11 124.13 32.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.173 -0.467 . . . . 50.43 110.927 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.5 ' O ' HG23 ' A' ' 97' ' ' THR . 40.4 p -96.65 -31.04 12.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.24 -0.436 . . . . 73.45 111.161 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.5 HG23 ' O ' ' A' ' 96' ' ' THR . 1.0 OUTLIER -159.52 128.33 5.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.193 -0.458 . . . . 71.01 111.091 -179.974 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.9 m -105.8 152.79 22.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 74.32 110.844 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 56.1 m -147.52 137.42 22.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 63.13 111.15 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' TRP . . . . . 0.404 ' CB ' HD23 ' A' ' 167' ' ' LEU . 16.7 m-90 -130.27 156.86 43.94 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.202 -0.453 . . . . 64.53 110.883 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 19.7 t -128.95 114.84 34.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.234 -0.439 . . . . 63.25 111.163 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.914 HD11 HD12 ' A' ' 104' ' ' LEU . 0.5 OUTLIER -141.33 147.52 38.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.27 -0.423 . . . . 45.45 110.899 179.986 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.54 92.78 2.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 74.41 110.853 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.914 HD12 HD11 ' A' ' 102' ' ' LEU . 0.3 OUTLIER -122.1 152.66 39.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 70.13 110.852 -179.954 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 64.93 14.78 9.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.17 -0.468 . . . . 61.51 110.887 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.08 0.43 80.77 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.747 -0.739 . . . . 61.32 112.514 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -139.92 172.78 12.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.847 0.356 . . . . 73.32 110.873 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -68.29 89.44 0.33 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.158 -0.473 . . . . 60.23 110.836 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.591 HD13 ' HB3' ' A' ' 104' ' ' LEU . 0.4 OUTLIER -77.36 127.27 32.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.221 -0.445 . . . . 74.34 110.937 179.999 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 12.2 ttp180 -106.08 116.01 31.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.135 -0.484 . . . . 73.31 110.897 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.444 HG21 ' CD2' ' A' ' 167' ' ' LEU . 0.2 OUTLIER -101.83 141.98 17.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.248 -0.433 . . . . 75.45 111.081 -179.974 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 96.9 t -135.93 126.47 42.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 64.12 111.168 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.616 HD11 ' HA ' ' A' ' 118' ' ' MET . 2.5 tp -110.48 111.9 23.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.468 . . . . 74.1 110.871 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.486 ' N ' HD12 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -86.26 135.25 33.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 71.42 110.888 179.881 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.16 -16.25 61.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.476 . . . . 73.13 110.885 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -51.74 -55.87 17.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 75.41 110.879 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.1 p -136.22 17.09 3.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.436 . . . . 65.11 111.122 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' MET . . . . . 0.616 ' HA ' HD11 ' A' ' 113' ' ' LEU . 69.0 mtp 58.16 29.33 17.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 70.4 110.947 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.64 146.05 34.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 74.12 110.909 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.631 HG21 ' CE2' ' A' ' 142' ' ' PHE . 98.4 t -105.0 123.51 59.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.235 -0.439 . . . . 61.15 111.154 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 2.3 t90 -105.27 131.59 52.54 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.178 -0.465 . . . . 73.34 110.943 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' CYS . . . . . 0.436 ' SG ' HG13 ' A' ' 111' ' ' VAL . 1.2 m -128.3 103.3 7.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.258 -0.428 . . . . 75.21 110.883 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 24.2 m-20 45.56 70.54 0.35 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 71.34 110.886 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 48.6 40.16 24.3 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.748 -0.739 . . . . 70.22 112.438 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.04 107.23 4.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.903 0.383 . . . . 71.24 110.91 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 4.3 mttt -53.41 152.62 4.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 62.34 110.945 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' MET . . . . . 0.649 ' CE ' HG22 ' A' ' 144' ' ' VAL . 27.2 mmm -123.89 164.83 18.47 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.295 -0.411 . . . . 73.11 110.867 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -118.97 110.14 16.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 74.23 110.941 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.736 ' HB ' HG22 ' A' ' 140' ' ' THR . 19.3 p -95.63 174.34 7.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 73.33 111.162 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -174.77 -169.59 0.43 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 72.22 111.116 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 118.63 -111.54 2.15 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.736 -0.745 . . . . 63.13 112.523 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -177.55 175.52 1.4 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.832 0.348 . . . . 75.13 110.931 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.462 ' CB ' HG23 ' A' ' 138' ' ' THR . 55.2 p90 -110.85 145.07 38.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 70.23 110.929 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 7.6 m -108.34 -179.77 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.15 -0.477 . . . . 72.33 111.147 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -52.68 -29.34 26.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 44.34 110.872 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -151.66 97.32 2.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.25 -0.432 . . . . 74.25 110.851 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 111.44 169.24 18.71 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.726 -0.75 . . . . 72.01 112.472 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.485 ' O ' ' HB3' ' A' ' 153' ' ' ALA . 0.1 OUTLIER -134.8 130.76 36.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.727 0.299 . . . . 72.33 111.134 -179.851 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -87.32 96.5 10.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 75.3 110.963 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.736 HG22 ' HB ' ' A' ' 129' ' ' THR . 0.0 OUTLIER -79.92 110.17 15.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 74.21 111.133 -179.907 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -108.31 111.96 24.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 74.11 110.861 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.631 ' CE2' HG21 ' A' ' 120' ' ' VAL . 15.1 p90 -125.46 134.02 52.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 73.41 110.854 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 60.6 p -78.6 139.2 38.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.169 -0.469 . . . . 71.11 110.896 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.649 HG22 ' CE ' ' A' ' 127' ' ' MET . 21.4 t -130.87 98.06 3.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 72.03 111.123 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 51.85 -124.24 23.15 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.669 -0.777 . . . . 54.14 112.502 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -95.89 25.23 4.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.813 0.34 . . . . 71.34 110.856 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 45.9 m-70 -121.64 -169.99 1.96 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 74.52 110.838 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -149.83 81.48 1.39 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 71.3 110.847 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' CYS . . . . . 0.52 ' SG ' HG13 ' A' ' 169' ' ' VAL . 8.3 m -96.29 166.07 11.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.242 -0.435 . . . . 60.21 110.843 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -167.27 144.48 4.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 74.21 110.961 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.6 HD12 HG22 ' A' ' 120' ' ' VAL . 44.9 mt -99.5 111.21 28.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 72.42 111.139 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 5.0 tttp -80.56 103.11 10.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.153 -0.476 . . . . 74.14 110.851 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.485 ' HB3' ' O ' ' A' ' 138' ' ' THR . . . -95.23 143.07 26.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.462 . . . . 44.23 111.074 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.2 t -136.58 120.61 24.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 45.14 111.077 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.2 p -90.75 132.84 35.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 74.04 110.794 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 9.5 p -124.38 138.64 54.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.091 -0.504 . . . . 41.13 110.907 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 132.85 -104.05 0.53 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.71 -0.757 . . . . 63.51 112.471 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 12.3 ttmt -142.73 -46.14 0.32 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.785 0.326 . . . . 71.25 110.906 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 5.9 ttt180 -137.21 -45.83 0.56 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.216 -0.447 . . . . 71.51 110.869 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 11.6 tttt -167.83 55.64 0.07 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 75.23 110.955 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -82.43 -64.53 1.16 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 63.51 110.849 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -135.34 114.2 1.2 Allowed Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.685 -0.769 . . . . 70.12 112.441 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 76.2 mt -105.97 139.56 26.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.848 0.356 . . . . 73.13 111.121 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 72.0 mt -126.43 122.83 62.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.46 . . . . 73.53 111.131 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 18.1 m80 -96.66 137.8 35.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 54.25 110.881 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.79 104.26 7.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.21 -0.45 . . . . 71.42 111.138 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.607 HD12 ' H ' ' A' ' 168' ' ' ILE . 15.9 tp -63.81 138.97 58.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.289 -0.414 . . . . 64.33 110.925 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.607 ' H ' HD12 ' A' ' 167' ' ' LEU . 10.0 mt -137.76 120.75 20.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 62.41 111.089 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.663 HG21 HD13 ' A' ' 102' ' ' LEU . 89.5 t -121.32 130.83 74.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.095 -0.502 . . . . 64.34 111.089 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 58.79 36.91 24.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.12 -0.491 . . . . 53.21 110.832 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 2.6 t30 63.34 43.07 6.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 72.35 110.877 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.14 128.77 21.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 73.45 110.875 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -62.62 146.5 51.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 74.23 110.856 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -123.81 131.37 24.25 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.569 0.699 . . . . 64.03 111.097 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 135.18 29.81 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.7 2.266 . . . . 54.4 112.334 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -91.06 151.14 21.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 74.5 110.91 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.3 tp -68.28 102.48 1.39 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.149 -0.478 . . . . 74.43 110.969 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 80.5 p -111.25 -42.1 4.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 74.02 111.166 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.248 -0.433 . . . . 73.31 110.886 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.245 0 CA-C-O 121.419 0.455 . . . . 71.52 112.54 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.66 156.78 62.7 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.661 2.241 . . . . 74.01 112.347 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 9.7 mt -112.86 -26.73 8.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 73.43 110.95 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 111.38 -40.8 2.42 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.759 -0.734 . . . . 30.41 112.506 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.9 m 56.56 -173.68 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.857 0.36 . . . . 60.41 110.85 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -116.65 164.71 14.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.471 . . . . 72.02 110.935 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -85.34 170.45 12.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.137 -0.483 . . . . 63.2 110.85 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 9.5 ttt180 56.32 54.24 7.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 74.03 110.925 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 83.4 p -141.3 38.9 1.73 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.114 -0.494 . . . . 50.15 110.841 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.16 44.3 1.15 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.118 -0.492 . . . . 74.32 110.892 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.505 ' O ' HG23 ' A' ' 97' ' ' THR . 0.0 OUTLIER -158.99 -42.75 0.06 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 73.23 111.099 -179.944 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.505 HG23 ' O ' ' A' ' 96' ' ' THR . 1.0 OUTLIER -159.56 127.89 5.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 72.41 111.197 -179.956 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.7 m -106.22 155.04 19.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.241 -0.436 . . . . 71.23 110.894 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.808 HG22 HG22 ' A' ' 112' ' ' VAL . 72.3 p -144.88 155.08 43.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 53.52 111.177 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 15.3 m-90 -151.35 133.54 15.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.242 -0.435 . . . . 74.25 110.928 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.3 t -112.95 114.84 48.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.283 -0.417 . . . . 61.32 111.055 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.721 HD11 HD12 ' A' ' 104' ' ' LEU . 0.5 OUTLIER -139.73 145.87 38.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 73.11 110.914 179.916 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -74.62 92.99 2.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 55.34 110.851 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.721 HD12 HD11 ' A' ' 102' ' ' LEU . 0.4 OUTLIER -124.9 153.73 42.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.471 . . . . 64.52 110.987 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.7 t70 64.5 15.42 9.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.271 -0.422 . . . . 73.4 110.805 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.69 1.31 83.12 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.768 -0.729 . . . . 74.24 112.502 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -139.92 173.03 11.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.779 0.323 . . . . 65.32 110.884 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -69.74 87.85 0.52 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.161 -0.472 . . . . 62.51 110.884 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.643 HD13 ' HB3' ' A' ' 104' ' ' LEU . 0.7 OUTLIER -70.52 127.43 32.7 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.258 -0.428 . . . . 63.12 110.93 -179.96 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 8.8 ttm180 -107.87 115.29 29.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.185 -0.461 . . . . 71.53 110.83 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.434 HG21 ' CD2' ' A' ' 167' ' ' LEU . 0.1 OUTLIER -106.67 137.64 36.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.12 -0.491 . . . . 73.45 111.081 -179.99 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.808 HG22 HG22 ' A' ' 99' ' ' THR . 90.1 t -135.76 128.56 47.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.187 -0.461 . . . . 74.34 111.182 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.52 HD11 ' HA ' ' A' ' 118' ' ' MET . 2.5 tp -110.2 103.46 12.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.476 . . . . 72.22 110.96 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.437 ' HG3' HG22 ' A' ' 97' ' ' THR . 0.9 OUTLIER -78.24 134.95 37.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.232 -0.44 . . . . 75.45 110.863 179.977 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 9.2 mmmt -73.13 -17.2 61.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.126 -0.488 . . . . 53.53 110.889 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -51.6 -55.18 20.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 71.13 110.838 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.45 16.97 4.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 74.13 111.105 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' MET . . . . . 0.52 ' HA ' HD11 ' A' ' 113' ' ' LEU . 4.0 ttm 53.54 32.36 14.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.232 -0.44 . . . . 73.41 110.848 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.99 155.03 20.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.289 -0.414 . . . . 52.52 110.863 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.682 HG22 HD12 ' A' ' 151' ' ' ILE . 99.6 t -104.83 130.18 56.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 63.24 111.172 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 7.7 t-105 -112.7 122.88 48.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.089 -0.505 . . . . 75.03 110.872 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 24.6 t -128.48 131.78 48.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.134 -0.485 . . . . 75.13 110.805 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 27.3 m-20 50.08 54.63 10.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 71.12 110.862 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 49.82 37.42 28.25 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.754 -0.736 . . . . 64.54 112.483 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -143.38 165.77 26.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.868 0.366 . . . . 70.03 110.916 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -85.93 157.92 20.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 70.51 110.88 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 35.2 mmm -124.76 166.98 15.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 63.41 110.88 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -119.23 106.59 12.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 71.14 110.853 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.676 ' HB ' HG22 ' A' ' 140' ' ' THR . 19.2 p -95.91 -175.26 3.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 72.12 111.113 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -104.61 -29.54 10.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 72.11 111.107 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 61.98 39.92 98.2 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.733 -0.746 . . . . 54.25 112.452 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 49.5 tt0 -71.43 138.72 49.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.865 0.364 . . . . 73.4 110.898 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -109.95 125.66 53.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.161 -0.472 . . . . 71.24 110.908 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.452 HG23 ' H ' ' A' ' 136' ' ' ASP . 31.1 m -105.56 -178.36 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.471 . . . . 63.11 111.197 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -53.47 -30.37 40.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 63.33 110.878 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.452 ' H ' HG23 ' A' ' 134' ' ' VAL . 1.2 p-10 -160.65 88.45 0.78 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.174 -0.466 . . . . 72.13 110.866 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 134.44 -178.32 18.52 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.765 -0.731 . . . . 74.14 112.549 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.462 ' O ' ' HB3' ' A' ' 153' ' ' ALA . 0.1 OUTLIER -135.25 130.8 35.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.762 0.315 . . . . 71.44 111.145 -179.87 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -108.18 103.62 12.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.481 . . . . 73.43 110.982 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.676 HG22 ' HB ' ' A' ' 129' ' ' THR . 0.0 OUTLIER -83.13 110.35 17.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.211 -0.45 . . . . 63.55 111.14 -179.892 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 68.4 m-70 -105.37 105.26 15.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 73.25 110.784 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.491 ' CE2' HG21 ' A' ' 120' ' ' VAL . 18.2 p90 -123.85 134.56 53.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 74.11 110.913 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 3.3 p -77.8 139.51 39.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 42.31 110.867 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.6 t -133.48 106.3 9.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 62.44 111.092 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 53.31 -116.35 5.65 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.741 -0.742 . . . . 73.03 112.435 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -110.25 26.22 10.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.795 0.331 . . . . 74.04 110.872 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 16.0 m170 -124.1 -169.81 2.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 64.11 110.86 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -140.85 81.69 1.81 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 71.21 110.902 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' CYS . . . . . 0.417 ' SG ' HG13 ' A' ' 169' ' ' VAL . 11.1 m -91.62 157.43 16.98 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.24 -0.436 . . . . 74.25 110.917 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 39.3 p90 -159.83 143.33 14.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 74.51 110.882 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.682 HD12 HG22 ' A' ' 120' ' ' VAL . 35.5 mt -97.54 111.67 27.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.126 -0.488 . . . . 72.21 111.064 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 33.2 ttmt -80.04 102.87 9.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.475 . . . . 71.21 110.968 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.462 ' HB3' ' O ' ' A' ' 138' ' ' THR . . . -95.02 142.21 27.77 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.176 -0.465 . . . . 55.13 111.137 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.3 t -138.8 124.58 23.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.254 -0.43 . . . . 75.44 111.138 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.4 p -95.81 133.14 40.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 53.24 110.932 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -133.68 133.21 41.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.151 -0.477 . . . . 63.24 110.891 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 112.01 -176.33 17.95 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.754 -0.736 . . . . 20.35 112.428 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.84 130.55 35.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.849 0.357 . . . . 74.43 110.916 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 20.5 mmt180 54.31 43.06 31.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 61.14 110.874 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 3.0 mttt 55.51 48.06 19.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.136 -0.484 . . . . 75.13 110.911 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -52.17 -68.42 0.17 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 64.22 110.889 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -110.86 125.43 7.39 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.768 -0.73 . . . . 21.21 112.526 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 64.7 mt -114.81 143.98 23.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.824 0.345 . . . . 73.51 111.085 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 64.4 mt -132.18 127.35 57.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 60.34 111.102 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' HIS . . . . . 0.42 ' CG ' HD23 ' A' ' 113' ' ' LEU . 12.7 m80 -102.81 140.07 37.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.161 -0.472 . . . . 73.25 110.893 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.37 106.44 8.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.163 -0.471 . . . . 62.43 111.166 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.434 ' CD2' HG21 ' A' ' 111' ' ' VAL . 30.7 tp -66.8 136.61 55.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 71.14 110.964 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.405 ' H ' HD12 ' A' ' 167' ' ' LEU . 10.2 mt -137.78 129.78 40.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.446 . . . . 72.54 111.12 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.417 HG21 HD13 ' A' ' 102' ' ' LEU . 57.6 t -126.46 117.78 49.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 65.44 111.164 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.9 t0 63.69 41.81 6.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.178 -0.464 . . . . 40.2 110.834 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 62.5 42.92 8.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 74.34 110.861 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -138.32 124.5 20.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.179 -0.464 . . . . 72.44 110.892 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -62.59 145.92 53.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.2 -0.455 . . . . 54.31 110.86 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.499 HD12 HD22 ' A' ' 102' ' ' LEU . 0.9 OUTLIER -121.02 131.16 24.56 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.623 0.725 . . . . 73.01 111.123 179.942 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 134.44 28.0 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.689 2.259 . . . . 73.22 112.356 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.53 ' O ' HG22 ' A' ' 178' ' ' THR . 1.7 tm-20 -92.57 112.82 24.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.24 -0.436 . . . . 75.31 110.874 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 9.6 tp -59.03 120.39 9.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 73.21 110.941 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.53 HG22 ' O ' ' A' ' 176' ' ' GLU . 4.0 t -173.98 129.39 0.39 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.153 -0.476 . . . . 61.43 111.074 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.109 -0.496 . . . . 73.24 110.887 180.0 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 CA-C-O 121.396 0.442 . . . . 73.32 112.506 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 95.55 0.56 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.687 2.258 . . . . 32.11 112.297 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -70.22 -43.73 70.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.186 -0.461 . . . . 65.12 110.906 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 84.94 26.86 36.03 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.744 -0.741 . . . . 63.34 112.469 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 36.2 p -74.44 128.73 36.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.748 0.309 . . . . 72.33 110.882 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 60.31 98.27 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.217 -0.447 . . . . 74.23 110.874 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -116.93 46.96 1.56 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 74.23 110.871 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 45.9 mtm180 -140.51 44.12 1.86 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 72.15 110.842 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.6 m -141.18 -179.01 5.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 75.04 110.863 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.81 -28.95 14.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 73.55 110.92 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.491 ' O ' HG23 ' A' ' 97' ' ' THR . 13.5 p 49.89 41.03 22.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.261 -0.427 . . . . 62.15 111.179 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.638 HG22 ' HA ' ' A' ' 114' ' ' GLU . 1.1 p -159.36 128.07 5.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 71.43 111.159 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -105.97 149.63 26.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.26 -0.427 . . . . 73.11 110.912 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 92.3 m -137.88 138.47 39.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 73.31 111.133 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' TRP . . . . . 0.462 ' CB ' HD23 ' A' ' 167' ' ' LEU . 12.0 m-90 -133.36 123.27 25.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.204 -0.453 . . . . 63.31 110.969 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 18.7 t -103.63 115.01 44.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 40.5 111.122 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.661 HD11 HD12 ' A' ' 104' ' ' LEU . 0.5 OUTLIER -141.25 146.0 36.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 74.22 110.888 -179.979 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 56.4 mtm-85 -76.34 93.75 3.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 73.42 110.862 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.672 ' HB3' HD13 ' A' ' 109' ' ' LEU . 0.4 OUTLIER -125.73 155.43 40.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 72.34 110.844 -179.977 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.3 t0 64.7 15.06 9.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 75.13 110.891 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 88.17 0.91 82.43 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.756 -0.735 . . . . 75.24 112.561 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -139.93 172.98 11.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.862 0.363 . . . . 74.33 110.887 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -70.33 88.16 0.63 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.142 -0.481 . . . . 62.32 110.875 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.672 HD13 ' HB3' ' A' ' 104' ' ' LEU . 0.5 OUTLIER -70.36 123.6 22.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.202 -0.454 . . . . 74.02 110.875 -179.941 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 4.9 ttp180 -101.94 109.38 21.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.107 -0.497 . . . . 74.01 110.804 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.442 HG21 ' CD2' ' A' ' 167' ' ' LEU . 2.2 t -95.6 134.55 32.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.452 . . . . 74.23 111.126 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 76.4 t -137.25 125.31 32.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 53.25 111.083 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.568 HD11 ' HA ' ' A' ' 118' ' ' MET . 3.0 tp -110.35 106.8 16.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 42.31 110.883 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.638 ' HA ' HG22 ' A' ' 97' ' ' THR . 0.0 OUTLIER -82.83 136.46 34.63 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.142 -0.481 . . . . 73.51 110.887 179.945 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.9 mmmt -73.77 -16.51 61.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 73.32 110.853 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -51.41 -54.21 28.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.466 . . . . 74.1 110.89 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.86 17.03 3.05 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.191 -0.459 . . . . 62.25 111.179 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' MET . . . . . 0.568 ' HA ' HD11 ' A' ' 113' ' ' LEU . 81.6 mtp 56.77 26.26 11.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 65.33 110.895 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.55 151.71 32.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.273 -0.421 . . . . 73.14 110.862 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.561 HG22 HD12 ' A' ' 151' ' ' ILE . 70.6 t -105.04 133.5 49.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.171 -0.468 . . . . 62.32 111.074 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 6.6 t-105 -117.64 123.77 46.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.2 -0.454 . . . . 75.13 110.891 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 17.9 m -131.18 132.19 44.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.216 -0.447 . . . . 65.13 110.934 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 4.4 m120 50.99 53.83 12.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.125 -0.489 . . . . 70.25 110.93 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 49.09 39.64 27.09 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.765 -0.731 . . . . 74.11 112.436 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.02 154.81 41.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.848 0.356 . . . . 74.2 110.907 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 15.8 ttpt -75.67 159.5 31.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 75.12 110.855 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 38.8 mmm -125.51 166.12 17.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.239 -0.437 . . . . 53.55 110.879 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -119.25 106.53 12.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.269 -0.423 . . . . 73.43 110.877 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.566 ' HB ' HG22 ' A' ' 140' ' ' THR . 17.6 p -95.53 -175.29 3.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 63.11 111.175 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -107.49 -28.77 9.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.476 . . . . 44.11 111.102 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 55.64 53.59 40.48 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.78 -0.724 . . . . 71.42 112.514 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -85.45 102.77 13.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.887 0.375 . . . . 75.42 110.897 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -77.7 114.07 16.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.108 -0.496 . . . . 72.51 110.85 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.616 HG23 ' H ' ' A' ' 136' ' ' ASP . 35.6 m -95.75 -177.29 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.17 -0.468 . . . . 71.25 111.136 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.99 -26.29 64.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.144 -0.48 . . . . 64.15 110.861 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.616 ' H ' HG23 ' A' ' 134' ' ' VAL . 0.1 OUTLIER -157.99 102.32 1.81 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 55.04 110.839 179.992 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 111.41 -177.23 18.9 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.766 -0.73 . . . . 43.14 112.512 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.454 ' O ' ' HB3' ' A' ' 153' ' ' ALA . 0.1 OUTLIER -135.37 130.83 35.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.706 0.289 . . . . 64.43 111.176 -179.919 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -108.6 96.6 6.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 72.2 110.889 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.566 HG22 ' HB ' ' A' ' 129' ' ' THR . 0.0 OUTLIER -80.67 110.47 16.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.173 -0.467 . . . . 71.41 111.151 -179.879 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 -105.22 106.61 17.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 73.25 110.805 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 17.8 p90 -124.02 129.54 51.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 71.11 110.906 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 90.9 p -79.58 156.98 27.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 65.03 110.88 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 86.6 t -149.62 98.49 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 60.13 111.118 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 57.01 -106.63 0.75 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.767 -0.73 . . . . 62.33 112.486 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 21.5 t30 -116.9 24.56 11.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.896 0.379 . . . . 74.51 110.911 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 35.4 m170 -117.25 -175.3 2.77 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.13 -0.486 . . . . 74.43 110.815 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -143.73 78.56 1.6 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 75.34 110.878 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' CYS . . . . . 0.431 ' SG ' HG13 ' A' ' 169' ' ' VAL . 12.0 m -93.49 158.89 15.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.146 -0.479 . . . . 75.32 110.916 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -161.75 144.15 11.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.445 . . . . 71.51 110.935 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.562 HD13 HD22 ' A' ' 113' ' ' LEU . 22.7 mt -97.46 111.2 26.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.169 -0.469 . . . . 73.1 111.149 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 61.6 tttt -80.1 102.79 9.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.455 . . . . 70.54 110.897 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.454 ' HB3' ' O ' ' A' ' 138' ' ' THR . . . -93.65 143.51 26.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.283 -0.417 . . . . 42.13 111.08 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.3 t -139.89 119.64 13.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 33.32 111.093 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.2 p -89.04 148.42 23.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.121 -0.49 . . . . 72.32 110.883 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.55 140.11 24.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.47 . . . . 71.21 110.906 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 132.47 -152.23 20.17 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.79 -0.719 . . . . 55.21 112.493 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 9.3 mttp -79.04 -29.84 43.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.77 0.319 . . . . 74.4 110.921 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 21.0 ptt-85 -169.16 -41.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 52.02 110.849 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 3.0 ttmm -157.06 30.41 0.3 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 75.23 110.893 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -56.81 -61.98 2.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 75.21 110.892 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -136.11 157.91 23.67 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.716 -0.754 . . . . 74.52 112.48 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 57.5 mt -141.19 146.42 23.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.725 0.298 . . . . 71.24 111.188 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 2.9 mt -133.01 124.36 49.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.188 -0.46 . . . . 65.45 111.169 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 17.3 m-70 -103.44 138.34 40.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 61.22 110.845 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.63 109.28 10.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.162 -0.472 . . . . 73.13 111.132 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.511 HD12 ' H ' ' A' ' 168' ' ' ILE . 21.0 tp -67.45 137.6 56.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.224 -0.444 . . . . 45.14 110.884 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.511 ' H ' HD12 ' A' ' 167' ' ' LEU . 9.6 mt -138.32 129.64 37.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 62.04 111.147 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.431 HG13 ' SG ' ' A' ' 149' ' ' CYS . 58.4 t -125.68 122.77 63.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 74.34 111.12 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 58.84 41.29 21.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 74.11 110.859 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 63.22 43.09 6.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.248 -0.433 . . . . 55.12 110.888 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 15.4 mtp180 -138.52 125.3 21.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.166 -0.47 . . . . 73.45 110.865 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -62.36 146.54 50.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 62.23 110.901 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.407 HD12 HD22 ' A' ' 102' ' ' LEU . 0.9 OUTLIER -123.06 131.01 24.38 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.576 0.703 . . . . 72.43 111.156 179.938 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.72 137.57 35.91 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.611 2.207 . . . . 72.13 112.404 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.59 167.56 12.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.44 . . . . 53.23 110.834 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 11.4 tp -116.86 114.76 24.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.12 -0.491 . . . . 74.31 110.919 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 4.9 t -176.24 -36.3 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 73.23 111.081 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 116.297 -0.41 . . . . 71.4 110.941 179.994 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 CA-C-O 121.465 0.48 . . . . 44.0 112.513 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 125.78 12.56 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.738 2.292 . . . . 64.23 112.303 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -107.55 151.39 25.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.248 -0.433 . . . . 74.35 110.915 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -94.61 -148.17 23.64 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.713 -0.756 . . . . 51.3 112.495 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.7 p -148.87 98.81 2.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.833 0.349 . . . . 62.34 110.852 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -111.86 109.74 19.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 74.24 110.886 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -162.91 123.61 2.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.123 -0.489 . . . . 60.24 110.894 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.5 mtm180 -141.42 97.49 3.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 24.21 110.908 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 15.4 m 55.09 31.86 17.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 72.41 110.794 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.37 129.67 49.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.174 -0.466 . . . . 70.04 110.883 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.496 ' O ' HG23 ' A' ' 97' ' ' THR . 50.6 p -136.44 37.15 2.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.17 -0.468 . . . . 50.42 111.169 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.602 HG22 ' HA ' ' A' ' 114' ' ' GLU . 1.0 OUTLIER -159.51 127.99 5.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 65.42 111.136 -179.985 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.3 m -106.05 149.64 26.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 50.03 110.894 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 90.1 m -136.98 137.15 39.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.139 -0.482 . . . . 75.34 111.095 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' TRP . . . . . 0.498 ' CB ' HD23 ' A' ' 167' ' ' LEU . 9.9 m-90 -132.98 122.81 24.79 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.126 -0.488 . . . . 75.44 110.891 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 20.0 t -102.7 114.89 43.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.247 -0.433 . . . . 33.53 111.181 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.883 HD11 HD12 ' A' ' 104' ' ' LEU . 0.5 OUTLIER -142.56 147.3 35.7 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.257 -0.429 . . . . 54.52 110.927 179.935 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 5.6 mtt180 -74.63 92.23 2.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 71.31 110.864 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.883 HD12 HD11 ' A' ' 102' ' ' LEU . 0.4 OUTLIER -121.95 153.94 37.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 54.33 110.908 -179.975 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 65.17 14.37 9.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 62.2 110.91 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.99 -0.39 78.99 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.735 -0.745 . . . . 65.13 112.48 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -139.92 172.89 12.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.797 0.332 . . . . 52.15 110.919 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -68.36 88.42 0.32 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.155 -0.475 . . . . 72.52 110.841 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.607 HD13 ' HB3' ' A' ' 104' ' ' LEU . 0.4 OUTLIER -74.65 125.94 29.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.236 -0.438 . . . . 65.05 110.937 -179.961 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 29.5 ttt180 -102.36 110.9 22.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.191 -0.459 . . . . 74.42 110.85 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.5 t -95.12 136.43 26.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 72.33 111.168 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 96.8 t -136.99 127.04 39.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.258 -0.428 . . . . 65.34 111.137 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.638 HD22 HD13 ' A' ' 151' ' ' ILE . 4.1 tp -110.32 104.44 13.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 55.34 110.847 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.602 ' HA ' HG22 ' A' ' 97' ' ' THR . 0.0 OUTLIER -81.14 136.42 35.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.113 -0.494 . . . . 75.3 110.949 179.917 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 3.6 mmmt -73.73 -16.74 61.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 74.03 110.936 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -51.38 -53.0 40.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.232 -0.44 . . . . 72.15 110.854 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.38 17.04 2.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 61.52 111.151 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' MET . . . . . 0.495 ' HA ' HD11 ' A' ' 113' ' ' LEU . 2.4 ttp 55.55 26.29 8.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.234 -0.439 . . . . 74.14 110.889 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -80.65 154.54 27.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 51.24 110.871 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.6 HG22 HD12 ' A' ' 151' ' ' ILE . 53.5 t -105.16 134.8 45.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.469 . . . . 72.21 111.156 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 6.0 t-105 -119.41 126.54 51.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.156 -0.475 . . . . 73.12 110.826 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 64.4 m -132.93 131.9 41.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 75.41 110.838 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 2.9 m120 49.85 54.39 11.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 64.11 110.837 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 48.55 40.53 24.48 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.797 -0.716 . . . . 64.41 112.481 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.94 147.7 28.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.873 0.368 . . . . 64.42 110.893 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 13.1 tttp -68.04 159.91 29.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.258 -0.428 . . . . 74.34 110.918 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 41.0 mmm -124.55 164.31 20.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.212 -0.449 . . . . 71.34 110.897 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -119.3 106.29 12.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 63.02 110.86 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.69 ' CB ' HG22 ' A' ' 140' ' ' THR . 21.3 p -95.96 -175.05 3.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.112 -0.494 . . . . 64.51 111.111 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.432 ' HB2' ' HB2' ' A' ' 141' ' ' HIS . . . -100.22 -32.2 11.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 74.13 111.125 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 59.99 96.4 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.709 -0.757 . . . . 44.32 112.519 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -150.49 102.85 3.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.909 0.385 . . . . 70.32 110.91 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -83.2 148.79 27.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 64.14 110.883 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.54 HG23 ' H ' ' A' ' 136' ' ' ASP . 19.3 m -140.45 -177.09 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.162 -0.472 . . . . 65.25 111.121 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -57.24 -22.11 38.76 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.166 -0.47 . . . . 71.23 110.877 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.54 ' H ' HG23 ' A' ' 134' ' ' VAL . 0.3 OUTLIER -92.29 -73.69 0.54 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 73.42 110.827 -179.989 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -150.17 -123.22 1.16 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.77 -0.728 . . . . 63.34 112.481 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -136.1 130.79 33.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.733 0.301 . . . . 72.13 111.146 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -104.13 96.29 6.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.234 -0.439 . . . . 63.22 110.923 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.69 HG22 ' CB ' ' A' ' 129' ' ' THR . 0.0 OUTLIER -86.98 109.73 19.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.173 -0.467 . . . . 60.12 111.177 -179.887 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 141' ' ' HIS . . . . . 0.432 ' HB2' ' HB2' ' A' ' 130' ' ' ALA . 34.3 m80 -102.68 106.84 17.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.24 -0.436 . . . . 72.42 110.836 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -121.9 123.02 40.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.148 -0.478 . . . . 73.31 110.903 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.03 153.78 22.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 62.32 110.85 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.448 HG11 HD22 ' A' ' 104' ' ' LEU . 47.0 t -147.19 106.7 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 74.13 111.096 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 56.59 -110.14 1.94 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.733 -0.746 . . . . 64.44 112.529 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 29.4 m120 -117.38 25.68 10.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.871 0.367 . . . . 75.23 110.88 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 24.4 m-70 -123.26 163.57 20.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 73.11 110.891 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -122.23 122.07 38.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 74.45 110.914 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' CYS . . . . . 0.575 ' HB3' HG22 ' A' ' 169' ' ' VAL . 1.2 p -141.48 146.95 37.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.448 . . . . 72.53 110.887 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 26.0 p90 -149.79 147.61 28.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.471 . . . . 72.05 110.937 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.638 HD13 HD22 ' A' ' 113' ' ' LEU . 12.0 mt -97.97 111.74 28.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.136 -0.484 . . . . 71.22 111.129 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 62.1 tttt -82.52 102.71 11.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 71.43 110.907 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -95.89 146.05 24.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 64.24 111.127 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.5 t -145.32 116.86 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.273 -0.421 . . . . 64.15 111.09 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 14.7 p -89.53 147.41 23.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 43.21 110.853 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 30.6 p -145.88 152.59 39.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.076 -0.511 . . . . 70.14 110.88 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 112.98 179.29 19.47 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.785 -0.721 . . . . 71.1 112.501 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.58 -64.0 1.11 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.725 0.298 . . . . 65.45 110.891 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 11.3 ttm-85 -133.39 83.78 2.08 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.265 -0.425 . . . . 62.31 110.897 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 13.6 mtmt 52.59 44.52 29.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 63.12 110.83 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -66.63 -49.18 67.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 73.1 110.871 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -144.96 132.02 4.53 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.774 -0.727 . . . . 44.11 112.524 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 50.8 mt -119.37 146.88 23.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.826 0.346 . . . . 74.14 111.129 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 58.9 mt -132.45 126.89 56.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 70.42 111.159 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 11.9 m-70 -109.63 135.34 50.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.258 -0.428 . . . . 74.51 110.893 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.26 116.91 22.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 73.0 111.191 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.498 HD23 ' CB ' ' A' ' 100' ' ' TRP . 17.7 tp -72.85 133.52 44.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 75.21 110.944 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.472 ' N ' HD12 ' A' ' 167' ' ' LEU . 10.9 mt -136.3 118.16 20.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 72.4 111.07 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.575 HG22 ' HB3' ' A' ' 149' ' ' CYS . 14.6 t -120.54 127.06 75.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.435 . . . . 74.44 111.133 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 63.6 36.64 10.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.213 -0.449 . . . . 72.21 110.853 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 62.84 43.04 7.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 72.34 110.927 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 20.4 mtt180 -142.14 128.12 19.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.112 -0.494 . . . . 62.12 110.862 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -62.48 146.47 51.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.199 -0.455 . . . . 73.32 110.916 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -121.85 131.29 24.46 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.685 0.755 . . . . 75.42 111.126 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 137.93 36.53 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.638 2.225 . . . . 73.21 112.351 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.12 105.1 17.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.465 . . . . 73.21 110.904 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 4.6 tp -52.11 130.55 30.41 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.138 -0.483 . . . . 61.54 110.916 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 53.7 p -121.06 -44.84 2.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 73.42 111.186 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 73.42 110.853 -179.933 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 CA-C-O 121.505 0.503 . . . . 74.15 112.552 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 161.17 46.97 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.76 2.307 . . . . 74.33 112.344 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -163.8 128.05 2.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 65.23 110.931 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 155.54 -161.33 30.49 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.747 -0.739 . . . . 72.45 112.478 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.4 m -163.97 57.1 0.16 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.866 0.365 . . . . 63.21 110.875 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -140.31 71.9 1.38 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.151 -0.477 . . . . 54.45 110.907 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -163.56 169.4 18.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.106 -0.497 . . . . 65.41 110.865 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.22 -68.24 0.2 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.144 -0.48 . . . . 61.33 110.887 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 25.3 m -129.7 38.81 3.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.257 -0.428 . . . . 73.25 110.845 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 6.1 mtpt -117.71 -30.79 5.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.094 -0.503 . . . . 72.11 110.908 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.498 ' O ' HG23 ' A' ' 97' ' ' THR . 82.3 p -94.17 40.61 1.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.292 -0.413 . . . . 74.42 111.094 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.498 HG23 ' O ' ' A' ' 96' ' ' THR . 1.1 p -159.47 128.1 5.12 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.214 -0.448 . . . . 74.34 111.093 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.03 152.2 23.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.196 -0.456 . . . . 51.32 110.897 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.78 HG22 HG22 ' A' ' 112' ' ' VAL . 0.5 OUTLIER -139.17 156.76 46.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.126 -0.488 . . . . 75.14 111.125 -179.869 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 100' ' ' TRP . . . . . 0.502 ' CB ' HD23 ' A' ' 167' ' ' LEU . 12.6 m-90 -151.62 127.28 10.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.23 -0.441 . . . . 73.33 111.004 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 18.8 t -105.63 115.21 46.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.236 -0.438 . . . . 55.45 111.156 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.918 HD11 HD12 ' A' ' 104' ' ' LEU . 0.5 OUTLIER -141.67 147.36 37.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.199 -0.455 . . . . 75.32 110.958 179.953 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 61.4 mtt180 -72.93 91.7 1.56 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 64.04 110.955 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.918 HD12 HD11 ' A' ' 102' ' ' LEU . 0.3 OUTLIER -121.64 152.01 39.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 74.31 110.898 -179.925 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 15.2 t0 65.09 14.51 9.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.144 -0.48 . . . . 63.12 110.854 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.7 0.12 79.17 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.773 -0.727 . . . . 65.42 112.498 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -139.94 172.73 12.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.843 0.354 . . . . 61.35 110.889 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -68.54 89.49 0.36 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.137 -0.483 . . . . 62.12 110.884 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.592 HD13 ' HB3' ' A' ' 104' ' ' LEU . 0.4 OUTLIER -76.21 130.63 38.49 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.126 -0.488 . . . . 73.33 110.951 -179.946 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 6.1 ttp180 -106.4 113.84 27.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 72.15 110.882 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.496 HG21 ' CD2' ' A' ' 167' ' ' LEU . 1.7 t -95.52 139.43 18.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 73.25 111.093 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.78 HG22 HG22 ' A' ' 99' ' ' THR . 92.0 t -136.46 124.95 36.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.473 . . . . 72.34 111.125 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.538 HD22 HD13 ' A' ' 151' ' ' ILE . 3.4 tp -111.16 105.45 14.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 71.32 110.943 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.484 ' HA ' HG22 ' A' ' 97' ' ' THR . 0.0 OUTLIER -80.19 134.85 36.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 73.01 110.884 179.918 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 3.9 mmmt -73.87 -16.72 61.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.074 -0.512 . . . . 75.33 110.849 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -51.45 -55.97 15.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.228 -0.442 . . . . 63.11 110.857 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.34 17.1 3.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 72.24 111.133 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' MET . . . . . 0.51 ' HA ' HD11 ' A' ' 113' ' ' LEU . 0.2 OUTLIER 61.95 18.11 9.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.44 . . . . 73.12 110.921 179.911 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.77 139.23 58.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.186 -0.461 . . . . 72.13 110.843 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 96.0 t -105.0 118.12 51.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.111 -0.495 . . . . 75.22 111.153 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -100.6 129.05 46.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 75.03 110.898 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -123.76 103.37 8.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 72.04 110.87 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 45.44 69.97 0.4 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 73.45 110.905 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 49.09 38.73 25.53 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.698 -0.763 . . . . 71.03 112.505 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -146.38 114.04 6.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.812 0.339 . . . . 70.01 110.877 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -53.39 160.38 1.19 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.249 -0.432 . . . . 70.21 110.856 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 30.2 mmm -126.82 163.62 23.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 74.41 110.875 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -118.79 106.44 12.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.239 -0.437 . . . . 74.13 110.848 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.548 HG22 ' HD2' ' A' ' 142' ' ' PHE . 17.1 p -95.55 -177.76 4.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.478 . . . . 64.04 111.155 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.431 ' HB2' ' HB2' ' A' ' 141' ' ' HIS . . . -92.5 -31.3 15.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.22 -0.445 . . . . 51.43 111.068 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 55.09 69.25 1.32 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.78 -0.724 . . . . 73.03 112.492 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -127.1 113.93 17.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.888 0.375 . . . . 50.13 110.899 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -85.16 115.72 23.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.457 . . . . 75.15 110.874 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.438 HG22 ' O ' ' A' ' 137' ' ' GLY . 22.1 m -84.82 -177.54 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.477 . . . . 61.14 111.143 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -53.02 -29.95 32.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.264 -0.425 . . . . 75.35 110.813 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.435 ' H ' HG23 ' A' ' 134' ' ' VAL . 0.2 OUTLIER -163.49 93.0 0.74 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 72.3 110.824 -179.985 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.438 ' O ' HG22 ' A' ' 134' ' ' VAL . . . 128.96 178.31 15.31 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.808 -0.71 . . . . 73.41 112.459 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.636 ' O ' ' HB3' ' A' ' 153' ' ' ALA . 0.1 OUTLIER -134.73 131.03 37.13 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.73 0.3 . . . . 70.11 111.175 -179.963 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -115.34 96.33 5.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 72.01 110.895 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.504 HG22 ' HB ' ' A' ' 129' ' ' THR . 0.0 OUTLIER -77.1 110.02 11.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.117 -0.492 . . . . 33.33 111.139 -179.918 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 141' ' ' HIS . . . . . 0.431 ' HB2' ' HB2' ' A' ' 130' ' ' ALA . 81.4 m-70 -106.93 104.26 13.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.259 -0.428 . . . . 74.02 110.862 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.548 ' HD2' HG22 ' A' ' 129' ' ' THR . 2.9 p90 -124.72 -175.96 3.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 75.25 110.856 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 58.4 p -148.71 160.78 42.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.12 -0.491 . . . . 75.31 110.84 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 90.8 t -135.2 97.92 2.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.12 -0.491 . . . . 43.02 111.137 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 54.49 -113.12 3.15 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.752 -0.737 . . . . 63.24 112.521 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -103.01 25.46 9.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.814 0.34 . . . . 53.01 110.899 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 22.9 m170 -111.18 -170.33 1.62 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 71.12 110.852 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -154.39 107.52 2.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.439 . . . . 62.14 110.821 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' CYS . . . . . 0.59 ' HB3' HG22 ' A' ' 169' ' ' VAL . 0.8 OUTLIER -142.69 161.81 37.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 64.21 110.91 -179.969 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -159.4 149.33 18.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.242 -0.435 . . . . 70.54 110.88 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.538 HD13 HD22 ' A' ' 113' ' ' LEU . 8.2 mt -99.12 113.82 35.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.121 -0.49 . . . . 74.34 111.162 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.54 102.67 10.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.102 -0.499 . . . . 74.23 110.921 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.636 ' HB3' ' O ' ' A' ' 138' ' ' THR . . . -100.57 145.46 28.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.24 -0.436 . . . . 71.33 111.113 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.3 t -144.84 133.74 17.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.202 -0.454 . . . . 74.51 111.144 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.1 p -104.94 130.34 53.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 64.45 110.891 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 79.7 p -143.7 150.83 39.26 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.151 -0.477 . . . . 64.12 110.824 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 129.26 171.27 12.92 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.698 -0.763 . . . . 55.34 112.452 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 38.1 mttp -63.78 94.55 0.1 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.795 0.331 . . . . 64.31 110.947 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 15.6 mtt-85 62.86 60.69 1.23 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.227 -0.442 . . . . 73.11 110.84 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 58.11 82.33 0.13 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.45 . . . . 74.53 110.885 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -103.73 -53.2 2.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.244 -0.435 . . . . 72.55 110.938 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -133.66 147.56 19.08 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.795 -0.717 . . . . 41.22 112.517 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 58.5 mt -127.45 140.99 47.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.768 0.318 . . . . 44.21 111.137 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 66.1 mt -124.99 141.1 46.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.469 . . . . 71.1 111.105 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -115.92 142.91 46.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.103 -0.498 . . . . 73.32 110.847 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.6 107.69 8.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.193 -0.458 . . . . 74.22 111.155 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.502 HD23 ' CB ' ' A' ' 100' ' ' TRP . 16.8 tp -68.61 133.01 47.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.243 -0.435 . . . . 71.01 110.939 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.492 ' N ' HD12 ' A' ' 167' ' ' LEU . 12.7 mt -135.01 113.89 16.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.45 . . . . 75.31 111.099 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.59 HG22 ' HB3' ' A' ' 149' ' ' CYS . 21.3 t -118.38 129.37 74.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 71.02 111.164 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 63.52 34.64 12.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.155 -0.475 . . . . 72.42 110.878 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 63.36 42.96 6.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 71.01 110.923 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -142.22 128.54 19.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.1 -0.5 . . . . 65.02 110.892 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -62.74 146.32 52.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.264 -0.425 . . . . 72.02 110.959 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -123.04 131.23 24.36 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.629 0.728 . . . . 70.33 111.101 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.68 137.01 34.68 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.628 2.219 . . . . 71.02 112.365 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.545 ' O ' HG23 ' A' ' 178' ' ' THR . 1.8 tm-20 -89.98 132.66 35.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.236 -0.438 . . . . 75.14 110.866 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 28.1 tp -55.53 114.23 1.76 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 74.2 110.943 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.545 HG23 ' O ' ' A' ' 176' ' ' GLU . 79.1 p -124.19 28.76 6.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 63.5 111.164 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.436 . . . . 65.15 110.843 179.958 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.237 0 CA-C-O 121.462 0.479 . . . . 73.34 112.468 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -38.86 7.22 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.733 2.288 . . . . 73.21 112.332 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.32 135.26 56.02 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.212 -0.449 . . . . 74.51 110.866 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 96.98 -140.23 14.93 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.739 -0.743 . . . . 55.43 112.514 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -156.28 173.13 17.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.842 0.353 . . . . 64.04 110.841 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -110.79 105.43 14.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.132 -0.486 . . . . 72.23 110.876 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 22.2 m-20 -78.13 -179.04 5.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 71.45 110.921 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -110.32 175.91 5.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 65.33 110.933 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -172.87 177.73 2.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.269 -0.423 . . . . 74.34 110.899 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -128.79 47.32 2.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 71.35 110.937 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.506 ' O ' HG23 ' A' ' 97' ' ' THR . 30.2 p -142.17 40.99 1.64 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.459 . . . . 54.2 111.166 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.506 HG23 ' O ' ' A' ' 96' ' ' THR . 1.0 OUTLIER -159.55 128.4 5.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 72.04 111.095 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.3 m -105.95 151.88 24.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.171 -0.468 . . . . 51.43 110.843 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.958 HG23 HG22 ' A' ' 112' ' ' VAL . 0.1 OUTLIER -141.24 158.86 43.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.155 -0.475 . . . . 74.01 111.112 -179.921 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 18.9 m-90 -151.75 157.32 41.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.218 -0.447 . . . . 74.04 110.93 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.3 t -135.9 114.98 16.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.448 . . . . 55.21 111.129 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 1.029 HD11 HD12 ' A' ' 104' ' ' LEU . 0.5 OUTLIER -142.61 148.47 37.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.1 -0.5 . . . . 71.12 110.956 179.973 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 2.4 mmm180 -72.48 89.66 1.28 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 64.22 110.886 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 1.029 HD12 HD11 ' A' ' 102' ' ' LEU . 0.3 OUTLIER -117.16 148.95 41.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.205 -0.452 . . . . 71.23 110.857 -179.906 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.3 t0 64.88 14.77 9.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.458 . . . . 61.43 110.878 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.67 1.25 77.67 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.675 -0.774 . . . . 63.42 112.487 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -139.82 168.83 18.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.858 0.361 . . . . 63.21 110.899 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.97 89.01 0.16 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 74.12 110.85 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.469 HD21 ' SG ' ' A' ' 122' ' ' CYS . 0.5 OUTLIER -79.8 130.61 35.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 74.21 110.846 -179.905 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 10.9 ttp85 -105.73 121.92 45.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 65.13 110.917 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.518 HG21 HD21 ' A' ' 167' ' ' LEU . 0.1 OUTLIER -106.59 144.99 14.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.145 -0.48 . . . . 62.43 111.139 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.958 HG22 HG23 ' A' ' 99' ' ' THR . 85.5 t -135.83 144.45 33.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.456 . . . . 73.22 111.169 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.527 HD11 ' HA ' ' A' ' 118' ' ' MET . 3.2 tp -128.8 102.84 6.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.253 -0.431 . . . . 74.13 110.989 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.26 132.56 42.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 44.33 110.853 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 9.9 mmmt -73.8 -16.88 61.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.446 . . . . 73.02 110.884 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -51.44 -55.81 16.72 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.225 -0.443 . . . . 74.41 110.865 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.45 17.06 3.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.188 -0.46 . . . . 75.32 111.094 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' MET . . . . . 0.527 ' HA ' HD11 ' A' ' 113' ' ' LEU . 8.8 ttm 60.11 29.71 19.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 72.41 110.869 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -77.07 145.39 37.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.211 -0.449 . . . . 73.15 110.783 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 36.1 t -104.75 139.24 26.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 70.54 111.108 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 2.7 t-105 -125.19 124.22 41.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.16 -0.473 . . . . 74.15 110.891 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' CYS . . . . . 0.469 ' SG ' HD21 ' A' ' 109' ' ' LEU . 0.8 OUTLIER -114.06 109.95 19.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.238 -0.437 . . . . 62.1 110.862 -179.954 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 12.6 m-20 47.89 67.43 0.83 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 55.22 110.826 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 49.52 30.64 13.21 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.701 -0.762 . . . . 62.21 112.497 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.66 120.95 20.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.863 0.363 . . . . 75.44 110.901 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 18.5 tttt -53.86 151.25 6.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.224 -0.444 . . . . 74.54 110.84 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' MET . . . . . 0.43 ' CE ' HG22 ' A' ' 144' ' ' VAL . 44.2 mmm -117.89 165.61 13.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 63.1 110.88 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -118.97 106.49 12.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 73.13 110.829 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.65 ' HB ' HG22 ' A' ' 140' ' ' THR . 21.7 p -95.95 168.93 10.33 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.126 -0.488 . . . . 53.43 111.137 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -95.82 -24.26 16.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.204 -0.453 . . . . 72.23 111.118 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 62.36 76.07 0.28 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.763 -0.732 . . . . 53.31 112.536 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -128.94 101.89 6.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.881 0.372 . . . . 74.52 110.894 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -88.25 129.9 35.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.149 -0.478 . . . . 73.44 110.853 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.664 HG13 ' HG3' ' A' ' 139' ' ' GLU . 27.3 m -81.51 -175.59 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.157 -0.474 . . . . 74.11 111.14 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -52.1 -28.84 19.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.466 . . . . 64.15 110.927 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.593 ' H ' HG23 ' A' ' 134' ' ' VAL . 0.0 OUTLIER -133.58 -76.13 0.48 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 74.54 110.93 179.919 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.523 ' C ' HG22 ' A' ' 134' ' ' VAL . . . -62.62 -162.8 0.31 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.718 -0.753 . . . . 71.24 112.494 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.559 ' O ' ' HB3' ' A' ' 153' ' ' ALA . 0.2 OUTLIER -142.39 133.41 25.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.827 0.346 . . . . 73.41 111.111 -179.851 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.664 ' HG3' HG13 ' A' ' 134' ' ' VAL . 18.5 mt-10 -108.2 132.96 53.1 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.253 -0.431 . . . . 72.53 110.884 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.65 HG22 ' HB ' ' A' ' 129' ' ' THR . 0.0 OUTLIER -118.67 110.28 17.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.155 -0.475 . . . . 43.33 111.067 -179.821 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 22.6 m-70 -100.88 110.5 22.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.157 -0.474 . . . . 74.42 110.868 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.757 ' CE2' HD12 ' A' ' 151' ' ' ILE . 5.9 p90 -135.38 134.7 40.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 73.14 110.908 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 2.9 p -84.39 151.85 24.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.153 -0.476 . . . . 32.51 110.865 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.43 HG22 ' CE ' ' A' ' 127' ' ' MET . 94.0 t -136.74 97.98 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.117 -0.492 . . . . 60.31 111.096 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 54.2 -106.34 0.47 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.731 -0.747 . . . . 64.32 112.492 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 22.8 t30 -116.28 26.32 10.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.868 0.366 . . . . 73.24 110.851 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 50.3 m-70 -125.19 -169.93 2.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 61.21 110.823 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -143.18 105.61 4.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.261 -0.427 . . . . 74.23 110.894 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' CYS . . . . . 0.432 ' SG ' HG13 ' A' ' 169' ' ' VAL . 13.3 m -120.5 158.41 27.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.444 . . . . 75.31 110.865 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -158.72 143.61 16.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 73.14 110.886 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.757 HD12 ' CE2' ' A' ' 142' ' ' PHE . 3.1 mt -99.27 111.06 27.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.139 -0.482 . . . . 71.41 111.178 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 7.8 tttm -80.87 102.96 10.38 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.194 -0.457 . . . . 72.43 110.877 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.559 ' HB3' ' O ' ' A' ' 138' ' ' THR . . . -92.5 132.45 36.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.246 -0.433 . . . . 54.22 111.092 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.5 t -127.0 125.6 66.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.243 -0.435 . . . . 62.45 111.105 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.3 p -93.56 136.97 33.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 71.23 110.798 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 1.4 p -138.94 146.12 40.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.08 -0.509 . . . . 71.43 110.793 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 132.44 162.48 10.34 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.679 -0.772 . . . . 65.11 112.501 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -54.72 -41.37 70.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.816 0.341 . . . . 61.0 110.898 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 12.9 mmt180 -136.35 46.08 2.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.237 -0.438 . . . . 63.35 110.843 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.54 74.23 0.36 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.191 -0.459 . . . . 75.43 110.908 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -113.04 -36.58 5.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.222 -0.444 . . . . 72.31 110.888 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -112.15 111.24 2.79 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.71 -0.757 . . . . 73.44 112.5 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 46.2 mt -109.91 147.98 13.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.803 0.335 . . . . 63.33 111.084 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 66.4 mt -137.88 122.17 22.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.136 -0.484 . . . . 74.42 111.191 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 17.1 m-70 -94.95 135.82 36.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 62.32 110.864 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.09 106.75 10.16 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.147 -0.479 . . . . 75.02 111.095 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.518 HD21 HG21 ' A' ' 111' ' ' VAL . 43.9 tp -66.74 136.47 55.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.215 -0.448 . . . . 74.05 110.895 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 10.2 mt -137.09 125.73 34.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.196 -0.456 . . . . 71.5 111.171 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.432 HG13 ' SG ' ' A' ' 149' ' ' CYS . 67.4 t -122.6 119.89 59.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 71.3 111.146 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 64.0 39.34 8.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 72.43 110.847 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 63.23 43.06 6.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 75.42 110.886 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -138.94 127.14 22.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.227 -0.442 . . . . 65.12 110.882 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -62.44 146.38 51.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.18 -0.464 . . . . 70.5 110.888 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.712 HD12 HD22 ' A' ' 102' ' ' LEU . 0.9 OUTLIER -119.99 130.88 24.62 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.645 0.736 . . . . 74.11 111.136 179.921 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 127.64 14.87 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.642 2.228 . . . . 72.34 112.302 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -93.29 126.63 38.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 64.44 110.888 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.16 99.33 5.38 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.222 -0.445 . . . . 44.43 110.927 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 3.1 t -153.03 151.47 30.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 71.54 111.104 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.127 -0.488 . . . . 74.35 110.88 -179.964 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 CA-C-O 121.451 0.473 . . . . 60.31 112.502 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.74 -177.29 1.8 Allowed 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.67 2.247 . . . . 71.53 112.328 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.8 mt -100.89 70.89 1.41 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.179 -0.464 . . . . 74.32 110.87 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -111.37 -67.22 0.54 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.804 -0.712 . . . . 72.22 112.481 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -175.25 -69.38 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.94 0.4 . . . . 75.31 110.898 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -165.89 156.85 13.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.056 -0.52 . . . . 72.23 110.877 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 9.0 m-20 -121.44 155.94 33.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.087 -0.506 . . . . 71.44 110.864 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 3.8 mtt180 -55.75 133.47 50.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.127 -0.488 . . . . 73.25 110.866 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.8 p -103.92 54.16 0.74 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.141 -0.481 . . . . 50.42 110.835 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -90.28 -28.79 18.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.106 -0.497 . . . . 74.13 110.91 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.497 ' O ' HG23 ' A' ' 97' ' ' THR . 16.6 p -124.36 26.48 7.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.45 . . . . 73.5 111.132 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.567 HG22 ' HA ' ' A' ' 114' ' ' GLU . 1.0 OUTLIER -159.48 128.04 5.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 63.2 111.176 179.972 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.2 m -106.19 153.33 22.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.185 -0.462 . . . . 73.5 110.813 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.56 HG22 HG22 ' A' ' 112' ' ' VAL . 78.9 p -138.54 155.05 48.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.095 -0.502 . . . . 71.41 111.141 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' TRP . . . . . 0.414 ' CB ' HD23 ' A' ' 167' ' ' LEU . 10.8 m-90 -151.52 123.64 8.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 75.15 110.903 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 19.5 t -105.14 114.9 45.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.246 -0.434 . . . . 62.33 111.168 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.868 HD11 HD12 ' A' ' 104' ' ' LEU . 0.5 OUTLIER -142.74 146.96 34.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.166 -0.47 . . . . 75.23 110.936 179.952 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -73.85 93.0 2.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 75.22 110.914 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.868 HD12 HD11 ' A' ' 102' ' ' LEU . 0.4 OUTLIER -123.54 152.87 41.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 53.42 110.922 -179.938 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.1 t70 64.8 15.03 9.59 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.201 -0.454 . . . . 74.4 110.882 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 88.55 0.65 81.81 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.79 -0.719 . . . . 61.34 112.548 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -139.85 172.92 12.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.796 0.331 . . . . 65.0 110.909 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.69 89.0 0.37 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.134 -0.485 . . . . 72.21 110.877 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.571 HD13 ' HB3' ' A' ' 104' ' ' LEU . 0.5 OUTLIER -74.12 125.41 28.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.147 -0.479 . . . . 65.25 110.911 -179.951 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 3.6 ttm180 -104.54 109.63 21.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 74.12 110.888 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.483 HG21 HD21 ' A' ' 167' ' ' LEU . 0.9 OUTLIER -95.78 136.19 27.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 54.12 111.111 179.995 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.56 HG22 HG22 ' A' ' 99' ' ' THR . 94.0 t -136.25 127.03 42.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.097 -0.501 . . . . 72.43 111.127 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.7 HD22 HD13 ' A' ' 151' ' ' ILE . 3.9 tp -110.11 107.31 17.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.48 . . . . 74.4 110.885 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.567 ' HA ' HG22 ' A' ' 97' ' ' THR . 0.0 OUTLIER -83.17 136.08 34.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 52.43 110.918 179.952 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 6.6 mmmt -73.54 -16.34 61.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.171 -0.468 . . . . 71.04 110.888 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -51.51 -55.49 18.68 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.237 -0.438 . . . . 73.13 110.904 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -136.43 17.0 3.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 75.1 111.187 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' MET . . . . . 0.528 ' HA ' HD11 ' A' ' 113' ' ' LEU . 70.9 mtp 58.49 23.25 10.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 64.21 110.849 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.99 147.61 42.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 75.53 110.778 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.547 HG22 HD12 ' A' ' 151' ' ' ILE . 85.8 t -105.13 122.54 58.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.138 -0.483 . . . . 75.11 111.176 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 2.8 t90 -103.63 131.78 50.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.203 -0.453 . . . . 61.12 110.926 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 1.2 m -126.86 108.21 10.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.286 -0.415 . . . . 54.21 110.847 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 39.42 70.1 0.25 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 73.23 110.83 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 49.75 42.42 36.92 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.775 -0.726 . . . . 64.25 112.466 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -148.12 110.09 4.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.885 0.374 . . . . 72.22 110.917 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.3 154.95 2.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 64.21 110.912 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' MET . . . . . 0.516 ' CE ' HG22 ' A' ' 144' ' ' VAL . 29.9 mmm -124.61 160.53 28.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 74.41 110.848 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -115.47 106.96 14.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 63.44 110.845 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.728 ' HB ' HG22 ' A' ' 140' ' ' THR . 18.8 p -95.36 179.03 5.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.171 -0.468 . . . . 74.52 111.098 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.502 ' HB2' ' HB2' ' A' ' 141' ' ' HIS . . . -90.58 -40.41 11.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 63.25 111.098 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 58.6 60.23 9.31 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.769 -0.729 . . . . 72.21 112.449 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -115.43 109.23 17.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.834 0.349 . . . . 62.24 110.973 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -70.92 130.08 40.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.128 -0.487 . . . . 73.3 110.908 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.535 HG23 ' H ' ' A' ' 136' ' ' ASP . 27.8 m -102.94 -177.0 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.159 -0.473 . . . . 71.25 111.134 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -53.21 -29.58 32.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 74.14 110.894 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.535 ' H ' HG23 ' A' ' 134' ' ' VAL . 0.2 OUTLIER -164.22 92.47 0.65 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.121 -0.491 . . . . 74.3 110.788 179.999 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.452 ' O ' HG22 ' A' ' 134' ' ' VAL . . . 127.4 -176.56 17.83 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.782 -0.723 . . . . 31.13 112.493 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.575 ' O ' ' HB3' ' A' ' 153' ' ' ALA . 0.1 OUTLIER -135.25 130.82 35.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.683 0.278 . . . . 70.43 111.155 -179.858 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -113.73 96.87 6.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 73.24 110.867 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.728 HG22 ' HB ' ' A' ' 129' ' ' THR . 0.0 OUTLIER -81.42 110.43 16.83 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.127 -0.488 . . . . 74.21 111.175 -179.965 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 141' ' ' HIS . . . . . 0.502 ' HB2' ' HB2' ' A' ' 130' ' ' ALA . 82.4 m-70 -103.89 106.01 16.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.446 . . . . 61.1 110.827 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.435 ' HB3' HG22 ' A' ' 129' ' ' THR . 20.0 p90 -124.48 131.99 53.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 62.11 110.871 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 22.9 p -82.02 146.9 29.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.459 . . . . 63.24 110.852 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.516 HG22 ' CE ' ' A' ' 127' ' ' MET . 21.9 t -137.68 98.35 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.097 -0.501 . . . . 75.12 111.137 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 52.34 -121.28 13.72 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.71 -0.757 . . . . 42.31 112.501 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -98.75 26.74 5.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.901 0.382 . . . . 71.11 110.886 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 31.1 m-70 -126.7 174.21 8.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.177 -0.465 . . . . 71.41 110.834 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -132.79 88.35 2.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 73.41 110.821 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' CYS . . . . . 0.482 ' SG ' HG13 ' A' ' 169' ' ' VAL . 10.4 m -100.67 164.78 11.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.166 -0.47 . . . . 75.23 110.938 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -167.85 144.85 4.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.213 -0.449 . . . . 74.42 110.97 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.7 HD13 HD22 ' A' ' 113' ' ' LEU . 22.7 mt -97.6 111.4 27.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.117 -0.492 . . . . 53.31 111.066 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 1.8 ttmt -80.12 102.82 9.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 73.22 110.927 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.575 ' HB3' ' O ' ' A' ' 138' ' ' THR . . . -93.38 146.47 23.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.271 -0.422 . . . . 74.43 111.067 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.2 t -144.28 121.42 5.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 54.32 111.157 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -94.26 137.21 33.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 72.32 110.889 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 2.2 t -132.45 133.21 43.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.112 -0.494 . . . . 61.45 110.833 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 143.87 -174.94 24.04 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.795 -0.717 . . . . 64.52 112.488 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.96 -26.51 67.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.728 0.299 . . . . 73.53 110.881 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.65 -41.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.267 -0.424 . . . . 65.31 110.861 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 25.4 tttp -162.56 55.75 0.22 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 74.13 110.842 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -76.74 -62.66 1.56 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.267 -0.424 . . . . 61.24 110.86 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -141.35 160.38 26.84 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.813 -0.708 . . . . 55.32 112.457 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 64.1 mt -136.4 139.61 45.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.82 0.343 . . . . 74.3 111.162 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 64.4 mt -126.7 131.05 71.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.138 -0.483 . . . . 73.45 111.13 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' HIS . . . . . 0.415 ' CG ' HD23 ' A' ' 113' ' ' LEU . 14.5 m80 -105.83 139.63 40.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.445 . . . . 62.31 110.883 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.64 103.98 6.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.435 . . . . 73.31 111.155 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.483 HD21 HG21 ' A' ' 111' ' ' VAL . 28.2 tp -65.5 137.8 57.66 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.243 -0.435 . . . . 63.23 110.878 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.462 ' H ' HD12 ' A' ' 167' ' ' LEU . 9.8 mt -137.6 130.04 41.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 33.01 111.168 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.482 HG13 ' SG ' ' A' ' 149' ' ' CYS . 74.2 t -126.51 116.36 44.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.451 . . . . 74.25 111.166 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.4 t0 63.64 46.12 4.29 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.196 -0.456 . . . . 62.24 110.82 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 1.6 m120 59.08 42.93 18.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.262 -0.426 . . . . 51.33 110.879 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 10.4 mtm180 -139.69 124.99 18.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 74.11 110.955 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -62.55 146.48 51.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 64.32 110.84 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.537 HD12 HD22 ' A' ' 102' ' ' LEU . 0.9 OUTLIER -120.32 130.97 24.59 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.597 0.713 . . . . 73.22 111.195 179.885 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.74 134.15 27.33 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.64 2.227 . . . . 75.33 112.402 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -92.4 131.7 37.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.269 -0.423 . . . . 73.53 110.907 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.68 136.5 47.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 54.41 110.889 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 69.4 p -145.99 160.84 41.29 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.149 -0.478 . . . . 72.14 111.154 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.216 -0.447 . . . . 73.44 110.936 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.349 0 CA-C-O 121.453 0.474 . . . . 75.25 112.533 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 154.0 68.43 Favored 'Trans proline' 0 C--O 1.233 0.231 0 C-N-CA 122.704 2.269 . . . . 74.32 112.386 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -135.21 147.67 49.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.236 -0.438 . . . . 72.13 110.95 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 130.8 -28.8 3.66 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.748 -0.739 . . . . 65.25 112.426 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 62.51 168.42 0.12 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.852 0.358 . . . . 75.33 110.869 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 60.13 44.07 13.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.127 -0.488 . . . . 75.31 110.905 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -77.96 119.94 22.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 72.24 110.88 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 8.0 mtt85 -149.29 -57.86 0.2 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.146 -0.479 . . . . 74.01 110.867 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -52.27 130.55 31.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 73.02 110.837 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.12 126.45 0.15 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.071 -0.513 . . . . 74.51 110.949 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.497 ' O ' HG23 ' A' ' 97' ' ' THR . 0.2 OUTLIER -90.07 148.04 23.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.251 -0.432 . . . . 73.11 111.083 -179.939 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.66 HG22 ' HA ' ' A' ' 114' ' ' GLU . 1.0 OUTLIER -159.74 127.77 4.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 72.22 111.114 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 62.5 m -106.52 116.83 32.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 71.44 110.841 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.536 HG22 HG22 ' A' ' 112' ' ' VAL . 71.6 p -112.34 163.88 13.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.15 -0.477 . . . . 73.22 111.134 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' TRP . . . . . 0.46 ' CB ' HD23 ' A' ' 167' ' ' LEU . 21.8 m-90 -149.56 152.17 35.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.196 -0.456 . . . . 74.2 110.86 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 20.3 t -124.84 115.11 43.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.217 -0.447 . . . . 61.0 111.079 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.901 HD11 HD12 ' A' ' 104' ' ' LEU . 0.5 OUTLIER -141.17 147.22 38.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.132 -0.485 . . . . 75.05 110.934 179.926 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 8.7 mtm-85 -72.17 90.99 1.25 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 72.32 110.913 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.901 HD12 HD11 ' A' ' 102' ' ' LEU . 0.4 OUTLIER -121.62 151.62 40.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.105 -0.498 . . . . 72.22 110.922 -179.969 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.7 t70 65.11 14.59 9.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 73.31 110.853 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.63 0.14 79.38 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.738 -0.744 . . . . 63.12 112.479 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -139.88 172.77 12.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.839 0.352 . . . . 75.51 110.898 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -69.02 89.22 0.42 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.206 -0.452 . . . . 63.42 110.906 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.601 HD13 ' HB3' ' A' ' 104' ' ' LEU . 0.4 OUTLIER -75.56 130.95 39.65 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.164 -0.471 . . . . 73.23 110.897 -179.92 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 8.2 ttt180 -107.02 113.12 26.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 74.34 110.88 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.555 HG21 ' CD2' ' A' ' 167' ' ' LEU . 0.8 OUTLIER -95.52 141.2 15.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 75.43 111.19 179.937 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.536 HG22 HG22 ' A' ' 99' ' ' THR . 47.5 t -135.85 126.41 42.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 73.35 111.149 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.565 HD11 ' HA ' ' A' ' 118' ' ' MET . 4.2 tp -113.17 99.82 8.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.463 . . . . 64.54 110.897 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.66 ' HA ' HG22 ' A' ' 97' ' ' THR . 0.0 OUTLIER -76.59 123.54 26.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 71.33 110.924 179.916 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.47 -16.07 59.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 62.14 110.867 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -51.4 -56.02 15.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 74.34 110.906 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 76.3 p -132.49 16.94 4.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 72.25 111.128 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' MET . . . . . 0.565 ' HA ' HD11 ' A' ' 113' ' ' LEU . 48.2 mtp 55.7 28.43 12.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 63.5 110.868 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -81.37 147.14 29.97 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.212 -0.449 . . . . 61.0 110.867 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.51 HG22 HD12 ' A' ' 151' ' ' ILE . 79.5 t -104.81 129.41 57.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.445 . . . . 71.23 111.163 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 6.1 t-105 -119.95 109.57 15.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.173 -0.467 . . . . 74.44 110.962 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' CYS . . . . . 0.538 ' HB3' HD21 ' A' ' 109' ' ' LEU . 7.7 m -97.0 117.81 32.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.441 . . . . 75.54 110.939 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 64.8 -82.75 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.468 . . . . 72.3 110.874 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -156.88 46.17 0.49 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.774 -0.727 . . . . 52.15 112.449 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -159.01 134.29 8.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.908 0.385 . . . . 62.35 110.899 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 24.9 ttpt -53.74 162.11 0.96 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.161 -0.472 . . . . 72.22 110.897 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 31.4 mmm -127.76 167.11 16.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 64.04 110.888 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -119.19 106.62 12.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.285 -0.416 . . . . 64.05 110.92 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.723 ' CB ' HG22 ' A' ' 140' ' ' THR . 19.6 p -95.61 -175.3 3.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.118 -0.492 . . . . 60.12 111.127 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -104.95 -25.16 12.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 53.42 111.087 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 53.23 47.63 61.04 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.752 -0.737 . . . . 73.12 112.453 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -81.92 101.97 10.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.816 0.341 . . . . 73.43 110.945 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -77.4 130.91 37.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.247 -0.433 . . . . 73.43 110.836 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.424 HG23 ' H ' ' A' ' 136' ' ' ASP . 17.4 m -112.54 -178.16 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 54.24 111.128 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -55.58 -26.27 42.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.138 -0.483 . . . . 73.02 110.895 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.424 ' H ' HG23 ' A' ' 134' ' ' VAL . 0.1 OUTLIER -159.88 101.56 1.46 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.143 -0.48 . . . . 74.22 110.932 179.921 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 113.73 -179.26 18.78 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.669 -0.777 . . . . 73.02 112.462 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.632 ' O ' ' HB3' ' A' ' 153' ' ' ALA . 0.1 OUTLIER -134.83 130.8 36.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.74 0.305 . . . . 64.34 111.214 -179.933 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -106.43 96.37 6.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.256 -0.429 . . . . 73.23 110.886 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.723 HG22 ' CB ' ' A' ' 129' ' ' THR . 0.0 OUTLIER -81.86 110.09 16.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 71.43 111.173 -179.9 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 76.7 m-70 -106.86 106.42 16.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 73.4 110.814 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -121.74 128.82 52.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 72.45 110.855 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 56.1 p -89.35 159.3 17.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.112 -0.495 . . . . 65.12 110.85 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 87.0 t -147.86 109.22 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 73.12 111.101 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 52.0 -118.92 7.92 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.68 -0.771 . . . . 74.33 112.563 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -107.16 23.49 14.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.881 0.372 . . . . 65.12 110.916 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -112.57 -169.6 1.51 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 72.13 110.893 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -151.64 118.9 5.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 73.53 110.866 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' CYS . . . . . 0.611 ' CB ' HG22 ' A' ' 169' ' ' VAL . 1.4 p -142.53 163.67 32.21 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.274 -0.421 . . . . 72.31 110.898 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -167.16 145.53 4.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.173 -0.467 . . . . 75.41 110.878 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.51 HD12 HG22 ' A' ' 120' ' ' VAL . 22.5 mt -97.58 111.55 27.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.086 -0.506 . . . . 72.12 111.172 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -80.9 106.96 13.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 73.22 110.879 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.632 ' HB3' ' O ' ' A' ' 138' ' ' THR . . . -101.83 146.6 27.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.256 -0.429 . . . . 73.1 111.126 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.3 t -142.05 132.94 25.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.246 -0.434 . . . . 62.32 111.108 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.1 p -101.17 140.35 35.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.09 -0.505 . . . . 71.52 110.881 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -133.32 136.74 45.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.138 -0.483 . . . . 71.1 110.841 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 135.73 -169.16 23.64 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.763 -0.732 . . . . 73.02 112.477 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 14.2 mttt -64.2 -28.6 69.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.734 0.302 . . . . 73.52 110.891 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.73 -46.9 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.25 -0.432 . . . . 75.2 110.904 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 51.6 pttt -162.79 56.21 0.2 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 54.23 110.901 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -75.2 -56.1 5.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.233 -0.439 . . . . 62.22 110.915 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -138.85 141.56 12.05 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.714 -0.755 . . . . 75.12 112.458 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 73.7 mt -125.4 137.19 58.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.739 0.304 . . . . 53.24 111.188 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 2.8 mt -123.94 131.53 72.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 74.4 111.08 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 16.4 m80 -105.09 144.94 31.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 74.44 110.813 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.99 105.09 5.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.142 -0.481 . . . . 72.14 111.07 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.611 HD12 ' N ' ' A' ' 168' ' ' ILE . 11.7 tp -64.06 135.21 56.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 71.22 110.923 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.611 ' N ' HD12 ' A' ' 167' ' ' LEU . 11.0 mt -136.22 104.78 4.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 72.55 111.118 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.611 HG22 ' CB ' ' A' ' 149' ' ' CYS . 42.2 t -112.66 135.42 52.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 72.23 111.096 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 63.62 31.69 14.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.137 -0.483 . . . . 73.0 110.86 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 2.2 t30 63.33 42.93 6.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.46 . . . . 73.34 110.851 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 9.9 mtt85 -143.94 130.18 19.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 74.43 110.968 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -62.61 146.42 52.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.257 -0.429 . . . . 74.13 110.879 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -125.03 131.34 24.08 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.686 0.755 . . . . 62.21 111.078 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.86 133.22 24.87 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.658 2.238 . . . . 71.14 112.356 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -89.87 133.67 34.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 73.13 110.876 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.53 106.82 17.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.192 -0.458 . . . . 72.02 110.871 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 8.3 t -161.39 154.94 21.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.185 -0.461 . . . . 73.12 111.113 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 65.5 mm-40 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 74.41 110.93 179.994 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 CA-C-O 121.447 0.471 . . . . 75.54 112.499 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -69.83 -178.07 2.2 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.719 2.279 . . . . 61.5 112.275 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -160.51 94.46 1.06 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 72.41 110.901 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -97.17 -147.4 22.55 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.795 -0.717 . . . . 42.04 112.536 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.2 p -173.03 120.49 0.36 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.854 0.359 . . . . 44.32 110.911 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -88.58 -66.15 0.95 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.152 -0.476 . . . . 73.53 110.977 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -173.91 127.15 0.38 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.105 -0.498 . . . . 75.11 110.876 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 2.2 tpt85 -142.51 156.13 45.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.117 -0.492 . . . . 74.41 110.845 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -111.25 89.75 3.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.127 -0.488 . . . . 35.0 110.859 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -132.33 174.84 9.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.1 -0.5 . . . . 73.41 110.892 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.492 ' O ' HG23 ' A' ' 97' ' ' THR . 15.2 t -140.54 21.11 2.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 63.23 111.117 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.587 HG22 ' HA ' ' A' ' 114' ' ' GLU . 1.0 OUTLIER -159.62 128.22 5.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.231 -0.44 . . . . 75.02 111.157 -179.964 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.4 m -105.8 147.47 28.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 72.12 110.872 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' THR . . . . . 1.075 HG22 HG22 ' A' ' 112' ' ' VAL . 0.7 OUTLIER -136.35 138.25 41.45 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.118 -0.492 . . . . 44.22 111.176 -179.972 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 100' ' ' TRP . . . . . 0.491 ' CB ' HD23 ' A' ' 167' ' ' LEU . 11.1 m-90 -133.42 123.0 24.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.198 -0.456 . . . . 64.34 110.995 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 19.9 t -102.48 114.92 43.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.339 -0.391 . . . . 74.32 111.114 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.915 HD11 HD12 ' A' ' 104' ' ' LEU . 0.5 OUTLIER -142.61 147.27 35.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.153 -0.476 . . . . 75.21 110.925 -179.977 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 83.4 mtt180 -74.34 92.08 2.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 73.02 110.946 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.915 HD12 HD11 ' A' ' 102' ' ' LEU . 0.4 OUTLIER -121.48 153.57 37.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.193 -0.458 . . . . 63.5 110.947 -179.935 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 65.03 14.65 9.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.175 -0.466 . . . . 72.1 110.873 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.61 -0.06 79.7 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.705 -0.759 . . . . 63.51 112.492 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -139.82 172.67 12.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.824 0.345 . . . . 72.31 110.897 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.3 88.64 0.32 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.141 -0.481 . . . . 72.21 110.875 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.628 HD12 ' ND2' ' A' ' 123' ' ' ASN . 0.5 OUTLIER -75.45 125.82 29.76 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.251 -0.431 . . . . 62.2 110.911 -179.954 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 10.1 ttt180 -102.4 111.06 23.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 74.23 110.881 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.4 t -94.8 135.89 27.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.14 -0.482 . . . . 73.12 111.153 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 1.075 HG22 HG22 ' A' ' 99' ' ' THR . 99.4 t -136.55 126.43 39.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 52.25 111.137 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.597 HD11 ' HA ' ' A' ' 118' ' ' MET . 2.7 tp -111.6 103.84 12.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 62.32 110.871 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.587 ' HA ' HG22 ' A' ' 97' ' ' THR . 0.1 OUTLIER -80.26 129.69 34.68 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.183 -0.462 . . . . 75.51 110.891 179.947 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 58.4 mttt -68.71 -15.41 63.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 73.34 110.895 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -51.27 -52.72 42.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.273 -0.421 . . . . 61.54 110.831 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -138.2 16.93 2.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.213 -0.449 . . . . 71.22 111.136 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' MET . . . . . 0.597 ' HA ' HD11 ' A' ' 113' ' ' LEU . 1.9 ttp 57.48 26.54 12.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 74.14 110.874 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -80.38 150.68 29.75 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.29 -0.414 . . . . 71.44 110.846 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.534 HG22 HD12 ' A' ' 151' ' ' ILE . 62.0 t -104.86 134.37 46.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.15 -0.477 . . . . 71.04 111.13 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 1.1 t90 -123.5 116.2 22.8 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.184 -0.462 . . . . 73.12 110.909 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' CYS . . . . . 0.552 ' HB2' HD21 ' A' ' 109' ' ' LEU . 17.9 p -120.95 132.94 55.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.302 -0.408 . . . . 72.43 110.819 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ASN . . . . . 0.628 ' ND2' HD12 ' A' ' 109' ' ' LEU . 58.9 m-20 44.57 51.54 7.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.125 -0.489 . . . . 61.4 110.865 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 50.82 40.83 42.67 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.748 -0.739 . . . . 63.52 112.456 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.46 122.61 12.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.854 0.359 . . . . 65.1 110.965 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.49 147.98 9.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.44 . . . . 71.21 110.894 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' MET . . . . . 0.463 ' SD ' HG22 ' A' ' 144' ' ' VAL . 32.5 mmm -114.14 169.05 9.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 63.42 110.847 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.56 106.37 12.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 74.0 110.903 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.671 ' HB ' HG22 ' A' ' 140' ' ' THR . 17.4 p -99.35 -175.11 2.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 63.22 111.178 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.623 ' HB2' ' HB2' ' A' ' 141' ' ' HIS . . . -94.77 -44.8 7.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 75.11 111.06 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 65.11 52.87 37.3 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.707 -0.759 . . . . 64.04 112.483 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -103.89 102.18 11.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.889 0.376 . . . . 65.43 110.903 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -73.01 114.36 11.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 74.33 110.833 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.56 HG23 ' H ' ' A' ' 136' ' ' ASP . 35.2 m -92.4 -179.98 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.101 -0.499 . . . . 63.44 111.093 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -52.62 -30.14 29.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.189 -0.46 . . . . 62.31 110.885 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.56 ' H ' HG23 ' A' ' 134' ' ' VAL . 0.2 OUTLIER -161.54 101.63 1.19 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.472 . . . . 74.11 110.817 -179.969 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.52 ' O ' HG22 ' A' ' 134' ' ' VAL . . . 116.4 176.48 18.0 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.767 -0.73 . . . . 61.54 112.508 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.654 ' O ' ' HB3' ' A' ' 153' ' ' ALA . 0.1 OUTLIER -134.86 130.91 36.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.735 0.302 . . . . 71.44 111.203 -179.896 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -111.91 96.3 5.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 64.51 110.882 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.671 HG22 ' HB ' ' A' ' 129' ' ' THR . 0.0 OUTLIER -78.81 110.23 13.8 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.22 -0.446 . . . . 71.34 111.157 -179.939 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 141' ' ' HIS . . . . . 0.623 ' HB2' ' HB2' ' A' ' 130' ' ' ALA . 82.7 m-70 -104.52 106.38 16.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 75.03 110.87 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.527 ' HD2' HG22 ' A' ' 129' ' ' THR . 3.4 p90 -128.09 175.52 8.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 71.5 110.845 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 83.3 p -142.42 155.75 45.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.088 -0.506 . . . . 73.23 110.911 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.554 HG11 HD22 ' A' ' 104' ' ' LEU . 84.7 t -136.87 105.29 4.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.469 . . . . 71.54 111.073 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 62.34 -103.48 0.61 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.726 -0.749 . . . . 62.43 112.496 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -114.23 -27.43 7.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.81 0.338 . . . . 73.14 110.893 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 52.0 m-70 -61.37 -170.43 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.191 -0.459 . . . . 73.34 110.855 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -152.6 116.39 4.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 73.03 110.921 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' CYS . . . . . 0.597 ' HB3' HG22 ' A' ' 169' ' ' VAL . 0.7 OUTLIER -142.66 161.98 36.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.242 -0.435 . . . . 72.32 110.852 -179.844 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 18.3 p90 -156.71 152.72 27.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 73.13 110.905 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.563 HD13 HD22 ' A' ' 113' ' ' LEU . 13.4 mt -99.55 111.53 29.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 71.31 111.14 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.587 ' HD3' HD12 ' A' ' 168' ' ' ILE . 1.1 ttpp -81.89 102.62 10.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 65.35 110.893 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.654 ' HB3' ' O ' ' A' ' 138' ' ' THR . . . -98.6 147.99 24.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.281 -0.418 . . . . 52.32 111.119 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.5 t -145.18 122.44 4.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 54.3 111.122 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.2 p -89.67 139.97 30.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.472 . . . . 70.53 110.852 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 14.7 t -141.67 142.17 33.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.084 -0.507 . . . . 52.23 110.859 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 128.65 175.64 14.14 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.792 -0.718 . . . . 52.01 112.519 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 9.6 mttt -58.48 -38.11 76.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.749 0.309 . . . . 74.04 110.938 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -158.74 76.98 0.75 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 70.31 110.868 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 2.3 mtmt 55.85 28.89 13.11 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.208 -0.451 . . . . 73.21 110.88 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -54.39 -44.74 72.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 71.32 110.892 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -143.87 132.3 4.83 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.705 -0.759 . . . . 43.22 112.434 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 50.5 mt -121.13 147.15 25.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.812 0.339 . . . . 64.52 111.126 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 59.9 mt -129.45 131.01 67.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 62.24 111.118 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 15.5 m-70 -108.69 137.27 46.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.446 . . . . 61.25 110.869 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.99 112.0 13.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.253 -0.43 . . . . 64.21 111.177 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.491 HD23 ' CB ' ' A' ' 100' ' ' TRP . 18.1 tp -70.22 134.85 48.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 55.11 110.938 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.587 HD12 ' HD3' ' A' ' 152' ' ' LYS . 10.7 mt -136.74 121.45 25.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.474 . . . . 75.3 111.098 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.597 HG22 ' HB3' ' A' ' 149' ' ' CYS . 16.4 t -121.86 124.08 70.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 72.25 111.178 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 63.63 37.96 9.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.235 -0.439 . . . . 73.03 110.868 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 62.83 42.9 7.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.142 -0.481 . . . . 51.35 110.887 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -140.67 127.98 21.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.169 -0.469 . . . . 71.41 110.879 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -62.67 146.5 52.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.45 . . . . 75.43 110.856 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -122.18 131.31 24.43 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.675 0.75 . . . . 74.41 111.043 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 137.79 36.23 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.731 2.288 . . . . 73.32 112.292 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.03 -172.66 3.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.462 . . . . 63.12 110.914 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 21.2 tp -79.84 -66.27 0.9 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.169 -0.469 . . . . 64.03 110.928 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 6.2 t -66.62 137.18 56.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.157 -0.474 . . . . 72.45 111.189 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.252 -0.431 . . . . 74.44 110.973 179.927 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.382 0 CA-C-O 121.452 0.473 . . . . 23.5 112.489 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.68 130.54 19.62 Favored 'Trans proline' 0 C--O 1.233 0.225 0 C-N-CA 122.674 2.249 . . . . 75.1 112.365 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.7 mt -131.01 -51.09 1.03 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.3 -0.409 . . . . 64.45 110.977 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -177.49 -114.61 0.4 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.643 -0.789 . . . . 63.52 112.416 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -135.84 155.83 49.72 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.785 0.326 . . . . 75.52 110.871 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -103.16 26.17 8.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.133 -0.485 . . . . 75.33 110.88 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 4.2 t30 54.06 49.58 18.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 73.43 110.834 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.6 mtt180 61.13 -170.25 0.16 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 72.4 110.893 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -51.99 -44.47 64.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.214 -0.448 . . . . 75.24 110.878 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 61.27 -174.33 0.13 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 72.43 110.917 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.505 ' O ' HG23 ' A' ' 97' ' ' THR . 30.7 p -84.5 54.37 2.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 50.14 111.09 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.505 HG23 ' O ' ' A' ' 96' ' ' THR . 1.0 OUTLIER -159.61 128.14 5.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.265 -0.425 . . . . 54.43 111.175 179.961 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -106.04 155.01 19.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 74.32 110.903 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.746 HG22 HG22 ' A' ' 112' ' ' VAL . 68.4 p -146.81 154.73 41.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.113 -0.494 . . . . 71.13 111.154 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' TRP . . . . . 0.47 ' CB ' HD23 ' A' ' 167' ' ' LEU . 14.2 m-90 -151.26 133.98 15.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.19 -0.459 . . . . 61.51 110.919 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.3 t -113.14 114.77 47.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 64.45 111.172 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.644 HD11 HD12 ' A' ' 104' ' ' LEU . 0.5 OUTLIER -138.91 146.01 40.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 71.21 110.918 -179.997 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -74.22 94.1 2.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 74.14 110.833 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.644 HD12 HD11 ' A' ' 102' ' ' LEU . 0.4 OUTLIER -127.44 153.39 46.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 75.34 110.927 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 64.43 15.65 9.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.204 -0.453 . . . . 70.2 110.824 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 86.3 2.05 85.73 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.665 -0.779 . . . . 74.54 112.503 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -139.94 173.06 11.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.89 0.376 . . . . 73.43 110.859 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.1 87.88 0.4 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.458 . . . . 74.31 110.872 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.6 HD13 ' HB3' ' A' ' 104' ' ' LEU . 1.4 tp -69.04 124.87 24.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.471 . . . . 73.04 110.906 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 10.8 ttm180 -107.05 113.91 27.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 72.15 110.87 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -106.37 139.37 27.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.456 . . . . 74.45 111.131 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.746 HG22 HG22 ' A' ' 99' ' ' THR . 85.8 t -135.8 135.36 50.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.125 -0.488 . . . . 72.43 111.207 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.437 HD11 ' HA ' ' A' ' 118' ' ' MET . 3.2 tp -117.58 100.35 7.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 62.14 110.954 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.449 ' HG3' HG22 ' A' ' 97' ' ' THR . 0.0 OUTLIER -75.57 134.85 40.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 71.15 110.878 179.977 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.3 mttt -73.78 -17.46 61.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.474 . . . . 64.51 110.924 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -51.33 -54.12 29.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 64.14 110.853 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -134.29 17.01 3.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.219 -0.446 . . . . 65.13 111.138 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' MET . . . . . 0.437 ' HA ' HD11 ' A' ' 113' ' ' LEU . 3.9 ttm 54.41 27.09 7.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.252 -0.431 . . . . 61.3 110.914 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -80.97 149.39 29.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 73.43 110.851 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.503 HG23 HG21 ' A' ' 129' ' ' THR . 31.3 t -104.84 128.92 58.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.107 -0.497 . . . . 64.11 111.163 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 3.7 t90 -113.1 127.55 56.24 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.093 -0.503 . . . . 71.23 110.951 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 9.2 t -141.6 129.52 21.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 74.24 110.93 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 2.8 m120 48.25 50.79 15.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 73.41 110.945 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 49.29 47.46 34.58 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.774 -0.727 . . . . 75.44 112.44 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.44 114.71 4.79 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.81 0.338 . . . . 64.42 110.966 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 7.5 ttmt -55.56 100.36 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 75.33 110.857 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 65.5 mtp -59.63 159.7 8.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 73.41 110.916 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -104.97 106.38 16.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.212 -0.449 . . . . 62.13 110.892 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.819 ' HB ' HG22 ' A' ' 140' ' ' THR . 13.9 p -99.2 -175.21 2.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.161 -0.472 . . . . 44.35 111.16 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.42 ' HB2' ' HB2' ' A' ' 141' ' ' HIS . . . -114.01 -47.86 2.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 41.14 111.136 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 74.83 50.43 8.99 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.716 -0.754 . . . . 70.13 112.484 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -80.82 110.81 16.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.878 0.37 . . . . 74.32 110.835 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -82.21 119.17 23.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 75.42 110.882 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.531 HG22 ' O ' ' A' ' 137' ' ' GLY . 22.1 m -105.18 -177.71 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 73.44 111.12 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -55.39 -32.94 63.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.16 -0.473 . . . . 74.42 110.861 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -156.91 90.09 1.12 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 53.11 110.89 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.531 ' O ' HG22 ' A' ' 134' ' ' VAL . . . 128.02 -179.39 16.54 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.777 -0.725 . . . . 64.13 112.501 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.63 130.81 34.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.706 0.288 . . . . 60.44 111.132 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -103.18 97.98 7.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.273 -0.422 . . . . 72.4 110.895 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.819 HG22 ' HB ' ' A' ' 129' ' ' THR . 0.0 OUTLIER -80.72 110.26 16.05 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.157 -0.474 . . . . 75.14 111.135 -179.897 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 141' ' ' HIS . . . . . 0.42 ' HB2' ' HB2' ' A' ' 130' ' ' ALA . 46.4 m80 -102.0 109.3 21.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 70.55 110.809 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.718 ' CE2' HD12 ' A' ' 151' ' ' ILE . 3.0 p90 -138.75 153.33 48.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.252 -0.431 . . . . 74.31 110.905 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 89.6 p -114.52 167.44 10.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 73.12 110.812 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 83.8 t -149.39 98.12 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.119 -0.492 . . . . 65.2 111.09 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 60.18 -101.93 0.31 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.777 -0.725 . . . . 74.4 112.461 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -123.59 29.24 6.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.945 0.403 . . . . 75.03 110.943 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 36.5 m80 -121.31 -175.02 2.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.475 . . . . 71.24 110.951 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -145.09 117.48 8.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.287 -0.415 . . . . 62.42 110.84 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' CYS . . . . . 0.611 ' HB3' HG22 ' A' ' 169' ' ' VAL . 1.3 p -142.45 156.41 45.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.216 -0.447 . . . . 54.45 110.893 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -151.66 146.32 25.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 70.1 110.875 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.718 HD12 ' CE2' ' A' ' 142' ' ' PHE . 3.8 mt -97.37 111.69 27.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.082 -0.508 . . . . 73.41 111.113 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.646 ' HD2' HD12 ' A' ' 168' ' ' ILE . 8.1 tttt -79.83 102.5 9.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.253 -0.431 . . . . 74.43 110.88 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -95.12 139.68 31.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.242 -0.436 . . . . 74.43 111.156 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.3 t -135.68 123.01 35.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.252 -0.431 . . . . 75.4 111.135 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.3 p -91.12 150.4 21.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 74.21 110.87 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 63.4 p -144.8 128.45 17.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.104 -0.498 . . . . 63.44 110.885 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 136.03 -144.03 15.68 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.712 -0.756 . . . . 64.52 112.526 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 19.7 mtmt -95.04 -63.42 1.17 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.721 0.296 . . . . 75.25 110.866 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.99 -36.38 3.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.308 -0.405 . . . . 74.43 110.926 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -173.17 52.3 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 35.23 110.916 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -69.23 -61.98 1.57 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 65.14 110.922 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -143.33 138.77 8.41 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.734 -0.746 . . . . 62.04 112.55 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 61.2 mt -124.54 146.11 30.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.796 0.331 . . . . 72.5 111.159 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 59.4 mt -133.92 123.18 44.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.242 -0.436 . . . . 72.3 111.171 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 9.7 m80 -99.41 141.49 32.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.464 . . . . 71.52 110.875 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.33 106.93 8.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 75.42 111.073 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.546 HD12 ' N ' ' A' ' 168' ' ' ILE . 14.5 tp -65.14 134.02 52.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 72.52 110.936 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.646 HD12 ' HD2' ' A' ' 152' ' ' LYS . 10.7 mt -137.01 111.27 9.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 53.12 111.113 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.611 HG22 ' HB3' ' A' ' 149' ' ' CYS . 35.6 t -113.56 124.71 70.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.458 . . . . 54.13 111.143 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 4.5 t0 63.37 43.22 6.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.451 . . . . 63.34 110.883 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 58.3 m-20 56.8 41.54 27.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.111 -0.495 . . . . 70.14 110.841 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 26.4 mtt180 -137.94 125.76 22.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 75.2 110.849 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -62.7 144.96 55.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.174 -0.466 . . . . 65.13 110.889 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -122.99 131.16 24.38 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.581 0.705 . . . . 73.22 111.143 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 138.21 37.31 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.725 2.283 . . . . 71.31 112.299 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -88.18 127.46 35.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 72.43 110.855 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.93 106.28 4.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 45.24 110.973 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 15.3 t -174.19 158.76 3.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.166 -0.47 . . . . 73.24 111.103 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.155 -0.475 . . . . 74.24 110.893 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 CA-C-O 121.471 0.484 . . . . 72.23 112.524 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.83 -42.61 3.18 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.63 2.22 . . . . 60.22 112.358 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.2 mp 56.66 88.83 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 71.34 110.985 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -102.8 115.51 5.21 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.682 -0.77 . . . . 72.52 112.492 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -133.21 95.64 3.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.861 0.363 . . . . 62.12 110.845 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 59.77 68.3 0.8 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.087 -0.506 . . . . 61.31 110.87 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -167.23 118.11 0.88 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 73.21 110.814 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 20.0 ptt180 -114.68 139.61 49.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 72.34 110.888 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.7 t -90.74 -70.35 0.68 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.22 -0.446 . . . . 62.45 110.834 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.06 -174.65 4.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.108 -0.497 . . . . 61.01 110.931 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.495 ' O ' HG23 ' A' ' 97' ' ' THR . 39.2 p -105.2 32.34 4.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.248 -0.433 . . . . 74.22 111.107 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.495 HG23 ' O ' ' A' ' 96' ' ' THR . 1.0 OUTLIER -159.46 127.78 5.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.286 -0.416 . . . . 64.43 111.096 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.4 m -106.48 152.18 23.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.443 . . . . 71.41 110.833 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.433 HG23 HG22 ' A' ' 112' ' ' VAL . 6.9 m -135.86 155.19 50.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.126 -0.488 . . . . 72.55 111.124 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' TRP . . . . . 0.426 ' CB ' HD23 ' A' ' 167' ' ' LEU . 16.6 m-90 -148.97 133.02 17.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.208 -0.451 . . . . 74.24 110.88 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.0 t -113.03 114.92 48.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 71.44 111.124 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.847 HD11 HD12 ' A' ' 104' ' ' LEU . 0.5 OUTLIER -140.03 147.27 40.13 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.179 -0.464 . . . . 72.43 110.892 179.973 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -73.29 93.44 1.89 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.133 -0.485 . . . . 42.43 110.874 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.847 HD12 HD11 ' A' ' 102' ' ' LEU . 0.3 OUTLIER -124.8 151.74 44.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 72.33 110.868 -179.901 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.8 t0 64.54 15.21 9.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 75.31 110.847 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.37 1.8 83.43 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.758 -0.734 . . . . 60.1 112.527 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -139.92 172.88 12.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.841 0.353 . . . . 74.01 110.902 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.67 89.28 0.37 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 73.14 110.855 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.616 HD13 ' HB3' ' A' ' 104' ' ' LEU . 0.6 OUTLIER -74.38 131.49 41.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 64.53 110.955 179.986 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 11.7 ttp180 -110.8 118.48 36.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 75.12 110.862 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.583 HG13 ' HB2' ' A' ' 122' ' ' CYS . 0.1 OUTLIER -108.63 143.74 18.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 52.42 111.112 179.955 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.433 HG22 HG23 ' A' ' 99' ' ' THR . 15.6 t -135.85 153.04 31.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.13 -0.486 . . . . 31.11 111.111 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.605 HD22 HD13 ' A' ' 151' ' ' ILE . 4.3 tp -129.71 105.92 8.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.165 -0.471 . . . . 74.41 110.927 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.488 ' HA ' HG22 ' A' ' 97' ' ' THR . 0.0 OUTLIER -81.43 135.51 35.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.231 -0.44 . . . . 74.43 110.823 179.955 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.0 mtmt -73.52 -16.54 61.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.098 -0.501 . . . . 64.44 110.859 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -51.34 -55.85 16.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.254 -0.43 . . . . 71.41 110.884 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.86 16.81 3.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 63.43 111.207 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' MET . . . . . 0.534 ' HA ' HD11 ' A' ' 113' ' ' LEU . 1.9 mtp 59.99 20.21 9.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.464 . . . . 53.22 110.891 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -70.91 151.03 45.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 73.1 110.886 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.7 HG22 HD12 ' A' ' 151' ' ' ILE . 80.4 t -105.07 117.81 51.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 74.4 111.095 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 55.2 t-105 -95.61 113.63 25.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.211 -0.45 . . . . 71.33 110.946 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' CYS . . . . . 0.583 ' HB2' HG13 ' A' ' 111' ' ' VAL . 9.0 t -140.26 133.03 29.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.246 -0.434 . . . . 74.32 110.897 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 57.98 34.06 23.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 62.01 110.915 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 57.76 49.85 70.62 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.743 -0.741 . . . . 55.4 112.476 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.93 121.6 2.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.836 0.35 . . . . 73.44 110.934 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -54.08 100.39 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 73.34 110.942 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' MET . . . . . 0.426 ' HB2' ' HB ' ' A' ' 120' ' ' VAL . 17.2 mmm -56.47 174.23 0.15 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.283 -0.417 . . . . 72.34 110.868 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -119.27 106.29 12.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.212 -0.449 . . . . 75.43 110.847 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.713 ' HB ' HG22 ' A' ' 140' ' ' THR . 19.8 p -98.64 -175.23 3.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.135 -0.484 . . . . 70.21 111.16 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.501 ' HB2' ' HB2' ' A' ' 141' ' ' HIS . . . -99.87 -38.38 8.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.269 -0.423 . . . . 71.04 111.092 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 69.77 43.56 66.47 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.711 -0.756 . . . . 44.03 112.55 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -83.32 115.92 22.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.922 0.392 . . . . 74.51 110.921 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -91.35 121.01 32.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 63.33 110.895 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.486 HG22 ' O ' ' A' ' 137' ' ' GLY . 27.3 m -101.83 177.56 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 71.24 111.074 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -52.92 -30.67 35.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.459 . . . . 73.13 110.925 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.427 ' H ' HG23 ' A' ' 134' ' ' VAL . 0.7 OUTLIER -158.03 91.88 1.14 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 51.33 110.841 179.959 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.486 ' O ' HG22 ' A' ' 134' ' ' VAL . . . 128.21 179.31 15.8 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.716 -0.754 . . . . 75.22 112.508 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.573 ' O ' ' HB3' ' A' ' 153' ' ' ALA . 0.1 OUTLIER -135.03 130.78 36.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.763 0.316 . . . . 74.52 111.109 -179.842 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -108.57 96.78 6.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.444 . . . . 74.13 110.893 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.713 HG22 ' HB ' ' A' ' 129' ' ' THR . 0.0 OUTLIER -83.64 109.99 17.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.168 -0.469 . . . . 64.13 111.075 -179.881 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 141' ' ' HIS . . . . . 0.501 ' HB2' ' HB2' ' A' ' 130' ' ' ALA . 44.4 m80 -101.83 104.53 15.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 64.53 110.86 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 23.2 p90 -126.43 135.63 51.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 71.35 110.896 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 36.6 p -102.72 157.38 16.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.441 . . . . 74.21 110.849 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 90.5 t -138.7 105.59 2.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.101 -0.499 . . . . 50.13 111.093 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 55.06 -105.58 0.41 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.701 -0.761 . . . . 72.03 112.512 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -117.32 24.81 10.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.793 0.33 . . . . 71.32 110.869 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -117.1 172.18 7.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 60.12 110.877 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -130.24 120.74 24.92 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.241 -0.436 . . . . 72.34 110.867 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' CYS . . . . . 0.592 ' HB3' HG22 ' A' ' 169' ' ' VAL . 1.0 OUTLIER -142.68 170.73 15.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.179 -0.464 . . . . 74.43 110.913 -179.932 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -175.2 147.71 0.93 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.21 -0.45 . . . . 75.34 110.914 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.7 HD12 HG22 ' A' ' 120' ' ' VAL . 12.9 mt -97.5 111.16 26.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.086 -0.506 . . . . 74.14 111.097 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 20.2 tttt -82.03 102.65 11.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.25 -0.432 . . . . 70.53 110.827 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.573 ' HB3' ' O ' ' A' ' 138' ' ' THR . . . -95.07 147.15 23.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 53.4 111.113 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.5 t -145.08 119.22 2.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 65.33 111.173 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.3 p -84.26 137.95 33.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.471 . . . . 71.23 110.871 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 1.5 t -133.54 152.47 51.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 63.53 110.794 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 112.25 -126.57 7.65 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.763 -0.732 . . . . 74.35 112.476 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -121.75 -65.05 1.16 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.756 0.313 . . . . 74.02 110.928 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -136.8 91.9 2.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.172 -0.467 . . . . 71.32 110.927 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 60.1 26.5 15.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 63.04 110.888 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.91 -69.96 0.19 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.198 -0.456 . . . . 55.11 110.931 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -137.39 120.49 2.09 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.719 -0.753 . . . . 54.34 112.479 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 72.2 mt -110.1 144.97 17.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.746 0.308 . . . . 74.42 111.158 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 3.0 mt -128.16 130.53 69.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.262 -0.426 . . . . 62.34 111.112 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' HIS . . . . . 0.469 ' CG ' HD23 ' A' ' 113' ' ' LEU . 22.0 m-70 -108.2 137.29 46.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 73.23 110.862 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.38 107.19 9.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.243 -0.435 . . . . 73.32 111.149 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.597 HD12 ' N ' ' A' ' 168' ' ' ILE . 13.6 tp -67.37 137.21 55.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.249 -0.432 . . . . 75.11 110.982 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.597 ' N ' HD12 ' A' ' 167' ' ' LEU . 9.7 mt -138.76 114.21 9.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.184 -0.462 . . . . 65.22 111.161 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.592 HG22 ' HB3' ' A' ' 149' ' ' CYS . 43.8 t -115.88 126.5 73.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 75.4 111.104 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.3 t0 63.53 39.26 9.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 74.44 110.935 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 60.06 42.3 15.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.47 . . . . 72.24 110.872 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -138.45 124.99 20.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 64.41 110.883 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -62.65 140.49 58.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.272 -0.422 . . . . 74.13 110.891 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.475 HD12 HD22 ' A' ' 102' ' ' LEU . 0.9 OUTLIER -118.64 131.26 24.36 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.616 0.722 . . . . 70.41 111.126 179.992 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.66 135.85 31.74 Favored 'Trans proline' 0 N--CA 1.465 -0.179 0 C-N-CA 122.744 2.296 . . . . 73.13 112.386 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -89.51 131.51 35.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.259 -0.428 . . . . 72.14 110.854 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.35 126.7 31.55 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.143 -0.481 . . . . 74.5 110.85 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 30.0 p -135.53 174.42 10.63 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.188 -0.46 . . . . 74.22 111.092 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.181 -0.463 . . . . 63.41 110.842 -179.959 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 CA-C-O 121.416 0.453 . . . . 24.11 112.496 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -33.97 15.47 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.659 2.24 . . . . 73.22 112.303 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 61.03 170.08 0.1 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.267 -0.424 . . . . 65.1 110.963 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -106.82 -113.4 3.78 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.763 -0.732 . . . . 64.1 112.53 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 20.8 t -142.63 97.37 3.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.909 0.385 . . . . 63.22 110.838 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 61.13 170.36 0.1 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.082 -0.508 . . . . 72.32 110.896 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 10.8 p-10 -146.4 131.78 18.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 71.12 110.859 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 4.2 ttm180 61.27 171.74 0.11 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.133 -0.485 . . . . 63.21 110.878 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.1 t 52.53 55.55 8.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 31.45 110.823 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 6.5 ttpt -162.19 91.64 0.79 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.111 -0.495 . . . . 71.35 110.839 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.504 ' O ' HG23 ' A' ' 97' ' ' THR . 54.4 p -117.74 33.96 5.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.228 -0.442 . . . . 75.41 111.108 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.504 HG23 ' O ' ' A' ' 96' ' ' THR . 1.0 OUTLIER -159.58 127.94 5.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.265 -0.425 . . . . 64.43 111.207 -179.986 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.413 ' O ' HG13 ' A' ' 112' ' ' VAL . 1.1 m -106.27 151.9 24.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.271 -0.422 . . . . 73.31 110.85 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.949 HG23 HG22 ' A' ' 112' ' ' VAL . 1.3 m -137.85 148.46 45.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.125 -0.488 . . . . 71.24 111.095 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' TRP . . . . . 0.445 ' CB ' HD23 ' A' ' 167' ' ' LEU . 10.1 m-90 -146.4 124.67 12.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.206 -0.452 . . . . 63.33 110.936 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 19.1 t -108.37 114.81 47.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.284 -0.416 . . . . 64.3 111.164 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.909 HD11 HD12 ' A' ' 104' ' ' LEU . 0.5 OUTLIER -139.94 147.62 40.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.205 -0.452 . . . . 64.33 110.894 -179.989 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -73.32 92.83 1.84 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 74.32 110.856 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.909 HD12 HD11 ' A' ' 102' ' ' LEU . 0.3 OUTLIER -123.82 151.0 43.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 54.1 110.89 179.967 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 64.43 15.45 9.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 74.11 110.832 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.83 1.42 82.65 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.717 -0.754 . . . . 54.21 112.516 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -139.81 172.81 12.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.894 0.378 . . . . 61.32 110.808 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -69.53 89.64 0.52 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.081 -0.509 . . . . 64.53 110.878 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.58 HD13 ' HB3' ' A' ' 104' ' ' LEU . 0.5 OUTLIER -76.5 129.33 36.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 73.44 110.937 -179.953 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 2.5 ttm180 -107.76 118.3 36.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 73.14 110.893 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.6 HG12 ' CG1' ' A' ' 120' ' ' VAL . 0.0 OUTLIER -111.73 115.68 50.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 72.32 111.201 179.933 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.949 HG22 HG23 ' A' ' 99' ' ' THR . 28.3 t -114.51 140.29 36.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.242 -0.435 . . . . 73.25 111.127 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.677 HD22 HD13 ' A' ' 151' ' ' ILE . 3.1 tp -114.0 108.66 17.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.17 -0.468 . . . . 52.2 110.962 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.424 ' N ' HD12 ' A' ' 113' ' ' LEU . 0.6 OUTLIER -81.8 134.79 35.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 63.13 110.874 179.984 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.7 mmmt -73.79 -16.31 61.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 73.13 110.883 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -51.49 -53.82 33.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 53.23 110.871 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.54 17.0 2.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.117 -0.492 . . . . 75.11 111.158 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' MET . . . . . 0.586 ' HA ' HD11 ' A' ' 113' ' ' LEU . 64.6 mtp 56.49 33.12 22.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.216 -0.447 . . . . 64.32 110.89 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.73 154.22 20.74 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.229 -0.441 . . . . 74.03 110.88 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.644 HG22 HD12 ' A' ' 151' ' ' ILE . 45.3 t -104.81 131.0 54.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.227 -0.442 . . . . 43.4 111.09 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 2.2 t90 -111.85 124.69 52.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 73.54 110.973 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 16.5 t -121.45 103.35 8.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.293 -0.412 . . . . 61.32 110.926 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 46.56 70.99 0.34 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.236 -0.438 . . . . 74.22 110.9 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 47.69 40.31 17.69 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.71 -0.757 . . . . 74.1 112.503 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -141.78 102.27 4.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.92 0.391 . . . . 74.44 110.847 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 4.6 tttt -53.44 102.11 0.05 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 65.34 110.862 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 21.7 mmm -64.79 167.29 7.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.481 . . . . 62.14 110.867 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -119.33 106.09 11.95 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.204 -0.453 . . . . 53.32 110.882 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.683 ' CB ' HG22 ' A' ' 140' ' ' THR . 18.8 p -95.83 177.9 5.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 50.31 111.144 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.674 ' HB3' ' HB2' ' A' ' 141' ' ' HIS . . . -125.08 83.59 2.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 73.42 111.128 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -51.58 113.68 2.54 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.751 -0.738 . . . . 55.13 112.498 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -134.23 109.94 9.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.813 0.34 . . . . 73.42 110.894 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -69.46 113.77 7.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.2 -0.454 . . . . 63.12 110.887 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.581 HG22 ' O ' ' A' ' 137' ' ' GLY . 34.1 m -102.34 -176.78 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 74.35 111.192 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -52.9 -43.8 66.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.44 . . . . 63.11 110.886 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -151.09 104.54 3.14 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.17 -0.468 . . . . 65.03 110.945 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.581 ' O ' HG22 ' A' ' 134' ' ' VAL . . . 109.0 -171.13 15.1 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.739 -0.744 . . . . 64.23 112.455 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.597 ' O ' ' HB3' ' A' ' 153' ' ' ALA . 0.1 OUTLIER -134.87 130.87 36.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.761 0.315 . . . . 74.12 111.138 -179.863 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -104.38 98.19 8.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 71.21 110.914 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.683 HG22 ' CB ' ' A' ' 129' ' ' THR . 0.0 OUTLIER -77.24 109.85 11.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.458 . . . . 75.2 111.134 -179.907 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 141' ' ' HIS . . . . . 0.674 ' HB2' ' HB3' ' A' ' 130' ' ' ALA . 86.6 m-70 -101.15 108.04 19.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.158 -0.474 . . . . 64.32 110.861 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -123.97 124.26 42.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.142 -0.481 . . . . 73.52 110.799 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 66.5 p -85.86 157.97 20.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.119 -0.491 . . . . 65.22 110.838 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 97.5 t -150.16 104.32 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.085 -0.507 . . . . 62.31 111.14 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 52.75 -113.58 2.88 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.697 -0.763 . . . . 52.14 112.516 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -110.46 25.81 11.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.844 0.354 . . . . 74.35 110.867 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 20.9 m-70 -124.84 159.66 30.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.242 -0.435 . . . . 63.1 110.897 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -121.02 123.68 42.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.255 -0.43 . . . . 74.23 110.841 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' CYS . . . . . 0.614 ' HB3' HG22 ' A' ' 169' ' ' VAL . 1.2 p -142.49 154.6 44.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.141 -0.481 . . . . 71.24 110.946 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -157.62 149.03 21.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.218 -0.446 . . . . 72.12 110.943 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.677 HD13 HD22 ' A' ' 113' ' ' LEU . 9.4 mt -97.84 113.93 33.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 61.22 111.067 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 2.4 tttt -80.13 102.65 9.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.207 -0.451 . . . . 74.25 110.866 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.597 ' HB3' ' O ' ' A' ' 138' ' ' THR . . . -98.8 143.92 28.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 75.41 111.115 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 39.4 t -146.68 124.93 4.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.212 -0.449 . . . . 63.4 111.164 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.2 p -94.22 139.54 30.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.221 -0.445 . . . . 65.43 110.823 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.23 145.72 35.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 74.2 110.844 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 129.81 -179.12 17.02 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.701 -0.762 . . . . 53.33 112.491 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 6.4 mtmt -52.81 -58.02 8.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.801 0.334 . . . . 73.11 110.915 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 3.9 ptm180 -150.17 79.45 1.35 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.255 -0.429 . . . . 74.54 110.912 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 15.6 ttmt 61.73 56.49 2.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 73.52 110.915 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -90.89 -68.81 0.77 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.176 -0.465 . . . . 71.44 110.894 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -111.63 128.44 8.63 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.792 -0.718 . . . . 65.45 112.512 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 56.9 mt -120.29 145.0 27.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.767 0.318 . . . . 54.32 111.11 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 57.2 mt -128.58 140.12 50.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.177 -0.465 . . . . 75.32 111.12 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' HIS . . . . . 0.42 ' CG ' HD23 ' A' ' 113' ' ' LEU . 9.4 m80 -117.91 135.48 54.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.137 -0.483 . . . . 53.41 110.816 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.82 109.88 12.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.133 -0.485 . . . . 73.5 111.126 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.555 HD12 ' N ' ' A' ' 168' ' ' ILE . 15.1 tp -68.43 135.63 52.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 73.44 110.981 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.555 ' N ' HD12 ' A' ' 167' ' ' LEU . 10.5 mt -138.63 117.27 13.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.455 . . . . 75.44 111.119 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.614 HG22 ' HB3' ' A' ' 149' ' ' CYS . 21.7 t -117.93 125.82 74.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.172 -0.467 . . . . 63.31 111.103 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 63.56 37.98 10.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 72.44 110.934 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 61.4 43.0 10.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 72.24 110.864 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 16.5 mtt180 -140.23 129.1 23.29 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.177 -0.465 . . . . 72.14 110.852 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -62.69 146.43 52.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.136 -0.484 . . . . 74.34 110.899 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.435 HD12 HD22 ' A' ' 102' ' ' LEU . 0.8 OUTLIER -122.85 130.89 24.45 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.699 0.762 . . . . 71.03 111.14 179.961 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 135.57 30.82 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.66 2.24 . . . . 61.3 112.332 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.572 ' O ' HG23 ' A' ' 178' ' ' THR . 1.8 tm-20 -91.7 124.3 35.74 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.229 -0.441 . . . . 55.43 110.889 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 6.6 tp -52.23 123.15 10.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 64.12 110.869 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.572 HG23 ' O ' ' A' ' 176' ' ' GLU . 69.5 p -131.91 128.66 39.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.228 -0.442 . . . . 65.13 111.135 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.268 -0.423 . . . . 72.24 110.941 179.892 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 CA-C-O 121.43 0.461 . . . . 73.22 112.473 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.84 128.83 16.52 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.664 2.243 . . . . 74.12 112.345 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.8 mt -110.94 -53.69 2.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.213 -0.449 . . . . 73.51 110.967 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 132.31 122.24 2.33 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.736 -0.745 . . . . 71.05 112.52 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.18 141.14 47.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.838 0.352 . . . . 63.53 110.868 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.95 173.12 6.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.476 . . . . 75.52 110.86 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -107.1 157.59 17.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.467 . . . . 71.13 110.857 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.03 81.59 2.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.159 -0.473 . . . . 73.12 110.88 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.0 145.24 21.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.026 0.441 . . . . 74.13 110.86 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 17.2 mttt -121.85 83.26 2.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.052 -0.522 . . . . 64.51 110.896 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.501 ' O ' HG23 ' A' ' 97' ' ' THR . 0.1 OUTLIER -68.64 141.69 55.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.202 -0.454 . . . . 73.31 111.157 179.981 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.501 HG23 ' O ' ' A' ' 96' ' ' THR . 1.0 OUTLIER -159.54 127.8 4.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.234 -0.439 . . . . 74.04 111.181 179.993 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.3 m -106.37 153.95 21.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 70.02 110.879 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.968 HG22 HG22 ' A' ' 112' ' ' VAL . 0.6 OUTLIER -142.21 156.57 45.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.104 -0.498 . . . . 72.15 111.11 -179.904 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 17.2 m-90 -151.45 130.6 12.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.237 -0.438 . . . . 74.1 110.97 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.3 t -110.25 114.79 48.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.249 -0.432 . . . . 75.33 111.107 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.947 HD11 HD12 ' A' ' 104' ' ' LEU . 0.5 OUTLIER -141.69 148.42 39.06 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.197 -0.456 . . . . 74.14 110.95 179.932 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.3 mtm180 -74.73 92.79 2.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.178 -0.464 . . . . 70.5 110.857 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.947 HD12 HD11 ' A' ' 102' ' ' LEU . 0.3 OUTLIER -121.79 152.07 39.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 72.45 110.979 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 64.72 15.03 9.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.213 -0.449 . . . . 74.13 110.889 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.0 0.48 80.95 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.719 -0.753 . . . . 60.34 112.444 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -139.84 172.76 12.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.854 0.359 . . . . 75.01 110.914 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -68.58 89.68 0.37 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 73.22 110.858 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.551 HD13 ' HB3' ' A' ' 104' ' ' LEU . 0.5 OUTLIER -78.91 128.58 33.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 71.15 110.878 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.74 119.7 40.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.131 -0.486 . . . . 54.45 110.875 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.589 HG13 ' SG ' ' A' ' 122' ' ' CYS . 0.1 OUTLIER -107.13 142.61 19.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.124 -0.489 . . . . 50.41 111.131 179.956 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.968 HG22 HG22 ' A' ' 99' ' ' THR . 48.1 t -135.82 146.72 29.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 63.53 111.153 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.58 HD11 ' HA ' ' A' ' 118' ' ' MET . 3.1 tp -128.4 101.24 6.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 73.2 110.878 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.402 ' HG3' HG22 ' A' ' 97' ' ' THR . 0.2 OUTLIER -78.11 122.77 26.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.189 -0.459 . . . . 73.34 110.878 179.924 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.39 -15.94 59.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 65.51 110.946 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -51.44 -56.0 15.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.455 . . . . 74.12 110.868 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 9.5 p -133.87 16.98 3.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.458 . . . . 65.45 111.129 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' MET . . . . . 0.58 ' HA ' HD11 ' A' ' 113' ' ' LEU . 9.6 mtp 58.43 24.55 11.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.302 -0.408 . . . . 71.12 110.856 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -76.18 144.55 40.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.267 -0.424 . . . . 71.44 110.842 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.504 HG21 ' CE2' ' A' ' 142' ' ' PHE . 71.4 t -105.1 118.26 52.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 70.0 111.156 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 2.2 t90 -98.34 134.86 40.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.173 -0.467 . . . . 72.01 110.909 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' CYS . . . . . 0.589 ' SG ' HG13 ' A' ' 111' ' ' VAL . 0.6 OUTLIER -131.18 103.14 6.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 75.25 110.914 179.982 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 22.7 m-20 45.43 69.66 0.43 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 73.52 110.992 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 48.65 41.02 25.99 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.773 -0.727 . . . . 70.4 112.428 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -149.81 115.3 5.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.801 0.334 . . . . 64.11 110.927 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -53.56 162.21 0.87 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.247 -0.433 . . . . 75.4 110.85 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' MET . . . . . 0.526 ' CE ' HG22 ' A' ' 144' ' ' VAL . 35.1 mmm -126.54 166.49 17.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.445 . . . . 73.42 110.945 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -119.26 106.41 12.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.268 -0.424 . . . . 74.14 110.861 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.593 ' CB ' HG22 ' A' ' 140' ' ' THR . 21.7 p -95.8 -175.17 3.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.161 -0.472 . . . . 61.15 111.126 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.468 ' HB2' ' HB2' ' A' ' 141' ' ' HIS . . . -93.33 -35.76 12.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.449 . . . . 64.2 111.138 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 73.88 40.57 43.97 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.769 -0.729 . . . . 51.43 112.496 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -86.04 125.61 33.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.907 0.384 . . . . 65.4 110.832 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -113.16 127.05 56.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.474 . . . . 73.03 110.92 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 11.5 m -108.1 179.89 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 74.44 111.155 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -53.18 -29.75 33.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 75.33 110.845 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -158.12 92.66 1.18 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 65.44 110.897 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 128.93 172.7 13.23 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.74 -0.743 . . . . 64.11 112.483 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.42 ' O ' ' HB3' ' A' ' 153' ' ' ALA . 0.1 OUTLIER -135.04 130.82 36.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.807 0.336 . . . . 63.12 111.164 -179.862 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -104.86 96.63 6.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.222 -0.445 . . . . 73.44 110.858 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.593 HG22 ' CB ' ' A' ' 129' ' ' THR . 0.0 OUTLIER -85.39 110.21 18.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 43.23 111.098 -179.912 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 141' ' ' HIS . . . . . 0.468 ' HB2' ' HB2' ' A' ' 130' ' ' ALA . 41.9 m170 -109.53 106.24 15.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 75.03 110.821 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.547 ' HD2' HG22 ' A' ' 129' ' ' THR . 9.1 p90 -124.54 144.66 50.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 72.3 110.899 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 77.0 p -91.28 141.61 28.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 74.03 110.892 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.526 HG22 ' CE ' ' A' ' 127' ' ' MET . 17.4 t -138.87 103.47 2.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.175 -0.466 . . . . 54.21 111.096 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 53.76 31.43 46.01 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.704 -0.76 . . . . 70.44 112.476 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 63.36 25.35 14.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.874 0.369 . . . . 65.25 110.883 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -93.5 -11.93 30.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.14 -0.482 . . . . 75.32 110.825 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 63.87 104.88 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.244 -0.434 . . . . 73.24 110.801 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' CYS . . . . . 0.543 ' SG ' HG13 ' A' ' 169' ' ' VAL . 10.9 m -137.91 167.86 20.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.165 -0.47 . . . . 65.4 110.846 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 18.4 p90 -174.39 142.79 0.8 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.474 . . . . 75.11 110.919 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.504 HD13 HD22 ' A' ' 113' ' ' LEU . 32.0 mt -98.59 111.3 27.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.076 -0.511 . . . . 71.31 111.141 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 16.9 tttt -80.11 104.03 10.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.485 . . . . 71.31 110.858 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.42 ' HB3' ' O ' ' A' ' 138' ' ' THR . . . -99.04 146.67 25.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 73.03 111.084 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.2 t -144.9 124.3 6.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.251 -0.431 . . . . 75.24 111.174 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -93.32 129.62 39.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.21 -0.45 . . . . 60.44 110.839 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -130.17 153.45 48.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 74.02 110.858 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 83.3 90.24 0.71 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.659 -0.782 . . . . 64.11 112.516 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.01 -170.13 0.16 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.845 0.355 . . . . 74.14 110.913 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 11.1 mtt180 -52.89 -32.34 44.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.239 -0.437 . . . . 74.22 110.854 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 11.7 pttt -173.41 124.1 0.39 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 70.2 110.916 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -158.58 -54.0 0.07 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.227 -0.442 . . . . 75.05 110.91 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -128.06 105.98 0.76 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.712 -0.756 . . . . 70.12 112.482 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 63.3 mt -103.91 134.76 44.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.751 0.31 . . . . 75.51 111.121 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 53.5 mt -121.04 133.34 68.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.227 -0.442 . . . . 73.1 111.135 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' HIS . . . . . 0.409 ' CG ' HD23 ' A' ' 113' ' ' LEU . 14.2 m80 -108.96 137.94 46.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 54.13 110.848 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.65 103.64 6.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 75.12 111.128 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.559 HD12 ' H ' ' A' ' 168' ' ' ILE . 15.9 tp -66.35 138.35 57.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.237 -0.438 . . . . 74.03 110.907 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.559 ' H ' HD12 ' A' ' 167' ' ' LEU . 11.0 mt -135.95 119.53 23.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.216 -0.447 . . . . 72.52 111.105 179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.543 HG13 ' SG ' ' A' ' 149' ' ' CYS . 88.2 t -118.5 135.46 58.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 64.52 111.082 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 54.01 37.01 25.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 63.42 110.898 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 10.3 t30 63.37 42.93 6.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.166 -0.47 . . . . 54.41 110.956 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 4.2 mtm180 -141.44 130.46 23.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 65.45 110.88 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -62.83 146.45 52.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.208 -0.451 . . . . 75.12 110.853 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.477 HD12 HD22 ' A' ' 102' ' ' LEU . 0.9 OUTLIER -122.98 131.14 24.38 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.65 0.738 . . . . 63.23 111.11 179.965 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.74 135.89 31.66 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.624 2.216 . . . . 75.35 112.398 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -89.84 153.97 20.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 73.1 110.89 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.567 ' O ' HD13 ' A' ' 177' ' ' LEU . 0.4 OUTLIER -51.78 -36.91 49.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.162 -0.472 . . . . 63.54 110.89 -179.939 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 72.8 p -51.77 149.9 4.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 43.0 111.087 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 64.42 110.891 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 CA-C-O 121.416 0.453 . . . . 62.14 112.483 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.462 ' O ' HD12 ' A' ' 88' ' ' LEU . 54.1 Cg_endo -69.83 153.58 68.44 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.699 2.266 . . . . 52.3 112.296 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.462 HD12 ' O ' ' A' ' 87' ' ' PRO . 0.4 OUTLIER -144.6 120.52 10.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 71.01 110.971 179.998 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.8 79.6 0.24 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.742 -0.742 . . . . 61.43 112.452 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -160.98 126.06 3.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.882 0.372 . . . . 71.32 110.873 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -125.08 151.83 45.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.109 -0.496 . . . . 74.02 110.923 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 69.19 -75.7 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 73.32 110.884 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 23.3 mtm180 56.66 35.37 26.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.166 -0.47 . . . . 63.42 110.865 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 7.2 t -178.78 133.29 0.13 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 74.41 110.866 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.31 -72.44 0.19 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.066 -0.515 . . . . 70.23 110.911 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.499 ' O ' HG23 ' A' ' 97' ' ' THR . 0.2 OUTLIER -151.24 23.74 0.73 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 70.11 111.157 179.962 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.499 HG23 ' O ' ' A' ' 96' ' ' THR . 1.0 OUTLIER -159.47 128.09 5.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 41.44 111.084 -179.987 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.8 m -105.98 154.04 21.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.237 -0.438 . . . . 74.54 110.855 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 27.3 m -141.56 148.58 39.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.139 -0.482 . . . . 74.04 111.153 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' TRP . . . . . 0.54 ' CB ' HD23 ' A' ' 167' ' ' LEU . 9.3 m-90 -145.37 122.91 11.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.198 -0.455 . . . . 73.41 110.89 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.409 HG23 HD23 ' A' ' 177' ' ' LEU . 19.5 t -103.32 114.79 43.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 71.24 111.075 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.788 HD11 HD12 ' A' ' 104' ' ' LEU . 0.5 OUTLIER -141.97 146.6 35.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.119 -0.491 . . . . 75.05 110.898 179.925 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 4.8 mtt85 -74.44 92.18 2.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 73.54 110.88 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.788 HD12 HD11 ' A' ' 102' ' ' LEU . 0.4 OUTLIER -122.99 153.74 39.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.207 -0.452 . . . . 73.04 110.926 -179.974 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.5 t70 65.14 14.44 9.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.181 -0.463 . . . . 43.23 110.877 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.55 0.0 79.81 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.791 -0.719 . . . . 51.13 112.503 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -139.86 172.91 12.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.868 0.366 . . . . 74.34 110.836 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -68.78 88.13 0.36 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.112 -0.495 . . . . 74.21 110.879 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.608 HD13 ' HB3' ' A' ' 104' ' ' LEU . 0.5 OUTLIER -73.26 124.85 26.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.259 -0.428 . . . . 74.34 110.907 -179.907 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -102.03 109.79 21.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 73.12 110.893 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.568 HG13 ' SG ' ' A' ' 122' ' ' CYS . 2.5 t -95.25 136.7 25.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 65.33 111.09 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 86.6 t -136.51 128.58 44.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.163 -0.471 . . . . 75.0 111.126 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.609 HD22 HD13 ' A' ' 151' ' ' ILE . 4.9 tp -110.07 102.31 11.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.138 -0.483 . . . . 71.54 110.875 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.455 ' HA ' HG22 ' A' ' 97' ' ' THR . 0.1 OUTLIER -78.7 136.15 37.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.211 -0.449 . . . . 64.24 110.914 179.875 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.431 ' HG3' HG22 ' A' ' 96' ' ' THR . 21.0 mmmt -73.77 -17.15 61.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.135 -0.484 . . . . 73.42 110.861 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -51.49 -53.88 32.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 63.11 110.869 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.82 17.0 3.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.201 -0.454 . . . . 64.22 111.112 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' MET . . . . . 0.426 ' HA ' HD11 ' A' ' 113' ' ' LEU . 2.6 ttp 53.67 28.22 7.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 60.34 110.876 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -85.23 158.62 20.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 73.15 110.87 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.545 HG23 HG21 ' A' ' 129' ' ' THR . 21.6 t -104.87 138.4 29.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.207 -0.451 . . . . 72.2 111.15 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 1.2 t90 -123.28 121.12 35.07 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.252 -0.431 . . . . 75.2 110.872 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' CYS . . . . . 0.568 ' SG ' HG13 ' A' ' 111' ' ' VAL . 60.8 m -132.21 131.77 42.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.236 -0.438 . . . . 63.11 110.877 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 2.7 m120 49.3 50.24 18.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.189 -0.459 . . . . 63.43 110.92 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 49.04 45.08 33.12 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.795 -0.717 . . . . 71.33 112.447 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -147.96 116.96 6.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.828 0.347 . . . . 74.4 110.921 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 13.2 mttt -53.17 102.3 0.05 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.295 -0.411 . . . . 71.33 110.922 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 23.4 mmm -64.52 166.5 8.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 75.25 110.882 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.17 106.0 11.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.994 0.426 . . . . 72.34 110.836 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.603 ' CB ' HG22 ' A' ' 140' ' ' THR . 16.0 p -97.72 175.29 6.23 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.099 -0.501 . . . . 73.22 111.117 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.618 ' HB3' ' HB2' ' A' ' 141' ' ' HIS . . . -122.48 90.13 3.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.227 -0.442 . . . . 73.21 111.074 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -50.85 117.19 5.09 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.726 -0.749 . . . . 72.51 112.482 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -146.05 101.97 3.58 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.952 0.406 . . . . 74.43 110.823 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -69.52 150.3 47.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.113 -0.494 . . . . 75.44 110.897 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 8.3 m -140.39 -177.79 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.168 -0.469 . . . . 64.52 111.087 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.55 -17.85 56.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.186 -0.461 . . . . 71.1 110.861 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -106.21 -75.32 0.63 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.159 -0.473 . . . . 55.22 110.854 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -137.72 -120.97 1.94 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.717 -0.754 . . . . 35.01 112.446 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -134.19 130.78 37.73 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.734 0.302 . . . . 72.14 111.184 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -98.08 96.13 7.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.296 -0.411 . . . . 63.53 110.914 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.603 HG22 ' CB ' ' A' ' 129' ' ' THR . 0.0 OUTLIER -79.14 109.4 13.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 71.22 111.202 -179.973 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 141' ' ' HIS . . . . . 0.618 ' HB2' ' HB3' ' A' ' 130' ' ' ALA . 38.0 m170 -100.66 112.69 25.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.306 -0.406 . . . . 63.41 110.832 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.436 ' CD2' HG22 ' A' ' 129' ' ' THR . 6.5 p90 -125.84 114.43 18.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 74.42 110.852 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 98.4 p -78.28 151.57 32.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.081 -0.508 . . . . 53.52 110.842 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 46.9 t -146.81 108.67 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.086 -0.506 . . . . 54.23 111.147 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 52.92 -109.98 1.14 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.759 -0.734 . . . . 74.22 112.488 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -116.6 26.4 9.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.881 0.372 . . . . 71.44 110.916 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 23.9 m-70 -123.49 164.2 19.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 64.43 110.853 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -126.06 123.17 37.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 52.3 110.809 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' CYS . . . . . 0.594 ' HB3' HG22 ' A' ' 169' ' ' VAL . 0.9 OUTLIER -142.67 150.66 40.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.226 -0.443 . . . . 52.14 110.878 -179.93 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 17.6 p90 -150.87 149.61 29.89 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.181 -0.463 . . . . 73.23 110.979 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.609 HD13 HD22 ' A' ' 113' ' ' LEU . 7.6 mt -99.65 114.27 37.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.176 -0.465 . . . . 72.45 111.126 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.633 ' HD3' HD12 ' A' ' 168' ' ' ILE . 0.1 OUTLIER -80.24 103.09 9.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.225 -0.443 . . . . 73.24 110.871 179.834 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -100.13 146.65 26.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.195 -0.457 . . . . 61.11 111.1 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 66.2 t -149.21 122.94 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.199 -0.455 . . . . 61.3 111.134 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.2 p -92.26 144.56 25.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.186 -0.461 . . . . 71.1 110.859 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.25 141.82 30.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.487 . . . . 63.13 110.851 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 129.71 -168.84 21.02 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.696 -0.764 . . . . 63.52 112.507 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 8.4 mtmt -56.39 -26.75 54.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.794 0.331 . . . . 71.54 110.93 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -176.97 -40.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 70.24 110.818 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 34.9 mttt -155.87 31.8 0.35 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 73.2 110.905 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -55.93 -60.57 3.28 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.179 -0.464 . . . . 74.13 110.92 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -143.6 142.24 11.09 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.773 -0.727 . . . . 74.42 112.5 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 47.8 mt -126.16 147.15 31.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.756 0.312 . . . . 63.03 111.087 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 38.3 mt -128.29 137.14 58.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.205 -0.452 . . . . 65.23 111.14 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -120.72 134.39 55.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 63.23 110.876 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.48 117.17 23.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.449 . . . . 52.53 111.183 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.54 HD23 ' CB ' ' A' ' 100' ' ' TRP . 14.0 tp -71.3 132.56 45.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 70.42 110.953 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.633 HD12 ' HD3' ' A' ' 152' ' ' LYS . 11.0 mt -135.92 116.53 18.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.263 -0.426 . . . . 63.2 111.126 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.594 HG22 ' HB3' ' A' ' 149' ' ' CYS . 17.0 t -119.08 127.99 75.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 63.41 111.171 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 2.2 t0 63.89 35.56 10.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 74.3 110.842 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 1.8 m120 63.33 43.09 6.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 55.34 110.887 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 58.3 mtt180 -142.97 128.72 19.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.112 -0.495 . . . . 64.34 110.867 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -62.44 146.5 51.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.457 . . . . 71.44 110.906 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -121.28 130.65 24.72 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.578 0.704 . . . . 62.32 111.121 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.67 143.92 52.84 Favored 'Trans proline' 0 N--CA 1.465 -0.157 0 C-N-CA 122.737 2.292 . . . . 74.33 112.364 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -89.49 144.23 26.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.268 -0.424 . . . . 73.35 110.835 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.572 ' O ' HD13 ' A' ' 177' ' ' LEU . 0.6 OUTLIER -52.29 -38.86 59.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 52.33 110.917 -179.967 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 30.0 p -51.99 141.18 18.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 72.23 111.124 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 82.1 mm-40 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.465 . . . . 75.02 110.869 179.966 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.35 0 CA-C-O 121.514 0.508 . . . . 64.01 112.464 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 159.34 53.75 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.688 2.259 . . . . 61.41 112.335 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -139.69 133.59 30.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.242 -0.435 . . . . 73.33 110.955 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -155.27 78.35 0.2 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.776 -0.726 . . . . 61.22 112.523 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 24.0 p -171.11 98.05 0.21 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.815 0.341 . . . . 74.31 110.86 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -165.36 138.35 4.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.074 -0.512 . . . . 71.55 110.937 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 30.8 m120 -76.43 161.72 28.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.17 -0.468 . . . . 71.35 110.827 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -133.47 33.93 3.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.084 -0.507 . . . . 63.12 110.822 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -126.76 48.4 2.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.241 -0.436 . . . . 74.53 110.877 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.81 91.41 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.107 -0.497 . . . . 75.31 110.882 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.499 ' O ' HG23 ' A' ' 97' ' ' THR . 1.1 t -142.15 118.44 10.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 74.42 111.158 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.499 HG23 ' O ' ' A' ' 96' ' ' THR . 1.0 OUTLIER -159.62 133.08 7.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 72.53 111.119 -179.981 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.3 m -105.66 150.43 25.46 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.197 -0.456 . . . . 52.01 110.776 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.618 HG23 HG22 ' A' ' 112' ' ' VAL . 2.2 m -141.79 154.7 45.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.053 -0.521 . . . . 71.34 111.12 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' TRP . . . . . 0.494 ' CB ' HD23 ' A' ' 167' ' ' LEU . 12.1 m-90 -151.52 128.61 11.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.437 . . . . 65.13 110.957 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 19.5 t -108.1 114.9 47.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.237 -0.438 . . . . 74.44 111.21 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.735 HD11 HD12 ' A' ' 104' ' ' LEU . 0.5 OUTLIER -140.19 146.06 38.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 75.24 110.887 179.992 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.9 mtm180 -73.37 92.54 1.84 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.137 -0.483 . . . . 74.34 110.872 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.735 HD12 HD11 ' A' ' 102' ' ' LEU . 0.4 OUTLIER -124.89 153.14 43.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.096 -0.502 . . . . 73.22 110.867 -179.996 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 64.62 15.14 9.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.475 . . . . 75.2 110.891 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 88.1 1.01 82.49 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.722 -0.752 . . . . 71.21 112.502 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -139.79 172.95 12.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.844 0.354 . . . . 74.14 110.866 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.42 87.01 0.44 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.165 -0.47 . . . . 54.01 110.886 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.56 HD13 ' HB3' ' A' ' 104' ' ' LEU . 0.7 OUTLIER -69.05 125.29 26.21 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.225 -0.443 . . . . 74.3 110.855 -179.87 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 17.3 ttm180 -103.99 109.79 21.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 74.54 110.841 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.478 HG21 ' CD2' ' A' ' 167' ' ' LEU . 1.4 t -95.54 136.37 26.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.216 -0.447 . . . . 73.03 111.155 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.618 HG22 HG23 ' A' ' 99' ' ' THR . 93.2 t -136.03 122.65 32.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.204 -0.453 . . . . 63.24 111.142 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.579 HD11 ' HA ' ' A' ' 118' ' ' MET . 2.4 tp -110.31 108.6 18.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.117 -0.492 . . . . 63.14 110.966 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.437 ' N ' HD12 ' A' ' 113' ' ' LEU . 0.1 OUTLIER -85.08 136.73 33.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 74.3 110.913 179.91 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.449 ' HB2' HG23 ' A' ' 96' ' ' THR . 0.0 OUTLIER -73.85 -16.42 61.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.138 -0.483 . . . . 72.44 110.892 179.936 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -51.46 -54.57 25.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.277 -0.419 . . . . 63.25 110.798 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.55 17.06 2.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 53.1 111.174 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' MET . . . . . 0.579 ' HA ' HD11 ' A' ' 113' ' ' LEU . 24.7 mtp 59.18 21.76 9.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 75.43 110.862 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.57 142.5 51.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.283 -0.417 . . . . 63.23 110.89 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 65.3 t -105.02 118.45 52.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 74.23 111.112 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 2.8 t90 -101.16 131.84 46.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.459 . . . . 65.52 110.908 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -123.97 103.76 8.51 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.22 -0.445 . . . . 71.25 110.922 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 39.51 71.59 0.17 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.462 . . . . 63.34 110.915 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 51.0 41.05 44.61 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.773 -0.727 . . . . 73.31 112.523 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -150.45 112.66 4.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.878 0.371 . . . . 73.33 110.866 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 6.4 mtmm -53.63 162.05 0.93 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.217 -0.447 . . . . 61.04 110.888 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 27.7 mmm -127.89 162.99 25.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 75.05 110.91 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -119.28 106.35 12.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.295 -0.411 . . . . 75.23 110.901 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.613 ' CB ' HG22 ' A' ' 140' ' ' THR . 18.0 p -95.46 -176.71 3.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.142 -0.481 . . . . 73.35 111.156 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -89.04 -34.57 16.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.44 . . . . 42.22 111.095 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 60.89 72.99 0.55 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.741 -0.742 . . . . 74.31 112.53 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -131.94 124.34 29.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.913 0.387 . . . . 63.53 110.895 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -95.7 115.77 27.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.126 -0.488 . . . . 71.53 110.88 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.467 HG23 ' H ' ' A' ' 136' ' ' ASP . 30.2 m -83.14 -179.33 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.134 -0.484 . . . . 75.21 111.147 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -53.16 -28.95 28.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.244 -0.435 . . . . 74.31 110.891 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.467 ' H ' HG23 ' A' ' 134' ' ' VAL . 3.7 p-10 -164.02 85.01 0.46 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.166 -0.47 . . . . 65.33 110.919 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.436 ' O ' HG22 ' A' ' 134' ' ' VAL . . . 140.29 -179.06 19.42 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.749 -0.739 . . . . 31.44 112.449 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.628 ' O ' ' HB3' ' A' ' 153' ' ' ALA . 0.1 OUTLIER -135.37 130.81 35.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.748 0.308 . . . . 64.33 111.188 -179.862 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -116.14 96.35 5.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 61.32 110.885 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.613 HG22 ' CB ' ' A' ' 129' ' ' THR . 0.0 OUTLIER -83.77 110.23 18.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 70.14 111.11 -179.903 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 67.6 m-70 -109.25 107.1 17.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 64.32 110.891 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.529 ' HD2' HG22 ' A' ' 129' ' ' THR . 1.8 p90 -119.64 -176.15 3.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.23 -0.441 . . . . 64.2 110.925 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 25.3 p -140.33 165.25 27.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 61.42 110.835 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.575 HG11 HD22 ' A' ' 104' ' ' LEU . 58.3 t -148.85 98.18 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.092 -0.504 . . . . 53.15 111.08 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 61.19 -108.25 1.83 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.77 -0.728 . . . . 75.3 112.529 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -106.14 -26.9 11.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.896 0.379 . . . . 42.42 110.914 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 52.3 m-70 -64.37 -170.19 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.124 -0.489 . . . . 74.21 110.859 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -153.68 116.38 4.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 72.2 110.861 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' CYS . . . . . 0.591 ' HB3' HG22 ' A' ' 169' ' ' VAL . 0.8 OUTLIER -142.66 163.5 32.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.261 -0.427 . . . . 51.33 110.886 -179.867 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 28.5 p90 -161.17 152.87 19.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.191 -0.459 . . . . 73.12 110.877 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.52 HD13 HD22 ' A' ' 113' ' ' LEU . 21.0 mt -99.36 121.44 49.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.133 -0.485 . . . . 73.01 111.168 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.435 ' HD2' HD12 ' A' ' 168' ' ' ILE . 2.1 tttm -89.95 102.56 15.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 72.45 110.909 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.628 ' HB3' ' O ' ' A' ' 138' ' ' THR . . . -99.65 147.24 25.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.439 . . . . 72.21 111.064 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.8 t -145.46 131.29 13.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.184 -0.462 . . . . 71.43 111.045 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.1 p -102.2 145.48 29.35 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.162 -0.472 . . . . 52.05 110.83 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 2.0 p -150.54 165.62 32.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.08 -0.509 . . . . 71.04 110.897 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 112.56 -49.87 0.81 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.713 -0.756 . . . . 71.25 112.493 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -178.54 -64.81 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.806 0.336 . . . . 63.41 110.892 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.31 -42.93 0.29 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 75.42 110.887 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.77 26.82 0.64 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 63.41 110.833 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -62.52 -71.91 0.15 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.282 -0.417 . . . . 71.53 110.875 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -127.46 145.08 15.62 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.794 -0.717 . . . . 64.41 112.568 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 62.9 mt -138.59 139.97 40.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.823 0.344 . . . . 65.44 111.088 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 68.0 mt -127.37 140.36 49.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.122 -0.49 . . . . 73.35 111.147 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 16.0 m-70 -113.21 142.21 46.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 61.43 110.831 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.87 106.57 7.36 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.197 -0.456 . . . . 75.15 111.123 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.554 HD21 HD22 ' A' ' 102' ' ' LEU . 17.1 tp -67.35 136.39 54.73 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.251 -0.431 . . . . 73.52 110.951 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.534 ' H ' HD12 ' A' ' 167' ' ' LEU . 9.3 mt -138.31 121.16 19.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 75.35 111.158 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.66 HG21 HD13 ' A' ' 102' ' ' LEU . 18.0 t -121.93 124.98 72.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 64.34 111.12 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.5 t0 64.03 36.5 9.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 74.35 110.822 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 63.4 43.05 6.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.436 . . . . 51.54 110.873 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 3.9 mtm180 -140.51 128.98 22.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 74.31 110.92 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.69 146.52 52.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.434 . . . . 65.24 110.843 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -122.95 130.92 24.42 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.63 0.729 . . . . 75.55 111.189 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 140.4 42.68 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.738 2.292 . . . . 64.22 112.351 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -85.63 55.54 3.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 70.53 110.866 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.408 HD22 ' HA ' ' A' ' 177' ' ' LEU . 0.7 OUTLIER 72.53 -67.54 0.26 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.237 -0.438 . . . . 71.23 110.909 -179.955 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 11.2 t -58.22 -32.01 67.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.248 -0.433 . . . . 73.51 111.097 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.235 -0.439 . . . . 65.42 110.945 179.984 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 CA-C-O 121.493 0.496 . . . . 72.11 112.491 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.73 -35.36 12.89 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.654 2.236 . . . . 64.12 112.328 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 53.2 59.97 4.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.255 -0.429 . . . . 73.32 110.982 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 101.7 78.28 1.31 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.728 -0.749 . . . . 44.12 112.507 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 21.4 p -106.46 -174.01 2.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.87 0.367 . . . . 75.25 110.806 -179.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -140.72 -72.28 0.36 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.127 -0.488 . . . . 73.31 110.849 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -103.24 -63.64 1.16 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.128 -0.487 . . . . 75.41 110.904 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 12.6 mmt180 54.17 28.23 8.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.147 -0.479 . . . . 74.45 110.927 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -85.88 112.77 21.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.149 -0.478 . . . . 52.13 110.896 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.401 ' O ' HG23 ' A' ' 96' ' ' THR . 15.1 mttt -83.24 -74.38 0.37 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.117 -0.492 . . . . 65.21 110.912 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.509 ' O ' HG23 ' A' ' 97' ' ' THR . 2.1 p -155.23 22.22 0.42 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.246 -0.434 . . . . 60.14 111.155 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.509 HG23 ' O ' ' A' ' 96' ' ' THR . 1.1 p -159.51 128.29 5.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.224 -0.444 . . . . 72.41 111.17 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -105.75 150.94 25.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.03 0.443 . . . . 54.25 110.838 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 12.0 m -143.05 153.07 42.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.095 -0.502 . . . . 62.52 111.214 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' TRP . . . . . 0.498 ' CB ' HD23 ' A' ' 167' ' ' LEU . 11.0 m-90 -151.47 127.4 10.34 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.296 -0.411 . . . . 64.24 110.907 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.5 t -106.99 114.99 47.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.455 . . . . 62.14 111.148 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.944 HD11 HD12 ' A' ' 104' ' ' LEU . 0.5 OUTLIER -141.17 147.36 38.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.117 -0.492 . . . . 74.3 110.962 179.973 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 2.7 mtt180 -72.82 91.81 1.53 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 74.23 110.798 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.944 HD12 HD11 ' A' ' 102' ' ' LEU . 0.3 OUTLIER -122.1 151.99 40.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 65.03 110.892 179.988 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 64.84 14.75 9.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 75.43 110.946 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.15 0.39 80.57 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.775 -0.726 . . . . 63.51 112.506 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -139.72 172.86 12.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.797 0.332 . . . . 73.43 110.954 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -68.85 89.25 0.4 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.241 -0.436 . . . . 71.43 110.901 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.587 HD13 ' HB3' ' A' ' 104' ' ' LEU . 0.4 OUTLIER -75.43 127.92 34.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 64.43 110.9 -179.893 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 58.6 ttt180 -105.5 110.21 22.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.225 -0.443 . . . . 74.11 110.788 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.41 HG21 ' CD2' ' A' ' 167' ' ' LEU . 0.9 OUTLIER -95.5 139.75 18.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.103 -0.499 . . . . 52.24 111.056 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 93.3 t -136.23 130.02 47.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.133 -0.485 . . . . 74.33 111.134 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.594 HD11 ' HA ' ' A' ' 118' ' ' MET . 2.3 tp -118.07 104.46 10.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.102 -0.499 . . . . 74.32 110.846 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.477 ' HG3' HG22 ' A' ' 97' ' ' THR . 0.1 OUTLIER -81.6 124.67 29.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 63.03 110.854 179.932 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.59 -16.02 59.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 71.44 110.927 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -51.63 -55.98 16.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.203 -0.453 . . . . 72.15 110.884 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.3 m -132.76 17.02 4.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.264 -0.425 . . . . 74.31 111.147 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' MET . . . . . 0.594 ' HA ' HD11 ' A' ' 113' ' ' LEU . 82.5 mtp 54.68 31.53 15.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 63.32 110.85 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -86.46 147.18 26.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.444 . . . . 74.32 110.893 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.537 HG23 HG21 ' A' ' 129' ' ' THR . 25.2 t -104.84 137.6 33.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.247 -0.433 . . . . 63.41 111.14 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 1.2 t90 -125.51 129.7 50.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.133 -0.485 . . . . 55.44 110.881 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 16.8 p -138.48 133.87 33.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.221 -0.445 . . . . 62.41 110.912 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 2.8 m120 46.05 49.14 12.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 52.22 110.859 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 50.79 44.1 48.27 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.657 -0.782 . . . . 73.32 112.533 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -147.89 119.0 7.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.849 0.357 . . . . 72.11 110.952 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 1.5 mtpt -53.1 136.39 35.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 73.24 110.877 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' MET . . . . . 0.412 ' HB2' ' HB ' ' A' ' 120' ' ' VAL . 67.7 mtp -102.78 165.19 11.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 64.21 110.87 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -113.31 107.1 15.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.215 -0.448 . . . . 74.43 110.878 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.709 ' HB ' HG22 ' A' ' 140' ' ' THR . 16.6 p -99.98 -175.15 2.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.49 . . . . 64.14 111.099 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -115.06 -29.49 6.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 64.3 111.109 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 52.41 32.4 37.69 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.724 -0.75 . . . . 51.35 112.482 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -55.14 108.96 0.46 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.831 0.348 . . . . 75.2 110.853 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -82.91 116.18 22.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.147 -0.478 . . . . 74.25 110.902 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 19.7 m -100.46 -178.35 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.21 -0.45 . . . . 63.24 111.183 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -53.13 -30.53 37.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 73.11 110.896 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -159.19 91.75 1.04 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.199 -0.455 . . . . 70.02 110.9 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 128.86 178.96 15.63 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.634 -0.793 . . . . 74.22 112.483 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.67 ' O ' ' HB3' ' A' ' 153' ' ' ALA . 0.1 OUTLIER -134.85 130.84 36.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.71 0.291 . . . . 62.4 111.144 -179.826 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -109.49 96.35 6.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 73.43 110.818 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.709 HG22 ' HB ' ' A' ' 129' ' ' THR . 0.0 OUTLIER -79.29 110.24 14.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.449 . . . . 72.41 111.116 -179.915 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -105.68 113.03 26.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.272 -0.422 . . . . 73.11 110.907 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.544 ' HD2' HG22 ' A' ' 129' ' ' THR . 3.2 p90 -133.92 178.99 6.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.177 -0.465 . . . . 74.21 110.883 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 90.7 p -140.39 162.62 34.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 72.41 110.874 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.598 HG11 HD22 ' A' ' 104' ' ' LEU . 39.7 t -146.55 99.48 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 72.02 111.146 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 68.41 -108.05 2.31 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.704 -0.76 . . . . 73.31 112.482 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -111.66 -26.35 9.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.781 0.324 . . . . 75.34 110.913 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 24.7 m-70 -65.9 -169.97 0.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.484 . . . . 75.13 110.794 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -149.79 119.51 7.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.135 -0.484 . . . . 61.34 110.885 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' CYS . . . . . 0.599 ' HB3' HG22 ' A' ' 169' ' ' VAL . 0.8 OUTLIER -142.41 161.53 37.8 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.252 -0.431 . . . . 71.35 110.9 -179.878 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 22.2 p90 -156.89 150.36 24.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.251 -0.431 . . . . 64.43 110.904 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.577 HD13 HD22 ' A' ' 113' ' ' LEU . 10.3 mt -97.61 112.83 30.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.089 -0.505 . . . . 73.31 111.156 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.611 ' HD2' HD12 ' A' ' 168' ' ' ILE . 0.2 OUTLIER -80.92 102.68 10.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.126 -0.488 . . . . 74.32 110.872 179.921 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.67 ' HB3' ' O ' ' A' ' 138' ' ' THR . . . -98.05 148.13 23.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.259 -0.428 . . . . 64.22 111.154 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.0 t -144.5 127.31 11.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.262 -0.427 . . . . 63.43 111.21 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.1 p -97.13 133.71 41.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 64.35 110.845 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -127.9 137.66 52.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.083 -0.508 . . . . 51.23 110.8 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 134.55 -174.17 21.13 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.738 -0.744 . . . . 60.12 112.489 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 5.7 mttm -86.66 -48.88 7.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.79 0.329 . . . . 73.25 110.914 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 44.4 mtm180 -134.77 69.18 1.45 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 71.31 110.84 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 26.1 mttp 58.32 60.36 2.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.226 -0.443 . . . . 73.52 110.889 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -77.81 -65.22 1.0 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 72.11 110.859 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -136.8 145.23 17.05 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.758 -0.734 . . . . 72.21 112.511 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 69.4 mt -126.5 143.45 39.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.807 0.337 . . . . 61.04 111.145 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 60.1 mt -128.44 132.93 67.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.143 -0.48 . . . . 75.22 111.131 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 20.0 m-70 -106.91 141.11 38.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 52.22 110.873 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.6 106.36 7.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.225 -0.443 . . . . 74.41 111.124 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.537 HD21 HD22 ' A' ' 102' ' ' LEU . 17.1 tp -64.91 135.87 56.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 72.33 110.891 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.611 HD12 ' HD2' ' A' ' 152' ' ' LYS . 10.0 mt -138.1 117.38 14.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.061 -0.518 . . . . 64.33 111.193 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.599 HG22 ' HB3' ' A' ' 149' ' ' CYS . 20.2 t -119.45 127.02 75.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 72.52 111.149 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 2.9 t0 63.8 35.29 11.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.144 -0.48 . . . . 73.12 110.897 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 63.43 43.11 6.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.235 -0.439 . . . . 52.52 110.872 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 42.4 mtt180 -140.85 129.7 23.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.484 . . . . 73.2 110.831 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -62.77 146.47 52.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 73.3 110.848 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -123.04 130.86 24.43 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.581 0.705 . . . . 52.41 111.132 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.76 139.03 39.21 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.643 2.229 . . . . 71.03 112.369 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -88.57 153.41 21.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.199 -0.455 . . . . 73.43 110.899 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 26.4 tp -52.05 -73.45 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 61.44 110.932 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 21.5 p 48.92 49.88 18.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 54.04 111.099 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.453 . . . . 64.45 110.914 179.994 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 CA-C-O 121.42 0.455 . . . . 33.45 112.508 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 168.29 21.96 Favored 'Trans proline' 0 C--O 1.232 0.213 0 C-N-CA 122.728 2.285 . . . . 72.12 112.356 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -124.12 167.64 13.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.26 -0.427 . . . . 65.43 110.924 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -107.83 144.54 16.11 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.752 -0.737 . . . . 53.24 112.446 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 80.7 p -88.68 -178.38 5.78 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.912 0.387 . . . . 63.34 110.836 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -123.92 32.32 5.6 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.066 -0.515 . . . . 63.14 110.852 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -85.4 132.88 34.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 61.52 110.899 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 5.2 mtt180 -138.11 -60.95 0.62 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 74.3 110.843 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.2 t -150.18 -42.73 0.13 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.187 -0.46 . . . . 72.31 110.822 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.29 -174.91 0.14 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.177 -0.465 . . . . 70.42 110.902 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.502 ' O ' HG23 ' A' ' 97' ' ' THR . 13.4 t -139.04 16.33 2.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.253 -0.43 . . . . 74.52 111.13 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.502 HG23 ' O ' ' A' ' 96' ' ' THR . 1.1 p -159.35 128.1 5.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.27 -0.423 . . . . 72.34 111.181 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.4 m -105.92 149.61 26.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.455 . . . . 53.54 110.847 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 24.7 m -140.19 138.81 35.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.15 -0.477 . . . . 54.44 111.153 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 18.7 m-90 -131.68 133.51 44.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.242 -0.436 . . . . 71.04 110.951 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.2 t -112.88 114.78 47.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.451 . . . . 72.24 111.157 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.78 HD11 HD12 ' A' ' 104' ' ' LEU . 0.5 OUTLIER -141.2 146.48 36.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 73.24 110.9 -179.998 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.9 91.89 2.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 74.11 110.874 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.78 HD12 HD11 ' A' ' 102' ' ' LEU . 0.4 OUTLIER -123.09 152.97 40.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 70.42 110.915 -179.959 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 64.87 14.86 9.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.165 -0.47 . . . . 53.11 110.829 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 88.94 0.4 81.2 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.745 -0.74 . . . . 53.35 112.498 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -139.83 173.0 11.98 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.788 0.327 . . . . 75.24 110.89 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -68.98 87.45 0.37 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.138 -0.483 . . . . 64.13 110.886 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.624 HD13 ' HB3' ' A' ' 104' ' ' LEU . 0.5 OUTLIER -72.3 127.51 32.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 74.01 110.909 -179.896 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -107.6 117.35 33.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 75.44 110.916 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.429 HG21 ' CD2' ' A' ' 167' ' ' LEU . 0.1 OUTLIER -107.25 146.02 13.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 70.41 111.106 -179.982 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 22.0 t -135.92 152.69 31.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 62.14 111.182 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.504 HD22 HD13 ' A' ' 151' ' ' ILE . 5.1 tp -131.38 99.83 4.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 65.52 110.882 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.83 134.37 43.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 52.12 110.896 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 3.0 mmmt -73.78 -17.92 61.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 70.44 110.861 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -51.35 -55.1 20.28 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.216 -0.447 . . . . 75.15 110.83 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.86 16.72 4.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 74.45 111.156 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' MET . . . . . 0.431 ' HA ' HD11 ' A' ' 113' ' ' LEU . 3.8 ttm 54.05 27.24 7.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.208 -0.451 . . . . 54.14 110.886 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.83 160.51 22.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.184 -0.462 . . . . 73.13 110.835 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.714 HG22 HD12 ' A' ' 151' ' ' ILE . 55.5 t -104.64 143.58 15.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 74.4 111.125 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 2.3 t90 -123.75 120.89 34.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.185 -0.461 . . . . 74.52 110.924 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' CYS . . . . . 0.482 ' SG ' HD21 ' A' ' 109' ' ' LEU . 19.6 t -136.55 132.55 35.35 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.276 -0.42 . . . . 72.24 110.905 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 2.9 m120 51.92 48.33 22.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.157 -0.474 . . . . 41.34 110.884 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 48.62 47.21 30.1 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.733 -0.746 . . . . 71.31 112.474 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.6 118.76 5.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.838 0.351 . . . . 75.33 110.932 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.24 101.95 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.212 -0.449 . . . . 55.24 110.88 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' MET . . . . . 0.59 ' HE1' HG22 ' A' ' 144' ' ' VAL . 38.5 mmm -55.68 176.65 0.06 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 73.34 110.843 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -119.16 106.51 12.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 72.34 110.914 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.576 ' HB ' HG22 ' A' ' 140' ' ' THR . 59.4 p -99.14 -175.3 2.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 52.15 111.151 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.512 ' HB2' ' HB2' ' A' ' 141' ' ' HIS . . . -106.55 -44.64 4.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 72.22 111.126 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 77.04 53.07 5.42 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.825 -0.702 . . . . 73.31 112.456 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -97.08 115.02 26.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.86 0.362 . . . . 65.1 110.846 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -90.95 126.62 36.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 75.53 110.995 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.495 HG22 ' O ' ' A' ' 137' ' ' GLY . 29.2 m -111.53 -178.29 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.178 -0.464 . . . . 71.11 111.123 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -52.71 -36.35 57.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 61.22 110.872 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -152.78 102.46 2.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 75.34 110.871 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.495 ' O ' HG22 ' A' ' 134' ' ' VAL . . . 111.53 178.47 20.2 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.693 -0.765 . . . . 62.44 112.499 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.04 130.79 36.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.688 0.28 . . . . 72.23 111.218 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -98.89 100.23 11.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.271 -0.422 . . . . 73.35 110.955 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.576 HG22 ' HB ' ' A' ' 129' ' ' THR . 0.0 OUTLIER -82.98 110.24 17.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.46 . . . . 74.01 111.193 -179.93 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 141' ' ' HIS . . . . . 0.512 ' HB2' ' HB2' ' A' ' 130' ' ' ALA . 47.0 m80 -100.77 105.78 17.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.257 -0.429 . . . . 75.31 110.814 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.608 ' CE2' HG21 ' A' ' 120' ' ' VAL . 21.9 p90 -139.29 156.54 46.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.245 -0.434 . . . . 75.1 110.849 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -111.64 123.73 50.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.086 -0.506 . . . . 74.42 110.917 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.59 HG22 ' HE1' ' A' ' 127' ' ' MET . 27.2 t -106.15 125.89 61.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.114 -0.494 . . . . 52.41 111.082 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 52.36 41.3 54.84 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.727 -0.749 . . . . 65.32 112.478 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 64.33 26.02 13.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.799 0.333 . . . . 74.51 110.837 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 18.4 m170 -113.12 -169.27 1.45 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 73.55 110.832 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -116.48 110.63 18.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 62.33 110.898 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' CYS . . . . . 0.516 ' SG ' HG13 ' A' ' 169' ' ' VAL . 12.1 m -138.38 173.47 11.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 74.01 110.923 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 32.0 p90 -174.97 143.44 0.71 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.199 -0.455 . . . . 75.21 110.953 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.714 HD12 HG22 ' A' ' 120' ' ' VAL . 20.6 mt -97.73 113.63 32.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.076 -0.511 . . . . 61.11 111.094 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 27.9 tttt -79.84 102.74 9.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 72.34 110.914 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -97.19 136.02 38.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 64.41 111.075 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.3 t -133.91 121.14 38.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.23 -0.441 . . . . 74.05 111.185 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.3 p -94.53 143.1 26.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.145 -0.48 . . . . 74.25 110.833 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 2.3 t -136.52 134.14 37.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.091 -0.504 . . . . 73.55 110.89 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 136.12 171.92 12.46 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.728 -0.749 . . . . 71.13 112.493 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 6.5 mmtt -59.06 -28.64 66.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.764 0.316 . . . . 65.53 110.884 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 2.1 mtt180 -148.82 -63.43 0.24 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 72.41 110.872 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -152.75 44.39 0.67 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 75.51 110.84 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -57.68 -58.55 7.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.313 -0.403 . . . . 65.44 110.866 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -145.1 162.27 28.14 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.725 -0.75 . . . . 64.13 112.5 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 55.4 mt -144.85 145.45 21.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.786 0.327 . . . . 73.52 111.144 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 75.6 mt -133.82 123.68 45.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.466 . . . . 75.05 111.186 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 5.6 m80 -104.38 137.19 42.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 71.25 110.932 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.91 108.8 11.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 53.23 111.2 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.492 HD12 ' N ' ' A' ' 168' ' ' ILE . 14.8 tp -66.33 136.36 55.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.277 -0.419 . . . . 62.12 110.904 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.492 ' N ' HD12 ' A' ' 167' ' ' LEU . 12.4 mt -133.62 129.41 55.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.146 -0.479 . . . . 72.22 111.17 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.516 HG13 ' SG ' ' A' ' 149' ' ' CYS . 95.6 t -127.17 118.17 49.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.446 . . . . 74.34 111.149 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 63.61 41.0 7.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.134 -0.485 . . . . 72.33 110.853 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 63.34 43.01 6.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 73.43 110.812 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 17.7 mtm180 -138.98 121.97 16.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.216 -0.447 . . . . 74.44 110.922 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -62.75 146.48 52.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 52.4 110.913 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.582 HD12 HD22 ' A' ' 102' ' ' LEU . 0.9 OUTLIER -123.99 131.55 24.24 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.619 0.723 . . . . 63.24 111.117 179.996 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 133.44 25.49 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.625 2.217 . . . . 74.43 112.34 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.22 163.52 14.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.246 -0.433 . . . . 72.5 110.924 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 22.0 tp -52.35 -73.93 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 71.02 110.952 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 1.3 p 46.61 78.14 0.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 62.13 111.155 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.273 -0.421 . . . . 74.34 110.882 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.286 0 CA-C-O 121.411 0.451 . . . . 75.1 112.557 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.69 -171.97 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.689 2.259 . . . . 72.24 112.326 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -126.32 132.55 51.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.122 -0.49 . . . . 70.42 110.876 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -129.26 97.46 0.41 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.706 -0.759 . . . . 62.3 112.418 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 77.3 p -141.14 76.61 1.56 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.805 0.336 . . . . 52.51 110.802 -179.723 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -130.58 131.29 44.91 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.137 -0.483 . . . . 61.01 110.88 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -132.83 151.72 51.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.121 -0.49 . . . . 73.23 110.919 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.61 160.53 22.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 71.54 110.924 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 58.0 m -73.22 112.49 9.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.239 -0.437 . . . . 72.32 110.882 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -146.26 111.03 5.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.069 -0.514 . . . . 64.11 110.872 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.494 ' O ' HG23 ' A' ' 97' ' ' THR . 71.8 p -94.56 47.1 1.16 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.456 . . . . 64.51 111.209 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.661 HG22 ' HA ' ' A' ' 114' ' ' GLU . 1.0 OUTLIER -159.53 127.77 4.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.187 -0.46 . . . . 71.12 111.151 -179.968 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 14.5 m -106.42 113.16 26.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.263 -0.426 . . . . 72.11 110.842 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.982 HG22 HG22 ' A' ' 112' ' ' VAL . 17.2 p -110.18 159.59 17.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.121 -0.491 . . . . 73.23 111.064 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 14.6 m-90 -149.57 155.97 41.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.223 -0.444 . . . . 72.45 110.911 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 18.9 t -131.52 114.95 26.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 73.33 111.158 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.887 HD11 HD12 ' A' ' 104' ' ' LEU . 0.5 OUTLIER -141.22 147.63 38.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 73.32 110.884 179.985 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.65 94.29 3.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.155 -0.475 . . . . 71.14 110.834 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.887 HD12 HD11 ' A' ' 102' ' ' LEU . 0.3 OUTLIER -123.68 154.05 39.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 71.3 110.908 179.985 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.1 t70 64.91 14.87 9.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.19 -0.459 . . . . 74.52 110.833 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 88.79 0.48 81.43 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.714 -0.755 . . . . 62.11 112.489 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -139.79 172.88 12.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.88 0.372 . . . . 60.31 110.855 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -68.43 89.4 0.35 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 71.31 110.907 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.621 HD13 ' HB3' ' A' ' 104' ' ' LEU . 0.5 OUTLIER -75.72 123.99 26.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.437 . . . . 74.24 110.96 -179.999 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -104.09 115.04 29.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 71.52 110.87 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.465 HG21 HD21 ' A' ' 167' ' ' LEU . 0.2 OUTLIER -102.98 138.89 25.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.183 -0.462 . . . . 73.22 111.184 179.906 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.982 HG22 HG22 ' A' ' 99' ' ' THR . 96.3 t -135.77 126.99 44.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.434 . . . . 72.41 111.169 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.629 HD22 HD13 ' A' ' 151' ' ' ILE . 6.3 tp -110.36 100.4 9.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.444 . . . . 72.23 110.959 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.661 ' HA ' HG22 ' A' ' 97' ' ' THR . 0.0 OUTLIER -77.4 136.15 38.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.447 . . . . 62.55 110.921 179.962 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 3.6 mtmt -73.21 -17.48 61.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 62.4 110.834 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -51.39 -54.91 21.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.222 -0.445 . . . . 74.14 110.871 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 14.9 p -132.55 16.82 4.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.176 -0.465 . . . . 62.11 111.12 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 81.2 mtp 51.59 31.1 7.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 74.21 110.895 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -86.57 153.27 21.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 71.3 110.875 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.6 HG22 HD12 ' A' ' 151' ' ' ILE . 95.6 t -104.92 123.09 58.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.233 -0.439 . . . . 64.11 111.18 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -104.94 131.97 51.77 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.232 -0.44 . . . . 64.43 110.91 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' CYS . . . . . 0.4 ' SG ' HD21 ' A' ' 109' ' ' LEU . 24.4 t -126.99 103.19 7.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 73.34 110.931 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 12.0 m-20 45.35 70.28 0.37 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 53.33 110.885 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 48.72 39.01 23.34 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.78 -0.724 . . . . 61.24 112.504 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.25 107.42 4.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.893 0.377 . . . . 72.04 110.88 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.28 143.27 18.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 73.52 110.89 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' MET . . . . . 0.457 ' CE ' HG22 ' A' ' 144' ' ' VAL . 22.7 mmm -111.24 163.99 13.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 52.4 110.866 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -117.79 107.8 14.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 75.14 110.876 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.694 ' HB ' HG22 ' A' ' 140' ' ' THR . 19.2 p -95.26 -179.36 4.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.144 -0.48 . . . . 71.1 111.177 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.459 ' HB2' ' HB2' ' A' ' 141' ' ' HIS . . . -92.41 -31.26 15.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 71.25 111.114 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 58.82 54.69 35.88 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.791 -0.718 . . . . 72.0 112.458 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -97.14 103.28 15.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.915 0.388 . . . . 74.25 110.957 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -84.61 116.21 23.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.176 -0.465 . . . . 73.02 110.904 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.451 HG22 ' O ' ' A' ' 137' ' ' GLY . 20.4 m -97.94 -178.0 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.111 -0.495 . . . . 71.34 111.153 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.58 -27.73 67.93 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.138 -0.483 . . . . 71.54 110.84 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -155.53 102.46 2.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.251 -0.432 . . . . 72.41 110.834 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.451 ' O ' HG22 ' A' ' 134' ' ' VAL . . . 110.92 174.98 20.28 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.743 -0.742 . . . . 33.01 112.498 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.21 130.8 35.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.686 0.279 . . . . 71.12 111.21 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -109.82 97.44 6.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.302 -0.408 . . . . 63.12 110.865 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.694 HG22 ' HB ' ' A' ' 129' ' ' THR . 0.0 OUTLIER -85.51 110.44 19.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 72.22 111.142 -179.943 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 141' ' ' HIS . . . . . 0.459 ' HB2' ' HB2' ' A' ' 130' ' ' ALA . 67.5 m-70 -106.15 105.6 15.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 73.52 110.837 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.408 ' HB3' HG22 ' A' ' 129' ' ' THR . 18.8 p90 -122.97 131.07 53.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 70.51 110.808 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 27.8 p -83.07 149.79 26.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 74.0 110.857 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.457 HG22 ' CE ' ' A' ' 127' ' ' MET . 21.8 t -140.65 99.65 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.051 -0.522 . . . . 52.52 111.066 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 54.58 -115.88 5.88 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.726 -0.749 . . . . 61.5 112.479 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -106.04 25.41 10.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.81 0.338 . . . . 72.22 110.884 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 36.1 m170 -119.2 -175.48 2.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 72.44 110.824 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -145.33 84.42 1.7 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 61.0 110.872 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' CYS . . . . . 0.448 ' SG ' HG13 ' A' ' 169' ' ' VAL . 6.8 m -99.53 165.08 11.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.231 -0.441 . . . . 74.15 110.897 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 19.9 p90 -167.48 145.04 4.56 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.175 -0.466 . . . . 75.02 110.89 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.629 HD13 HD22 ' A' ' 113' ' ' LEU . 32.9 mt -98.63 111.26 27.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.134 -0.485 . . . . 72.12 111.155 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.33 103.14 12.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.122 -0.49 . . . . 63.54 110.902 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -94.27 146.08 24.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 71.32 111.157 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.5 t -138.41 124.79 25.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.289 -0.414 . . . . 74.3 111.126 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -99.86 146.87 26.14 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.184 -0.462 . . . . 73.53 110.878 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 1.4 p -149.29 150.6 32.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 64.01 110.826 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 109.1 64.56 0.55 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.778 -0.725 . . . . 72.42 112.507 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.19 -75.44 0.07 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.794 0.33 . . . . 73.21 110.876 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -138.72 -58.97 0.62 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 65.44 110.962 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 2.9 tttt -135.39 103.07 5.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.116 -0.493 . . . . 72.54 110.98 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -144.87 -62.8 0.36 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 61.11 110.852 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -135.16 127.38 4.35 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.765 -0.731 . . . . 64.14 112.459 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 69.1 mt -122.99 138.57 52.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.763 0.316 . . . . 62.41 111.185 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 54.9 mt -127.53 128.92 70.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.178 -0.464 . . . . 72.25 111.088 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 15.3 m80 -100.22 137.98 37.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 73.44 110.914 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.88 109.3 11.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 74.35 111.107 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.574 HD12 ' H ' ' A' ' 168' ' ' ILE . 19.1 tp -67.3 138.46 56.85 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.152 -0.477 . . . . 75.44 110.893 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.574 ' H ' HD12 ' A' ' 167' ' ' LEU . 8.6 mt -139.01 128.59 30.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 74.05 111.114 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.633 HG21 HD13 ' A' ' 102' ' ' LEU . 64.1 t -127.81 122.73 59.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.109 -0.496 . . . . 74.41 111.15 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 2.4 t0 63.77 38.24 9.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.204 -0.453 . . . . 72.21 110.867 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 2.0 t30 63.32 43.11 6.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 61.42 110.842 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.14 131.61 23.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 74.21 110.879 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -62.34 146.4 51.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.218 -0.446 . . . . 75.24 110.954 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.473 HD12 HD22 ' A' ' 102' ' ' LEU . 0.8 OUTLIER -123.72 130.52 24.43 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.646 0.736 . . . . 73.13 111.137 179.998 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 147.83 63.53 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.713 2.275 . . . . 73.43 112.324 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -89.83 -175.66 4.69 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.245 -0.434 . . . . 75.42 110.91 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 17.4 tp -76.82 109.09 10.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 62.22 110.915 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 53.3 p -135.3 -45.12 0.7 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 74.41 111.134 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 63.34 110.953 179.964 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.362 0 CA-C-O 121.425 0.458 . . . . 65.24 112.486 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 154.75 67.36 Favored 'Trans proline' 0 C--O 1.233 0.238 0 C-N-CA 122.666 2.244 . . . . 71.21 112.318 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.2 mt -144.9 148.05 33.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 53.33 110.922 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 99.2 -137.7 13.41 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.781 -0.723 . . . . 35.04 112.483 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.5 m -85.47 163.39 18.48 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.827 0.346 . . . . 73.34 110.856 -179.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -118.76 41.57 2.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 73.23 110.918 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 57.0 -172.06 0.08 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.117 -0.492 . . . . 64.15 110.864 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.78 -37.44 24.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 74.13 110.9 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 61.88 94.6 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.157 -0.474 . . . . 64.31 110.906 -179.767 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 14.0 pttp -174.03 -171.29 0.62 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 73.41 110.935 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.511 ' O ' HG23 ' A' ' 97' ' ' THR . 2.4 m 72.57 -68.62 0.22 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 55.03 111.115 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.511 HG23 ' O ' ' A' ' 96' ' ' THR . 1.0 OUTLIER -159.8 128.15 4.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 53.54 111.138 -179.998 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.9 m -106.04 151.99 23.95 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.209 -0.451 . . . . 45.21 110.826 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 95.7 m -146.34 141.81 27.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.111 -0.495 . . . . 52.12 111.145 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 21.7 m-90 -132.35 158.8 41.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 75.25 110.968 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.0 t -133.26 114.82 21.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.342 -0.39 . . . . 63.51 111.144 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.952 HD11 HD12 ' A' ' 104' ' ' LEU . 0.5 OUTLIER -141.64 147.58 37.79 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.226 -0.443 . . . . 64.14 110.919 179.975 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 42.3 mtp180 -72.72 92.09 1.53 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 75.43 110.858 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.952 HD12 HD11 ' A' ' 102' ' ' LEU . 0.3 OUTLIER -121.61 151.52 40.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 72.12 110.904 -179.944 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 64.85 14.69 9.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.232 -0.44 . . . . 62.23 110.884 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.2 0.69 80.03 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.752 -0.737 . . . . 62.53 112.489 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -139.87 172.73 12.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.867 0.365 . . . . 74.42 110.942 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -68.24 89.88 0.33 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.162 -0.472 . . . . 63.34 110.865 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.596 HD13 ' HB3' ' A' ' 104' ' ' LEU . 0.6 OUTLIER -76.96 134.14 38.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 71.25 110.912 -179.981 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 25.9 ttm180 -111.11 119.51 39.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 64.45 110.877 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.447 HG21 ' CD2' ' A' ' 167' ' ' LEU . 0.1 OUTLIER -105.41 145.13 13.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.2 -0.455 . . . . 73.5 111.167 179.956 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 91.4 t -134.37 144.24 35.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.249 -0.432 . . . . 61.42 111.135 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.496 HD11 ' HA ' ' A' ' 118' ' ' MET . 3.4 tp -131.52 101.53 5.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 75.21 110.929 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.478 ' HG3' HG22 ' A' ' 97' ' ' THR . 0.0 OUTLIER -73.63 132.11 42.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.27 -0.423 . . . . 72.45 110.881 179.942 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.35 -16.58 61.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 70.52 110.93 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -52.59 -55.96 18.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 74.3 110.829 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.56 16.99 3.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 74.2 111.116 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' MET . . . . . 0.496 ' HA ' HD11 ' A' ' 113' ' ' LEU . 68.1 mtp 57.91 30.23 18.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.445 . . . . 62.35 110.884 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -77.83 143.07 38.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.455 . . . . 72.15 110.902 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.432 HG23 HG21 ' A' ' 129' ' ' THR . 17.2 t -104.62 128.06 58.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 74.51 111.209 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 3.2 t90 -119.97 114.39 21.96 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.23 -0.441 . . . . 73.11 110.894 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' CYS . . . . . 0.538 ' SG ' HD11 ' A' ' 109' ' ' LEU . 3.0 t -100.97 103.09 14.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.25 -0.432 . . . . 73.35 110.892 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 67.91 -76.16 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 60.31 110.926 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -159.08 45.77 0.44 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.739 -0.744 . . . . 60.43 112.462 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.86 114.2 4.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.893 0.378 . . . . 74.22 110.868 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.3 101.94 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.459 . . . . 72.0 110.879 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' MET . . . . . 0.443 ' HE2' ' CG ' ' A' ' 142' ' ' PHE . 64.1 mtp -60.85 157.32 15.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 61.42 110.9 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -102.9 106.65 17.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 72.41 110.868 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.803 ' HB ' HG22 ' A' ' 140' ' ' THR . 15.5 p -98.66 -176.28 3.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 45.2 111.111 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -112.89 -75.36 0.6 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.275 -0.42 . . . . 55.03 111.094 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 104.68 86.15 1.9 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.727 -0.749 . . . . 73.04 112.511 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -148.17 132.54 17.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.869 0.366 . . . . 73.34 110.914 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -69.84 151.7 45.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 70.11 110.92 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.561 HG11 ' HG3' ' A' ' 139' ' ' GLU . 16.4 m -136.98 -176.42 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 71.4 111.182 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -55.88 -24.05 34.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 75.13 110.891 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.471 ' H ' HG23 ' A' ' 134' ' ' VAL . 0.1 OUTLIER -107.95 -77.2 0.6 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 53.45 110.865 179.988 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -129.99 -102.68 1.0 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.8 -0.714 . . . . 54.01 112.539 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.32 130.87 33.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.76 0.314 . . . . 71.2 111.145 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.561 ' HG3' HG11 ' A' ' 134' ' ' VAL . 0.4 OUTLIER -90.73 97.68 11.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 73.53 110.881 -179.967 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.803 HG22 ' HB ' ' A' ' 129' ' ' THR . 0.1 OUTLIER -77.46 110.55 12.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.114 -0.494 . . . . 74.14 111.112 -179.878 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -98.91 111.63 23.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.267 -0.424 . . . . 63.02 110.869 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.764 ' CE2' HD12 ' A' ' 151' ' ' ILE . 1.4 p90 -144.8 159.55 42.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.454 . . . . 63.24 110.903 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.8 166.5 14.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 54.51 110.895 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 24.2 t -145.54 97.97 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.159 -0.473 . . . . 73.55 111.084 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 67.22 -88.98 0.16 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.738 -0.744 . . . . 61.02 112.478 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -139.5 25.9 2.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.828 0.347 . . . . 61.34 110.86 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 67.1 m-70 -115.77 -175.77 2.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 73.0 110.899 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -140.89 116.56 10.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.26 -0.427 . . . . 71.24 110.893 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' CYS . . . . . 0.708 ' CB ' HG22 ' A' ' 169' ' ' VAL . 1.9 p -142.56 158.19 43.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 70.25 110.959 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 19.9 p90 -150.84 145.34 25.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.227 -0.442 . . . . 72.43 110.926 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.764 HD12 ' CE2' ' A' ' 142' ' ' PHE . 3.2 mt -97.74 112.46 29.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.095 -0.502 . . . . 73.2 111.174 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.69 102.88 9.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 74.4 110.93 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -99.02 143.85 28.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.229 -0.441 . . . . 53.13 111.098 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 20.9 t -142.33 124.43 13.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 71.14 111.149 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.3 p -94.38 140.43 29.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.455 . . . . 73.31 110.821 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 10.4 t -134.47 135.7 42.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.068 -0.515 . . . . 62.02 110.886 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 135.78 -145.65 17.65 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.709 -0.757 . . . . 74.45 112.447 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -88.79 -36.4 16.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.819 0.342 . . . . 45.43 110.858 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 1.7 mtm-85 -152.35 -47.5 0.1 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.284 -0.416 . . . . 55.41 110.831 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 7.7 pttp -159.55 37.82 0.2 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.165 -0.471 . . . . 70.4 110.931 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -59.08 -70.6 0.15 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.236 -0.438 . . . . 74.13 110.896 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -129.58 128.23 5.66 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.76 -0.733 . . . . 74.43 112.485 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 48.6 mt -120.44 147.46 24.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.816 0.341 . . . . 64.34 111.122 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 3.0 mt -131.96 130.23 61.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 64.23 111.074 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 8.7 m80 -108.71 134.96 50.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 74.25 110.917 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.28 110.14 13.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.188 -0.46 . . . . 52.24 111.156 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.587 HD12 ' N ' ' A' ' 168' ' ' ILE . 11.8 tp -66.96 135.38 53.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.212 -0.449 . . . . 70.04 110.951 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.587 ' N ' HD12 ' A' ' 167' ' ' LEU . 10.8 mt -136.81 106.19 4.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 74.11 111.206 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.708 HG22 ' CB ' ' A' ' 149' ' ' CYS . 47.7 t -109.39 128.94 64.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 74.31 111.142 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 63.31 41.28 7.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.194 -0.457 . . . . 74.12 110.816 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 56.6 42.68 26.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.237 -0.438 . . . . 72.32 110.87 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 10.5 mtp180 -140.44 126.44 19.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 75.31 110.836 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.58 145.29 54.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 74.41 110.885 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.446 HD12 HD22 ' A' ' 102' ' ' LEU . 0.9 OUTLIER -123.61 131.29 24.28 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.663 0.744 . . . . 65.34 111.125 179.964 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 132.25 22.99 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.755 2.303 . . . . 73.5 112.336 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -92.52 164.01 13.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.245 -0.434 . . . . 73.1 110.85 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -81.33 99.58 8.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 70.21 110.927 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 22.9 p -117.59 34.11 5.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 74.44 111.144 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 61.44 110.912 179.984 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.503 ' O ' HG23 ' A' ' 97' ' ' THR . 68.3 p . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.836 0.35 . . . . 72.3 111.143 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.503 HG23 ' O ' ' A' ' 96' ' ' THR . 1.0 OUTLIER -159.65 127.98 4.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.23 -0.441 . . . . 53.41 111.134 -179.92 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.3 m -106.17 152.79 23.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 61.14 110.863 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.534 HG23 HG22 ' A' ' 112' ' ' VAL . 7.9 m -140.66 154.79 46.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.147 -0.479 . . . . 74.32 111.172 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 14.0 m-90 -151.12 131.54 13.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.231 -0.44 . . . . 72.33 110.915 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.2 t -113.03 114.61 47.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 64.21 111.115 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.688 HD11 HD12 ' A' ' 104' ' ' LEU . 0.5 OUTLIER -139.36 145.95 39.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 74.43 110.888 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 17.2 ttt180 -74.0 93.39 2.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 63.22 110.827 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.688 HD12 HD11 ' A' ' 102' ' ' LEU . 0.4 OUTLIER -126.27 152.95 45.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.187 -0.46 . . . . 62.12 110.911 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 3.1 t70 64.51 15.32 9.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 64.4 110.894 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.23 1.55 84.04 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.734 -0.746 . . . . 52.24 112.467 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -139.83 173.07 11.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.876 0.37 . . . . 75.22 110.899 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -69.63 87.97 0.5 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.146 -0.479 . . . . 64.11 110.876 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.638 HD13 ' HB3' ' A' ' 104' ' ' LEU . 0.8 OUTLIER -70.39 126.7 30.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 75.23 110.913 -179.948 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 12.3 ttt180 -108.14 116.72 32.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 75.24 110.865 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.412 HG21 ' CD2' ' A' ' 167' ' ' LEU . 0.0 OUTLIER -109.6 139.96 30.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 63.55 111.128 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.534 HG22 HG23 ' A' ' 99' ' ' THR . 47.3 t -135.66 139.36 46.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 72.52 111.109 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.529 HD22 HD13 ' A' ' 151' ' ' ILE . 2.9 tp -114.75 99.87 7.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 53.15 110.93 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.22 134.24 42.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.441 . . . . 75.44 110.88 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.7 mmmt -73.81 -17.63 61.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.13 -0.486 . . . . 75.02 110.907 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -51.27 -52.75 42.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 65.02 110.886 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 17.0 p -134.92 16.98 3.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 71.43 111.204 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . 0.468 ' HA ' HD11 ' A' ' 113' ' ' LEU . 0.0 OUTLIER 53.13 28.66 7.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 71.04 110.92 179.934 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.62 159.67 19.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 63.55 110.914 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.731 HG22 HD12 ' A' ' 151' ' ' ILE . 85.8 t -104.93 134.09 47.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 73.1 111.121 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 4.1 t90 -115.94 120.24 38.53 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.154 -0.475 . . . . 70.42 110.933 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . 0.42 ' SG ' HD11 ' A' ' 109' ' ' LEU . 11.3 t -136.6 132.05 34.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.242 -0.436 . . . . 74.33 110.857 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 50.51 48.03 23.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.197 -0.456 . . . . 62.13 110.851 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 49.45 47.88 35.27 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.785 -0.722 . . . . 54.12 112.508 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.18 113.85 4.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.835 0.35 . . . . 74.32 110.88 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 2.5 ttpm? -53.71 101.72 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 75.23 110.897 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' MET . . . . . 0.544 ' CE ' HG22 ' A' ' 144' ' ' VAL . 25.1 mmm -60.97 169.92 1.76 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 64.13 110.897 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -119.17 106.96 12.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 74.24 110.906 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.677 ' HB ' HG22 ' A' ' 140' ' ' THR . 24.4 p -95.6 -175.28 3.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 74.04 111.198 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.561 ' HB2' ' HB2' ' A' ' 141' ' ' HIS . . . -95.12 -39.47 10.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.259 -0.428 . . . . 75.14 111.124 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 69.53 40.03 78.69 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.727 -0.749 . . . . 72.44 112.466 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 . . . . . 0 C--N 1.329 -0.312 0 CA-C-O 120.858 0.361 . . . . 74.3 110.902 -179.876 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 N-CA-C 112.54 -0.224 . . . . 73.13 112.54 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.52 ' O ' ' HB3' ' A' ' 153' ' ' ALA . 0.1 OUTLIER -135.24 130.71 35.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.73 0.3 . . . . 75.33 111.186 -179.874 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -106.35 96.36 6.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.259 -0.428 . . . . 75.42 110.867 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.677 HG22 ' HB ' ' A' ' 129' ' ' THR . 0.0 OUTLIER -80.06 110.26 15.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 74.42 111.153 -179.963 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . 0.561 ' HB2' ' HB2' ' A' ' 130' ' ' ALA . 77.1 m-70 -104.83 105.38 15.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.455 . . . . 73.12 110.87 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.514 ' CE2' HG21 ' A' ' 120' ' ' VAL . 19.0 p90 -126.13 132.92 51.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.471 . . . . 75.01 110.887 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 54.7 p -83.33 144.48 29.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 62.24 110.88 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.544 HG22 ' CE ' ' A' ' 127' ' ' MET . 21.6 t -134.58 98.1 2.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 62.24 111.102 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 52.12 -119.29 8.71 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.674 -0.774 . . . . 75.42 112.537 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -100.4 28.25 5.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.851 0.358 . . . . 64.14 110.849 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 49.0 m-70 -130.87 165.67 22.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 72.15 110.868 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -124.35 88.9 2.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 74.41 110.866 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' CYS . . . . . 0.514 ' SG ' HG13 ' A' ' 169' ' ' VAL . 9.8 m -98.49 172.76 7.31 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.207 -0.451 . . . . 60.4 110.903 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 55.5 p90 -175.22 145.6 0.79 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.196 -0.456 . . . . 72.01 110.937 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.731 HD12 HG22 ' A' ' 120' ' ' VAL . 23.2 mt -97.43 111.23 26.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.117 -0.492 . . . . 74.41 111.127 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -80.18 102.86 9.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 54.33 110.868 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . 0.52 ' HB3' ' O ' ' A' ' 138' ' ' THR . . . -95.49 146.44 24.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 30.41 111.088 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.4 t -143.89 120.49 5.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.264 -0.425 . . . . 72.32 111.14 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.3 p -87.25 140.72 29.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 64.45 110.869 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 5.0 p -132.56 148.68 52.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.118 -0.492 . . . . 75.14 110.863 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 111.06 -162.93 12.32 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.792 -0.718 . . . . 63.23 112.479 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.47 -44.87 85.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.794 0.331 . . . . 72.44 110.906 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.23 -60.83 0.13 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 71.13 110.852 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 17.7 mtmt -137.18 37.72 2.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 35.33 110.86 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.25 -62.21 1.84 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.266 -0.424 . . . . 71.21 110.884 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -135.16 122.47 2.83 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.768 -0.73 . . . . 33.25 112.516 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 69.6 mt -110.77 144.85 17.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.846 0.355 . . . . 74.15 111.112 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 3.0 mt -129.84 127.97 64.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 74.21 111.173 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' HIS . . . . . 0.438 ' CG ' HD23 ' A' ' 113' ' ' LEU . 13.0 m80 -105.01 136.51 44.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 74.32 110.857 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.61 106.1 8.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 63.3 111.092 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.454 HD12 ' H ' ' A' ' 168' ' ' ILE . 30.4 tp -65.29 139.36 58.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.193 -0.458 . . . . 64.41 110.917 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.454 ' H ' HD12 ' A' ' 167' ' ' LEU . 9.4 mt -137.43 129.97 42.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 61.13 111.118 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.514 HG13 ' SG ' ' A' ' 149' ' ' CYS . 99.5 t -125.49 115.43 43.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.47 . . . . 74.11 111.125 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 63.66 46.88 3.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.15 -0.477 . . . . 74.43 110.918 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 58.69 42.8 19.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.143 -0.481 . . . . 74.41 110.918 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.19 124.9 19.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 70.25 110.85 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -62.56 146.2 52.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 74.44 110.903 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.573 HD12 HD22 ' A' ' 102' ' ' LEU . 0.9 OUTLIER -120.73 131.12 24.56 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.606 0.717 . . . . 63.43 111.135 179.986 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 134.4 27.9 Favored 'Trans proline' 0 N--CA 1.465 -0.161 0 C-N-CA 122.714 2.276 . . . . 73.4 112.348 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.234 -0.439 . . . . 52.2 110.913 -179.998 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.5 ' O ' HG23 ' A' ' 97' ' ' THR . 40.4 p . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.871 0.367 . . . . 73.45 111.161 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.5 HG23 ' O ' ' A' ' 96' ' ' THR . 1.0 OUTLIER -159.52 128.33 5.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.193 -0.458 . . . . 71.01 111.091 -179.974 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.9 m -105.8 152.79 22.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 74.32 110.844 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 56.1 m -147.52 137.42 22.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 63.13 111.15 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . 0.404 ' CB ' HD23 ' A' ' 167' ' ' LEU . 16.7 m-90 -130.27 156.86 43.94 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.202 -0.453 . . . . 64.53 110.883 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 19.7 t -128.95 114.84 34.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.234 -0.439 . . . . 63.25 111.163 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.914 HD11 HD12 ' A' ' 104' ' ' LEU . 0.5 OUTLIER -141.33 147.52 38.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.27 -0.423 . . . . 45.45 110.899 179.986 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.54 92.78 2.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 74.41 110.853 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.914 HD12 HD11 ' A' ' 102' ' ' LEU . 0.3 OUTLIER -122.1 152.66 39.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 70.13 110.852 -179.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 64.93 14.78 9.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.17 -0.468 . . . . 61.51 110.887 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.08 0.43 80.77 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.747 -0.739 . . . . 61.32 112.514 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -139.92 172.78 12.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.847 0.356 . . . . 73.32 110.873 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -68.29 89.44 0.33 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.158 -0.473 . . . . 60.23 110.836 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.591 HD13 ' HB3' ' A' ' 104' ' ' LEU . 0.4 OUTLIER -77.36 127.27 32.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.221 -0.445 . . . . 74.34 110.937 179.999 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 12.2 ttp180 -106.08 116.01 31.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.135 -0.484 . . . . 73.31 110.897 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.444 HG21 ' CD2' ' A' ' 167' ' ' LEU . 0.2 OUTLIER -101.83 141.98 17.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.248 -0.433 . . . . 75.45 111.081 -179.974 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 96.9 t -135.93 126.47 42.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 64.12 111.168 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.616 HD11 ' HA ' ' A' ' 118' ' ' MET . 2.5 tp -110.48 111.9 23.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.468 . . . . 74.1 110.871 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.486 ' N ' HD12 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -86.26 135.25 33.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 71.42 110.888 179.881 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.16 -16.25 61.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.476 . . . . 73.13 110.885 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -51.74 -55.87 17.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 75.41 110.879 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.1 p -136.22 17.09 3.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.436 . . . . 65.11 111.122 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . 0.616 ' HA ' HD11 ' A' ' 113' ' ' LEU . 69.0 mtp 58.16 29.33 17.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 70.4 110.947 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.64 146.05 34.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 74.12 110.909 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.631 HG21 ' CE2' ' A' ' 142' ' ' PHE . 98.4 t -105.0 123.51 59.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.235 -0.439 . . . . 61.15 111.154 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 2.3 t90 -105.27 131.59 52.54 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.178 -0.465 . . . . 73.34 110.943 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . 0.436 ' SG ' HG13 ' A' ' 111' ' ' VAL . 1.2 m -128.3 103.3 7.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.258 -0.428 . . . . 75.21 110.883 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 24.2 m-20 45.56 70.54 0.35 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 71.34 110.886 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 48.6 40.16 24.3 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.748 -0.739 . . . . 70.22 112.438 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.04 107.23 4.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.903 0.383 . . . . 71.24 110.91 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 4.3 mttt -53.41 152.62 4.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 62.34 110.945 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' MET . . . . . 0.649 ' CE ' HG22 ' A' ' 144' ' ' VAL . 27.2 mmm -123.89 164.83 18.47 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.295 -0.411 . . . . 73.11 110.867 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -118.97 110.14 16.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 74.23 110.941 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.736 ' HB ' HG22 ' A' ' 140' ' ' THR . 19.3 p -95.63 174.34 7.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 73.33 111.162 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -174.77 -169.59 0.43 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 72.22 111.116 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 118.63 -111.54 2.15 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.736 -0.745 . . . . 63.13 112.523 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 . . . . . 0 C--N 1.33 -0.277 0 CA-C-O 120.832 0.348 . . . . 75.13 110.931 -179.902 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.282 0 N-CA-C 112.472 -0.251 . . . . 72.01 112.472 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.485 ' O ' ' HB3' ' A' ' 153' ' ' ALA . 0.1 OUTLIER -134.8 130.76 36.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.727 0.299 . . . . 72.33 111.134 -179.851 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -87.32 96.5 10.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 75.3 110.963 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.736 HG22 ' HB ' ' A' ' 129' ' ' THR . 0.0 OUTLIER -79.92 110.17 15.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 74.21 111.133 -179.907 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -108.31 111.96 24.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 74.11 110.861 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.631 ' CE2' HG21 ' A' ' 120' ' ' VAL . 15.1 p90 -125.46 134.02 52.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 73.41 110.854 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 60.6 p -78.6 139.2 38.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.169 -0.469 . . . . 71.11 110.896 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.649 HG22 ' CE ' ' A' ' 127' ' ' MET . 21.4 t -130.87 98.06 3.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 72.03 111.123 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 51.85 -124.24 23.15 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.669 -0.777 . . . . 54.14 112.502 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -95.89 25.23 4.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.813 0.34 . . . . 71.34 110.856 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 45.9 m-70 -121.64 -169.99 1.96 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 74.52 110.838 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -149.83 81.48 1.39 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 71.3 110.847 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' CYS . . . . . 0.52 ' SG ' HG13 ' A' ' 169' ' ' VAL . 8.3 m -96.29 166.07 11.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.242 -0.435 . . . . 60.21 110.843 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -167.27 144.48 4.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 74.21 110.961 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.6 HD12 HG22 ' A' ' 120' ' ' VAL . 44.9 mt -99.5 111.21 28.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 72.42 111.139 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 5.0 tttp -80.56 103.11 10.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.153 -0.476 . . . . 74.14 110.851 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . 0.485 ' HB3' ' O ' ' A' ' 138' ' ' THR . . . -95.23 143.07 26.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.462 . . . . 44.23 111.074 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.2 t -136.58 120.61 24.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 45.14 111.077 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.2 p -90.75 132.84 35.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 74.04 110.794 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 9.5 p -124.38 138.64 54.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.091 -0.504 . . . . 41.13 110.907 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 132.85 -104.05 0.53 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.71 -0.757 . . . . 63.51 112.471 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 12.3 ttmt -142.73 -46.14 0.32 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.785 0.326 . . . . 71.25 110.906 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 5.9 ttt180 -137.21 -45.83 0.56 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.216 -0.447 . . . . 71.51 110.869 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 11.6 tttt -167.83 55.64 0.07 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 75.23 110.955 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -82.43 -64.53 1.16 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 63.51 110.849 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -135.34 114.2 1.2 Allowed Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.685 -0.769 . . . . 70.12 112.441 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 76.2 mt -105.97 139.56 26.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.848 0.356 . . . . 73.13 111.121 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 72.0 mt -126.43 122.83 62.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.46 . . . . 73.53 111.131 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 18.1 m80 -96.66 137.8 35.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 54.25 110.881 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.79 104.26 7.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.21 -0.45 . . . . 71.42 111.138 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.607 HD12 ' H ' ' A' ' 168' ' ' ILE . 15.9 tp -63.81 138.97 58.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.289 -0.414 . . . . 64.33 110.925 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.607 ' H ' HD12 ' A' ' 167' ' ' LEU . 10.0 mt -137.76 120.75 20.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 62.41 111.089 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.663 HG21 HD13 ' A' ' 102' ' ' LEU . 89.5 t -121.32 130.83 74.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.095 -0.502 . . . . 64.34 111.089 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 58.79 36.91 24.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.12 -0.491 . . . . 53.21 110.832 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 2.6 t30 63.34 43.07 6.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 72.35 110.877 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.14 128.77 21.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 73.45 110.875 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -62.62 146.5 51.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 74.23 110.856 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -123.81 131.37 24.25 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.569 0.699 . . . . 64.03 111.097 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 135.18 29.81 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.7 2.266 . . . . 54.4 112.334 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 74.5 110.91 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.505 ' O ' HG23 ' A' ' 97' ' ' THR . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.187 0 CA-C-O 120.866 0.365 . . . . 73.23 111.099 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.505 HG23 ' O ' ' A' ' 96' ' ' THR . 1.0 OUTLIER -159.56 127.89 5.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 72.41 111.197 -179.956 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.7 m -106.22 155.04 19.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.241 -0.436 . . . . 71.23 110.894 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.808 HG22 HG22 ' A' ' 112' ' ' VAL . 72.3 p -144.88 155.08 43.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 53.52 111.177 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 15.3 m-90 -151.35 133.54 15.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.242 -0.435 . . . . 74.25 110.928 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.3 t -112.95 114.84 48.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.283 -0.417 . . . . 61.32 111.055 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.721 HD11 HD12 ' A' ' 104' ' ' LEU . 0.5 OUTLIER -139.73 145.87 38.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 73.11 110.914 179.916 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -74.62 92.99 2.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 55.34 110.851 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.721 HD12 HD11 ' A' ' 102' ' ' LEU . 0.4 OUTLIER -124.9 153.73 42.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.471 . . . . 64.52 110.987 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.7 t70 64.5 15.42 9.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.271 -0.422 . . . . 73.4 110.805 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.69 1.31 83.12 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.768 -0.729 . . . . 74.24 112.502 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -139.92 173.03 11.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.779 0.323 . . . . 65.32 110.884 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -69.74 87.85 0.52 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.161 -0.472 . . . . 62.51 110.884 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.643 HD13 ' HB3' ' A' ' 104' ' ' LEU . 0.7 OUTLIER -70.52 127.43 32.7 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.258 -0.428 . . . . 63.12 110.93 -179.96 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 8.8 ttm180 -107.87 115.29 29.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.185 -0.461 . . . . 71.53 110.83 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.434 HG21 ' CD2' ' A' ' 167' ' ' LEU . 0.1 OUTLIER -106.67 137.64 36.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.12 -0.491 . . . . 73.45 111.081 -179.99 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.808 HG22 HG22 ' A' ' 99' ' ' THR . 90.1 t -135.76 128.56 47.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.187 -0.461 . . . . 74.34 111.182 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.52 HD11 ' HA ' ' A' ' 118' ' ' MET . 2.5 tp -110.2 103.46 12.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.476 . . . . 72.22 110.96 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.437 ' HG3' HG22 ' A' ' 97' ' ' THR . 0.9 OUTLIER -78.24 134.95 37.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.232 -0.44 . . . . 75.45 110.863 179.977 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 9.2 mmmt -73.13 -17.2 61.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.126 -0.488 . . . . 53.53 110.889 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -51.6 -55.18 20.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 71.13 110.838 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.45 16.97 4.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 74.13 111.105 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . 0.52 ' HA ' HD11 ' A' ' 113' ' ' LEU . 4.0 ttm 53.54 32.36 14.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.232 -0.44 . . . . 73.41 110.848 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.99 155.03 20.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.289 -0.414 . . . . 52.52 110.863 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.682 HG22 HD12 ' A' ' 151' ' ' ILE . 99.6 t -104.83 130.18 56.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 63.24 111.172 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 7.7 t-105 -112.7 122.88 48.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.089 -0.505 . . . . 75.03 110.872 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 24.6 t -128.48 131.78 48.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.134 -0.485 . . . . 75.13 110.805 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 27.3 m-20 50.08 54.63 10.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 71.12 110.862 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 49.82 37.42 28.25 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.754 -0.736 . . . . 64.54 112.483 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -143.38 165.77 26.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.868 0.366 . . . . 70.03 110.916 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -85.93 157.92 20.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 70.51 110.88 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 35.2 mmm -124.76 166.98 15.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 63.41 110.88 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -119.23 106.59 12.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 71.14 110.853 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.676 ' HB ' HG22 ' A' ' 140' ' ' THR . 19.2 p -95.91 -175.26 3.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 72.12 111.113 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -104.61 -29.54 10.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 72.11 111.107 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 61.98 39.92 98.2 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.733 -0.746 . . . . 54.25 112.452 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 49.5 tt0 . . . . . 0 C--N 1.329 -0.287 0 CA-C-O 120.865 0.364 . . . . 73.4 110.898 -179.868 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 N-CA-C 112.549 -0.22 . . . . 74.14 112.549 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.462 ' O ' ' HB3' ' A' ' 153' ' ' ALA . 0.1 OUTLIER -135.25 130.8 35.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.762 0.315 . . . . 71.44 111.145 -179.87 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -108.18 103.62 12.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.481 . . . . 73.43 110.982 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.676 HG22 ' HB ' ' A' ' 129' ' ' THR . 0.0 OUTLIER -83.13 110.35 17.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.211 -0.45 . . . . 63.55 111.14 -179.892 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 68.4 m-70 -105.37 105.26 15.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 73.25 110.784 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.491 ' CE2' HG21 ' A' ' 120' ' ' VAL . 18.2 p90 -123.85 134.56 53.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 74.11 110.913 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 3.3 p -77.8 139.51 39.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 42.31 110.867 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.6 t -133.48 106.3 9.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 62.44 111.092 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 53.31 -116.35 5.65 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.741 -0.742 . . . . 73.03 112.435 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -110.25 26.22 10.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.795 0.331 . . . . 74.04 110.872 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 24.6 m-70 -124.1 -169.81 2.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 64.11 110.86 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -140.85 81.69 1.81 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 71.21 110.902 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' CYS . . . . . 0.417 ' SG ' HG13 ' A' ' 169' ' ' VAL . 11.1 m -91.62 157.43 16.98 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.24 -0.436 . . . . 74.25 110.917 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 39.3 p90 -159.83 143.33 14.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 74.51 110.882 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.682 HD12 HG22 ' A' ' 120' ' ' VAL . 35.5 mt -97.54 111.67 27.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.126 -0.488 . . . . 72.21 111.064 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 33.2 ttmt -80.04 102.87 9.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.475 . . . . 71.21 110.968 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . 0.462 ' HB3' ' O ' ' A' ' 138' ' ' THR . . . -95.02 142.21 27.77 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.176 -0.465 . . . . 55.13 111.137 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.3 t -138.8 124.58 23.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.254 -0.43 . . . . 75.44 111.138 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.4 p -95.81 133.14 40.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 53.24 110.932 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -133.68 133.21 41.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.151 -0.477 . . . . 63.24 110.891 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 112.01 -176.33 17.95 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.754 -0.736 . . . . 20.35 112.428 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.84 130.55 35.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.849 0.357 . . . . 74.43 110.916 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 20.5 mmt180 54.31 43.06 31.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 61.14 110.874 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 3.0 mttt 55.51 48.06 19.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.136 -0.484 . . . . 75.13 110.911 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -52.17 -68.42 0.17 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 64.22 110.889 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -110.86 125.43 7.39 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.768 -0.73 . . . . 21.21 112.526 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 64.7 mt -114.81 143.98 23.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.824 0.345 . . . . 73.51 111.085 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 64.4 mt -132.18 127.35 57.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 60.34 111.102 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' HIS . . . . . 0.42 ' CG ' HD23 ' A' ' 113' ' ' LEU . 12.7 m80 -102.81 140.07 37.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.161 -0.472 . . . . 73.25 110.893 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.37 106.44 8.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.163 -0.471 . . . . 62.43 111.166 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.434 ' CD2' HG21 ' A' ' 111' ' ' VAL . 30.7 tp -66.8 136.61 55.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 71.14 110.964 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.405 ' H ' HD12 ' A' ' 167' ' ' LEU . 10.2 mt -137.78 129.78 40.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.446 . . . . 72.54 111.12 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.417 HG21 HD13 ' A' ' 102' ' ' LEU . 57.6 t -126.46 117.78 49.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 65.44 111.164 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.9 t0 63.69 41.81 6.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.178 -0.464 . . . . 40.2 110.834 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 62.5 42.92 8.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 74.34 110.861 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -138.32 124.5 20.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.179 -0.464 . . . . 72.44 110.892 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -62.59 145.92 53.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.2 -0.455 . . . . 54.31 110.86 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.499 HD12 HD22 ' A' ' 102' ' ' LEU . 0.9 OUTLIER -121.02 131.16 24.56 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.623 0.725 . . . . 73.01 111.123 179.942 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 134.44 28.0 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.689 2.259 . . . . 73.22 112.356 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.24 -0.436 . . . . 75.31 110.874 -179.993 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.491 ' O ' HG23 ' A' ' 97' ' ' THR . 13.5 p . . . . . 0 C--O 1.233 0.195 0 CA-C-O 120.883 0.373 . . . . 62.15 111.179 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.638 HG22 ' HA ' ' A' ' 114' ' ' GLU . 1.1 p -159.36 128.07 5.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 71.43 111.159 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -105.97 149.63 26.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.26 -0.427 . . . . 73.11 110.912 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 92.3 m -137.88 138.47 39.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 73.31 111.133 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . 0.462 ' CB ' HD23 ' A' ' 167' ' ' LEU . 12.0 m-90 -133.36 123.27 25.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.204 -0.453 . . . . 63.31 110.969 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 18.7 t -103.63 115.01 44.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 40.5 111.122 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.661 HD11 HD12 ' A' ' 104' ' ' LEU . 0.5 OUTLIER -141.25 146.0 36.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 74.22 110.888 -179.979 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 56.4 mtm-85 -76.34 93.75 3.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 73.42 110.862 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.672 ' HB3' HD13 ' A' ' 109' ' ' LEU . 0.4 OUTLIER -125.73 155.43 40.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 72.34 110.844 -179.977 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.3 t0 64.7 15.06 9.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 75.13 110.891 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 88.17 0.91 82.43 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.756 -0.735 . . . . 75.24 112.561 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -139.93 172.98 11.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.862 0.363 . . . . 74.33 110.887 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -70.33 88.16 0.63 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.142 -0.481 . . . . 62.32 110.875 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.672 HD13 ' HB3' ' A' ' 104' ' ' LEU . 0.5 OUTLIER -70.36 123.6 22.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.202 -0.454 . . . . 74.02 110.875 -179.941 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 4.9 ttp180 -101.94 109.38 21.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.107 -0.497 . . . . 74.01 110.804 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.442 HG21 ' CD2' ' A' ' 167' ' ' LEU . 2.2 t -95.6 134.55 32.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.452 . . . . 74.23 111.126 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 76.4 t -137.25 125.31 32.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 53.25 111.083 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.568 HD11 ' HA ' ' A' ' 118' ' ' MET . 3.0 tp -110.35 106.8 16.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 42.31 110.883 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.638 ' HA ' HG22 ' A' ' 97' ' ' THR . 0.0 OUTLIER -82.83 136.46 34.63 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.142 -0.481 . . . . 73.51 110.887 179.945 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.9 mmmt -73.77 -16.51 61.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 73.32 110.853 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -51.41 -54.21 28.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.466 . . . . 74.1 110.89 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.86 17.03 3.05 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.191 -0.459 . . . . 62.25 111.179 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . 0.568 ' HA ' HD11 ' A' ' 113' ' ' LEU . 81.6 mtp 56.77 26.26 11.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 65.33 110.895 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.55 151.71 32.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.273 -0.421 . . . . 73.14 110.862 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.561 HG22 HD12 ' A' ' 151' ' ' ILE . 70.6 t -105.04 133.5 49.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.171 -0.468 . . . . 62.32 111.074 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 6.6 t-105 -117.64 123.77 46.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.2 -0.454 . . . . 75.13 110.891 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 17.9 m -131.18 132.19 44.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.216 -0.447 . . . . 65.13 110.934 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . 0.452 ' ND2' HD12 ' A' ' 109' ' ' LEU . 40.9 m-20 50.99 53.83 12.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.125 -0.489 . . . . 70.25 110.93 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 49.09 39.64 27.09 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.765 -0.731 . . . . 74.11 112.436 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.02 154.81 41.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.848 0.356 . . . . 74.2 110.907 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 15.8 ttpt -75.67 159.5 31.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 75.12 110.855 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 38.8 mmm -125.51 166.12 17.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.239 -0.437 . . . . 53.55 110.879 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -119.25 106.53 12.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.269 -0.423 . . . . 73.43 110.877 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.566 ' HB ' HG22 ' A' ' 140' ' ' THR . 17.6 p -95.53 -175.29 3.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 63.11 111.175 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -107.49 -28.77 9.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.476 . . . . 44.11 111.102 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 55.64 53.59 40.48 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.78 -0.724 . . . . 71.42 112.514 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.325 0 CA-C-O 120.887 0.375 . . . . 75.42 110.897 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 112.512 -0.235 . . . . 43.14 112.512 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.454 ' O ' ' HB3' ' A' ' 153' ' ' ALA . 0.1 OUTLIER -135.37 130.83 35.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.706 0.289 . . . . 64.43 111.176 -179.919 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -108.6 96.6 6.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 72.2 110.889 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.566 HG22 ' HB ' ' A' ' 129' ' ' THR . 0.0 OUTLIER -80.67 110.47 16.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.173 -0.467 . . . . 71.41 111.151 -179.879 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 -105.22 106.61 17.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 73.25 110.805 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 17.8 p90 -124.02 129.54 51.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 71.11 110.906 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 90.9 p -79.58 156.98 27.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 65.03 110.88 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 86.6 t -149.62 98.49 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 60.13 111.118 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 57.01 -106.63 0.75 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.767 -0.73 . . . . 62.33 112.486 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 21.5 t30 -116.9 24.56 11.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.896 0.379 . . . . 74.51 110.911 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 66.0 m-70 -117.25 -175.3 2.77 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.13 -0.486 . . . . 74.43 110.815 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -143.73 78.56 1.6 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 75.34 110.878 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' CYS . . . . . 0.431 ' SG ' HG13 ' A' ' 169' ' ' VAL . 12.0 m -93.49 158.89 15.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.146 -0.479 . . . . 75.32 110.916 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -161.75 144.15 11.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.445 . . . . 71.51 110.935 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.562 HD13 HD22 ' A' ' 113' ' ' LEU . 22.7 mt -97.46 111.2 26.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.169 -0.469 . . . . 73.1 111.149 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 61.6 tttt -80.1 102.79 9.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.455 . . . . 70.54 110.897 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . 0.454 ' HB3' ' O ' ' A' ' 138' ' ' THR . . . -93.65 143.51 26.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.283 -0.417 . . . . 42.13 111.08 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.3 t -139.89 119.64 13.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 33.32 111.093 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.2 p -89.04 148.42 23.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.121 -0.49 . . . . 72.32 110.883 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.55 140.11 24.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.47 . . . . 71.21 110.906 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 132.47 -152.23 20.17 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.79 -0.719 . . . . 55.21 112.493 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 9.3 mttp -79.04 -29.84 43.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.77 0.319 . . . . 74.4 110.921 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 21.0 ptt-85 -169.16 -41.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 52.02 110.849 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 3.0 ttmm -157.06 30.41 0.3 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 75.23 110.893 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -56.81 -61.98 2.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 75.21 110.892 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -136.11 157.91 23.67 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.716 -0.754 . . . . 74.52 112.48 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 57.5 mt -141.19 146.42 23.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.725 0.298 . . . . 71.24 111.188 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 2.9 mt -133.01 124.36 49.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.188 -0.46 . . . . 65.45 111.169 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 12.1 m80 -103.44 138.34 40.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 61.22 110.845 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.63 109.28 10.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.162 -0.472 . . . . 73.13 111.132 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.511 HD12 ' H ' ' A' ' 168' ' ' ILE . 21.0 tp -67.45 137.6 56.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.224 -0.444 . . . . 45.14 110.884 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.511 ' H ' HD12 ' A' ' 167' ' ' LEU . 9.6 mt -138.32 129.64 37.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 62.04 111.147 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.431 HG13 ' SG ' ' A' ' 149' ' ' CYS . 58.4 t -125.68 122.77 63.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 74.34 111.12 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 58.84 41.29 21.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 74.11 110.859 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 63.22 43.09 6.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.248 -0.433 . . . . 55.12 110.888 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 15.4 mtp180 -138.52 125.3 21.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.166 -0.47 . . . . 73.45 110.865 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -62.36 146.54 50.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 62.23 110.901 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.407 HD12 HD22 ' A' ' 102' ' ' LEU . 0.9 OUTLIER -123.06 131.01 24.38 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.576 0.703 . . . . 72.43 111.156 179.938 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.72 137.57 35.91 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.611 2.207 . . . . 72.13 112.404 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.44 . . . . 53.23 110.834 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.496 ' O ' HG23 ' A' ' 97' ' ' THR . 50.6 p . . . . . 0 N--CA 1.457 -0.12 0 CA-C-O 120.897 0.379 . . . . 50.42 111.169 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.602 HG22 ' HA ' ' A' ' 114' ' ' GLU . 1.0 OUTLIER -159.51 127.99 5.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 65.42 111.136 -179.985 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.3 m -106.05 149.64 26.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 50.03 110.894 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 90.1 m -136.98 137.15 39.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.139 -0.482 . . . . 75.34 111.095 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . 0.498 ' CB ' HD23 ' A' ' 167' ' ' LEU . 9.9 m-90 -132.98 122.81 24.79 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.126 -0.488 . . . . 75.44 110.891 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 20.0 t -102.7 114.89 43.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.247 -0.433 . . . . 33.53 111.181 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.883 HD11 HD12 ' A' ' 104' ' ' LEU . 0.5 OUTLIER -142.56 147.3 35.7 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.257 -0.429 . . . . 54.52 110.927 179.935 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 5.6 mtt180 -74.63 92.23 2.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 71.31 110.864 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.883 HD12 HD11 ' A' ' 102' ' ' LEU . 0.4 OUTLIER -121.95 153.94 37.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 54.33 110.908 -179.975 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 65.17 14.37 9.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 62.2 110.91 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.99 -0.39 78.99 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.735 -0.745 . . . . 65.13 112.48 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -139.92 172.89 12.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.797 0.332 . . . . 52.15 110.919 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -68.36 88.42 0.32 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.155 -0.475 . . . . 72.52 110.841 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.607 HD13 ' HB3' ' A' ' 104' ' ' LEU . 0.4 OUTLIER -74.65 125.94 29.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.236 -0.438 . . . . 65.05 110.937 -179.961 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 29.5 ttt180 -102.36 110.9 22.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.191 -0.459 . . . . 74.42 110.85 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.5 t -95.12 136.43 26.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 72.33 111.168 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 96.8 t -136.99 127.04 39.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.258 -0.428 . . . . 65.34 111.137 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.638 HD22 HD13 ' A' ' 151' ' ' ILE . 4.1 tp -110.32 104.44 13.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 55.34 110.847 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.602 ' HA ' HG22 ' A' ' 97' ' ' THR . 0.0 OUTLIER -81.14 136.42 35.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.113 -0.494 . . . . 75.3 110.949 179.917 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 3.6 mmmt -73.73 -16.74 61.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 74.03 110.936 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -51.38 -53.0 40.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.232 -0.44 . . . . 72.15 110.854 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.38 17.04 2.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 61.52 111.151 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . 0.495 ' HA ' HD11 ' A' ' 113' ' ' LEU . 2.4 ttp 55.55 26.29 8.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.234 -0.439 . . . . 74.14 110.889 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -80.65 154.54 27.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 51.24 110.871 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.6 HG22 HD12 ' A' ' 151' ' ' ILE . 53.5 t -105.16 134.8 45.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.469 . . . . 72.21 111.156 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 6.0 t-105 -119.41 126.54 51.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.156 -0.475 . . . . 73.12 110.826 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 64.4 m -132.93 131.9 41.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 75.41 110.838 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . 0.47 ' ND2' HD12 ' A' ' 109' ' ' LEU . 43.5 m-20 49.85 54.39 11.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 64.11 110.837 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 48.55 40.53 24.48 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.797 -0.716 . . . . 64.41 112.481 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.94 147.7 28.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.873 0.368 . . . . 64.42 110.893 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 13.1 tttp -68.04 159.91 29.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.258 -0.428 . . . . 74.34 110.918 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 41.0 mmm -124.55 164.31 20.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.212 -0.449 . . . . 71.34 110.897 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -119.3 106.29 12.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 63.02 110.86 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.69 ' CB ' HG22 ' A' ' 140' ' ' THR . 21.3 p -95.96 -175.05 3.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.112 -0.494 . . . . 64.51 111.111 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.432 ' HB2' ' HB2' ' A' ' 141' ' ' HIS . . . -100.22 -32.2 11.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 74.13 111.125 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 59.99 96.4 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.709 -0.757 . . . . 44.32 112.519 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 . . . . . 0 C--N 1.329 -0.296 0 CA-C-O 120.909 0.385 . . . . 70.32 110.91 -179.855 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 N-CA-C 112.481 -0.248 . . . . 63.34 112.481 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -136.1 130.79 33.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.733 0.301 . . . . 72.13 111.146 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -104.13 96.29 6.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.234 -0.439 . . . . 63.22 110.923 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.69 HG22 ' CB ' ' A' ' 129' ' ' THR . 0.0 OUTLIER -86.98 109.73 19.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.173 -0.467 . . . . 60.12 111.177 -179.887 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . 0.432 ' HB2' ' HB2' ' A' ' 130' ' ' ALA . 70.3 m-70 -102.68 106.84 17.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.24 -0.436 . . . . 72.42 110.836 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -121.9 123.02 40.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.148 -0.478 . . . . 73.31 110.903 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.03 153.78 22.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 62.32 110.85 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.448 HG11 HD22 ' A' ' 104' ' ' LEU . 47.0 t -147.19 106.7 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 74.13 111.096 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 56.59 -110.14 1.94 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.733 -0.746 . . . . 64.44 112.529 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 29.4 m120 -117.38 25.68 10.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.871 0.367 . . . . 75.23 110.88 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 24.4 m-70 -123.26 163.57 20.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 73.11 110.891 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -122.23 122.07 38.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 74.45 110.914 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' CYS . . . . . 0.575 ' HB3' HG22 ' A' ' 169' ' ' VAL . 1.2 p -141.48 146.95 37.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.448 . . . . 72.53 110.887 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 26.0 p90 -149.79 147.61 28.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.471 . . . . 72.05 110.937 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.638 HD13 HD22 ' A' ' 113' ' ' LEU . 12.0 mt -97.97 111.74 28.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.136 -0.484 . . . . 71.22 111.129 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 62.1 tttt -82.52 102.71 11.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 71.43 110.907 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -95.89 146.05 24.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 64.24 111.127 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.5 t -145.32 116.86 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.273 -0.421 . . . . 64.15 111.09 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 14.7 p -89.53 147.41 23.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 43.21 110.853 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 30.6 p -145.88 152.59 39.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.076 -0.511 . . . . 70.14 110.88 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 112.98 179.29 19.47 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.785 -0.721 . . . . 71.1 112.501 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.58 -64.0 1.11 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.725 0.298 . . . . 65.45 110.891 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 11.3 ttm-85 -133.39 83.78 2.08 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.265 -0.425 . . . . 62.31 110.897 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 13.6 mtmt 52.59 44.52 29.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 63.12 110.83 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -66.63 -49.18 67.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 73.1 110.871 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -144.96 132.02 4.53 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.774 -0.727 . . . . 44.11 112.524 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 50.8 mt -119.37 146.88 23.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.826 0.346 . . . . 74.14 111.129 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 58.9 mt -132.45 126.89 56.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 70.42 111.159 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 8.5 m80 -109.63 135.34 50.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.258 -0.428 . . . . 74.51 110.893 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.26 116.91 22.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 73.0 111.191 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.498 HD23 ' CB ' ' A' ' 100' ' ' TRP . 17.7 tp -72.85 133.52 44.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 75.21 110.944 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.472 ' N ' HD12 ' A' ' 167' ' ' LEU . 10.9 mt -136.3 118.16 20.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 72.4 111.07 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.575 HG22 ' HB3' ' A' ' 149' ' ' CYS . 14.6 t -120.54 127.06 75.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.435 . . . . 74.44 111.133 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 63.6 36.64 10.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.213 -0.449 . . . . 72.21 110.853 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 62.84 43.04 7.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 72.34 110.927 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 20.4 mtt180 -142.14 128.12 19.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.112 -0.494 . . . . 62.12 110.862 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -62.48 146.47 51.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.199 -0.455 . . . . 73.32 110.916 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -121.85 131.29 24.46 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.685 0.755 . . . . 75.42 111.126 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 137.93 36.53 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.638 2.225 . . . . 73.21 112.351 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.465 . . . . 73.21 110.904 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.498 ' O ' HG23 ' A' ' 97' ' ' THR . 82.3 p . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.876 0.37 . . . . 74.42 111.094 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.498 HG23 ' O ' ' A' ' 96' ' ' THR . 1.1 p -159.47 128.1 5.12 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.214 -0.448 . . . . 74.34 111.093 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.03 152.2 23.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.196 -0.456 . . . . 51.32 110.897 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.78 HG22 HG22 ' A' ' 112' ' ' VAL . 0.5 OUTLIER -139.17 156.76 46.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.126 -0.488 . . . . 75.14 111.125 -179.869 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . 0.502 ' CB ' HD23 ' A' ' 167' ' ' LEU . 12.6 m-90 -151.62 127.28 10.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.23 -0.441 . . . . 73.33 111.004 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 18.8 t -105.63 115.21 46.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.236 -0.438 . . . . 55.45 111.156 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.918 HD11 HD12 ' A' ' 104' ' ' LEU . 0.5 OUTLIER -141.67 147.36 37.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.199 -0.455 . . . . 75.32 110.958 179.953 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 61.4 mtt180 -72.93 91.7 1.56 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 64.04 110.955 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.918 HD12 HD11 ' A' ' 102' ' ' LEU . 0.3 OUTLIER -121.64 152.01 39.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 74.31 110.898 -179.925 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 15.2 t0 65.09 14.51 9.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.144 -0.48 . . . . 63.12 110.854 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.7 0.12 79.17 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.773 -0.727 . . . . 65.42 112.498 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -139.94 172.73 12.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.843 0.354 . . . . 61.35 110.889 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -68.54 89.49 0.36 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.137 -0.483 . . . . 62.12 110.884 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.592 HD13 ' HB3' ' A' ' 104' ' ' LEU . 0.4 OUTLIER -76.21 130.63 38.49 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.126 -0.488 . . . . 73.33 110.951 -179.946 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 6.1 ttp180 -106.4 113.84 27.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 72.15 110.882 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.496 HG21 ' CD2' ' A' ' 167' ' ' LEU . 1.7 t -95.52 139.43 18.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 73.25 111.093 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.78 HG22 HG22 ' A' ' 99' ' ' THR . 92.0 t -136.46 124.95 36.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.473 . . . . 72.34 111.125 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.538 HD22 HD13 ' A' ' 151' ' ' ILE . 3.4 tp -111.16 105.45 14.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 71.32 110.943 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.484 ' HA ' HG22 ' A' ' 97' ' ' THR . 0.0 OUTLIER -80.19 134.85 36.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 73.01 110.884 179.918 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 3.9 mmmt -73.87 -16.72 61.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.074 -0.512 . . . . 75.33 110.849 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -51.45 -55.97 15.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.228 -0.442 . . . . 63.11 110.857 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.34 17.1 3.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 72.24 111.133 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . 0.51 ' HA ' HD11 ' A' ' 113' ' ' LEU . 0.2 OUTLIER 61.95 18.11 9.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.44 . . . . 73.12 110.921 179.911 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.77 139.23 58.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.186 -0.461 . . . . 72.13 110.843 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 96.0 t -105.0 118.12 51.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.111 -0.495 . . . . 75.22 111.153 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -100.6 129.05 46.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 75.03 110.898 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -123.76 103.37 8.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 72.04 110.87 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 45.44 69.97 0.4 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 73.45 110.905 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 49.09 38.73 25.53 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.698 -0.763 . . . . 71.03 112.505 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -146.38 114.04 6.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.812 0.339 . . . . 70.01 110.877 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -53.39 160.38 1.19 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.249 -0.432 . . . . 70.21 110.856 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 30.2 mmm -126.82 163.62 23.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 74.41 110.875 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -118.79 106.44 12.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.239 -0.437 . . . . 74.13 110.848 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.548 HG22 ' HD2' ' A' ' 142' ' ' PHE . 17.1 p -95.55 -177.76 4.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.478 . . . . 64.04 111.155 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.431 ' HB2' ' HB2' ' A' ' 141' ' ' HIS . . . -92.5 -31.3 15.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.22 -0.445 . . . . 51.43 111.068 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 55.09 69.25 1.32 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.78 -0.724 . . . . 73.03 112.492 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 . . . . . 0 C--N 1.329 -0.286 0 CA-C-O 120.888 0.375 . . . . 50.13 110.899 -179.838 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.276 0 N-CA-C 112.459 -0.257 . . . . 73.41 112.459 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.636 ' O ' ' HB3' ' A' ' 153' ' ' ALA . 0.1 OUTLIER -134.73 131.03 37.13 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.73 0.3 . . . . 70.11 111.175 -179.963 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -115.34 96.33 5.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 72.01 110.895 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.504 HG22 ' HB ' ' A' ' 129' ' ' THR . 0.0 OUTLIER -77.1 110.02 11.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.117 -0.492 . . . . 33.33 111.139 -179.918 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . 0.431 ' HB2' ' HB2' ' A' ' 130' ' ' ALA . 81.4 m-70 -106.93 104.26 13.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.259 -0.428 . . . . 74.02 110.862 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.548 ' HD2' HG22 ' A' ' 129' ' ' THR . 2.9 p90 -124.72 -175.96 3.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 75.25 110.856 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 58.4 p -148.71 160.78 42.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.12 -0.491 . . . . 75.31 110.84 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 90.8 t -135.2 97.92 2.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.12 -0.491 . . . . 43.02 111.137 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 54.49 -113.12 3.15 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.752 -0.737 . . . . 63.24 112.521 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -103.01 25.46 9.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.814 0.34 . . . . 53.01 110.899 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . 0.447 ' HD2' HD21 ' A' ' 104' ' ' LEU . 28.9 m-70 -111.18 -170.33 1.62 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 71.12 110.852 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -154.39 107.52 2.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.439 . . . . 62.14 110.821 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' CYS . . . . . 0.59 ' HB3' HG22 ' A' ' 169' ' ' VAL . 0.8 OUTLIER -142.69 161.81 37.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 64.21 110.91 -179.969 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -159.4 149.33 18.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.242 -0.435 . . . . 70.54 110.88 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.538 HD13 HD22 ' A' ' 113' ' ' LEU . 8.2 mt -99.12 113.82 35.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.121 -0.49 . . . . 74.34 111.162 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.54 102.67 10.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.102 -0.499 . . . . 74.23 110.921 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . 0.636 ' HB3' ' O ' ' A' ' 138' ' ' THR . . . -100.57 145.46 28.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.24 -0.436 . . . . 71.33 111.113 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.3 t -144.84 133.74 17.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.202 -0.454 . . . . 74.51 111.144 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.1 p -104.94 130.34 53.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 64.45 110.891 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 79.7 p -143.7 150.83 39.26 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.151 -0.477 . . . . 64.12 110.824 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 129.26 171.27 12.92 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.698 -0.763 . . . . 55.34 112.452 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 38.1 mttp -63.78 94.55 0.1 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.795 0.331 . . . . 64.31 110.947 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 15.6 mtt-85 62.86 60.69 1.23 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.227 -0.442 . . . . 73.11 110.84 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 58.11 82.33 0.13 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.45 . . . . 74.53 110.885 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -103.73 -53.2 2.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.244 -0.435 . . . . 72.55 110.938 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -133.66 147.56 19.08 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.795 -0.717 . . . . 41.22 112.517 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 58.5 mt -127.45 140.99 47.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.768 0.318 . . . . 44.21 111.137 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 66.1 mt -124.99 141.1 46.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.469 . . . . 71.1 111.105 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 10.0 m80 -115.92 142.91 46.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.103 -0.498 . . . . 73.32 110.847 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.6 107.69 8.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.193 -0.458 . . . . 74.22 111.155 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.502 HD23 ' CB ' ' A' ' 100' ' ' TRP . 16.8 tp -68.61 133.01 47.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.243 -0.435 . . . . 71.01 110.939 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.492 ' N ' HD12 ' A' ' 167' ' ' LEU . 12.7 mt -135.01 113.89 16.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.45 . . . . 75.31 111.099 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.59 HG22 ' HB3' ' A' ' 149' ' ' CYS . 21.3 t -118.38 129.37 74.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 71.02 111.164 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 63.52 34.64 12.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.155 -0.475 . . . . 72.42 110.878 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 63.36 42.96 6.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 71.01 110.923 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -142.22 128.54 19.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.1 -0.5 . . . . 65.02 110.892 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -62.74 146.32 52.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.264 -0.425 . . . . 72.02 110.959 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -123.04 131.23 24.36 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.629 0.728 . . . . 70.33 111.101 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.68 137.01 34.68 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.628 2.219 . . . . 71.02 112.365 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.236 -0.438 . . . . 75.14 110.866 -179.958 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.506 ' O ' HG23 ' A' ' 97' ' ' THR . 30.2 p . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.864 0.364 . . . . 54.2 111.166 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.506 HG23 ' O ' ' A' ' 96' ' ' THR . 1.0 OUTLIER -159.55 128.4 5.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 72.04 111.095 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.3 m -105.95 151.88 24.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.171 -0.468 . . . . 51.43 110.843 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.958 HG23 HG22 ' A' ' 112' ' ' VAL . 0.1 OUTLIER -141.24 158.86 43.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.155 -0.475 . . . . 74.01 111.112 -179.921 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 18.9 m-90 -151.75 157.32 41.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.218 -0.447 . . . . 74.04 110.93 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.3 t -135.9 114.98 16.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.448 . . . . 55.21 111.129 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 1.029 HD11 HD12 ' A' ' 104' ' ' LEU . 0.5 OUTLIER -142.61 148.47 37.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.1 -0.5 . . . . 71.12 110.956 179.973 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 2.4 mmm180 -72.48 89.66 1.28 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 64.22 110.886 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 1.029 HD12 HD11 ' A' ' 102' ' ' LEU . 0.3 OUTLIER -117.16 148.95 41.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.205 -0.452 . . . . 71.23 110.857 -179.906 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.3 t0 64.88 14.77 9.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.458 . . . . 61.43 110.878 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.67 1.25 77.67 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.675 -0.774 . . . . 63.42 112.487 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -139.82 168.83 18.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.858 0.361 . . . . 63.21 110.899 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.97 89.01 0.16 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 74.12 110.85 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.469 HD21 ' SG ' ' A' ' 122' ' ' CYS . 0.5 OUTLIER -79.8 130.61 35.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 74.21 110.846 -179.905 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 10.9 ttp85 -105.73 121.92 45.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 65.13 110.917 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.518 HG21 HD21 ' A' ' 167' ' ' LEU . 0.1 OUTLIER -106.59 144.99 14.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.145 -0.48 . . . . 62.43 111.139 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.958 HG22 HG23 ' A' ' 99' ' ' THR . 85.5 t -135.83 144.45 33.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.456 . . . . 73.22 111.169 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.527 HD11 ' HA ' ' A' ' 118' ' ' MET . 3.2 tp -128.8 102.84 6.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.253 -0.431 . . . . 74.13 110.989 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.26 132.56 42.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 44.33 110.853 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 9.9 mmmt -73.8 -16.88 61.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.446 . . . . 73.02 110.884 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -51.44 -55.81 16.72 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.225 -0.443 . . . . 74.41 110.865 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.45 17.06 3.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.188 -0.46 . . . . 75.32 111.094 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . 0.527 ' HA ' HD11 ' A' ' 113' ' ' LEU . 8.8 ttm 60.11 29.71 19.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 72.41 110.869 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -77.07 145.39 37.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.211 -0.449 . . . . 73.15 110.783 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 36.1 t -104.75 139.24 26.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 70.54 111.108 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 2.7 t-105 -125.19 124.22 41.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.16 -0.473 . . . . 74.15 110.891 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . 0.469 ' SG ' HD21 ' A' ' 109' ' ' LEU . 0.8 OUTLIER -114.06 109.95 19.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.238 -0.437 . . . . 62.1 110.862 -179.954 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 12.6 m-20 47.89 67.43 0.83 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 55.22 110.826 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 49.52 30.64 13.21 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.701 -0.762 . . . . 62.21 112.497 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.66 120.95 20.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.863 0.363 . . . . 75.44 110.901 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 18.5 tttt -53.86 151.25 6.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.224 -0.444 . . . . 74.54 110.84 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' MET . . . . . 0.43 ' CE ' HG22 ' A' ' 144' ' ' VAL . 44.2 mmm -117.89 165.61 13.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 63.1 110.88 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -118.97 106.49 12.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 73.13 110.829 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.65 ' HB ' HG22 ' A' ' 140' ' ' THR . 21.7 p -95.95 168.93 10.33 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.126 -0.488 . . . . 53.43 111.137 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -95.82 -24.26 16.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.204 -0.453 . . . . 72.23 111.118 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 62.36 76.07 0.28 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.763 -0.732 . . . . 53.31 112.536 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 . . . . . 0 C--N 1.329 -0.286 0 CA-C-O 120.881 0.372 . . . . 74.52 110.894 -179.871 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 N-CA-C 112.494 -0.242 . . . . 71.24 112.494 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.559 ' O ' ' HB3' ' A' ' 153' ' ' ALA . 0.2 OUTLIER -142.39 133.41 25.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.827 0.346 . . . . 73.41 111.111 -179.851 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -108.2 132.96 53.1 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.253 -0.431 . . . . 72.53 110.884 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.65 HG22 ' HB ' ' A' ' 129' ' ' THR . 0.0 OUTLIER -118.67 110.28 17.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.155 -0.475 . . . . 43.33 111.067 -179.821 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 22.6 m-70 -100.88 110.5 22.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.157 -0.474 . . . . 74.42 110.868 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.757 ' CE2' HD12 ' A' ' 151' ' ' ILE . 5.9 p90 -135.38 134.7 40.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 73.14 110.908 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 2.9 p -84.39 151.85 24.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.153 -0.476 . . . . 32.51 110.865 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.43 HG22 ' CE ' ' A' ' 127' ' ' MET . 94.0 t -136.74 97.98 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.117 -0.492 . . . . 60.31 111.096 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 54.2 -106.34 0.47 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.731 -0.747 . . . . 64.32 112.492 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 22.8 t30 -116.28 26.32 10.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.868 0.366 . . . . 73.24 110.851 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 50.3 m-70 -125.19 -169.93 2.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 61.21 110.823 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -143.18 105.61 4.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.261 -0.427 . . . . 74.23 110.894 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' CYS . . . . . 0.432 ' SG ' HG13 ' A' ' 169' ' ' VAL . 13.3 m -120.5 158.41 27.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.444 . . . . 75.31 110.865 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -158.72 143.61 16.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 73.14 110.886 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.757 HD12 ' CE2' ' A' ' 142' ' ' PHE . 3.1 mt -99.27 111.06 27.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.139 -0.482 . . . . 71.41 111.178 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 7.8 tttm -80.87 102.96 10.38 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.194 -0.457 . . . . 72.43 110.877 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . 0.559 ' HB3' ' O ' ' A' ' 138' ' ' THR . . . -92.5 132.45 36.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.246 -0.433 . . . . 54.22 111.092 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.5 t -127.0 125.6 66.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.243 -0.435 . . . . 62.45 111.105 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.3 p -93.56 136.97 33.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 71.23 110.798 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 1.4 p -138.94 146.12 40.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.08 -0.509 . . . . 71.43 110.793 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 132.44 162.48 10.34 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.679 -0.772 . . . . 65.11 112.501 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -54.72 -41.37 70.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.816 0.341 . . . . 61.0 110.898 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 12.9 mmt180 -136.35 46.08 2.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.237 -0.438 . . . . 63.35 110.843 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.54 74.23 0.36 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.191 -0.459 . . . . 75.43 110.908 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -113.04 -36.58 5.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.222 -0.444 . . . . 72.31 110.888 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -112.15 111.24 2.79 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.71 -0.757 . . . . 73.44 112.5 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 46.2 mt -109.91 147.98 13.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.803 0.335 . . . . 63.33 111.084 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 66.4 mt -137.88 122.17 22.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.136 -0.484 . . . . 74.42 111.191 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 12.0 m80 -94.95 135.82 36.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 62.32 110.864 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.09 106.75 10.16 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.147 -0.479 . . . . 75.02 111.095 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.518 HD21 HG21 ' A' ' 111' ' ' VAL . 43.9 tp -66.74 136.47 55.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.215 -0.448 . . . . 74.05 110.895 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 10.2 mt -137.09 125.73 34.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.196 -0.456 . . . . 71.5 111.171 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.432 HG13 ' SG ' ' A' ' 149' ' ' CYS . 67.4 t -122.6 119.89 59.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 71.3 111.146 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 64.0 39.34 8.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 72.43 110.847 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 63.23 43.06 6.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 75.42 110.886 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -138.94 127.14 22.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.227 -0.442 . . . . 65.12 110.882 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -62.44 146.38 51.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.18 -0.464 . . . . 70.5 110.888 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.712 HD12 HD22 ' A' ' 102' ' ' LEU . 0.9 OUTLIER -119.99 130.88 24.62 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.645 0.736 . . . . 74.11 111.136 179.921 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 127.64 14.87 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.642 2.228 . . . . 72.34 112.302 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 64.44 110.888 -179.988 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.497 ' O ' HG23 ' A' ' 97' ' ' THR . 16.6 p . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.923 0.392 . . . . 73.5 111.132 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.567 HG22 ' HA ' ' A' ' 114' ' ' GLU . 1.0 OUTLIER -159.48 128.04 5.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 63.2 111.176 179.972 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.2 m -106.19 153.33 22.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.185 -0.462 . . . . 73.5 110.813 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.56 HG22 HG22 ' A' ' 112' ' ' VAL . 78.9 p -138.54 155.05 48.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.095 -0.502 . . . . 71.41 111.141 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . 0.414 ' CB ' HD23 ' A' ' 167' ' ' LEU . 10.8 m-90 -151.52 123.64 8.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 75.15 110.903 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 19.5 t -105.14 114.9 45.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.246 -0.434 . . . . 62.33 111.168 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.868 HD11 HD12 ' A' ' 104' ' ' LEU . 0.5 OUTLIER -142.74 146.96 34.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.166 -0.47 . . . . 75.23 110.936 179.952 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -73.85 93.0 2.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 75.22 110.914 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.868 HD12 HD11 ' A' ' 102' ' ' LEU . 0.4 OUTLIER -123.54 152.87 41.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 53.42 110.922 -179.938 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.1 t70 64.8 15.03 9.59 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.201 -0.454 . . . . 74.4 110.882 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 88.55 0.65 81.81 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.79 -0.719 . . . . 61.34 112.548 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -139.85 172.92 12.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.796 0.331 . . . . 65.0 110.909 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.69 89.0 0.37 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.134 -0.485 . . . . 72.21 110.877 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.571 HD13 ' HB3' ' A' ' 104' ' ' LEU . 0.5 OUTLIER -74.12 125.41 28.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.147 -0.479 . . . . 65.25 110.911 -179.951 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 3.6 ttm180 -104.54 109.63 21.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 74.12 110.888 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.483 HG21 HD21 ' A' ' 167' ' ' LEU . 0.9 OUTLIER -95.78 136.19 27.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 54.12 111.111 179.995 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.56 HG22 HG22 ' A' ' 99' ' ' THR . 94.0 t -136.25 127.03 42.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.097 -0.501 . . . . 72.43 111.127 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.7 HD22 HD13 ' A' ' 151' ' ' ILE . 3.9 tp -110.11 107.31 17.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.48 . . . . 74.4 110.885 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.567 ' HA ' HG22 ' A' ' 97' ' ' THR . 0.0 OUTLIER -83.17 136.08 34.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 52.43 110.918 179.952 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 6.6 mmmt -73.54 -16.34 61.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.171 -0.468 . . . . 71.04 110.888 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -51.51 -55.49 18.68 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.237 -0.438 . . . . 73.13 110.904 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -136.43 17.0 3.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 75.1 111.187 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . 0.528 ' HA ' HD11 ' A' ' 113' ' ' LEU . 70.9 mtp 58.49 23.25 10.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 64.21 110.849 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.99 147.61 42.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 75.53 110.778 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.547 HG22 HD12 ' A' ' 151' ' ' ILE . 85.8 t -105.13 122.54 58.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.138 -0.483 . . . . 75.11 111.176 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 2.8 t90 -103.63 131.78 50.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.203 -0.453 . . . . 61.12 110.926 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 1.2 m -126.86 108.21 10.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.286 -0.415 . . . . 54.21 110.847 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 4.8 p30 39.42 70.1 0.25 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 73.23 110.83 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 49.75 42.42 36.92 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.775 -0.726 . . . . 64.25 112.466 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -148.12 110.09 4.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.885 0.374 . . . . 72.22 110.917 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.3 154.95 2.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 64.21 110.912 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' MET . . . . . 0.516 ' CE ' HG22 ' A' ' 144' ' ' VAL . 29.9 mmm -124.61 160.53 28.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 74.41 110.848 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -115.47 106.96 14.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 63.44 110.845 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.728 ' HB ' HG22 ' A' ' 140' ' ' THR . 18.8 p -95.36 179.03 5.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.171 -0.468 . . . . 74.52 111.098 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.502 ' HB2' ' HB2' ' A' ' 141' ' ' HIS . . . -90.58 -40.41 11.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 63.25 111.098 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 58.6 60.23 9.31 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.769 -0.729 . . . . 72.21 112.449 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 . . . . . 0 C--N 1.329 -0.303 0 CA-C-O 120.834 0.349 . . . . 62.24 110.973 -179.918 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.282 0 N-CA-C 112.493 -0.243 . . . . 31.13 112.493 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.575 ' O ' ' HB3' ' A' ' 153' ' ' ALA . 0.1 OUTLIER -135.25 130.82 35.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.683 0.278 . . . . 70.43 111.155 -179.858 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -113.73 96.87 6.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 73.24 110.867 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.728 HG22 ' HB ' ' A' ' 129' ' ' THR . 0.0 OUTLIER -81.42 110.43 16.83 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.127 -0.488 . . . . 74.21 111.175 -179.965 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . 0.502 ' HB2' ' HB2' ' A' ' 130' ' ' ALA . 82.4 m-70 -103.89 106.01 16.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.446 . . . . 61.1 110.827 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.435 ' HB3' HG22 ' A' ' 129' ' ' THR . 20.0 p90 -124.48 131.99 53.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 62.11 110.871 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 22.9 p -82.02 146.9 29.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.459 . . . . 63.24 110.852 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.516 HG22 ' CE ' ' A' ' 127' ' ' MET . 21.9 t -137.68 98.35 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.097 -0.501 . . . . 75.12 111.137 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 52.34 -121.28 13.72 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.71 -0.757 . . . . 42.31 112.501 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -98.75 26.74 5.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.901 0.382 . . . . 71.11 110.886 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 31.1 m-70 -126.7 174.21 8.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.177 -0.465 . . . . 71.41 110.834 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -132.79 88.35 2.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 73.41 110.821 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' CYS . . . . . 0.482 ' SG ' HG13 ' A' ' 169' ' ' VAL . 10.4 m -100.67 164.78 11.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.166 -0.47 . . . . 75.23 110.938 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -167.85 144.85 4.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.213 -0.449 . . . . 74.42 110.97 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.7 HD13 HD22 ' A' ' 113' ' ' LEU . 22.7 mt -97.6 111.4 27.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.117 -0.492 . . . . 53.31 111.066 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 1.8 ttmt -80.12 102.82 9.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 73.22 110.927 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . 0.575 ' HB3' ' O ' ' A' ' 138' ' ' THR . . . -93.38 146.47 23.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.271 -0.422 . . . . 74.43 111.067 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.2 t -144.28 121.42 5.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 54.32 111.157 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -94.26 137.21 33.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 72.32 110.889 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 2.2 t -132.45 133.21 43.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.112 -0.494 . . . . 61.45 110.833 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 143.87 -174.94 24.04 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.795 -0.717 . . . . 64.52 112.488 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.96 -26.51 67.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.728 0.299 . . . . 73.53 110.881 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.65 -41.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.267 -0.424 . . . . 65.31 110.861 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 25.4 tttp -162.56 55.75 0.22 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 74.13 110.842 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -76.74 -62.66 1.56 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.267 -0.424 . . . . 61.24 110.86 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -141.35 160.38 26.84 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.813 -0.708 . . . . 55.32 112.457 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 64.1 mt -136.4 139.61 45.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.82 0.343 . . . . 74.3 111.162 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 64.4 mt -126.7 131.05 71.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.138 -0.483 . . . . 73.45 111.13 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' HIS . . . . . 0.415 ' CG ' HD23 ' A' ' 113' ' ' LEU . 14.5 m80 -105.83 139.63 40.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.445 . . . . 62.31 110.883 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.64 103.98 6.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.435 . . . . 73.31 111.155 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.483 HD21 HG21 ' A' ' 111' ' ' VAL . 28.2 tp -65.5 137.8 57.66 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.243 -0.435 . . . . 63.23 110.878 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.462 ' H ' HD12 ' A' ' 167' ' ' LEU . 9.8 mt -137.6 130.04 41.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 33.01 111.168 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.482 HG13 ' SG ' ' A' ' 149' ' ' CYS . 74.2 t -126.51 116.36 44.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.451 . . . . 74.25 111.166 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.4 t0 63.64 46.12 4.29 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.196 -0.456 . . . . 62.24 110.82 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 1.6 m120 59.08 42.93 18.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.262 -0.426 . . . . 51.33 110.879 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 10.4 mtm180 -139.69 124.99 18.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 74.11 110.955 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -62.55 146.48 51.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 64.32 110.84 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.537 HD12 HD22 ' A' ' 102' ' ' LEU . 0.9 OUTLIER -120.32 130.97 24.59 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.597 0.713 . . . . 73.22 111.195 179.885 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.74 134.15 27.33 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.64 2.227 . . . . 75.33 112.402 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.269 -0.423 . . . . 73.53 110.907 -179.977 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.497 ' O ' HG23 ' A' ' 97' ' ' THR . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.853 0.359 . . . . 73.11 111.083 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.66 HG22 ' HA ' ' A' ' 114' ' ' GLU . 1.0 OUTLIER -159.74 127.77 4.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 72.22 111.114 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 62.5 m -106.52 116.83 32.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 71.44 110.841 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.536 HG22 HG22 ' A' ' 112' ' ' VAL . 71.6 p -112.34 163.88 13.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.15 -0.477 . . . . 73.22 111.134 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . 0.46 ' CB ' HD23 ' A' ' 167' ' ' LEU . 21.8 m-90 -149.56 152.17 35.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.196 -0.456 . . . . 74.2 110.86 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 20.3 t -124.84 115.11 43.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.217 -0.447 . . . . 61.0 111.079 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.901 HD11 HD12 ' A' ' 104' ' ' LEU . 0.5 OUTLIER -141.17 147.22 38.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.132 -0.485 . . . . 75.05 110.934 179.926 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 8.7 mtm-85 -72.17 90.99 1.25 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 72.32 110.913 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.901 HD12 HD11 ' A' ' 102' ' ' LEU . 0.4 OUTLIER -121.62 151.62 40.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.105 -0.498 . . . . 72.22 110.922 -179.969 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.7 t70 65.11 14.59 9.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 73.31 110.853 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.63 0.14 79.38 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.738 -0.744 . . . . 63.12 112.479 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -139.88 172.77 12.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.839 0.352 . . . . 75.51 110.898 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -69.02 89.22 0.42 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.206 -0.452 . . . . 63.42 110.906 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.601 HD13 ' HB3' ' A' ' 104' ' ' LEU . 0.4 OUTLIER -75.56 130.95 39.65 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.164 -0.471 . . . . 73.23 110.897 -179.92 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 8.2 ttt180 -107.02 113.12 26.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 74.34 110.88 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.555 HG21 ' CD2' ' A' ' 167' ' ' LEU . 0.8 OUTLIER -95.52 141.2 15.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 75.43 111.19 179.937 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.536 HG22 HG22 ' A' ' 99' ' ' THR . 47.5 t -135.85 126.41 42.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 73.35 111.149 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.565 HD11 ' HA ' ' A' ' 118' ' ' MET . 4.2 tp -113.17 99.82 8.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.463 . . . . 64.54 110.897 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.66 ' HA ' HG22 ' A' ' 97' ' ' THR . 0.0 OUTLIER -76.59 123.54 26.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 71.33 110.924 179.916 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.47 -16.07 59.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 62.14 110.867 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -51.4 -56.02 15.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 74.34 110.906 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 76.3 p -132.49 16.94 4.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 72.25 111.128 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . 0.565 ' HA ' HD11 ' A' ' 113' ' ' LEU . 48.2 mtp 55.7 28.43 12.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 63.5 110.868 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -81.37 147.14 29.97 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.212 -0.449 . . . . 61.0 110.867 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.51 HG22 HD12 ' A' ' 151' ' ' ILE . 79.5 t -104.81 129.41 57.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.445 . . . . 71.23 111.163 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 6.1 t-105 -119.95 109.57 15.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.173 -0.467 . . . . 74.44 110.962 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . 0.538 ' HB3' HD21 ' A' ' 109' ' ' LEU . 7.7 m -97.0 117.81 32.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.441 . . . . 75.54 110.939 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 64.8 -82.75 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.468 . . . . 72.3 110.874 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -156.88 46.17 0.49 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.774 -0.727 . . . . 52.15 112.449 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -159.01 134.29 8.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.908 0.385 . . . . 62.35 110.899 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 24.9 ttpt -53.74 162.11 0.96 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.161 -0.472 . . . . 72.22 110.897 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 31.4 mmm -127.76 167.11 16.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 64.04 110.888 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -119.19 106.62 12.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.285 -0.416 . . . . 64.05 110.92 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.723 ' CB ' HG22 ' A' ' 140' ' ' THR . 19.6 p -95.61 -175.3 3.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.118 -0.492 . . . . 60.12 111.127 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -104.95 -25.16 12.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 53.42 111.087 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 53.23 47.63 61.04 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.752 -0.737 . . . . 73.12 112.453 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 . . . . . 0 C--N 1.33 -0.278 0 CA-C-O 120.816 0.341 . . . . 73.43 110.945 -179.944 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 N-CA-C 112.462 -0.255 . . . . 73.02 112.462 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.632 ' O ' ' HB3' ' A' ' 153' ' ' ALA . 0.1 OUTLIER -134.83 130.8 36.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.74 0.305 . . . . 64.34 111.214 -179.933 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -106.43 96.37 6.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.256 -0.429 . . . . 73.23 110.886 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.723 HG22 ' CB ' ' A' ' 129' ' ' THR . 0.0 OUTLIER -81.86 110.09 16.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 71.43 111.173 -179.9 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 76.7 m-70 -106.86 106.42 16.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 73.4 110.814 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -121.74 128.82 52.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 72.45 110.855 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 56.1 p -89.35 159.3 17.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.112 -0.495 . . . . 65.12 110.85 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 87.0 t -147.86 109.22 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 73.12 111.101 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 52.0 -118.92 7.92 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.68 -0.771 . . . . 74.33 112.563 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -107.16 23.49 14.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.881 0.372 . . . . 65.12 110.916 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -112.57 -169.6 1.51 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 72.13 110.893 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -151.64 118.9 5.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 73.53 110.866 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' CYS . . . . . 0.611 ' CB ' HG22 ' A' ' 169' ' ' VAL . 1.4 p -142.53 163.67 32.21 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.274 -0.421 . . . . 72.31 110.898 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -167.16 145.53 4.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.173 -0.467 . . . . 75.41 110.878 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.51 HD12 HG22 ' A' ' 120' ' ' VAL . 22.5 mt -97.58 111.55 27.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.086 -0.506 . . . . 72.12 111.172 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -80.9 106.96 13.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 73.22 110.879 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . 0.632 ' HB3' ' O ' ' A' ' 138' ' ' THR . . . -101.83 146.6 27.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.256 -0.429 . . . . 73.1 111.126 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.3 t -142.05 132.94 25.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.246 -0.434 . . . . 62.32 111.108 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.1 p -101.17 140.35 35.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.09 -0.505 . . . . 71.52 110.881 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -133.32 136.74 45.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.138 -0.483 . . . . 71.1 110.841 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 135.73 -169.16 23.64 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.763 -0.732 . . . . 73.02 112.477 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 14.2 mttt -64.2 -28.6 69.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.734 0.302 . . . . 73.52 110.891 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.73 -46.9 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.25 -0.432 . . . . 75.2 110.904 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 51.6 pttt -162.79 56.21 0.2 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 54.23 110.901 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -75.2 -56.1 5.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.233 -0.439 . . . . 62.22 110.915 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -138.85 141.56 12.05 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.714 -0.755 . . . . 75.12 112.458 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 73.7 mt -125.4 137.19 58.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.739 0.304 . . . . 53.24 111.188 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 2.8 mt -123.94 131.53 72.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 74.4 111.08 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 16.4 m80 -105.09 144.94 31.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 74.44 110.813 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.99 105.09 5.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.142 -0.481 . . . . 72.14 111.07 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.611 HD12 ' N ' ' A' ' 168' ' ' ILE . 11.7 tp -64.06 135.21 56.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 71.22 110.923 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.611 ' N ' HD12 ' A' ' 167' ' ' LEU . 11.0 mt -136.22 104.78 4.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 72.55 111.118 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.611 HG22 ' CB ' ' A' ' 149' ' ' CYS . 42.2 t -112.66 135.42 52.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 72.23 111.096 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 63.62 31.69 14.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.137 -0.483 . . . . 73.0 110.86 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 2.2 t30 63.33 42.93 6.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.46 . . . . 73.34 110.851 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 9.9 mtt85 -143.94 130.18 19.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 74.43 110.968 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -62.61 146.42 52.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.257 -0.429 . . . . 74.13 110.879 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -125.03 131.34 24.08 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.686 0.755 . . . . 62.21 111.078 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.86 133.22 24.87 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.658 2.238 . . . . 71.14 112.356 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 73.13 110.876 -179.948 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.492 ' O ' HG23 ' A' ' 97' ' ' THR . 15.2 t . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.852 0.358 . . . . 63.23 111.117 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.587 HG22 ' HA ' ' A' ' 114' ' ' GLU . 1.0 OUTLIER -159.62 128.22 5.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.231 -0.44 . . . . 75.02 111.157 -179.964 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.4 m -105.8 147.47 28.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 72.12 110.872 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 1.075 HG22 HG22 ' A' ' 112' ' ' VAL . 0.7 OUTLIER -136.35 138.25 41.45 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.118 -0.492 . . . . 44.22 111.176 -179.972 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . 0.491 ' CB ' HD23 ' A' ' 167' ' ' LEU . 11.1 m-90 -133.42 123.0 24.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.198 -0.456 . . . . 64.34 110.995 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 19.9 t -102.48 114.92 43.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.339 -0.391 . . . . 74.32 111.114 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.915 HD11 HD12 ' A' ' 104' ' ' LEU . 0.5 OUTLIER -142.61 147.27 35.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.153 -0.476 . . . . 75.21 110.925 -179.977 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 83.4 mtt180 -74.34 92.08 2.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 73.02 110.946 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.915 HD12 HD11 ' A' ' 102' ' ' LEU . 0.4 OUTLIER -121.48 153.57 37.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.193 -0.458 . . . . 63.5 110.947 -179.935 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 65.03 14.65 9.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.175 -0.466 . . . . 72.1 110.873 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.61 -0.06 79.7 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.705 -0.759 . . . . 63.51 112.492 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -139.82 172.67 12.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.824 0.345 . . . . 72.31 110.897 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.3 88.64 0.32 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.141 -0.481 . . . . 72.21 110.875 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.628 HD12 ' ND2' ' A' ' 123' ' ' ASN . 0.5 OUTLIER -75.45 125.82 29.76 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.251 -0.431 . . . . 62.2 110.911 -179.954 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 10.1 ttt180 -102.4 111.06 23.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 74.23 110.881 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.4 t -94.8 135.89 27.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.14 -0.482 . . . . 73.12 111.153 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 1.075 HG22 HG22 ' A' ' 99' ' ' THR . 99.4 t -136.55 126.43 39.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 52.25 111.137 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.597 HD11 ' HA ' ' A' ' 118' ' ' MET . 2.7 tp -111.6 103.84 12.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 62.32 110.871 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.587 ' HA ' HG22 ' A' ' 97' ' ' THR . 0.1 OUTLIER -80.26 129.69 34.68 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.183 -0.462 . . . . 75.51 110.891 179.947 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 58.4 mttt -68.71 -15.41 63.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 73.34 110.895 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -51.27 -52.72 42.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.273 -0.421 . . . . 61.54 110.831 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -138.2 16.93 2.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.213 -0.449 . . . . 71.22 111.136 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . 0.597 ' HA ' HD11 ' A' ' 113' ' ' LEU . 1.9 ttp 57.48 26.54 12.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 74.14 110.874 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -80.38 150.68 29.75 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.29 -0.414 . . . . 71.44 110.846 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.534 HG22 HD12 ' A' ' 151' ' ' ILE . 62.0 t -104.86 134.37 46.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.15 -0.477 . . . . 71.04 111.13 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 1.1 t90 -123.5 116.2 22.8 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.184 -0.462 . . . . 73.12 110.909 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . 0.552 ' HB2' HD21 ' A' ' 109' ' ' LEU . 17.9 p -120.95 132.94 55.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.302 -0.408 . . . . 72.43 110.819 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . 0.628 ' ND2' HD12 ' A' ' 109' ' ' LEU . 58.9 m-20 44.57 51.54 7.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.125 -0.489 . . . . 61.4 110.865 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 50.82 40.83 42.67 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.748 -0.739 . . . . 63.52 112.456 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.46 122.61 12.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.854 0.359 . . . . 65.1 110.965 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.49 147.98 9.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.44 . . . . 71.21 110.894 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' MET . . . . . 0.463 ' SD ' HG22 ' A' ' 144' ' ' VAL . 32.5 mmm -114.14 169.05 9.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 63.42 110.847 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.56 106.37 12.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 74.0 110.903 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.671 ' HB ' HG22 ' A' ' 140' ' ' THR . 17.4 p -99.35 -175.11 2.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 63.22 111.178 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.623 ' HB2' ' HB2' ' A' ' 141' ' ' HIS . . . -94.77 -44.8 7.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 75.11 111.06 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 65.11 52.87 37.3 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.707 -0.759 . . . . 64.04 112.483 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 . . . . . 0 C--N 1.329 -0.306 0 CA-C-O 120.889 0.376 . . . . 65.43 110.903 -179.894 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 N-CA-C 112.508 -0.237 . . . . 61.54 112.508 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.654 ' O ' ' HB3' ' A' ' 153' ' ' ALA . 0.1 OUTLIER -134.86 130.91 36.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.735 0.302 . . . . 71.44 111.203 -179.896 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -111.91 96.3 5.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 64.51 110.882 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.671 HG22 ' HB ' ' A' ' 129' ' ' THR . 0.0 OUTLIER -78.81 110.23 13.8 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.22 -0.446 . . . . 71.34 111.157 -179.939 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . 0.623 ' HB2' ' HB2' ' A' ' 130' ' ' ALA . 82.7 m-70 -104.52 106.38 16.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 75.03 110.87 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.527 ' HD2' HG22 ' A' ' 129' ' ' THR . 3.4 p90 -128.09 175.52 8.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 71.5 110.845 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 83.3 p -142.42 155.75 45.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.088 -0.506 . . . . 73.23 110.911 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.554 HG11 HD22 ' A' ' 104' ' ' LEU . 84.7 t -136.87 105.29 4.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.469 . . . . 71.54 111.073 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 62.34 -103.48 0.61 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.726 -0.749 . . . . 62.43 112.496 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -114.23 -27.43 7.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.81 0.338 . . . . 73.14 110.893 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 52.0 m-70 -61.37 -170.43 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.191 -0.459 . . . . 73.34 110.855 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -152.6 116.39 4.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 73.03 110.921 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' CYS . . . . . 0.597 ' HB3' HG22 ' A' ' 169' ' ' VAL . 0.7 OUTLIER -142.66 161.98 36.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.242 -0.435 . . . . 72.32 110.852 -179.844 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 18.3 p90 -156.71 152.72 27.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 73.13 110.905 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.563 HD13 HD22 ' A' ' 113' ' ' LEU . 13.4 mt -99.55 111.53 29.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 71.31 111.14 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.587 ' HD3' HD12 ' A' ' 168' ' ' ILE . 1.1 ttpp -81.89 102.62 10.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 65.35 110.893 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . 0.654 ' HB3' ' O ' ' A' ' 138' ' ' THR . . . -98.6 147.99 24.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.281 -0.418 . . . . 52.32 111.119 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.5 t -145.18 122.44 4.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 54.3 111.122 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.2 p -89.67 139.97 30.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.472 . . . . 70.53 110.852 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 14.7 t -141.67 142.17 33.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.084 -0.507 . . . . 52.23 110.859 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 128.65 175.64 14.14 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.792 -0.718 . . . . 52.01 112.519 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 9.6 mttt -58.48 -38.11 76.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.749 0.309 . . . . 74.04 110.938 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -158.74 76.98 0.75 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 70.31 110.868 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 2.3 mtmt 55.85 28.89 13.11 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.208 -0.451 . . . . 73.21 110.88 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -54.39 -44.74 72.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 71.32 110.892 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -143.87 132.3 4.83 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.705 -0.759 . . . . 43.22 112.434 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 50.5 mt -121.13 147.15 25.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.812 0.339 . . . . 64.52 111.126 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 59.9 mt -129.45 131.01 67.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 62.24 111.118 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 10.8 m80 -108.69 137.27 46.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.446 . . . . 61.25 110.869 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.99 112.0 13.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.253 -0.43 . . . . 64.21 111.177 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.491 HD23 ' CB ' ' A' ' 100' ' ' TRP . 18.1 tp -70.22 134.85 48.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 55.11 110.938 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.587 HD12 ' HD3' ' A' ' 152' ' ' LYS . 10.7 mt -136.74 121.45 25.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.474 . . . . 75.3 111.098 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.597 HG22 ' HB3' ' A' ' 149' ' ' CYS . 16.4 t -121.86 124.08 70.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 72.25 111.178 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 63.63 37.96 9.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.235 -0.439 . . . . 73.03 110.868 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 62.83 42.9 7.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.142 -0.481 . . . . 51.35 110.887 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -140.67 127.98 21.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.169 -0.469 . . . . 71.41 110.879 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -62.67 146.5 52.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.45 . . . . 75.43 110.856 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -122.18 131.31 24.43 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.675 0.75 . . . . 74.41 111.043 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 137.79 36.23 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.731 2.288 . . . . 73.32 112.292 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.462 . . . . 63.12 110.914 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.505 ' O ' HG23 ' A' ' 97' ' ' THR . 30.7 p . . . . . 0 C--O 1.233 0.188 0 CA-C-O 120.856 0.36 . . . . 50.14 111.09 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.505 HG23 ' O ' ' A' ' 96' ' ' THR . 1.0 OUTLIER -159.61 128.14 5.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.265 -0.425 . . . . 54.43 111.175 179.961 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -106.04 155.01 19.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 74.32 110.903 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.746 HG22 HG22 ' A' ' 112' ' ' VAL . 68.4 p -146.81 154.73 41.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.113 -0.494 . . . . 71.13 111.154 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . 0.47 ' CB ' HD23 ' A' ' 167' ' ' LEU . 14.2 m-90 -151.26 133.98 15.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.19 -0.459 . . . . 61.51 110.919 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.3 t -113.14 114.77 47.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 64.45 111.172 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.644 HD11 HD12 ' A' ' 104' ' ' LEU . 0.5 OUTLIER -138.91 146.01 40.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 71.21 110.918 -179.997 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -74.22 94.1 2.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 74.14 110.833 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.644 HD12 HD11 ' A' ' 102' ' ' LEU . 0.4 OUTLIER -127.44 153.39 46.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 75.34 110.927 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 64.43 15.65 9.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.204 -0.453 . . . . 70.2 110.824 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 86.3 2.05 85.73 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.665 -0.779 . . . . 74.54 112.503 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -139.94 173.06 11.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.89 0.376 . . . . 73.43 110.859 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.1 87.88 0.4 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.458 . . . . 74.31 110.872 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.6 HD13 ' HB3' ' A' ' 104' ' ' LEU . 1.4 tp -69.04 124.87 24.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.471 . . . . 73.04 110.906 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 10.8 ttm180 -107.05 113.91 27.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 72.15 110.87 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -106.37 139.37 27.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.456 . . . . 74.45 111.131 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.746 HG22 HG22 ' A' ' 99' ' ' THR . 85.8 t -135.8 135.36 50.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.125 -0.488 . . . . 72.43 111.207 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.437 HD11 ' HA ' ' A' ' 118' ' ' MET . 3.2 tp -117.58 100.35 7.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 62.14 110.954 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.449 ' HG3' HG22 ' A' ' 97' ' ' THR . 0.0 OUTLIER -75.57 134.85 40.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 71.15 110.878 179.977 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.3 mttt -73.78 -17.46 61.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.474 . . . . 64.51 110.924 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -51.33 -54.12 29.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 64.14 110.853 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -134.29 17.01 3.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.219 -0.446 . . . . 65.13 111.138 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . 0.437 ' HA ' HD11 ' A' ' 113' ' ' LEU . 3.9 ttm 54.41 27.09 7.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.252 -0.431 . . . . 61.3 110.914 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -80.97 149.39 29.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 73.43 110.851 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.503 HG23 HG21 ' A' ' 129' ' ' THR . 31.3 t -104.84 128.92 58.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.107 -0.497 . . . . 64.11 111.163 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 3.7 t90 -113.1 127.55 56.24 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.093 -0.503 . . . . 71.23 110.951 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 9.2 t -141.6 129.52 21.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 74.24 110.93 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 48.25 50.79 15.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 73.41 110.945 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 49.29 47.46 34.58 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.774 -0.727 . . . . 75.44 112.44 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.44 114.71 4.79 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.81 0.338 . . . . 64.42 110.966 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 7.5 ttmt -55.56 100.36 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 75.33 110.857 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 65.5 mtp -59.63 159.7 8.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 73.41 110.916 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -104.97 106.38 16.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.212 -0.449 . . . . 62.13 110.892 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.819 ' HB ' HG22 ' A' ' 140' ' ' THR . 13.9 p -99.2 -175.21 2.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.161 -0.472 . . . . 44.35 111.16 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.42 ' HB2' ' HB2' ' A' ' 141' ' ' HIS . . . -114.01 -47.86 2.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 41.14 111.136 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 74.83 50.43 8.99 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.716 -0.754 . . . . 70.13 112.484 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 . . . . . 0 C--N 1.328 -0.326 0 CA-C-O 120.878 0.37 . . . . 74.32 110.835 -179.827 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 N-CA-C 112.501 -0.24 . . . . 64.13 112.501 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.63 130.81 34.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.706 0.288 . . . . 60.44 111.132 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -103.18 97.98 7.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.273 -0.422 . . . . 72.4 110.895 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.819 HG22 ' HB ' ' A' ' 129' ' ' THR . 0.0 OUTLIER -80.72 110.26 16.05 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.157 -0.474 . . . . 75.14 111.135 -179.897 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . 0.42 ' HB2' ' HB2' ' A' ' 130' ' ' ALA . 73.9 m-70 -102.0 109.3 21.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 70.55 110.809 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.718 ' CE2' HD12 ' A' ' 151' ' ' ILE . 3.0 p90 -138.75 153.33 48.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.252 -0.431 . . . . 74.31 110.905 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 89.6 p -114.52 167.44 10.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 73.12 110.812 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 83.8 t -149.39 98.12 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.119 -0.492 . . . . 65.2 111.09 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 60.18 -101.93 0.31 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.777 -0.725 . . . . 74.4 112.461 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -123.59 29.24 6.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.945 0.403 . . . . 75.03 110.943 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 75.3 m-70 -121.31 -175.02 2.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.475 . . . . 71.24 110.951 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -145.09 117.48 8.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.287 -0.415 . . . . 62.42 110.84 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' CYS . . . . . 0.611 ' HB3' HG22 ' A' ' 169' ' ' VAL . 1.3 p -142.45 156.41 45.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.216 -0.447 . . . . 54.45 110.893 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -151.66 146.32 25.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 70.1 110.875 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.718 HD12 ' CE2' ' A' ' 142' ' ' PHE . 3.8 mt -97.37 111.69 27.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.082 -0.508 . . . . 73.41 111.113 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.646 ' HD2' HD12 ' A' ' 168' ' ' ILE . 8.1 tttt -79.83 102.5 9.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.253 -0.431 . . . . 74.43 110.88 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -95.12 139.68 31.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.242 -0.436 . . . . 74.43 111.156 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.3 t -135.68 123.01 35.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.252 -0.431 . . . . 75.4 111.135 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.3 p -91.12 150.4 21.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 74.21 110.87 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 63.4 p -144.8 128.45 17.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.104 -0.498 . . . . 63.44 110.885 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 136.03 -144.03 15.68 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.712 -0.756 . . . . 64.52 112.526 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 19.7 mtmt -95.04 -63.42 1.17 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.721 0.296 . . . . 75.25 110.866 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.99 -36.38 3.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.308 -0.405 . . . . 74.43 110.926 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -173.17 52.3 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 35.23 110.916 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -69.23 -61.98 1.57 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 65.14 110.922 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -143.33 138.77 8.41 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.734 -0.746 . . . . 62.04 112.55 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 61.2 mt -124.54 146.11 30.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.796 0.331 . . . . 72.5 111.159 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 59.4 mt -133.92 123.18 44.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.242 -0.436 . . . . 72.3 111.171 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 9.7 m80 -99.41 141.49 32.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.464 . . . . 71.52 110.875 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.33 106.93 8.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 75.42 111.073 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.546 HD12 ' N ' ' A' ' 168' ' ' ILE . 14.5 tp -65.14 134.02 52.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 72.52 110.936 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.646 HD12 ' HD2' ' A' ' 152' ' ' LYS . 10.7 mt -137.01 111.27 9.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 53.12 111.113 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.611 HG22 ' HB3' ' A' ' 149' ' ' CYS . 35.6 t -113.56 124.71 70.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.458 . . . . 54.13 111.143 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 4.5 t0 63.37 43.22 6.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.451 . . . . 63.34 110.883 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 58.3 m-20 56.8 41.54 27.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.111 -0.495 . . . . 70.14 110.841 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 26.4 mtt180 -137.94 125.76 22.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 75.2 110.849 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -62.7 144.96 55.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.174 -0.466 . . . . 65.13 110.889 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -122.99 131.16 24.38 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.581 0.705 . . . . 73.22 111.143 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 138.21 37.31 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.725 2.283 . . . . 71.31 112.299 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 72.43 110.855 -179.956 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.495 ' O ' HG23 ' A' ' 97' ' ' THR . 39.2 p . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.831 0.348 . . . . 74.22 111.107 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.495 HG23 ' O ' ' A' ' 96' ' ' THR . 1.0 OUTLIER -159.46 127.78 5.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.286 -0.416 . . . . 64.43 111.096 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.4 m -106.48 152.18 23.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.443 . . . . 71.41 110.833 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.433 HG23 HG22 ' A' ' 112' ' ' VAL . 6.9 m -135.86 155.19 50.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.126 -0.488 . . . . 72.55 111.124 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . 0.426 ' CB ' HD23 ' A' ' 167' ' ' LEU . 16.6 m-90 -148.97 133.02 17.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.208 -0.451 . . . . 74.24 110.88 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.0 t -113.03 114.92 48.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 71.44 111.124 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.847 HD11 HD12 ' A' ' 104' ' ' LEU . 0.5 OUTLIER -140.03 147.27 40.13 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.179 -0.464 . . . . 72.43 110.892 179.973 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -73.29 93.44 1.89 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.133 -0.485 . . . . 42.43 110.874 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.847 HD12 HD11 ' A' ' 102' ' ' LEU . 0.3 OUTLIER -124.8 151.74 44.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 72.33 110.868 -179.901 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.8 t0 64.54 15.21 9.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 75.31 110.847 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.37 1.8 83.43 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.758 -0.734 . . . . 60.1 112.527 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -139.92 172.88 12.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.841 0.353 . . . . 74.01 110.902 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.67 89.28 0.37 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 73.14 110.855 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.616 HD13 ' HB3' ' A' ' 104' ' ' LEU . 0.6 OUTLIER -74.38 131.49 41.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 64.53 110.955 179.986 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 11.7 ttp180 -110.8 118.48 36.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 75.12 110.862 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.583 HG13 ' HB2' ' A' ' 122' ' ' CYS . 0.1 OUTLIER -108.63 143.74 18.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 52.42 111.112 179.955 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.433 HG22 HG23 ' A' ' 99' ' ' THR . 15.6 t -135.85 153.04 31.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.13 -0.486 . . . . 31.11 111.111 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.605 HD22 HD13 ' A' ' 151' ' ' ILE . 4.3 tp -129.71 105.92 8.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.165 -0.471 . . . . 74.41 110.927 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.488 ' HA ' HG22 ' A' ' 97' ' ' THR . 0.0 OUTLIER -81.43 135.51 35.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.231 -0.44 . . . . 74.43 110.823 179.955 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.0 mtmt -73.52 -16.54 61.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.098 -0.501 . . . . 64.44 110.859 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -51.34 -55.85 16.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.254 -0.43 . . . . 71.41 110.884 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.86 16.81 3.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 63.43 111.207 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . 0.534 ' HA ' HD11 ' A' ' 113' ' ' LEU . 1.9 mtp 59.99 20.21 9.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.464 . . . . 53.22 110.891 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -70.91 151.03 45.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 73.1 110.886 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.7 HG22 HD12 ' A' ' 151' ' ' ILE . 80.4 t -105.07 117.81 51.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 74.4 111.095 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 55.2 t-105 -95.61 113.63 25.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.211 -0.45 . . . . 71.33 110.946 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . 0.583 ' HB2' HG13 ' A' ' 111' ' ' VAL . 9.0 t -140.26 133.03 29.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.246 -0.434 . . . . 74.32 110.897 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 57.98 34.06 23.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 62.01 110.915 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 57.76 49.85 70.62 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.743 -0.741 . . . . 55.4 112.476 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.93 121.6 2.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.836 0.35 . . . . 73.44 110.934 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -54.08 100.39 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 73.34 110.942 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' MET . . . . . 0.426 ' HB2' ' HB ' ' A' ' 120' ' ' VAL . 17.2 mmm -56.47 174.23 0.15 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.283 -0.417 . . . . 72.34 110.868 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -119.27 106.29 12.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.212 -0.449 . . . . 75.43 110.847 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.713 ' HB ' HG22 ' A' ' 140' ' ' THR . 19.8 p -98.64 -175.23 3.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.135 -0.484 . . . . 70.21 111.16 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.501 ' HB2' ' HB2' ' A' ' 141' ' ' HIS . . . -99.87 -38.38 8.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.269 -0.423 . . . . 71.04 111.092 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 69.77 43.56 66.47 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.711 -0.756 . . . . 44.03 112.55 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 . . . . . 0 C--N 1.329 -0.291 0 CA-C-O 120.922 0.392 . . . . 74.51 110.921 -179.898 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 N-CA-C 112.508 -0.237 . . . . 75.22 112.508 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.573 ' O ' ' HB3' ' A' ' 153' ' ' ALA . 0.1 OUTLIER -135.03 130.78 36.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.763 0.316 . . . . 74.52 111.109 -179.842 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -108.57 96.78 6.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.444 . . . . 74.13 110.893 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.713 HG22 ' HB ' ' A' ' 129' ' ' THR . 0.0 OUTLIER -83.64 109.99 17.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.168 -0.469 . . . . 64.13 111.075 -179.881 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . 0.501 ' HB2' ' HB2' ' A' ' 130' ' ' ALA . 71.8 m-70 -101.83 104.53 15.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 64.53 110.86 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 23.2 p90 -126.43 135.63 51.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 71.35 110.896 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 36.6 p -102.72 157.38 16.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.441 . . . . 74.21 110.849 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 90.5 t -138.7 105.59 2.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.101 -0.499 . . . . 50.13 111.093 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 55.06 -105.58 0.41 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.701 -0.761 . . . . 72.03 112.512 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -117.32 24.81 10.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.793 0.33 . . . . 71.32 110.869 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -117.1 172.18 7.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 60.12 110.877 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -130.24 120.74 24.92 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.241 -0.436 . . . . 72.34 110.867 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' CYS . . . . . 0.592 ' HB3' HG22 ' A' ' 169' ' ' VAL . 1.0 OUTLIER -142.68 170.73 15.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.179 -0.464 . . . . 74.43 110.913 -179.932 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -175.2 147.71 0.93 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.21 -0.45 . . . . 75.34 110.914 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.7 HD12 HG22 ' A' ' 120' ' ' VAL . 12.9 mt -97.5 111.16 26.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.086 -0.506 . . . . 74.14 111.097 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 20.2 tttt -82.03 102.65 11.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.25 -0.432 . . . . 70.53 110.827 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . 0.573 ' HB3' ' O ' ' A' ' 138' ' ' THR . . . -95.07 147.15 23.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 53.4 111.113 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.5 t -145.08 119.22 2.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 65.33 111.173 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.3 p -84.26 137.95 33.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.471 . . . . 71.23 110.871 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 1.5 t -133.54 152.47 51.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 63.53 110.794 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 112.25 -126.57 7.65 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.763 -0.732 . . . . 74.35 112.476 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -121.75 -65.05 1.16 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.756 0.313 . . . . 74.02 110.928 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -136.8 91.9 2.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.172 -0.467 . . . . 71.32 110.927 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 60.1 26.5 15.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 63.04 110.888 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.91 -69.96 0.19 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.198 -0.456 . . . . 55.11 110.931 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -137.39 120.49 2.09 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.719 -0.753 . . . . 54.34 112.479 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 72.2 mt -110.1 144.97 17.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.746 0.308 . . . . 74.42 111.158 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 3.0 mt -128.16 130.53 69.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.262 -0.426 . . . . 62.34 111.112 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' HIS . . . . . 0.469 ' CG ' HD23 ' A' ' 113' ' ' LEU . 13.1 m80 -108.2 137.29 46.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 73.23 110.862 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.38 107.19 9.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.243 -0.435 . . . . 73.32 111.149 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.597 HD12 ' N ' ' A' ' 168' ' ' ILE . 13.6 tp -67.37 137.21 55.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.249 -0.432 . . . . 75.11 110.982 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.597 ' N ' HD12 ' A' ' 167' ' ' LEU . 9.7 mt -138.76 114.21 9.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.184 -0.462 . . . . 65.22 111.161 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.592 HG22 ' HB3' ' A' ' 149' ' ' CYS . 43.8 t -115.88 126.5 73.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 75.4 111.104 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.3 t0 63.53 39.26 9.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 74.44 110.935 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 60.06 42.3 15.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.47 . . . . 72.24 110.872 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -138.45 124.99 20.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 64.41 110.883 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -62.65 140.49 58.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.272 -0.422 . . . . 74.13 110.891 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.475 HD12 HD22 ' A' ' 102' ' ' LEU . 0.9 OUTLIER -118.64 131.26 24.36 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.616 0.722 . . . . 70.41 111.126 179.992 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.66 135.85 31.74 Favored 'Trans proline' 0 N--CA 1.465 -0.179 0 C-N-CA 122.744 2.296 . . . . 73.13 112.386 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.259 -0.428 . . . . 72.14 110.854 -179.936 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.504 ' O ' HG23 ' A' ' 97' ' ' THR . 54.4 p . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.829 0.347 . . . . 75.41 111.108 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.504 HG23 ' O ' ' A' ' 96' ' ' THR . 1.0 OUTLIER -159.58 127.94 5.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.265 -0.425 . . . . 64.43 111.207 -179.986 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.413 ' O ' HG13 ' A' ' 112' ' ' VAL . 1.1 m -106.27 151.9 24.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.271 -0.422 . . . . 73.31 110.85 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.949 HG23 HG22 ' A' ' 112' ' ' VAL . 1.3 m -137.85 148.46 45.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.125 -0.488 . . . . 71.24 111.095 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . 0.445 ' CB ' HD23 ' A' ' 167' ' ' LEU . 10.1 m-90 -146.4 124.67 12.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.206 -0.452 . . . . 63.33 110.936 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 19.1 t -108.37 114.81 47.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.284 -0.416 . . . . 64.3 111.164 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.909 HD11 HD12 ' A' ' 104' ' ' LEU . 0.5 OUTLIER -139.94 147.62 40.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.205 -0.452 . . . . 64.33 110.894 -179.989 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -73.32 92.83 1.84 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 74.32 110.856 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.909 HD12 HD11 ' A' ' 102' ' ' LEU . 0.3 OUTLIER -123.82 151.0 43.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 54.1 110.89 179.967 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 64.43 15.45 9.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 74.11 110.832 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.83 1.42 82.65 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.717 -0.754 . . . . 54.21 112.516 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -139.81 172.81 12.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.894 0.378 . . . . 61.32 110.808 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -69.53 89.64 0.52 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.081 -0.509 . . . . 64.53 110.878 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.58 HD13 ' HB3' ' A' ' 104' ' ' LEU . 0.5 OUTLIER -76.5 129.33 36.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 73.44 110.937 -179.953 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 2.5 ttm180 -107.76 118.3 36.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 73.14 110.893 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.6 HG12 ' CG1' ' A' ' 120' ' ' VAL . 0.0 OUTLIER -111.73 115.68 50.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 72.32 111.201 179.933 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.949 HG22 HG23 ' A' ' 99' ' ' THR . 28.3 t -114.51 140.29 36.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.242 -0.435 . . . . 73.25 111.127 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.677 HD22 HD13 ' A' ' 151' ' ' ILE . 3.1 tp -114.0 108.66 17.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.17 -0.468 . . . . 52.2 110.962 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.424 ' N ' HD12 ' A' ' 113' ' ' LEU . 0.6 OUTLIER -81.8 134.79 35.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 63.13 110.874 179.984 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.7 mmmt -73.79 -16.31 61.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 73.13 110.883 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -51.49 -53.82 33.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 53.23 110.871 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.54 17.0 2.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.117 -0.492 . . . . 75.11 111.158 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . 0.586 ' HA ' HD11 ' A' ' 113' ' ' LEU . 64.6 mtp 56.49 33.12 22.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.216 -0.447 . . . . 64.32 110.89 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.73 154.22 20.74 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.229 -0.441 . . . . 74.03 110.88 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.644 HG22 HD12 ' A' ' 151' ' ' ILE . 45.3 t -104.81 131.0 54.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.227 -0.442 . . . . 43.4 111.09 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 2.2 t90 -111.85 124.69 52.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 73.54 110.973 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 16.5 t -121.45 103.35 8.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.293 -0.412 . . . . 61.32 110.926 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 46.56 70.99 0.34 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.236 -0.438 . . . . 74.22 110.9 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 47.69 40.31 17.69 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.71 -0.757 . . . . 74.1 112.503 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -141.78 102.27 4.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.92 0.391 . . . . 74.44 110.847 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 4.6 tttt -53.44 102.11 0.05 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 65.34 110.862 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 21.7 mmm -64.79 167.29 7.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.481 . . . . 62.14 110.867 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -119.33 106.09 11.95 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.204 -0.453 . . . . 53.32 110.882 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.683 ' CB ' HG22 ' A' ' 140' ' ' THR . 18.8 p -95.83 177.9 5.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 50.31 111.144 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.674 ' HB3' ' HB2' ' A' ' 141' ' ' HIS . . . -125.08 83.59 2.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 73.42 111.128 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -51.58 113.68 2.54 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.751 -0.738 . . . . 55.13 112.498 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.297 0 CA-C-O 120.813 0.34 . . . . 73.42 110.894 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.252 0 N-CA-C 112.455 -0.258 . . . . 64.23 112.455 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.597 ' O ' ' HB3' ' A' ' 153' ' ' ALA . 0.1 OUTLIER -134.87 130.87 36.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.761 0.315 . . . . 74.12 111.138 -179.863 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -104.38 98.19 8.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 71.21 110.914 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.683 HG22 ' CB ' ' A' ' 129' ' ' THR . 0.0 OUTLIER -77.24 109.85 11.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.458 . . . . 75.2 111.134 -179.907 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . 0.674 ' HB2' ' HB3' ' A' ' 130' ' ' ALA . 86.6 m-70 -101.15 108.04 19.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.158 -0.474 . . . . 64.32 110.861 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -123.97 124.26 42.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.142 -0.481 . . . . 73.52 110.799 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 66.5 p -85.86 157.97 20.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.119 -0.491 . . . . 65.22 110.838 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 97.5 t -150.16 104.32 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.085 -0.507 . . . . 62.31 111.14 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 52.75 -113.58 2.88 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.697 -0.763 . . . . 52.14 112.516 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -110.46 25.81 11.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.844 0.354 . . . . 74.35 110.867 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 20.9 m-70 -124.84 159.66 30.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.242 -0.435 . . . . 63.1 110.897 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -121.02 123.68 42.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.255 -0.43 . . . . 74.23 110.841 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' CYS . . . . . 0.614 ' HB3' HG22 ' A' ' 169' ' ' VAL . 1.2 p -142.49 154.6 44.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.141 -0.481 . . . . 71.24 110.946 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -157.62 149.03 21.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.218 -0.446 . . . . 72.12 110.943 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.677 HD13 HD22 ' A' ' 113' ' ' LEU . 9.4 mt -97.84 113.93 33.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 61.22 111.067 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 2.4 tttt -80.13 102.65 9.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.207 -0.451 . . . . 74.25 110.866 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . 0.597 ' HB3' ' O ' ' A' ' 138' ' ' THR . . . -98.8 143.92 28.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 75.41 111.115 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 39.4 t -146.68 124.93 4.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.212 -0.449 . . . . 63.4 111.164 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.2 p -94.22 139.54 30.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.221 -0.445 . . . . 65.43 110.823 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.23 145.72 35.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 74.2 110.844 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 129.81 -179.12 17.02 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.701 -0.762 . . . . 53.33 112.491 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 6.4 mtmt -52.81 -58.02 8.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.801 0.334 . . . . 73.11 110.915 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 3.9 ptm180 -150.17 79.45 1.35 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.255 -0.429 . . . . 74.54 110.912 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 15.6 ttmt 61.73 56.49 2.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 73.52 110.915 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -90.89 -68.81 0.77 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.176 -0.465 . . . . 71.44 110.894 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -111.63 128.44 8.63 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.792 -0.718 . . . . 65.45 112.512 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 56.9 mt -120.29 145.0 27.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.767 0.318 . . . . 54.32 111.11 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 57.2 mt -128.58 140.12 50.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.177 -0.465 . . . . 75.32 111.12 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' HIS . . . . . 0.42 ' CG ' HD23 ' A' ' 113' ' ' LEU . 9.4 m80 -117.91 135.48 54.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.137 -0.483 . . . . 53.41 110.816 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.82 109.88 12.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.133 -0.485 . . . . 73.5 111.126 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.555 HD12 ' N ' ' A' ' 168' ' ' ILE . 15.1 tp -68.43 135.63 52.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 73.44 110.981 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.555 ' N ' HD12 ' A' ' 167' ' ' LEU . 10.5 mt -138.63 117.27 13.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.455 . . . . 75.44 111.119 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.614 HG22 ' HB3' ' A' ' 149' ' ' CYS . 21.7 t -117.93 125.82 74.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.172 -0.467 . . . . 63.31 111.103 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 63.56 37.98 10.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 72.44 110.934 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 61.4 43.0 10.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 72.24 110.864 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 16.5 mtt180 -140.23 129.1 23.29 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.177 -0.465 . . . . 72.14 110.852 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -62.69 146.43 52.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.136 -0.484 . . . . 74.34 110.899 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.435 HD12 HD22 ' A' ' 102' ' ' LEU . 0.8 OUTLIER -122.85 130.89 24.45 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.699 0.762 . . . . 71.03 111.14 179.961 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 135.57 30.82 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.66 2.24 . . . . 61.3 112.332 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 116.229 -0.441 . . . . 55.43 110.889 179.999 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.501 ' O ' HG23 ' A' ' 97' ' ' THR . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.873 0.368 . . . . 73.31 111.157 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.501 HG23 ' O ' ' A' ' 96' ' ' THR . 1.0 OUTLIER -159.54 127.8 4.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.234 -0.439 . . . . 74.04 111.181 179.993 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.3 m -106.37 153.95 21.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 70.02 110.879 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.968 HG22 HG22 ' A' ' 112' ' ' VAL . 0.6 OUTLIER -142.21 156.57 45.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.104 -0.498 . . . . 72.15 111.11 -179.904 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 17.2 m-90 -151.45 130.6 12.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.237 -0.438 . . . . 74.1 110.97 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.3 t -110.25 114.79 48.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.249 -0.432 . . . . 75.33 111.107 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.947 HD11 HD12 ' A' ' 104' ' ' LEU . 0.5 OUTLIER -141.69 148.42 39.06 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.197 -0.456 . . . . 74.14 110.95 179.932 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.3 mtm180 -74.73 92.79 2.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.178 -0.464 . . . . 70.5 110.857 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.947 HD12 HD11 ' A' ' 102' ' ' LEU . 0.3 OUTLIER -121.79 152.07 39.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 72.45 110.979 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 64.72 15.03 9.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.213 -0.449 . . . . 74.13 110.889 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.0 0.48 80.95 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.719 -0.753 . . . . 60.34 112.444 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -139.84 172.76 12.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.854 0.359 . . . . 75.01 110.914 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -68.58 89.68 0.37 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 73.22 110.858 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.551 HD13 ' HB3' ' A' ' 104' ' ' LEU . 0.5 OUTLIER -78.91 128.58 33.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 71.15 110.878 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.74 119.7 40.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.131 -0.486 . . . . 54.45 110.875 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.589 HG13 ' SG ' ' A' ' 122' ' ' CYS . 0.1 OUTLIER -107.13 142.61 19.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.124 -0.489 . . . . 50.41 111.131 179.956 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.968 HG22 HG22 ' A' ' 99' ' ' THR . 48.1 t -135.82 146.72 29.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 63.53 111.153 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.58 HD11 ' HA ' ' A' ' 118' ' ' MET . 3.1 tp -128.4 101.24 6.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 73.2 110.878 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.402 ' HG3' HG22 ' A' ' 97' ' ' THR . 0.2 OUTLIER -78.11 122.77 26.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.189 -0.459 . . . . 73.34 110.878 179.924 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.39 -15.94 59.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 65.51 110.946 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -51.44 -56.0 15.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.455 . . . . 74.12 110.868 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 9.5 p -133.87 16.98 3.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.458 . . . . 65.45 111.129 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . 0.58 ' HA ' HD11 ' A' ' 113' ' ' LEU . 9.6 mtp 58.43 24.55 11.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.302 -0.408 . . . . 71.12 110.856 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -76.18 144.55 40.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.267 -0.424 . . . . 71.44 110.842 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.504 HG21 ' CE2' ' A' ' 142' ' ' PHE . 71.4 t -105.1 118.26 52.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 70.0 111.156 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 2.2 t90 -98.34 134.86 40.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.173 -0.467 . . . . 72.01 110.909 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . 0.589 ' SG ' HG13 ' A' ' 111' ' ' VAL . 0.6 OUTLIER -131.18 103.14 6.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 75.25 110.914 179.982 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 22.7 m-20 45.43 69.66 0.43 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 73.52 110.992 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 48.65 41.02 25.99 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.773 -0.727 . . . . 70.4 112.428 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -149.81 115.3 5.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.801 0.334 . . . . 64.11 110.927 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -53.56 162.21 0.87 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.247 -0.433 . . . . 75.4 110.85 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' MET . . . . . 0.526 ' CE ' HG22 ' A' ' 144' ' ' VAL . 35.1 mmm -126.54 166.49 17.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.445 . . . . 73.42 110.945 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -119.26 106.41 12.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.268 -0.424 . . . . 74.14 110.861 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.593 ' CB ' HG22 ' A' ' 140' ' ' THR . 21.7 p -95.8 -175.17 3.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.161 -0.472 . . . . 61.15 111.126 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.468 ' HB2' ' HB2' ' A' ' 141' ' ' HIS . . . -93.33 -35.76 12.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.449 . . . . 64.2 111.138 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 73.88 40.57 43.97 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.769 -0.729 . . . . 51.43 112.496 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 . . . . . 0 C--N 1.33 -0.28 0 CA-C-O 120.907 0.384 . . . . 65.4 110.832 -179.846 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 N-CA-C 112.483 -0.247 . . . . 64.11 112.483 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.42 ' O ' ' HB3' ' A' ' 153' ' ' ALA . 0.1 OUTLIER -135.04 130.82 36.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.807 0.336 . . . . 63.12 111.164 -179.862 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -104.86 96.63 6.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.222 -0.445 . . . . 73.44 110.858 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.593 HG22 ' CB ' ' A' ' 129' ' ' THR . 0.0 OUTLIER -85.39 110.21 18.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 43.23 111.098 -179.912 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . 0.468 ' HB2' ' HB2' ' A' ' 130' ' ' ALA . 41.9 m170 -109.53 106.24 15.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 75.03 110.821 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.547 ' HD2' HG22 ' A' ' 129' ' ' THR . 9.1 p90 -124.54 144.66 50.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 72.3 110.899 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 77.0 p -91.28 141.61 28.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 74.03 110.892 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.526 HG22 ' CE ' ' A' ' 127' ' ' MET . 17.4 t -138.87 103.47 2.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.175 -0.466 . . . . 54.21 111.096 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 53.76 31.43 46.01 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.704 -0.76 . . . . 70.44 112.476 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 63.36 25.35 14.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.874 0.369 . . . . 65.25 110.883 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 77.6 m-70 -93.5 -11.93 30.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.14 -0.482 . . . . 75.32 110.825 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 63.87 104.88 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.244 -0.434 . . . . 73.24 110.801 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' CYS . . . . . 0.543 ' SG ' HG13 ' A' ' 169' ' ' VAL . 10.9 m -137.91 167.86 20.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.165 -0.47 . . . . 65.4 110.846 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 18.4 p90 -174.39 142.79 0.8 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.474 . . . . 75.11 110.919 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.504 HD13 HD22 ' A' ' 113' ' ' LEU . 32.0 mt -98.59 111.3 27.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.076 -0.511 . . . . 71.31 111.141 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 16.9 tttt -80.11 104.03 10.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.485 . . . . 71.31 110.858 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . 0.42 ' HB3' ' O ' ' A' ' 138' ' ' THR . . . -99.04 146.67 25.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 73.03 111.084 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.2 t -144.9 124.3 6.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.251 -0.431 . . . . 75.24 111.174 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -93.32 129.62 39.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.21 -0.45 . . . . 60.44 110.839 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -130.17 153.45 48.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 74.02 110.858 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 83.3 90.24 0.71 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.659 -0.782 . . . . 64.11 112.516 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.01 -170.13 0.16 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.845 0.355 . . . . 74.14 110.913 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 11.1 mtt180 -52.89 -32.34 44.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.239 -0.437 . . . . 74.22 110.854 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 11.7 pttt -173.41 124.1 0.39 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 70.2 110.916 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -158.58 -54.0 0.07 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.227 -0.442 . . . . 75.05 110.91 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -128.06 105.98 0.76 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.712 -0.756 . . . . 70.12 112.482 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 63.3 mt -103.91 134.76 44.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.751 0.31 . . . . 75.51 111.121 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 53.5 mt -121.04 133.34 68.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.227 -0.442 . . . . 73.1 111.135 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' HIS . . . . . 0.409 ' CG ' HD23 ' A' ' 113' ' ' LEU . 14.2 m80 -108.96 137.94 46.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 54.13 110.848 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.65 103.64 6.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 75.12 111.128 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.559 HD12 ' H ' ' A' ' 168' ' ' ILE . 15.9 tp -66.35 138.35 57.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.237 -0.438 . . . . 74.03 110.907 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.559 ' H ' HD12 ' A' ' 167' ' ' LEU . 11.0 mt -135.95 119.53 23.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.216 -0.447 . . . . 72.52 111.105 179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.543 HG13 ' SG ' ' A' ' 149' ' ' CYS . 88.2 t -118.5 135.46 58.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 64.52 111.082 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 54.01 37.01 25.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 63.42 110.898 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 10.3 t30 63.37 42.93 6.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.166 -0.47 . . . . 54.41 110.956 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 4.2 mtm180 -141.44 130.46 23.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 65.45 110.88 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -62.83 146.45 52.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.208 -0.451 . . . . 75.12 110.853 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.477 HD12 HD22 ' A' ' 102' ' ' LEU . 0.9 OUTLIER -122.98 131.14 24.38 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.65 0.738 . . . . 63.23 111.11 179.965 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.74 135.89 31.66 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.624 2.216 . . . . 75.35 112.398 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 73.1 110.89 -179.962 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.499 ' O ' HG23 ' A' ' 97' ' ' THR . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.881 0.372 . . . . 70.11 111.157 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.499 HG23 ' O ' ' A' ' 96' ' ' THR . 1.0 OUTLIER -159.47 128.09 5.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 41.44 111.084 -179.987 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.8 m -105.98 154.04 21.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.237 -0.438 . . . . 74.54 110.855 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 27.3 m -141.56 148.58 39.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.139 -0.482 . . . . 74.04 111.153 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . 0.54 ' CB ' HD23 ' A' ' 167' ' ' LEU . 9.3 m-90 -145.37 122.91 11.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.198 -0.455 . . . . 73.41 110.89 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 19.5 t -103.32 114.79 43.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 71.24 111.075 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.788 HD11 HD12 ' A' ' 104' ' ' LEU . 0.5 OUTLIER -141.97 146.6 35.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.119 -0.491 . . . . 75.05 110.898 179.925 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 4.8 mtt85 -74.44 92.18 2.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 73.54 110.88 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.788 HD12 HD11 ' A' ' 102' ' ' LEU . 0.4 OUTLIER -122.99 153.74 39.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.207 -0.452 . . . . 73.04 110.926 -179.974 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.5 t70 65.14 14.44 9.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.181 -0.463 . . . . 43.23 110.877 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.55 0.0 79.81 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.791 -0.719 . . . . 51.13 112.503 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -139.86 172.91 12.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.868 0.366 . . . . 74.34 110.836 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -68.78 88.13 0.36 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.112 -0.495 . . . . 74.21 110.879 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.608 HD13 ' HB3' ' A' ' 104' ' ' LEU . 0.5 OUTLIER -73.26 124.85 26.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.259 -0.428 . . . . 74.34 110.907 -179.907 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -102.03 109.79 21.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 73.12 110.893 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.568 HG13 ' SG ' ' A' ' 122' ' ' CYS . 2.5 t -95.25 136.7 25.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 65.33 111.09 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 86.6 t -136.51 128.58 44.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.163 -0.471 . . . . 75.0 111.126 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.609 HD22 HD13 ' A' ' 151' ' ' ILE . 4.9 tp -110.07 102.31 11.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.138 -0.483 . . . . 71.54 110.875 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.455 ' HA ' HG22 ' A' ' 97' ' ' THR . 0.1 OUTLIER -78.7 136.15 37.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.211 -0.449 . . . . 64.24 110.914 179.875 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.431 ' HG3' HG22 ' A' ' 96' ' ' THR . 21.0 mmmt -73.77 -17.15 61.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.135 -0.484 . . . . 73.42 110.861 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -51.49 -53.88 32.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 63.11 110.869 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.82 17.0 3.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.201 -0.454 . . . . 64.22 111.112 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . 0.426 ' HA ' HD11 ' A' ' 113' ' ' LEU . 2.6 ttp 53.67 28.22 7.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 60.34 110.876 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -85.23 158.62 20.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 73.15 110.87 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.545 HG23 HG21 ' A' ' 129' ' ' THR . 21.6 t -104.87 138.4 29.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.207 -0.451 . . . . 72.2 111.15 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 1.2 t90 -123.28 121.12 35.07 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.252 -0.431 . . . . 75.2 110.872 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . 0.568 ' SG ' HG13 ' A' ' 111' ' ' VAL . 60.8 m -132.21 131.77 42.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.236 -0.438 . . . . 63.11 110.877 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . 0.46 ' ND2' HD12 ' A' ' 109' ' ' LEU . 41.0 m-20 49.3 50.24 18.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.189 -0.459 . . . . 63.43 110.92 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 49.04 45.08 33.12 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.795 -0.717 . . . . 71.33 112.447 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -147.96 116.96 6.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.828 0.347 . . . . 74.4 110.921 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 13.2 mttt -53.17 102.3 0.05 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.295 -0.411 . . . . 71.33 110.922 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 23.4 mmm -64.52 166.5 8.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 75.25 110.882 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.17 106.0 11.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.994 0.426 . . . . 72.34 110.836 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.603 ' CB ' HG22 ' A' ' 140' ' ' THR . 16.0 p -97.72 175.29 6.23 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.099 -0.501 . . . . 73.22 111.117 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.618 ' HB3' ' HB2' ' A' ' 141' ' ' HIS . . . -122.48 90.13 3.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.227 -0.442 . . . . 73.21 111.074 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -50.85 117.19 5.09 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.726 -0.749 . . . . 72.51 112.482 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 . . . . . 0 C--N 1.33 -0.252 0 CA-C-O 120.952 0.406 . . . . 74.43 110.823 -179.864 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 N-CA-C 112.446 -0.262 . . . . 35.01 112.446 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -134.19 130.78 37.73 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.734 0.302 . . . . 72.14 111.184 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -98.08 96.13 7.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.296 -0.411 . . . . 63.53 110.914 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.603 HG22 ' CB ' ' A' ' 129' ' ' THR . 0.0 OUTLIER -79.14 109.4 13.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 71.22 111.202 -179.973 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . 0.618 ' HB2' ' HB3' ' A' ' 130' ' ' ALA . 38.0 m170 -100.66 112.69 25.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.306 -0.406 . . . . 63.41 110.832 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.436 ' CD2' HG22 ' A' ' 129' ' ' THR . 6.5 p90 -125.84 114.43 18.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 74.42 110.852 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 98.4 p -78.28 151.57 32.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.081 -0.508 . . . . 53.52 110.842 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 46.9 t -146.81 108.67 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.086 -0.506 . . . . 54.23 111.147 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 52.92 -109.98 1.14 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.759 -0.734 . . . . 74.22 112.488 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -116.6 26.4 9.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.881 0.372 . . . . 71.44 110.916 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 23.9 m-70 -123.49 164.2 19.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 64.43 110.853 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -126.06 123.17 37.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 52.3 110.809 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' CYS . . . . . 0.594 ' HB3' HG22 ' A' ' 169' ' ' VAL . 0.9 OUTLIER -142.67 150.66 40.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.226 -0.443 . . . . 52.14 110.878 -179.93 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 17.6 p90 -150.87 149.61 29.89 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.181 -0.463 . . . . 73.23 110.979 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.609 HD13 HD22 ' A' ' 113' ' ' LEU . 7.6 mt -99.65 114.27 37.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.176 -0.465 . . . . 72.45 111.126 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.633 ' HD3' HD12 ' A' ' 168' ' ' ILE . 0.1 OUTLIER -80.24 103.09 9.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.225 -0.443 . . . . 73.24 110.871 179.834 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -100.13 146.65 26.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.195 -0.457 . . . . 61.11 111.1 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 66.2 t -149.21 122.94 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.199 -0.455 . . . . 61.3 111.134 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.2 p -92.26 144.56 25.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.186 -0.461 . . . . 71.1 110.859 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.25 141.82 30.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.487 . . . . 63.13 110.851 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 129.71 -168.84 21.02 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.696 -0.764 . . . . 63.52 112.507 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 8.4 mtmt -56.39 -26.75 54.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.794 0.331 . . . . 71.54 110.93 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -176.97 -40.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 70.24 110.818 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 34.9 mttt -155.87 31.8 0.35 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 73.2 110.905 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -55.93 -60.57 3.28 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.179 -0.464 . . . . 74.13 110.92 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -143.6 142.24 11.09 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.773 -0.727 . . . . 74.42 112.5 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 47.8 mt -126.16 147.15 31.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.756 0.312 . . . . 63.03 111.087 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 38.3 mt -128.29 137.14 58.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.205 -0.452 . . . . 65.23 111.14 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 5.8 m80 -120.72 134.39 55.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 63.23 110.876 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.48 117.17 23.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.449 . . . . 52.53 111.183 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.54 HD23 ' CB ' ' A' ' 100' ' ' TRP . 14.0 tp -71.3 132.56 45.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 70.42 110.953 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.633 HD12 ' HD3' ' A' ' 152' ' ' LYS . 11.0 mt -135.92 116.53 18.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.263 -0.426 . . . . 63.2 111.126 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.594 HG22 ' HB3' ' A' ' 149' ' ' CYS . 17.0 t -119.08 127.99 75.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 63.41 111.171 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 2.2 t0 63.89 35.56 10.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 74.3 110.842 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 1.8 m120 63.33 43.09 6.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 55.34 110.887 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 58.3 mtt180 -142.97 128.72 19.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.112 -0.495 . . . . 64.34 110.867 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -62.44 146.5 51.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.457 . . . . 71.44 110.906 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -121.28 130.65 24.72 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.578 0.704 . . . . 62.32 111.121 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.67 143.92 52.84 Favored 'Trans proline' 0 N--CA 1.465 -0.157 0 C-N-CA 122.737 2.292 . . . . 74.33 112.364 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.268 -0.424 . . . . 73.35 110.835 -179.971 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.499 ' O ' HG23 ' A' ' 97' ' ' THR . 1.1 t . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.841 0.353 . . . . 74.42 111.158 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.499 HG23 ' O ' ' A' ' 96' ' ' THR . 1.0 OUTLIER -159.62 133.08 7.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 72.53 111.119 -179.981 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.3 m -105.66 150.43 25.46 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.197 -0.456 . . . . 52.01 110.776 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.618 HG23 HG22 ' A' ' 112' ' ' VAL . 2.2 m -141.79 154.7 45.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.053 -0.521 . . . . 71.34 111.12 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . 0.494 ' CB ' HD23 ' A' ' 167' ' ' LEU . 12.1 m-90 -151.52 128.61 11.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.437 . . . . 65.13 110.957 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 19.5 t -108.1 114.9 47.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.237 -0.438 . . . . 74.44 111.21 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.735 HD11 HD12 ' A' ' 104' ' ' LEU . 0.5 OUTLIER -140.19 146.06 38.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 75.24 110.887 179.992 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.9 mtm180 -73.37 92.54 1.84 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.137 -0.483 . . . . 74.34 110.872 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.735 HD12 HD11 ' A' ' 102' ' ' LEU . 0.4 OUTLIER -124.89 153.14 43.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.096 -0.502 . . . . 73.22 110.867 -179.996 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 64.62 15.14 9.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.475 . . . . 75.2 110.891 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 88.1 1.01 82.49 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.722 -0.752 . . . . 71.21 112.502 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -139.79 172.95 12.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.844 0.354 . . . . 74.14 110.866 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.42 87.01 0.44 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.165 -0.47 . . . . 54.01 110.886 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.56 HD13 ' HB3' ' A' ' 104' ' ' LEU . 0.7 OUTLIER -69.05 125.29 26.21 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.225 -0.443 . . . . 74.3 110.855 -179.87 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 17.3 ttm180 -103.99 109.79 21.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 74.54 110.841 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.478 HG21 ' CD2' ' A' ' 167' ' ' LEU . 1.4 t -95.54 136.37 26.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.216 -0.447 . . . . 73.03 111.155 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.618 HG22 HG23 ' A' ' 99' ' ' THR . 93.2 t -136.03 122.65 32.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.204 -0.453 . . . . 63.24 111.142 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.579 HD11 ' HA ' ' A' ' 118' ' ' MET . 2.4 tp -110.31 108.6 18.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.117 -0.492 . . . . 63.14 110.966 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.437 ' N ' HD12 ' A' ' 113' ' ' LEU . 0.1 OUTLIER -85.08 136.73 33.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 74.3 110.913 179.91 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.449 ' HB2' HG23 ' A' ' 96' ' ' THR . 0.0 OUTLIER -73.85 -16.42 61.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.138 -0.483 . . . . 72.44 110.892 179.936 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -51.46 -54.57 25.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.277 -0.419 . . . . 63.25 110.798 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.55 17.06 2.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 53.1 111.174 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . 0.579 ' HA ' HD11 ' A' ' 113' ' ' LEU . 24.7 mtp 59.18 21.76 9.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 75.43 110.862 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.57 142.5 51.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.283 -0.417 . . . . 63.23 110.89 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 65.3 t -105.02 118.45 52.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 74.23 111.112 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 2.8 t90 -101.16 131.84 46.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.459 . . . . 65.52 110.908 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -123.97 103.76 8.51 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.22 -0.445 . . . . 71.25 110.922 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 4.9 p30 39.51 71.59 0.17 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.462 . . . . 63.34 110.915 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 51.0 41.05 44.61 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.773 -0.727 . . . . 73.31 112.523 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -150.45 112.66 4.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.878 0.371 . . . . 73.33 110.866 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 6.4 mtmm -53.63 162.05 0.93 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.217 -0.447 . . . . 61.04 110.888 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 27.7 mmm -127.89 162.99 25.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 75.05 110.91 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -119.28 106.35 12.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.295 -0.411 . . . . 75.23 110.901 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.613 ' CB ' HG22 ' A' ' 140' ' ' THR . 18.0 p -95.46 -176.71 3.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.142 -0.481 . . . . 73.35 111.156 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -89.04 -34.57 16.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.44 . . . . 42.22 111.095 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 60.89 72.99 0.55 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.741 -0.742 . . . . 74.31 112.53 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 . . . . . 0 C--N 1.329 -0.3 0 CA-C-O 120.913 0.387 . . . . 63.53 110.895 -179.883 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.378 0 N-CA-C 112.449 -0.261 . . . . 31.44 112.449 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.628 ' O ' ' HB3' ' A' ' 153' ' ' ALA . 0.1 OUTLIER -135.37 130.81 35.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.748 0.308 . . . . 64.33 111.188 -179.862 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -116.14 96.35 5.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 61.32 110.885 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.613 HG22 ' CB ' ' A' ' 129' ' ' THR . 0.0 OUTLIER -83.77 110.23 18.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 70.14 111.11 -179.903 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 67.6 m-70 -109.25 107.1 17.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 64.32 110.891 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.529 ' HD2' HG22 ' A' ' 129' ' ' THR . 1.8 p90 -119.64 -176.15 3.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.23 -0.441 . . . . 64.2 110.925 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 25.3 p -140.33 165.25 27.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 61.42 110.835 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.575 HG11 HD22 ' A' ' 104' ' ' LEU . 58.3 t -148.85 98.18 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.092 -0.504 . . . . 53.15 111.08 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 61.19 -108.25 1.83 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.77 -0.728 . . . . 75.3 112.529 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -106.14 -26.9 11.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.896 0.379 . . . . 42.42 110.914 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 52.3 m-70 -64.37 -170.19 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.124 -0.489 . . . . 74.21 110.859 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -153.68 116.38 4.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 72.2 110.861 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' CYS . . . . . 0.591 ' HB3' HG22 ' A' ' 169' ' ' VAL . 0.8 OUTLIER -142.66 163.5 32.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.261 -0.427 . . . . 51.33 110.886 -179.867 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 28.5 p90 -161.17 152.87 19.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.191 -0.459 . . . . 73.12 110.877 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.52 HD13 HD22 ' A' ' 113' ' ' LEU . 21.0 mt -99.36 121.44 49.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.133 -0.485 . . . . 73.01 111.168 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.435 ' HD2' HD12 ' A' ' 168' ' ' ILE . 2.1 tttm -89.95 102.56 15.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 72.45 110.909 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . 0.628 ' HB3' ' O ' ' A' ' 138' ' ' THR . . . -99.65 147.24 25.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.439 . . . . 72.21 111.064 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.8 t -145.46 131.29 13.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.184 -0.462 . . . . 71.43 111.045 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.1 p -102.2 145.48 29.35 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.162 -0.472 . . . . 52.05 110.83 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 2.0 p -150.54 165.62 32.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.08 -0.509 . . . . 71.04 110.897 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 112.56 -49.87 0.81 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.713 -0.756 . . . . 71.25 112.493 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -178.54 -64.81 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.806 0.336 . . . . 63.41 110.892 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.31 -42.93 0.29 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 75.42 110.887 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.77 26.82 0.64 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 63.41 110.833 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -62.52 -71.91 0.15 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.282 -0.417 . . . . 71.53 110.875 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -127.46 145.08 15.62 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.794 -0.717 . . . . 64.41 112.568 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 62.9 mt -138.59 139.97 40.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.823 0.344 . . . . 65.44 111.088 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 68.0 mt -127.37 140.36 49.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.122 -0.49 . . . . 73.35 111.147 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 11.1 m80 -113.21 142.21 46.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 61.43 110.831 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.87 106.57 7.36 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.197 -0.456 . . . . 75.15 111.123 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.554 HD21 HD22 ' A' ' 102' ' ' LEU . 17.1 tp -67.35 136.39 54.73 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.251 -0.431 . . . . 73.52 110.951 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.534 ' H ' HD12 ' A' ' 167' ' ' LEU . 9.3 mt -138.31 121.16 19.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 75.35 111.158 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.66 HG21 HD13 ' A' ' 102' ' ' LEU . 18.0 t -121.93 124.98 72.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 64.34 111.12 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.5 t0 64.03 36.5 9.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 74.35 110.822 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 63.4 43.05 6.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.436 . . . . 51.54 110.873 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 3.9 mtm180 -140.51 128.98 22.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 74.31 110.92 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.69 146.52 52.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.434 . . . . 65.24 110.843 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -122.95 130.92 24.42 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.63 0.729 . . . . 75.55 111.189 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 140.4 42.68 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.738 2.292 . . . . 64.22 112.351 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 70.53 110.866 -179.967 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.509 ' O ' HG23 ' A' ' 97' ' ' THR . 2.1 p . . . . . 0 N--CA 1.457 -0.115 0 CA-C-O 120.886 0.374 . . . . 60.14 111.155 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.509 HG23 ' O ' ' A' ' 96' ' ' THR . 1.1 p -159.51 128.29 5.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.224 -0.444 . . . . 72.41 111.17 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -105.75 150.94 25.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.03 0.443 . . . . 54.25 110.838 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 12.0 m -143.05 153.07 42.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.095 -0.502 . . . . 62.52 111.214 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . 0.498 ' CB ' HD23 ' A' ' 167' ' ' LEU . 11.0 m-90 -151.47 127.4 10.34 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.296 -0.411 . . . . 64.24 110.907 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.5 t -106.99 114.99 47.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.455 . . . . 62.14 111.148 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.944 HD11 HD12 ' A' ' 104' ' ' LEU . 0.5 OUTLIER -141.17 147.36 38.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.117 -0.492 . . . . 74.3 110.962 179.973 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 2.7 mtt180 -72.82 91.81 1.53 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 74.23 110.798 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.944 HD12 HD11 ' A' ' 102' ' ' LEU . 0.3 OUTLIER -122.1 151.99 40.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 65.03 110.892 179.988 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 64.84 14.75 9.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 75.43 110.946 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.15 0.39 80.57 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.775 -0.726 . . . . 63.51 112.506 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -139.72 172.86 12.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.797 0.332 . . . . 73.43 110.954 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -68.85 89.25 0.4 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.241 -0.436 . . . . 71.43 110.901 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.587 HD13 ' HB3' ' A' ' 104' ' ' LEU . 0.4 OUTLIER -75.43 127.92 34.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 64.43 110.9 -179.893 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 58.6 ttt180 -105.5 110.21 22.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.225 -0.443 . . . . 74.11 110.788 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.41 HG21 ' CD2' ' A' ' 167' ' ' LEU . 0.9 OUTLIER -95.5 139.75 18.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.103 -0.499 . . . . 52.24 111.056 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 93.3 t -136.23 130.02 47.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.133 -0.485 . . . . 74.33 111.134 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.594 HD11 ' HA ' ' A' ' 118' ' ' MET . 2.3 tp -118.07 104.46 10.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.102 -0.499 . . . . 74.32 110.846 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.477 ' HG3' HG22 ' A' ' 97' ' ' THR . 0.1 OUTLIER -81.6 124.67 29.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 63.03 110.854 179.932 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.59 -16.02 59.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 71.44 110.927 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -51.63 -55.98 16.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.203 -0.453 . . . . 72.15 110.884 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.3 m -132.76 17.02 4.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.264 -0.425 . . . . 74.31 111.147 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . 0.594 ' HA ' HD11 ' A' ' 113' ' ' LEU . 82.5 mtp 54.68 31.53 15.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 63.32 110.85 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -86.46 147.18 26.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.444 . . . . 74.32 110.893 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.537 HG23 HG21 ' A' ' 129' ' ' THR . 25.2 t -104.84 137.6 33.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.247 -0.433 . . . . 63.41 111.14 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 1.2 t90 -125.51 129.7 50.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.133 -0.485 . . . . 55.44 110.881 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 16.8 p -138.48 133.87 33.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.221 -0.445 . . . . 62.41 110.912 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 46.05 49.14 12.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 52.22 110.859 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 50.79 44.1 48.27 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.657 -0.782 . . . . 73.32 112.533 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -147.89 119.0 7.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.849 0.357 . . . . 72.11 110.952 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 1.5 mtpt -53.1 136.39 35.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 73.24 110.877 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' MET . . . . . 0.412 ' HB2' ' HB ' ' A' ' 120' ' ' VAL . 67.7 mtp -102.78 165.19 11.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 64.21 110.87 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -113.31 107.1 15.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.215 -0.448 . . . . 74.43 110.878 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.709 ' HB ' HG22 ' A' ' 140' ' ' THR . 16.6 p -99.98 -175.15 2.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.49 . . . . 64.14 111.099 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -115.06 -29.49 6.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 64.3 111.109 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 52.41 32.4 37.69 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.724 -0.75 . . . . 51.35 112.482 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 . . . . . 0 C--N 1.329 -0.312 0 CA-C-O 120.831 0.348 . . . . 75.2 110.853 -179.854 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 N-CA-C 112.483 -0.247 . . . . 74.22 112.483 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.67 ' O ' ' HB3' ' A' ' 153' ' ' ALA . 0.1 OUTLIER -134.85 130.84 36.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.71 0.291 . . . . 62.4 111.144 -179.826 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -109.49 96.35 6.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 73.43 110.818 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.709 HG22 ' HB ' ' A' ' 129' ' ' THR . 0.0 OUTLIER -79.29 110.24 14.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.449 . . . . 72.41 111.116 -179.915 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -105.68 113.03 26.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.272 -0.422 . . . . 73.11 110.907 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.544 ' HD2' HG22 ' A' ' 129' ' ' THR . 3.2 p90 -133.92 178.99 6.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.177 -0.465 . . . . 74.21 110.883 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 90.7 p -140.39 162.62 34.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 72.41 110.874 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.598 HG11 HD22 ' A' ' 104' ' ' LEU . 39.7 t -146.55 99.48 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 72.02 111.146 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 68.41 -108.05 2.31 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.704 -0.76 . . . . 73.31 112.482 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -111.66 -26.35 9.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.781 0.324 . . . . 75.34 110.913 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 24.7 m-70 -65.9 -169.97 0.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.484 . . . . 75.13 110.794 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -149.79 119.51 7.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.135 -0.484 . . . . 61.34 110.885 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' CYS . . . . . 0.599 ' HB3' HG22 ' A' ' 169' ' ' VAL . 0.8 OUTLIER -142.41 161.53 37.8 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.252 -0.431 . . . . 71.35 110.9 -179.878 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 22.2 p90 -156.89 150.36 24.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.251 -0.431 . . . . 64.43 110.904 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.577 HD13 HD22 ' A' ' 113' ' ' LEU . 10.3 mt -97.61 112.83 30.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.089 -0.505 . . . . 73.31 111.156 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.611 ' HD2' HD12 ' A' ' 168' ' ' ILE . 0.2 OUTLIER -80.92 102.68 10.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.126 -0.488 . . . . 74.32 110.872 179.921 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . 0.67 ' HB3' ' O ' ' A' ' 138' ' ' THR . . . -98.05 148.13 23.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.259 -0.428 . . . . 64.22 111.154 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.0 t -144.5 127.31 11.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.262 -0.427 . . . . 63.43 111.21 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.1 p -97.13 133.71 41.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 64.35 110.845 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -127.9 137.66 52.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.083 -0.508 . . . . 51.23 110.8 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 134.55 -174.17 21.13 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.738 -0.744 . . . . 60.12 112.489 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 5.7 mttm -86.66 -48.88 7.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.79 0.329 . . . . 73.25 110.914 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 44.4 mtm180 -134.77 69.18 1.45 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 71.31 110.84 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 26.1 mttp 58.32 60.36 2.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.226 -0.443 . . . . 73.52 110.889 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -77.81 -65.22 1.0 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 72.11 110.859 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -136.8 145.23 17.05 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.758 -0.734 . . . . 72.21 112.511 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 69.4 mt -126.5 143.45 39.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.807 0.337 . . . . 61.04 111.145 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 60.1 mt -128.44 132.93 67.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.143 -0.48 . . . . 75.22 111.131 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 13.5 m80 -106.91 141.11 38.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 52.22 110.873 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.6 106.36 7.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.225 -0.443 . . . . 74.41 111.124 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.537 HD21 HD22 ' A' ' 102' ' ' LEU . 17.1 tp -64.91 135.87 56.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 72.33 110.891 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.611 HD12 ' HD2' ' A' ' 152' ' ' LYS . 10.0 mt -138.1 117.38 14.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.061 -0.518 . . . . 64.33 111.193 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.599 HG22 ' HB3' ' A' ' 149' ' ' CYS . 20.2 t -119.45 127.02 75.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 72.52 111.149 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 2.9 t0 63.8 35.29 11.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.144 -0.48 . . . . 73.12 110.897 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 63.43 43.11 6.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.235 -0.439 . . . . 52.52 110.872 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 42.4 mtt180 -140.85 129.7 23.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.484 . . . . 73.2 110.831 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -62.77 146.47 52.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 73.3 110.848 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -123.04 130.86 24.43 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.581 0.705 . . . . 52.41 111.132 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.76 139.03 39.21 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.643 2.229 . . . . 71.03 112.369 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.199 -0.455 . . . . 73.43 110.899 -179.97 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.502 ' O ' HG23 ' A' ' 97' ' ' THR . 13.4 t . . . . . 0 C--O 1.233 0.204 0 CA-C-O 120.811 0.338 . . . . 74.52 111.13 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.502 HG23 ' O ' ' A' ' 96' ' ' THR . 1.1 p -159.35 128.1 5.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.27 -0.423 . . . . 72.34 111.181 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.4 m -105.92 149.61 26.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.455 . . . . 53.54 110.847 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 24.7 m -140.19 138.81 35.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.15 -0.477 . . . . 54.44 111.153 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 18.7 m-90 -131.68 133.51 44.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.242 -0.436 . . . . 71.04 110.951 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.2 t -112.88 114.78 47.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.451 . . . . 72.24 111.157 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.78 HD11 HD12 ' A' ' 104' ' ' LEU . 0.5 OUTLIER -141.2 146.48 36.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 73.24 110.9 -179.998 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.9 91.89 2.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 74.11 110.874 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.78 HD12 HD11 ' A' ' 102' ' ' LEU . 0.4 OUTLIER -123.09 152.97 40.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 70.42 110.915 -179.959 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 64.87 14.86 9.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.165 -0.47 . . . . 53.11 110.829 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 88.94 0.4 81.2 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.745 -0.74 . . . . 53.35 112.498 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -139.83 173.0 11.98 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.788 0.327 . . . . 75.24 110.89 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -68.98 87.45 0.37 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.138 -0.483 . . . . 64.13 110.886 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.624 HD13 ' HB3' ' A' ' 104' ' ' LEU . 0.5 OUTLIER -72.3 127.51 32.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 74.01 110.909 -179.896 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -107.6 117.35 33.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 75.44 110.916 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.429 HG21 ' CD2' ' A' ' 167' ' ' LEU . 0.1 OUTLIER -107.25 146.02 13.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 70.41 111.106 -179.982 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 22.0 t -135.92 152.69 31.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 62.14 111.182 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.504 HD22 HD13 ' A' ' 151' ' ' ILE . 5.1 tp -131.38 99.83 4.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 65.52 110.882 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.83 134.37 43.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 52.12 110.896 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 3.0 mmmt -73.78 -17.92 61.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 70.44 110.861 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -51.35 -55.1 20.28 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.216 -0.447 . . . . 75.15 110.83 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.86 16.72 4.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 74.45 111.156 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . 0.431 ' HA ' HD11 ' A' ' 113' ' ' LEU . 3.8 ttm 54.05 27.24 7.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.208 -0.451 . . . . 54.14 110.886 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.83 160.51 22.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.184 -0.462 . . . . 73.13 110.835 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.714 HG22 HD12 ' A' ' 151' ' ' ILE . 55.5 t -104.64 143.58 15.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 74.4 111.125 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 2.3 t90 -123.75 120.89 34.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.185 -0.461 . . . . 74.52 110.924 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . 0.482 ' SG ' HD21 ' A' ' 109' ' ' LEU . 19.6 t -136.55 132.55 35.35 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.276 -0.42 . . . . 72.24 110.905 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 51.92 48.33 22.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.157 -0.474 . . . . 41.34 110.884 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 48.62 47.21 30.1 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.733 -0.746 . . . . 71.31 112.474 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.6 118.76 5.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.838 0.351 . . . . 75.33 110.932 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.24 101.95 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.212 -0.449 . . . . 55.24 110.88 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' MET . . . . . 0.59 ' HE1' HG22 ' A' ' 144' ' ' VAL . 38.5 mmm -55.68 176.65 0.06 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 73.34 110.843 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -119.16 106.51 12.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 72.34 110.914 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.576 ' HB ' HG22 ' A' ' 140' ' ' THR . 59.4 p -99.14 -175.3 2.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 52.15 111.151 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.512 ' HB2' ' HB2' ' A' ' 141' ' ' HIS . . . -106.55 -44.64 4.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 72.22 111.126 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 77.04 53.07 5.42 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.825 -0.702 . . . . 73.31 112.456 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 . . . . . 0 C--N 1.329 -0.286 0 CA-C-O 120.86 0.362 . . . . 65.1 110.846 -179.875 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.255 0 N-CA-C 112.499 -0.24 . . . . 62.44 112.499 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.04 130.79 36.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.688 0.28 . . . . 72.23 111.218 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -98.89 100.23 11.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.271 -0.422 . . . . 73.35 110.955 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.576 HG22 ' HB ' ' A' ' 129' ' ' THR . 0.0 OUTLIER -82.98 110.24 17.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.46 . . . . 74.01 111.193 -179.93 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . 0.512 ' HB2' ' HB2' ' A' ' 130' ' ' ALA . 63.7 m-70 -100.77 105.78 17.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.257 -0.429 . . . . 75.31 110.814 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.608 ' CE2' HG21 ' A' ' 120' ' ' VAL . 21.9 p90 -139.29 156.54 46.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.245 -0.434 . . . . 75.1 110.849 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -111.64 123.73 50.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.086 -0.506 . . . . 74.42 110.917 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.59 HG22 ' HE1' ' A' ' 127' ' ' MET . 27.2 t -106.15 125.89 61.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.114 -0.494 . . . . 52.41 111.082 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 52.36 41.3 54.84 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.727 -0.749 . . . . 65.32 112.478 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 64.33 26.02 13.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.799 0.333 . . . . 74.51 110.837 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . 0.591 ' HD2' HD21 ' A' ' 104' ' ' LEU . 25.7 m-70 -113.12 -169.27 1.45 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 73.55 110.832 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -116.48 110.63 18.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 62.33 110.898 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' CYS . . . . . 0.516 ' SG ' HG13 ' A' ' 169' ' ' VAL . 12.1 m -138.38 173.47 11.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 74.01 110.923 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 32.0 p90 -174.97 143.44 0.71 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.199 -0.455 . . . . 75.21 110.953 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.714 HD12 HG22 ' A' ' 120' ' ' VAL . 20.6 mt -97.73 113.63 32.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.076 -0.511 . . . . 61.11 111.094 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 27.9 tttt -79.84 102.74 9.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 72.34 110.914 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -97.19 136.02 38.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 64.41 111.075 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.3 t -133.91 121.14 38.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.23 -0.441 . . . . 74.05 111.185 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.3 p -94.53 143.1 26.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.145 -0.48 . . . . 74.25 110.833 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 2.3 t -136.52 134.14 37.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.091 -0.504 . . . . 73.55 110.89 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 136.12 171.92 12.46 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.728 -0.749 . . . . 71.13 112.493 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 6.5 mmtt -59.06 -28.64 66.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.764 0.316 . . . . 65.53 110.884 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 2.1 mtt180 -148.82 -63.43 0.24 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 72.41 110.872 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -152.75 44.39 0.67 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 75.51 110.84 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -57.68 -58.55 7.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.313 -0.403 . . . . 65.44 110.866 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -145.1 162.27 28.14 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.725 -0.75 . . . . 64.13 112.5 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 55.4 mt -144.85 145.45 21.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.786 0.327 . . . . 73.52 111.144 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 75.6 mt -133.82 123.68 45.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.466 . . . . 75.05 111.186 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 5.6 m80 -104.38 137.19 42.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 71.25 110.932 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.91 108.8 11.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 53.23 111.2 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.492 HD12 ' N ' ' A' ' 168' ' ' ILE . 14.8 tp -66.33 136.36 55.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.277 -0.419 . . . . 62.12 110.904 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.492 ' N ' HD12 ' A' ' 167' ' ' LEU . 12.4 mt -133.62 129.41 55.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.146 -0.479 . . . . 72.22 111.17 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.516 HG13 ' SG ' ' A' ' 149' ' ' CYS . 95.6 t -127.17 118.17 49.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.446 . . . . 74.34 111.149 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 63.61 41.0 7.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.134 -0.485 . . . . 72.33 110.853 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 63.34 43.01 6.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 73.43 110.812 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 17.7 mtm180 -138.98 121.97 16.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.216 -0.447 . . . . 74.44 110.922 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -62.75 146.48 52.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 52.4 110.913 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.582 HD12 HD22 ' A' ' 102' ' ' LEU . 0.9 OUTLIER -123.99 131.55 24.24 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.619 0.723 . . . . 63.24 111.117 179.996 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 133.44 25.49 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.625 2.217 . . . . 74.43 112.34 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.246 -0.433 . . . . 72.5 110.924 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.494 ' O ' HG23 ' A' ' 97' ' ' THR . 71.8 p . . . . . 0 N--CA 1.458 -0.069 0 CA-C-O 120.864 0.364 . . . . 64.51 111.209 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.661 HG22 ' HA ' ' A' ' 114' ' ' GLU . 1.0 OUTLIER -159.53 127.77 4.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.187 -0.46 . . . . 71.12 111.151 -179.968 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 14.5 m -106.42 113.16 26.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.263 -0.426 . . . . 72.11 110.842 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.982 HG22 HG22 ' A' ' 112' ' ' VAL . 17.2 p -110.18 159.59 17.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.121 -0.491 . . . . 73.23 111.064 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 14.6 m-90 -149.57 155.97 41.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.223 -0.444 . . . . 72.45 110.911 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 18.9 t -131.52 114.95 26.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 73.33 111.158 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.887 HD11 HD12 ' A' ' 104' ' ' LEU . 0.5 OUTLIER -141.22 147.63 38.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 73.32 110.884 179.985 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.65 94.29 3.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.155 -0.475 . . . . 71.14 110.834 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.887 HD12 HD11 ' A' ' 102' ' ' LEU . 0.3 OUTLIER -123.68 154.05 39.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 71.3 110.908 179.985 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.1 t70 64.91 14.87 9.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.19 -0.459 . . . . 74.52 110.833 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 88.79 0.48 81.43 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.714 -0.755 . . . . 62.11 112.489 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -139.79 172.88 12.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.88 0.372 . . . . 60.31 110.855 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -68.43 89.4 0.35 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 71.31 110.907 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.621 HD13 ' HB3' ' A' ' 104' ' ' LEU . 0.5 OUTLIER -75.72 123.99 26.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.437 . . . . 74.24 110.96 -179.999 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -104.09 115.04 29.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 71.52 110.87 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.465 HG21 HD21 ' A' ' 167' ' ' LEU . 0.2 OUTLIER -102.98 138.89 25.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.183 -0.462 . . . . 73.22 111.184 179.906 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.982 HG22 HG22 ' A' ' 99' ' ' THR . 96.3 t -135.77 126.99 44.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.434 . . . . 72.41 111.169 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.629 HD22 HD13 ' A' ' 151' ' ' ILE . 6.3 tp -110.36 100.4 9.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.444 . . . . 72.23 110.959 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.661 ' HA ' HG22 ' A' ' 97' ' ' THR . 0.0 OUTLIER -77.4 136.15 38.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.447 . . . . 62.55 110.921 179.962 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 3.6 mtmt -73.21 -17.48 61.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 62.4 110.834 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -51.39 -54.91 21.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.222 -0.445 . . . . 74.14 110.871 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 14.9 p -132.55 16.82 4.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.176 -0.465 . . . . 62.11 111.12 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 81.2 mtp 51.59 31.1 7.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 74.21 110.895 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -86.57 153.27 21.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 71.3 110.875 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.6 HG22 HD12 ' A' ' 151' ' ' ILE . 95.6 t -104.92 123.09 58.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.233 -0.439 . . . . 64.11 111.18 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -104.94 131.97 51.77 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.232 -0.44 . . . . 64.43 110.91 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . 0.4 ' SG ' HD21 ' A' ' 109' ' ' LEU . 24.4 t -126.99 103.19 7.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 73.34 110.931 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 12.0 m-20 45.35 70.28 0.37 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 53.33 110.885 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 48.72 39.01 23.34 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.78 -0.724 . . . . 61.24 112.504 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.25 107.42 4.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.893 0.377 . . . . 72.04 110.88 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.28 143.27 18.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 73.52 110.89 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' MET . . . . . 0.457 ' CE ' HG22 ' A' ' 144' ' ' VAL . 22.7 mmm -111.24 163.99 13.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 52.4 110.866 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -117.79 107.8 14.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 75.14 110.876 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.694 ' HB ' HG22 ' A' ' 140' ' ' THR . 19.2 p -95.26 -179.36 4.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.144 -0.48 . . . . 71.1 111.177 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.459 ' HB2' ' HB2' ' A' ' 141' ' ' HIS . . . -92.41 -31.26 15.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 71.25 111.114 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 58.82 54.69 35.88 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.791 -0.718 . . . . 72.0 112.458 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.309 0 CA-C-O 120.915 0.388 . . . . 74.25 110.957 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 N-CA-C 112.498 -0.241 . . . . 33.01 112.498 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.21 130.8 35.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.686 0.279 . . . . 71.12 111.21 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -109.82 97.44 6.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.302 -0.408 . . . . 63.12 110.865 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.694 HG22 ' HB ' ' A' ' 129' ' ' THR . 0.0 OUTLIER -85.51 110.44 19.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 72.22 111.142 -179.943 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . 0.459 ' HB2' ' HB2' ' A' ' 130' ' ' ALA . 67.5 m-70 -106.15 105.6 15.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 73.52 110.837 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.408 ' HB3' HG22 ' A' ' 129' ' ' THR . 18.8 p90 -122.97 131.07 53.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 70.51 110.808 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 27.8 p -83.07 149.79 26.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 74.0 110.857 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.457 HG22 ' CE ' ' A' ' 127' ' ' MET . 21.8 t -140.65 99.65 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.051 -0.522 . . . . 52.52 111.066 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 54.58 -115.88 5.88 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.726 -0.749 . . . . 61.5 112.479 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -106.04 25.41 10.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.81 0.338 . . . . 72.22 110.884 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 67.4 m-70 -119.2 -175.48 2.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 72.44 110.824 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -145.33 84.42 1.7 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 61.0 110.872 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' CYS . . . . . 0.448 ' SG ' HG13 ' A' ' 169' ' ' VAL . 6.8 m -99.53 165.08 11.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.231 -0.441 . . . . 74.15 110.897 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 19.9 p90 -167.48 145.04 4.56 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.175 -0.466 . . . . 75.02 110.89 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.629 HD13 HD22 ' A' ' 113' ' ' LEU . 32.9 mt -98.63 111.26 27.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.134 -0.485 . . . . 72.12 111.155 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.33 103.14 12.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.122 -0.49 . . . . 63.54 110.902 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -94.27 146.08 24.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 71.32 111.157 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.5 t -138.41 124.79 25.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.289 -0.414 . . . . 74.3 111.126 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -99.86 146.87 26.14 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.184 -0.462 . . . . 73.53 110.878 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 1.4 p -149.29 150.6 32.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 64.01 110.826 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 109.1 64.56 0.55 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.778 -0.725 . . . . 72.42 112.507 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.19 -75.44 0.07 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.794 0.33 . . . . 73.21 110.876 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -138.72 -58.97 0.62 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 65.44 110.962 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 2.9 tttt -135.39 103.07 5.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.116 -0.493 . . . . 72.54 110.98 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -144.87 -62.8 0.36 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 61.11 110.852 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -135.16 127.38 4.35 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.765 -0.731 . . . . 64.14 112.459 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 69.1 mt -122.99 138.57 52.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.763 0.316 . . . . 62.41 111.185 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 54.9 mt -127.53 128.92 70.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.178 -0.464 . . . . 72.25 111.088 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 15.3 m80 -100.22 137.98 37.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 73.44 110.914 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.88 109.3 11.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 74.35 111.107 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.574 HD12 ' H ' ' A' ' 168' ' ' ILE . 19.1 tp -67.3 138.46 56.85 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.152 -0.477 . . . . 75.44 110.893 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.574 ' H ' HD12 ' A' ' 167' ' ' LEU . 8.6 mt -139.01 128.59 30.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 74.05 111.114 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.633 HG21 HD13 ' A' ' 102' ' ' LEU . 64.1 t -127.81 122.73 59.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.109 -0.496 . . . . 74.41 111.15 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 2.4 t0 63.77 38.24 9.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.204 -0.453 . . . . 72.21 110.867 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 2.0 t30 63.32 43.11 6.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 61.42 110.842 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.14 131.61 23.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 74.21 110.879 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -62.34 146.4 51.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.218 -0.446 . . . . 75.24 110.954 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.473 HD12 HD22 ' A' ' 102' ' ' LEU . 0.8 OUTLIER -123.72 130.52 24.43 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.646 0.736 . . . . 73.13 111.137 179.998 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 147.83 63.53 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.713 2.275 . . . . 73.43 112.324 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 116.245 -0.434 . . . . 75.42 110.91 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.511 ' O ' HG23 ' A' ' 97' ' ' THR . 2.4 m . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.837 0.351 . . . . 55.03 111.115 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.511 HG23 ' O ' ' A' ' 96' ' ' THR . 1.0 OUTLIER -159.8 128.15 4.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 53.54 111.138 -179.998 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.9 m -106.04 151.99 23.95 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.209 -0.451 . . . . 45.21 110.826 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 95.7 m -146.34 141.81 27.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.111 -0.495 . . . . 52.12 111.145 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 21.7 m-90 -132.35 158.8 41.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 75.25 110.968 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.0 t -133.26 114.82 21.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.342 -0.39 . . . . 63.51 111.144 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.952 HD11 HD12 ' A' ' 104' ' ' LEU . 0.5 OUTLIER -141.64 147.58 37.79 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.226 -0.443 . . . . 64.14 110.919 179.975 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 42.3 mtp180 -72.72 92.09 1.53 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 75.43 110.858 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.952 HD12 HD11 ' A' ' 102' ' ' LEU . 0.3 OUTLIER -121.61 151.52 40.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 72.12 110.904 -179.944 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 64.85 14.69 9.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.232 -0.44 . . . . 62.23 110.884 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.2 0.69 80.03 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.752 -0.737 . . . . 62.53 112.489 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -139.87 172.73 12.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.867 0.365 . . . . 74.42 110.942 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -68.24 89.88 0.33 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.162 -0.472 . . . . 63.34 110.865 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.596 HD13 ' HB3' ' A' ' 104' ' ' LEU . 0.6 OUTLIER -76.96 134.14 38.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 71.25 110.912 -179.981 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 25.9 ttm180 -111.11 119.51 39.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 64.45 110.877 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.447 HG21 ' CD2' ' A' ' 167' ' ' LEU . 0.1 OUTLIER -105.41 145.13 13.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.2 -0.455 . . . . 73.5 111.167 179.956 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 91.4 t -134.37 144.24 35.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.249 -0.432 . . . . 61.42 111.135 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.496 HD11 ' HA ' ' A' ' 118' ' ' MET . 3.4 tp -131.52 101.53 5.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 75.21 110.929 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.478 ' HG3' HG22 ' A' ' 97' ' ' THR . 0.0 OUTLIER -73.63 132.11 42.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.27 -0.423 . . . . 72.45 110.881 179.942 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.35 -16.58 61.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 70.52 110.93 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -52.59 -55.96 18.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 74.3 110.829 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.56 16.99 3.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 74.2 111.116 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . 0.496 ' HA ' HD11 ' A' ' 113' ' ' LEU . 68.1 mtp 57.91 30.23 18.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.445 . . . . 62.35 110.884 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -77.83 143.07 38.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.455 . . . . 72.15 110.902 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.432 HG23 HG21 ' A' ' 129' ' ' THR . 17.2 t -104.62 128.06 58.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 74.51 111.209 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 3.2 t90 -119.97 114.39 21.96 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.23 -0.441 . . . . 73.11 110.894 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' CYS . . . . . 0.538 ' SG ' HD11 ' A' ' 109' ' ' LEU . 3.0 t -100.97 103.09 14.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.25 -0.432 . . . . 73.35 110.892 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 67.91 -76.16 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 60.31 110.926 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -159.08 45.77 0.44 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.739 -0.744 . . . . 60.43 112.462 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.86 114.2 4.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.893 0.378 . . . . 74.22 110.868 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.3 101.94 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.459 . . . . 72.0 110.879 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' MET . . . . . 0.443 ' HE2' ' CG ' ' A' ' 142' ' ' PHE . 64.1 mtp -60.85 157.32 15.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 61.42 110.9 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -102.9 106.65 17.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 72.41 110.868 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.803 ' HB ' HG22 ' A' ' 140' ' ' THR . 15.5 p -98.66 -176.28 3.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 45.2 111.111 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -112.89 -75.36 0.6 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.275 -0.42 . . . . 55.03 111.094 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 104.68 86.15 1.9 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.727 -0.749 . . . . 73.04 112.511 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 . . . . . 0 C--N 1.329 -0.297 0 CA-C-O 120.869 0.366 . . . . 73.34 110.914 -179.889 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 N-CA-C 112.539 -0.224 . . . . 54.01 112.539 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.32 130.87 33.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.76 0.314 . . . . 71.2 111.145 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.73 97.68 11.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 73.53 110.881 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.803 HG22 ' HB ' ' A' ' 129' ' ' THR . 0.1 OUTLIER -77.46 110.55 12.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.114 -0.494 . . . . 74.14 111.112 -179.878 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -98.91 111.63 23.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.267 -0.424 . . . . 63.02 110.869 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.764 ' CE2' HD12 ' A' ' 151' ' ' ILE . 1.4 p90 -144.8 159.55 42.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.454 . . . . 63.24 110.903 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.8 166.5 14.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 54.51 110.895 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 24.2 t -145.54 97.97 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.159 -0.473 . . . . 73.55 111.084 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 67.22 -88.98 0.16 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.738 -0.744 . . . . 61.02 112.478 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -139.5 25.9 2.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.828 0.347 . . . . 61.34 110.86 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 67.1 m-70 -115.77 -175.77 2.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 73.0 110.899 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -140.89 116.56 10.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.26 -0.427 . . . . 71.24 110.893 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' CYS . . . . . 0.708 ' CB ' HG22 ' A' ' 169' ' ' VAL . 1.9 p -142.56 158.19 43.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 70.25 110.959 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 19.9 p90 -150.84 145.34 25.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.227 -0.442 . . . . 72.43 110.926 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.764 HD12 ' CE2' ' A' ' 142' ' ' PHE . 3.2 mt -97.74 112.46 29.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.095 -0.502 . . . . 73.2 111.174 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.69 102.88 9.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 74.4 110.93 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -99.02 143.85 28.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.229 -0.441 . . . . 53.13 111.098 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 20.9 t -142.33 124.43 13.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 71.14 111.149 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.3 p -94.38 140.43 29.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.455 . . . . 73.31 110.821 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 10.4 t -134.47 135.7 42.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.068 -0.515 . . . . 62.02 110.886 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 135.78 -145.65 17.65 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.709 -0.757 . . . . 74.45 112.447 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -88.79 -36.4 16.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.819 0.342 . . . . 45.43 110.858 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 1.7 mtm-85 -152.35 -47.5 0.1 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.284 -0.416 . . . . 55.41 110.831 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 7.7 pttp -159.55 37.82 0.2 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.165 -0.471 . . . . 70.4 110.931 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -59.08 -70.6 0.15 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.236 -0.438 . . . . 74.13 110.896 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -129.58 128.23 5.66 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.76 -0.733 . . . . 74.43 112.485 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 48.6 mt -120.44 147.46 24.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.816 0.341 . . . . 64.34 111.122 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 3.0 mt -131.96 130.23 61.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 64.23 111.074 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 8.7 m80 -108.71 134.96 50.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 74.25 110.917 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.28 110.14 13.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.188 -0.46 . . . . 52.24 111.156 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.587 HD12 ' N ' ' A' ' 168' ' ' ILE . 11.8 tp -66.96 135.38 53.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.212 -0.449 . . . . 70.04 110.951 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.587 ' N ' HD12 ' A' ' 167' ' ' LEU . 10.8 mt -136.81 106.19 4.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 74.11 111.206 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.708 HG22 ' CB ' ' A' ' 149' ' ' CYS . 47.7 t -109.39 128.94 64.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 74.31 111.142 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 63.31 41.28 7.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.194 -0.457 . . . . 74.12 110.816 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 56.6 42.68 26.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.237 -0.438 . . . . 72.32 110.87 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 10.5 mtp180 -140.44 126.44 19.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 75.31 110.836 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.58 145.29 54.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 74.41 110.885 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.446 HD12 HD22 ' A' ' 102' ' ' LEU . 0.9 OUTLIER -123.61 131.29 24.28 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.663 0.744 . . . . 65.34 111.125 179.964 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 132.25 22.99 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.755 2.303 . . . . 73.5 112.336 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.245 -0.434 . . . . 73.1 110.85 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 CA-C-O 121.444 0.469 . . . . 45.41 112.478 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 138.8 38.84 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.724 2.283 . . . . 72.14 112.318 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -81.0 58.29 3.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.441 . . . . 74.12 110.918 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -177.39 178.95 48.31 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.735 -0.745 . . . . 51.12 112.493 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 9.3 t 59.25 -179.0 0.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.831 0.348 . . . . 61.11 110.879 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -165.94 -51.2 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 71.42 110.89 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -158.23 58.66 0.46 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 74.04 110.835 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.75 98.57 3.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.464 . . . . 72.34 110.868 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 36.5 m -120.6 35.81 4.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.454 . . . . 54.54 110.835 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.83 -31.59 68.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 72.11 110.89 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.503 ' O ' HG23 ' A' ' 97' ' ' THR . 68.3 p -110.19 29.87 7.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 72.3 111.143 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.503 HG23 ' O ' ' A' ' 96' ' ' THR . 1.0 OUTLIER -159.65 127.98 4.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.23 -0.441 . . . . 53.41 111.134 -179.92 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.3 m -106.17 152.79 23.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 61.14 110.863 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.534 HG23 HG22 ' A' ' 112' ' ' VAL . 7.9 m -140.66 154.79 46.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.147 -0.479 . . . . 74.32 111.172 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 14.0 m-90 -151.12 131.54 13.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.231 -0.44 . . . . 72.33 110.915 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.2 t -113.03 114.61 47.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 64.21 111.115 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.688 HD11 HD12 ' A' ' 104' ' ' LEU . 0.5 OUTLIER -139.36 145.95 39.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 74.43 110.888 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 17.2 ttt180 -74.0 93.39 2.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 63.22 110.827 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.688 HD12 HD11 ' A' ' 102' ' ' LEU . 0.4 OUTLIER -126.27 152.95 45.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.187 -0.46 . . . . 62.12 110.911 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 3.1 t70 64.51 15.32 9.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 64.4 110.894 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.23 1.55 84.04 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.734 -0.746 . . . . 52.24 112.467 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -139.83 173.07 11.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.876 0.37 . . . . 75.22 110.899 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -69.63 87.97 0.5 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.146 -0.479 . . . . 64.11 110.876 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.638 HD13 ' HB3' ' A' ' 104' ' ' LEU . 0.8 OUTLIER -70.39 126.7 30.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 75.23 110.913 -179.948 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 12.3 ttt180 -108.14 116.72 32.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 75.24 110.865 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.412 HG21 ' CD2' ' A' ' 167' ' ' LEU . 0.0 OUTLIER -109.6 139.96 30.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 63.55 111.128 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.534 HG22 HG23 ' A' ' 99' ' ' THR . 47.3 t -135.66 139.36 46.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 72.52 111.109 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.529 HD22 HD13 ' A' ' 151' ' ' ILE . 2.9 tp -114.75 99.87 7.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 53.15 110.93 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.22 134.24 42.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.441 . . . . 75.44 110.88 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.7 mmmt -73.81 -17.63 61.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.13 -0.486 . . . . 75.02 110.907 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -51.27 -52.75 42.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 65.02 110.886 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 17.0 p -134.92 16.98 3.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 71.43 111.204 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . 0.468 ' HA ' HD11 ' A' ' 113' ' ' LEU . 0.0 OUTLIER 53.13 28.66 7.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 71.04 110.92 179.934 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.62 159.67 19.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 63.55 110.914 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.731 HG22 HD12 ' A' ' 151' ' ' ILE . 85.8 t -104.93 134.09 47.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 73.1 111.121 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 4.1 t90 -115.94 120.24 38.53 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.154 -0.475 . . . . 70.42 110.933 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . 0.42 ' SG ' HD11 ' A' ' 109' ' ' LEU . 11.3 t -136.6 132.05 34.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.242 -0.436 . . . . 74.33 110.857 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 50.51 48.03 23.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.197 -0.456 . . . . 62.13 110.851 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 49.45 47.88 35.27 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.785 -0.722 . . . . 54.12 112.508 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.18 113.85 4.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.835 0.35 . . . . 74.32 110.88 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 2.5 ttpm? -53.71 101.72 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 75.23 110.897 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' MET . . . . . 0.544 ' CE ' HG22 ' A' ' 144' ' ' VAL . 25.1 mmm -60.97 169.92 1.76 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 64.13 110.897 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -119.17 106.96 12.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 74.24 110.906 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.677 ' HB ' HG22 ' A' ' 140' ' ' THR . 24.4 p -95.6 -175.28 3.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 74.04 111.198 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.561 ' HB2' ' HB2' ' A' ' 141' ' ' HIS . . . -95.12 -39.47 10.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.259 -0.428 . . . . 75.14 111.124 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 69.53 40.03 78.69 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.727 -0.749 . . . . 72.44 112.466 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -87.2 117.78 26.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.858 0.361 . . . . 74.3 110.902 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -95.46 114.36 26.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 72.13 110.848 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.405 HG22 ' O ' ' A' ' 137' ' ' GLY . 23.5 m -93.34 -178.47 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.137 -0.483 . . . . 63.23 111.112 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -55.49 -34.07 64.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 74.23 110.875 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -151.93 102.05 2.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.202 -0.453 . . . . 75.2 110.835 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.405 ' O ' HG22 ' A' ' 134' ' ' VAL . . . 111.98 178.36 20.01 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.749 -0.739 . . . . 73.13 112.54 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.52 ' O ' ' HB3' ' A' ' 153' ' ' ALA . 0.1 OUTLIER -135.24 130.71 35.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.73 0.3 . . . . 75.33 111.186 -179.874 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -106.35 96.36 6.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.259 -0.428 . . . . 75.42 110.867 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.677 HG22 ' HB ' ' A' ' 129' ' ' THR . 0.0 OUTLIER -80.06 110.26 15.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 74.42 111.153 -179.963 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . 0.561 ' HB2' ' HB2' ' A' ' 130' ' ' ALA . 77.1 m-70 -104.83 105.38 15.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.455 . . . . 73.12 110.87 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.514 ' CE2' HG21 ' A' ' 120' ' ' VAL . 19.0 p90 -126.13 132.92 51.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.471 . . . . 75.01 110.887 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 54.7 p -83.33 144.48 29.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 62.24 110.88 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.544 HG22 ' CE ' ' A' ' 127' ' ' MET . 21.6 t -134.58 98.1 2.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 62.24 111.102 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 52.12 -119.29 8.71 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.674 -0.774 . . . . 75.42 112.537 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -100.4 28.25 5.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.851 0.358 . . . . 64.14 110.849 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 49.0 m-70 -130.87 165.67 22.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 72.15 110.868 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -124.35 88.9 2.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 74.41 110.866 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' CYS . . . . . 0.514 ' SG ' HG13 ' A' ' 169' ' ' VAL . 9.8 m -98.49 172.76 7.31 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.207 -0.451 . . . . 60.4 110.903 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 55.5 p90 -175.22 145.6 0.79 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.196 -0.456 . . . . 72.01 110.937 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.731 HD12 HG22 ' A' ' 120' ' ' VAL . 23.2 mt -97.43 111.23 26.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.117 -0.492 . . . . 74.41 111.127 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -80.18 102.86 9.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 54.33 110.868 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.52 ' HB3' ' O ' ' A' ' 138' ' ' THR . . . -95.49 146.44 24.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 30.41 111.088 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.4 t -143.89 120.49 5.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.264 -0.425 . . . . 72.32 111.14 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.3 p -87.25 140.72 29.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 64.45 110.869 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 5.0 p -132.56 148.68 52.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.118 -0.492 . . . . 75.14 110.863 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 111.06 -162.93 12.32 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.792 -0.718 . . . . 63.23 112.479 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.47 -44.87 85.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.794 0.331 . . . . 72.44 110.906 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.23 -60.83 0.13 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 71.13 110.852 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 17.7 mtmt -137.18 37.72 2.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 35.33 110.86 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.25 -62.21 1.84 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.266 -0.424 . . . . 71.21 110.884 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -135.16 122.47 2.83 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.768 -0.73 . . . . 33.25 112.516 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 69.6 mt -110.77 144.85 17.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.846 0.355 . . . . 74.15 111.112 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 3.0 mt -129.84 127.97 64.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 74.21 111.173 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' HIS . . . . . 0.438 ' CG ' HD23 ' A' ' 113' ' ' LEU . 13.0 m80 -105.01 136.51 44.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 74.32 110.857 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.61 106.1 8.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 63.3 111.092 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.454 HD12 ' H ' ' A' ' 168' ' ' ILE . 30.4 tp -65.29 139.36 58.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.193 -0.458 . . . . 64.41 110.917 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.454 ' H ' HD12 ' A' ' 167' ' ' LEU . 9.4 mt -137.43 129.97 42.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 61.13 111.118 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.514 HG13 ' SG ' ' A' ' 149' ' ' CYS . 99.5 t -125.49 115.43 43.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.47 . . . . 74.11 111.125 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 63.66 46.88 3.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.15 -0.477 . . . . 74.43 110.918 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 58.69 42.8 19.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.143 -0.481 . . . . 74.41 110.918 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.19 124.9 19.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 70.25 110.85 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -62.56 146.2 52.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 74.44 110.903 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.573 HD12 HD22 ' A' ' 102' ' ' LEU . 0.9 OUTLIER -120.73 131.12 24.56 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.606 0.717 . . . . 63.43 111.135 179.986 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 134.4 27.9 Favored 'Trans proline' 0 N--CA 1.465 -0.161 0 C-N-CA 122.714 2.276 . . . . 73.4 112.348 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -91.37 152.01 20.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.234 -0.439 . . . . 52.2 110.913 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.567 ' O ' HD13 ' A' ' 177' ' ' LEU . 0.4 OUTLIER -52.13 -36.96 52.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 73.2 110.938 -179.985 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 63.4 p -51.72 118.97 3.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 65.21 111.133 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 74.55 110.965 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 CA-C-O 121.485 0.492 . . . . 63.44 112.488 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.77 140.58 42.99 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.737 2.292 . . . . 63.3 112.324 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.33 -45.67 2.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.191 -0.459 . . . . 65.44 110.903 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 109.52 -47.83 1.0 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.665 -0.778 . . . . 54.5 112.497 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 56.03 28.12 12.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.866 0.365 . . . . 75.54 110.88 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -103.52 67.88 0.92 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 64.44 110.91 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -113.02 -66.62 1.07 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.484 . . . . 74.32 110.867 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.06 130.2 56.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.148 -0.478 . . . . 71.4 110.857 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 20.2 m -67.19 161.14 25.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.192 -0.458 . . . . 70.35 110.903 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.11 124.13 32.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.173 -0.467 . . . . 50.43 110.927 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.5 ' O ' HG23 ' A' ' 97' ' ' THR . 40.4 p -96.65 -31.04 12.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.24 -0.436 . . . . 73.45 111.161 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.5 HG23 ' O ' ' A' ' 96' ' ' THR . 1.0 OUTLIER -159.52 128.33 5.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.193 -0.458 . . . . 71.01 111.091 -179.974 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.9 m -105.8 152.79 22.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 74.32 110.844 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 56.1 m -147.52 137.42 22.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 63.13 111.15 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . 0.404 ' CB ' HD23 ' A' ' 167' ' ' LEU . 16.7 m-90 -130.27 156.86 43.94 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.202 -0.453 . . . . 64.53 110.883 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 19.7 t -128.95 114.84 34.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.234 -0.439 . . . . 63.25 111.163 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.914 HD11 HD12 ' A' ' 104' ' ' LEU . 0.5 OUTLIER -141.33 147.52 38.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.27 -0.423 . . . . 45.45 110.899 179.986 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.54 92.78 2.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 74.41 110.853 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.914 HD12 HD11 ' A' ' 102' ' ' LEU . 0.3 OUTLIER -122.1 152.66 39.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 70.13 110.852 -179.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 64.93 14.78 9.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.17 -0.468 . . . . 61.51 110.887 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.08 0.43 80.77 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.747 -0.739 . . . . 61.32 112.514 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -139.92 172.78 12.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.847 0.356 . . . . 73.32 110.873 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -68.29 89.44 0.33 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.158 -0.473 . . . . 60.23 110.836 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.591 HD13 ' HB3' ' A' ' 104' ' ' LEU . 0.4 OUTLIER -77.36 127.27 32.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.221 -0.445 . . . . 74.34 110.937 179.999 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 12.2 ttp180 -106.08 116.01 31.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.135 -0.484 . . . . 73.31 110.897 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.444 HG21 ' CD2' ' A' ' 167' ' ' LEU . 0.2 OUTLIER -101.83 141.98 17.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.248 -0.433 . . . . 75.45 111.081 -179.974 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 96.9 t -135.93 126.47 42.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 64.12 111.168 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.616 HD11 ' HA ' ' A' ' 118' ' ' MET . 2.5 tp -110.48 111.9 23.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.468 . . . . 74.1 110.871 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.486 ' N ' HD12 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -86.26 135.25 33.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 71.42 110.888 179.881 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.16 -16.25 61.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.476 . . . . 73.13 110.885 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -51.74 -55.87 17.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 75.41 110.879 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.1 p -136.22 17.09 3.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.436 . . . . 65.11 111.122 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . 0.616 ' HA ' HD11 ' A' ' 113' ' ' LEU . 69.0 mtp 58.16 29.33 17.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 70.4 110.947 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.64 146.05 34.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 74.12 110.909 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.631 HG21 ' CE2' ' A' ' 142' ' ' PHE . 98.4 t -105.0 123.51 59.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.235 -0.439 . . . . 61.15 111.154 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 2.3 t90 -105.27 131.59 52.54 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.178 -0.465 . . . . 73.34 110.943 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . 0.436 ' SG ' HG13 ' A' ' 111' ' ' VAL . 1.2 m -128.3 103.3 7.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.258 -0.428 . . . . 75.21 110.883 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 24.2 m-20 45.56 70.54 0.35 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 71.34 110.886 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 48.6 40.16 24.3 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.748 -0.739 . . . . 70.22 112.438 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.04 107.23 4.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.903 0.383 . . . . 71.24 110.91 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 4.3 mttt -53.41 152.62 4.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 62.34 110.945 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' MET . . . . . 0.649 ' CE ' HG22 ' A' ' 144' ' ' VAL . 27.2 mmm -123.89 164.83 18.47 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.295 -0.411 . . . . 73.11 110.867 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -118.97 110.14 16.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 74.23 110.941 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.736 ' HB ' HG22 ' A' ' 140' ' ' THR . 19.3 p -95.63 174.34 7.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 73.33 111.162 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -174.77 -169.59 0.43 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 72.22 111.116 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 118.63 -111.54 2.15 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.736 -0.745 . . . . 63.13 112.523 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -177.55 175.52 1.4 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.832 0.348 . . . . 75.13 110.931 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.462 ' CB ' HG23 ' A' ' 138' ' ' THR . 55.2 p90 -110.85 145.07 38.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 70.23 110.929 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 7.6 m -108.34 -179.77 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.15 -0.477 . . . . 72.33 111.147 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -52.68 -29.34 26.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 44.34 110.872 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -151.66 97.32 2.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.25 -0.432 . . . . 74.25 110.851 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 111.44 169.24 18.71 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.726 -0.75 . . . . 72.01 112.472 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.485 ' O ' ' HB3' ' A' ' 153' ' ' ALA . 0.1 OUTLIER -134.8 130.76 36.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.727 0.299 . . . . 72.33 111.134 -179.851 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -87.32 96.5 10.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 75.3 110.963 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.736 HG22 ' HB ' ' A' ' 129' ' ' THR . 0.0 OUTLIER -79.92 110.17 15.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 74.21 111.133 -179.907 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -108.31 111.96 24.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 74.11 110.861 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.631 ' CE2' HG21 ' A' ' 120' ' ' VAL . 15.1 p90 -125.46 134.02 52.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 73.41 110.854 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 60.6 p -78.6 139.2 38.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.169 -0.469 . . . . 71.11 110.896 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.649 HG22 ' CE ' ' A' ' 127' ' ' MET . 21.4 t -130.87 98.06 3.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 72.03 111.123 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 51.85 -124.24 23.15 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.669 -0.777 . . . . 54.14 112.502 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -95.89 25.23 4.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.813 0.34 . . . . 71.34 110.856 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 45.9 m-70 -121.64 -169.99 1.96 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 74.52 110.838 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -149.83 81.48 1.39 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 71.3 110.847 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' CYS . . . . . 0.52 ' SG ' HG13 ' A' ' 169' ' ' VAL . 8.3 m -96.29 166.07 11.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.242 -0.435 . . . . 60.21 110.843 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -167.27 144.48 4.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 74.21 110.961 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.6 HD12 HG22 ' A' ' 120' ' ' VAL . 44.9 mt -99.5 111.21 28.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 72.42 111.139 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 5.0 tttp -80.56 103.11 10.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.153 -0.476 . . . . 74.14 110.851 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.485 ' HB3' ' O ' ' A' ' 138' ' ' THR . . . -95.23 143.07 26.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.462 . . . . 44.23 111.074 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.2 t -136.58 120.61 24.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 45.14 111.077 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.2 p -90.75 132.84 35.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 74.04 110.794 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 9.5 p -124.38 138.64 54.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.091 -0.504 . . . . 41.13 110.907 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 132.85 -104.05 0.53 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.71 -0.757 . . . . 63.51 112.471 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 12.3 ttmt -142.73 -46.14 0.32 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.785 0.326 . . . . 71.25 110.906 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 5.9 ttt180 -137.21 -45.83 0.56 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.216 -0.447 . . . . 71.51 110.869 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 11.6 tttt -167.83 55.64 0.07 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 75.23 110.955 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -82.43 -64.53 1.16 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 63.51 110.849 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -135.34 114.2 1.2 Allowed Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.685 -0.769 . . . . 70.12 112.441 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 76.2 mt -105.97 139.56 26.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.848 0.356 . . . . 73.13 111.121 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 72.0 mt -126.43 122.83 62.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.46 . . . . 73.53 111.131 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 18.1 m80 -96.66 137.8 35.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 54.25 110.881 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.79 104.26 7.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.21 -0.45 . . . . 71.42 111.138 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.607 HD12 ' H ' ' A' ' 168' ' ' ILE . 15.9 tp -63.81 138.97 58.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.289 -0.414 . . . . 64.33 110.925 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.607 ' H ' HD12 ' A' ' 167' ' ' LEU . 10.0 mt -137.76 120.75 20.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 62.41 111.089 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.663 HG21 HD13 ' A' ' 102' ' ' LEU . 89.5 t -121.32 130.83 74.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.095 -0.502 . . . . 64.34 111.089 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 58.79 36.91 24.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.12 -0.491 . . . . 53.21 110.832 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 2.6 t30 63.34 43.07 6.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 72.35 110.877 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.14 128.77 21.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 73.45 110.875 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -62.62 146.5 51.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 74.23 110.856 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -123.81 131.37 24.25 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.569 0.699 . . . . 64.03 111.097 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 135.18 29.81 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.7 2.266 . . . . 54.4 112.334 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -91.06 151.14 21.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 74.5 110.91 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 24.3 tp -68.28 102.48 1.39 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.149 -0.478 . . . . 74.43 110.969 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 80.5 p -111.25 -42.1 4.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 74.02 111.166 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.248 -0.433 . . . . 73.31 110.886 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.245 0 CA-C-O 121.419 0.455 . . . . 71.52 112.54 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.66 156.78 62.7 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.661 2.241 . . . . 74.01 112.347 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 9.7 mt -112.86 -26.73 8.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 73.43 110.95 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 111.38 -40.8 2.42 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.759 -0.734 . . . . 30.41 112.506 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.9 m 56.56 -173.68 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.857 0.36 . . . . 60.41 110.85 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -116.65 164.71 14.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.471 . . . . 72.02 110.935 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -85.34 170.45 12.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.137 -0.483 . . . . 63.2 110.85 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 9.5 ttt180 56.32 54.24 7.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 74.03 110.925 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 83.4 p -141.3 38.9 1.73 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.114 -0.494 . . . . 50.15 110.841 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.16 44.3 1.15 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.118 -0.492 . . . . 74.32 110.892 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.505 ' O ' HG23 ' A' ' 97' ' ' THR . 0.0 OUTLIER -158.99 -42.75 0.06 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 73.23 111.099 -179.944 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.505 HG23 ' O ' ' A' ' 96' ' ' THR . 1.0 OUTLIER -159.56 127.89 5.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 72.41 111.197 -179.956 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.7 m -106.22 155.04 19.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.241 -0.436 . . . . 71.23 110.894 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.808 HG22 HG22 ' A' ' 112' ' ' VAL . 72.3 p -144.88 155.08 43.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 53.52 111.177 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 15.3 m-90 -151.35 133.54 15.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.242 -0.435 . . . . 74.25 110.928 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.3 t -112.95 114.84 48.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.283 -0.417 . . . . 61.32 111.055 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.721 HD11 HD12 ' A' ' 104' ' ' LEU . 0.5 OUTLIER -139.73 145.87 38.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 73.11 110.914 179.916 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -74.62 92.99 2.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 55.34 110.851 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.721 HD12 HD11 ' A' ' 102' ' ' LEU . 0.4 OUTLIER -124.9 153.73 42.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.471 . . . . 64.52 110.987 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.7 t70 64.5 15.42 9.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.271 -0.422 . . . . 73.4 110.805 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.69 1.31 83.12 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.768 -0.729 . . . . 74.24 112.502 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -139.92 173.03 11.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.779 0.323 . . . . 65.32 110.884 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -69.74 87.85 0.52 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.161 -0.472 . . . . 62.51 110.884 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.643 HD13 ' HB3' ' A' ' 104' ' ' LEU . 0.7 OUTLIER -70.52 127.43 32.7 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.258 -0.428 . . . . 63.12 110.93 -179.96 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 8.8 ttm180 -107.87 115.29 29.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.185 -0.461 . . . . 71.53 110.83 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.434 HG21 ' CD2' ' A' ' 167' ' ' LEU . 0.1 OUTLIER -106.67 137.64 36.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.12 -0.491 . . . . 73.45 111.081 -179.99 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.808 HG22 HG22 ' A' ' 99' ' ' THR . 90.1 t -135.76 128.56 47.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.187 -0.461 . . . . 74.34 111.182 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.52 HD11 ' HA ' ' A' ' 118' ' ' MET . 2.5 tp -110.2 103.46 12.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.476 . . . . 72.22 110.96 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.437 ' HG3' HG22 ' A' ' 97' ' ' THR . 0.9 OUTLIER -78.24 134.95 37.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.232 -0.44 . . . . 75.45 110.863 179.977 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 9.2 mmmt -73.13 -17.2 61.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.126 -0.488 . . . . 53.53 110.889 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -51.6 -55.18 20.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 71.13 110.838 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.45 16.97 4.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 74.13 111.105 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . 0.52 ' HA ' HD11 ' A' ' 113' ' ' LEU . 4.0 ttm 53.54 32.36 14.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.232 -0.44 . . . . 73.41 110.848 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.99 155.03 20.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.289 -0.414 . . . . 52.52 110.863 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.682 HG22 HD12 ' A' ' 151' ' ' ILE . 99.6 t -104.83 130.18 56.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 63.24 111.172 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 7.7 t-105 -112.7 122.88 48.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.089 -0.505 . . . . 75.03 110.872 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 24.6 t -128.48 131.78 48.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.134 -0.485 . . . . 75.13 110.805 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 27.3 m-20 50.08 54.63 10.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 71.12 110.862 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 49.82 37.42 28.25 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.754 -0.736 . . . . 64.54 112.483 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -143.38 165.77 26.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.868 0.366 . . . . 70.03 110.916 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -85.93 157.92 20.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 70.51 110.88 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 35.2 mmm -124.76 166.98 15.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 63.41 110.88 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -119.23 106.59 12.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 71.14 110.853 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.676 ' HB ' HG22 ' A' ' 140' ' ' THR . 19.2 p -95.91 -175.26 3.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 72.12 111.113 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -104.61 -29.54 10.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 72.11 111.107 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 61.98 39.92 98.2 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.733 -0.746 . . . . 54.25 112.452 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 49.5 tt0 -71.43 138.72 49.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.865 0.364 . . . . 73.4 110.898 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -109.95 125.66 53.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.161 -0.472 . . . . 71.24 110.908 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.452 HG23 ' H ' ' A' ' 136' ' ' ASP . 31.1 m -105.56 -178.36 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.471 . . . . 63.11 111.197 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -53.47 -30.37 40.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 63.33 110.878 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.452 ' H ' HG23 ' A' ' 134' ' ' VAL . 1.2 p-10 -160.65 88.45 0.78 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.174 -0.466 . . . . 72.13 110.866 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 134.44 -178.32 18.52 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.765 -0.731 . . . . 74.14 112.549 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.462 ' O ' ' HB3' ' A' ' 153' ' ' ALA . 0.1 OUTLIER -135.25 130.8 35.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.762 0.315 . . . . 71.44 111.145 -179.87 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -108.18 103.62 12.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.481 . . . . 73.43 110.982 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.676 HG22 ' HB ' ' A' ' 129' ' ' THR . 0.0 OUTLIER -83.13 110.35 17.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.211 -0.45 . . . . 63.55 111.14 -179.892 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 68.4 m-70 -105.37 105.26 15.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 73.25 110.784 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.491 ' CE2' HG21 ' A' ' 120' ' ' VAL . 18.2 p90 -123.85 134.56 53.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 74.11 110.913 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 3.3 p -77.8 139.51 39.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 42.31 110.867 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.6 t -133.48 106.3 9.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 62.44 111.092 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 53.31 -116.35 5.65 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.741 -0.742 . . . . 73.03 112.435 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -110.25 26.22 10.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.795 0.331 . . . . 74.04 110.872 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 24.6 m-70 -124.1 -169.81 2.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 64.11 110.86 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -140.85 81.69 1.81 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 71.21 110.902 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' CYS . . . . . 0.417 ' SG ' HG13 ' A' ' 169' ' ' VAL . 11.1 m -91.62 157.43 16.98 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.24 -0.436 . . . . 74.25 110.917 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 39.3 p90 -159.83 143.33 14.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 74.51 110.882 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.682 HD12 HG22 ' A' ' 120' ' ' VAL . 35.5 mt -97.54 111.67 27.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.126 -0.488 . . . . 72.21 111.064 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 33.2 ttmt -80.04 102.87 9.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.475 . . . . 71.21 110.968 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.462 ' HB3' ' O ' ' A' ' 138' ' ' THR . . . -95.02 142.21 27.77 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.176 -0.465 . . . . 55.13 111.137 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.3 t -138.8 124.58 23.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.254 -0.43 . . . . 75.44 111.138 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.4 p -95.81 133.14 40.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 53.24 110.932 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -133.68 133.21 41.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.151 -0.477 . . . . 63.24 110.891 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 112.01 -176.33 17.95 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.754 -0.736 . . . . 20.35 112.428 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.84 130.55 35.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.849 0.357 . . . . 74.43 110.916 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 20.5 mmt180 54.31 43.06 31.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 61.14 110.874 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 3.0 mttt 55.51 48.06 19.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.136 -0.484 . . . . 75.13 110.911 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -52.17 -68.42 0.17 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 64.22 110.889 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -110.86 125.43 7.39 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.768 -0.73 . . . . 21.21 112.526 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 64.7 mt -114.81 143.98 23.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.824 0.345 . . . . 73.51 111.085 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 64.4 mt -132.18 127.35 57.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 60.34 111.102 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' HIS . . . . . 0.42 ' CG ' HD23 ' A' ' 113' ' ' LEU . 12.7 m80 -102.81 140.07 37.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.161 -0.472 . . . . 73.25 110.893 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.37 106.44 8.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.163 -0.471 . . . . 62.43 111.166 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.434 ' CD2' HG21 ' A' ' 111' ' ' VAL . 30.7 tp -66.8 136.61 55.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 71.14 110.964 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.405 ' H ' HD12 ' A' ' 167' ' ' LEU . 10.2 mt -137.78 129.78 40.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.446 . . . . 72.54 111.12 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.417 HG21 HD13 ' A' ' 102' ' ' LEU . 57.6 t -126.46 117.78 49.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 65.44 111.164 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.9 t0 63.69 41.81 6.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.178 -0.464 . . . . 40.2 110.834 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 62.5 42.92 8.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 74.34 110.861 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -138.32 124.5 20.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.179 -0.464 . . . . 72.44 110.892 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -62.59 145.92 53.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.2 -0.455 . . . . 54.31 110.86 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.499 HD12 HD22 ' A' ' 102' ' ' LEU . 0.9 OUTLIER -121.02 131.16 24.56 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.623 0.725 . . . . 73.01 111.123 179.942 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 134.44 28.0 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.689 2.259 . . . . 73.22 112.356 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.53 ' O ' HG22 ' A' ' 178' ' ' THR . 1.7 tm-20 -92.57 112.82 24.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.24 -0.436 . . . . 75.31 110.874 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 9.6 tp -59.03 120.39 9.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 73.21 110.941 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.53 HG22 ' O ' ' A' ' 176' ' ' GLU . 4.0 t -173.98 129.39 0.39 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.153 -0.476 . . . . 61.43 111.074 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.109 -0.496 . . . . 73.24 110.887 180.0 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 CA-C-O 121.396 0.442 . . . . 73.32 112.506 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 95.55 0.56 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.687 2.258 . . . . 32.11 112.297 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -70.22 -43.73 70.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.186 -0.461 . . . . 65.12 110.906 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 84.94 26.86 36.03 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.744 -0.741 . . . . 63.34 112.469 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 36.2 p -74.44 128.73 36.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.748 0.309 . . . . 72.33 110.882 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 60.31 98.27 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.217 -0.447 . . . . 74.23 110.874 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -116.93 46.96 1.56 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 74.23 110.871 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 45.9 mtm180 -140.51 44.12 1.86 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 72.15 110.842 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.6 m -141.18 -179.01 5.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 75.04 110.863 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.81 -28.95 14.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.142 -0.481 . . . . 73.55 110.92 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.491 ' O ' HG23 ' A' ' 97' ' ' THR . 13.5 p 49.89 41.03 22.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.261 -0.427 . . . . 62.15 111.179 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.638 HG22 ' HA ' ' A' ' 114' ' ' GLU . 1.1 p -159.36 128.07 5.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 71.43 111.159 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -105.97 149.63 26.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.26 -0.427 . . . . 73.11 110.912 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 92.3 m -137.88 138.47 39.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 73.31 111.133 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . 0.462 ' CB ' HD23 ' A' ' 167' ' ' LEU . 12.0 m-90 -133.36 123.27 25.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.204 -0.453 . . . . 63.31 110.969 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 18.7 t -103.63 115.01 44.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 40.5 111.122 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.661 HD11 HD12 ' A' ' 104' ' ' LEU . 0.5 OUTLIER -141.25 146.0 36.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 74.22 110.888 -179.979 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 56.4 mtm-85 -76.34 93.75 3.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 73.42 110.862 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.672 ' HB3' HD13 ' A' ' 109' ' ' LEU . 0.4 OUTLIER -125.73 155.43 40.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 72.34 110.844 -179.977 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.3 t0 64.7 15.06 9.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 75.13 110.891 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 88.17 0.91 82.43 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.756 -0.735 . . . . 75.24 112.561 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -139.93 172.98 11.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.862 0.363 . . . . 74.33 110.887 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -70.33 88.16 0.63 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.142 -0.481 . . . . 62.32 110.875 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.672 HD13 ' HB3' ' A' ' 104' ' ' LEU . 0.5 OUTLIER -70.36 123.6 22.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.202 -0.454 . . . . 74.02 110.875 -179.941 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 4.9 ttp180 -101.94 109.38 21.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.107 -0.497 . . . . 74.01 110.804 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.442 HG21 ' CD2' ' A' ' 167' ' ' LEU . 2.2 t -95.6 134.55 32.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.452 . . . . 74.23 111.126 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 76.4 t -137.25 125.31 32.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 53.25 111.083 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.568 HD11 ' HA ' ' A' ' 118' ' ' MET . 3.0 tp -110.35 106.8 16.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 42.31 110.883 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.638 ' HA ' HG22 ' A' ' 97' ' ' THR . 0.0 OUTLIER -82.83 136.46 34.63 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.142 -0.481 . . . . 73.51 110.887 179.945 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.9 mmmt -73.77 -16.51 61.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 73.32 110.853 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -51.41 -54.21 28.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.466 . . . . 74.1 110.89 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.86 17.03 3.05 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.191 -0.459 . . . . 62.25 111.179 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . 0.568 ' HA ' HD11 ' A' ' 113' ' ' LEU . 81.6 mtp 56.77 26.26 11.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 65.33 110.895 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.55 151.71 32.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.273 -0.421 . . . . 73.14 110.862 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.561 HG22 HD12 ' A' ' 151' ' ' ILE . 70.6 t -105.04 133.5 49.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.171 -0.468 . . . . 62.32 111.074 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 6.6 t-105 -117.64 123.77 46.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.2 -0.454 . . . . 75.13 110.891 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 17.9 m -131.18 132.19 44.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.216 -0.447 . . . . 65.13 110.934 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . 0.452 ' ND2' HD12 ' A' ' 109' ' ' LEU . 40.9 m-20 50.99 53.83 12.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.125 -0.489 . . . . 70.25 110.93 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 49.09 39.64 27.09 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.765 -0.731 . . . . 74.11 112.436 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.02 154.81 41.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.848 0.356 . . . . 74.2 110.907 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 15.8 ttpt -75.67 159.5 31.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 75.12 110.855 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 38.8 mmm -125.51 166.12 17.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.239 -0.437 . . . . 53.55 110.879 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -119.25 106.53 12.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.269 -0.423 . . . . 73.43 110.877 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.566 ' HB ' HG22 ' A' ' 140' ' ' THR . 17.6 p -95.53 -175.29 3.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 63.11 111.175 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -107.49 -28.77 9.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.476 . . . . 44.11 111.102 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 55.64 53.59 40.48 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.78 -0.724 . . . . 71.42 112.514 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -85.45 102.77 13.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.887 0.375 . . . . 75.42 110.897 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -77.7 114.07 16.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.108 -0.496 . . . . 72.51 110.85 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.616 HG23 ' H ' ' A' ' 136' ' ' ASP . 35.6 m -95.75 -177.29 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.17 -0.468 . . . . 71.25 111.136 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.99 -26.29 64.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.144 -0.48 . . . . 64.15 110.861 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.616 ' H ' HG23 ' A' ' 134' ' ' VAL . 0.1 OUTLIER -157.99 102.32 1.81 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 55.04 110.839 179.992 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 111.41 -177.23 18.9 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.766 -0.73 . . . . 43.14 112.512 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.454 ' O ' ' HB3' ' A' ' 153' ' ' ALA . 0.1 OUTLIER -135.37 130.83 35.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.706 0.289 . . . . 64.43 111.176 -179.919 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -108.6 96.6 6.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 72.2 110.889 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.566 HG22 ' HB ' ' A' ' 129' ' ' THR . 0.0 OUTLIER -80.67 110.47 16.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.173 -0.467 . . . . 71.41 111.151 -179.879 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 -105.22 106.61 17.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 73.25 110.805 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 17.8 p90 -124.02 129.54 51.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 71.11 110.906 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 90.9 p -79.58 156.98 27.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 65.03 110.88 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 86.6 t -149.62 98.49 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 60.13 111.118 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 57.01 -106.63 0.75 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.767 -0.73 . . . . 62.33 112.486 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 21.5 t30 -116.9 24.56 11.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.896 0.379 . . . . 74.51 110.911 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 66.0 m-70 -117.25 -175.3 2.77 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.13 -0.486 . . . . 74.43 110.815 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -143.73 78.56 1.6 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 75.34 110.878 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' CYS . . . . . 0.431 ' SG ' HG13 ' A' ' 169' ' ' VAL . 12.0 m -93.49 158.89 15.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.146 -0.479 . . . . 75.32 110.916 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -161.75 144.15 11.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.445 . . . . 71.51 110.935 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.562 HD13 HD22 ' A' ' 113' ' ' LEU . 22.7 mt -97.46 111.2 26.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.169 -0.469 . . . . 73.1 111.149 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 61.6 tttt -80.1 102.79 9.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.455 . . . . 70.54 110.897 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.454 ' HB3' ' O ' ' A' ' 138' ' ' THR . . . -93.65 143.51 26.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.283 -0.417 . . . . 42.13 111.08 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.3 t -139.89 119.64 13.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 33.32 111.093 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.2 p -89.04 148.42 23.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.121 -0.49 . . . . 72.32 110.883 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.55 140.11 24.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.47 . . . . 71.21 110.906 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 132.47 -152.23 20.17 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.79 -0.719 . . . . 55.21 112.493 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 9.3 mttp -79.04 -29.84 43.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.77 0.319 . . . . 74.4 110.921 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 21.0 ptt-85 -169.16 -41.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 52.02 110.849 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 3.0 ttmm -157.06 30.41 0.3 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 75.23 110.893 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -56.81 -61.98 2.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 75.21 110.892 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -136.11 157.91 23.67 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.716 -0.754 . . . . 74.52 112.48 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 57.5 mt -141.19 146.42 23.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.725 0.298 . . . . 71.24 111.188 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 2.9 mt -133.01 124.36 49.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.188 -0.46 . . . . 65.45 111.169 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 12.1 m80 -103.44 138.34 40.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 61.22 110.845 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.63 109.28 10.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.162 -0.472 . . . . 73.13 111.132 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.511 HD12 ' H ' ' A' ' 168' ' ' ILE . 21.0 tp -67.45 137.6 56.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.224 -0.444 . . . . 45.14 110.884 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.511 ' H ' HD12 ' A' ' 167' ' ' LEU . 9.6 mt -138.32 129.64 37.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 62.04 111.147 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.431 HG13 ' SG ' ' A' ' 149' ' ' CYS . 58.4 t -125.68 122.77 63.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 74.34 111.12 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 58.84 41.29 21.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 74.11 110.859 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 63.22 43.09 6.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.248 -0.433 . . . . 55.12 110.888 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 15.4 mtp180 -138.52 125.3 21.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.166 -0.47 . . . . 73.45 110.865 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -62.36 146.54 50.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 62.23 110.901 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.407 HD12 HD22 ' A' ' 102' ' ' LEU . 0.9 OUTLIER -123.06 131.01 24.38 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.576 0.703 . . . . 72.43 111.156 179.938 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.72 137.57 35.91 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.611 2.207 . . . . 72.13 112.404 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.59 167.56 12.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.44 . . . . 53.23 110.834 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 11.4 tp -116.86 114.76 24.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.12 -0.491 . . . . 74.31 110.919 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 4.9 t -176.24 -36.3 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 73.23 111.081 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 116.297 -0.41 . . . . 71.4 110.941 179.994 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 CA-C-O 121.465 0.48 . . . . 44.0 112.513 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 125.78 12.56 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.738 2.292 . . . . 64.23 112.303 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -107.55 151.39 25.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.248 -0.433 . . . . 74.35 110.915 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -94.61 -148.17 23.64 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.713 -0.756 . . . . 51.3 112.495 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.7 p -148.87 98.81 2.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.833 0.349 . . . . 62.34 110.852 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -111.86 109.74 19.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 74.24 110.886 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -162.91 123.61 2.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.123 -0.489 . . . . 60.24 110.894 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.5 mtm180 -141.42 97.49 3.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 24.21 110.908 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 15.4 m 55.09 31.86 17.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 72.41 110.794 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.37 129.67 49.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.174 -0.466 . . . . 70.04 110.883 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.496 ' O ' HG23 ' A' ' 97' ' ' THR . 50.6 p -136.44 37.15 2.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.17 -0.468 . . . . 50.42 111.169 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.602 HG22 ' HA ' ' A' ' 114' ' ' GLU . 1.0 OUTLIER -159.51 127.99 5.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 65.42 111.136 -179.985 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.3 m -106.05 149.64 26.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 50.03 110.894 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 90.1 m -136.98 137.15 39.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.139 -0.482 . . . . 75.34 111.095 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . 0.498 ' CB ' HD23 ' A' ' 167' ' ' LEU . 9.9 m-90 -132.98 122.81 24.79 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.126 -0.488 . . . . 75.44 110.891 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 20.0 t -102.7 114.89 43.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.247 -0.433 . . . . 33.53 111.181 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.883 HD11 HD12 ' A' ' 104' ' ' LEU . 0.5 OUTLIER -142.56 147.3 35.7 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.257 -0.429 . . . . 54.52 110.927 179.935 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 5.6 mtt180 -74.63 92.23 2.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 71.31 110.864 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.883 HD12 HD11 ' A' ' 102' ' ' LEU . 0.4 OUTLIER -121.95 153.94 37.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 54.33 110.908 -179.975 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 65.17 14.37 9.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 62.2 110.91 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.99 -0.39 78.99 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.735 -0.745 . . . . 65.13 112.48 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -139.92 172.89 12.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.797 0.332 . . . . 52.15 110.919 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -68.36 88.42 0.32 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.155 -0.475 . . . . 72.52 110.841 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.607 HD13 ' HB3' ' A' ' 104' ' ' LEU . 0.4 OUTLIER -74.65 125.94 29.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.236 -0.438 . . . . 65.05 110.937 -179.961 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 29.5 ttt180 -102.36 110.9 22.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.191 -0.459 . . . . 74.42 110.85 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.5 t -95.12 136.43 26.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 72.33 111.168 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 96.8 t -136.99 127.04 39.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.258 -0.428 . . . . 65.34 111.137 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.638 HD22 HD13 ' A' ' 151' ' ' ILE . 4.1 tp -110.32 104.44 13.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 55.34 110.847 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.602 ' HA ' HG22 ' A' ' 97' ' ' THR . 0.0 OUTLIER -81.14 136.42 35.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.113 -0.494 . . . . 75.3 110.949 179.917 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 3.6 mmmt -73.73 -16.74 61.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 74.03 110.936 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -51.38 -53.0 40.86 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.232 -0.44 . . . . 72.15 110.854 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.38 17.04 2.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 61.52 111.151 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . 0.495 ' HA ' HD11 ' A' ' 113' ' ' LEU . 2.4 ttp 55.55 26.29 8.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.234 -0.439 . . . . 74.14 110.889 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -80.65 154.54 27.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 51.24 110.871 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.6 HG22 HD12 ' A' ' 151' ' ' ILE . 53.5 t -105.16 134.8 45.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.469 . . . . 72.21 111.156 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 6.0 t-105 -119.41 126.54 51.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.156 -0.475 . . . . 73.12 110.826 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 64.4 m -132.93 131.9 41.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 75.41 110.838 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . 0.47 ' ND2' HD12 ' A' ' 109' ' ' LEU . 43.5 m-20 49.85 54.39 11.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 64.11 110.837 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 48.55 40.53 24.48 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.797 -0.716 . . . . 64.41 112.481 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.94 147.7 28.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.873 0.368 . . . . 64.42 110.893 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 13.1 tttp -68.04 159.91 29.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.258 -0.428 . . . . 74.34 110.918 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 41.0 mmm -124.55 164.31 20.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.212 -0.449 . . . . 71.34 110.897 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -119.3 106.29 12.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 63.02 110.86 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.69 ' CB ' HG22 ' A' ' 140' ' ' THR . 21.3 p -95.96 -175.05 3.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.112 -0.494 . . . . 64.51 111.111 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.432 ' HB2' ' HB2' ' A' ' 141' ' ' HIS . . . -100.22 -32.2 11.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 74.13 111.125 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 59.99 96.4 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.709 -0.757 . . . . 44.32 112.519 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -150.49 102.85 3.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.909 0.385 . . . . 70.32 110.91 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -83.2 148.79 27.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 64.14 110.883 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.54 HG23 ' H ' ' A' ' 136' ' ' ASP . 19.3 m -140.45 -177.09 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.162 -0.472 . . . . 65.25 111.121 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -57.24 -22.11 38.76 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.166 -0.47 . . . . 71.23 110.877 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.54 ' H ' HG23 ' A' ' 134' ' ' VAL . 0.3 OUTLIER -92.29 -73.69 0.54 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 73.42 110.827 -179.989 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -150.17 -123.22 1.16 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.77 -0.728 . . . . 63.34 112.481 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -136.1 130.79 33.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.733 0.301 . . . . 72.13 111.146 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -104.13 96.29 6.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.234 -0.439 . . . . 63.22 110.923 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.69 HG22 ' CB ' ' A' ' 129' ' ' THR . 0.0 OUTLIER -86.98 109.73 19.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.173 -0.467 . . . . 60.12 111.177 -179.887 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . 0.432 ' HB2' ' HB2' ' A' ' 130' ' ' ALA . 70.3 m-70 -102.68 106.84 17.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.24 -0.436 . . . . 72.42 110.836 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -121.9 123.02 40.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.148 -0.478 . . . . 73.31 110.903 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.03 153.78 22.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 62.32 110.85 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.448 HG11 HD22 ' A' ' 104' ' ' LEU . 47.0 t -147.19 106.7 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 74.13 111.096 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 56.59 -110.14 1.94 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.733 -0.746 . . . . 64.44 112.529 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 29.4 m120 -117.38 25.68 10.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.871 0.367 . . . . 75.23 110.88 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 24.4 m-70 -123.26 163.57 20.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 73.11 110.891 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -122.23 122.07 38.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 74.45 110.914 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' CYS . . . . . 0.575 ' HB3' HG22 ' A' ' 169' ' ' VAL . 1.2 p -141.48 146.95 37.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.448 . . . . 72.53 110.887 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 26.0 p90 -149.79 147.61 28.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.471 . . . . 72.05 110.937 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.638 HD13 HD22 ' A' ' 113' ' ' LEU . 12.0 mt -97.97 111.74 28.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.136 -0.484 . . . . 71.22 111.129 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 62.1 tttt -82.52 102.71 11.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 71.43 110.907 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -95.89 146.05 24.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 64.24 111.127 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.5 t -145.32 116.86 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.273 -0.421 . . . . 64.15 111.09 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 14.7 p -89.53 147.41 23.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 43.21 110.853 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 30.6 p -145.88 152.59 39.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.076 -0.511 . . . . 70.14 110.88 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 112.98 179.29 19.47 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.785 -0.721 . . . . 71.1 112.501 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.58 -64.0 1.11 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.725 0.298 . . . . 65.45 110.891 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 11.3 ttm-85 -133.39 83.78 2.08 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.265 -0.425 . . . . 62.31 110.897 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 13.6 mtmt 52.59 44.52 29.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 63.12 110.83 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -66.63 -49.18 67.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 73.1 110.871 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -144.96 132.02 4.53 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.774 -0.727 . . . . 44.11 112.524 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 50.8 mt -119.37 146.88 23.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.826 0.346 . . . . 74.14 111.129 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 58.9 mt -132.45 126.89 56.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 70.42 111.159 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 8.5 m80 -109.63 135.34 50.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.258 -0.428 . . . . 74.51 110.893 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.26 116.91 22.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 73.0 111.191 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.498 HD23 ' CB ' ' A' ' 100' ' ' TRP . 17.7 tp -72.85 133.52 44.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 75.21 110.944 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.472 ' N ' HD12 ' A' ' 167' ' ' LEU . 10.9 mt -136.3 118.16 20.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 72.4 111.07 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.575 HG22 ' HB3' ' A' ' 149' ' ' CYS . 14.6 t -120.54 127.06 75.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.435 . . . . 74.44 111.133 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 63.6 36.64 10.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.213 -0.449 . . . . 72.21 110.853 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 62.84 43.04 7.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 72.34 110.927 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 20.4 mtt180 -142.14 128.12 19.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.112 -0.494 . . . . 62.12 110.862 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -62.48 146.47 51.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.199 -0.455 . . . . 73.32 110.916 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -121.85 131.29 24.46 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.685 0.755 . . . . 75.42 111.126 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 137.93 36.53 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.638 2.225 . . . . 73.21 112.351 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.12 105.1 17.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.465 . . . . 73.21 110.904 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 4.6 tp -52.11 130.55 30.41 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.138 -0.483 . . . . 61.54 110.916 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 53.7 p -121.06 -44.84 2.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 73.42 111.186 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 73.42 110.853 -179.933 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 CA-C-O 121.505 0.503 . . . . 74.15 112.552 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 161.17 46.97 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.76 2.307 . . . . 74.33 112.344 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -163.8 128.05 2.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 65.23 110.931 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 155.54 -161.33 30.49 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.747 -0.739 . . . . 72.45 112.478 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.4 m -163.97 57.1 0.16 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.866 0.365 . . . . 63.21 110.875 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -140.31 71.9 1.38 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.151 -0.477 . . . . 54.45 110.907 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -163.56 169.4 18.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.106 -0.497 . . . . 65.41 110.865 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.22 -68.24 0.2 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.144 -0.48 . . . . 61.33 110.887 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 25.3 m -129.7 38.81 3.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.257 -0.428 . . . . 73.25 110.845 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 6.1 mtpt -117.71 -30.79 5.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.094 -0.503 . . . . 72.11 110.908 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.498 ' O ' HG23 ' A' ' 97' ' ' THR . 82.3 p -94.17 40.61 1.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.292 -0.413 . . . . 74.42 111.094 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.498 HG23 ' O ' ' A' ' 96' ' ' THR . 1.1 p -159.47 128.1 5.12 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.214 -0.448 . . . . 74.34 111.093 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.03 152.2 23.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.196 -0.456 . . . . 51.32 110.897 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.78 HG22 HG22 ' A' ' 112' ' ' VAL . 0.5 OUTLIER -139.17 156.76 46.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.126 -0.488 . . . . 75.14 111.125 -179.869 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . 0.502 ' CB ' HD23 ' A' ' 167' ' ' LEU . 12.6 m-90 -151.62 127.28 10.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.23 -0.441 . . . . 73.33 111.004 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 18.8 t -105.63 115.21 46.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.236 -0.438 . . . . 55.45 111.156 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.918 HD11 HD12 ' A' ' 104' ' ' LEU . 0.5 OUTLIER -141.67 147.36 37.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.199 -0.455 . . . . 75.32 110.958 179.953 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 61.4 mtt180 -72.93 91.7 1.56 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 64.04 110.955 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.918 HD12 HD11 ' A' ' 102' ' ' LEU . 0.3 OUTLIER -121.64 152.01 39.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 74.31 110.898 -179.925 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 15.2 t0 65.09 14.51 9.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.144 -0.48 . . . . 63.12 110.854 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.7 0.12 79.17 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.773 -0.727 . . . . 65.42 112.498 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -139.94 172.73 12.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.843 0.354 . . . . 61.35 110.889 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -68.54 89.49 0.36 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.137 -0.483 . . . . 62.12 110.884 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.592 HD13 ' HB3' ' A' ' 104' ' ' LEU . 0.4 OUTLIER -76.21 130.63 38.49 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.126 -0.488 . . . . 73.33 110.951 -179.946 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 6.1 ttp180 -106.4 113.84 27.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 72.15 110.882 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.496 HG21 ' CD2' ' A' ' 167' ' ' LEU . 1.7 t -95.52 139.43 18.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 73.25 111.093 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.78 HG22 HG22 ' A' ' 99' ' ' THR . 92.0 t -136.46 124.95 36.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.473 . . . . 72.34 111.125 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.538 HD22 HD13 ' A' ' 151' ' ' ILE . 3.4 tp -111.16 105.45 14.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 71.32 110.943 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.484 ' HA ' HG22 ' A' ' 97' ' ' THR . 0.0 OUTLIER -80.19 134.85 36.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 73.01 110.884 179.918 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 3.9 mmmt -73.87 -16.72 61.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.074 -0.512 . . . . 75.33 110.849 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -51.45 -55.97 15.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.228 -0.442 . . . . 63.11 110.857 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.34 17.1 3.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 72.24 111.133 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . 0.51 ' HA ' HD11 ' A' ' 113' ' ' LEU . 0.2 OUTLIER 61.95 18.11 9.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.44 . . . . 73.12 110.921 179.911 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.77 139.23 58.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.186 -0.461 . . . . 72.13 110.843 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 96.0 t -105.0 118.12 51.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.111 -0.495 . . . . 75.22 111.153 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -100.6 129.05 46.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 75.03 110.898 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -123.76 103.37 8.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 72.04 110.87 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 45.44 69.97 0.4 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 73.45 110.905 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 49.09 38.73 25.53 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.698 -0.763 . . . . 71.03 112.505 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -146.38 114.04 6.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.812 0.339 . . . . 70.01 110.877 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -53.39 160.38 1.19 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.249 -0.432 . . . . 70.21 110.856 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 30.2 mmm -126.82 163.62 23.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 74.41 110.875 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -118.79 106.44 12.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.239 -0.437 . . . . 74.13 110.848 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.548 HG22 ' HD2' ' A' ' 142' ' ' PHE . 17.1 p -95.55 -177.76 4.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.478 . . . . 64.04 111.155 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.431 ' HB2' ' HB2' ' A' ' 141' ' ' HIS . . . -92.5 -31.3 15.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.22 -0.445 . . . . 51.43 111.068 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 55.09 69.25 1.32 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.78 -0.724 . . . . 73.03 112.492 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -127.1 113.93 17.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.888 0.375 . . . . 50.13 110.899 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -85.16 115.72 23.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.457 . . . . 75.15 110.874 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.438 HG22 ' O ' ' A' ' 137' ' ' GLY . 22.1 m -84.82 -177.54 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.477 . . . . 61.14 111.143 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -53.02 -29.95 32.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.264 -0.425 . . . . 75.35 110.813 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.435 ' H ' HG23 ' A' ' 134' ' ' VAL . 0.2 OUTLIER -163.49 93.0 0.74 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 72.3 110.824 -179.985 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.438 ' O ' HG22 ' A' ' 134' ' ' VAL . . . 128.96 178.31 15.31 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.808 -0.71 . . . . 73.41 112.459 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.636 ' O ' ' HB3' ' A' ' 153' ' ' ALA . 0.1 OUTLIER -134.73 131.03 37.13 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.73 0.3 . . . . 70.11 111.175 -179.963 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -115.34 96.33 5.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 72.01 110.895 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.504 HG22 ' HB ' ' A' ' 129' ' ' THR . 0.0 OUTLIER -77.1 110.02 11.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.117 -0.492 . . . . 33.33 111.139 -179.918 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . 0.431 ' HB2' ' HB2' ' A' ' 130' ' ' ALA . 81.4 m-70 -106.93 104.26 13.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.259 -0.428 . . . . 74.02 110.862 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.548 ' HD2' HG22 ' A' ' 129' ' ' THR . 2.9 p90 -124.72 -175.96 3.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 75.25 110.856 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 58.4 p -148.71 160.78 42.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.12 -0.491 . . . . 75.31 110.84 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 90.8 t -135.2 97.92 2.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.12 -0.491 . . . . 43.02 111.137 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 54.49 -113.12 3.15 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.752 -0.737 . . . . 63.24 112.521 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -103.01 25.46 9.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.814 0.34 . . . . 53.01 110.899 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . 0.447 ' HD2' HD21 ' A' ' 104' ' ' LEU . 28.9 m-70 -111.18 -170.33 1.62 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 71.12 110.852 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -154.39 107.52 2.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.439 . . . . 62.14 110.821 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' CYS . . . . . 0.59 ' HB3' HG22 ' A' ' 169' ' ' VAL . 0.8 OUTLIER -142.69 161.81 37.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 64.21 110.91 -179.969 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -159.4 149.33 18.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.242 -0.435 . . . . 70.54 110.88 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.538 HD13 HD22 ' A' ' 113' ' ' LEU . 8.2 mt -99.12 113.82 35.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.121 -0.49 . . . . 74.34 111.162 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.54 102.67 10.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.102 -0.499 . . . . 74.23 110.921 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.636 ' HB3' ' O ' ' A' ' 138' ' ' THR . . . -100.57 145.46 28.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.24 -0.436 . . . . 71.33 111.113 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.3 t -144.84 133.74 17.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.202 -0.454 . . . . 74.51 111.144 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.1 p -104.94 130.34 53.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 64.45 110.891 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 79.7 p -143.7 150.83 39.26 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.151 -0.477 . . . . 64.12 110.824 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 129.26 171.27 12.92 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.698 -0.763 . . . . 55.34 112.452 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 38.1 mttp -63.78 94.55 0.1 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.795 0.331 . . . . 64.31 110.947 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 15.6 mtt-85 62.86 60.69 1.23 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.227 -0.442 . . . . 73.11 110.84 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 58.11 82.33 0.13 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.45 . . . . 74.53 110.885 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -103.73 -53.2 2.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.244 -0.435 . . . . 72.55 110.938 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -133.66 147.56 19.08 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.795 -0.717 . . . . 41.22 112.517 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 58.5 mt -127.45 140.99 47.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.768 0.318 . . . . 44.21 111.137 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 66.1 mt -124.99 141.1 46.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.469 . . . . 71.1 111.105 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 10.0 m80 -115.92 142.91 46.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.103 -0.498 . . . . 73.32 110.847 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.6 107.69 8.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.193 -0.458 . . . . 74.22 111.155 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.502 HD23 ' CB ' ' A' ' 100' ' ' TRP . 16.8 tp -68.61 133.01 47.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.243 -0.435 . . . . 71.01 110.939 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.492 ' N ' HD12 ' A' ' 167' ' ' LEU . 12.7 mt -135.01 113.89 16.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.45 . . . . 75.31 111.099 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.59 HG22 ' HB3' ' A' ' 149' ' ' CYS . 21.3 t -118.38 129.37 74.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 71.02 111.164 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 63.52 34.64 12.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.155 -0.475 . . . . 72.42 110.878 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 63.36 42.96 6.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 71.01 110.923 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -142.22 128.54 19.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.1 -0.5 . . . . 65.02 110.892 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -62.74 146.32 52.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.264 -0.425 . . . . 72.02 110.959 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -123.04 131.23 24.36 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.629 0.728 . . . . 70.33 111.101 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.68 137.01 34.68 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.628 2.219 . . . . 71.02 112.365 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.545 ' O ' HG23 ' A' ' 178' ' ' THR . 1.8 tm-20 -89.98 132.66 35.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.236 -0.438 . . . . 75.14 110.866 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 28.1 tp -55.53 114.23 1.76 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 74.2 110.943 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.545 HG23 ' O ' ' A' ' 176' ' ' GLU . 79.1 p -124.19 28.76 6.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 63.5 111.164 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.436 . . . . 65.15 110.843 179.958 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.237 0 CA-C-O 121.462 0.479 . . . . 73.34 112.468 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -38.86 7.22 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.733 2.288 . . . . 73.21 112.332 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.32 135.26 56.02 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.212 -0.449 . . . . 74.51 110.866 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 96.98 -140.23 14.93 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.739 -0.743 . . . . 55.43 112.514 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -156.28 173.13 17.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.842 0.353 . . . . 64.04 110.841 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -110.79 105.43 14.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.132 -0.486 . . . . 72.23 110.876 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 22.2 m-20 -78.13 -179.04 5.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 71.45 110.921 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -110.32 175.91 5.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 65.33 110.933 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -172.87 177.73 2.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.269 -0.423 . . . . 74.34 110.899 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -128.79 47.32 2.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 71.35 110.937 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.506 ' O ' HG23 ' A' ' 97' ' ' THR . 30.2 p -142.17 40.99 1.64 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.459 . . . . 54.2 111.166 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.506 HG23 ' O ' ' A' ' 96' ' ' THR . 1.0 OUTLIER -159.55 128.4 5.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 72.04 111.095 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.3 m -105.95 151.88 24.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.171 -0.468 . . . . 51.43 110.843 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.958 HG23 HG22 ' A' ' 112' ' ' VAL . 0.1 OUTLIER -141.24 158.86 43.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.155 -0.475 . . . . 74.01 111.112 -179.921 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 18.9 m-90 -151.75 157.32 41.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.218 -0.447 . . . . 74.04 110.93 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.3 t -135.9 114.98 16.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.448 . . . . 55.21 111.129 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 1.029 HD11 HD12 ' A' ' 104' ' ' LEU . 0.5 OUTLIER -142.61 148.47 37.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.1 -0.5 . . . . 71.12 110.956 179.973 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 2.4 mmm180 -72.48 89.66 1.28 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 64.22 110.886 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 1.029 HD12 HD11 ' A' ' 102' ' ' LEU . 0.3 OUTLIER -117.16 148.95 41.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.205 -0.452 . . . . 71.23 110.857 -179.906 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.3 t0 64.88 14.77 9.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.458 . . . . 61.43 110.878 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.67 1.25 77.67 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.675 -0.774 . . . . 63.42 112.487 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -139.82 168.83 18.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.858 0.361 . . . . 63.21 110.899 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.97 89.01 0.16 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 74.12 110.85 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.469 HD21 ' SG ' ' A' ' 122' ' ' CYS . 0.5 OUTLIER -79.8 130.61 35.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 74.21 110.846 -179.905 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 10.9 ttp85 -105.73 121.92 45.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 65.13 110.917 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.518 HG21 HD21 ' A' ' 167' ' ' LEU . 0.1 OUTLIER -106.59 144.99 14.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.145 -0.48 . . . . 62.43 111.139 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.958 HG22 HG23 ' A' ' 99' ' ' THR . 85.5 t -135.83 144.45 33.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.456 . . . . 73.22 111.169 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.527 HD11 ' HA ' ' A' ' 118' ' ' MET . 3.2 tp -128.8 102.84 6.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.253 -0.431 . . . . 74.13 110.989 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.26 132.56 42.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 44.33 110.853 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 9.9 mmmt -73.8 -16.88 61.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.446 . . . . 73.02 110.884 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -51.44 -55.81 16.72 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.225 -0.443 . . . . 74.41 110.865 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.45 17.06 3.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.188 -0.46 . . . . 75.32 111.094 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . 0.527 ' HA ' HD11 ' A' ' 113' ' ' LEU . 8.8 ttm 60.11 29.71 19.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 72.41 110.869 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -77.07 145.39 37.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.211 -0.449 . . . . 73.15 110.783 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 36.1 t -104.75 139.24 26.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 70.54 111.108 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 2.7 t-105 -125.19 124.22 41.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.16 -0.473 . . . . 74.15 110.891 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . 0.469 ' SG ' HD21 ' A' ' 109' ' ' LEU . 0.8 OUTLIER -114.06 109.95 19.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.238 -0.437 . . . . 62.1 110.862 -179.954 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 12.6 m-20 47.89 67.43 0.83 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 55.22 110.826 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 49.52 30.64 13.21 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.701 -0.762 . . . . 62.21 112.497 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.66 120.95 20.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.863 0.363 . . . . 75.44 110.901 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 18.5 tttt -53.86 151.25 6.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.224 -0.444 . . . . 74.54 110.84 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' MET . . . . . 0.43 ' CE ' HG22 ' A' ' 144' ' ' VAL . 44.2 mmm -117.89 165.61 13.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 63.1 110.88 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -118.97 106.49 12.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 73.13 110.829 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.65 ' HB ' HG22 ' A' ' 140' ' ' THR . 21.7 p -95.95 168.93 10.33 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.126 -0.488 . . . . 53.43 111.137 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -95.82 -24.26 16.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.204 -0.453 . . . . 72.23 111.118 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 62.36 76.07 0.28 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.763 -0.732 . . . . 53.31 112.536 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -128.94 101.89 6.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.881 0.372 . . . . 74.52 110.894 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -88.25 129.9 35.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.149 -0.478 . . . . 73.44 110.853 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.664 HG13 ' HG3' ' A' ' 139' ' ' GLU . 27.3 m -81.51 -175.59 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.157 -0.474 . . . . 74.11 111.14 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -52.1 -28.84 19.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.466 . . . . 64.15 110.927 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.593 ' H ' HG23 ' A' ' 134' ' ' VAL . 0.0 OUTLIER -133.58 -76.13 0.48 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 74.54 110.93 179.919 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.523 ' C ' HG22 ' A' ' 134' ' ' VAL . . . -62.62 -162.8 0.31 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.718 -0.753 . . . . 71.24 112.494 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.559 ' O ' ' HB3' ' A' ' 153' ' ' ALA . 0.2 OUTLIER -142.39 133.41 25.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.827 0.346 . . . . 73.41 111.111 -179.851 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.664 ' HG3' HG13 ' A' ' 134' ' ' VAL . 18.5 mt-10 -108.2 132.96 53.1 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.253 -0.431 . . . . 72.53 110.884 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.65 HG22 ' HB ' ' A' ' 129' ' ' THR . 0.0 OUTLIER -118.67 110.28 17.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.155 -0.475 . . . . 43.33 111.067 -179.821 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 22.6 m-70 -100.88 110.5 22.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.157 -0.474 . . . . 74.42 110.868 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.757 ' CE2' HD12 ' A' ' 151' ' ' ILE . 5.9 p90 -135.38 134.7 40.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 73.14 110.908 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 2.9 p -84.39 151.85 24.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.153 -0.476 . . . . 32.51 110.865 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.43 HG22 ' CE ' ' A' ' 127' ' ' MET . 94.0 t -136.74 97.98 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.117 -0.492 . . . . 60.31 111.096 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 54.2 -106.34 0.47 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.731 -0.747 . . . . 64.32 112.492 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 22.8 t30 -116.28 26.32 10.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.868 0.366 . . . . 73.24 110.851 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 50.3 m-70 -125.19 -169.93 2.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 61.21 110.823 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -143.18 105.61 4.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.261 -0.427 . . . . 74.23 110.894 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' CYS . . . . . 0.432 ' SG ' HG13 ' A' ' 169' ' ' VAL . 13.3 m -120.5 158.41 27.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.444 . . . . 75.31 110.865 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -158.72 143.61 16.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 73.14 110.886 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.757 HD12 ' CE2' ' A' ' 142' ' ' PHE . 3.1 mt -99.27 111.06 27.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.139 -0.482 . . . . 71.41 111.178 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 7.8 tttm -80.87 102.96 10.38 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.194 -0.457 . . . . 72.43 110.877 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.559 ' HB3' ' O ' ' A' ' 138' ' ' THR . . . -92.5 132.45 36.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.246 -0.433 . . . . 54.22 111.092 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.5 t -127.0 125.6 66.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.243 -0.435 . . . . 62.45 111.105 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.3 p -93.56 136.97 33.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 71.23 110.798 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 1.4 p -138.94 146.12 40.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.08 -0.509 . . . . 71.43 110.793 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 132.44 162.48 10.34 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.679 -0.772 . . . . 65.11 112.501 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -54.72 -41.37 70.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.816 0.341 . . . . 61.0 110.898 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 12.9 mmt180 -136.35 46.08 2.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.237 -0.438 . . . . 63.35 110.843 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.54 74.23 0.36 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.191 -0.459 . . . . 75.43 110.908 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -113.04 -36.58 5.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.222 -0.444 . . . . 72.31 110.888 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -112.15 111.24 2.79 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.71 -0.757 . . . . 73.44 112.5 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 46.2 mt -109.91 147.98 13.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.803 0.335 . . . . 63.33 111.084 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 66.4 mt -137.88 122.17 22.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.136 -0.484 . . . . 74.42 111.191 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 12.0 m80 -94.95 135.82 36.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 62.32 110.864 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.09 106.75 10.16 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.147 -0.479 . . . . 75.02 111.095 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.518 HD21 HG21 ' A' ' 111' ' ' VAL . 43.9 tp -66.74 136.47 55.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.215 -0.448 . . . . 74.05 110.895 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 10.2 mt -137.09 125.73 34.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.196 -0.456 . . . . 71.5 111.171 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.432 HG13 ' SG ' ' A' ' 149' ' ' CYS . 67.4 t -122.6 119.89 59.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 71.3 111.146 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 64.0 39.34 8.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 72.43 110.847 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 63.23 43.06 6.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 75.42 110.886 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -138.94 127.14 22.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.227 -0.442 . . . . 65.12 110.882 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -62.44 146.38 51.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.18 -0.464 . . . . 70.5 110.888 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.712 HD12 HD22 ' A' ' 102' ' ' LEU . 0.9 OUTLIER -119.99 130.88 24.62 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.645 0.736 . . . . 74.11 111.136 179.921 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 127.64 14.87 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.642 2.228 . . . . 72.34 112.302 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -93.29 126.63 38.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 64.44 110.888 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.16 99.33 5.38 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.222 -0.445 . . . . 44.43 110.927 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 3.1 t -153.03 151.47 30.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 71.54 111.104 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.127 -0.488 . . . . 74.35 110.88 -179.964 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 CA-C-O 121.451 0.473 . . . . 60.31 112.502 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.74 -177.29 1.8 Allowed 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.67 2.247 . . . . 71.53 112.328 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.8 mt -100.89 70.89 1.41 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.179 -0.464 . . . . 74.32 110.87 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -111.37 -67.22 0.54 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.804 -0.712 . . . . 72.22 112.481 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -175.25 -69.38 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.94 0.4 . . . . 75.31 110.898 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -165.89 156.85 13.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.056 -0.52 . . . . 72.23 110.877 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 9.0 m-20 -121.44 155.94 33.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.087 -0.506 . . . . 71.44 110.864 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 3.8 mtt180 -55.75 133.47 50.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.127 -0.488 . . . . 73.25 110.866 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.8 p -103.92 54.16 0.74 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.141 -0.481 . . . . 50.42 110.835 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -90.28 -28.79 18.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.106 -0.497 . . . . 74.13 110.91 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.497 ' O ' HG23 ' A' ' 97' ' ' THR . 16.6 p -124.36 26.48 7.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.45 . . . . 73.5 111.132 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.567 HG22 ' HA ' ' A' ' 114' ' ' GLU . 1.0 OUTLIER -159.48 128.04 5.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 63.2 111.176 179.972 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.2 m -106.19 153.33 22.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.185 -0.462 . . . . 73.5 110.813 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.56 HG22 HG22 ' A' ' 112' ' ' VAL . 78.9 p -138.54 155.05 48.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.095 -0.502 . . . . 71.41 111.141 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . 0.414 ' CB ' HD23 ' A' ' 167' ' ' LEU . 10.8 m-90 -151.52 123.64 8.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 75.15 110.903 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 19.5 t -105.14 114.9 45.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.246 -0.434 . . . . 62.33 111.168 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.868 HD11 HD12 ' A' ' 104' ' ' LEU . 0.5 OUTLIER -142.74 146.96 34.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.166 -0.47 . . . . 75.23 110.936 179.952 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -73.85 93.0 2.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 75.22 110.914 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.868 HD12 HD11 ' A' ' 102' ' ' LEU . 0.4 OUTLIER -123.54 152.87 41.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 53.42 110.922 -179.938 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.1 t70 64.8 15.03 9.59 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.201 -0.454 . . . . 74.4 110.882 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 88.55 0.65 81.81 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.79 -0.719 . . . . 61.34 112.548 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -139.85 172.92 12.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.796 0.331 . . . . 65.0 110.909 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.69 89.0 0.37 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.134 -0.485 . . . . 72.21 110.877 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.571 HD13 ' HB3' ' A' ' 104' ' ' LEU . 0.5 OUTLIER -74.12 125.41 28.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.147 -0.479 . . . . 65.25 110.911 -179.951 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 3.6 ttm180 -104.54 109.63 21.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 74.12 110.888 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.483 HG21 HD21 ' A' ' 167' ' ' LEU . 0.9 OUTLIER -95.78 136.19 27.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 54.12 111.111 179.995 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.56 HG22 HG22 ' A' ' 99' ' ' THR . 94.0 t -136.25 127.03 42.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.097 -0.501 . . . . 72.43 111.127 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.7 HD22 HD13 ' A' ' 151' ' ' ILE . 3.9 tp -110.11 107.31 17.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.48 . . . . 74.4 110.885 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.567 ' HA ' HG22 ' A' ' 97' ' ' THR . 0.0 OUTLIER -83.17 136.08 34.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 52.43 110.918 179.952 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 6.6 mmmt -73.54 -16.34 61.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.171 -0.468 . . . . 71.04 110.888 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -51.51 -55.49 18.68 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.237 -0.438 . . . . 73.13 110.904 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -136.43 17.0 3.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 75.1 111.187 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . 0.528 ' HA ' HD11 ' A' ' 113' ' ' LEU . 70.9 mtp 58.49 23.25 10.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 64.21 110.849 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.99 147.61 42.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 75.53 110.778 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.547 HG22 HD12 ' A' ' 151' ' ' ILE . 85.8 t -105.13 122.54 58.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.138 -0.483 . . . . 75.11 111.176 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 2.8 t90 -103.63 131.78 50.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.203 -0.453 . . . . 61.12 110.926 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 1.2 m -126.86 108.21 10.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.286 -0.415 . . . . 54.21 110.847 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 4.8 p30 39.42 70.1 0.25 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 73.23 110.83 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 49.75 42.42 36.92 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.775 -0.726 . . . . 64.25 112.466 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -148.12 110.09 4.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.885 0.374 . . . . 72.22 110.917 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.3 154.95 2.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 64.21 110.912 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' MET . . . . . 0.516 ' CE ' HG22 ' A' ' 144' ' ' VAL . 29.9 mmm -124.61 160.53 28.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 74.41 110.848 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -115.47 106.96 14.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 63.44 110.845 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.728 ' HB ' HG22 ' A' ' 140' ' ' THR . 18.8 p -95.36 179.03 5.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.171 -0.468 . . . . 74.52 111.098 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.502 ' HB2' ' HB2' ' A' ' 141' ' ' HIS . . . -90.58 -40.41 11.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 63.25 111.098 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 58.6 60.23 9.31 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.769 -0.729 . . . . 72.21 112.449 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -115.43 109.23 17.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.834 0.349 . . . . 62.24 110.973 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -70.92 130.08 40.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.128 -0.487 . . . . 73.3 110.908 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.535 HG23 ' H ' ' A' ' 136' ' ' ASP . 27.8 m -102.94 -177.0 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.159 -0.473 . . . . 71.25 111.134 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -53.21 -29.58 32.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 74.14 110.894 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.535 ' H ' HG23 ' A' ' 134' ' ' VAL . 0.2 OUTLIER -164.22 92.47 0.65 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.121 -0.491 . . . . 74.3 110.788 179.999 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.452 ' O ' HG22 ' A' ' 134' ' ' VAL . . . 127.4 -176.56 17.83 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.782 -0.723 . . . . 31.13 112.493 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.575 ' O ' ' HB3' ' A' ' 153' ' ' ALA . 0.1 OUTLIER -135.25 130.82 35.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.683 0.278 . . . . 70.43 111.155 -179.858 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -113.73 96.87 6.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 73.24 110.867 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.728 HG22 ' HB ' ' A' ' 129' ' ' THR . 0.0 OUTLIER -81.42 110.43 16.83 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.127 -0.488 . . . . 74.21 111.175 -179.965 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . 0.502 ' HB2' ' HB2' ' A' ' 130' ' ' ALA . 82.4 m-70 -103.89 106.01 16.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.446 . . . . 61.1 110.827 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.435 ' HB3' HG22 ' A' ' 129' ' ' THR . 20.0 p90 -124.48 131.99 53.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 62.11 110.871 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 22.9 p -82.02 146.9 29.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.459 . . . . 63.24 110.852 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.516 HG22 ' CE ' ' A' ' 127' ' ' MET . 21.9 t -137.68 98.35 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.097 -0.501 . . . . 75.12 111.137 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 52.34 -121.28 13.72 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.71 -0.757 . . . . 42.31 112.501 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -98.75 26.74 5.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.901 0.382 . . . . 71.11 110.886 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 31.1 m-70 -126.7 174.21 8.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.177 -0.465 . . . . 71.41 110.834 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -132.79 88.35 2.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 73.41 110.821 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' CYS . . . . . 0.482 ' SG ' HG13 ' A' ' 169' ' ' VAL . 10.4 m -100.67 164.78 11.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.166 -0.47 . . . . 75.23 110.938 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -167.85 144.85 4.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.213 -0.449 . . . . 74.42 110.97 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.7 HD13 HD22 ' A' ' 113' ' ' LEU . 22.7 mt -97.6 111.4 27.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.117 -0.492 . . . . 53.31 111.066 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 1.8 ttmt -80.12 102.82 9.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 73.22 110.927 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.575 ' HB3' ' O ' ' A' ' 138' ' ' THR . . . -93.38 146.47 23.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.271 -0.422 . . . . 74.43 111.067 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.2 t -144.28 121.42 5.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 54.32 111.157 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -94.26 137.21 33.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 72.32 110.889 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 2.2 t -132.45 133.21 43.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.112 -0.494 . . . . 61.45 110.833 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 143.87 -174.94 24.04 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.795 -0.717 . . . . 64.52 112.488 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.96 -26.51 67.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.728 0.299 . . . . 73.53 110.881 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.65 -41.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.267 -0.424 . . . . 65.31 110.861 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 25.4 tttp -162.56 55.75 0.22 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 74.13 110.842 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -76.74 -62.66 1.56 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.267 -0.424 . . . . 61.24 110.86 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -141.35 160.38 26.84 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.813 -0.708 . . . . 55.32 112.457 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 64.1 mt -136.4 139.61 45.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.82 0.343 . . . . 74.3 111.162 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 64.4 mt -126.7 131.05 71.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.138 -0.483 . . . . 73.45 111.13 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' HIS . . . . . 0.415 ' CG ' HD23 ' A' ' 113' ' ' LEU . 14.5 m80 -105.83 139.63 40.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.445 . . . . 62.31 110.883 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.64 103.98 6.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.435 . . . . 73.31 111.155 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.483 HD21 HG21 ' A' ' 111' ' ' VAL . 28.2 tp -65.5 137.8 57.66 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.243 -0.435 . . . . 63.23 110.878 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.462 ' H ' HD12 ' A' ' 167' ' ' LEU . 9.8 mt -137.6 130.04 41.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 33.01 111.168 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.482 HG13 ' SG ' ' A' ' 149' ' ' CYS . 74.2 t -126.51 116.36 44.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.451 . . . . 74.25 111.166 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.4 t0 63.64 46.12 4.29 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.196 -0.456 . . . . 62.24 110.82 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 1.6 m120 59.08 42.93 18.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.262 -0.426 . . . . 51.33 110.879 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 10.4 mtm180 -139.69 124.99 18.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 74.11 110.955 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -62.55 146.48 51.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 64.32 110.84 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.537 HD12 HD22 ' A' ' 102' ' ' LEU . 0.9 OUTLIER -120.32 130.97 24.59 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.597 0.713 . . . . 73.22 111.195 179.885 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.74 134.15 27.33 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.64 2.227 . . . . 75.33 112.402 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -92.4 131.7 37.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.269 -0.423 . . . . 73.53 110.907 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.68 136.5 47.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 54.41 110.889 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 69.4 p -145.99 160.84 41.29 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.149 -0.478 . . . . 72.14 111.154 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.216 -0.447 . . . . 73.44 110.936 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.349 0 CA-C-O 121.453 0.474 . . . . 75.25 112.533 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 154.0 68.43 Favored 'Trans proline' 0 C--O 1.233 0.231 0 C-N-CA 122.704 2.269 . . . . 74.32 112.386 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -135.21 147.67 49.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.236 -0.438 . . . . 72.13 110.95 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 130.8 -28.8 3.66 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.748 -0.739 . . . . 65.25 112.426 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 62.51 168.42 0.12 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.852 0.358 . . . . 75.33 110.869 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 60.13 44.07 13.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.127 -0.488 . . . . 75.31 110.905 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -77.96 119.94 22.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 72.24 110.88 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 8.0 mtt85 -149.29 -57.86 0.2 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.146 -0.479 . . . . 74.01 110.867 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -52.27 130.55 31.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 73.02 110.837 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.12 126.45 0.15 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.071 -0.513 . . . . 74.51 110.949 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.497 ' O ' HG23 ' A' ' 97' ' ' THR . 0.2 OUTLIER -90.07 148.04 23.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.251 -0.432 . . . . 73.11 111.083 -179.939 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.66 HG22 ' HA ' ' A' ' 114' ' ' GLU . 1.0 OUTLIER -159.74 127.77 4.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 72.22 111.114 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 62.5 m -106.52 116.83 32.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 71.44 110.841 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.536 HG22 HG22 ' A' ' 112' ' ' VAL . 71.6 p -112.34 163.88 13.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.15 -0.477 . . . . 73.22 111.134 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . 0.46 ' CB ' HD23 ' A' ' 167' ' ' LEU . 21.8 m-90 -149.56 152.17 35.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.196 -0.456 . . . . 74.2 110.86 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 20.3 t -124.84 115.11 43.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.217 -0.447 . . . . 61.0 111.079 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.901 HD11 HD12 ' A' ' 104' ' ' LEU . 0.5 OUTLIER -141.17 147.22 38.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.132 -0.485 . . . . 75.05 110.934 179.926 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 8.7 mtm-85 -72.17 90.99 1.25 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 72.32 110.913 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.901 HD12 HD11 ' A' ' 102' ' ' LEU . 0.4 OUTLIER -121.62 151.62 40.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.105 -0.498 . . . . 72.22 110.922 -179.969 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.7 t70 65.11 14.59 9.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 73.31 110.853 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.63 0.14 79.38 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.738 -0.744 . . . . 63.12 112.479 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -139.88 172.77 12.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.839 0.352 . . . . 75.51 110.898 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -69.02 89.22 0.42 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.206 -0.452 . . . . 63.42 110.906 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.601 HD13 ' HB3' ' A' ' 104' ' ' LEU . 0.4 OUTLIER -75.56 130.95 39.65 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.164 -0.471 . . . . 73.23 110.897 -179.92 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 8.2 ttt180 -107.02 113.12 26.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 74.34 110.88 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.555 HG21 ' CD2' ' A' ' 167' ' ' LEU . 0.8 OUTLIER -95.52 141.2 15.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 75.43 111.19 179.937 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.536 HG22 HG22 ' A' ' 99' ' ' THR . 47.5 t -135.85 126.41 42.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 73.35 111.149 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.565 HD11 ' HA ' ' A' ' 118' ' ' MET . 4.2 tp -113.17 99.82 8.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.463 . . . . 64.54 110.897 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.66 ' HA ' HG22 ' A' ' 97' ' ' THR . 0.0 OUTLIER -76.59 123.54 26.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 71.33 110.924 179.916 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.47 -16.07 59.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 62.14 110.867 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -51.4 -56.02 15.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 74.34 110.906 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 76.3 p -132.49 16.94 4.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 72.25 111.128 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . 0.565 ' HA ' HD11 ' A' ' 113' ' ' LEU . 48.2 mtp 55.7 28.43 12.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 63.5 110.868 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -81.37 147.14 29.97 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.212 -0.449 . . . . 61.0 110.867 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.51 HG22 HD12 ' A' ' 151' ' ' ILE . 79.5 t -104.81 129.41 57.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.445 . . . . 71.23 111.163 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 6.1 t-105 -119.95 109.57 15.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.173 -0.467 . . . . 74.44 110.962 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . 0.538 ' HB3' HD21 ' A' ' 109' ' ' LEU . 7.7 m -97.0 117.81 32.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.441 . . . . 75.54 110.939 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 64.8 -82.75 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.468 . . . . 72.3 110.874 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -156.88 46.17 0.49 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.774 -0.727 . . . . 52.15 112.449 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -159.01 134.29 8.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.908 0.385 . . . . 62.35 110.899 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 24.9 ttpt -53.74 162.11 0.96 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.161 -0.472 . . . . 72.22 110.897 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 31.4 mmm -127.76 167.11 16.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 64.04 110.888 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -119.19 106.62 12.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.285 -0.416 . . . . 64.05 110.92 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.723 ' CB ' HG22 ' A' ' 140' ' ' THR . 19.6 p -95.61 -175.3 3.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.118 -0.492 . . . . 60.12 111.127 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -104.95 -25.16 12.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 53.42 111.087 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 53.23 47.63 61.04 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.752 -0.737 . . . . 73.12 112.453 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -81.92 101.97 10.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.816 0.341 . . . . 73.43 110.945 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -77.4 130.91 37.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.247 -0.433 . . . . 73.43 110.836 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.424 HG23 ' H ' ' A' ' 136' ' ' ASP . 17.4 m -112.54 -178.16 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 54.24 111.128 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -55.58 -26.27 42.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.138 -0.483 . . . . 73.02 110.895 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.424 ' H ' HG23 ' A' ' 134' ' ' VAL . 0.1 OUTLIER -159.88 101.56 1.46 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.143 -0.48 . . . . 74.22 110.932 179.921 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 113.73 -179.26 18.78 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.669 -0.777 . . . . 73.02 112.462 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.632 ' O ' ' HB3' ' A' ' 153' ' ' ALA . 0.1 OUTLIER -134.83 130.8 36.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.74 0.305 . . . . 64.34 111.214 -179.933 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -106.43 96.37 6.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.256 -0.429 . . . . 73.23 110.886 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.723 HG22 ' CB ' ' A' ' 129' ' ' THR . 0.0 OUTLIER -81.86 110.09 16.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 71.43 111.173 -179.9 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 76.7 m-70 -106.86 106.42 16.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 73.4 110.814 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -121.74 128.82 52.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 72.45 110.855 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 56.1 p -89.35 159.3 17.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.112 -0.495 . . . . 65.12 110.85 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 87.0 t -147.86 109.22 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 73.12 111.101 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 52.0 -118.92 7.92 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.68 -0.771 . . . . 74.33 112.563 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -107.16 23.49 14.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.881 0.372 . . . . 65.12 110.916 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -112.57 -169.6 1.51 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 72.13 110.893 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -151.64 118.9 5.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 73.53 110.866 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' CYS . . . . . 0.611 ' CB ' HG22 ' A' ' 169' ' ' VAL . 1.4 p -142.53 163.67 32.21 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.274 -0.421 . . . . 72.31 110.898 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -167.16 145.53 4.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.173 -0.467 . . . . 75.41 110.878 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.51 HD12 HG22 ' A' ' 120' ' ' VAL . 22.5 mt -97.58 111.55 27.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.086 -0.506 . . . . 72.12 111.172 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -80.9 106.96 13.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 73.22 110.879 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.632 ' HB3' ' O ' ' A' ' 138' ' ' THR . . . -101.83 146.6 27.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.256 -0.429 . . . . 73.1 111.126 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.3 t -142.05 132.94 25.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.246 -0.434 . . . . 62.32 111.108 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.1 p -101.17 140.35 35.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.09 -0.505 . . . . 71.52 110.881 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -133.32 136.74 45.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.138 -0.483 . . . . 71.1 110.841 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 135.73 -169.16 23.64 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.763 -0.732 . . . . 73.02 112.477 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 14.2 mttt -64.2 -28.6 69.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.734 0.302 . . . . 73.52 110.891 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.73 -46.9 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.25 -0.432 . . . . 75.2 110.904 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 51.6 pttt -162.79 56.21 0.2 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 54.23 110.901 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -75.2 -56.1 5.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.233 -0.439 . . . . 62.22 110.915 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -138.85 141.56 12.05 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.714 -0.755 . . . . 75.12 112.458 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 73.7 mt -125.4 137.19 58.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.739 0.304 . . . . 53.24 111.188 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 2.8 mt -123.94 131.53 72.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 74.4 111.08 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 16.4 m80 -105.09 144.94 31.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 74.44 110.813 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.99 105.09 5.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.142 -0.481 . . . . 72.14 111.07 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.611 HD12 ' N ' ' A' ' 168' ' ' ILE . 11.7 tp -64.06 135.21 56.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 71.22 110.923 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.611 ' N ' HD12 ' A' ' 167' ' ' LEU . 11.0 mt -136.22 104.78 4.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 72.55 111.118 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.611 HG22 ' CB ' ' A' ' 149' ' ' CYS . 42.2 t -112.66 135.42 52.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 72.23 111.096 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 63.62 31.69 14.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.137 -0.483 . . . . 73.0 110.86 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 2.2 t30 63.33 42.93 6.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.46 . . . . 73.34 110.851 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 9.9 mtt85 -143.94 130.18 19.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 74.43 110.968 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -62.61 146.42 52.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.257 -0.429 . . . . 74.13 110.879 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -125.03 131.34 24.08 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.686 0.755 . . . . 62.21 111.078 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.86 133.22 24.87 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.658 2.238 . . . . 71.14 112.356 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -89.87 133.67 34.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 73.13 110.876 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.53 106.82 17.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.192 -0.458 . . . . 72.02 110.871 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 8.3 t -161.39 154.94 21.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.185 -0.461 . . . . 73.12 111.113 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 65.5 mm-40 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 74.41 110.93 179.994 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 CA-C-O 121.447 0.471 . . . . 75.54 112.499 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -69.83 -178.07 2.2 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.719 2.279 . . . . 61.5 112.275 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -160.51 94.46 1.06 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 72.41 110.901 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -97.17 -147.4 22.55 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.795 -0.717 . . . . 42.04 112.536 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.2 p -173.03 120.49 0.36 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.854 0.359 . . . . 44.32 110.911 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -88.58 -66.15 0.95 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.152 -0.476 . . . . 73.53 110.977 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -173.91 127.15 0.38 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.105 -0.498 . . . . 75.11 110.876 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 2.2 tpt85 -142.51 156.13 45.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.117 -0.492 . . . . 74.41 110.845 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -111.25 89.75 3.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.127 -0.488 . . . . 35.0 110.859 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -132.33 174.84 9.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.1 -0.5 . . . . 73.41 110.892 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.492 ' O ' HG23 ' A' ' 97' ' ' THR . 15.2 t -140.54 21.11 2.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 63.23 111.117 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.587 HG22 ' HA ' ' A' ' 114' ' ' GLU . 1.0 OUTLIER -159.62 128.22 5.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.231 -0.44 . . . . 75.02 111.157 -179.964 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.4 m -105.8 147.47 28.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 72.12 110.872 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 1.075 HG22 HG22 ' A' ' 112' ' ' VAL . 0.7 OUTLIER -136.35 138.25 41.45 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.118 -0.492 . . . . 44.22 111.176 -179.972 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . 0.491 ' CB ' HD23 ' A' ' 167' ' ' LEU . 11.1 m-90 -133.42 123.0 24.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.198 -0.456 . . . . 64.34 110.995 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 19.9 t -102.48 114.92 43.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.339 -0.391 . . . . 74.32 111.114 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.915 HD11 HD12 ' A' ' 104' ' ' LEU . 0.5 OUTLIER -142.61 147.27 35.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.153 -0.476 . . . . 75.21 110.925 -179.977 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 83.4 mtt180 -74.34 92.08 2.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 73.02 110.946 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.915 HD12 HD11 ' A' ' 102' ' ' LEU . 0.4 OUTLIER -121.48 153.57 37.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.193 -0.458 . . . . 63.5 110.947 -179.935 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 65.03 14.65 9.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.175 -0.466 . . . . 72.1 110.873 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.61 -0.06 79.7 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.705 -0.759 . . . . 63.51 112.492 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -139.82 172.67 12.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.824 0.345 . . . . 72.31 110.897 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.3 88.64 0.32 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.141 -0.481 . . . . 72.21 110.875 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.628 HD12 ' ND2' ' A' ' 123' ' ' ASN . 0.5 OUTLIER -75.45 125.82 29.76 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.251 -0.431 . . . . 62.2 110.911 -179.954 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 10.1 ttt180 -102.4 111.06 23.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 74.23 110.881 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.4 t -94.8 135.89 27.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.14 -0.482 . . . . 73.12 111.153 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 1.075 HG22 HG22 ' A' ' 99' ' ' THR . 99.4 t -136.55 126.43 39.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 52.25 111.137 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.597 HD11 ' HA ' ' A' ' 118' ' ' MET . 2.7 tp -111.6 103.84 12.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 62.32 110.871 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.587 ' HA ' HG22 ' A' ' 97' ' ' THR . 0.1 OUTLIER -80.26 129.69 34.68 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.183 -0.462 . . . . 75.51 110.891 179.947 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 58.4 mttt -68.71 -15.41 63.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 73.34 110.895 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -51.27 -52.72 42.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.273 -0.421 . . . . 61.54 110.831 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -138.2 16.93 2.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.213 -0.449 . . . . 71.22 111.136 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . 0.597 ' HA ' HD11 ' A' ' 113' ' ' LEU . 1.9 ttp 57.48 26.54 12.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 74.14 110.874 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -80.38 150.68 29.75 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.29 -0.414 . . . . 71.44 110.846 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.534 HG22 HD12 ' A' ' 151' ' ' ILE . 62.0 t -104.86 134.37 46.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.15 -0.477 . . . . 71.04 111.13 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 1.1 t90 -123.5 116.2 22.8 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.184 -0.462 . . . . 73.12 110.909 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . 0.552 ' HB2' HD21 ' A' ' 109' ' ' LEU . 17.9 p -120.95 132.94 55.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.302 -0.408 . . . . 72.43 110.819 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . 0.628 ' ND2' HD12 ' A' ' 109' ' ' LEU . 58.9 m-20 44.57 51.54 7.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.125 -0.489 . . . . 61.4 110.865 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 50.82 40.83 42.67 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.748 -0.739 . . . . 63.52 112.456 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.46 122.61 12.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.854 0.359 . . . . 65.1 110.965 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.49 147.98 9.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.44 . . . . 71.21 110.894 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' MET . . . . . 0.463 ' SD ' HG22 ' A' ' 144' ' ' VAL . 32.5 mmm -114.14 169.05 9.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 63.42 110.847 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.56 106.37 12.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 74.0 110.903 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.671 ' HB ' HG22 ' A' ' 140' ' ' THR . 17.4 p -99.35 -175.11 2.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 63.22 111.178 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.623 ' HB2' ' HB2' ' A' ' 141' ' ' HIS . . . -94.77 -44.8 7.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 75.11 111.06 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 65.11 52.87 37.3 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.707 -0.759 . . . . 64.04 112.483 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -103.89 102.18 11.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.889 0.376 . . . . 65.43 110.903 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -73.01 114.36 11.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 74.33 110.833 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.56 HG23 ' H ' ' A' ' 136' ' ' ASP . 35.2 m -92.4 -179.98 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.101 -0.499 . . . . 63.44 111.093 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -52.62 -30.14 29.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.189 -0.46 . . . . 62.31 110.885 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.56 ' H ' HG23 ' A' ' 134' ' ' VAL . 0.2 OUTLIER -161.54 101.63 1.19 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.472 . . . . 74.11 110.817 -179.969 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.52 ' O ' HG22 ' A' ' 134' ' ' VAL . . . 116.4 176.48 18.0 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.767 -0.73 . . . . 61.54 112.508 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.654 ' O ' ' HB3' ' A' ' 153' ' ' ALA . 0.1 OUTLIER -134.86 130.91 36.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.735 0.302 . . . . 71.44 111.203 -179.896 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -111.91 96.3 5.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 64.51 110.882 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.671 HG22 ' HB ' ' A' ' 129' ' ' THR . 0.0 OUTLIER -78.81 110.23 13.8 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.22 -0.446 . . . . 71.34 111.157 -179.939 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . 0.623 ' HB2' ' HB2' ' A' ' 130' ' ' ALA . 82.7 m-70 -104.52 106.38 16.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 75.03 110.87 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.527 ' HD2' HG22 ' A' ' 129' ' ' THR . 3.4 p90 -128.09 175.52 8.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 71.5 110.845 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 83.3 p -142.42 155.75 45.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.088 -0.506 . . . . 73.23 110.911 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.554 HG11 HD22 ' A' ' 104' ' ' LEU . 84.7 t -136.87 105.29 4.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.469 . . . . 71.54 111.073 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 62.34 -103.48 0.61 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.726 -0.749 . . . . 62.43 112.496 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -114.23 -27.43 7.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.81 0.338 . . . . 73.14 110.893 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 52.0 m-70 -61.37 -170.43 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.191 -0.459 . . . . 73.34 110.855 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -152.6 116.39 4.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 73.03 110.921 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' CYS . . . . . 0.597 ' HB3' HG22 ' A' ' 169' ' ' VAL . 0.7 OUTLIER -142.66 161.98 36.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.242 -0.435 . . . . 72.32 110.852 -179.844 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 18.3 p90 -156.71 152.72 27.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 73.13 110.905 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.563 HD13 HD22 ' A' ' 113' ' ' LEU . 13.4 mt -99.55 111.53 29.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 71.31 111.14 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.587 ' HD3' HD12 ' A' ' 168' ' ' ILE . 1.1 ttpp -81.89 102.62 10.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 65.35 110.893 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.654 ' HB3' ' O ' ' A' ' 138' ' ' THR . . . -98.6 147.99 24.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.281 -0.418 . . . . 52.32 111.119 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.5 t -145.18 122.44 4.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 54.3 111.122 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.2 p -89.67 139.97 30.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.472 . . . . 70.53 110.852 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 14.7 t -141.67 142.17 33.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.084 -0.507 . . . . 52.23 110.859 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 128.65 175.64 14.14 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.792 -0.718 . . . . 52.01 112.519 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 9.6 mttt -58.48 -38.11 76.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.749 0.309 . . . . 74.04 110.938 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -158.74 76.98 0.75 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 70.31 110.868 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 2.3 mtmt 55.85 28.89 13.11 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.208 -0.451 . . . . 73.21 110.88 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -54.39 -44.74 72.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 71.32 110.892 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -143.87 132.3 4.83 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.705 -0.759 . . . . 43.22 112.434 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 50.5 mt -121.13 147.15 25.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.812 0.339 . . . . 64.52 111.126 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 59.9 mt -129.45 131.01 67.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 62.24 111.118 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 10.8 m80 -108.69 137.27 46.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.446 . . . . 61.25 110.869 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.99 112.0 13.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.253 -0.43 . . . . 64.21 111.177 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.491 HD23 ' CB ' ' A' ' 100' ' ' TRP . 18.1 tp -70.22 134.85 48.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 55.11 110.938 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.587 HD12 ' HD3' ' A' ' 152' ' ' LYS . 10.7 mt -136.74 121.45 25.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.474 . . . . 75.3 111.098 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.597 HG22 ' HB3' ' A' ' 149' ' ' CYS . 16.4 t -121.86 124.08 70.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 72.25 111.178 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 63.63 37.96 9.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.235 -0.439 . . . . 73.03 110.868 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 62.83 42.9 7.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.142 -0.481 . . . . 51.35 110.887 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -140.67 127.98 21.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.169 -0.469 . . . . 71.41 110.879 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -62.67 146.5 52.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.45 . . . . 75.43 110.856 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -122.18 131.31 24.43 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.675 0.75 . . . . 74.41 111.043 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 137.79 36.23 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.731 2.288 . . . . 73.32 112.292 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.03 -172.66 3.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.462 . . . . 63.12 110.914 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 21.2 tp -79.84 -66.27 0.9 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.169 -0.469 . . . . 64.03 110.928 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 6.2 t -66.62 137.18 56.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.157 -0.474 . . . . 72.45 111.189 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.252 -0.431 . . . . 74.44 110.973 179.927 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.382 0 CA-C-O 121.452 0.473 . . . . 23.5 112.489 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.68 130.54 19.62 Favored 'Trans proline' 0 C--O 1.233 0.225 0 C-N-CA 122.674 2.249 . . . . 75.1 112.365 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.7 mt -131.01 -51.09 1.03 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.3 -0.409 . . . . 64.45 110.977 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -177.49 -114.61 0.4 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.643 -0.789 . . . . 63.52 112.416 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -135.84 155.83 49.72 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.785 0.326 . . . . 75.52 110.871 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -103.16 26.17 8.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.133 -0.485 . . . . 75.33 110.88 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 4.2 t30 54.06 49.58 18.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 73.43 110.834 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.6 mtt180 61.13 -170.25 0.16 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 72.4 110.893 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -51.99 -44.47 64.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.214 -0.448 . . . . 75.24 110.878 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 61.27 -174.33 0.13 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 72.43 110.917 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.505 ' O ' HG23 ' A' ' 97' ' ' THR . 30.7 p -84.5 54.37 2.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 50.14 111.09 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.505 HG23 ' O ' ' A' ' 96' ' ' THR . 1.0 OUTLIER -159.61 128.14 5.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.265 -0.425 . . . . 54.43 111.175 179.961 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -106.04 155.01 19.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 74.32 110.903 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.746 HG22 HG22 ' A' ' 112' ' ' VAL . 68.4 p -146.81 154.73 41.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.113 -0.494 . . . . 71.13 111.154 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . 0.47 ' CB ' HD23 ' A' ' 167' ' ' LEU . 14.2 m-90 -151.26 133.98 15.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.19 -0.459 . . . . 61.51 110.919 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.3 t -113.14 114.77 47.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 64.45 111.172 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.644 HD11 HD12 ' A' ' 104' ' ' LEU . 0.5 OUTLIER -138.91 146.01 40.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 71.21 110.918 -179.997 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -74.22 94.1 2.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 74.14 110.833 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.644 HD12 HD11 ' A' ' 102' ' ' LEU . 0.4 OUTLIER -127.44 153.39 46.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 75.34 110.927 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 64.43 15.65 9.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.204 -0.453 . . . . 70.2 110.824 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 86.3 2.05 85.73 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.665 -0.779 . . . . 74.54 112.503 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -139.94 173.06 11.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.89 0.376 . . . . 73.43 110.859 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.1 87.88 0.4 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.458 . . . . 74.31 110.872 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.6 HD13 ' HB3' ' A' ' 104' ' ' LEU . 1.4 tp -69.04 124.87 24.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.471 . . . . 73.04 110.906 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 10.8 ttm180 -107.05 113.91 27.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 72.15 110.87 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -106.37 139.37 27.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.456 . . . . 74.45 111.131 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.746 HG22 HG22 ' A' ' 99' ' ' THR . 85.8 t -135.8 135.36 50.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.125 -0.488 . . . . 72.43 111.207 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.437 HD11 ' HA ' ' A' ' 118' ' ' MET . 3.2 tp -117.58 100.35 7.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 62.14 110.954 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.449 ' HG3' HG22 ' A' ' 97' ' ' THR . 0.0 OUTLIER -75.57 134.85 40.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 71.15 110.878 179.977 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.3 mttt -73.78 -17.46 61.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.474 . . . . 64.51 110.924 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -51.33 -54.12 29.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 64.14 110.853 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -134.29 17.01 3.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.219 -0.446 . . . . 65.13 111.138 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . 0.437 ' HA ' HD11 ' A' ' 113' ' ' LEU . 3.9 ttm 54.41 27.09 7.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.252 -0.431 . . . . 61.3 110.914 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -80.97 149.39 29.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 73.43 110.851 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.503 HG23 HG21 ' A' ' 129' ' ' THR . 31.3 t -104.84 128.92 58.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.107 -0.497 . . . . 64.11 111.163 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 3.7 t90 -113.1 127.55 56.24 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.093 -0.503 . . . . 71.23 110.951 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 9.2 t -141.6 129.52 21.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 74.24 110.93 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 48.25 50.79 15.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 73.41 110.945 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 49.29 47.46 34.58 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.774 -0.727 . . . . 75.44 112.44 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.44 114.71 4.79 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.81 0.338 . . . . 64.42 110.966 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 7.5 ttmt -55.56 100.36 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 75.33 110.857 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 65.5 mtp -59.63 159.7 8.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 73.41 110.916 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -104.97 106.38 16.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.212 -0.449 . . . . 62.13 110.892 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.819 ' HB ' HG22 ' A' ' 140' ' ' THR . 13.9 p -99.2 -175.21 2.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.161 -0.472 . . . . 44.35 111.16 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.42 ' HB2' ' HB2' ' A' ' 141' ' ' HIS . . . -114.01 -47.86 2.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 41.14 111.136 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 74.83 50.43 8.99 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.716 -0.754 . . . . 70.13 112.484 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -80.82 110.81 16.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.878 0.37 . . . . 74.32 110.835 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -82.21 119.17 23.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 75.42 110.882 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.531 HG22 ' O ' ' A' ' 137' ' ' GLY . 22.1 m -105.18 -177.71 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 73.44 111.12 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -55.39 -32.94 63.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.16 -0.473 . . . . 74.42 110.861 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -156.91 90.09 1.12 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 53.11 110.89 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.531 ' O ' HG22 ' A' ' 134' ' ' VAL . . . 128.02 -179.39 16.54 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.777 -0.725 . . . . 64.13 112.501 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.63 130.81 34.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.706 0.288 . . . . 60.44 111.132 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -103.18 97.98 7.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.273 -0.422 . . . . 72.4 110.895 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.819 HG22 ' HB ' ' A' ' 129' ' ' THR . 0.0 OUTLIER -80.72 110.26 16.05 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.157 -0.474 . . . . 75.14 111.135 -179.897 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . 0.42 ' HB2' ' HB2' ' A' ' 130' ' ' ALA . 73.9 m-70 -102.0 109.3 21.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 70.55 110.809 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.718 ' CE2' HD12 ' A' ' 151' ' ' ILE . 3.0 p90 -138.75 153.33 48.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.252 -0.431 . . . . 74.31 110.905 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 89.6 p -114.52 167.44 10.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 73.12 110.812 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 83.8 t -149.39 98.12 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.119 -0.492 . . . . 65.2 111.09 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 60.18 -101.93 0.31 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.777 -0.725 . . . . 74.4 112.461 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -123.59 29.24 6.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.945 0.403 . . . . 75.03 110.943 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 75.3 m-70 -121.31 -175.02 2.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.475 . . . . 71.24 110.951 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -145.09 117.48 8.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.287 -0.415 . . . . 62.42 110.84 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' CYS . . . . . 0.611 ' HB3' HG22 ' A' ' 169' ' ' VAL . 1.3 p -142.45 156.41 45.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.216 -0.447 . . . . 54.45 110.893 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -151.66 146.32 25.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 70.1 110.875 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.718 HD12 ' CE2' ' A' ' 142' ' ' PHE . 3.8 mt -97.37 111.69 27.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.082 -0.508 . . . . 73.41 111.113 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.646 ' HD2' HD12 ' A' ' 168' ' ' ILE . 8.1 tttt -79.83 102.5 9.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.253 -0.431 . . . . 74.43 110.88 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -95.12 139.68 31.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.242 -0.436 . . . . 74.43 111.156 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.3 t -135.68 123.01 35.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.252 -0.431 . . . . 75.4 111.135 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.3 p -91.12 150.4 21.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 74.21 110.87 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 63.4 p -144.8 128.45 17.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.104 -0.498 . . . . 63.44 110.885 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 136.03 -144.03 15.68 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.712 -0.756 . . . . 64.52 112.526 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 19.7 mtmt -95.04 -63.42 1.17 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.721 0.296 . . . . 75.25 110.866 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.99 -36.38 3.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.308 -0.405 . . . . 74.43 110.926 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -173.17 52.3 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 35.23 110.916 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -69.23 -61.98 1.57 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 65.14 110.922 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -143.33 138.77 8.41 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.734 -0.746 . . . . 62.04 112.55 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 61.2 mt -124.54 146.11 30.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.796 0.331 . . . . 72.5 111.159 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 59.4 mt -133.92 123.18 44.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.242 -0.436 . . . . 72.3 111.171 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 9.7 m80 -99.41 141.49 32.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.464 . . . . 71.52 110.875 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.33 106.93 8.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 75.42 111.073 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.546 HD12 ' N ' ' A' ' 168' ' ' ILE . 14.5 tp -65.14 134.02 52.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 72.52 110.936 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.646 HD12 ' HD2' ' A' ' 152' ' ' LYS . 10.7 mt -137.01 111.27 9.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 53.12 111.113 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.611 HG22 ' HB3' ' A' ' 149' ' ' CYS . 35.6 t -113.56 124.71 70.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.458 . . . . 54.13 111.143 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 4.5 t0 63.37 43.22 6.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.451 . . . . 63.34 110.883 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 58.3 m-20 56.8 41.54 27.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.111 -0.495 . . . . 70.14 110.841 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 26.4 mtt180 -137.94 125.76 22.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 75.2 110.849 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -62.7 144.96 55.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.174 -0.466 . . . . 65.13 110.889 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -122.99 131.16 24.38 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.581 0.705 . . . . 73.22 111.143 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 138.21 37.31 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.725 2.283 . . . . 71.31 112.299 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -88.18 127.46 35.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 72.43 110.855 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.93 106.28 4.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 45.24 110.973 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 15.3 t -174.19 158.76 3.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.166 -0.47 . . . . 73.24 111.103 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.155 -0.475 . . . . 74.24 110.893 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 CA-C-O 121.471 0.484 . . . . 72.23 112.524 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.83 -42.61 3.18 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.63 2.22 . . . . 60.22 112.358 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.2 mp 56.66 88.83 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 71.34 110.985 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -102.8 115.51 5.21 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.682 -0.77 . . . . 72.52 112.492 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -133.21 95.64 3.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.861 0.363 . . . . 62.12 110.845 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 59.77 68.3 0.8 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.087 -0.506 . . . . 61.31 110.87 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -167.23 118.11 0.88 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 73.21 110.814 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 20.0 ptt180 -114.68 139.61 49.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 72.34 110.888 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.7 t -90.74 -70.35 0.68 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.22 -0.446 . . . . 62.45 110.834 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.06 -174.65 4.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.108 -0.497 . . . . 61.01 110.931 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.495 ' O ' HG23 ' A' ' 97' ' ' THR . 39.2 p -105.2 32.34 4.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.248 -0.433 . . . . 74.22 111.107 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.495 HG23 ' O ' ' A' ' 96' ' ' THR . 1.0 OUTLIER -159.46 127.78 5.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.286 -0.416 . . . . 64.43 111.096 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.4 m -106.48 152.18 23.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.443 . . . . 71.41 110.833 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.433 HG23 HG22 ' A' ' 112' ' ' VAL . 6.9 m -135.86 155.19 50.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.126 -0.488 . . . . 72.55 111.124 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . 0.426 ' CB ' HD23 ' A' ' 167' ' ' LEU . 16.6 m-90 -148.97 133.02 17.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.208 -0.451 . . . . 74.24 110.88 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.0 t -113.03 114.92 48.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 71.44 111.124 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.847 HD11 HD12 ' A' ' 104' ' ' LEU . 0.5 OUTLIER -140.03 147.27 40.13 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.179 -0.464 . . . . 72.43 110.892 179.973 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -73.29 93.44 1.89 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.133 -0.485 . . . . 42.43 110.874 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.847 HD12 HD11 ' A' ' 102' ' ' LEU . 0.3 OUTLIER -124.8 151.74 44.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 72.33 110.868 -179.901 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.8 t0 64.54 15.21 9.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 75.31 110.847 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.37 1.8 83.43 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.758 -0.734 . . . . 60.1 112.527 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -139.92 172.88 12.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.841 0.353 . . . . 74.01 110.902 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.67 89.28 0.37 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 73.14 110.855 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.616 HD13 ' HB3' ' A' ' 104' ' ' LEU . 0.6 OUTLIER -74.38 131.49 41.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 64.53 110.955 179.986 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 11.7 ttp180 -110.8 118.48 36.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 75.12 110.862 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.583 HG13 ' HB2' ' A' ' 122' ' ' CYS . 0.1 OUTLIER -108.63 143.74 18.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 52.42 111.112 179.955 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.433 HG22 HG23 ' A' ' 99' ' ' THR . 15.6 t -135.85 153.04 31.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.13 -0.486 . . . . 31.11 111.111 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.605 HD22 HD13 ' A' ' 151' ' ' ILE . 4.3 tp -129.71 105.92 8.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.165 -0.471 . . . . 74.41 110.927 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.488 ' HA ' HG22 ' A' ' 97' ' ' THR . 0.0 OUTLIER -81.43 135.51 35.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.231 -0.44 . . . . 74.43 110.823 179.955 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.0 mtmt -73.52 -16.54 61.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.098 -0.501 . . . . 64.44 110.859 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -51.34 -55.85 16.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.254 -0.43 . . . . 71.41 110.884 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.86 16.81 3.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 63.43 111.207 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . 0.534 ' HA ' HD11 ' A' ' 113' ' ' LEU . 1.9 mtp 59.99 20.21 9.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.464 . . . . 53.22 110.891 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -70.91 151.03 45.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 73.1 110.886 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.7 HG22 HD12 ' A' ' 151' ' ' ILE . 80.4 t -105.07 117.81 51.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 74.4 111.095 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 55.2 t-105 -95.61 113.63 25.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.211 -0.45 . . . . 71.33 110.946 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . 0.583 ' HB2' HG13 ' A' ' 111' ' ' VAL . 9.0 t -140.26 133.03 29.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.246 -0.434 . . . . 74.32 110.897 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 57.98 34.06 23.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 62.01 110.915 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 57.76 49.85 70.62 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.743 -0.741 . . . . 55.4 112.476 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.93 121.6 2.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.836 0.35 . . . . 73.44 110.934 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -54.08 100.39 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 73.34 110.942 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' MET . . . . . 0.426 ' HB2' ' HB ' ' A' ' 120' ' ' VAL . 17.2 mmm -56.47 174.23 0.15 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.283 -0.417 . . . . 72.34 110.868 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -119.27 106.29 12.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.212 -0.449 . . . . 75.43 110.847 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.713 ' HB ' HG22 ' A' ' 140' ' ' THR . 19.8 p -98.64 -175.23 3.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.135 -0.484 . . . . 70.21 111.16 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.501 ' HB2' ' HB2' ' A' ' 141' ' ' HIS . . . -99.87 -38.38 8.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.269 -0.423 . . . . 71.04 111.092 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 69.77 43.56 66.47 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.711 -0.756 . . . . 44.03 112.55 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -83.32 115.92 22.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.922 0.392 . . . . 74.51 110.921 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -91.35 121.01 32.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 63.33 110.895 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.486 HG22 ' O ' ' A' ' 137' ' ' GLY . 27.3 m -101.83 177.56 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 71.24 111.074 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -52.92 -30.67 35.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.459 . . . . 73.13 110.925 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.427 ' H ' HG23 ' A' ' 134' ' ' VAL . 0.7 OUTLIER -158.03 91.88 1.14 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 51.33 110.841 179.959 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.486 ' O ' HG22 ' A' ' 134' ' ' VAL . . . 128.21 179.31 15.8 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.716 -0.754 . . . . 75.22 112.508 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.573 ' O ' ' HB3' ' A' ' 153' ' ' ALA . 0.1 OUTLIER -135.03 130.78 36.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.763 0.316 . . . . 74.52 111.109 -179.842 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -108.57 96.78 6.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.444 . . . . 74.13 110.893 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.713 HG22 ' HB ' ' A' ' 129' ' ' THR . 0.0 OUTLIER -83.64 109.99 17.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.168 -0.469 . . . . 64.13 111.075 -179.881 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . 0.501 ' HB2' ' HB2' ' A' ' 130' ' ' ALA . 71.8 m-70 -101.83 104.53 15.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 64.53 110.86 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 23.2 p90 -126.43 135.63 51.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 71.35 110.896 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 36.6 p -102.72 157.38 16.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.441 . . . . 74.21 110.849 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 90.5 t -138.7 105.59 2.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.101 -0.499 . . . . 50.13 111.093 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 55.06 -105.58 0.41 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.701 -0.761 . . . . 72.03 112.512 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -117.32 24.81 10.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.793 0.33 . . . . 71.32 110.869 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -117.1 172.18 7.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 60.12 110.877 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -130.24 120.74 24.92 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.241 -0.436 . . . . 72.34 110.867 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' CYS . . . . . 0.592 ' HB3' HG22 ' A' ' 169' ' ' VAL . 1.0 OUTLIER -142.68 170.73 15.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.179 -0.464 . . . . 74.43 110.913 -179.932 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -175.2 147.71 0.93 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.21 -0.45 . . . . 75.34 110.914 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.7 HD12 HG22 ' A' ' 120' ' ' VAL . 12.9 mt -97.5 111.16 26.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.086 -0.506 . . . . 74.14 111.097 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 20.2 tttt -82.03 102.65 11.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.25 -0.432 . . . . 70.53 110.827 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.573 ' HB3' ' O ' ' A' ' 138' ' ' THR . . . -95.07 147.15 23.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 53.4 111.113 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.5 t -145.08 119.22 2.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 65.33 111.173 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.3 p -84.26 137.95 33.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.471 . . . . 71.23 110.871 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 1.5 t -133.54 152.47 51.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 63.53 110.794 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 112.25 -126.57 7.65 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.763 -0.732 . . . . 74.35 112.476 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -121.75 -65.05 1.16 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.756 0.313 . . . . 74.02 110.928 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -136.8 91.9 2.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.172 -0.467 . . . . 71.32 110.927 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 60.1 26.5 15.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 63.04 110.888 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.91 -69.96 0.19 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.198 -0.456 . . . . 55.11 110.931 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -137.39 120.49 2.09 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.719 -0.753 . . . . 54.34 112.479 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 72.2 mt -110.1 144.97 17.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.746 0.308 . . . . 74.42 111.158 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 3.0 mt -128.16 130.53 69.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.262 -0.426 . . . . 62.34 111.112 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' HIS . . . . . 0.469 ' CG ' HD23 ' A' ' 113' ' ' LEU . 13.1 m80 -108.2 137.29 46.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 73.23 110.862 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.38 107.19 9.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.243 -0.435 . . . . 73.32 111.149 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.597 HD12 ' N ' ' A' ' 168' ' ' ILE . 13.6 tp -67.37 137.21 55.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.249 -0.432 . . . . 75.11 110.982 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.597 ' N ' HD12 ' A' ' 167' ' ' LEU . 9.7 mt -138.76 114.21 9.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.184 -0.462 . . . . 65.22 111.161 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.592 HG22 ' HB3' ' A' ' 149' ' ' CYS . 43.8 t -115.88 126.5 73.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 75.4 111.104 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.3 t0 63.53 39.26 9.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 74.44 110.935 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 60.06 42.3 15.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.47 . . . . 72.24 110.872 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -138.45 124.99 20.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 64.41 110.883 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -62.65 140.49 58.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.272 -0.422 . . . . 74.13 110.891 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.475 HD12 HD22 ' A' ' 102' ' ' LEU . 0.9 OUTLIER -118.64 131.26 24.36 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.616 0.722 . . . . 70.41 111.126 179.992 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.66 135.85 31.74 Favored 'Trans proline' 0 N--CA 1.465 -0.179 0 C-N-CA 122.744 2.296 . . . . 73.13 112.386 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -89.51 131.51 35.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.259 -0.428 . . . . 72.14 110.854 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.35 126.7 31.55 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.143 -0.481 . . . . 74.5 110.85 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 30.0 p -135.53 174.42 10.63 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.188 -0.46 . . . . 74.22 111.092 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.181 -0.463 . . . . 63.41 110.842 -179.959 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 CA-C-O 121.416 0.453 . . . . 24.11 112.496 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -33.97 15.47 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.659 2.24 . . . . 73.22 112.303 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 61.03 170.08 0.1 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.267 -0.424 . . . . 65.1 110.963 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -106.82 -113.4 3.78 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.763 -0.732 . . . . 64.1 112.53 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 20.8 t -142.63 97.37 3.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.909 0.385 . . . . 63.22 110.838 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 61.13 170.36 0.1 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.082 -0.508 . . . . 72.32 110.896 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 10.8 p-10 -146.4 131.78 18.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 71.12 110.859 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 4.2 ttm180 61.27 171.74 0.11 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.133 -0.485 . . . . 63.21 110.878 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.1 t 52.53 55.55 8.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 31.45 110.823 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 6.5 ttpt -162.19 91.64 0.79 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.111 -0.495 . . . . 71.35 110.839 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.504 ' O ' HG23 ' A' ' 97' ' ' THR . 54.4 p -117.74 33.96 5.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.228 -0.442 . . . . 75.41 111.108 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.504 HG23 ' O ' ' A' ' 96' ' ' THR . 1.0 OUTLIER -159.58 127.94 5.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.265 -0.425 . . . . 64.43 111.207 -179.986 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.413 ' O ' HG13 ' A' ' 112' ' ' VAL . 1.1 m -106.27 151.9 24.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.271 -0.422 . . . . 73.31 110.85 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.949 HG23 HG22 ' A' ' 112' ' ' VAL . 1.3 m -137.85 148.46 45.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.125 -0.488 . . . . 71.24 111.095 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . 0.445 ' CB ' HD23 ' A' ' 167' ' ' LEU . 10.1 m-90 -146.4 124.67 12.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.206 -0.452 . . . . 63.33 110.936 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 19.1 t -108.37 114.81 47.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.284 -0.416 . . . . 64.3 111.164 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.909 HD11 HD12 ' A' ' 104' ' ' LEU . 0.5 OUTLIER -139.94 147.62 40.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.205 -0.452 . . . . 64.33 110.894 -179.989 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -73.32 92.83 1.84 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 74.32 110.856 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.909 HD12 HD11 ' A' ' 102' ' ' LEU . 0.3 OUTLIER -123.82 151.0 43.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 54.1 110.89 179.967 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 64.43 15.45 9.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 74.11 110.832 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.83 1.42 82.65 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.717 -0.754 . . . . 54.21 112.516 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -139.81 172.81 12.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.894 0.378 . . . . 61.32 110.808 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -69.53 89.64 0.52 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.081 -0.509 . . . . 64.53 110.878 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.58 HD13 ' HB3' ' A' ' 104' ' ' LEU . 0.5 OUTLIER -76.5 129.33 36.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 73.44 110.937 -179.953 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 2.5 ttm180 -107.76 118.3 36.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 73.14 110.893 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.6 HG12 ' CG1' ' A' ' 120' ' ' VAL . 0.0 OUTLIER -111.73 115.68 50.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 72.32 111.201 179.933 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.949 HG22 HG23 ' A' ' 99' ' ' THR . 28.3 t -114.51 140.29 36.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.242 -0.435 . . . . 73.25 111.127 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.677 HD22 HD13 ' A' ' 151' ' ' ILE . 3.1 tp -114.0 108.66 17.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.17 -0.468 . . . . 52.2 110.962 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.424 ' N ' HD12 ' A' ' 113' ' ' LEU . 0.6 OUTLIER -81.8 134.79 35.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 63.13 110.874 179.984 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.7 mmmt -73.79 -16.31 61.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 73.13 110.883 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -51.49 -53.82 33.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 53.23 110.871 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.54 17.0 2.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.117 -0.492 . . . . 75.11 111.158 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . 0.586 ' HA ' HD11 ' A' ' 113' ' ' LEU . 64.6 mtp 56.49 33.12 22.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.216 -0.447 . . . . 64.32 110.89 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.73 154.22 20.74 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.229 -0.441 . . . . 74.03 110.88 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.644 HG22 HD12 ' A' ' 151' ' ' ILE . 45.3 t -104.81 131.0 54.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.227 -0.442 . . . . 43.4 111.09 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 2.2 t90 -111.85 124.69 52.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 73.54 110.973 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 16.5 t -121.45 103.35 8.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.293 -0.412 . . . . 61.32 110.926 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 46.56 70.99 0.34 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.236 -0.438 . . . . 74.22 110.9 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 47.69 40.31 17.69 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.71 -0.757 . . . . 74.1 112.503 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -141.78 102.27 4.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.92 0.391 . . . . 74.44 110.847 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 4.6 tttt -53.44 102.11 0.05 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 65.34 110.862 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 21.7 mmm -64.79 167.29 7.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.481 . . . . 62.14 110.867 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -119.33 106.09 11.95 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.204 -0.453 . . . . 53.32 110.882 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.683 ' CB ' HG22 ' A' ' 140' ' ' THR . 18.8 p -95.83 177.9 5.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 50.31 111.144 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.674 ' HB3' ' HB2' ' A' ' 141' ' ' HIS . . . -125.08 83.59 2.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 73.42 111.128 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -51.58 113.68 2.54 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.751 -0.738 . . . . 55.13 112.498 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -134.23 109.94 9.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.813 0.34 . . . . 73.42 110.894 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -69.46 113.77 7.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.2 -0.454 . . . . 63.12 110.887 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.581 HG22 ' O ' ' A' ' 137' ' ' GLY . 34.1 m -102.34 -176.78 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 74.35 111.192 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -52.9 -43.8 66.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.44 . . . . 63.11 110.886 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -151.09 104.54 3.14 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.17 -0.468 . . . . 65.03 110.945 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.581 ' O ' HG22 ' A' ' 134' ' ' VAL . . . 109.0 -171.13 15.1 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.739 -0.744 . . . . 64.23 112.455 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.597 ' O ' ' HB3' ' A' ' 153' ' ' ALA . 0.1 OUTLIER -134.87 130.87 36.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.761 0.315 . . . . 74.12 111.138 -179.863 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -104.38 98.19 8.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 71.21 110.914 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.683 HG22 ' CB ' ' A' ' 129' ' ' THR . 0.0 OUTLIER -77.24 109.85 11.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.458 . . . . 75.2 111.134 -179.907 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . 0.674 ' HB2' ' HB3' ' A' ' 130' ' ' ALA . 86.6 m-70 -101.15 108.04 19.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.158 -0.474 . . . . 64.32 110.861 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -123.97 124.26 42.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.142 -0.481 . . . . 73.52 110.799 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 66.5 p -85.86 157.97 20.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.119 -0.491 . . . . 65.22 110.838 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 97.5 t -150.16 104.32 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.085 -0.507 . . . . 62.31 111.14 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 52.75 -113.58 2.88 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.697 -0.763 . . . . 52.14 112.516 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -110.46 25.81 11.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.844 0.354 . . . . 74.35 110.867 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 20.9 m-70 -124.84 159.66 30.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.242 -0.435 . . . . 63.1 110.897 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -121.02 123.68 42.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.255 -0.43 . . . . 74.23 110.841 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' CYS . . . . . 0.614 ' HB3' HG22 ' A' ' 169' ' ' VAL . 1.2 p -142.49 154.6 44.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.141 -0.481 . . . . 71.24 110.946 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -157.62 149.03 21.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.218 -0.446 . . . . 72.12 110.943 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.677 HD13 HD22 ' A' ' 113' ' ' LEU . 9.4 mt -97.84 113.93 33.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 61.22 111.067 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 2.4 tttt -80.13 102.65 9.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.207 -0.451 . . . . 74.25 110.866 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.597 ' HB3' ' O ' ' A' ' 138' ' ' THR . . . -98.8 143.92 28.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 75.41 111.115 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 39.4 t -146.68 124.93 4.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.212 -0.449 . . . . 63.4 111.164 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.2 p -94.22 139.54 30.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.221 -0.445 . . . . 65.43 110.823 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.23 145.72 35.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 74.2 110.844 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 129.81 -179.12 17.02 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.701 -0.762 . . . . 53.33 112.491 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 6.4 mtmt -52.81 -58.02 8.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.801 0.334 . . . . 73.11 110.915 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 3.9 ptm180 -150.17 79.45 1.35 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.255 -0.429 . . . . 74.54 110.912 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 15.6 ttmt 61.73 56.49 2.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 73.52 110.915 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -90.89 -68.81 0.77 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.176 -0.465 . . . . 71.44 110.894 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -111.63 128.44 8.63 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.792 -0.718 . . . . 65.45 112.512 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 56.9 mt -120.29 145.0 27.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.767 0.318 . . . . 54.32 111.11 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 57.2 mt -128.58 140.12 50.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.177 -0.465 . . . . 75.32 111.12 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' HIS . . . . . 0.42 ' CG ' HD23 ' A' ' 113' ' ' LEU . 9.4 m80 -117.91 135.48 54.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.137 -0.483 . . . . 53.41 110.816 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.82 109.88 12.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.133 -0.485 . . . . 73.5 111.126 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.555 HD12 ' N ' ' A' ' 168' ' ' ILE . 15.1 tp -68.43 135.63 52.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 73.44 110.981 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.555 ' N ' HD12 ' A' ' 167' ' ' LEU . 10.5 mt -138.63 117.27 13.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.455 . . . . 75.44 111.119 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.614 HG22 ' HB3' ' A' ' 149' ' ' CYS . 21.7 t -117.93 125.82 74.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.172 -0.467 . . . . 63.31 111.103 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 63.56 37.98 10.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 72.44 110.934 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 61.4 43.0 10.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 72.24 110.864 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 16.5 mtt180 -140.23 129.1 23.29 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.177 -0.465 . . . . 72.14 110.852 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -62.69 146.43 52.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.136 -0.484 . . . . 74.34 110.899 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.435 HD12 HD22 ' A' ' 102' ' ' LEU . 0.8 OUTLIER -122.85 130.89 24.45 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.699 0.762 . . . . 71.03 111.14 179.961 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 135.57 30.82 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.66 2.24 . . . . 61.3 112.332 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.572 ' O ' HG23 ' A' ' 178' ' ' THR . 1.8 tm-20 -91.7 124.3 35.74 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.229 -0.441 . . . . 55.43 110.889 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 6.6 tp -52.23 123.15 10.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 64.12 110.869 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.572 HG23 ' O ' ' A' ' 176' ' ' GLU . 69.5 p -131.91 128.66 39.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.228 -0.442 . . . . 65.13 111.135 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.268 -0.423 . . . . 72.24 110.941 179.892 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 CA-C-O 121.43 0.461 . . . . 73.22 112.473 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.84 128.83 16.52 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.664 2.243 . . . . 74.12 112.345 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.8 mt -110.94 -53.69 2.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.213 -0.449 . . . . 73.51 110.967 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 132.31 122.24 2.33 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.736 -0.745 . . . . 71.05 112.52 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.18 141.14 47.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.838 0.352 . . . . 63.53 110.868 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.95 173.12 6.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.476 . . . . 75.52 110.86 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -107.1 157.59 17.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.467 . . . . 71.13 110.857 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.03 81.59 2.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.159 -0.473 . . . . 73.12 110.88 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.0 145.24 21.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.026 0.441 . . . . 74.13 110.86 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 17.2 mttt -121.85 83.26 2.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.052 -0.522 . . . . 64.51 110.896 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.501 ' O ' HG23 ' A' ' 97' ' ' THR . 0.1 OUTLIER -68.64 141.69 55.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.202 -0.454 . . . . 73.31 111.157 179.981 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.501 HG23 ' O ' ' A' ' 96' ' ' THR . 1.0 OUTLIER -159.54 127.8 4.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.234 -0.439 . . . . 74.04 111.181 179.993 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.3 m -106.37 153.95 21.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 70.02 110.879 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.968 HG22 HG22 ' A' ' 112' ' ' VAL . 0.6 OUTLIER -142.21 156.57 45.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.104 -0.498 . . . . 72.15 111.11 -179.904 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 17.2 m-90 -151.45 130.6 12.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.237 -0.438 . . . . 74.1 110.97 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.3 t -110.25 114.79 48.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.249 -0.432 . . . . 75.33 111.107 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.947 HD11 HD12 ' A' ' 104' ' ' LEU . 0.5 OUTLIER -141.69 148.42 39.06 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.197 -0.456 . . . . 74.14 110.95 179.932 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.3 mtm180 -74.73 92.79 2.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.178 -0.464 . . . . 70.5 110.857 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.947 HD12 HD11 ' A' ' 102' ' ' LEU . 0.3 OUTLIER -121.79 152.07 39.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 72.45 110.979 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 64.72 15.03 9.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.213 -0.449 . . . . 74.13 110.889 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.0 0.48 80.95 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.719 -0.753 . . . . 60.34 112.444 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -139.84 172.76 12.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.854 0.359 . . . . 75.01 110.914 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -68.58 89.68 0.37 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 73.22 110.858 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.551 HD13 ' HB3' ' A' ' 104' ' ' LEU . 0.5 OUTLIER -78.91 128.58 33.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 71.15 110.878 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.74 119.7 40.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.131 -0.486 . . . . 54.45 110.875 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.589 HG13 ' SG ' ' A' ' 122' ' ' CYS . 0.1 OUTLIER -107.13 142.61 19.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.124 -0.489 . . . . 50.41 111.131 179.956 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.968 HG22 HG22 ' A' ' 99' ' ' THR . 48.1 t -135.82 146.72 29.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 63.53 111.153 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.58 HD11 ' HA ' ' A' ' 118' ' ' MET . 3.1 tp -128.4 101.24 6.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 73.2 110.878 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.402 ' HG3' HG22 ' A' ' 97' ' ' THR . 0.2 OUTLIER -78.11 122.77 26.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.189 -0.459 . . . . 73.34 110.878 179.924 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.39 -15.94 59.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 65.51 110.946 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -51.44 -56.0 15.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.455 . . . . 74.12 110.868 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 9.5 p -133.87 16.98 3.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.458 . . . . 65.45 111.129 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . 0.58 ' HA ' HD11 ' A' ' 113' ' ' LEU . 9.6 mtp 58.43 24.55 11.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.302 -0.408 . . . . 71.12 110.856 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -76.18 144.55 40.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.267 -0.424 . . . . 71.44 110.842 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.504 HG21 ' CE2' ' A' ' 142' ' ' PHE . 71.4 t -105.1 118.26 52.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 70.0 111.156 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 2.2 t90 -98.34 134.86 40.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.173 -0.467 . . . . 72.01 110.909 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . 0.589 ' SG ' HG13 ' A' ' 111' ' ' VAL . 0.6 OUTLIER -131.18 103.14 6.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 75.25 110.914 179.982 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 22.7 m-20 45.43 69.66 0.43 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 73.52 110.992 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 48.65 41.02 25.99 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.773 -0.727 . . . . 70.4 112.428 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -149.81 115.3 5.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.801 0.334 . . . . 64.11 110.927 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -53.56 162.21 0.87 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.247 -0.433 . . . . 75.4 110.85 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' MET . . . . . 0.526 ' CE ' HG22 ' A' ' 144' ' ' VAL . 35.1 mmm -126.54 166.49 17.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.445 . . . . 73.42 110.945 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -119.26 106.41 12.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.268 -0.424 . . . . 74.14 110.861 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.593 ' CB ' HG22 ' A' ' 140' ' ' THR . 21.7 p -95.8 -175.17 3.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.161 -0.472 . . . . 61.15 111.126 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.468 ' HB2' ' HB2' ' A' ' 141' ' ' HIS . . . -93.33 -35.76 12.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.449 . . . . 64.2 111.138 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 73.88 40.57 43.97 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.769 -0.729 . . . . 51.43 112.496 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -86.04 125.61 33.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.907 0.384 . . . . 65.4 110.832 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -113.16 127.05 56.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.474 . . . . 73.03 110.92 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 11.5 m -108.1 179.89 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 74.44 111.155 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -53.18 -29.75 33.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 75.33 110.845 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -158.12 92.66 1.18 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 65.44 110.897 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 128.93 172.7 13.23 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.74 -0.743 . . . . 64.11 112.483 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.42 ' O ' ' HB3' ' A' ' 153' ' ' ALA . 0.1 OUTLIER -135.04 130.82 36.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.807 0.336 . . . . 63.12 111.164 -179.862 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -104.86 96.63 6.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.222 -0.445 . . . . 73.44 110.858 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.593 HG22 ' CB ' ' A' ' 129' ' ' THR . 0.0 OUTLIER -85.39 110.21 18.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 43.23 111.098 -179.912 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . 0.468 ' HB2' ' HB2' ' A' ' 130' ' ' ALA . 41.9 m170 -109.53 106.24 15.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 75.03 110.821 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.547 ' HD2' HG22 ' A' ' 129' ' ' THR . 9.1 p90 -124.54 144.66 50.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 72.3 110.899 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 77.0 p -91.28 141.61 28.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 74.03 110.892 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.526 HG22 ' CE ' ' A' ' 127' ' ' MET . 17.4 t -138.87 103.47 2.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.175 -0.466 . . . . 54.21 111.096 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 53.76 31.43 46.01 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.704 -0.76 . . . . 70.44 112.476 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 63.36 25.35 14.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.874 0.369 . . . . 65.25 110.883 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 77.6 m-70 -93.5 -11.93 30.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.14 -0.482 . . . . 75.32 110.825 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 63.87 104.88 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.244 -0.434 . . . . 73.24 110.801 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' CYS . . . . . 0.543 ' SG ' HG13 ' A' ' 169' ' ' VAL . 10.9 m -137.91 167.86 20.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.165 -0.47 . . . . 65.4 110.846 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 18.4 p90 -174.39 142.79 0.8 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.474 . . . . 75.11 110.919 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.504 HD13 HD22 ' A' ' 113' ' ' LEU . 32.0 mt -98.59 111.3 27.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.076 -0.511 . . . . 71.31 111.141 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 16.9 tttt -80.11 104.03 10.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.485 . . . . 71.31 110.858 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.42 ' HB3' ' O ' ' A' ' 138' ' ' THR . . . -99.04 146.67 25.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 73.03 111.084 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.2 t -144.9 124.3 6.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.251 -0.431 . . . . 75.24 111.174 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -93.32 129.62 39.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.21 -0.45 . . . . 60.44 110.839 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -130.17 153.45 48.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 74.02 110.858 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 83.3 90.24 0.71 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.659 -0.782 . . . . 64.11 112.516 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.01 -170.13 0.16 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.845 0.355 . . . . 74.14 110.913 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 11.1 mtt180 -52.89 -32.34 44.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.239 -0.437 . . . . 74.22 110.854 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 11.7 pttt -173.41 124.1 0.39 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 70.2 110.916 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -158.58 -54.0 0.07 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.227 -0.442 . . . . 75.05 110.91 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -128.06 105.98 0.76 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.712 -0.756 . . . . 70.12 112.482 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 63.3 mt -103.91 134.76 44.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.751 0.31 . . . . 75.51 111.121 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 53.5 mt -121.04 133.34 68.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.227 -0.442 . . . . 73.1 111.135 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' HIS . . . . . 0.409 ' CG ' HD23 ' A' ' 113' ' ' LEU . 14.2 m80 -108.96 137.94 46.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 54.13 110.848 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.65 103.64 6.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 75.12 111.128 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.559 HD12 ' H ' ' A' ' 168' ' ' ILE . 15.9 tp -66.35 138.35 57.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.237 -0.438 . . . . 74.03 110.907 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.559 ' H ' HD12 ' A' ' 167' ' ' LEU . 11.0 mt -135.95 119.53 23.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.216 -0.447 . . . . 72.52 111.105 179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.543 HG13 ' SG ' ' A' ' 149' ' ' CYS . 88.2 t -118.5 135.46 58.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 64.52 111.082 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 54.01 37.01 25.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 63.42 110.898 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 10.3 t30 63.37 42.93 6.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.166 -0.47 . . . . 54.41 110.956 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 4.2 mtm180 -141.44 130.46 23.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 65.45 110.88 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -62.83 146.45 52.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.208 -0.451 . . . . 75.12 110.853 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.477 HD12 HD22 ' A' ' 102' ' ' LEU . 0.9 OUTLIER -122.98 131.14 24.38 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.65 0.738 . . . . 63.23 111.11 179.965 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.74 135.89 31.66 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.624 2.216 . . . . 75.35 112.398 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -89.84 153.97 20.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 73.1 110.89 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.567 ' O ' HD13 ' A' ' 177' ' ' LEU . 0.4 OUTLIER -51.78 -36.91 49.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.162 -0.472 . . . . 63.54 110.89 -179.939 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 72.8 p -51.77 149.9 4.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 43.0 111.087 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 64.42 110.891 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 CA-C-O 121.416 0.453 . . . . 62.14 112.483 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.462 ' O ' HD12 ' A' ' 88' ' ' LEU . 54.1 Cg_endo -69.83 153.58 68.44 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.699 2.266 . . . . 52.3 112.296 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.462 HD12 ' O ' ' A' ' 87' ' ' PRO . 0.4 OUTLIER -144.6 120.52 10.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 71.01 110.971 179.998 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.8 79.6 0.24 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.742 -0.742 . . . . 61.43 112.452 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -160.98 126.06 3.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.882 0.372 . . . . 71.32 110.873 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -125.08 151.83 45.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.109 -0.496 . . . . 74.02 110.923 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 69.19 -75.7 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 73.32 110.884 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 23.3 mtm180 56.66 35.37 26.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.166 -0.47 . . . . 63.42 110.865 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 7.2 t -178.78 133.29 0.13 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 74.41 110.866 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.31 -72.44 0.19 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.066 -0.515 . . . . 70.23 110.911 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.499 ' O ' HG23 ' A' ' 97' ' ' THR . 0.2 OUTLIER -151.24 23.74 0.73 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 70.11 111.157 179.962 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.499 HG23 ' O ' ' A' ' 96' ' ' THR . 1.0 OUTLIER -159.47 128.09 5.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 41.44 111.084 -179.987 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.8 m -105.98 154.04 21.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.237 -0.438 . . . . 74.54 110.855 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 27.3 m -141.56 148.58 39.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.139 -0.482 . . . . 74.04 111.153 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . 0.54 ' CB ' HD23 ' A' ' 167' ' ' LEU . 9.3 m-90 -145.37 122.91 11.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.198 -0.455 . . . . 73.41 110.89 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.409 HG23 HD23 ' A' ' 177' ' ' LEU . 19.5 t -103.32 114.79 43.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 71.24 111.075 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.788 HD11 HD12 ' A' ' 104' ' ' LEU . 0.5 OUTLIER -141.97 146.6 35.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.119 -0.491 . . . . 75.05 110.898 179.925 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 4.8 mtt85 -74.44 92.18 2.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 73.54 110.88 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.788 HD12 HD11 ' A' ' 102' ' ' LEU . 0.4 OUTLIER -122.99 153.74 39.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.207 -0.452 . . . . 73.04 110.926 -179.974 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.5 t70 65.14 14.44 9.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.181 -0.463 . . . . 43.23 110.877 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.55 0.0 79.81 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.791 -0.719 . . . . 51.13 112.503 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -139.86 172.91 12.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.868 0.366 . . . . 74.34 110.836 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -68.78 88.13 0.36 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.112 -0.495 . . . . 74.21 110.879 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.608 HD13 ' HB3' ' A' ' 104' ' ' LEU . 0.5 OUTLIER -73.26 124.85 26.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.259 -0.428 . . . . 74.34 110.907 -179.907 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -102.03 109.79 21.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 73.12 110.893 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.568 HG13 ' SG ' ' A' ' 122' ' ' CYS . 2.5 t -95.25 136.7 25.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 65.33 111.09 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 86.6 t -136.51 128.58 44.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.163 -0.471 . . . . 75.0 111.126 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.609 HD22 HD13 ' A' ' 151' ' ' ILE . 4.9 tp -110.07 102.31 11.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.138 -0.483 . . . . 71.54 110.875 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.455 ' HA ' HG22 ' A' ' 97' ' ' THR . 0.1 OUTLIER -78.7 136.15 37.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.211 -0.449 . . . . 64.24 110.914 179.875 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.431 ' HG3' HG22 ' A' ' 96' ' ' THR . 21.0 mmmt -73.77 -17.15 61.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.135 -0.484 . . . . 73.42 110.861 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -51.49 -53.88 32.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 63.11 110.869 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.82 17.0 3.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.201 -0.454 . . . . 64.22 111.112 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . 0.426 ' HA ' HD11 ' A' ' 113' ' ' LEU . 2.6 ttp 53.67 28.22 7.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 60.34 110.876 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -85.23 158.62 20.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 73.15 110.87 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.545 HG23 HG21 ' A' ' 129' ' ' THR . 21.6 t -104.87 138.4 29.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.207 -0.451 . . . . 72.2 111.15 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 1.2 t90 -123.28 121.12 35.07 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.252 -0.431 . . . . 75.2 110.872 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . 0.568 ' SG ' HG13 ' A' ' 111' ' ' VAL . 60.8 m -132.21 131.77 42.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.236 -0.438 . . . . 63.11 110.877 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . 0.46 ' ND2' HD12 ' A' ' 109' ' ' LEU . 41.0 m-20 49.3 50.24 18.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.189 -0.459 . . . . 63.43 110.92 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 49.04 45.08 33.12 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.795 -0.717 . . . . 71.33 112.447 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -147.96 116.96 6.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.828 0.347 . . . . 74.4 110.921 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 13.2 mttt -53.17 102.3 0.05 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.295 -0.411 . . . . 71.33 110.922 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 23.4 mmm -64.52 166.5 8.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 75.25 110.882 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.17 106.0 11.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.994 0.426 . . . . 72.34 110.836 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.603 ' CB ' HG22 ' A' ' 140' ' ' THR . 16.0 p -97.72 175.29 6.23 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.099 -0.501 . . . . 73.22 111.117 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.618 ' HB3' ' HB2' ' A' ' 141' ' ' HIS . . . -122.48 90.13 3.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.227 -0.442 . . . . 73.21 111.074 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -50.85 117.19 5.09 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.726 -0.749 . . . . 72.51 112.482 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -146.05 101.97 3.58 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.952 0.406 . . . . 74.43 110.823 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -69.52 150.3 47.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.113 -0.494 . . . . 75.44 110.897 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 8.3 m -140.39 -177.79 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.168 -0.469 . . . . 64.52 111.087 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.55 -17.85 56.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.186 -0.461 . . . . 71.1 110.861 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -106.21 -75.32 0.63 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.159 -0.473 . . . . 55.22 110.854 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -137.72 -120.97 1.94 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.717 -0.754 . . . . 35.01 112.446 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -134.19 130.78 37.73 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.734 0.302 . . . . 72.14 111.184 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -98.08 96.13 7.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.296 -0.411 . . . . 63.53 110.914 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.603 HG22 ' CB ' ' A' ' 129' ' ' THR . 0.0 OUTLIER -79.14 109.4 13.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 71.22 111.202 -179.973 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . 0.618 ' HB2' ' HB3' ' A' ' 130' ' ' ALA . 38.0 m170 -100.66 112.69 25.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.306 -0.406 . . . . 63.41 110.832 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.436 ' CD2' HG22 ' A' ' 129' ' ' THR . 6.5 p90 -125.84 114.43 18.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 74.42 110.852 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 98.4 p -78.28 151.57 32.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.081 -0.508 . . . . 53.52 110.842 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 46.9 t -146.81 108.67 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.086 -0.506 . . . . 54.23 111.147 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 52.92 -109.98 1.14 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.759 -0.734 . . . . 74.22 112.488 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -116.6 26.4 9.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.881 0.372 . . . . 71.44 110.916 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 23.9 m-70 -123.49 164.2 19.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 64.43 110.853 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -126.06 123.17 37.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 52.3 110.809 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' CYS . . . . . 0.594 ' HB3' HG22 ' A' ' 169' ' ' VAL . 0.9 OUTLIER -142.67 150.66 40.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.226 -0.443 . . . . 52.14 110.878 -179.93 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 17.6 p90 -150.87 149.61 29.89 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.181 -0.463 . . . . 73.23 110.979 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.609 HD13 HD22 ' A' ' 113' ' ' LEU . 7.6 mt -99.65 114.27 37.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.176 -0.465 . . . . 72.45 111.126 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.633 ' HD3' HD12 ' A' ' 168' ' ' ILE . 0.1 OUTLIER -80.24 103.09 9.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.225 -0.443 . . . . 73.24 110.871 179.834 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -100.13 146.65 26.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.195 -0.457 . . . . 61.11 111.1 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 66.2 t -149.21 122.94 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.199 -0.455 . . . . 61.3 111.134 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.2 p -92.26 144.56 25.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.186 -0.461 . . . . 71.1 110.859 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.25 141.82 30.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.487 . . . . 63.13 110.851 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 129.71 -168.84 21.02 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.696 -0.764 . . . . 63.52 112.507 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 8.4 mtmt -56.39 -26.75 54.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.794 0.331 . . . . 71.54 110.93 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -176.97 -40.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 70.24 110.818 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 34.9 mttt -155.87 31.8 0.35 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 73.2 110.905 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -55.93 -60.57 3.28 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.179 -0.464 . . . . 74.13 110.92 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -143.6 142.24 11.09 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.773 -0.727 . . . . 74.42 112.5 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 47.8 mt -126.16 147.15 31.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.756 0.312 . . . . 63.03 111.087 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 38.3 mt -128.29 137.14 58.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.205 -0.452 . . . . 65.23 111.14 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 5.8 m80 -120.72 134.39 55.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 63.23 110.876 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.48 117.17 23.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.449 . . . . 52.53 111.183 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.54 HD23 ' CB ' ' A' ' 100' ' ' TRP . 14.0 tp -71.3 132.56 45.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 70.42 110.953 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.633 HD12 ' HD3' ' A' ' 152' ' ' LYS . 11.0 mt -135.92 116.53 18.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.263 -0.426 . . . . 63.2 111.126 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.594 HG22 ' HB3' ' A' ' 149' ' ' CYS . 17.0 t -119.08 127.99 75.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 63.41 111.171 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 2.2 t0 63.89 35.56 10.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 74.3 110.842 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 1.8 m120 63.33 43.09 6.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 55.34 110.887 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 58.3 mtt180 -142.97 128.72 19.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.112 -0.495 . . . . 64.34 110.867 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -62.44 146.5 51.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.457 . . . . 71.44 110.906 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -121.28 130.65 24.72 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.578 0.704 . . . . 62.32 111.121 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.67 143.92 52.84 Favored 'Trans proline' 0 N--CA 1.465 -0.157 0 C-N-CA 122.737 2.292 . . . . 74.33 112.364 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -89.49 144.23 26.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.268 -0.424 . . . . 73.35 110.835 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.572 ' O ' HD13 ' A' ' 177' ' ' LEU . 0.6 OUTLIER -52.29 -38.86 59.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 52.33 110.917 -179.967 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 30.0 p -51.99 141.18 18.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 72.23 111.124 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 82.1 mm-40 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.465 . . . . 75.02 110.869 179.966 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.35 0 CA-C-O 121.514 0.508 . . . . 64.01 112.464 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 159.34 53.75 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.688 2.259 . . . . 61.41 112.335 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -139.69 133.59 30.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.242 -0.435 . . . . 73.33 110.955 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -155.27 78.35 0.2 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.776 -0.726 . . . . 61.22 112.523 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 24.0 p -171.11 98.05 0.21 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.815 0.341 . . . . 74.31 110.86 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -165.36 138.35 4.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.074 -0.512 . . . . 71.55 110.937 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 30.8 m120 -76.43 161.72 28.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.17 -0.468 . . . . 71.35 110.827 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -133.47 33.93 3.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.084 -0.507 . . . . 63.12 110.822 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -126.76 48.4 2.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.241 -0.436 . . . . 74.53 110.877 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.81 91.41 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.107 -0.497 . . . . 75.31 110.882 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.499 ' O ' HG23 ' A' ' 97' ' ' THR . 1.1 t -142.15 118.44 10.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 74.42 111.158 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.499 HG23 ' O ' ' A' ' 96' ' ' THR . 1.0 OUTLIER -159.62 133.08 7.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 72.53 111.119 -179.981 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.3 m -105.66 150.43 25.46 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.197 -0.456 . . . . 52.01 110.776 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.618 HG23 HG22 ' A' ' 112' ' ' VAL . 2.2 m -141.79 154.7 45.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.053 -0.521 . . . . 71.34 111.12 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . 0.494 ' CB ' HD23 ' A' ' 167' ' ' LEU . 12.1 m-90 -151.52 128.61 11.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.437 . . . . 65.13 110.957 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 19.5 t -108.1 114.9 47.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.237 -0.438 . . . . 74.44 111.21 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.735 HD11 HD12 ' A' ' 104' ' ' LEU . 0.5 OUTLIER -140.19 146.06 38.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 75.24 110.887 179.992 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.9 mtm180 -73.37 92.54 1.84 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.137 -0.483 . . . . 74.34 110.872 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.735 HD12 HD11 ' A' ' 102' ' ' LEU . 0.4 OUTLIER -124.89 153.14 43.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.096 -0.502 . . . . 73.22 110.867 -179.996 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 64.62 15.14 9.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.475 . . . . 75.2 110.891 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 88.1 1.01 82.49 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.722 -0.752 . . . . 71.21 112.502 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -139.79 172.95 12.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.844 0.354 . . . . 74.14 110.866 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.42 87.01 0.44 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.165 -0.47 . . . . 54.01 110.886 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.56 HD13 ' HB3' ' A' ' 104' ' ' LEU . 0.7 OUTLIER -69.05 125.29 26.21 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.225 -0.443 . . . . 74.3 110.855 -179.87 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 17.3 ttm180 -103.99 109.79 21.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 74.54 110.841 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.478 HG21 ' CD2' ' A' ' 167' ' ' LEU . 1.4 t -95.54 136.37 26.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.216 -0.447 . . . . 73.03 111.155 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.618 HG22 HG23 ' A' ' 99' ' ' THR . 93.2 t -136.03 122.65 32.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.204 -0.453 . . . . 63.24 111.142 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.579 HD11 ' HA ' ' A' ' 118' ' ' MET . 2.4 tp -110.31 108.6 18.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.117 -0.492 . . . . 63.14 110.966 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.437 ' N ' HD12 ' A' ' 113' ' ' LEU . 0.1 OUTLIER -85.08 136.73 33.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 74.3 110.913 179.91 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.449 ' HB2' HG23 ' A' ' 96' ' ' THR . 0.0 OUTLIER -73.85 -16.42 61.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.138 -0.483 . . . . 72.44 110.892 179.936 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -51.46 -54.57 25.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.277 -0.419 . . . . 63.25 110.798 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.55 17.06 2.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 53.1 111.174 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . 0.579 ' HA ' HD11 ' A' ' 113' ' ' LEU . 24.7 mtp 59.18 21.76 9.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 75.43 110.862 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.57 142.5 51.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.283 -0.417 . . . . 63.23 110.89 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 65.3 t -105.02 118.45 52.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 74.23 111.112 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 2.8 t90 -101.16 131.84 46.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.459 . . . . 65.52 110.908 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -123.97 103.76 8.51 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.22 -0.445 . . . . 71.25 110.922 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 4.9 p30 39.51 71.59 0.17 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.462 . . . . 63.34 110.915 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 51.0 41.05 44.61 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.773 -0.727 . . . . 73.31 112.523 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -150.45 112.66 4.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.878 0.371 . . . . 73.33 110.866 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 6.4 mtmm -53.63 162.05 0.93 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.217 -0.447 . . . . 61.04 110.888 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' MET . . . . . . . . . . . . . 27.7 mmm -127.89 162.99 25.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 75.05 110.91 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -119.28 106.35 12.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.295 -0.411 . . . . 75.23 110.901 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.613 ' CB ' HG22 ' A' ' 140' ' ' THR . 18.0 p -95.46 -176.71 3.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.142 -0.481 . . . . 73.35 111.156 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -89.04 -34.57 16.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.44 . . . . 42.22 111.095 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 60.89 72.99 0.55 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.741 -0.742 . . . . 74.31 112.53 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -131.94 124.34 29.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.913 0.387 . . . . 63.53 110.895 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -95.7 115.77 27.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.126 -0.488 . . . . 71.53 110.88 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.467 HG23 ' H ' ' A' ' 136' ' ' ASP . 30.2 m -83.14 -179.33 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.134 -0.484 . . . . 75.21 111.147 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -53.16 -28.95 28.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.244 -0.435 . . . . 74.31 110.891 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.467 ' H ' HG23 ' A' ' 134' ' ' VAL . 3.7 p-10 -164.02 85.01 0.46 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.166 -0.47 . . . . 65.33 110.919 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.436 ' O ' HG22 ' A' ' 134' ' ' VAL . . . 140.29 -179.06 19.42 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.749 -0.739 . . . . 31.44 112.449 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.628 ' O ' ' HB3' ' A' ' 153' ' ' ALA . 0.1 OUTLIER -135.37 130.81 35.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.748 0.308 . . . . 64.33 111.188 -179.862 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -116.14 96.35 5.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 61.32 110.885 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.613 HG22 ' CB ' ' A' ' 129' ' ' THR . 0.0 OUTLIER -83.77 110.23 18.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 70.14 111.11 -179.903 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 67.6 m-70 -109.25 107.1 17.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 64.32 110.891 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.529 ' HD2' HG22 ' A' ' 129' ' ' THR . 1.8 p90 -119.64 -176.15 3.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.23 -0.441 . . . . 64.2 110.925 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 25.3 p -140.33 165.25 27.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 61.42 110.835 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.575 HG11 HD22 ' A' ' 104' ' ' LEU . 58.3 t -148.85 98.18 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.092 -0.504 . . . . 53.15 111.08 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 61.19 -108.25 1.83 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.77 -0.728 . . . . 75.3 112.529 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -106.14 -26.9 11.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.896 0.379 . . . . 42.42 110.914 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 52.3 m-70 -64.37 -170.19 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.124 -0.489 . . . . 74.21 110.859 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -153.68 116.38 4.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 72.2 110.861 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' CYS . . . . . 0.591 ' HB3' HG22 ' A' ' 169' ' ' VAL . 0.8 OUTLIER -142.66 163.5 32.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.261 -0.427 . . . . 51.33 110.886 -179.867 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 28.5 p90 -161.17 152.87 19.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.191 -0.459 . . . . 73.12 110.877 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.52 HD13 HD22 ' A' ' 113' ' ' LEU . 21.0 mt -99.36 121.44 49.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.133 -0.485 . . . . 73.01 111.168 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.435 ' HD2' HD12 ' A' ' 168' ' ' ILE . 2.1 tttm -89.95 102.56 15.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 72.45 110.909 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.628 ' HB3' ' O ' ' A' ' 138' ' ' THR . . . -99.65 147.24 25.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.439 . . . . 72.21 111.064 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.8 t -145.46 131.29 13.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.184 -0.462 . . . . 71.43 111.045 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.1 p -102.2 145.48 29.35 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.162 -0.472 . . . . 52.05 110.83 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 2.0 p -150.54 165.62 32.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.08 -0.509 . . . . 71.04 110.897 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 112.56 -49.87 0.81 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.713 -0.756 . . . . 71.25 112.493 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -178.54 -64.81 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.806 0.336 . . . . 63.41 110.892 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.31 -42.93 0.29 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 75.42 110.887 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.77 26.82 0.64 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 63.41 110.833 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -62.52 -71.91 0.15 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.282 -0.417 . . . . 71.53 110.875 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -127.46 145.08 15.62 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.794 -0.717 . . . . 64.41 112.568 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 62.9 mt -138.59 139.97 40.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.823 0.344 . . . . 65.44 111.088 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 68.0 mt -127.37 140.36 49.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.122 -0.49 . . . . 73.35 111.147 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 11.1 m80 -113.21 142.21 46.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 61.43 110.831 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.87 106.57 7.36 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.197 -0.456 . . . . 75.15 111.123 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.554 HD21 HD22 ' A' ' 102' ' ' LEU . 17.1 tp -67.35 136.39 54.73 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.251 -0.431 . . . . 73.52 110.951 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.534 ' H ' HD12 ' A' ' 167' ' ' LEU . 9.3 mt -138.31 121.16 19.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 75.35 111.158 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.66 HG21 HD13 ' A' ' 102' ' ' LEU . 18.0 t -121.93 124.98 72.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 64.34 111.12 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.5 t0 64.03 36.5 9.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 74.35 110.822 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 63.4 43.05 6.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.436 . . . . 51.54 110.873 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 3.9 mtm180 -140.51 128.98 22.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 74.31 110.92 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.69 146.52 52.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.434 . . . . 65.24 110.843 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -122.95 130.92 24.42 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.63 0.729 . . . . 75.55 111.189 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 140.4 42.68 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.738 2.292 . . . . 64.22 112.351 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -85.63 55.54 3.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 70.53 110.866 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.408 HD22 ' HA ' ' A' ' 177' ' ' LEU . 0.7 OUTLIER 72.53 -67.54 0.26 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.237 -0.438 . . . . 71.23 110.909 -179.955 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 11.2 t -58.22 -32.01 67.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.248 -0.433 . . . . 73.51 111.097 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.235 -0.439 . . . . 65.42 110.945 179.984 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 CA-C-O 121.493 0.496 . . . . 72.11 112.491 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.73 -35.36 12.89 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.654 2.236 . . . . 64.12 112.328 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 53.2 59.97 4.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.255 -0.429 . . . . 73.32 110.982 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 101.7 78.28 1.31 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.728 -0.749 . . . . 44.12 112.507 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 21.4 p -106.46 -174.01 2.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.87 0.367 . . . . 75.25 110.806 -179.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -140.72 -72.28 0.36 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.127 -0.488 . . . . 73.31 110.849 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -103.24 -63.64 1.16 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.128 -0.487 . . . . 75.41 110.904 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 12.6 mmt180 54.17 28.23 8.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.147 -0.479 . . . . 74.45 110.927 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -85.88 112.77 21.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.149 -0.478 . . . . 52.13 110.896 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.401 ' O ' HG23 ' A' ' 96' ' ' THR . 15.1 mttt -83.24 -74.38 0.37 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.117 -0.492 . . . . 65.21 110.912 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.509 ' O ' HG23 ' A' ' 97' ' ' THR . 2.1 p -155.23 22.22 0.42 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.246 -0.434 . . . . 60.14 111.155 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.509 HG23 ' O ' ' A' ' 96' ' ' THR . 1.1 p -159.51 128.29 5.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.224 -0.444 . . . . 72.41 111.17 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -105.75 150.94 25.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.03 0.443 . . . . 54.25 110.838 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 12.0 m -143.05 153.07 42.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.095 -0.502 . . . . 62.52 111.214 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . 0.498 ' CB ' HD23 ' A' ' 167' ' ' LEU . 11.0 m-90 -151.47 127.4 10.34 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.296 -0.411 . . . . 64.24 110.907 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.5 t -106.99 114.99 47.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.455 . . . . 62.14 111.148 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.944 HD11 HD12 ' A' ' 104' ' ' LEU . 0.5 OUTLIER -141.17 147.36 38.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.117 -0.492 . . . . 74.3 110.962 179.973 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 2.7 mtt180 -72.82 91.81 1.53 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 74.23 110.798 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.944 HD12 HD11 ' A' ' 102' ' ' LEU . 0.3 OUTLIER -122.1 151.99 40.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 65.03 110.892 179.988 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 64.84 14.75 9.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 75.43 110.946 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.15 0.39 80.57 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.775 -0.726 . . . . 63.51 112.506 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -139.72 172.86 12.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.797 0.332 . . . . 73.43 110.954 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -68.85 89.25 0.4 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.241 -0.436 . . . . 71.43 110.901 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.587 HD13 ' HB3' ' A' ' 104' ' ' LEU . 0.4 OUTLIER -75.43 127.92 34.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 64.43 110.9 -179.893 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 58.6 ttt180 -105.5 110.21 22.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.225 -0.443 . . . . 74.11 110.788 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.41 HG21 ' CD2' ' A' ' 167' ' ' LEU . 0.9 OUTLIER -95.5 139.75 18.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.103 -0.499 . . . . 52.24 111.056 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 93.3 t -136.23 130.02 47.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.133 -0.485 . . . . 74.33 111.134 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.594 HD11 ' HA ' ' A' ' 118' ' ' MET . 2.3 tp -118.07 104.46 10.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.102 -0.499 . . . . 74.32 110.846 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.477 ' HG3' HG22 ' A' ' 97' ' ' THR . 0.1 OUTLIER -81.6 124.67 29.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 63.03 110.854 179.932 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.59 -16.02 59.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 71.44 110.927 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -51.63 -55.98 16.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.203 -0.453 . . . . 72.15 110.884 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.3 m -132.76 17.02 4.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.264 -0.425 . . . . 74.31 111.147 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . 0.594 ' HA ' HD11 ' A' ' 113' ' ' LEU . 82.5 mtp 54.68 31.53 15.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 63.32 110.85 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -86.46 147.18 26.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.444 . . . . 74.32 110.893 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.537 HG23 HG21 ' A' ' 129' ' ' THR . 25.2 t -104.84 137.6 33.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.247 -0.433 . . . . 63.41 111.14 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 1.2 t90 -125.51 129.7 50.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.133 -0.485 . . . . 55.44 110.881 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 16.8 p -138.48 133.87 33.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.221 -0.445 . . . . 62.41 110.912 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 46.05 49.14 12.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 52.22 110.859 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 50.79 44.1 48.27 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.657 -0.782 . . . . 73.32 112.533 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -147.89 119.0 7.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.849 0.357 . . . . 72.11 110.952 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 1.5 mtpt -53.1 136.39 35.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 73.24 110.877 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' MET . . . . . 0.412 ' HB2' ' HB ' ' A' ' 120' ' ' VAL . 67.7 mtp -102.78 165.19 11.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 64.21 110.87 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -113.31 107.1 15.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.215 -0.448 . . . . 74.43 110.878 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.709 ' HB ' HG22 ' A' ' 140' ' ' THR . 16.6 p -99.98 -175.15 2.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.49 . . . . 64.14 111.099 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -115.06 -29.49 6.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 64.3 111.109 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 52.41 32.4 37.69 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.724 -0.75 . . . . 51.35 112.482 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -55.14 108.96 0.46 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.831 0.348 . . . . 75.2 110.853 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -82.91 116.18 22.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.147 -0.478 . . . . 74.25 110.902 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 19.7 m -100.46 -178.35 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.21 -0.45 . . . . 63.24 111.183 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -53.13 -30.53 37.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 73.11 110.896 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -159.19 91.75 1.04 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.199 -0.455 . . . . 70.02 110.9 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 128.86 178.96 15.63 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.634 -0.793 . . . . 74.22 112.483 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.67 ' O ' ' HB3' ' A' ' 153' ' ' ALA . 0.1 OUTLIER -134.85 130.84 36.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.71 0.291 . . . . 62.4 111.144 -179.826 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -109.49 96.35 6.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 73.43 110.818 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.709 HG22 ' HB ' ' A' ' 129' ' ' THR . 0.0 OUTLIER -79.29 110.24 14.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.449 . . . . 72.41 111.116 -179.915 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -105.68 113.03 26.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.272 -0.422 . . . . 73.11 110.907 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.544 ' HD2' HG22 ' A' ' 129' ' ' THR . 3.2 p90 -133.92 178.99 6.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.177 -0.465 . . . . 74.21 110.883 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 90.7 p -140.39 162.62 34.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 72.41 110.874 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.598 HG11 HD22 ' A' ' 104' ' ' LEU . 39.7 t -146.55 99.48 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 72.02 111.146 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 68.41 -108.05 2.31 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.704 -0.76 . . . . 73.31 112.482 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -111.66 -26.35 9.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.781 0.324 . . . . 75.34 110.913 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 24.7 m-70 -65.9 -169.97 0.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.484 . . . . 75.13 110.794 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -149.79 119.51 7.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.135 -0.484 . . . . 61.34 110.885 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' CYS . . . . . 0.599 ' HB3' HG22 ' A' ' 169' ' ' VAL . 0.8 OUTLIER -142.41 161.53 37.8 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.252 -0.431 . . . . 71.35 110.9 -179.878 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 22.2 p90 -156.89 150.36 24.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.251 -0.431 . . . . 64.43 110.904 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.577 HD13 HD22 ' A' ' 113' ' ' LEU . 10.3 mt -97.61 112.83 30.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.089 -0.505 . . . . 73.31 111.156 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.611 ' HD2' HD12 ' A' ' 168' ' ' ILE . 0.2 OUTLIER -80.92 102.68 10.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.126 -0.488 . . . . 74.32 110.872 179.921 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.67 ' HB3' ' O ' ' A' ' 138' ' ' THR . . . -98.05 148.13 23.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.259 -0.428 . . . . 64.22 111.154 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.0 t -144.5 127.31 11.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.262 -0.427 . . . . 63.43 111.21 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.1 p -97.13 133.71 41.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 64.35 110.845 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -127.9 137.66 52.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.083 -0.508 . . . . 51.23 110.8 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 134.55 -174.17 21.13 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.738 -0.744 . . . . 60.12 112.489 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 5.7 mttm -86.66 -48.88 7.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.79 0.329 . . . . 73.25 110.914 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 44.4 mtm180 -134.77 69.18 1.45 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 71.31 110.84 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 26.1 mttp 58.32 60.36 2.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.226 -0.443 . . . . 73.52 110.889 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -77.81 -65.22 1.0 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 72.11 110.859 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -136.8 145.23 17.05 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.758 -0.734 . . . . 72.21 112.511 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 69.4 mt -126.5 143.45 39.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.807 0.337 . . . . 61.04 111.145 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 60.1 mt -128.44 132.93 67.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.143 -0.48 . . . . 75.22 111.131 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 13.5 m80 -106.91 141.11 38.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 52.22 110.873 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.6 106.36 7.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.225 -0.443 . . . . 74.41 111.124 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.537 HD21 HD22 ' A' ' 102' ' ' LEU . 17.1 tp -64.91 135.87 56.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 72.33 110.891 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.611 HD12 ' HD2' ' A' ' 152' ' ' LYS . 10.0 mt -138.1 117.38 14.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.061 -0.518 . . . . 64.33 111.193 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.599 HG22 ' HB3' ' A' ' 149' ' ' CYS . 20.2 t -119.45 127.02 75.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 72.52 111.149 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 2.9 t0 63.8 35.29 11.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.144 -0.48 . . . . 73.12 110.897 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 63.43 43.11 6.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.235 -0.439 . . . . 52.52 110.872 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 42.4 mtt180 -140.85 129.7 23.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.484 . . . . 73.2 110.831 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -62.77 146.47 52.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 73.3 110.848 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -123.04 130.86 24.43 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.581 0.705 . . . . 52.41 111.132 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.76 139.03 39.21 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.643 2.229 . . . . 71.03 112.369 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -88.57 153.41 21.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.199 -0.455 . . . . 73.43 110.899 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 26.4 tp -52.05 -73.45 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 61.44 110.932 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 21.5 p 48.92 49.88 18.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 54.04 111.099 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.453 . . . . 64.45 110.914 179.994 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 CA-C-O 121.42 0.455 . . . . 33.45 112.508 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 168.29 21.96 Favored 'Trans proline' 0 C--O 1.232 0.213 0 C-N-CA 122.728 2.285 . . . . 72.12 112.356 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -124.12 167.64 13.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.26 -0.427 . . . . 65.43 110.924 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -107.83 144.54 16.11 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.752 -0.737 . . . . 53.24 112.446 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 80.7 p -88.68 -178.38 5.78 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.912 0.387 . . . . 63.34 110.836 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -123.92 32.32 5.6 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.066 -0.515 . . . . 63.14 110.852 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -85.4 132.88 34.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 61.52 110.899 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 5.2 mtt180 -138.11 -60.95 0.62 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 74.3 110.843 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.2 t -150.18 -42.73 0.13 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.187 -0.46 . . . . 72.31 110.822 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.29 -174.91 0.14 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.177 -0.465 . . . . 70.42 110.902 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.502 ' O ' HG23 ' A' ' 97' ' ' THR . 13.4 t -139.04 16.33 2.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.253 -0.43 . . . . 74.52 111.13 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.502 HG23 ' O ' ' A' ' 96' ' ' THR . 1.1 p -159.35 128.1 5.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.27 -0.423 . . . . 72.34 111.181 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.4 m -105.92 149.61 26.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.455 . . . . 53.54 110.847 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 24.7 m -140.19 138.81 35.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.15 -0.477 . . . . 54.44 111.153 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 18.7 m-90 -131.68 133.51 44.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.242 -0.436 . . . . 71.04 110.951 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.2 t -112.88 114.78 47.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.451 . . . . 72.24 111.157 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.78 HD11 HD12 ' A' ' 104' ' ' LEU . 0.5 OUTLIER -141.2 146.48 36.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 73.24 110.9 -179.998 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.9 91.89 2.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 74.11 110.874 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.78 HD12 HD11 ' A' ' 102' ' ' LEU . 0.4 OUTLIER -123.09 152.97 40.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 70.42 110.915 -179.959 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 64.87 14.86 9.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.165 -0.47 . . . . 53.11 110.829 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 88.94 0.4 81.2 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.745 -0.74 . . . . 53.35 112.498 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -139.83 173.0 11.98 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.788 0.327 . . . . 75.24 110.89 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -68.98 87.45 0.37 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.138 -0.483 . . . . 64.13 110.886 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.624 HD13 ' HB3' ' A' ' 104' ' ' LEU . 0.5 OUTLIER -72.3 127.51 32.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 74.01 110.909 -179.896 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -107.6 117.35 33.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 75.44 110.916 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.429 HG21 ' CD2' ' A' ' 167' ' ' LEU . 0.1 OUTLIER -107.25 146.02 13.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 70.41 111.106 -179.982 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 22.0 t -135.92 152.69 31.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 62.14 111.182 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.504 HD22 HD13 ' A' ' 151' ' ' ILE . 5.1 tp -131.38 99.83 4.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 65.52 110.882 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.83 134.37 43.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 52.12 110.896 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 3.0 mmmt -73.78 -17.92 61.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 70.44 110.861 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -51.35 -55.1 20.28 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.216 -0.447 . . . . 75.15 110.83 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.86 16.72 4.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 74.45 111.156 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . 0.431 ' HA ' HD11 ' A' ' 113' ' ' LEU . 3.8 ttm 54.05 27.24 7.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.208 -0.451 . . . . 54.14 110.886 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.83 160.51 22.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.184 -0.462 . . . . 73.13 110.835 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.714 HG22 HD12 ' A' ' 151' ' ' ILE . 55.5 t -104.64 143.58 15.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 74.4 111.125 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 2.3 t90 -123.75 120.89 34.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.185 -0.461 . . . . 74.52 110.924 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . 0.482 ' SG ' HD21 ' A' ' 109' ' ' LEU . 19.6 t -136.55 132.55 35.35 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.276 -0.42 . . . . 72.24 110.905 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 51.92 48.33 22.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.157 -0.474 . . . . 41.34 110.884 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 48.62 47.21 30.1 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.733 -0.746 . . . . 71.31 112.474 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.6 118.76 5.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.838 0.351 . . . . 75.33 110.932 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.24 101.95 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.212 -0.449 . . . . 55.24 110.88 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' MET . . . . . 0.59 ' HE1' HG22 ' A' ' 144' ' ' VAL . 38.5 mmm -55.68 176.65 0.06 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 73.34 110.843 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -119.16 106.51 12.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 72.34 110.914 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.576 ' HB ' HG22 ' A' ' 140' ' ' THR . 59.4 p -99.14 -175.3 2.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 52.15 111.151 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.512 ' HB2' ' HB2' ' A' ' 141' ' ' HIS . . . -106.55 -44.64 4.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 72.22 111.126 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 77.04 53.07 5.42 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.825 -0.702 . . . . 73.31 112.456 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -97.08 115.02 26.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.86 0.362 . . . . 65.1 110.846 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -90.95 126.62 36.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 75.53 110.995 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.495 HG22 ' O ' ' A' ' 137' ' ' GLY . 29.2 m -111.53 -178.29 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.178 -0.464 . . . . 71.11 111.123 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -52.71 -36.35 57.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 61.22 110.872 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -152.78 102.46 2.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 75.34 110.871 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.495 ' O ' HG22 ' A' ' 134' ' ' VAL . . . 111.53 178.47 20.2 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.693 -0.765 . . . . 62.44 112.499 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.04 130.79 36.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.688 0.28 . . . . 72.23 111.218 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -98.89 100.23 11.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.271 -0.422 . . . . 73.35 110.955 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.576 HG22 ' HB ' ' A' ' 129' ' ' THR . 0.0 OUTLIER -82.98 110.24 17.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.46 . . . . 74.01 111.193 -179.93 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . 0.512 ' HB2' ' HB2' ' A' ' 130' ' ' ALA . 63.7 m-70 -100.77 105.78 17.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.257 -0.429 . . . . 75.31 110.814 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.608 ' CE2' HG21 ' A' ' 120' ' ' VAL . 21.9 p90 -139.29 156.54 46.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.245 -0.434 . . . . 75.1 110.849 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -111.64 123.73 50.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.086 -0.506 . . . . 74.42 110.917 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.59 HG22 ' HE1' ' A' ' 127' ' ' MET . 27.2 t -106.15 125.89 61.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.114 -0.494 . . . . 52.41 111.082 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 52.36 41.3 54.84 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.727 -0.749 . . . . 65.32 112.478 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 64.33 26.02 13.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.799 0.333 . . . . 74.51 110.837 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . 0.591 ' HD2' HD21 ' A' ' 104' ' ' LEU . 25.7 m-70 -113.12 -169.27 1.45 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 73.55 110.832 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -116.48 110.63 18.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 62.33 110.898 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' CYS . . . . . 0.516 ' SG ' HG13 ' A' ' 169' ' ' VAL . 12.1 m -138.38 173.47 11.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 74.01 110.923 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 32.0 p90 -174.97 143.44 0.71 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.199 -0.455 . . . . 75.21 110.953 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.714 HD12 HG22 ' A' ' 120' ' ' VAL . 20.6 mt -97.73 113.63 32.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.076 -0.511 . . . . 61.11 111.094 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 27.9 tttt -79.84 102.74 9.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 72.34 110.914 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -97.19 136.02 38.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 64.41 111.075 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.3 t -133.91 121.14 38.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.23 -0.441 . . . . 74.05 111.185 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.3 p -94.53 143.1 26.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.145 -0.48 . . . . 74.25 110.833 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 2.3 t -136.52 134.14 37.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.091 -0.504 . . . . 73.55 110.89 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 136.12 171.92 12.46 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.728 -0.749 . . . . 71.13 112.493 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 6.5 mmtt -59.06 -28.64 66.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.764 0.316 . . . . 65.53 110.884 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 2.1 mtt180 -148.82 -63.43 0.24 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 72.41 110.872 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -152.75 44.39 0.67 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 75.51 110.84 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -57.68 -58.55 7.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.313 -0.403 . . . . 65.44 110.866 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -145.1 162.27 28.14 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.725 -0.75 . . . . 64.13 112.5 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 55.4 mt -144.85 145.45 21.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.786 0.327 . . . . 73.52 111.144 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 75.6 mt -133.82 123.68 45.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.466 . . . . 75.05 111.186 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 5.6 m80 -104.38 137.19 42.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 71.25 110.932 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.91 108.8 11.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 53.23 111.2 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.492 HD12 ' N ' ' A' ' 168' ' ' ILE . 14.8 tp -66.33 136.36 55.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.277 -0.419 . . . . 62.12 110.904 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.492 ' N ' HD12 ' A' ' 167' ' ' LEU . 12.4 mt -133.62 129.41 55.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.146 -0.479 . . . . 72.22 111.17 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.516 HG13 ' SG ' ' A' ' 149' ' ' CYS . 95.6 t -127.17 118.17 49.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.446 . . . . 74.34 111.149 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 63.61 41.0 7.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.134 -0.485 . . . . 72.33 110.853 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 63.34 43.01 6.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 73.43 110.812 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 17.7 mtm180 -138.98 121.97 16.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.216 -0.447 . . . . 74.44 110.922 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -62.75 146.48 52.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 52.4 110.913 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.582 HD12 HD22 ' A' ' 102' ' ' LEU . 0.9 OUTLIER -123.99 131.55 24.24 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.619 0.723 . . . . 63.24 111.117 179.996 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 133.44 25.49 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.625 2.217 . . . . 74.43 112.34 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.22 163.52 14.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.246 -0.433 . . . . 72.5 110.924 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 22.0 tp -52.35 -73.93 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 71.02 110.952 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 1.3 p 46.61 78.14 0.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 62.13 111.155 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.273 -0.421 . . . . 74.34 110.882 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.286 0 CA-C-O 121.411 0.451 . . . . 75.1 112.557 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.69 -171.97 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.689 2.259 . . . . 72.24 112.326 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -126.32 132.55 51.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.122 -0.49 . . . . 70.42 110.876 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -129.26 97.46 0.41 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.706 -0.759 . . . . 62.3 112.418 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 77.3 p -141.14 76.61 1.56 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.805 0.336 . . . . 52.51 110.802 -179.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -130.58 131.29 44.91 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.137 -0.483 . . . . 61.01 110.88 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -132.83 151.72 51.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.121 -0.49 . . . . 73.23 110.919 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.61 160.53 22.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 71.54 110.924 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 58.0 m -73.22 112.49 9.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.239 -0.437 . . . . 72.32 110.882 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -146.26 111.03 5.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.069 -0.514 . . . . 64.11 110.872 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.494 ' O ' HG23 ' A' ' 97' ' ' THR . 71.8 p -94.56 47.1 1.16 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.456 . . . . 64.51 111.209 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.661 HG22 ' HA ' ' A' ' 114' ' ' GLU . 1.0 OUTLIER -159.53 127.77 4.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.187 -0.46 . . . . 71.12 111.151 -179.968 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 14.5 m -106.42 113.16 26.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.263 -0.426 . . . . 72.11 110.842 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.982 HG22 HG22 ' A' ' 112' ' ' VAL . 17.2 p -110.18 159.59 17.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.121 -0.491 . . . . 73.23 111.064 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 14.6 m-90 -149.57 155.97 41.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.223 -0.444 . . . . 72.45 110.911 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 18.9 t -131.52 114.95 26.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 73.33 111.158 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.887 HD11 HD12 ' A' ' 104' ' ' LEU . 0.5 OUTLIER -141.22 147.63 38.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 73.32 110.884 179.985 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.65 94.29 3.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.155 -0.475 . . . . 71.14 110.834 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.887 HD12 HD11 ' A' ' 102' ' ' LEU . 0.3 OUTLIER -123.68 154.05 39.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 71.3 110.908 179.985 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.1 t70 64.91 14.87 9.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.19 -0.459 . . . . 74.52 110.833 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 88.79 0.48 81.43 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.714 -0.755 . . . . 62.11 112.489 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -139.79 172.88 12.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.88 0.372 . . . . 60.31 110.855 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -68.43 89.4 0.35 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 71.31 110.907 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.621 HD13 ' HB3' ' A' ' 104' ' ' LEU . 0.5 OUTLIER -75.72 123.99 26.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.437 . . . . 74.24 110.96 -179.999 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -104.09 115.04 29.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 71.52 110.87 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.465 HG21 HD21 ' A' ' 167' ' ' LEU . 0.2 OUTLIER -102.98 138.89 25.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.183 -0.462 . . . . 73.22 111.184 179.906 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.982 HG22 HG22 ' A' ' 99' ' ' THR . 96.3 t -135.77 126.99 44.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.434 . . . . 72.41 111.169 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.629 HD22 HD13 ' A' ' 151' ' ' ILE . 6.3 tp -110.36 100.4 9.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.444 . . . . 72.23 110.959 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.661 ' HA ' HG22 ' A' ' 97' ' ' THR . 0.0 OUTLIER -77.4 136.15 38.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.447 . . . . 62.55 110.921 179.962 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 3.6 mtmt -73.21 -17.48 61.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 62.4 110.834 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -51.39 -54.91 21.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.222 -0.445 . . . . 74.14 110.871 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 14.9 p -132.55 16.82 4.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.176 -0.465 . . . . 62.11 111.12 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 81.2 mtp 51.59 31.1 7.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 74.21 110.895 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -86.57 153.27 21.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 71.3 110.875 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.6 HG22 HD12 ' A' ' 151' ' ' ILE . 95.6 t -104.92 123.09 58.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.233 -0.439 . . . . 64.11 111.18 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -104.94 131.97 51.77 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.232 -0.44 . . . . 64.43 110.91 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . 0.4 ' SG ' HD21 ' A' ' 109' ' ' LEU . 24.4 t -126.99 103.19 7.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 73.34 110.931 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 12.0 m-20 45.35 70.28 0.37 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 53.33 110.885 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 48.72 39.01 23.34 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.78 -0.724 . . . . 61.24 112.504 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.25 107.42 4.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.893 0.377 . . . . 72.04 110.88 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.28 143.27 18.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 73.52 110.89 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' MET . . . . . 0.457 ' CE ' HG22 ' A' ' 144' ' ' VAL . 22.7 mmm -111.24 163.99 13.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 52.4 110.866 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -117.79 107.8 14.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 75.14 110.876 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.694 ' HB ' HG22 ' A' ' 140' ' ' THR . 19.2 p -95.26 -179.36 4.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.144 -0.48 . . . . 71.1 111.177 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.459 ' HB2' ' HB2' ' A' ' 141' ' ' HIS . . . -92.41 -31.26 15.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 71.25 111.114 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 58.82 54.69 35.88 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.791 -0.718 . . . . 72.0 112.458 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -97.14 103.28 15.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.915 0.388 . . . . 74.25 110.957 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -84.61 116.21 23.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.176 -0.465 . . . . 73.02 110.904 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.451 HG22 ' O ' ' A' ' 137' ' ' GLY . 20.4 m -97.94 -178.0 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.111 -0.495 . . . . 71.34 111.153 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.58 -27.73 67.93 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.138 -0.483 . . . . 71.54 110.84 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -155.53 102.46 2.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.251 -0.432 . . . . 72.41 110.834 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.451 ' O ' HG22 ' A' ' 134' ' ' VAL . . . 110.92 174.98 20.28 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.743 -0.742 . . . . 33.01 112.498 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.21 130.8 35.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.686 0.279 . . . . 71.12 111.21 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -109.82 97.44 6.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.302 -0.408 . . . . 63.12 110.865 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.694 HG22 ' HB ' ' A' ' 129' ' ' THR . 0.0 OUTLIER -85.51 110.44 19.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 72.22 111.142 -179.943 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . 0.459 ' HB2' ' HB2' ' A' ' 130' ' ' ALA . 67.5 m-70 -106.15 105.6 15.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 73.52 110.837 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.408 ' HB3' HG22 ' A' ' 129' ' ' THR . 18.8 p90 -122.97 131.07 53.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 70.51 110.808 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 27.8 p -83.07 149.79 26.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 74.0 110.857 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.457 HG22 ' CE ' ' A' ' 127' ' ' MET . 21.8 t -140.65 99.65 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.051 -0.522 . . . . 52.52 111.066 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 54.58 -115.88 5.88 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.726 -0.749 . . . . 61.5 112.479 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -106.04 25.41 10.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.81 0.338 . . . . 72.22 110.884 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 67.4 m-70 -119.2 -175.48 2.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 72.44 110.824 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -145.33 84.42 1.7 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 61.0 110.872 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' CYS . . . . . 0.448 ' SG ' HG13 ' A' ' 169' ' ' VAL . 6.8 m -99.53 165.08 11.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.231 -0.441 . . . . 74.15 110.897 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 19.9 p90 -167.48 145.04 4.56 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.175 -0.466 . . . . 75.02 110.89 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.629 HD13 HD22 ' A' ' 113' ' ' LEU . 32.9 mt -98.63 111.26 27.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.134 -0.485 . . . . 72.12 111.155 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.33 103.14 12.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.122 -0.49 . . . . 63.54 110.902 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -94.27 146.08 24.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 71.32 111.157 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.5 t -138.41 124.79 25.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.289 -0.414 . . . . 74.3 111.126 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -99.86 146.87 26.14 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.184 -0.462 . . . . 73.53 110.878 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 1.4 p -149.29 150.6 32.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 64.01 110.826 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 109.1 64.56 0.55 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.778 -0.725 . . . . 72.42 112.507 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.19 -75.44 0.07 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.794 0.33 . . . . 73.21 110.876 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -138.72 -58.97 0.62 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 65.44 110.962 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 2.9 tttt -135.39 103.07 5.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.116 -0.493 . . . . 72.54 110.98 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -144.87 -62.8 0.36 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 61.11 110.852 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -135.16 127.38 4.35 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.765 -0.731 . . . . 64.14 112.459 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 69.1 mt -122.99 138.57 52.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.763 0.316 . . . . 62.41 111.185 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 54.9 mt -127.53 128.92 70.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.178 -0.464 . . . . 72.25 111.088 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 15.3 m80 -100.22 137.98 37.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 73.44 110.914 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.88 109.3 11.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 74.35 111.107 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.574 HD12 ' H ' ' A' ' 168' ' ' ILE . 19.1 tp -67.3 138.46 56.85 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.152 -0.477 . . . . 75.44 110.893 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.574 ' H ' HD12 ' A' ' 167' ' ' LEU . 8.6 mt -139.01 128.59 30.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 74.05 111.114 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.633 HG21 HD13 ' A' ' 102' ' ' LEU . 64.1 t -127.81 122.73 59.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.109 -0.496 . . . . 74.41 111.15 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 2.4 t0 63.77 38.24 9.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.204 -0.453 . . . . 72.21 110.867 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 2.0 t30 63.32 43.11 6.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 61.42 110.842 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.14 131.61 23.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 74.21 110.879 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -62.34 146.4 51.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.218 -0.446 . . . . 75.24 110.954 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.473 HD12 HD22 ' A' ' 102' ' ' LEU . 0.8 OUTLIER -123.72 130.52 24.43 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.646 0.736 . . . . 73.13 111.137 179.998 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 147.83 63.53 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.713 2.275 . . . . 73.43 112.324 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -89.83 -175.66 4.69 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.245 -0.434 . . . . 75.42 110.91 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 17.4 tp -76.82 109.09 10.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 62.22 110.915 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 53.3 p -135.3 -45.12 0.7 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 74.41 111.134 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 63.34 110.953 179.964 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.362 0 CA-C-O 121.425 0.458 . . . . 65.24 112.486 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 154.75 67.36 Favored 'Trans proline' 0 C--O 1.233 0.238 0 C-N-CA 122.666 2.244 . . . . 71.21 112.318 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.2 mt -144.9 148.05 33.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 53.33 110.922 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 99.2 -137.7 13.41 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.781 -0.723 . . . . 35.04 112.483 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.5 m -85.47 163.39 18.48 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.827 0.346 . . . . 73.34 110.856 -179.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -118.76 41.57 2.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 73.23 110.918 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 57.0 -172.06 0.08 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.117 -0.492 . . . . 64.15 110.864 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.78 -37.44 24.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 74.13 110.9 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 61.88 94.6 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.157 -0.474 . . . . 64.31 110.906 -179.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 14.0 pttp -174.03 -171.29 0.62 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 73.41 110.935 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.511 ' O ' HG23 ' A' ' 97' ' ' THR . 2.4 m 72.57 -68.62 0.22 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 55.03 111.115 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.511 HG23 ' O ' ' A' ' 96' ' ' THR . 1.0 OUTLIER -159.8 128.15 4.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 53.54 111.138 -179.998 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.9 m -106.04 151.99 23.95 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.209 -0.451 . . . . 45.21 110.826 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 95.7 m -146.34 141.81 27.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.111 -0.495 . . . . 52.12 111.145 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 21.7 m-90 -132.35 158.8 41.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 75.25 110.968 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.0 t -133.26 114.82 21.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.342 -0.39 . . . . 63.51 111.144 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.952 HD11 HD12 ' A' ' 104' ' ' LEU . 0.5 OUTLIER -141.64 147.58 37.79 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.226 -0.443 . . . . 64.14 110.919 179.975 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 42.3 mtp180 -72.72 92.09 1.53 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 75.43 110.858 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.952 HD12 HD11 ' A' ' 102' ' ' LEU . 0.3 OUTLIER -121.61 151.52 40.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 72.12 110.904 -179.944 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 64.85 14.69 9.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.232 -0.44 . . . . 62.23 110.884 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.2 0.69 80.03 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.752 -0.737 . . . . 62.53 112.489 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -139.87 172.73 12.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.867 0.365 . . . . 74.42 110.942 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -68.24 89.88 0.33 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.162 -0.472 . . . . 63.34 110.865 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.596 HD13 ' HB3' ' A' ' 104' ' ' LEU . 0.6 OUTLIER -76.96 134.14 38.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 71.25 110.912 -179.981 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 25.9 ttm180 -111.11 119.51 39.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 64.45 110.877 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.447 HG21 ' CD2' ' A' ' 167' ' ' LEU . 0.1 OUTLIER -105.41 145.13 13.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.2 -0.455 . . . . 73.5 111.167 179.956 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 91.4 t -134.37 144.24 35.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.249 -0.432 . . . . 61.42 111.135 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.496 HD11 ' HA ' ' A' ' 118' ' ' MET . 3.4 tp -131.52 101.53 5.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 75.21 110.929 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.478 ' HG3' HG22 ' A' ' 97' ' ' THR . 0.0 OUTLIER -73.63 132.11 42.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.27 -0.423 . . . . 72.45 110.881 179.942 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.35 -16.58 61.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 70.52 110.93 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -52.59 -55.96 18.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 74.3 110.829 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.56 16.99 3.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 74.2 111.116 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . 0.496 ' HA ' HD11 ' A' ' 113' ' ' LEU . 68.1 mtp 57.91 30.23 18.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.445 . . . . 62.35 110.884 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -77.83 143.07 38.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.455 . . . . 72.15 110.902 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.432 HG23 HG21 ' A' ' 129' ' ' THR . 17.2 t -104.62 128.06 58.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 74.51 111.209 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 3.2 t90 -119.97 114.39 21.96 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.23 -0.441 . . . . 73.11 110.894 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . 0.538 ' SG ' HD11 ' A' ' 109' ' ' LEU . 3.0 t -100.97 103.09 14.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.25 -0.432 . . . . 73.35 110.892 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 67.91 -76.16 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 60.31 110.926 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -159.08 45.77 0.44 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.739 -0.744 . . . . 60.43 112.462 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.86 114.2 4.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.893 0.378 . . . . 74.22 110.868 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.3 101.94 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.459 . . . . 72.0 110.879 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' MET . . . . . 0.443 ' HE2' ' CG ' ' A' ' 142' ' ' PHE . 64.1 mtp -60.85 157.32 15.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 61.42 110.9 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -102.9 106.65 17.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 72.41 110.868 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.803 ' HB ' HG22 ' A' ' 140' ' ' THR . 15.5 p -98.66 -176.28 3.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 45.2 111.111 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -112.89 -75.36 0.6 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.275 -0.42 . . . . 55.03 111.094 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 104.68 86.15 1.9 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.727 -0.749 . . . . 73.04 112.511 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -148.17 132.54 17.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.869 0.366 . . . . 73.34 110.914 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -69.84 151.7 45.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 70.11 110.92 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.561 HG11 ' HG3' ' A' ' 139' ' ' GLU . 16.4 m -136.98 -176.42 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 71.4 111.182 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -55.88 -24.05 34.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 75.13 110.891 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.471 ' H ' HG23 ' A' ' 134' ' ' VAL . 0.1 OUTLIER -107.95 -77.2 0.6 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 53.45 110.865 179.988 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -129.99 -102.68 1.0 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.8 -0.714 . . . . 54.01 112.539 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.32 130.87 33.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.76 0.314 . . . . 71.2 111.145 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.561 ' HG3' HG11 ' A' ' 134' ' ' VAL . 0.4 OUTLIER -90.73 97.68 11.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 73.53 110.881 -179.967 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.803 HG22 ' HB ' ' A' ' 129' ' ' THR . 0.1 OUTLIER -77.46 110.55 12.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.114 -0.494 . . . . 74.14 111.112 -179.878 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -98.91 111.63 23.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.267 -0.424 . . . . 63.02 110.869 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.764 ' CE2' HD12 ' A' ' 151' ' ' ILE . 1.4 p90 -144.8 159.55 42.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.454 . . . . 63.24 110.903 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.8 166.5 14.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 54.51 110.895 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 24.2 t -145.54 97.97 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.159 -0.473 . . . . 73.55 111.084 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 67.22 -88.98 0.16 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.738 -0.744 . . . . 61.02 112.478 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -139.5 25.9 2.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.828 0.347 . . . . 61.34 110.86 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 67.1 m-70 -115.77 -175.77 2.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 73.0 110.899 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -140.89 116.56 10.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.26 -0.427 . . . . 71.24 110.893 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' CYS . . . . . 0.708 ' CB ' HG22 ' A' ' 169' ' ' VAL . 1.9 p -142.56 158.19 43.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 70.25 110.959 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 19.9 p90 -150.84 145.34 25.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.227 -0.442 . . . . 72.43 110.926 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.764 HD12 ' CE2' ' A' ' 142' ' ' PHE . 3.2 mt -97.74 112.46 29.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.095 -0.502 . . . . 73.2 111.174 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.69 102.88 9.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 74.4 110.93 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -99.02 143.85 28.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.229 -0.441 . . . . 53.13 111.098 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 20.9 t -142.33 124.43 13.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 71.14 111.149 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.3 p -94.38 140.43 29.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.455 . . . . 73.31 110.821 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 10.4 t -134.47 135.7 42.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.068 -0.515 . . . . 62.02 110.886 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 135.78 -145.65 17.65 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.709 -0.757 . . . . 74.45 112.447 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -88.79 -36.4 16.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.819 0.342 . . . . 45.43 110.858 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 1.7 mtm-85 -152.35 -47.5 0.1 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.284 -0.416 . . . . 55.41 110.831 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 7.7 pttp -159.55 37.82 0.2 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.165 -0.471 . . . . 70.4 110.931 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -59.08 -70.6 0.15 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.236 -0.438 . . . . 74.13 110.896 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -129.58 128.23 5.66 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.76 -0.733 . . . . 74.43 112.485 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 48.6 mt -120.44 147.46 24.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.816 0.341 . . . . 64.34 111.122 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 3.0 mt -131.96 130.23 61.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 64.23 111.074 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 8.7 m80 -108.71 134.96 50.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 74.25 110.917 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.28 110.14 13.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.188 -0.46 . . . . 52.24 111.156 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.587 HD12 ' N ' ' A' ' 168' ' ' ILE . 11.8 tp -66.96 135.38 53.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.212 -0.449 . . . . 70.04 110.951 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.587 ' N ' HD12 ' A' ' 167' ' ' LEU . 10.8 mt -136.81 106.19 4.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 74.11 111.206 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.708 HG22 ' CB ' ' A' ' 149' ' ' CYS . 47.7 t -109.39 128.94 64.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 74.31 111.142 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 63.31 41.28 7.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.194 -0.457 . . . . 74.12 110.816 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 56.6 42.68 26.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.237 -0.438 . . . . 72.32 110.87 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 10.5 mtp180 -140.44 126.44 19.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 75.31 110.836 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.58 145.29 54.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 74.41 110.885 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.446 HD12 HD22 ' A' ' 102' ' ' LEU . 0.9 OUTLIER -123.61 131.29 24.28 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.663 0.744 . . . . 65.34 111.125 179.964 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 132.25 22.99 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.755 2.303 . . . . 73.5 112.336 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -92.52 164.01 13.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.245 -0.434 . . . . 73.1 110.85 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -81.33 99.58 8.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 70.21 110.927 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 22.9 p -117.59 34.11 5.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 74.44 111.144 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 61.44 110.912 179.984 . . . . . . . . 0 0 . 1 stop_ save_